Citrus Sinensis ID: 001710
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1022 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.930 | 0.941 | 0.379 | 1e-179 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.924 | 0.916 | 0.359 | 1e-163 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.928 | 0.925 | 0.358 | 1e-147 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.954 | 0.832 | 0.336 | 1e-147 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.909 | 0.744 | 0.343 | 1e-140 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.901 | 0.735 | 0.327 | 1e-133 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.809 | 0.843 | 0.367 | 1e-132 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.957 | 0.870 | 0.322 | 1e-129 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.972 | 0.896 | 0.318 | 1e-127 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.934 | 0.866 | 0.331 | 1e-126 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 394/1038 (37%), Positives = 579/1038 (55%), Gaps = 87/1038 (8%)
Query: 10 TDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIP 69
TD+ ALL FK+ V + + V+ ++W+ S+P+CNW G++CG ++ RV L
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHL------------ 71
Query: 70 PHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQIL 129
ELG+L +L G IG LS L L
Sbjct: 72 -------------------------ELGRL-----------QLGGVISPSIGNLSFLVSL 95
Query: 130 SFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIP 188
+ N F IP + LS+LE+LD+ N L G +P + +L L L SN G +P
Sbjct: 96 DLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVP 155
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
S L T+L L L N G+LP ++GNL+ L L L+ NNL+G++P+ + L + L
Sbjct: 156 SELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSL 215
Query: 249 NLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI 308
L NN SG PP ++N+S+++L+ + N SG L LG LPNL + GN G+I
Sbjct: 216 QLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSI 275
Query: 309 PNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSL 368
P +++N S L L ++ N +G IP TFGN+ L+ L L NSL ++SS FL+SL
Sbjct: 276 PTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSS--RDLEFLTSL 332
Query: 369 TNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKL 428
TNC L L + N L G LP I N SA L + + GSIP +IGNL L L L
Sbjct: 333 TNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLIL 392
Query: 429 DDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPAC 488
D N L+G +PT++G+ L+ LSL+ N L G IP ++ ++ L L L+ N G +P
Sbjct: 393 DQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTS 452
Query: 489 LGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDL 548
LG+ + L EL +G N L +IP + ++ +L +++S NSL G LP I L+ L L L
Sbjct: 453 LGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSL 512
Query: 549 SRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKS 608
N+LSG +P T+ + +L L GN F G IP+ G L+ ++ +D+S+N++SG IP+
Sbjct: 513 GDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEY 571
Query: 609 LEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPR-LQVPPCKEDKGKG 667
+ L+ LN+S+N LEG++P+KG F N + S GN LCG Q+ PC
Sbjct: 572 FASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSV 631
Query: 668 SKKAPFAL-KFILPLIISIVLIAIVIMFFI-------RRQNGNTKVPVKEDVLSLATWRR 719
KK L K ++ + + I L+ ++ M + R++N T P + L +
Sbjct: 632 VKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLH--EK 689
Query: 720 TSYLDIQRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECE 778
SY D++ AT+GF+ N++G GSFG VYK L + VA+KV N+Q A ++F +ECE
Sbjct: 690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749
Query: 779 ILRNVRHRNLVKIFSSCCNID-----FKALVLEFMPNGSFEKWLYSY--------NYFLD 825
L+++RHRNLVK+ ++C +ID F+AL+ EFMPNGS + WL+ + L
Sbjct: 750 SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809
Query: 826 ILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885
+L+RLNI IDVA VL+YLH H PI HCDLKP+N+LLD+++TAHVSDFG+++LL + D
Sbjct: 810 LLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFD 868
Query: 886 D-----SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
+ ++ TIGY APEYG G S DVYS+G+LL+E FT K+PT+E+F G
Sbjct: 869 EESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGN 928
Query: 941 MSLRRWVKESLPHGLTEVVDANL--VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM 998
+L + K +LP + ++VD ++ +G F +CL + ++ L CC ESP R+
Sbjct: 929 FTLNSYTKSALPERILDIVDESILHIGLRVGFPV-VECLTMVFEVGLRCCEESPMNRLAT 987
Query: 999 TDAAAELKKIRVKFLQQS 1016
+ EL IR +F + S
Sbjct: 988 SIVVKELISIRERFFKAS 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1489), Expect = e-163, Method: Compositional matrix adjust.
Identities = 374/1041 (35%), Positives = 558/1041 (53%), Gaps = 96/1041 (9%)
Query: 10 TDQSALLAFKADVIDS--RSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGI 67
TD ALL FK+ V ++ R VLA+ W+ S P CNW+G++CG R RV++LN LGG
Sbjct: 30 TDMQALLEFKSQVSENNKREVLAS-WNHSSPFCNWIGVTCGRRRERVISLN-----LGGF 83
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
+L+G IG LS L+
Sbjct: 84 -------------------------------------------KLTGVISPSIGNLSFLR 100
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQ 186
+L+ +NSF IP + L +L++L++ N L G +P+ + +L + L SN
Sbjct: 101 LLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHG 160
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
+PS L + L L L+ N +G P ++GNL+ L L+ A N ++G++P + L +
Sbjct: 161 VPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMV 220
Query: 247 HLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIG 306
+ +N+ SG PP ++NIS++ ++L +N SG+L G+ LPNL L L N G
Sbjct: 221 FFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTG 280
Query: 307 TIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLS 366
IP ++ N S L D+SSN SG IP +FG LR L +L + NSL SS + F+
Sbjct: 281 AIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE--FIG 338
Query: 367 SLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFL 426
++ NC L L + N L G LP I N S +L + + G+IP +IGNL L L
Sbjct: 339 AVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQEL 398
Query: 427 KLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIP 486
L+ N L+G +P + G+ LQ + LY N + G IP Y ++ RL +L LN N+ G IP
Sbjct: 399 SLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIP 458
Query: 487 ACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINL 546
LG L +L + +N L +IP + + + Y++LS+N L+G P + L++L+ L
Sbjct: 459 QSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGL 518
Query: 547 DLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIP 606
S N+LSG +P I G + L + GN F+G IP+ L+SL+++D S+NN+SG+IP
Sbjct: 519 GASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIP 577
Query: 607 KSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPR-LQVPPC----- 660
+ L +L L+ LN+S N+ EG +P G FRN +A S GN +CG R +Q+ PC
Sbjct: 578 RYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQAS 637
Query: 661 --KEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATW- 717
K KK + + ++ I+++A + F R++ N D +L +
Sbjct: 638 PRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFH 697
Query: 718 RRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSE 776
+ SY ++ AT F+ NL+G G+FG V+KG L + VA+KV NL A ++F +E
Sbjct: 698 EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAE 757
Query: 777 CEILRNVRHRNLVKIFSSCCNI-----DFKALVLEFMPNGSFEKWLY--------SYNYF 823
CE + +RHRNLVK+ + C ++ DF+ALV EFMP GS + WL ++
Sbjct: 758 CETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRS 817
Query: 824 LDILQRLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882
L ++LNI IDVA LEYLH H H P+ HCD+KP+NILLD+++TAHVSDFG+++LL
Sbjct: 818 LTPAEKLNIAIDVASALEYLHVHCHD--PVAHCDIKPSNILLDDDLTAHVSDFGLAQLLY 875
Query: 883 EGD-----DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF 937
+ D + + TIGY APEYG G S + DVYS+G+LL+E F+ KKPTDE F
Sbjct: 876 KYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESF 935
Query: 938 TGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997
G+ +L + K S+ G T +N + E L ++ + + C E P R+
Sbjct: 936 AGDYNLHSYTK-SILSGCTSSGGSNAIDEG---------LRLVLQVGIKCSEEYPRDRMR 985
Query: 998 MTDAAAELKKIRVKFLQQSSV 1018
+A EL IR KF +
Sbjct: 986 TDEAVRELISIRSKFFSSKTT 1006
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1351), Expect = e-147, Method: Compositional matrix adjust.
Identities = 372/1039 (35%), Positives = 549/1039 (52%), Gaps = 90/1039 (8%)
Query: 10 TDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIP 69
TD+ ALL FK+ V ++ V+ +W+ S P+C+W G+ CG +H RV ++ LGG+
Sbjct: 39 TDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVD-----LGGL-- 91
Query: 70 PHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQIL 129
+L+G ++G LS L+ L
Sbjct: 92 -----------------------------------------KLTGVVSPFVGNLSFLRSL 110
Query: 130 SFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQ-IP 188
+ +N F IP + NL +L++L++ N G +P + S++ Q +P
Sbjct: 111 NLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVP 170
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
+ L L L N +G+ P ++GNL+ L L+ N ++G++P I L+ +
Sbjct: 171 LEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFF 230
Query: 249 NLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI 308
+ +N +G PP I+N+S++ +++ N SG L G LPNL+ L + N+ GTI
Sbjct: 231 RIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTI 290
Query: 309 PNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSL 368
P +++N S L LD+ SN +G IP +FG L+ L L L NSL SS FL +L
Sbjct: 291 PETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSS--GDLDFLGAL 348
Query: 369 TNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKL 428
TNC L L + N L G LP FI N S L + + GSIP IGNL L L L
Sbjct: 349 TNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDL 408
Query: 429 DDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPAC 488
+N L G +P ++G +L+ + LY N L G IP L ++ L+ L L N+ G+IP+
Sbjct: 409 GENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSS 468
Query: 489 LGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDL 548
LGS + L +L+LG+N L SIP L L ++ +N+S N L GPL I LK L+ LD+
Sbjct: 469 LGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDV 528
Query: 549 SRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKS 608
S N+LSG IP T++ L L L GN F GPIP+ G L L LD+S NN+SG IP+
Sbjct: 529 SYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEY 587
Query: 609 LEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGP-PRLQVPPCKEDKGKG 667
+ L+ LN+S N +G +P +G FRN SA S GN LCG P LQ+ PC + +
Sbjct: 588 MANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRR 647
Query: 668 SKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVK-------EDVLSLAT---- 716
+++ I+ + +S V+ A++++ K+ VK E+ S +
Sbjct: 648 HS----SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSF 703
Query: 717 WRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTN-VAIKVFNLQLERAFRTFDS 775
+ + SY ++ + T GF+ NL+G G+FG V+KG L VAIKV NL A ++F +
Sbjct: 704 YEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIA 763
Query: 776 ECEILRNVRHRNLVKIFSSCCNI-----DFKALVLEFMPNGSFEKWLY--------SYNY 822
ECE L +RHRNLVK+ + C + DF+ALV EFMPNG+ + WL+ + +
Sbjct: 764 ECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSR 823
Query: 823 FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882
L + RLNI IDVA L YLH + PI HCD+KP+NILLD+++TAHVSDFG+++LL
Sbjct: 824 TLGLFARLNIAIDVASALVYLHT-YCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLL 882
Query: 883 EGDDSV-----TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF 937
+ D + TIGY APEYG G S DVYS+G++L+E FT K+PT+++F
Sbjct: 883 KFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLF 942
Query: 938 TGEMSLRRWVKESLP--HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
++L + K +L L + L G +CL + + + C ESP R
Sbjct: 943 VDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNR 1002
Query: 996 IHMTDAAAELKKIRVKFLQ 1014
I M +A ++L IR F +
Sbjct: 1003 ISMAEAISKLVSIRESFFR 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1346), Expect = e-147, Method: Compositional matrix adjust.
Identities = 387/1149 (33%), Positives = 574/1149 (49%), Gaps = 173/1149 (15%)
Query: 14 ALLAFKADVIDSRSVLANNWSI--SYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPH 71
AL +FK + + + ++W+I S CNW GI+C + H VV+++L L G++ P
Sbjct: 33 ALKSFKNGISNDPLGVLSDWTIIGSLRHCNWTGITCDSTGH-VVSVSLLEKQLEGVLSPA 91
Query: 72 LGNLSFLVSLDISENNFYGHLPNELGKLRRLR---------------------------- 103
+ NL++L LD++ N+F G +P E+GKL L
Sbjct: 92 IANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLDL 151
Query: 104 --------------------LINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDF 143
LI F YN L+G P +G L LQ+ N T IP
Sbjct: 152 RNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVS 211
Query: 144 LLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWL 202
+ L+ L LDL N L+G +P D L L+ L L N G IP+ + C+ L L L
Sbjct: 212 IGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLEL 271
Query: 203 ADNKFSGRLPENIGNL------------------------SQLTDLNLAQNNLQGDMPTA 238
DN+ +G++P +GNL +QLT L L++N+L G +
Sbjct: 272 YDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEE 331
Query: 239 IGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLT 298
IG L+ LE L L NN +G P +I N+ + ++ + N +SG LP LG L NL L+
Sbjct: 332 IGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRNLS 390
Query: 299 LFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSP 358
N L G IP+SI+N + L LDLS N +G IP FG + L F+++ N T E P
Sbjct: 391 AHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMN-LTFISIGRNHFTGEI-P 448
Query: 359 ADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIG 418
D + NC +L L++ N L G L P IG LR + L G IP+EIG
Sbjct: 449 DDIF-------NCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLTGPIPREIG 500
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG------------------- 459
NL L L L N G IP + LQGL +Y NDL+G
Sbjct: 501 NLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560
Query: 460 -----SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLT--------------------- 493
IP LE L+ L L GN +G+IPA L SL+
Sbjct: 561 NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620
Query: 494 -SLRELHL----GSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDL 548
SL+ + L +N LT +IP L LE + ++LS+N SG +P S+Q K + LD
Sbjct: 621 ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680
Query: 549 SRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPK 607
S+N LSG IP + G+ + +L+L+ N F+G IP+SFG++ L SLD+SSNN++G+IP+
Sbjct: 681 SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740
Query: 608 SLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKGKG 667
SL L LK L ++ N L+G +P G F+N +A GN LCG + + PC +
Sbjct: 741 SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQ--- 796
Query: 668 SKKAPFALKFILPLII-------------SIVLIAIVIMFFIRRQNGNTKVPVKEDVLSL 714
K + F+ + + LII ++L + + +P + L L
Sbjct: 797 -KSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL 855
Query: 715 ATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRT 772
+R ++++ATD FN N++G S VYKG L DGT +A+KV NL+ + +
Sbjct: 856 ---KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKW 912
Query: 773 FDSECEILRNVRHRNLVKIFS-SCCNIDFKALVLEFMPNGSFEKWLY-SYNYFLDILQRL 830
F +E + L ++HRNLVKI + + KALVL FM NG+ E ++ S +L+++
Sbjct: 913 FYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKI 972
Query: 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
++ + +A ++YLH G+ PIVHCDLKP NILLD + AHVSDFG +++LG +D T
Sbjct: 973 DLCVHIASGIDYLHSGYGF-PIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTT 1031
Query: 891 TITMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPT--DEMFTGEMSLRR 945
T A TIGY+APE+ V+ K DV+S+G+++ME T+++PT ++ + +M+LR+
Sbjct: 1032 ASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQ 1091
Query: 946 WVKESLPH---GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAA 1002
V++S+ + G+ V+D L G+ + + + + L L C PE R M +
Sbjct: 1092 LVEKSIGNGRKGMVRVLDMEL-GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEIL 1150
Query: 1003 AELKKIRVK 1011
L K+R K
Sbjct: 1151 THLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-140, Method: Compositional matrix adjust.
Identities = 362/1055 (34%), Positives = 530/1055 (50%), Gaps = 125/1055 (11%)
Query: 49 ARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFA 108
R RV +L L L G IP LGN S L +EN G +P ELG+L L ++N A
Sbjct: 188 GRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLA 247
Query: 109 YNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI 168
N L+G PS +G +S+LQ LS N IP L +L L+ LDL N+L+G +P +
Sbjct: 248 NNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEF 307
Query: 169 ------------------RLPK--------LEKLYLGSNDFFGQIPSSLSECTHLQTLWL 202
LPK LE+L L G+IP LS+C L+ L L
Sbjct: 308 WNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDL 367
Query: 203 ADNKFSGRLPENIGNLSQLTDLNLA------------------------QNNLQGDMPTA 238
++N +G +PE + L +LTDL L NNL+G +P
Sbjct: 368 SNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKE 427
Query: 239 IGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLT 298
I L+ LE L L N SG +P I N +++++I++ N G +P ++G L L L
Sbjct: 428 ISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR-LKELNLLH 486
Query: 299 LFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSP 358
L N L+G +P S+ N +L LDL+ N SG IP +FG L+ L L L NSL
Sbjct: 487 LRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSL------ 540
Query: 359 ADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIG 418
Q + SL + R+LT + L+ N L G + P G S+S F+ + IP E+G
Sbjct: 541 --QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFEDEIPLELG 596
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNG 478
N L L+L N+L G IP T+G+ ++L L + N L G+IP L ++L+ + LN
Sbjct: 597 NSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNN 656
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQ 538
N LSG IP LG L+ L EL L SN S+P+ L++ +L ++L NSL+G +P I
Sbjct: 657 NFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIG 716
Query: 539 HLKVL--INLD----------------------LSRNQLSGDIPITISGLKDL-ATLSLA 573
+L L +NLD LSRN L+G+IP+ I L+DL + L L+
Sbjct: 717 NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLS 776
Query: 574 GNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKG 633
N F G IP + G+L LE+LD+S N ++G++P S+ + L LNVS+N L G+ +K
Sbjct: 777 YNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGK--LKK 834
Query: 634 PFRNFSAQSFSGNYALCGPPRLQVPPCKE-DKGKG-SKKAPFALKFILPLIISIVLIAIV 691
F + A SF GN LCG P + + +K +G S ++ + I L ++I ++
Sbjct: 835 QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVI 894
Query: 692 IMFFIRRQNGNTKVPVKEDVLSL----------------ATWRRTSYLDIQRATDGFNEC 735
+FF +R + KV + A+ + DI AT +E
Sbjct: 895 ALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEE 954
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSS 794
++G G G VYK L +G VA+K + + + ++F E + L +RHR+LVK+
Sbjct: 955 FMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGY 1014
Query: 795 CCNID--FKALVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMIDVALVLEYLHH 845
C + L+ E+M NGS WL+ LD RL I + +A +EYLHH
Sbjct: 1015 CSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHH 1074
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGYMAPE 903
+ PIVH D+K +N+LLD NM AH+ DFG++K+L E D+ T + T + GY+APE
Sbjct: 1075 -DCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP---HGLTEVVD 960
Y + K DVYS G++LME T K PTD +F EM + RWV+ L +++D
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLID 1193
Query: 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
L + + D ++++AL C SP++R
Sbjct: 1194 PKL---KPLLPFEEDAACQVLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-133, Method: Compositional matrix adjust.
Identities = 342/1045 (32%), Positives = 524/1045 (50%), Gaps = 124/1045 (11%)
Query: 55 VALNLSSFS-LGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
+AL ++F+ L G +P L L L +L++ +N+F G +P++LG L ++ +N N+L
Sbjct: 218 LALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQ 277
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLP 171
G P + L+ LQ L +N+ T I + +++LEFL L +N LSGSLP I
Sbjct: 278 GLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNT 337
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
L++L+L G+IP+ +S C L+ L L++N +G++P+++ L +LT+L L N+L
Sbjct: 338 SLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSL 397
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH-- 289
+G + ++I NL L+ L NNL G VP I + + ++ L EN+ SG +P+ +G+
Sbjct: 398 EGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCT 457
Query: 290 ---------------------SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLF 328
L +L L L N L+G IP S+ N ++ +DL+ N
Sbjct: 458 RLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQL 517
Query: 329 SGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGIL 388
SG IP +FG L L + NSL Q + SL N ++LT + + N G +
Sbjct: 518 SGSIPSSFGFLTALELFMIYNNSL--------QGNLPDSLINLKNLTRINFSSNKFNGSI 569
Query: 389 PPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQ 448
P G S+S F+ + +G IP E+G + L L+L N+ G IP T G+ +L
Sbjct: 570 SPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELS 627
Query: 449 GLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYS 508
L + N L G IP L ++L+ + LN N LSG IP LG L L EL L SN S
Sbjct: 628 LLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGS 687
Query: 509 IPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLA 568
+P+ ++SL IL + L NSL+G +P I +L+ L L+L NQLSG +P TI L L
Sbjct: 688 LPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLF 747
Query: 569 TLSLAGNQFNGPIPESFGSLISLES-LDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEG 627
L L+ N G IP G L L+S LD+S NN +G+IP ++ L L+ L++S+N+L G
Sbjct: 748 ELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVG 807
Query: 628 EIP----------------------IKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKG 665
E+P +K F + A +F GN LCG P + C
Sbjct: 808 EVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSP---LSHCNRAGS 864
Query: 666 KGSKKAPFALKFILPLIISIVLIA----IVIMFFIRRQ---------------------- 699
K + I+ I S+ IA ++I+FF +
Sbjct: 865 KNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQA 924
Query: 700 ----NGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGT 755
NG K +K D DI AT NE ++G G G VYK L +G
Sbjct: 925 PLFSNGGAKSDIKWD-------------DIMEATHYLNEEFMIGSGGSGKVYKAELKNGE 971
Query: 756 NVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKALVLEFMPNGS 812
+A+K + + + ++F+ E + L +RHR+LVK+ C + L+ E+M NGS
Sbjct: 972 TIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGS 1031
Query: 813 FEKWLYS-----YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867
WL++ L RL I + +A +EYLH+ + PIVH D+K +N+LLD N
Sbjct: 1032 VWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHY-DCVPPIVHRDIKSSNVLLDSN 1090
Query: 868 MTAHVSDFGISKLLGEGDDSVTQTITM--ATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+ AH+ DFG++K+L D+ T++ TM + GY+APEY + K DVYS G++LME
Sbjct: 1091 IEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1150
Query: 926 TFTRKKPTDEMFTGEMSLRRWVKESL--PHG---LTEVVDANLVGEEQAFSAKTDCLLSI 980
T K PT+ MF E + RWV+ L P G +++D+ L + + + +
Sbjct: 1151 IVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL---KSLLPCEEEAAYQV 1207
Query: 981 MDLALDCCMESPEQRIHMTDAAAEL 1005
+++AL C P++R A+ L
Sbjct: 1208 LEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-132, Method: Compositional matrix adjust.
Identities = 329/896 (36%), Positives = 481/896 (53%), Gaps = 69/896 (7%)
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQ-LTDLNLAQNNLQG 233
+L + D G+I S++ T L L L+ N F G++P IG+L + L L+L++N L G
Sbjct: 70 ELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHG 129
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF---NISTIRLINLIENQLSGHLPLTLGHS 290
++P +G L L +L+LG N L+G +P +F + S+++ I+L N L+G +PL
Sbjct: 130 NIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCH 189
Query: 291 LPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP-HTFGNLRFLRFLNLMF 349
L L FL L+ N L GT+P+S++N++ L +DL SN+ SG +P + L+FL L +
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
N + ++ + F +SL N L EL L N L G + + + S +L + + +
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRI 309
Query: 410 KGSIPQEIG------------------------NLSGLMFLKLDDNELNGTIPTTVGRFQ 445
GSIP EI LS L + L +N L G IP +G
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369
Query: 446 QLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTL 505
+L L + N+L GSIP +L +L +LLL GN+LSG +P LG +L L L N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429
Query: 506 TYSIP----SSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITI 561
T +IP S+L +L+ LY+NLSSN LSGP+P + + +++++DLS N+LSG IP +
Sbjct: 430 TGTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQL 487
Query: 562 SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVS 621
L L+L+ N F+ +P S G L L+ LDVS N ++G IP S + LK LN S
Sbjct: 488 GSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFS 547
Query: 622 YNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKGKGSKKAPFALKFILPL 681
+N L G + KG F + +SF G+ LCG + + CK K K L +L L
Sbjct: 548 FNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACK----KKHKYPSVLLPVLLSL 602
Query: 682 IISIVLIAIVIMFFIRRQNG-NTKVPVKEDVLSLA-------TWRRTSYLDIQRATDGFN 733
I + VL R + G N V KE+V + R SY + AT GFN
Sbjct: 603 IATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFN 662
Query: 734 ECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKIF 792
+L+G G FG VYKG L + T VA+KV + + F +F EC+IL+ RHRNL++I
Sbjct: 663 ASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRII 722
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---LDILQRLNIMIDVALVLEYLHHGHSL 849
++C F ALVL MPNGS E+ LY Y LD++Q +NI DVA + YLHH +S
Sbjct: 723 TTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSP 781
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLG------EGDDSV----TQTITMATIGY 899
+VHCDLKP+NILLD+ MTA V+DFGIS+L+ DDSV T + ++GY
Sbjct: 782 VKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGY 841
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959
+APEYG S DVYS+GVLL+E + ++PTD + SL ++K P L ++
Sbjct: 842 IAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGII 901
Query: 960 DANLV------GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ L E+ + +L +++L L C +P R M D A E+ +++
Sbjct: 902 EQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 349/1082 (32%), Positives = 531/1082 (49%), Gaps = 103/1082 (9%)
Query: 7 NLTTDQSALLAFKADVIDSRSVLANNWS-ISYPICNWVGISCGARHHR-------VVALN 58
+L +D LL K +NW+ I CNW+G++C ++ V +L+
Sbjct: 32 SLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLD 91
Query: 59 LSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPS 118
LSS +L GI+ P +G L LV L+++ N G +P E+G +L ++ N+ GS P
Sbjct: 92 LSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPV 151
Query: 119 WIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLY 177
I LS+L+ + NN + +P+ + +L LE L N+L+G LP + L KL
Sbjct: 152 EINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFR 211
Query: 178 LGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPT 237
G NDF G IP+ + +C +L+ L LA N SG LP+ IG L +L ++ L QN G +P
Sbjct: 212 AGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPK 271
Query: 238 AIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFL 297
IGNL LE L L N+L GP+P I N+ +++ + L +NQL+G +P LG L + +
Sbjct: 272 DIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELG-KLSKVMEI 330
Query: 298 TLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESS 357
N L G IP ++ S+L L L N +G IP+ LR L L+L NSLT
Sbjct: 331 DFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIP 390
Query: 358 PADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI 417
P Q N S+ +L L N L G++P +G +S L + + +L G IP I
Sbjct: 391 PGFQ--------NLTSMRQLQLFHNSLSGVIPQGLGLYSP-LWVVDFSENQLSGKIPPFI 441
Query: 418 GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN 477
S L+ L L N + G IP V R + L L + N L G P LC L LS + L+
Sbjct: 442 CQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELD 501
Query: 478 GNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI 537
N SG +P +G+ L+ LHL +N + ++P+ + L ++ N+SSNSL+GP+PS I
Sbjct: 502 QNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEI 561
Query: 538 QHLKVLINLDLSRN------------------------QLSGDIPITISGLKDLATLSLA 573
+ K+L LDLSRN + SG+IP TI L L L +
Sbjct: 562 ANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMG 621
Query: 574 GNQFNGPIPESFGSLISLE-------------------------SLDVSSNNISGKIPKS 608
GN F+G IP G L SL+ L +++N++SG+IP +
Sbjct: 622 GNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTT 681
Query: 609 LEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCG-------PPRLQVPPCK 661
E L L N SYN L G++P F+N + SF GN LCG P P
Sbjct: 682 FENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHIS 741
Query: 662 EDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNT------KVP-VKEDVLSL 714
K +++ + + +L+ +++ F+R T K P +E +
Sbjct: 742 SLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYF 801
Query: 715 ATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFN-------LQLE 767
R + DI AT GF++ ++GRG+ G VYK + G +A+K
Sbjct: 802 VPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSN 861
Query: 768 RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA--LVLEFMPNGSFEKWLY-SYNYFL 824
+F +E L +RHRN+V+++S C + + L+ E+M GS + L+ ++ +
Sbjct: 862 NTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSM 921
Query: 825 DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884
D R I + A L YLHH I+H D+K NNIL+DEN AHV DFG++K++
Sbjct: 922 DWPTRFAIALGAAEGLAYLHH-DCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI--- 977
Query: 885 DDSVTQTIT--MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMS 942
D ++++++ + GY+APEY V+ KCD+YS+GV+L+E T K P + G
Sbjct: 978 DMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-D 1036
Query: 943 LRRWVKESL-PHGLT-EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTD 1000
L W + + H LT E++D L E + ++++ +A+ C SP R M +
Sbjct: 1037 LATWTRNHIRDHSLTSEILDPYLTKVED--DVILNHMITVTKIAVLCTKSSPSDRPTMRE 1094
Query: 1001 AA 1002
Sbjct: 1095 VV 1096
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 346/1085 (31%), Positives = 528/1085 (48%), Gaps = 91/1085 (8%)
Query: 8 LTTDQSALLAFKADVIDSRSVLANNWSISYPI-CNWVGISCGARHHRVVALNLSSFSLGG 66
L +D +ALL+ S + +W+ S C+W+G+ C R V LNLSS+ + G
Sbjct: 24 LNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRRQF-VDTLNLSSYGISG 82
Query: 67 IIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRL 126
P + +L L + +S N F+G +P++LG L I+ + N +G+ P +G L L
Sbjct: 83 EFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNL 142
Query: 127 QILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFG 185
+ LS NS P+ LL++ LE + N L+GS+P++I + +L L+L N F G
Sbjct: 143 RNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSG 202
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+PSSL T LQ L+L DN G LP + NL L L++ N+L G +P + + +
Sbjct: 203 PVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQI 262
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
+ ++L N +G +PP + N +++R LSG +P G L L+ L L GN+
Sbjct: 263 DTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQ-LTKLDTLYLAGNHFS 321
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
G IP + +I L L N G IP G L L++L+L N+L+ E P W
Sbjct: 322 GRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEV-PLSIWKIQ 380
Query: 366 S-----------------SLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCE 408
S +T + L LAL N G++P +G ++SL + +
Sbjct: 381 SLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLG-ANSSLEVLDLTRNM 439
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL 468
G IP + + L L L N L G++P+ +G L+ L L +N+L+G +P ++
Sbjct: 440 FTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFV-EK 498
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
+ L L+GNN +G IP LG+L ++ ++L SN L+ SIP L SL + ++NLS N
Sbjct: 499 QNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNI 558
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF--- 585
L G LPS + + L LD S N L+G IP T+ L +L LSL N F+G IP S
Sbjct: 559 LKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQS 618
Query: 586 --------------------GSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
G+L +L SL++SSN ++G++P L L L++L+VS+N L
Sbjct: 619 NKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNL 678
Query: 626 EGEIPI-----------------KGP-------FRNFSAQSFSGNYALC---------GP 652
G + + GP F N S SFSGN LC P
Sbjct: 679 SGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACP 738
Query: 653 PRLQVPPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVL 712
+ PC G K + I +++ +L I + F + K V+E +
Sbjct: 739 ESSILRPCNMQSNTG--KGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAI 796
Query: 713 SLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIK--VFNLQLERAF 770
S + + AT+ N+ ++G+G+ G +YK TL A+K VF ++
Sbjct: 797 SAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFT-GIKNGS 855
Query: 771 RTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYN--YFLDILQ 828
+ E E + VRHRNL+K+ ++ ++ +M NGS L+ N LD
Sbjct: 856 VSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWST 915
Query: 829 RLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888
R NI + A L YLH A IVH D+KP NILLD ++ H+SDFGI+KLL + S+
Sbjct: 916 RHNIAVGTAHGLAYLHFDCDPA-IVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSI 974
Query: 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
TIGYMAPE + S + DVYSYGV+L+E TRKK D F GE + WV+
Sbjct: 975 PSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVR 1034
Query: 949 ESLPHG--LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
+ ++VD +L+ +E S+ + + + LAL C + ++R M D +L
Sbjct: 1035 SVWTQTGEIQKIVDPSLL-DELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLT 1093
Query: 1007 KIRVK 1011
+ ++
Sbjct: 1094 RWSIR 1098
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 358/1081 (33%), Positives = 506/1081 (46%), Gaps = 126/1081 (11%)
Query: 8 LTTDQSALLAFKADVIDSRSVLAN-NWSISYPICNWVGISCG--ARHHRVVALNLSSFSL 64
L + LL K+ +D++ L N N + S P C W G+ C + V++LNLSS L
Sbjct: 27 LNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVP-CGWTGVMCSNYSSDPEVLSLNLSSMVL 85
Query: 65 GGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILS 124
G + P +G L L LD+S YN LSG P IG S
Sbjct: 86 SGKLSPSIGGLVHLKQLDLS------------------------YNGLSGKIPKEIGNCS 121
Query: 125 RLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDF 183
L+IL +NN F IP + L LE L + N +SGSLP +I L L +L SN+
Sbjct: 122 SLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNI 181
Query: 184 FGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQ 243
GQ+P S+ L + N SG LP IG L L LAQN L G++P IG L+
Sbjct: 182 SGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLK 241
Query: 244 MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNN 303
L + L N SG +P I N +++ + L +NQL G +P LG L +LEFL L+ N
Sbjct: 242 KLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNG 300
Query: 304 LIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT----TESSPA 359
L GTIP I N S I +D S N +G IP GN+ L L L N LT E S
Sbjct: 301 LNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTL 360
Query: 360 DQWSFLSSLTNC------------RSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKC 407
S L N R L L L N L G +PP +G +S L +
Sbjct: 361 KNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYS-DLWVLDMSDN 419
Query: 408 ELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCH 467
L G IP + S ++ L L N L+G IPT + + L L L N+L G P LC
Sbjct: 420 HLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCK 479
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
++ + L N G+IP +G+ ++L+ L L N T +P + L + +N+SSN
Sbjct: 480 QVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSN 539
Query: 528 SLSGPLPSSIQHLKVLINLD------------------------LSRNQLSGDIPITISG 563
L+G +PS I + K+L LD LS N LSG IP+ +
Sbjct: 540 KLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGN 599
Query: 564 LKDLATLSLAGNQFNGPIPESFGSLISLE-SLDVSSNNISGKIPKSLEALLYLK------ 616
L L L + GN FNG IP GSL L+ +L++S N ++G+IP L L+ L+
Sbjct: 600 LSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNN 659
Query: 617 ------------------KLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQV- 657
N SYN L G IP+ RN S SF GN LCGPP Q
Sbjct: 660 NNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLNQCI 716
Query: 658 -----PPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKED-- 710
P + G ++ + +I + L+ I ++ ++ R+ T +D
Sbjct: 717 QTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQ 776
Query: 711 --VLSLATW----RRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNL 764
+SL + ++ D+ ATD F+E ++GRG+ G VYK L G +A+K
Sbjct: 777 PSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLAS 836
Query: 765 QLE-----RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS 819
E +F +E L N+RHRN+VK+ C + L+ E+MP GS + L+
Sbjct: 837 NHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD 896
Query: 820 YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879
+ LD +R I + A L YLHH I H D+K NNILLD+ AHV DFG++K
Sbjct: 897 PSCNLDWSKRFKIALGAAQGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 955
Query: 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939
++ + S + + + GY+APEY V+ K D+YSYGV+L+E T K P + G
Sbjct: 956 VI-DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQG 1014
Query: 940 EMSLRRWVKESLPHGL--TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997
+ WV+ + + V+DA L E++ + +L+++ +AL C SP R
Sbjct: 1015 G-DVVNWVRSYIRRDALSSGVLDARLTLEDERIVSH---MLTVLKIALLCTSVSPVARPS 1070
Query: 998 M 998
M
Sbjct: 1071 M 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1022 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.918 | 0.535 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.979 | 0.919 | 0.517 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.958 | 0.961 | 0.522 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.931 | 0.897 | 0.554 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.986 | 0.966 | 0.530 | 0.0 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.921 | 0.487 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.963 | 0.941 | 0.491 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.931 | 0.654 | 0.519 | 0.0 | |
| 359482811 | 1118 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.898 | 0.465 | 0.0 | |
| 359492792 | 1067 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.940 | 0.488 | 0.0 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/1056 (53%), Positives = 721/1056 (68%), Gaps = 58/1056 (5%)
Query: 10 TDQSALLAFKADV-IDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGII 68
TDQS+LLA KA + +D VLA NWS C W+G+SC A+ RV+AL+LS+ L G I
Sbjct: 31 TDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTI 90
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQI 128
PP LGNLSFLVSLD+S NNF+G +P E+G+L L +N YN LSG P G L+RLQ
Sbjct: 91 PPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSFGNLNRLQS 150
Query: 129 LSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-------------------- 168
L NNSFT IP + N+S LE L L N L G++P +I
Sbjct: 151 LFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAI 210
Query: 169 -------------------------------RLPKLEKLYLGSNDFFGQIPSSLSECTHL 197
L L + L +N F G IPS+LS+C L
Sbjct: 211 PSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGEL 270
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG 257
QTL+L+ NKF+G +P +I +L++LT L+LA N+L G++P IG+L L LN+ N+L+G
Sbjct: 271 QTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTG 330
Query: 258 PVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASK 317
+P IFNIS++ +L N LSG+LP G LPNLE L L N L G IP+SI NASK
Sbjct: 331 HIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASK 390
Query: 318 LIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTEL 377
L LD N+ +G IPH G+LRFL LNL N+L ES + SFL+SLTNC+ L L
Sbjct: 391 LRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESY-IQELSFLTSLTNCKRLRIL 449
Query: 378 ALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTI 437
L+ NPL GILP IGN S SL++FEA C+LKG+IP EIGNLS L L L++N+L GTI
Sbjct: 450 YLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTI 509
Query: 438 PTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRE 497
P ++G+ Q+LQGL L N LQGSIP +C L L +L L N LSG+IPACLG LT LR
Sbjct: 510 PPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRH 569
Query: 498 LHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDI 557
L+LGSN L +IPS+LWSL +IL +++SSN L G LPS + +LKVL+ +DLSRNQLSG+I
Sbjct: 570 LYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEI 629
Query: 558 PITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKK 617
P I GL+DL +LSLA N+F GPI SF +L SLE +D+S N + G+IPKSLE L+YLK
Sbjct: 630 PSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKY 689
Query: 618 LNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKGKGSKKAPFALKF 677
L+VS+N L GEIP +GPF NFSA+SF N ALCG PRL++PPC+ + + LK+
Sbjct: 690 LDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLKY 749
Query: 678 ILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNL 737
ILP I+S +L +I + R + N +P + + L ATWRR SY +I +AT+GF+ NL
Sbjct: 750 ILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNL 809
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LGRGS G VY+GTL DG N AIKVFNLQ E AF++FD+ECE++ ++RHRNL+KI SSC N
Sbjct: 810 LGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSN 869
Query: 798 --IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
IDFKALVLE++PNGS E+WLYS+NY LDILQRLNIMIDVAL +EYLHHG S P+VHC
Sbjct: 870 SYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCS-TPVVHC 928
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DLKP+NILLDE+ HV DFGI+KLL E ++S+ +T T+ATIGYMAP+Y S GIV+ D
Sbjct: 929 DLKPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGD 987
Query: 916 VYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-GEEQAFSAKT 974
VYSYG++LMETFTR++PTDE+F+ EMS++ WV + L +TEVVDANL+ GE++ F AK
Sbjct: 988 VYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKK 1047
Query: 975 DCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010
C+ I+ LA+DC +SPE+RI M D LKKI+
Sbjct: 1048 QCISLILGLAMDCVADSPEERIKMKDVVTTLKKIKT 1083
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1015 bits (2624), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/1058 (51%), Positives = 717/1058 (67%), Gaps = 57/1058 (5%)
Query: 10 TDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIP 69
TD SALL K + ++ NWS + C+W G++C RH+RVVAL LS+ + GI+P
Sbjct: 30 TDLSALLVLKEHS-NFDPFMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIVP 88
Query: 70 PHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQIL 129
PH+GNLSFLV +D+S N++ GHLPNELG L RL+ +NF+ N G PS + +L +LQ L
Sbjct: 89 PHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQHL 148
Query: 130 SFHNNSFTD--------------RIPDFLL----------NLSKLEFLDLMENSLSGSLP 165
NNS T + D LL NLS L+ L++ N LSGS P
Sbjct: 149 LLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSFP 208
Query: 166 NDI-RLPKLEKLYL-------------------------GSNDFFGQIPSSLSECTHLQT 199
I LP L+ +YL N +GQIPS L +C L++
Sbjct: 209 PKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELRS 268
Query: 200 LWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPV 259
L L NKF+G +P IGNL++L L+L +NNL G +P IGNLQ L+ ++L NNL+G +
Sbjct: 269 LALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSI 328
Query: 260 PPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLI 319
P +FNIST++ I + N L G+LP +LG LPNL +L L N L G IP+ I+NASKL
Sbjct: 329 PHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLT 388
Query: 320 GLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELAL 379
L+L SN F+G IP + G+LR L+ L L N L+++ + + + + SSL NC++L L L
Sbjct: 389 ILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKT-SQELTIFSSLKNCQNLKYLWL 447
Query: 380 NVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPT 439
+ NPL G LP +GN S SL F A +KGS+ + IGNLS L L L +N+L G IPT
Sbjct: 448 SYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPT 507
Query: 440 TVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELH 499
T+G + LQGL L+ NDL GSIP LC L L L L GN LSG+IP C +LTSLR L
Sbjct: 508 TIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLF 567
Query: 500 LGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPI 559
L SN +I S+LW+L+ IL VNL+SN L+G LPS I++L+ + +++S+NQLSG+IPI
Sbjct: 568 LASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPI 627
Query: 560 TISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLN 619
+I GL+DLA L L+GN+ GPIP+S G + SLE LD+SSNN+SG IPKSL+ LLYLK N
Sbjct: 628 SIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFN 687
Query: 620 VSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKGKGSKK--APFALKF 677
VS+N L+GEIP G F NFSAQSF GN ALCG RLQV PCK+D + ++ + L++
Sbjct: 688 VSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRY 747
Query: 678 ILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNL 737
+LP I+ V + ++ R K +++D L+L T RR SY ++Q AT+GF E N
Sbjct: 748 VLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNF 807
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG GSFG VYKGTL DGT +A KVFNLQLERAF++FD+ECE+LRN+RHRNLVKI +SC
Sbjct: 808 LGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSG 867
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL 857
+FKALVLEFMPN S EKWLYS +YFL+ LQRLNIM+DVA VLEYLHHG+++ P+ HCD+
Sbjct: 868 PNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTI-PMAHCDI 926
Query: 858 KPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVY 917
KP+N+LL+E+M A ++DFGISKLLGE + SV QT+T+ATIGYMAPEYGSEGIVS + DVY
Sbjct: 927 KPSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVY 985
Query: 918 SYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG-EEQAFSAKTDC 976
SYGVLLMETFT+KKPTD+MFT ++SL+ WV++SL +T+V+DANL+G EE +AK DC
Sbjct: 986 SYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDC 1045
Query: 977 LLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQ 1014
++SI+ LAL C + P RI M L+KI+ KFL+
Sbjct: 1046 IVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLR 1083
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2530), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/1012 (52%), Positives = 685/1012 (67%), Gaps = 32/1012 (3%)
Query: 10 TDQSALLAFKADV-IDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGII 68
TDQSALLAFK + D +++L ++WS CNW+G+SC R RV AL+LSS L G I
Sbjct: 30 TDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTI 89
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF-PSWIGILSRLQ 127
PP LGNLSFL L + N+F+G LP+E+G LRRL++++ N+LS P G L RL+
Sbjct: 90 PPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLE 149
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFG 185
L F N+ T IP + N+S L+ LDLM N L GSLP ++ LP+LE L L SN G
Sbjct: 150 ELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSSNQLSG 209
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
QIPS L +C LQ LWL N F+G +PE +G L L LNL N L GD+P +I N+ L
Sbjct: 210 QIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSL 269
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
+ + NNLSG +P EN + LPNLE L L N +
Sbjct: 270 RTMQICCNNLSGSIPQ--------------ENSI----------DLPNLEELQLNLNGIT 305
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
G++P + N S+L LDLS N +G++ FGNLR L+ L+L NS T S + +F+
Sbjct: 306 GSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPS-SQTLNFI 364
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
+SLTN R L EL + NPL G+LP +GN S+ L KF +LKG+IP EIGNLS L+
Sbjct: 365 TSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIV 424
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
L L++N L G IPTTVG +++Q L L+ N+L GSIP +C RL + LN N LSG I
Sbjct: 425 LSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEI 484
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
P+C+G+LTSLR L+L N L+ +IP +LWSL+ +L +NL SN L G LPS + ++ I
Sbjct: 485 PSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIG 544
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
+ LS NQLSG+IP TI L++L SL+ N F G IPE+FG L+SLE LD+S NN+SG+I
Sbjct: 545 IRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEI 604
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKG 665
PKSLEAL YL+ +VS+N L+GEIP GPF NF+A+SF N LCGP RLQVPPC +
Sbjct: 605 PKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESR 664
Query: 666 KGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATWRRTSYLDI 725
K SK L+F LP + SI+L+ I + + K P+ E + A RR SYL++
Sbjct: 665 KDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLEL 724
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH 785
AT+ F+E NLLG GSFG VY+G L DG NVA+K+FNLQL+RAFR+FD+ECEI+RN+RH
Sbjct: 725 LHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRH 784
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
RNLVKI SC N+DFKALVLE+MP GS EKWLYS+NY LDI+QR+NIMIDVA LEYLHH
Sbjct: 785 RNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHH 844
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
G+ +P+VHCDLKP+N+LLDE+M AHV DFGI+KLLGE ++S QT T+ATIGYMAPEYG
Sbjct: 845 GYP-SPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGE-NESFAQTRTLATIGYMAPEYG 902
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965
+G+VS K DVYS+G++LME TRK+PTDEMF GEMSL+R VKESLP + ++VD+N++
Sbjct: 903 LDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLN 962
Query: 966 EEQAFSAKTD-CLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQS 1016
+S K + C+ SIM+LAL C ESP +R+ M + A LK I+ +FL+ S
Sbjct: 963 RGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDS 1014
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 977 bits (2526), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/963 (55%), Positives = 672/963 (69%), Gaps = 11/963 (1%)
Query: 56 ALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGS 115
LNL + G I + NLS L LD+ N+F G + L + LRLIN N LSG
Sbjct: 92 TLNLEGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLSGI 151
Query: 116 FPSWI---GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLP 171
+ I S L++L+ N RIP L ++L LDL N +GS+P +I L
Sbjct: 152 LQVVMIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLT 211
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
KL++LYLG N+ GQIP ++ L+ L L N +G +P IGN + L ++++ NNL
Sbjct: 212 KLKELYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNL 271
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSL 291
G +P +GNL L+ L+LG NN++G +P T FN S +R +N+ N LSGHLP G L
Sbjct: 272 TGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGL 331
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
PNLE L L N L G IP+SI NASKLI LDLS N FSG IP GNLR L+ LNL N
Sbjct: 332 PNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENI 391
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
LT++S + SFLSSL+NCRSL L N NPLRG LP IGN SASL + A C + G
Sbjct: 392 LTSKSL-RSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIG 450
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+IP+ IGNLS L+ L L NEL G IP+ +GR + LQ SL N LQG IP +CHLERL
Sbjct: 451 NIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERL 510
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
S L L N SG++PACL ++TSLREL+LGSN T SIP++ WSL+ +L +NLS NSL+G
Sbjct: 511 SYLYLLENGFSGSLPACLSNITSLRELYLGSNRFT-SIPTTFWSLKDLLQINLSFNSLTG 569
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
LP I +LKV+ +D S NQLSGDIP +I+ L++LA SL+ N+ GPIP SFG L+SL
Sbjct: 570 TLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSL 629
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCG 651
E LD+S N++SG IPKSLE L++LK NVS+NRL+GEI GPF NFS +SF N ALCG
Sbjct: 630 EFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCG 689
Query: 652 PPRLQVPPCKEDKGKGSKKAP--FALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKE 709
P R+QVPPCK K P F +++I+P I I+L+ + + RR + K+ +E
Sbjct: 690 PIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSH-KRKLSTQE 748
Query: 710 DVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERA 769
D L ATWR+ SY ++ RAT+GFNE NLLG GS G VYKGTL DG +A+KVF+LQLE
Sbjct: 749 DPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGE 808
Query: 770 FRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR 829
FDSECE+LR +RHRNLVKI SSCCN+DFKAL+LEF+P+GS EKWLYS+NY+LDILQR
Sbjct: 809 LMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQR 868
Query: 830 LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889
LNIMIDVA LEYLHHG + P+VHCDLKP+N+L++E+M AHVSDFGIS+LLGEG D+VT
Sbjct: 869 LNIMIDVASALEYLHHGCT-RPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG-DAVT 926
Query: 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949
QT+T+ATIGYMAPEYG EGIVS K DVYSYG+ LMETFTRKKPTD+MF GEMSL+ WVK+
Sbjct: 927 QTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQ 986
Query: 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
SLP +TEV+DANL+ EE+ F AK DC+ SI++LAL+C + P +RI M D L+KI+
Sbjct: 987 SLPKAITEVIDANLLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046
Query: 1010 VKF 1012
+K+
Sbjct: 1047 LKY 1049
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 975 bits (2520), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/1025 (53%), Positives = 703/1025 (68%), Gaps = 17/1025 (1%)
Query: 1 MATVINNLTTDQSALLAFKADVI-DSRSVLANNWSISYPICNWVGISCGARHHRVVALNL 59
+A + N+ +DQ ALLA K +I D ++LA NWSI+ +C WVG++CGARH RV AL+L
Sbjct: 24 IADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDL 83
Query: 60 SSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSW 119
S L G IPPHLGNLSFL + N F+G LP+EL KLRR++ + N SG PSW
Sbjct: 84 SDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSW 143
Query: 120 IGILSRLQILSFHNNSFTDRIPDFLLN--LSKLEFLDLMENSLSGSLPNDI--RLPKLEK 175
IG ++LQ LS +N FT +P L N +S L LD N+L+G LP +I L L
Sbjct: 144 IGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRA 203
Query: 176 LYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDM 235
LYL SN F G IPS+L C L+ L L+ N F G + ++IGNL+ L +L L NN G +
Sbjct: 204 LYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTI 263
Query: 236 PTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLE 295
P IG+L LE + L +N LSG VP I+N S + I L NQLSG+LP + +LPNLE
Sbjct: 264 PDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSS--SNLPNLE 321
Query: 296 FLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTE 355
F + NN G IP S+ NASKL +DL N F G IP GNL+ L + N LT +
Sbjct: 322 FFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVK 381
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ 415
SS + S SSLT C+ L L+ NPL G LP +GN S+SL E C + G+IP+
Sbjct: 382 SSSSGL-SLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPK 440
Query: 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLL 475
EIGNLS L +L L N+L GTIPTT+ + +LQ L L+ N L+GS PY LC L+ L+ L
Sbjct: 441 EIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLY 500
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
L N LSG IP+CLG++ SLR L +G N + +IPS+LW L IL +NLSSNSLSG L
Sbjct: 501 LEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAV 560
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLD 595
I +LK + +DLS NQLSG IP +I GLK L LSLA N+ G IP+ FG ISL+ LD
Sbjct: 561 DIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLD 620
Query: 596 VSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRL 655
+S+NN+SG+IPKSLE L YL NVS+N L+GEIP F N SA+SF GN LCG +L
Sbjct: 621 LSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKL 680
Query: 656 QVPPCKEDKGKGSKKA-PFALKF-ILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLS 713
QV PC+ +GSK A AL++ ++ ++I+ +A V + FIR + N + + E +L
Sbjct: 681 QVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMR--ITEGLLP 738
Query: 714 LATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTF 773
LAT +R SY ++++ATD FNE NLLGRGSFG VYKGT DG++VA+KVFNLQ+E AF++F
Sbjct: 739 LATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSF 798
Query: 774 DSECEILRNVRHRNLVKIFSSCC--NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN 831
D ECE+LR +RHRNLVKI +SC NIDFKALVLEFMPN S EKWL S +FL++L+RLN
Sbjct: 799 DVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLN 858
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
IM+DVA +EYLHHG+++ PIVHCDLKP+NILLDENM AHV+DFGI+KLLG+ + S QT
Sbjct: 859 IMLDVASAVEYLHHGYAM-PIVHCDLKPSNILLDENMVAHVTDFGIAKLLGD-EHSFIQT 916
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951
IT+AT+GYMAPEYGSEG+VS D+YS+G+LLMETFTRKKPTD+MF E+S+++WV+ES+
Sbjct: 917 ITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESV 976
Query: 952 PHGLTEVVDANLVG-EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010
P G+T++ D +L+ EEQ FSAK DC+LS+M +AL C + PE+R ++ D L +V
Sbjct: 977 PGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKV 1036
Query: 1011 KFLQQ 1015
KFL+
Sbjct: 1037 KFLKD 1041
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2460), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/1089 (48%), Positives = 709/1089 (65%), Gaps = 83/1089 (7%)
Query: 7 NLTTDQSALLAFKADVI-DSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLG 65
N+TTDQ+ALLA +A + D + NNWS + +CNWVGI CG +H RV +LN S L
Sbjct: 6 NITTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFSFMGLT 65
Query: 66 GIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRL--------------------- 104
G PP +G LSFL + I N+F+ LP EL L RL++
Sbjct: 66 GTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWIGRLPR 125
Query: 105 ---------------------------INFAYNELSGSFPSWIGILSRLQILSFHNNSFT 137
+N N+LSGS P IG L+ LQ L ++N T
Sbjct: 126 MEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLNSNQLT 185
Query: 138 D-----------------------RIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
+ IP F+ NLS L L L N+ G LP+DI LP
Sbjct: 186 EIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDICEDLPS 245
Query: 173 LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQ 232
L LYL N GQ+PS+L +C +L+ + LA N+F+G +P N+GNL+++ + L N L
Sbjct: 246 LGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLGVNYLS 305
Query: 233 GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLP 292
G++P +G LQ LE+L + N +G +PPTIFN+S + I L++NQLSG LP LG LP
Sbjct: 306 GEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADLGVGLP 365
Query: 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
NL L L N L GTIP SITN+S L D+ N FSG IP+ FG LR++NL N+
Sbjct: 366 NLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINLELNNF 425
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGS 412
TTES P+++ F S LTN SL L L+ NPL LP NFS+S + + +KG
Sbjct: 426 TTESPPSERGIF-SFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSMVNTGIKGM 484
Query: 413 IPQEIGN-LSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
IP++IGN L L+ L +DDN++ GTIPT++G+ +QLQGL L +N L+G+IP +C LE L
Sbjct: 485 IPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEICQLENL 544
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
+L L N LSGAIP C +L++LR L LGSN L ++PSSLWSL YIL++NLSSNSL G
Sbjct: 545 DELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLSSNSLRG 604
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
LP I +L+V++++D+S+NQLSG+IP +I GL +L LSL N+ G IP+SFG+L++L
Sbjct: 605 SLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSFGNLVNL 664
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALC- 650
E LD+SSNN++G IP+SLE L +L++ NVS+N+LEGEIP GPF NFSAQSF N LC
Sbjct: 665 EILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFISNIGLCS 724
Query: 651 GPPRLQVPPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKED 710
R QV PC +GS + L +ILP I+ +L I+++ F+ ++ K V+ED
Sbjct: 725 ASSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRH-RKKEQVRED 783
Query: 711 --VLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER 768
+ WRRT+Y ++ +ATDGF+E NL+GRGSFG VYK TL DGT A+K+F+L +
Sbjct: 784 TPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKIFDLLTQD 843
Query: 769 AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQ 828
A ++F+ ECEIL N+RHRNLVKI +SC ++DFKAL+LE+MPNG+ + WLY+++ L++L+
Sbjct: 844 ANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHDCGLNMLE 903
Query: 829 RLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888
RL+I+IDVAL L+YLH+G+ PIVHCDLKPNNILLD +M AH++DFGISKLLG G DS+
Sbjct: 904 RLDIVIDVALALDYLHNGYG-KPIVHCDLKPNNILLDGDMVAHLTDFGISKLLG-GGDSI 961
Query: 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT-GEMSLRRWV 947
TQTIT+AT+GYMAPE G +GIVS KCDVYSYG+LLMETFTRKKPTDEMF+ GEMSLR WV
Sbjct: 962 TQTITLATVGYMAPELGLDGIVSRKCDVYSYGILLMETFTRKKPTDEMFSAGEMSLREWV 1021
Query: 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
++ PH + VVD +L+ ++++F+ ++CL SIM LAL C ESPE+R D L K
Sbjct: 1022 AKAYPHSINNVVDPDLLNDDKSFNYASECLSSIMLLALTCTAESPEKRASSKDVLNSLNK 1081
Query: 1008 IRVKFLQQS 1016
I+ L S
Sbjct: 1082 IKAMILTYS 1090
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 940 bits (2430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/1057 (49%), Positives = 690/1057 (65%), Gaps = 72/1057 (6%)
Query: 10 TDQSALLAFKADVI-DSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGII 68
D+ AL+A KA + DS+ +LA NWS CNW GISC A RV A+NLS+ L G I
Sbjct: 8 VDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTI 67
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKL------------------------RRLRL 104
P +GNLSFLVSLD++ N+F G +PN +G L R LR
Sbjct: 68 APQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRG 127
Query: 105 INFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDL--------- 155
++ + N+ +G P IG LS L+ L + N T IP + NLS L L L
Sbjct: 128 LSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPI 187
Query: 156 ---------------MENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSECTHLQ 198
NSLSGSLP DI LP L+ LYL N GQ+P++LS C L
Sbjct: 188 PAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELL 247
Query: 199 TLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGP 258
+L L NKF+G +P IGNLS+L +++L++N+L G +PT+ GNL L+ L+
Sbjct: 248 SLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLS--------- 298
Query: 259 VPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKL 318
FNIS ++ + L++N LSG LP ++G LP+LE L + N GTIP SI+N SKL
Sbjct: 299 -----FNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKL 353
Query: 319 IGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELA 378
L LS N F+G++P NL L+FL+L +N LT E A FL+SLTNC+ L L
Sbjct: 354 TVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHL-ASGVGFLTSLTNCKFLRNLW 412
Query: 379 LNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIP 438
+ NPL G LP +GN +L F A C+ +G+IP IGNL+ L++L L N+L G+IP
Sbjct: 413 IGYNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIP 472
Query: 439 TTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLREL 498
TT+G+ Q+LQ LS+ N ++GSIP LCHL+ L L L+ N LSG+IP+C G L +LREL
Sbjct: 473 TTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALREL 532
Query: 499 HLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIP 558
L SN L ++IP S WSL +L +NLSSN L+G LP + ++K + LDLS+N +SG IP
Sbjct: 533 SLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIP 592
Query: 559 ITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKL 618
+ L++L TLSL+ N+ GPIP FG L+SLESLD+S NN+SG IPK+LEAL+YLK L
Sbjct: 593 SRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYL 652
Query: 619 NVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPC-KEDKGKGSKKAPFALKF 677
NVS+N+L+GEIP GPF F+A+SF N ALCG P QV C K ++ + K F LK+
Sbjct: 653 NVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKY 712
Query: 678 ILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNL 737
IL + S V + + I+ +IRR++ N ++P D T + S+ + AT+ F E NL
Sbjct: 713 ILLPVGSTVTLVVFIVLWIRRRD-NMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNL 771
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
+G+GS G+VYKG L +G VAIKVFNL+ + A R+F+SECE+++ +RHRNLV+I + C N
Sbjct: 772 IGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSN 831
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL 857
+DFKALVL++MPNGS EK LYS+ YFLD++QRLNIMIDVA LEYLHH S + +VHCDL
Sbjct: 832 LDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCS-SLVVHCDL 890
Query: 858 KPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVY 917
KP+N+LLD++M AHV+DFGI+KLL E +S+ QT T++TIGYMAPE+GS GIVS K DVY
Sbjct: 891 KPSNVLLDDDMVAHVADFGIAKLLTE-TESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVY 949
Query: 918 SYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV-GEEQAFSAKTDC 976
SYG+LLME F RKKP DEMFTG+++L+ WV ESL + + +VVD NL+ E++ + K C
Sbjct: 950 SYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSC 1008
Query: 977 LLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013
L SIM LAL C +SPE+RI M DA ELKK R+K L
Sbjct: 1009 LSSIMALALACTTDSPEERIDMKDAVVELKKSRIKLL 1045
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/961 (51%), Positives = 660/961 (68%), Gaps = 9/961 (0%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
++LSS L G IP L + L L +S N F G +P +G L L + AYN L G
Sbjct: 498 IDLSSNQLKGEIPSSLSHCPHLRGLSLSLNQFTGGIPQAIGSLSNLEELYLAYNNLVGGI 557
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLE 174
P IG LS L IL F ++ + IP + N+S L+ DL +NSL GSLP DI LP L+
Sbjct: 558 PREIGNLSNLNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYKHLPNLQ 617
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
+LYL N GQ+PS+LS C LQ+L L N+F+G +P + GNL+ L DL L NN+QG+
Sbjct: 618 ELYLSWNKLSGQLPSTLSLCGQLQSLSLWGNRFTGNIPPSFGNLTALQDLELGDNNIQGN 677
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+P +GNL L++L L NNL+G +P IFNIS ++ ++L +N SG LP +LG LP+L
Sbjct: 678 IPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDL 737
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
E L + N G IP SI+N S+L LD+ N F+G +P GNLR L FLNL N LT
Sbjct: 738 EGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTD 797
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP 414
E S A + FL+SLTNC L L + NPL+GILP +GN S SL F+A C+ +G+IP
Sbjct: 798 EHS-ASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFRGTIP 856
Query: 415 QEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
IGNL+ L+ L+L DN+L G IPTT+G+ ++LQ L + N L+GSIP LC L+ L L
Sbjct: 857 TGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYL 916
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLP 534
L+ N L+G+IP+CLG L LREL+L SN L +IP SLW+L +L +NLSSN L+G LP
Sbjct: 917 FLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLP 976
Query: 535 SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
+ ++K + LDLS+NQ+SG IP T+ L++L LSL+ N+ GPIP FG L+SL+ L
Sbjct: 977 PEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFL 1036
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPR 654
D+S NN+SG IPKSL+AL YLK LNVS+N+L+GEIP GPF NF+A+SF N ALCG P
Sbjct: 1037 DLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPH 1096
Query: 655 LQVPPC-KEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLS 713
QV C K + + + F LK+ILP +ISI+ + + ++ +IRR+ N +VP D
Sbjct: 1097 FQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRK-NLEVPTPIDSWL 1155
Query: 714 LATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTF 773
+ + S+ + AT+ F E NL+G+GS +VYKG L +G VA+KVFNL+ + AFR+F
Sbjct: 1156 PGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSF 1215
Query: 774 DSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIM 833
DSECE+++++RHRNLVKI + C N+DFKALVLE+MP GS +KWLYS+NYFLD++QRLNIM
Sbjct: 1216 DSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIM 1275
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
IDVA LEYLHH + +VHCDLKPNNILLD++M AHV DFGI++LL E +S+ QT T
Sbjct: 1276 IDVASALEYLHHDCP-SLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTE-TESMQQTKT 1333
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH 953
+ TIGYMAPEYGS+GIVS K DV+SYG++LME F RKKP DEMF G+++L+ WV ESL
Sbjct: 1334 LGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLAD 1392
Query: 954 GLTEVVDANLV-GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012
+ EVVDANL+ E++ F+ K CL SIM LAL C +SPE+RI M D LKKI+++
Sbjct: 1393 SMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIEL 1452
Query: 1013 L 1013
L
Sbjct: 1453 L 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482811|ref|XP_002270207.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 930 bits (2404), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/1088 (46%), Positives = 691/1088 (63%), Gaps = 84/1088 (7%)
Query: 10 TDQSALLAFKADVID-SRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGII 68
TDQSALLAFK+D+ID + S+L NW+ CNWVG+SC R RV AL L L G +
Sbjct: 32 TDQSALLAFKSDIIDPTHSILGGNWTQETSFCNWVGVSCSRRRQRVTALRLQKRGLKGTL 91
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKL------------------------RRLRL 104
P+LGNLSF+V LD+S N+F GHLP ELG L RRL
Sbjct: 92 SPYLGNLSFIVLLDLSNNSFGGHLPYELGHLYRLRILILQNNQLEGKIPPSISHCRRLEF 151
Query: 105 INFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSL 164
I+ A N LSG P +GIL +L L N+ IP L N+S LE L L E L+GS+
Sbjct: 152 ISLASNWLSGGIPEELGILPKLDSLLLGGNNLRGTIPSSLGNISTLELLGLRETGLTGSI 211
Query: 165 PNDI--------------------------RLPKLEKLYLGSNDFFGQIPSSLSEC---- 194
P+ I P +E+L N GQ+PS + C
Sbjct: 212 PSLIFNISSLLSIILTGNSISGSLSVDICQHSPNIEELLFTDNQLSGQLPSGIHRCRELL 271
Query: 195 --------------------THLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
+L+ L+L N +G +P +IGN+S L L L N +QG
Sbjct: 272 FASLSYNRFDGQIPEEIGSLRNLEELYLGGNHLTGPIPSSIGNISSLQILFLEDNKIQGS 331
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+P+ +GNL L +L L +N L+G +P IFNIS+++++++++N LSG+LP T G LPNL
Sbjct: 332 IPSTLGNLLNLSYLVLELNELTGAIPQEIFNISSLQILSVVKNNLSGNLPSTTGLGLPNL 391
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
L L GN L G IP S++N S+L +D+ +NLF+G IP + GNL+FL+ L+L N L
Sbjct: 392 MVLFLAGNGLSGKIPPSLSNYSQLTKIDIGNNLFTGPIPPSLGNLKFLQTLSLGENQLKV 451
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP 414
E + SF+++LTNCR L E+ + NPL GI+P IGN S +R A C+LKG IP
Sbjct: 452 EPG-RPELSFITALTNCRLLEEITMPNNPLGGIIPNSIGNLSNHVRNIVAFGCQLKGHIP 510
Query: 415 QEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
IG+L L L+L DN LNG IP+T+GR + LQ +++++N+L+G IP LC L L +L
Sbjct: 511 SGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNELEGPIPEELCGLRDLGEL 570
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLP 534
L N LSG+IP C+G+L+ L++L L SN+LT SIP+ LWSL +L++NLS NSL G LP
Sbjct: 571 SLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLGNLLFLNLSFNSLGGSLP 630
Query: 535 SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
S + L V+ ++DLS N+L G+IP + + L +L+L+ N F IPE+ G L +LE +
Sbjct: 631 SDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSFQEAIPETLGKLRALEFM 690
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPR 654
D+S NN+SG IPKS EAL +LK LN+S+N L GEIP GPF NF+AQSF N ALCG
Sbjct: 691 DLSQNNLSGTIPKSFEALSHLKYLNLSFNNLSGEIPNGGPFVNFTAQSFLENKALCGRSI 750
Query: 655 LQVPPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSL 714
L V PC ++ + SK LK++LP I ++V+ + + G ++ D+L
Sbjct: 751 LLVSPCPTNRTQESKTKQVLLKYVLPGIAAVVVFGALYYMLKNYRKGKLRIQNLVDLLPS 810
Query: 715 ATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFD 774
R SYL++QRAT+ F E NLLG GSFG VYKG L DGT VA+KV NL+LE AF++FD
Sbjct: 811 IQHRMISYLELQRATNSFCETNLLGVGSFGSVYKGILSDGTTVAVKVLNLRLEGAFKSFD 870
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
+EC++L +RHRNL+K+ SSC N+D +ALVL++M NGS EKWLYS+NY L++ QR++IM+
Sbjct: 871 AECKVLARIRHRNLIKVISSCSNLDVRALVLQYMSNGSLEKWLYSHNYCLNLFQRVSIML 930
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
DVAL LEYLHH S P+VHCDLKP+N+LLD++M AHV DFG++K+L E + VTQT T+
Sbjct: 931 DVALALEYLHHSQS-EPVVHCDLKPSNVLLDDDMVAHVGDFGLAKILVE-NKVVTQTKTL 988
Query: 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954
T+GY+APEYGSEG VS K DVYSYG++L+E FTRKKPTDEMF+ E+SLR+WV SLP
Sbjct: 989 GTLGYIAPEYGSEGRVSTKGDVYSYGIMLLEIFTRKKPTDEMFSEELSLRQWVNASLPEN 1048
Query: 955 LTEVVDANLVGEEQA------FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ EVVD L+ E + +++ LL+IM+L L+C + PE+R + D +L KI
Sbjct: 1049 VMEVVDGGLLSIEDGEAGGDVMATQSNLLLAIMELGLECSRDLPEERKGIKDVVVKLNKI 1108
Query: 1009 RVKFLQQS 1016
+++FL+++
Sbjct: 1109 KLQFLRRT 1116
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492792|ref|XP_002278117.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/1037 (48%), Positives = 672/1037 (64%), Gaps = 34/1037 (3%)
Query: 10 TDQSALLAFKADV-IDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGII 68
TDQ ALLAFK+ + S L +NW+ C WVG+SC + RV ALNLS G I
Sbjct: 35 TDQEALLAFKSQITFKSDDPLVSNWTTEASFCTWVGVSCSSHRQRVTALNLSFMGFQGTI 94
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQI 128
P +GNLSFL LD+S N+ +G LP +G LRRLR+IN N L G PS + RLQ
Sbjct: 95 SPCIGNLSFLTVLDLSNNSIHGQLPETVGHLRRLRVINLRSNNLEGKIPSSLSQCRRLQW 154
Query: 129 LSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-------------------- 168
L +N F IP + +LS LE LDL EN L+G++P+ I
Sbjct: 155 LLLRSNRFQGNIPKEIAHLSHLEELDLSENYLTGTIPSTIFNMSTLKYIDLVVNNLSGGI 214
Query: 169 ------RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLT 222
+LP LE LYL N G P+SL CT ++++ N F G +P +IG LS+L
Sbjct: 215 PTTICHKLPDLEVLYLSVNPLGGPFPASLCNCTSIRSISFNRNGFIGSIPADIGCLSKLE 274
Query: 223 DLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGH 282
L LA N L G +P ++GNL + L + NNLSG +P IFN+++ I+ + N+LSG
Sbjct: 275 GLGLAMNRLTGTIPLSLGNLSRMRRLRIAYNNLSGGIPEAIFNLTSAYAISFMGNRLSGS 334
Query: 283 LPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFL 342
+P LP L L L N L G IPNSI+NAS+L L+LS+NL +G +P + G+LRFL
Sbjct: 335 IPELTSLGLPKLNELNLRDNRLNGKIPNSISNASRLTFLELSNNLLNGPVPMSLGSLRFL 394
Query: 343 RFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKF 402
R LNL N L+ + S + FLSSLT CR L L + NP+ G+LP IGN S+SL F
Sbjct: 395 RTLNLQRNQLSNDPS-ERELHFLSSLTGCRDLINLVIGKNPINGVLPKSIGNLSSSLELF 453
Query: 403 EAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP 462
A ++KGS+P ++GNLS L+ L+L N+L GT+P+++G +LQ L L+ N ++G IP
Sbjct: 454 SADATQIKGSLPIKMGNLSNLLALELAGNDLIGTLPSSLGSLSRLQRLRLFINKIEGPIP 513
Query: 463 YYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYV 522
LC+L L +LLL+ N LSG IP C+G+L++++ + L SN L SIP +W+L + ++
Sbjct: 514 DELCNLRYLGELLLHENKLSGPIPTCIGNLSTMQVISLSSNALK-SIPPGMWNLNNLWFL 572
Query: 523 NLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIP 582
NLS NS++G LP I++LK+ DLS+NQLSG+IP IS LK L L+L+ N F G IP
Sbjct: 573 NLSLNSITGYLPPQIENLKMAETFDLSKNQLSGNIPGKISNLKMLRRLNLSDNAFQGSIP 632
Query: 583 ESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQS 642
+ L SLESLD+SSN +SG IP+S+E L YLK LN+S N L G++P GPF NF+ +S
Sbjct: 633 DGISELASLESLDLSSNKLSGIIPESMEKLRYLKYLNLSLNMLSGKVPTGGPFGNFTDRS 692
Query: 643 FSGNYALCGPPRLQVPPCKEDKGKGSKKAPFALKFI-LPLIISIVLIAIVIMFFIRRQNG 701
F GN LCG +L++ C D G S+K F LK++ LP+ +VL+A +I+ RR
Sbjct: 693 FVGNGELCGVSKLKLRACPTDSGPKSRKVTFWLKYVGLPIASVVVLVAFLIIIIKRRGKK 752
Query: 702 NTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKV 761
+ P R Y ++ AT+ F E NLLG GSFG VYKGTL D T A+K+
Sbjct: 753 KQEAPSWVQFSDGVAPRLIPYHELLSATNNFCEANLLGVGSFGSVYKGTLSDNTIAAVKI 812
Query: 762 FNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYN 821
+LQ+E A ++FD+ECE+LRNVRHRNLVKI SSC N+DF+ALVL++MPNGS E+ LYSYN
Sbjct: 813 LDLQVEGALKSFDAECEVLRNVRHRNLVKIISSCSNLDFRALVLQYMPNGSLERMLYSYN 872
Query: 822 YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881
YFLD+ QRLNIMIDVA +EYLHHG+S +VHCDLKP+N+LLDE M AHV+DFGI+K+
Sbjct: 873 YFLDLTQRLNIMIDVATAVEYLHHGYS-ETVVHCDLKPSNVLLDEEMVAHVNDFGIAKIF 931
Query: 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941
+ S+TQT T+ T+GY+APEYGSEG VS K DVYSYG++LMETFTRKKPT EMF G +
Sbjct: 932 AK-YKSMTQTATVGTMGYIAPEYGSEGRVSTKGDVYSYGIMLMETFTRKKPTHEMFVGGL 990
Query: 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKT--DCLLSIMDLALDCCMESPEQRIHMT 999
SLR+WV S P + EVVDANL+ +Q + CLLSIM L L C ++SPEQR+ M
Sbjct: 991 SLRQWVDSSFPDLIMEVVDANLLARDQNNTNGNLQTCLLSIMGLGLQCSLDSPEQRLDMK 1050
Query: 1000 DAAAELKKIRVKFLQQS 1016
+ L KIR +++ Q+
Sbjct: 1051 EVVVRLSKIRQQYISQT 1067
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1022 | ||||||
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.761 | 0.771 | 0.354 | 5.6e-167 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.699 | 0.707 | 0.352 | 2.1e-154 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.837 | 0.835 | 0.379 | 1.4e-144 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.708 | 0.702 | 0.333 | 1.8e-144 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.700 | 0.698 | 0.342 | 9.1e-141 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.913 | 0.796 | 0.329 | 1.2e-127 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.728 | 0.595 | 0.302 | 7.2e-121 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.773 | 0.782 | 0.341 | 6.4e-115 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.544 | 0.445 | 0.333 | 3.4e-114 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.569 | 0.512 | 0.334 | 6e-111 |
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1154 (411.3 bits), Expect = 5.6e-167, Sum P(2) = 5.6e-167
Identities = 286/806 (35%), Positives = 418/806 (51%)
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
K +R+ ++ +L G IG LS L L NNSF IP + NL +L++L +
Sbjct: 64 KHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGF 123
Query: 158 NSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
N L G +P + +L L L SN+ +PS L L L+L N G+ P I
Sbjct: 124 NYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIR 183
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
NL+ L LNL N+L+G++P I L + L L MNN SG PP +N+S++ + L+
Sbjct: 184 NLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLG 243
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
N SG+L G+ LPN+ L+L GN L G IP ++ N S L + N +G I F
Sbjct: 244 NGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNF 303
Query: 337 GXXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
G + S +FL +LTNC L L+++ N L G LP I N S
Sbjct: 304 GKLENLHYLELANNSLGSYSF--GDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMS 361
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
L + GSIP +IGNL GL L L DN L G +PT++G L L L+ N
Sbjct: 362 TELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNR 421
Query: 457 LQGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
G IP ++ +L + +P LG + + +L +G N L +IP + +
Sbjct: 422 FSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQI 481
Query: 517 EYILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
++++ I L+ L+ L L N LSG +P T+ + + L N
Sbjct: 482 PTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENH 541
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFR 636
F+G IP+ G L+ ++++D+S+NN+SG I + E L+ LN+S N EG +P +G F+
Sbjct: 542 FDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQ 600
Query: 637 NFSAQSFSGNYALCGPPR-LQVPPCKEDKGKGSKKAPFALKFXXXXXXXXXXXXXXXMFF 695
N + S GN LCG + L++ PC + P LK +F
Sbjct: 601 NATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLK-KVAIGVSVGIALLLLLFI 659
Query: 696 I-----RRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGT 750
+ +++ N K+ + SY D++ ATDGF+ N++G GSFG V+K
Sbjct: 660 VSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKAL 719
Query: 751 L-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF-----KALV 804
L + VA+KV N+Q A ++F +ECE L+++RHRNLVK+ ++C +IDF +AL+
Sbjct: 720 LQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALI 779
Query: 805 LEFMPNGSFEKWLYSYNY--------FLDILQRLNIMIDVALVLEYLH-HGHSLAPIVHC 855
EFMPNGS +KWL+ L +L+RLNI IDVA VL+YLH H H PI HC
Sbjct: 780 YEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHE--PIAHC 837
Query: 856 DLKPNNILLDENMTAHVSDFGISKLL 881
DLKP+NILLD+++TAHVSDFG+++LL
Sbjct: 838 DLKPSNILLDDDLTAHVSDFGLARLL 863
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 2.1e-154, Sum P(2) = 2.1e-154
Identities = 260/737 (35%), Positives = 383/737 (51%)
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
K +R+ + +L G IG LS L L + N F IP + LS+LE+LD+
Sbjct: 64 KNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGI 123
Query: 158 NSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
N L G +P + +L L L SN G +PS L T+L L L N G+LP ++G
Sbjct: 124 NYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLG 183
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
NL+ L L L+ NNL+G++P+ + L + L L NN SG PP ++N+S+++L+ +
Sbjct: 184 NLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGY 243
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
N SG L LG LPNL + GN G+IP +++N S L L ++ N +G IP TF
Sbjct: 244 NHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TF 302
Query: 337 GXXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
G ++SS FL+SLTNC L L + N L G LP I N S
Sbjct: 303 GNVPNLKLLFLHTNSLGSDSSR--DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLS 360
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
A L + + GSIP +IGNL L L LD N L+G +PT++G+ L+ LSL+ N
Sbjct: 361 AKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNR 420
Query: 457 LQGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
L G IP ++ ++ +P LG+ + L EL +G N L +IP + +
Sbjct: 421 LSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKI 480
Query: 517 EYILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
+ +L + I L+ L L L N+LSG +P T+ + +L L GN
Sbjct: 481 QQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNL 540
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFR 636
F G IP+ G L+ ++ +D+S+N++SG IP+ + L+ LN+S+N LEG++P+KG F
Sbjct: 541 FYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFE 599
Query: 637 NFSAQSFSGNYALCGPPR-LQVPPCKEDKGKGSKKAPFALKFXXXXXXXXXXX------X 689
N + S GN LCG Q+ PC KK LK
Sbjct: 600 NATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMA 659
Query: 690 XXXMFFIRRQNGN--TKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVY 747
+ ++R++ N T P + L + SY D++ AT+GF+ N++G GSFG VY
Sbjct: 660 SVTLIWLRKRKKNKETNNPTPSTLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVY 717
Query: 748 KGTLFDGTNV-AIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF-----K 801
K L V A+KV N+Q A ++F +ECE L+++RHRNLVK+ ++C +IDF +
Sbjct: 718 KALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFR 777
Query: 802 ALVLEFMPNGSFEKWLY 818
AL+ EFMPNGS + WL+
Sbjct: 778 ALIYEFMPNGSLDMWLH 794
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
Identities = 337/887 (37%), Positives = 483/887 (54%)
Query: 110 NELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI- 168
+ LSG +G LS L+ L +N + IP L LS+L+ L+L +NS+ GS+P I
Sbjct: 89 SNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIG 148
Query: 169 RLPKLEKLYLGSNDFFGQIPSSL-SECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLA 227
KL L L N G IP + + HL L+L N SG +P +GNL+ L + +L+
Sbjct: 149 ACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLS 208
Query: 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTL 287
N L G +P+++G L L +NLG NNLSG +P +I+N+S++R ++ EN+L G +P
Sbjct: 209 FNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNA 268
Query: 288 GHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGXXXXXXXXXX 347
+L LE + + N G IP S+ NAS L + + NLFSG I FG
Sbjct: 269 FKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYL 328
Query: 348 XXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKC 407
T D W F+S LTNC L L L N L G+LP N S SL F A++
Sbjct: 329 WRNLFQTREQ--DDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSL-SFLALEL 385
Query: 408 -ELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC 466
++ GSIP++IGNL GL L L +N G++P+++GR + L L Y+N+L GSIP +
Sbjct: 386 NKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIG 445
Query: 467 HLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYI-LYVXXX 525
+L IP L +LT+L L L +N L+ IPS L++++ + + +
Sbjct: 446 NLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVS 505
Query: 526 XXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF 585
I HLK L+ N+LSG IP T+ + L L L N +G IP +
Sbjct: 506 KNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSAL 565
Query: 586 GSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSG 645
G L LE+LD+SSNN+SG+IP SL + L LN+S+N GE+P G F S S G
Sbjct: 566 GQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQG 625
Query: 646 NYALCGP-PRLQVPPCKEDKGKGSKKAPFALKFXXXXXXXXXXXXXXXMFFIRRQNGNTK 704
N LCG P L +P C + K P L + +
Sbjct: 626 NAKLCGGIPDLHLPRCCPLL-ENRKHFP-VLPISVSLAAALAILSSLYLLITWHKRTKKG 683
Query: 705 VPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNL 764
P + S+ SY + +ATDGF NLLG GSFG VYKG L +VA+KV L
Sbjct: 684 APSRT---SMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKL 740
Query: 765 QLERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FKALVLEFMPNGSFEKWLY- 818
+ +A ++F +ECE LRN+RHRNLVKI + C +ID FKA+V +FMPNGS E W++
Sbjct: 741 ENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHP 800
Query: 819 -----SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873
+ L++ +R+ I++DVA L+YLH H P+VHCD+K +N+LLD +M AHV
Sbjct: 801 ETNDQADQRHLNLHRRVTILLDVACALDYLHR-HGPEPVVHCDIKSSNVLLDSDMVAHVG 859
Query: 874 DFGISKLLGEGDDSVTQTIT----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 929
DFG++++L +G + Q+ + + TIGY APEYG I S D+YSYG+L++E T
Sbjct: 860 DFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTG 919
Query: 930 KKPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLVGEEQAFSAKTD 975
K+PTD F ++ LR++V+ L HG +T+VVD L+ + + + T+
Sbjct: 920 KRPTDSTFRPDLGLRQYVELGL-HGRVTDVVDTKLILDSENWLNSTN 965
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 1.8e-144, Sum P(2) = 1.8e-144
Identities = 250/750 (33%), Positives = 380/750 (50%)
Query: 100 RRLRLI--NFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
RR R+I N +L+G IG LS L++L+ +NSF IP + L +L++L++
Sbjct: 71 RRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSY 130
Query: 158 NSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
N L G +P+ + +L + L SN +PS L + L L L+ N +G P ++G
Sbjct: 131 NLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLG 190
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
NL+ L L+ A N ++G++P + L + + +N+ SG PP ++NIS++ ++L +
Sbjct: 191 NLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLAD 250
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
N SG+L G+ LPNL L L N G IP ++ N S L D+SSN SG IP +F
Sbjct: 251 NSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSF 310
Query: 337 GXXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
G SS + F+ ++ NC L L + N L G LP I N S
Sbjct: 311 GKLRNLWWLGIRNNSLGNNSSSGLE--FIGAVANCTQLEYLDVGYNRLGGELPASIANLS 368
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
+L + + G+IP +IGNL L L L+ N L+G +P + G+ LQ + LY N
Sbjct: 369 TTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNA 428
Query: 457 LQGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
+ G IP Y ++ R IP LG L +L + +N L +IP + +
Sbjct: 429 ISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQI 488
Query: 517 EYILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
+ Y+ + L++L+ L S N+LSG +P I G + L + GN
Sbjct: 489 PSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNS 548
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFR 636
F+G IP+ L+SL+++D S+NN+SG+IP+ L +L L+ LN+S N+ EG +P G FR
Sbjct: 549 FDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFR 607
Query: 637 NFSAQSFSGNYALCGPPR-LQVPPC----KEDKGKG---SKKAPFALKFXXXXXXXXXXX 688
N +A S GN +CG R +Q+ PC K K KK +
Sbjct: 608 NATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIV 667
Query: 689 XXXXMFFIRRQNGNTKVPVKEDVLSLATWR-RTSYLDIQRATDGFNECNLLGRGSFGLVY 747
F R++ N D +L + + SY ++ AT F+ NL+G G+FG V+
Sbjct: 668 ASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVF 727
Query: 748 KGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FK 801
KG L + VA+KV NL A ++F +ECE + +RHRNLVK+ + C ++D F+
Sbjct: 728 KGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFR 787
Query: 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLN 831
ALV EFMP GS + WL L+ L+R+N
Sbjct: 788 ALVYEFMPKGSLDMWLQ-----LEDLERVN 812
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 9.1e-141, Sum P(2) = 9.1e-141
Identities = 253/738 (34%), Positives = 368/738 (49%)
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
K RR+ ++ +L+G ++G LS L+ L+ +N F IP + NL +L++L++
Sbjct: 79 KHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSN 138
Query: 158 NSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
N G +P + L L L SN +P + L L L N +G+ P ++G
Sbjct: 139 NLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLG 198
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
NL+ L L+ N ++G++P I L+ + + +N +G PP I+N+S++ +++
Sbjct: 199 NLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITG 258
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
N SG L G LPNL+ L + N+ GTIP +++N S L LD+ SN +G IP +F
Sbjct: 259 NSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSF 318
Query: 337 GXXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
G SS FL +LTNC L L + N L G LP FI N S
Sbjct: 319 GRLQNLLLLGLNNNSLGNYSS--GDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLS 376
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
L + + GSIP IGNL L L L +N L G +P ++G +L+ + LY N
Sbjct: 377 TQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNG 436
Query: 457 LQGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
L G IP L ++ +IP+ LGS + L +L+LG+N L SIP L L
Sbjct: 437 LSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMEL 496
Query: 517 EYILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
++ + I LK L+ LD+S N+LSG IP T++ L L L GN
Sbjct: 497 PSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNS 556
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFR 636
F GPIP+ G L L LD+S NN+SG IP+ + L+ LN+S N +G +P +G FR
Sbjct: 557 FVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFR 615
Query: 637 NFSAQSFSGNYALCGP-PRLQVPPCKEDKGKGSKKAPFALKFXXXXXXXXXXXXXXXMFF 695
N SA S GN LCG P LQ+ PC + + + + +
Sbjct: 616 NTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVY 675
Query: 696 I-----R----RQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLV 746
+ R R N N V S + + SY ++ + T GF+ NL+G G+FG V
Sbjct: 676 LCWYKLRVKSVRANNNENDRSFSPVKSF--YEKISYDELYKTTGGFSSSNLIGSGNFGAV 733
Query: 747 YKGTLFDGTN-VAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF----- 800
+KG L VAIKV NL A ++F +ECE L +RHRNLVK+ + C + DF
Sbjct: 734 FKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDF 793
Query: 801 KALVLEFMPNGSFEKWLY 818
+ALV EFMPNG+ + WL+
Sbjct: 794 RALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 320/970 (32%), Positives = 497/970 (51%)
Query: 64 LGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGIL 123
L G IP +G L+ L LD+S N G +P + G L L+ + N L G P+ IG
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 124 SRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSND 182
S L L ++N T +IP L NL +L+ L + +N L+ S+P+ + RL +L L L N
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNL 242
G I + L+ L L N F+G P++I NL LT L + NN+ G++P +G L
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLL 383
Query: 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
L +L+ N L+GP+P +I N + ++L++L NQ++G +P G NL F+++ N
Sbjct: 384 TNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGRN 441
Query: 303 NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGXXXXXXXXXXXXXXXTTESSPADQW 362
+ G IP+ I N S L L ++ N +G + G T P +
Sbjct: 442 HFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLT---GPIPR- 497
Query: 363 SFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSG 422
+ N + L L L+ N G +P + N + L+ +L+G IP+E+ ++
Sbjct: 498 ----EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKL 552
Query: 423 LMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERXXXXXXXXXXXX 482
L L L +N+ +G IP + + L LSL N GSIP L L
Sbjct: 553 LSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLT 612
Query: 483 XAIPA-CLGSLTSLR-ELHLGSNTLTYSIPSSLWSLEYILYVXXXXXXXXXXXXXXIQHL 540
IP L SL +++ L+ +N LT +IP L LE + + +Q
Sbjct: 613 GTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQAC 672
Query: 541 KVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSN 599
K + LD S+N LSG IP + G+ + +L+L+ N F+G IP+SFG++ L SLD+SSN
Sbjct: 673 KNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSN 732
Query: 600 NISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPP 659
N++G+IP+SL L LK L ++ N L+G +P G F+N +A GN LCG + + P
Sbjct: 733 NLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKP 791
Query: 660 C--KEDKGKGSKKAPFALKFXXXXXXXXXXXXXXXMFFIRRQNG----NTKVPVKEDVLS 713
C K+ SK+ L + ++ N+ D+ S
Sbjct: 792 CTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDS 851
Query: 714 LATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ--LERAFR 771
+R ++++ATD FN N++G S VYKG L DGT +A+KV NL+ + +
Sbjct: 852 ALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDK 911
Query: 772 TFDSECEILRNVRHRNLVKIFSSCCNID-FKALVLEFMPNGSFEKWLY-SYNYFLDILQR 829
F +E + L ++HRNLVKI KALVL FM NG+ E ++ S +L++
Sbjct: 912 WFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEK 971
Query: 830 LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889
+++ + +A ++YLH G+ PIVHCDLKP NILLD + AHVSDFG +++LG +D T
Sbjct: 972 IDLCVHIASGIDYLHSGYGF-PIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGST 1030
Query: 890 QTITMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPT--DEMFTGEMSLR 944
T A TIGY+APE+ V+ K DV+S+G+++ME T+++PT ++ + +M+LR
Sbjct: 1031 TASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLR 1090
Query: 945 RWVKESLPHG---LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ V++S+ +G + V+D L G+ + + + + L L C PE R M +
Sbjct: 1091 QLVEKSIGNGRKGMVRVLDMEL-GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEI 1149
Query: 1002 AAELKKIRVK 1011
L K+R K
Sbjct: 1150 LTHLMKLRGK 1159
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 7.2e-121, Sum P(2) = 7.2e-121
Identities = 238/788 (30%), Positives = 369/788 (46%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
LNL L G+IP L L+ L +LD+S NN G + E ++ +L + A N LSGS
Sbjct: 269 LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328
Query: 117 PSWI-GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLE 174
P I + L+ L + IP + N L+ LDL N+L+G +P+ + +L +L
Sbjct: 329 PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
LYL +N G + SS+S T+LQ L N G++P+ IG L +L + L +N G+
Sbjct: 389 NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
MP IGN L+ ++ N LSG +P +I + + ++L EN+L G++P +LG+ +
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC-HQM 507
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGXXXXXXXXXXXXXXXTT 354
+ L N L G+IP+S + L + +N G++P +
Sbjct: 508 TVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNG 567
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNV--NPLRGILPPFIGNFSASLRKFEAIKCELKGS 412
SP C S + L+ +V N G +P +G S +L + K + G
Sbjct: 568 SISPL-----------CGSSSYLSFDVTENGFEGDIPLELGK-STNLDRLRLGKNQFTGR 615
Query: 413 IPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERXX 472
IP+ G +S L L + N L+G IP +G ++L + L +N L G IP +L L
Sbjct: 616 IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675
Query: 473 XXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVXXXXXXXXXX 532
++P + SLT++ L L N+L SIP + +L+ + +
Sbjct: 676 ELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGP 735
Query: 533 XXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDL-ATLSLAGNQFNGPIPESFGSLISL 591
I L L L LSRN L+G+IP+ I L+DL + L L+ N F G IP + +L L
Sbjct: 736 LPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKL 795
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCG 651
ESLD+S N + G++P + + L LN+SYN LEG++ K F + A +F GN LCG
Sbjct: 796 ESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCG 853
Query: 652 PPRLQVPPCKEDKGKG----SKKAPFALKFXXXXXXXXXXXXXXXMFFIRRQNGNTKVPV 707
P + C K S K + +FF + + KV
Sbjct: 854 SP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRG 910
Query: 708 KEDVLSLATWRRTSYL-------------DIQRATDGFNECNLLGRGSFGLVYKGTLFDG 754
S + + L DI AT NE ++G G G VYK L +G
Sbjct: 911 GNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNG 970
Query: 755 TNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCN-ID-FKALVLEFMPNG 811
+A+K + + + ++F+ E + L +RHR+LVK+ C + D L+ E+M NG
Sbjct: 971 ETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANG 1030
Query: 812 SFEKWLYS 819
S WL++
Sbjct: 1031 SVWDWLHA 1038
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
Identities = 283/828 (34%), Positives = 420/828 (50%)
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
K +R+ +N +L G IG +S L L +N+F IP + NL +LE L +
Sbjct: 64 KHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAF 123
Query: 158 NSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
NSL G +P + +L L L SN +PS L T L L L N G+LP ++G
Sbjct: 124 NSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLG 183
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
NL+ L L NN++G++P + L + L L MN G PP I+N+S + + L
Sbjct: 184 NLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFG 243
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
+ SG L G+ LPN+ L L N+L+G IP +++N S L ++ N+ +G I F
Sbjct: 244 SGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNF 303
Query: 337 GXXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
G S F+ SLTNC L L++ L G LP I N S
Sbjct: 304 GKVPSLQYLDLSEN--PLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMS 361
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
L I GSIPQ+IGNL GL L+L N L G +PT++G+ +L LSLY N
Sbjct: 362 TELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNR 421
Query: 457 LQGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
+ G IP ++ +L + +P LG + + +L +G N L +IP + +
Sbjct: 422 MSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQI 481
Query: 517 EYILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
++ + I L+ L+ L L N+ SG +P T+ + L L GN
Sbjct: 482 PTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNS 541
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFR 636
F+G IP G L+ + +D+S+N++SG IP+ L+ LN+S N G++P KG F+
Sbjct: 542 FDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQ 600
Query: 637 NFSAQSFSGNYALCG--------PPRLQVPPCKEDKGKGSKKAPFALKFXXXXXXXXXXX 688
N + GN LCG P Q PP + KK +
Sbjct: 601 NSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIA 660
Query: 689 XXXXMFFIRR---QNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGL 745
+F +R Q N VP K ++ + SY D++ AT+GF+ N++G GSFG
Sbjct: 661 SMVLCWFRKRRKNQQTNNLVPSKLEIFH----EKISYGDLRNATNGFSSSNMVGSGSFGT 716
Query: 746 VYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF---- 800
V+K L + VA+KV N+Q A ++F +ECE L++ RHRNLVK+ ++C + DF
Sbjct: 717 VFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNE 776
Query: 801 -KALVLEFMPNGSFEKWLYSYNY--------FLDILQRLNIMIDVALVLEYLH-HGHSLA 850
+AL+ E++PNGS + WL+ L +L+RLNI+IDVA VL+YLH H H
Sbjct: 777 FRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHE-- 834
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSVTQTITMATI 897
PI HCDLKP+N+LL++++TAHVSDFG+++LL + D +S ++ A +
Sbjct: 835 PIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGV 882
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 3.4e-114, Sum P(2) = 3.4e-114
Identities = 198/594 (33%), Positives = 294/594 (49%)
Query: 64 LGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGIL 123
L G IP LG L L L+++ N+ G +P++LG++ +L+ ++ N+L G P + L
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286
Query: 124 SRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSN 181
LQ L N+ T IP+ N+S+L L L N LSGSLP I LE+L L
Sbjct: 287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 182 DFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGN 241
G+IP LS+C L+ L L++N +G +PE + L +LTDL L N L+G + +I N
Sbjct: 347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406
Query: 242 LQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFG 301
L L+ L L NNL G +P I + + ++ L EN+ SG +P +G+ +L+ + +FG
Sbjct: 407 LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCT-SLKMIDMFG 465
Query: 302 NNLIGTIPNSI----------TNASKLIG--------------LDLSSNLFSGHIPHTFG 337
N+ G IP SI ++L+G LDL+ N SG IP +FG
Sbjct: 466 NHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFG 525
Query: 338 XXXXXXXXXXXXXXXTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSA 397
Q + SL + R+LT + L+ N L G + P G S+
Sbjct: 526 FLKGLEQLMLYNNSL--------QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SS 575
Query: 398 SLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDL 457
S F+ + IP E+GN L L+L N+L G IP T+G+ ++L L + N L
Sbjct: 576 SYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNAL 635
Query: 458 QGSIPYYLCHLERXXXXXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517
G+IP L ++ IP LG L+ L EL L SN S+P+ L++
Sbjct: 636 TGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCT 695
Query: 518 YILYVXXXXXXXXXXXXXXIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQF 577
+L + I +L L L+L +NQ SG +P + L L L L+ N
Sbjct: 696 KLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSL 755
Query: 578 NGPIPESFGSLISLES-LDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
G IP G L L+S LD+S NN +G IP ++ L L+ L++S+N+L GE+P
Sbjct: 756 TGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVP 809
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 750 (269.1 bits), Expect = 6.0e-111, Sum P(2) = 6.0e-111
Identities = 200/598 (33%), Positives = 299/598 (50%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L +S+ +L G I +G+ S L+ +D+S N+ G +P+ LGKL+ L+ + N L+G
Sbjct: 111 LVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKI 170
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENS-LSGSLPNDI-RLPKLE 174
P +G L+ L +N ++ +P L +S LE + NS LSG +P +I L+
Sbjct: 171 PPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLK 230
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L L + G +P SL + + LQ+L + SG +P+ +GN S+L +L L N+L G
Sbjct: 231 VLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGT 290
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+P +G LQ LE + L NNL GP+P I + ++ I+L N SG +P + G+ L NL
Sbjct: 291 LPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGN-LSNL 349
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGXXXXXXXXXXXXXXXTT 354
+ L L NN+ G+IP+ ++N +KL+ + +N SG IP G
Sbjct: 350 QELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKL-- 407
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSA-SLRKFEAIKCELKGSI 413
E + D+ L C++L L L+ N L G LP G F +L K I + G I
Sbjct: 408 EGNIPDE------LAGCQNLQALDLSQNYLTGSLPA--GLFQLRNLTKLLLISNAISGVI 459
Query: 414 PQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERXXX 473
P EIGN + L+ L+L +N + G IP +G Q L L L +N+L G +P + + +
Sbjct: 460 PLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQM 519
Query: 474 XXXXXXXXXXAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVXXXXXXXXXXX 533
+P L SLT L+ L + SN LT IP SL L + +
Sbjct: 520 LNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEI 579
Query: 534 XXXIQHLKVLINLDLSRNQLSGDIPITISGLKDL-ATLSLAGNQFNGPIPESFGSLISLE 592
+ H L LDLS N +SG IP + ++DL L+L+ N +G IPE +L L
Sbjct: 580 PSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLS 639
Query: 593 SLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALC 650
LD+S N +SG + +L L L LN+S+NR G +P FR GN LC
Sbjct: 640 VLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLC 696
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3795 | 0.9305 | 0.9415 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025217001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1022 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-118 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 386 bits (994), Expect = e-118
Identities = 305/993 (30%), Positives = 472/993 (47%), Gaps = 100/993 (10%)
Query: 15 LLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGN 74
LL+FK+ + D L+N W+ S +C W GI+C RVV+++LS ++ G I +
Sbjct: 34 LLSFKSSINDPLKYLSN-WNSSADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFR 91
Query: 75 LSFLVSLDISENNFYGHLPNELGKL-RRLRLINFAYNELSGSFPSWIGILSRLQILSFHN 133
L ++ ++++S N G +P+++ LR +N + N +GS P G + L+ L N
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSN 149
Query: 134 NSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLS 192
N + IP+ + + S L+ LDL N L G +PN + L LE L L SN GQIP L
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 193 ECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGM 252
+ L+ ++L N SG +P IG L+ L L+L NNL G +P+++GNL+ L++L L
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 253 NNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI 312
N LSGP+PP+IF++ + ++L +N LSG +P L L NLE L LF NN G IP ++
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 313 TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCR 372
T+ +L L L SN FSG IP +L
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIP--------------------------------KNLGKHN 356
Query: 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNE 432
+LT L L+ N L G IP+ + + L L L N
Sbjct: 357 NLTVLDLSTN-------------------------NLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 433 LNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSL 492
L G IP ++G + L+ + L DN G +P L + L ++ NNL G I + +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 493 TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQ 552
SL+ L L N +P S S + + ++LS N SG +P + L L+ L LS N+
Sbjct: 452 PSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 553 LSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEAL 612
LSG+IP +S K L +L L+ NQ +G IP SF + L LD+S N +SG+IPK+L +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 613 LYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQ-VPPCKEDKGKGSKKA 671
L ++N+S+N L G +P G F +A + +GN LCG +PPCK + + +
Sbjct: 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK--RVRKTPSW 628
Query: 672 PFALKFILPLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATW-------RRTSYLD 724
F + L + + L+A +F R N K ED TW + + +
Sbjct: 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSIT 684
Query: 725 IQRATDGFNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV 783
I E N++ RG G YKG ++ +G +K N SE + +
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN----DVNSIPSSEIADMGKL 740
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
+H N+VK+ C + L+ E++ + + L + L +R I I +A L +L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFL 796
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE 903
H S A +V +L P I++D H+ + LL T T + Y+APE
Sbjct: 797 HCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPE 848
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH-GLTEVVDAN 962
++ K D+Y +G++L+E T K P D F S+ W + L +D +
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908
Query: 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
+ G+ S + ++ +M+LAL C P R
Sbjct: 909 IRGD---VSVNQNEIVEVMNLALHCTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 68/192 (35%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSC 795
LG G FG VY G VAIK+ + + E EIL+ + H N+VK++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+ + LV+E+ GS + L L + L I++ + LEYLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS----NGIIHR 116
Query: 856 DLKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-YGSEGIVSAK 913
DLKP NILLD N ++DFG+SKLL + + T YMAPE +G S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEK 174
Query: 914 CDVYSYGVLLME 925
D++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 67/200 (33%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKIFS 793
LG GSFG VY G VAIKV + + R E +IL+ ++H N+V+++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLAPI 852
+ D LV+E+ G L + + + LEYLH G I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG-----I 118
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
VH DLKP NILLDE+ ++DFG+++ L G+ T + T YMAPE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGKGYGK 175
Query: 913 KCDVYSYGVLLMETFTRKKP 932
D++S GV+L E T K P
Sbjct: 176 AVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 73/200 (36%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRNLVKIFSS 794
LG GSFG VYK G VA+K+ + E+ +T E ILR + H N+V++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
+ D LV+E+ G +L + I + + LEYLH I+H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLHS----NGIIH 121
Query: 855 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVSA 912
DLKP NILLDEN ++DFG++K L S T T YMAPE G G
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGY-GP 178
Query: 913 KCDVYSYGVLLMETFTRKKP 932
K DV+S GV+L E T K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 82/279 (29%), Positives = 123/279 (44%), Gaps = 39/279 (13%)
Query: 738 LGRGSFGLVYKGTLFD-----GTNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKG L VA+K E+ F E I+R + H N+VK+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C + +V+E+M G +L L + L+ + +A +EYL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN---- 122
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+H DL N L+ EN+ +SDFG+S+ L + DD + I +MAPE EG +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKE----SLPHGLTEVVDANLVGE 966
+K DV+S+GVLL E FT ++P M + E + ++K P
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGM-SNE-EVLEYLKNGYRLPQPP------------- 226
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005
+C + DL L C E PE R ++ L
Sbjct: 227 --------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 81/270 (30%), Positives = 119/270 (44%), Gaps = 40/270 (14%)
Query: 738 LGRGSFGLVYKGTLFDG-----TNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKGTL VA+K E+ F E I+R + H N+VK+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
C + +V+E+MP G +L L + L+ + +A +EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---- 122
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
+H DL N L+ EN+ +SDFG+S+ L + DD I +MAPE EG
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 911 SAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKE----SLPHGLTEVVDANLVG 965
++K DV+S+GVLL E FT ++P M + + ++K+ P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGM-SNA-EVLEYLKKGYRLPKPP------------ 227
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
+C + L L C E PE R
Sbjct: 228 ---------NCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 78/275 (28%), Positives = 118/275 (42%), Gaps = 40/275 (14%)
Query: 738 LGRGSFGLVYKGTLFD-----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKGTL T VA+K E F E I++ + H N+V+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR- 65
Query: 792 FSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
C +V E+MP G +L + L + L + + +A +EYL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--- 122
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
VH DL N L+ EN+ +SDFG+S+ + E D + I +MAPE +G
Sbjct: 123 -FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 911 SAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESL----PHGLTEVVDANLVG 965
++K DV+S+GVLL E FT ++P M E+ +++ P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV--LELLEDGYRLPRPEN----------- 228
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTD 1000
C + +L L C PE R ++
Sbjct: 229 ----------CPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 76/280 (27%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 736 NLLGRGSFGLVYKGTLFDGTN----VAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVK 790
LG G+FG VYKG L VA+K R F E +++ + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 791 IFSSCCNIDFK-ALVLEFMPNGSFEKWL--------YSYNYFLDILQRLNIMIDVALVLE 841
+ C + LVLE+M G +L L + L+ I +A +E
Sbjct: 61 LLG-VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL VH DL N L+ E++ +SDFG+S+ + + D +T I +MA
Sbjct: 120 YLAS----KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960
PE +GI ++K DV+S+GVLL E FT P + E+ ++++
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRK----------- 222
Query: 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTD 1000
G C + +L L C PE R ++
Sbjct: 223 ----GYRLPKPE--YCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 736 NLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIF 792
LLGRGSFG VY D G +A+K L E + E IL +++H N+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 793 SSCCNIDFKAL--VLEFMPNGSFEKWLYSY---------NYFLDILQRLNIMIDVALVLE 841
S + + L LE++ GS L + Y IL+ L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL----------A 115
Query: 842 YLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
YLH +G IVH D+K NIL+D + ++DFG +K LG+ + T +M
Sbjct: 116 YLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
APE D++S G ++E T K P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
F LG G FG V++G + VAIK+ + F E + L+ +RH++L+ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLA 850
F+ C + ++ E M GS +L S L + +++ VA + YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
+H DL NIL+ E++ V+DFG+++L+ +D + + APE S G
Sbjct: 125 -SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 911 SAKCDVYSYGVLLMETFTRKK-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969
S K DV+S+G+LL E FT + P M E+ + +P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------------- 224
Query: 970 FSAKTDCLLSIMDLALDCCMESPEQR 995
C I + L+C PE R
Sbjct: 225 --CPAKCPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKIFSSC 795
+G+G+FG VYKG L T VA+K L + F E EIL+ H N+VK+ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V+E +P GS +L L + + L + +D A +EYL + +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC----IHR 117
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ EN +SDFG+S+ G +V+ + I + APE + G +++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 916 VYSYGVLLMETFT 928
V+SYG+LL ETF+
Sbjct: 178 VWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 19/284 (6%)
Query: 736 NLLGRGSFGLVYKGT---LFDGTN--VAIKVFNLQLERAFRT-FDSECEILRNVRHRNLV 789
LG G FG V L D T VA+K N E R+ F+ E EILR + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 790 KIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
K + C L++E++P+GS +L + +++ + L + ++YL
Sbjct: 70 K-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT-QTITMATIGYMAPEYG 905
+H DL NIL++ +SDFG++K+L E D + + I + APE
Sbjct: 129 R----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965
S+ DV+S+GV L E FT P+ LR +T ++ L+
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA--EFLRMIGIAQGQMIVTRLL--ELLK 240
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
E + C + DL C P+ R D + ++R
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSC 795
LLG+G+FG V+KGTL D T VA+K L + + F SE IL+ H N+VK+ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V+E +P G F +L L Q + +D A + YL +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHR 117
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSV--TQTITMATIGYMAPEYGSEGIVSAK 913
DL N L+ EN +SDFG+S+ + DD + + + I + APE + G S++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 914 CDVYSYGVLLMETFT 928
DV+SYG+LL ETF+
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 738 LGRGSFGLVYK------GTLFDGTNVAIKVFNLQLERAFRTFD---SECEILRNVRHRNL 788
LG+GSFG V G L+ A+KV + + + +E IL + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 789 VKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
VK+ + F+ LVLE+ P G L F + R ++ L LEYL
Sbjct: 56 VKLHYA-----FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYL 109
Query: 844 H-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMA 901
H G I++ DLKP NILLD + ++DFG++K E ++T T T Y+A
Sbjct: 110 HSLG-----IIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLA 161
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
PE D +S GVLL E T K P F E
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G FG VYK G VAIKV L+ + +E +IL+ +H N+VK + S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+EF GS + L S N L Q + ++ LEYLH I+H D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----IIHRD 123
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEYGSEGIVSAKCD 915
+K NILL + + DFG+S L + TM T +MAPE + K D
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDT----KARNTMVGTPYWMAPEVINGKPYDYKAD 179
Query: 916 VYSYGVLLMETFTRKKP 932
++S G+ +E K P
Sbjct: 180 IWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 48/217 (22%)
Query: 738 LGRGSFGLVYKGTLFDGTN--VAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVK---I 791
LG+GS G+VYK T A+K ++ + FR E + LR+ +VK
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIM--IDVALV-------LEY 842
F I ++VLE+M GS D+L+++ + +A + L+Y
Sbjct: 68 FYKEGEI---SIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-MATIGYMA 901
LH I+H D+KP+N+L++ ++DFGISK+L ++++ Q T + T+ YM+
Sbjct: 115 LHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMS 168
Query: 902 PE------YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE Y S D++S G+ L+E K P
Sbjct: 169 PERIQGESY------SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVK 790
LG G+FG V+ G + D VA+K A + F+ E E+L N +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL-------------QRLNIMIDVA 837
+ C D +V E+M +G K+L S+ L Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+ YL H VH DL N L+ ++ + DFG+S+ + D TM I
Sbjct: 133 SGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLT 956
+M PE + + DV+S+GV+L E FT K+P + E+
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI-------------- 234
Query: 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
E + + + C + D+ L C P+QRI++ D L+K
Sbjct: 235 ECITQGRLLQR-----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 46/226 (20%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNL------QLERAFRTFDSECEILRNVRHRNL 788
+G+GSFG VY DG +K +L + E A E +IL+ + H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 789 VKIFSS-----CCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL---QRLNIMIDVALVL 840
+K + S I V+E+ G + + Q L+ + + L L
Sbjct: 62 IKYYESFEEKGKLCI-----VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
+YLH I+H D+KP NI L N + DFGISK+L + +T+ T Y+
Sbjct: 117 KYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYL 170
Query: 901 APE------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
+PE Y + K D++S G +L E T K P F GE
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 12/193 (6%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G FG V G + G VA+K A + F +E ++ +RH NLV++
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 797 NIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+ +V E+M GS +L S + + Q+L +DV +EYL + VH
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN----FVHR 126
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N+L+ E++ A VSDFG++K + S Q + + APE E S K D
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 916 VYSYGVLLMETFT 928
V+S+G+LL E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 2e-24
Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 731 GFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER---AFRTFDSECEILRNVRH-R 786
+ LG GSFG VY D VA+KV +LE F E +IL ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWL--YSYNYFLDILQRLNIMIDVALVLEYLH 844
N+VK++ + LV+E++ GS E L L + L I+ + LEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 845 HGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMA----TIGY 899
I+H D+KP NILLD + + DFG++KLL + + + + T GY
Sbjct: 119 SKG----IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 900 MAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
MAPE S S+ D++S G+ L E T P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 10/200 (5%)
Query: 736 NLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIF 792
+L+GRG+FG+VYKG L G VAIK +L+ E A ++ E ++L+N++H N+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
S D ++LE+ NGS + + + F + L + + V VL+ L + H +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHEQG-V 120
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H D+K NIL ++ ++DFG++ L + + T +MAPE S
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMAPEVIEMSGAST 178
Query: 913 KCDVYSYGVLLMETFTRKKP 932
D++S G ++E T P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 73/234 (31%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRN 782
L++Q+ T G ++G G FG V +G + G VA+K N++ + + F E ++
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL-DILQRLNIMIDVALVLE 841
+ H+NLV++ + +V+E M G+ +L + L ++Q L +DVA +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL +VH DL NIL+ E+ A VSDFG++++ G D+ + + + A
Sbjct: 115 YLES----KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTA 165
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHG 954
PE S+K DV+SYGVLL E F+ + P +M E VKE + G
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 41/267 (15%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG G FG V+ GT T VA+K + E F E +I++ +RH LV++++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYS-YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
C + +V E+M GS +L S L + Q +++ +A + YL + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN----YI 125
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL NIL+ EN+ ++DFG+++L+ E D+ + I + APE + G + K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 914 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH-GLT--EVVDANLVGEEQAF 970
DV+S+G+LL E T +P+ G+T EV++ E+ +
Sbjct: 185 SDVWSFGILLTEIVT-------------------YGRVPYPGMTNREVLEQ----VERGY 221
Query: 971 --SAKTDCLLSIMDLALDCCMESPEQR 995
+C + DL L C + PE+R
Sbjct: 222 RMPRPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF--RTFDSECEILRNVRHRNLVKIFSSC 795
+G G FGLV+ G + VAIK E A F E +++ + H LV+++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
LV EFM +G +L + L + +DV + YL + ++H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES----SNVIHR 124
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ EN VSDFG+++ + + D + T T + + +PE S S+K D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 916 VYSYGVLLMETFTR-KKPTDEMFTGEM 941
V+S+GVL+ E F+ K P + E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 6/193 (3%)
Query: 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSC 795
+GRG+FG V+ G L D T VA+K L + F E IL+ H N+V++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V+E + G F +L + L + + + ++ + A +EYL H +H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHR 118
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ E +SDFG+S+ +G + T + + + APE + G S++ D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 916 VYSYGVLLMETFT 928
V+S+G+LL E F+
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 41/290 (14%)
Query: 737 LLGRGSFGLVYKGTLF--DGTNVAIKVFNLQLE----RAFRTFDSECEILRNVRHRNLVK 790
+LG G FG V +G L DG+ + + V ++L+ F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 791 IFSSCCNIDFKA------LVLEFMPNGSFEKWLYSYN-----YFLDILQRLNIMIDVALV 839
+ C ++L FM +G +L L + L M+D+AL
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
+EYL S +H DL N +L E+MT V+DFG+SK + GD I + +
Sbjct: 126 MEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEV 958
+A E ++ + ++K DV+++GV + E TR + P + E+ + L HG
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYLRHG---- 231
Query: 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DCL + DL C P+ R T L+ I
Sbjct: 232 ---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 738 LGRGSFGLVYKGT-LFDGTN----VAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKG + +G VAIKV + A + E ++ +V H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C + L+ + MP G ++ ++ + LN + +A + YL
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---- 129
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+VH DL N+L+ ++DFG++KLL + I +MA E I +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 912 AKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 942
K DV+SYGV + E T KP + + E+
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 40/230 (17%)
Query: 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFN---LQLERAFRTFDSECEIL-RNVRHR 786
F ++G GSF V AIK+ + L E+ + E E+L R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 787 NLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
++K++ + F+ VLE+ PNG +++ LD ++ L LE
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALE 116
Query: 842 YLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG-- 898
YLH G I+H DLKP NILLD++M ++DFG +K+L + I
Sbjct: 117 YLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 899 ----------------YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
Y++PE +E D+++ G ++ + T K P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVK 790
LG G+FG VYKG L T+VAIK E + F E E++ +++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMID 835
+ C ++ E++ +G ++L + LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+A +EYL H VH DL N L+ E +T +SDFG+S+ + D Q+ ++
Sbjct: 133 IAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
+ +M PE G + + D++S+GV+L E F+ F+ +
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------------- 233
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
EV+ ++ Q DC + L ++C E P +R D L+
Sbjct: 234 -EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 72/260 (27%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG+G FG V+ GT T VAIK + F E ++++ +RH LV++++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 798 IDFKALVLEFMPNGSFEKWLY-SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ +V E+M GS +L +L + Q +++ +A + Y+ + VH D
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRD 127
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ EN+ V+DFG+++L+ + + + Q I + APE G + K DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 917 YSYGVLLMETFTRKK-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTD 975
+S+G+LL E T+ + P M EV+D V +
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVN-----------------REVLDQ--VERGYRMPCPPE 227
Query: 976 CLLSIMDLALDCCMESPEQR 995
C S+ DL C + PE+R
Sbjct: 228 CPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 738 LGRGSFGLVY----KGTLFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK 790
+ +G++G V+ K T G AIKV + + +E +IL + +VK
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSL 849
++ S LV+E++P G L + + + R + ++ L LEYLH +G
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG--- 113
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKL------LGEGDDSVTQTITMATIGYMAPE 903
I+H DLKP+NIL+D N ++DFG+SK+ + DD + T Y+APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 904 YGSEGIV-----SAKCDVYSYGVLLMETFT 928
++ S D +S G +L E
Sbjct: 172 -----VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG V+ + D VA+K A + F E E+L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSY---------------NYFLDILQRLNIMIDV 836
+ C + D +V E+M +G K+L ++ L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
A + YL H VH DL N L+ N+ + DFG+S+ + D TM
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956
I +M PE + + DV+S+GV+L E FT K + W + T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ----LSNT 232
Query: 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTD 1000
EV++ + + + C + D+ L C P+QR+++ +
Sbjct: 233 EVIEC--ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNV-AIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKI 791
++G+G+FG V D + A+K N Q + + R +E IL+ + H LV +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVALVLEYLHH 845
+ S + + LV++ + G Y L + + + ++ L LEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEY 904
I+H D+KP+NILLDE H++DF I+ + T T + + T GYMAPE
Sbjct: 119 KG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----TLTTSTSGTPGYMAPEV 170
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
S D +S GV E K+P
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 28/260 (10%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRT--FDSECEILRNVRHRNLVKIFSSC 795
LG G FG+V+ G +VAIK+ E A F E +++ + H NLV+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V E+M NG +L L L++ DV +EYL +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES----NGFIHR 124
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ E+ VSDFG+++ + + D + T + + PE S+K D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 916 VYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTD 975
V+S+GVL+ E F+ G+M R+ +EVV++ G
Sbjct: 184 VWSFGVLMWEVFS---------EGKMPYERFSN-------SEVVESVSAGYR--LYRPKL 225
Query: 976 CLLSIMDLALDCCMESPEQR 995
+ + C E PE R
Sbjct: 226 APTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 736 NLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRNLVKIF 792
N +G G+FG VY L G +A+K +Q + E ++L ++H NLVK +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLD--ILQRLNIMIDVALVLEYLH-HGHSL 849
+ + + +E+ G+ E+ L + LD +++ + + L YLH HG
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGL--AYLHSHG--- 119
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI--TMATIGYMAPEYGSE 907
IVH D+KP NI LD N + DFG + L ++ + + T YMAPE +
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 908 GIVSAK---CDVYSYGVLLMETFTRKKPTDEM 936
G D++S G +++E T K+P E+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 21/284 (7%)
Query: 737 LLGRGSFGLVYK---GTLFDGTN--VAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG+G+FG V L D T VA+K R F+ E EIL++++H N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 792 FSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
C + + LV+E++P GS +L + LD + L + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL----GS 126
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEG 908
VH DL NIL++ + DFG++K+L + + + + I + APE +E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 909 IVSAKCDVYSYGVLLMETFT---RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965
S DV+S+GV+L E FT + F M + + + H + L+
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------ELLK 240
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
A C I + +C P QR ++ A +++ IR
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG V+ D VA+K E A + F E E+L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL--------------QRLNIMIDVA 837
+ C +V E+M +G ++L S+ IL Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+ YL H VH DL N L+ + + + DFG+S+ + D TM I
Sbjct: 133 SGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLT 956
+M PE + + D++S+GV+L E FT K+P W + S T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WYQLS----NT 231
Query: 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
E ++ G E C + + C P+QR+ + D + L+
Sbjct: 232 EAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 737 LLGRGSFGLVY------KGTLFDGTNVAIKVFNLQLERAFRT----FDSECEILRNVRHR 786
L+G GSFG VY G L V + + + R+ E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
N+V+ S + D + LE++P GS L +Y F + L R N + + L YLH+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHN- 124
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-----MATIGYMA 901
I+H D+K NIL+D +SDFGISK L E + T+T ++ +MA
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMA 180
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE + + K D++S G L++E T K P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNL-----QLERAFRTFDSECEILRNVRHRNLVK 790
LLG+G+FG VY D G +A+K + ++ + E ++L+N++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 791 IFSSCCNIDFK-ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C D ++ +E+MP GS + L +Y + + R + +EYLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNM-- 124
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---------YM 900
IVH D+K NIL D + DFG SK L QTI + G +M
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICSSGTGMKSVTGTPYWM 174
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+PE S K DV+S G ++E T K P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 738 LGRGSFGLVYKGTLFDGTN--VAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSS 794
LG G+ G+V K L T +A+K L++ A + E +IL +V + +
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 795 CCNIDFKALVLEFMPNGSFEKWL-YSYNYF-LDILQRLNIMIDVALV--LEYLHHGHSLA 850
N ++ +E+M GS +K L IL + I VA++ L YLH H
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK----IAVAVLKGLTYLHEKHK-- 121
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
I+H D+KP+NIL++ + DFG+S G+ +S+ +T T YMAPE
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTFV-GTSSYMAPERIQGNDY 176
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
S K D++S G+ L+E T + P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
+G+G FG V G + G VA+K ++ + + F +E ++ +RH NLV++
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 798 IDFKA---LVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
++ K +V E+M GS +L S L L +DV +EYL + V
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FV 124
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL N+L+ E+ A VSDFG++K + S TQ + + APE E S K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 914 CDVYSYGVLLMETFT 928
DV+S+G+LL E ++
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 66/209 (31%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 738 LGRGSFGLVYKGTLF--DGT--NVAIKVF----NLQLERAFRTFDSECEILRNVRHRNLV 789
LG G+FG V KG G VA+K ++ F E ++ + H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL---REASVMAQLDHPCIV 59
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
++ C LV+E P G K+L + VA+ + YL H
Sbjct: 60 RLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH-- 115
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT-QTITMATIGYMAPEYGSEG 908
VH DL N+LL A +SDFG+S+ LG G D T + + APE + G
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 909 IVSAKCDVYSYGVLLMETFTR-KKPTDEM 936
S+K DV+SYGV L E F+ KP EM
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIK-VFNLQLERAFRTFDSECEILRNVRHRNLVK 790
LG+GSFG+VY+G T VAIK V R F +E +++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYS------YNYFLDILQRLNIM---IDVALVLE 841
+ +V+E M G + +L S N L + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL VH DL N ++ E++T + DFG+++ + E D + + +MA
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFT 928
PE +G+ + K DV+S+GV+L E T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 8/202 (3%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG+V G +VAIK+ + + F E +++ + H LV+++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL 857
+V E+M NG +L + Q L + DV + YL +H DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ----FIHRDL 126
Query: 858 KPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI-TMATIGYMAPEYGSEGIVSAKCDV 916
N L+D+ VSDFG+S+ + DD T ++ + + + PE S+K DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 917 YSYGVLLMETFTRKKPTDEMFT 938
+++GVL+ E ++ K E F
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 32/280 (11%)
Query: 737 LLGRGSFGLVYKGTL-FDG---TNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
++G G FG V++G L G VAIK E+ + F SE I+ H N++++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
++ E+M NG+ +K+L ++ Q + ++ +A ++YL S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG--YMAPEYGSEGI 909
VH DL NIL++ N+ VSDFG+S++L E D T T + I + APE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 910 VSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
++ DV+S+G+++ E + ++P +M EV+ A + +
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKA--INDGF 227
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
A DC ++ L L C + +R D L K+
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 737 LLGRGSFGLVYKG-TLFDGTNVAIKVFNL-----QLERAFRTFDSECEILRNVRHRNLVK 790
LLG GSFG VY+G L DG A+K +L + A + + E +L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ D + LE +P GS K L Y F + + RL + L LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLHDRN--- 122
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEY-GS 906
VH D+K NIL+D N ++DFG++K V + + G +MAPE
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP 932
+G D++S G ++E T K P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 56/157 (35%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
L L L G IP IS L+ L +++L+GN G IP S GS+ SLE LD+S N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIP--IKGPFRNFSAQSFSGNYALCGPPRLQVPPCKED 663
P+SL L L+ LN++ N L G +P + G + ++ +F+ N LCG P L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPH 540
Query: 664 KGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQN 700
G+K + F + + + L+ + ++ RRQN
Sbjct: 541 LSVGAK---IGIAFGVSVAF-LFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 29/278 (10%)
Query: 736 NLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
++G G FG V +G L +VAIK ++ F +E I+ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL-HHGHSL 849
+ ++ E+M NGS +K+L + + Q + ++ +A ++YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGI 909
VH DL NIL++ N+ VSDFG+S+ L + + + T I + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969
++ DV+S+G+++ E M GE + +V+ A V +
Sbjct: 185 FTSASDVWSFGIVMWEV---------MSYGERPYWDMSNQ-------DVIKA--VEDGYR 226
Query: 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
DC ++ L LDC + +R + + L K
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD--------SECEILRNVRHRNL 788
+G+GSFG V K DG + K + + SE ILR ++H N+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEID------YGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 789 VKIFSSCCNIDFKA----LVLEFMPNG---SFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
V+ + ID +V+E+ G + +++ I+ + L L
Sbjct: 62 VRYYDR--IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 842 YLHHGHSLAP-IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
H+ ++H DLKP NI LD N + DFG++K+LG D S +T + T YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTY-VGTPYYM 177
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+PE + K D++S G L+ E P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG V+ + D VA+K + A + F E E+L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYN------------YFLDILQRLNIMIDVALV 839
+ C D +V E+M +G K+L ++ L Q L+I +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
+ YL H VH DL N L+ EN+ + DFG+S+ + D TM I +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEM 941
M PE + + DV+S GV+L E FT K+P ++ E+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 70/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V++G + T VA+K + F +E +I++ +RH L+++++ C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 798 IDFKALVLEFMPNGSFEKWLY-SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ +V E M GS ++L L + Q +++ VA + YL + +H D
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRD 128
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L N+L+ EN V+DFG+++++ E D + I + APE S K DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 917 YSYGVLLMETFTRKK-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTD 975
+S+G+LL E T + P M E V + + G
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYR-------------MPCPPG 228
Query: 976 CLLSIMDLALDCCMESPEQR 995
C + D+ LDC E P+ R
Sbjct: 229 CPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 8e-18
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIK-VFNLQLERAF----RTFDSECEILRNVRHRN-- 787
LG G++ +VYK G VAIK + + + A T E ++L+ ++H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 788 -LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
L+ +F NI+ LV EFM EK + + L + M+ LEYLH
Sbjct: 66 GLLDVFGHKSNIN---LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--Y 904
I+H DLKPNN+L+ + ++DFG+++ G + T + T Y APE +
Sbjct: 122 W----ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLF 175
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRK 930
G+ D++S G + E R
Sbjct: 176 GARHYGVG-VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LG GS+G VYK G VAIKV + E + E IL+ +VK + S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 796 CNIDFKA----LVLEFMPNGSFEKWLYSYNYFLDILQRLN----------IMIDVALVLE 841
FK +V+E+ GS DI++ N I+ LE
Sbjct: 68 ----FKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YLH +H D+K NILL+E A ++DFG+S L + T+ + T +MA
Sbjct: 114 YLHSNK----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTV-IGTPFWMA 167
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE E + K D++S G+ +E K P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ------LERAFRTFDSECEILRNVRHRNLV 789
+LG+G++G VY G G +A+K L E+ + E ++L++++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR---LNIMIDVALVLEYLHHG 846
+ +C + + ++ +EF+P GS L + + + I+ VA YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG----YMAP 902
+VH D+K NN++L N + DFG ++ L T + + ++ +MAP
Sbjct: 122 C----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
E +E K D++S G + E T K P M
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 736 NLLGRGSFGLVYKGTLFD-GTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRNLVKI 791
+ LG G +G VY+G VA+K +++E F E +++ ++H NLV++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 67
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLA 850
C ++ EFM G+ +L N ++ + L + ++ +EYL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
+H DL N L+ EN V+DFG+S+L+ GD I + APE +
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 911 SAKCDVYSYGVLLMETFT 928
S K DV+++GVLL E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 44/209 (21%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G G++G VYK + G VAIKV L+ F E +L+ RH N+V F S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMID---VALV-------LEYLHHG 846
D +V+E+ GS + DI Q + +A V L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT----IG---Y 899
+H D+K NILL E+ ++DFG+S L T T+A IG +
Sbjct: 121 G----KIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPYW 167
Query: 900 MAPEYGSE---GIVSAKCDVYSYGVLLME 925
MAPE + G KCD+++ G+ +E
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 66/272 (24%), Positives = 103/272 (37%), Gaps = 41/272 (15%)
Query: 737 LLGRGSFGLVYKGT----LFDGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG GSFG+V +G VA+K + +L F E I+ ++ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 792 FSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ +V E P GS ++ I + + +A + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGI 909
+H DL NILL + + DFG+ + L + +D V + + APE
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFT-GEMSLRRWVKESLPHGLT-----EVVDANL 963
S DV+ +GV L EMFT GE W GL+ + +D
Sbjct: 177 FSHASDVWMFGVTLW----------EMFTYGEEP---WA------GLSGSQILKKIDKEG 217
Query: 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
E+ C I ++ L C +P R
Sbjct: 218 ERLERP----EACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 736 NLLGRGSFGLVYKGTLFD----GTN---VAIKVFNL-QLERAFRTFDSECEILRNVRHRN 787
N LG G+FG VY+GT D G+ VA+K ++ + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS------YNYFLDILQRLNIMIDVALVLE 841
+VK+ C + + +++E M G +L L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
YL H +H DL N L+ E + + DFG+++ + + D + +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE +G + + DV+S+GVL+ E T
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G G+ G VYK T G VAIK L+ + + E I+++ +H N+V + S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+E+M GS + ++ Q + +V LEYLH + ++H D
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN----VIHRD 141
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYMAPE------YGSEGI 909
+K +NILL ++ + ++DFG + L + ++ T +MAPE YG
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVIKRKDYG---- 194
Query: 910 VSAKCDVYSYGVLLME 925
K D++S G++ +E
Sbjct: 195 --PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 11/224 (4%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG+G FG V+ GT T VAIK F E +I++ +RH LV +++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 798 IDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ +V EFM GS +L + +L + Q +++ +A + Y+ + +H D
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHRD 127
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ +N+ ++DFG+++L+ + + + Q I + APE G + K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 917 YSYGVLLMETFTRKK-PTDEMFTGEM--SLRRWVKESLPHGLTE 957
+S+G+LL E T+ + P M E+ + R + P G E
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 28/260 (10%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V+ GT T VA+K + +F E +I++ +RH LV++++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 798 IDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+V E+M GS +L L + +++ VA + Y+ + +H D
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRD 127
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ + + ++DFG+++L+ + + + Q I + APE G + K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 917 YSYGVLLMETFTRKK-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTD 975
+S+G+LL E T+ + P M R V E + G D
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYR-------------MPCPQD 227
Query: 976 CLLSIMDLALDCCMESPEQR 995
C +S+ +L L C + PE+R
Sbjct: 228 CPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFR----------TFDSECEILRNVRH 785
L+G+G++G VY G +A+K L A R SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
N+V+ ++ ++ LE++P GS L +Y F + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLHS 126
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-- 903
I+H DLK +N+L+D + +SDFGISK + D+ ++ +MAPE
Sbjct: 127 KG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKP--TDEMF 937
+ SAK D++S G +++E F ++P +E
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 12/220 (5%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILR 781
L+ + D E +LG+G++G+VY L +AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS-YNYFLDILQRLNIMIDVALV- 839
++HRN+V+ S F + +E +P GS L S + D Q + L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
L+YLH IVH D+K +N+L++ + +SDFG SK L G + T+T T T+
Sbjct: 121 LKYLHDNQ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQ 174
Query: 899 YMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKKPTDEM 936
YMAPE +G A D++S G ++E T K P E+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 5e-17
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 60/227 (26%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNL 788
+G G++G+V G VAIK + + R R E ++LR++RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 789 VKIFSSCCNI-------DFKAL--VLEFMPNGSFEKWLYS--------YNYFLDILQRLN 831
+ + +I DF + V E M K + S YFL Q
Sbjct: 62 IGLL----DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL--YQ--- 111
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ- 890
+L L + HS A ++H DLKP+NIL++ N + DFG+++ + +D
Sbjct: 112 -------ILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 891 TITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T + T Y APE Y ++ I D++S G + E TRK
Sbjct: 164 TEYVVTRWYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER-AF-RTFDSECEILRNVRHRNLVK---I 791
+G G++G VYK G VA+K ++ E+ F T E ++L+ +RH N+V+ I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+S +V E+M + L S Q M + L+YLH
Sbjct: 67 VTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---- 120
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-------Y 904
I+H D+K +NIL++ + ++DFG+++ +S T + T+ Y PE Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGATRY 179
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRK 930
G E D++S G +L E F K
Sbjct: 180 GPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 32/280 (11%)
Query: 737 LLGRGSFGLVYKGTL-FDGTN---VAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
++G G FG V G L G VAIK E+ R F SE I+ H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+V E+M NGS + +L ++ ++Q + ++ +A ++YL S
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG--YMAPEYGSEGI 909
VH DL NIL++ N+ VSDFG+S++L E D T I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 910 VSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
++ DV+SYG+++ E + ++P EM +V+ A + E
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSN-----------------QDVIKA--IEEGY 226
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
A DC ++ L LDC + +R + L K+
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 738 LGRGSFGLVYKGTL---FDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKIFS 793
LG G+FG V KG +VAIKV + E++ R E EI+ + + +V++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
C + LV+E G K+L + + + +M V++ ++YL + V
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FV 117
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT--IGYMAPEYGSEGIVS 911
H DL N+LL A +SDFG+SK LG DDS + + + + APE + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEM 936
++ DV+SYG+ + E F+ +KP +M
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQ-LERAFRTFD-SECEILRNVRHRNLVKIF 792
N +G+GSFG+V+K D A+K +L + R R E +L + +++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL------NIMIDVALVLEYLHHG 846
S + +V+E+ NG K L + L I + L L +LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
I+H D+K N+ LD + D G++KLL + + + TI + T Y++PE
Sbjct: 121 K----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTI-VGTPYYLSPELCE 174
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTD 934
+ + K DV++ GV+L E T K P D
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 32/281 (11%)
Query: 737 LLGRGSFGLVYKGTL----FDGTNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
++G G FG V +G L VAIK E+ R F SE I+ H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
++ EFM NG+ + +L + ++Q + ++ +A ++YL S
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA---TIGYMAPEYGSEG 908
VH DL NIL++ N+ VSDFG+S+ L + T T ++ I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 909 IVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967
++ DV+SYG+++ E + ++P +M +V++A + ++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVINA--IEQD 227
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DC ++ L LDC + R + L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 54/212 (25%)
Query: 738 LGRGSFGLV----YKGTLFDGTNVAIKVFNL-------QLERAFRTFDSECEILRNVRHR 786
LG GSFG V +KG+ G A+K+ + Q+E +E IL+++RH
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKRILQSIRHP 61
Query: 787 NLVKIFSSCCNIDFKAL--VLEFMPNGSFEKWLYSYNYFLDILQRLNIMI------DVAL 838
LV ++ S D L V+E++P G L+S+ L R + V L
Sbjct: 62 FLVNLYGS--FQDDSNLYLVMEYVPGGE----LFSH---LRKSGRFPEPVARFYAAQVVL 112
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
LEYLH IV+ DLKP N+LLD + ++DFG +K + T T+ T
Sbjct: 113 ALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLC-GTPE 163
Query: 899 YMAPEYGSEGIVSAK-----CDVYSYGVLLME 925
Y+APE I+ +K D ++ G+L+ E
Sbjct: 164 YLAPE-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 65/215 (30%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 731 GFNECNLLGRGSFGLVYK-GTLFDGTNVAIKVFNLQLERAFRTFDS--ECEILRNVRHRN 787
F LG+GS+G VYK L D A+K +L D+ E IL +V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL-------NIMIDVALVL 840
++ + + + +V+E+ P G L ++L I I + L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGD----LSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG-- 898
+ LH I+H DLK NILL N + D GISK+L + + IG
Sbjct: 117 QALHEQK----ILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTP 165
Query: 899 -YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
YMAPE S K D++S G LL E T P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 30/212 (14%)
Query: 737 LLGRGSFGLVY--KGTLFDGTNVAIKVFNL-QLERAFR-TFDSECEILRNVRHRNLVKIF 792
++GRG+FG+V+ + D V IK + Q+ + R +EC++L+ + H N+++ +
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 793 SSCCNIDFKAL--VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY-------L 843
+ ++ KAL V+E+ P G+ ++ I +R N ++D +L + L
Sbjct: 66 ENF--LEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLAL 114
Query: 844 HHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
HH H+ I+H DLK NILLD++ M + DFGISK+L + T + T Y++P
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISP 170
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKPTD 934
E + K D+++ G +L E + K+ +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 44/300 (14%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIKVFNLQLERA-FRTFDSECEILRNVRHRNLVK 790
LG G FG V K T F T VA+K+ + R SE +L+ V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL-----------------YSYNYFLDILQRLNIM 833
++ +C L++E+ GS +L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 834 IDVALVLEYLHHGHSLA--PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
++ + LA +VH DL N+L+ E +SDFG+S+ + E D V ++
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951
+ +MA E + I + + DV+S+GVLL E T + G R +
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIAPERLF----- 239
Query: 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011
NL+ +C + +L L C + P++R D + EL+K+ VK
Sbjct: 240 ----------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNLVK 790
+G G++G+VYK G VAIK L+ E A R E ++L+ + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSL 849
+ + LV EFM + K + L + + + L + H HG
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSE 907
I+H DLKP N+L++ ++DFG+++ G T + T Y APE G +
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDK 174
Query: 908 GIVSAKCDVYSYGVLLMETFTRK 930
G S D++S G + E +R+
Sbjct: 175 G-YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 38/287 (13%)
Query: 738 LGRGSFGLVYKGTLFDGTN---VAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIF 792
LG G FG V +G L + VA+K + + F SE ++ H N++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 793 SSCC----NIDFKA--LVLEFMPNGSFEKWL-YSY----NYFLDILQRLNIMIDVALVLE 841
C + + + ++L FM +G +L YS +L + M D+A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL S +H DL N +L+ENM V+DFG+SK + GD I + ++A
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
E ++ + + K DV+S+GV + E TR + + G V+ S E+ D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPG-------VENS------EIYDY 226
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
G DCL + L C + +P+ R EL+K
Sbjct: 227 LRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 32/262 (12%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V+ G T VAIK Q + F +E +++ ++H LV++++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 798 IDFKALVLEFMPNGSFEKWL-YSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
++ E+M NGS +L L I + +++ +A + ++ + +H D
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHRD 127
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ E + ++DFG+++L+ E ++ + I + APE + G + K DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 917 YSYGVLLMETFTRKK-PTDEMFTGEM--SLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973
+S+G+LL E T + P M E+ +L R + P
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN------------------- 227
Query: 974 TDCLLSIMDLALDCCMESPEQR 995
C + +L C E PE+R
Sbjct: 228 --CPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF--RTFDSECEILRNVRHRNLVKIFSSC 795
LG G FG+V+ G VAIK N E A F E +++ + H LV+++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFL--DILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+V EFM NG +L L D+L L++ DV +EYL +
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FI 122
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL N L+ VSDFG+++ + + D+ + + + + PE + S+K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 914 CDVYSYGVLLMETFTRKK 931
DV+S+GVL+ E FT K
Sbjct: 182 SDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 61/217 (28%), Positives = 90/217 (41%), Gaps = 36/217 (16%)
Query: 738 LGRGSFGLVYKGTL-FDGTNVAIK------VFNLQLERAFRTFDSECEILRNVRHRNLVK 790
LG G FG V + A+K + + SE EIL H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNI--MIDVALVLEYLHHGHS 848
++ + + + +++E+ G L F + R I ++ L EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
I++ DLKP N+LLD N + DFG +K L G T T T Y+APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTF-CGTPEYVAPE----- 162
Query: 909 IVSAK-----CDVYSYGVLLMETFTRKKPTDEMFTGE 940
I+ K D +S G+LL E T + P F +
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 38/214 (17%)
Query: 736 NLLGRGSFGLVYK------GTLFDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNL 788
N +G G+ G VYK G L+ A+KV E R E EILR+V H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLY-----ALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 789 VKIFSSCCNIDFK-----ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
VK C+ F ++LEFM GS E + FL + R I+ +A YL
Sbjct: 135 VK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-QILSGIA----YL 184
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE 903
H H IVH D+KP+N+L++ ++DFG+S++L + D ++ TI YM+PE
Sbjct: 185 HRRH----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPE 238
Query: 904 YGSEGIVSAKC-----DVYSYGVLLMETFTRKKP 932
+ + D++S GV ++E + + P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 80/240 (33%), Positives = 111/240 (46%), Gaps = 40/240 (16%)
Query: 737 LLGRGSFG---LVYKGTLFD-GTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRNLV 789
+LG+GSFG LV K T D G A+KV L++ RT E +IL V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN--IMI---DVALVLEYL- 843
K+ + L+L+F+ G D+ RL+ +M DV L L
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 844 ---HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGY 899
H HSL I++ DLKP NILLDE ++DFG+SK E D + + T+ Y
Sbjct: 109 LALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEY 164
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLRRWVKESLPHGLT 956
MAPE + + D +S+GVL+ E T P D T M L+ K +P L+
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLS 222
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 732 FNECNLLGRGSFGLVYKGTLFD-GTN--VAIKVFNL-QLERAFRTFDSECEILRNVRHRN 787
F +G+GSFG VYK D TN VAIKV +L + E E + L R
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 788 LVKIFSSCCNIDFK-ALVLEFMPNGSFEKWLYSYNYFLDILQ--RLN------IMIDVAL 838
+ K + S K +++E+ GS LD+L+ +L+ I+ +V L
Sbjct: 61 ITKYYGSFLK-GSKLWIIMEYCGGGS----------CLDLLKPGKLDETYIAFILREVLL 109
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TI 897
LEYLH +H D+K NILL E ++DFG+S G+ ++++ T T
Sbjct: 110 GLEYLHEEGK----IHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTP 162
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+MAPE + K D++S G+ +E + P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 44/291 (15%)
Query: 738 LGRGSFGLVYKGTLF-----DGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG +FG +YKG L+ VAIK ++ + + F E ++ + H N+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLY----------------SYNYFLDILQRLNIMID 835
++ E++ G ++L + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+A +EYL S VH DL NIL+ E + +SD G+S+ + D Q ++
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
I +M PE G S+ D++S+GV+L E F+ F+ +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------------- 233
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
EV++ +V + Q DC + L +C E P +R D L+
Sbjct: 234 -EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 736 NLLGRGSFGLVYKGTLF-DGT--NVAIKVFN-LQLERAFRTFDSECEILRNV-RHRNLVK 790
+++G G+FG V + + DG N AIK+ E R F E E+L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------------LDILQRLNIMID 835
+ +C N + + +E+ P G+ +L L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
VA ++YL S +H DL N+L+ EN+ + ++DFG+S+ GE + V +T+
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRL 180
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+ +MA E + + + K DV+S+GVLL E
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 55/298 (18%)
Query: 734 ECNLLGRGSFGLVY----KGTLFDGTN--VAIKVF------NLQLERAFRTFDSECEILR 781
E LGRG FG V+ KG +G V +K NLQ E F E ++ R
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-----FRRELDMFR 63
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWL--------YSYNYFLDILQRLNIM 833
+ H+N+V++ C + ++LE+ G +++L L Q++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
+AL +++L + VH DL N L+ VS +SK + +
Sbjct: 124 TQIALGMDHLSNAR----FVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNA 178
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH 953
+ + ++APE E S K DV+S+GVL+ E FT GE+ P
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGEL----------PF 219
Query: 954 GLTEVVDANLVGEEQAFSAK----TDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
+ D ++ QA + C + L C +P+ R ++ + L +
Sbjct: 220 --YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 51/195 (26%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V+ G + T VA+K + + F E +++ ++H LV++++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL-NIMIDVALVLEYLHHGHSLAPIVHCD 856
+ ++ E+M GS +L S +L +L + +A + Y+ + +H D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ N+L+ E++ ++DFG+++++ E ++ + I + APE + G + K DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 917 YSYGVLLMETFTRKK 931
+S+G+LL E T K
Sbjct: 188 WSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 736 NLLGRGSFGLVYKGTL--FDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNL 788
LG G+FG VY+G DG V ++V L E+ F E I+ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLY------SYNYFLDILQRLNIMIDVALVLEY 842
V++ + ++LE M G + +L L + L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 843 LHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L H +H D+ N LL A ++DFG+++ + M I +
Sbjct: 132 LEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
M PE +GI ++K DV+S+GVLL E F+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR------HRNLVK 790
+G G+ +VY L + VAIK +L+ + D E+ + V+ H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VD---ELRKEVQAMSQCNHPNVVK 63
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNI---MIDVALVLEYLH-HG 846
++S D LV+ ++ GS + +Y L I + +V LEYLH +G
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS---VTQTITMATIGYMAPE 903
+H D+K NILL E+ + ++DFG+S L +G D V +T + T +MAPE
Sbjct: 123 Q-----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPE 176
Query: 904 YGSEGI-VSAKCDVYSYGVLLMETFTRKKP 932
+ K D++S+G+ +E T P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 58/238 (24%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNVAIKVFN--LQLERAFRTFD-SECEILRNV 783
D F ++GRG+FG LV G A+KV ++R +E +IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
+VK++ S + + LV+E+MP G L + F + R I ++ L L+ +
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSV 117
Query: 844 HH-GHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSV------------ 888
H G +H D+KP+NIL+D H+ +DFG+ K + + D
Sbjct: 118 HKLGF-----IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 889 ----------TQTITMA--TIG---YMAPE------YGSEGIVSAKCDVYSYGVLLME 925
Q A T+G Y+APE YG E CD +S GV+L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKV--FNLQLERAFRTFDS-ECEI--LRNVRHRNLVK 790
LLGRG+FG VY D G +A+K F+ + + ++ ECEI L+N+RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 791 IFSSCCNIDFKALVL--EFMPNGSFEKWLYSYNYFLDILQR---LNIMIDVALVLEYLHH 845
+ + + K L + E+MP GS + L +Y + + R I+ V+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YLHS 124
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK------LLGEGDDSVTQTITMATIGY 899
IVH D+K NIL D + DFG SK + G G SVT T +
Sbjct: 125 NM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-----GTPYW 175
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935
M+PE S K DV+S ++E T K P E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLE-----RAFRTFDSECEILRNVRHRNLVK 790
LLG+G+FG VY D G +A K E + + E ++L+N++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 791 IFSSCCNIDFKALV--LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ + K L +E+MP GS + L +Y + + R + + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSNM- 126
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---------Y 899
IVH D+K NIL D + DFG SK L QTI M+ G +
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYW 175
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935
M+PE S K DV+S G ++E T K P E
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 14/214 (6%)
Query: 725 IQRATDGFNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQLERAFR-TFDSECEI 779
IQR C +G G FG VY+G VA+K + R F E I
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 780 LRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+R H ++VK+ + +V+E P G +L Y LD+ + ++
Sbjct: 61 MRQFDHPHIVKLI-GVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L YL VH D+ N+L+ + DFG+S+ L E + + I +
Sbjct: 120 LAYLESKR----FVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKW 174
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKP 932
MAPE + ++ DV+ +GV + E KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 32/293 (10%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-----RAFRTFDSE 776
L I + T+ F + +LG G+FG VYKG +G V I V +L +A + E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 777 CEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
++ +V + ++ ++ C + L+ + MP G ++ + + LN + +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
A + YL +VH DL N+L+ ++DFG++KLLG +
Sbjct: 119 AKGMNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGL 955
I +MA E I + + DV+SYGV + E T KP D + E+S E LP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-- 232
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
C + + + + C M + R + E K+
Sbjct: 233 -----------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 74/292 (25%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 737 LLGRGSFGLVYKGTLF--DGT--NVAIKVFNLQLERA--FRTFDSECEILRNVRHRNLVK 790
+LG+G FG V + L DG+ VA+K+ + + F E ++ H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 791 IFSSCCNIDFKA------LVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMIDVA 837
+ K ++L FM +G +L + L L R MID+A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MIDIA 123
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+EYL S +H DL N +L+ENMT V+DFG+SK + GD + +
Sbjct: 124 SGMEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957
++A E ++ + + DV+++GV + E TR + + G V+ S E
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP---YAG-------VENS------E 223
Query: 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ + + G DCL + +L C P+ R +L+ I
Sbjct: 224 IYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 737 LLGRGSFGLVYK--GTLFDGTNVAIKVFNL----------QLERAFRTFDSECEILR-NV 783
LG G+FG VYK +A+K N+ + +++ SE I++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY----NYFLDILQRL-NIMIDVAL 838
RH N+V+ + + D +V++ + + S F + +R+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
L YLH IVH DL PNNI+L E+ ++DFG++K T + TI
Sbjct: 125 ALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---ESKLTSVVGTIL 178
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP--TDEMFTGEMSLRRWVKESLPHGL 955
Y PE K DV+++G +L + T + P + M + + V E LP G+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 5e-14
Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVR 784
+ + LG G++G+VYK G VA+K L E A R E +L+ ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
H N+VK+ LV E+ +K+L L +IM + L Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
I+H DLKP NIL++ + ++DFG+++ G + T + T+ Y APE
Sbjct: 116 SHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV--VTLWYRAPE- 168
Query: 905 GSEGIVSAKCDVYSYGV 921
+ YS V
Sbjct: 169 -----ILLGSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 738 LGRGSFGLVYKGTLF------DGTN--VAIKVFNLQLERAFRT-FDSECEILRNVRHRNL 788
LG G FG V +L+ DGT VA+K + + + + E IL+ + H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 789 VKIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
VK + CC+ L++E++P GS +L + L++ Q L + + YLH
Sbjct: 69 VK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHS 125
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD--SVTQTITMATIGYMAPE 903
H +H DL N+LLD + + DFG++K + EG + V + Y A E
Sbjct: 126 QH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E S DV+S+GV L E T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 736 NLLGRGSFGLVYKGTLF-DG--TNVAIKVFN-LQLERAFRTFDSECEILRNV-RHRNLVK 790
+++G G+FG V K + DG + AIK + R F E E+L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------------LDILQRLNIMID 835
+ +C + + L +E+ P+G+ +L L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
VA ++YL S +H DL NIL+ EN A ++DFG+S+ G+ + V +T+
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 173
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+ +MA E + + + DV+SYGVLL E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLE-----RAFRTFDSECEILRNVRHRNLVK 790
LLG+G+FG VY D G +A+K E + + E ++L+N+ H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 791 IFSSCCNIDFKAL--VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ + + L +E MP GS + L SY + + R +LE + + HS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY----TRQILEGVSYLHS 124
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLL------GEGDDSVTQTITMATIGYMAP 902
IVH D+K NIL D + DFG SK L G G SVT T +M+P
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-----GTPYWMSP 178
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935
E S K D++S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 738 LGRGSFGLVYK-GTLFDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSC 795
LG G+ G V K + GT +A KV ++ + + R E +I+ R +V + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALV--LEYLHHGHSLAPI 852
N + + +EFM GS ++ ++IL I VA+V L YL++ H I
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG----KIAVAVVEGLTYLYNVHR---I 125
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H D+KP+NIL++ + DFG+S GE +S+ T + T YM+PE G +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTV 181
Query: 913 KCDVYSYGVLLMETFTRKKPTDE 935
K DV+S G+ ++E K P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 47/281 (16%)
Query: 736 NLLGRGSFGLVYKGTLF-DG--TNVAIK-VFNLQLERAFRTFDSECEIL-RNVRHRNLVK 790
+++G G+FG V K + DG + AIK + + R F E E+L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNIMID 835
+ +C + + L +E+ P+G+ +L S L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
VA ++YL S +H DL NIL+ EN A ++DFG+S+ G+ + V +T+
Sbjct: 133 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 185
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHG 954
+ +MA E + + + DV+SYGVLL E + P M E+ E LP G
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 239
Query: 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
+C + DL C E P +R
Sbjct: 240 YR-------------LEKPLNCDDEVYDLMRQCWREKPYER 267
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 33/243 (13%)
Query: 773 FDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--- 829
F E +IL + N+ ++ C +++E+M NG ++L + L
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 830 -------LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882
L + +A + YL SL VH DL N L+ +N T ++DFG+S+ L
Sbjct: 126 SLSFSTLLYMATQIASGMRYLE---SLN-FVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKPTDEMFTGE 940
D Q I +MA E G + K DV+++GV L E T R++P + +
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239
Query: 941 MSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR----- 995
+ V E+ H + G + +C I +L L+C E R
Sbjct: 240 ----QQVIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289
Query: 996 IHM 998
IH+
Sbjct: 290 IHL 292
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 735 CNLLGRGSFGLVY----KGTLFDG--TNVAIKVFNLQLERAFRT-FDSECEILRNVRHRN 787
LG+GSFG+VY KG + D T VAIK N R F +E +++ +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMI----DVAL 838
+V++ +++E M G + +L S N + L MI ++A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+ YL+ VH DL N ++ E+ T + DFG+++ + E D + +
Sbjct: 131 GMAYLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR 944
+M+PE +G+ + DV+S+GV+L E T + + + E LR
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 51/221 (23%)
Query: 730 DGFNECNLLGRGSFGLVYK------GTLFDGTNVAIKVFNL--------QLERAFRTFDS 775
+ E + LG G+ G V K G +F A+K Q+ R
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIF-----ALKTITTDPNPDLQKQILR------- 48
Query: 776 ECEILRNVRHRNLVKIFSSC-----CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL 830
E EI ++ + +VK + + +I + +E+ GS + +Y + +R
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDS-IYK-----KVKKRG 99
Query: 831 NIMIDVAL------VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884
+ + L VL+ L + HS I+H D+KP+NILL + DFG+S GE
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVS---GEL 155
Query: 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+S+ T T T YMAPE S DV+S G+ L+E
Sbjct: 156 VNSLAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 35/88 (39%), Positives = 55/88 (62%)
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
L LD+ L G IP + + + LQ ++L N ++G+IP L + L L L+ N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSL 513
P LG LTSLR L+L N+L+ +P++L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-13
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 14/236 (5%)
Query: 737 LLGRGSFGLVYKGTLF-DGTNV----AIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
+LG G+FG VYKG +G V AIK+ N +A F E I+ ++ H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ C + + LV + MP+G +++ + + LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD-SVTQTITMATIGYMAPEYGSEGI 909
+VH DL N+L+ ++DFG+++LL EGD+ I +MA E
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 910 VSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964
+ + DV+SYGV + E T KP D + T E+ E LP +D +V
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 736 NLLGRGSFGLVYKGTLFDG----TNVAIKVFN--LQLERAFRTFDSECEILRNVRHRNLV 789
++G+G FG VY GTL D + A+K N LE F E I+++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 790 KIFSSCCNIDFKALV-LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ C + LV L +M +G ++ S + + + + VA +EYL +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL----A 115
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD-DSVTQ-TITMATIGYMAPEYGS 906
VH DL N +LDE+ T V+DFG+++ + + + SV T + +MA E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP 932
+ K DV+S+GVLL E TR P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 44/291 (15%)
Query: 738 LGRGSFGLVYKGTLFDGT------NVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVK 790
LG FG VYKG LF VAIK + E R F E + ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR---------------LNIMID 835
+ +++ + + ++L + D+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+A +E+L H +VH DL N+L+ + + +SD G+ + + D ++
Sbjct: 133 IAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
I +M+PE G S D++SYGV+L E F+ ++ +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------------LQPYCGYSN 232
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
+V++ ++ Q DC + L L+C E P +R D + L+
Sbjct: 233 QDVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEI-----LRNVRH 785
+ L+GRG++G VY+G + G VA+K+ NL D + E+ LR +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQP 61
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
N+ K + S +++E+ GS + + + I+ +V + L+Y+H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIHK 119
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY-MAPEY 904
++H D+K NIL+ + DFG++ LL + ++ T Y MAPE
Sbjct: 120 ----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---SKRSTFVGTPYWMAPEV 172
Query: 905 GSEGIV-SAKCDVYSYGVLLMETFTRKKP 932
+EG K D++S G+ + E T P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 734 ECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
+ +GRG+FG V K L + + V + R+ E E R + ++V S
Sbjct: 8 DLGEIGRGAFGTVNK-MLHKPSGTIMAV------KRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 794 SCCNI-DFKALV---------LEFMPNGSFEKWLYSYNYFLDILQRL---NIM--IDVAL 838
C I F + +E M + S +K Y Y Y ++L+ + I+ I VA
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY--EVLKSVIPEEILGKIAVAT 116
Query: 839 V--LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
V L YL I+H D+KP+NILLD N + DFGIS G+ DS+ +T
Sbjct: 117 VKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGC 170
Query: 897 IGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935
YMAPE +G + DV+S G+ L E T K P +
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK---VFNLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
+GRG F VY+ T L DG VA+K +F+L +A E ++L+ + H N++K ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
S + +VLE G + + + ++ + + L H HS ++
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVM 128
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIV 910
H D+KP N+ + + D G+ + S T + +G YM+PE E
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
+ K D++S G LL E + P
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 70/227 (30%), Positives = 105/227 (46%), Gaps = 36/227 (15%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLER------AFRTFDSECE 778
+R D F+ +G G++G VYK D G VA+K L E+ A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 779 ILRNVRHRNLVKIFSSCCN----IDFKA------LVLEFMPN---GSFEKWLYSYNYFLD 825
ILR + HRN+V + + +DFK LV E+M + G E L ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE--- 115
Query: 826 ILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885
+ M + L Y H + L H D+K +NILL+ ++DFG+++L +
Sbjct: 116 -DHIKSFMKQLLEGLNYCHKKNFL----HRDIKCSNILLNNKGQIKLADFGLARLY-NSE 169
Query: 886 DSVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+S T + T+ Y PE G E A DV+S G +L E FT+K
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPA-IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 41/98 (41%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL 468
L+G IP +I L L + L N + G IP ++G L+ L L N GSIP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLT 506
L L LNGN+LSG +PA LG R LH S T
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGG----RLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 38/89 (42%), Positives = 54/89 (60%)
Query: 449 GLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYS 508
GL L + L+G IP + L L + L+GN++ G IP LGS+TSL L L N+ S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 509 IPSSLWSLEYILYVNLSSNSLSGPLPSSI 537
IP SL L + +NL+ NSLSG +P+++
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 732 FNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVR 784
F + +G G++G+VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
H N+VK+ + LV EF+ + +K F+D I + L+ YL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGI--PLPLIKSYLF 107
Query: 845 ---------HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
H H ++H DLKP N+L++ ++DFG+++ G + T +
Sbjct: 108 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 162
Query: 896 TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T+ Y APE G + S D++S G + E TR+
Sbjct: 163 TLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 30/261 (11%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V+ T T VA+K + F +E +++ ++H LVK+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKL-HAVVT 71
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL-NIMIDVALVLEYLHHGHSLAPIVHCD 856
+ ++ EFM GS +L S L +L + +A + ++ + +H D
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ ++ ++DFG+++++ E ++ + I + APE + G + K DV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 917 YSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTD 975
+S+G+LLME T + P M E V +L G + +
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYR--------------MPRPE 226
Query: 976 -CLLSIMDLALDCCMESPEQR 995
C + ++ + C PE+R
Sbjct: 227 NCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 738 LGRGSFGLVYKGTLFDGTNVA-IKVFNLQLERAF---RTFDSECEILRNVRHRNLVKIFS 793
+G G FG V G + G A + V L++ + F E + R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYF------LDILQRLNIMIDVALVLEYLHHGH 847
C + LV+EF P G + +L S LQR+ ++AL L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---- 903
+H DL N LL ++T + D+G+S + D VT + ++APE
Sbjct: 121 ----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 904 -YGSEGIV--SAKCDVYSYGVLLMETF 927
+G+ +V + + +V+S GV + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ------LERAFRTFDSECEILRNVRHRNLV 789
LG G+F Y+ + GT +A+K E E ++ + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
++ + C L +E+M GS L Y F + + +N + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ-- 123
Query: 850 APIVHCDLKPNNILLDENMTAH---VSDFGI-----SKLLGEGDDSVTQTITMATIGYMA 901
I+H D+K N+L+D T ++DFG +K G G+ Q + TI +MA
Sbjct: 124 --IIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMA 176
Query: 902 PE------YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE YG CDV+S G +++E T K P
Sbjct: 177 PEVLRGEQYGRS------CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 38/89 (42%), Positives = 52/89 (58%), Gaps = 1/89 (1%)
Query: 153 LDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRL 211
L L L G +PNDI +L L+ + L N G IP SL T L+ L L+ N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 212 PENIGNLSQLTDLNLAQNNLQGDMPTAIG 240
PE++G L+ L LNL N+L G +P A+G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 30/76 (39%), Positives = 49/76 (64%)
Query: 185 GQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
G IP+ +S+ HLQ++ L+ N G +P ++G+++ L L+L+ N+ G +P ++G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 245 LEHLNLGMNNLSGPVP 260
L LNL N+LSG VP
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG G+FG VYK + G A K+ ++ E F E +IL +H N+V ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ +++EF G+ + + L Q + + L +LH ++H D
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIHRD 128
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY-----GSEGIVS 911
LK NILL + ++DFG+S I T +MAPE +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPYD 186
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEM 936
K D++S G+ L+E + P E+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 17/187 (9%)
Query: 754 GTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRNLVKIFSS-CCNIDFKALVLEFMP 809
G VAIK+ + E F E + + H N+V + S V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL---DE 866
+ + L + + L + +M+ V L+ L H+ IVH DLKP NI++
Sbjct: 63 GRTLREVLAA-DGALPAGETGRLMLQV---LDALACAHN-QGIVHRDLKPQNIMVSQTGV 117
Query: 867 NMTAHVSDFGISKLLGEGDDSVTQTITMAT--IG---YMAPEYGSEGIVSAKCDVYSYGV 921
A V DFGI LL D+ T+T T +G Y APE V+ D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 922 LLMETFT 928
+ +E T
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-12
Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 42 WVGISCG----ARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELG 97
W G C + L L + L G IP + L L S+++S N+ G++P LG
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIP 141
+ L +++ +YN +GS P +G L+ L+IL+ + NS + R+P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLER---------AFRTFDSECEILRNVRHR 786
L+G GS+G+V K + G VAIK F LE A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
NLV + LV EF+ + + L Y LD + + + +E+ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--- 903
+ I+H D+KP NIL+ ++ + DFG ++ L + T + AT Y APE
Sbjct: 120 N----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLV 173
Query: 904 ----YGSEGIVSAKCDVYSYGVLLMETFT 928
YG D+++ G L+ E T
Sbjct: 174 GDTKYGR------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-12
Identities = 75/252 (29%), Positives = 111/252 (44%), Gaps = 13/252 (5%)
Query: 72 LGNLSFLVSLDISENNFYGHLPN--ELGKLRRLRLINFAYNELSGSFPSWIGIL-SRLQI 128
L NL L SLD++ N ++ EL L L L N ++ P IG+L S L+
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDI----PPLIGLLKSNLKE 144
Query: 129 LSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIP 188
L +N +P L NL L+ LDL N LS L L L L N +P
Sbjct: 145 LDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLP 202
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
+ + L+ L L++N L ++ NL L+ L L+ NN D+P +IGNL LE L
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETL 260
Query: 249 NLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI 308
+L N +S ++ +++ +R ++L N LS LPL L L L +
Sbjct: 261 DLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318
Query: 309 PNSITNASKLIG 320
+ + I
Sbjct: 319 KLNSILLNNNIL 330
|
Length = 394 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDS-------ECEILRNVRHRNLV 789
+G G+ G+V+K G VA+K L+ R E + L+ +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALR-----RLEGGIPNQALREIKALQACQHPYVV 62
Query: 790 KIFS-----SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
K+ S LV+E+MP+ E L L Q + M ++L+ +
Sbjct: 63 KLLDVFPHGSGF-----VLVMEYMPSDLSEV-LRDEERPLPEAQVKSYM---RMLLKGVA 113
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE- 903
+ H+ I+H DLKP N+L+ + ++DFG+++L E + + + +AT Y APE
Sbjct: 114 YMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPEL 171
Query: 904 -YGS----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
YG+ G+ D+++ G + E P +F GE
Sbjct: 172 LYGARKYDPGV-----DLWAVGCIFAELL-NGSP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 57/247 (23%), Positives = 102/247 (41%), Gaps = 33/247 (13%)
Query: 776 ECEILRNVRHRNLVKIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
E EILRN+ H N+VK + C D L++EF+P+GS +++L +++ Q+L
Sbjct: 56 EIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
+ + ++YL VH DL N+L++ + DFG++K + + T
Sbjct: 115 AVQICKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 893 TM-ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT----RKKPTDEMFT------GEM 941
+ + + + APE + DV+S+GV L E T P G+M
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230
Query: 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
++ R V+ ++ E + +C + L C P +R +
Sbjct: 231 TVTRLVR--------------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
Query: 1002 AAELKKI 1008
+ I
Sbjct: 277 IEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 8e-12
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKV---FNLQL--ERAFRTFDSECEILRNVRHRNLV 789
+ +G G++G+V T G VAIK F Q +R R E +ILR +H N++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 790 KIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYN-------YFL-DILQRLNIMIDV 836
I F++ +V E M K + + + YFL IL+ L +
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYI--- 122
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQTITMA 895
HS A ++H DLKP+N+LL+ N + DFG++++ E D + T +A
Sbjct: 123 ----------HS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 896 TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T Y APE S+G A D++S G +L E + +
Sbjct: 172 TRWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 737 LLGRGSFGLVYKGTLF-DGTN----VAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVK 790
LLG G FG V+KG +G + VAIK + + F+ + ++ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSL 849
+ C + LV + P GS + + LD + LN + +A + YL H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGI 909
+VH +L NILL + ++DFG++ LL D + I +MA E G
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 910 VSAKCDVYSYGVLLMETFT 928
+ + DV+SYGV + E +
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 40/118 (33%), Positives = 63/118 (53%), Gaps = 7/118 (5%)
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+++ L + HS ++H D+KP+N+L++ N + DFGIS G DSV +TI
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKP 168
Query: 899 YMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952
YMAPE ++ K DV+S G+ ++E T + P D T L++ V+E P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 738 LGRGSFG---LVYKGTLFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIF 792
+G+GS+G LV T DG IK NL+ R + + E ++L ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 793 SSCCNID-FKALVLEFMPNGS-FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
S D +V+ F G + K L Q + + +A+ L+YLH H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--- 122
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
I+H DLK N+ L V D GI+++L D + I T YM+PE S
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GTPYYMSPELFSNKPY 179
Query: 911 SAKCDVYSYGVLLMETFTRK 930
+ K DV++ G + E T K
Sbjct: 180 NYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 69/302 (22%), Positives = 119/302 (39%), Gaps = 59/302 (19%)
Query: 738 LGRGSFGLVY--------KGTLFDGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRN 787
LG G FG V K T VA+K+ E+ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------YSYN------YFLDILQRLNI 832
++ + +C +++E+ G+ ++L Y YN L ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
VA +EYL + +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK------PTDEMFTGEMSLRRW 946
+ +MAPE + I + + DV+S+GVLL E FT P +E+F
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--------- 252
Query: 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
L+ E ++C + + DC P QR +L
Sbjct: 253 ---------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 1007 KI 1008
+I
Sbjct: 298 RI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTN---VAIKVFNLQ-LERAFRTFDSECEILRNVRHRN 787
F + +G+GSFG V+KG D VAIK+ +L+ E E +L
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+ K + S +++E++ GS L + + D Q ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEK 121
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE 907
+H D+K N+LL E ++DFG++ L D + + + T +MAPE +
Sbjct: 122 K----IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+K D++S G+ +E + P +M
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNL---QLERAFRTFDSECEILRNVRHRNLVKIFS 793
+G GSFG VY + VAIK + Q ++ E L+ +RH N ++ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 794 SCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDI----LQRLNIMIDVALVLEYLHHGHS 848
C + A LV+E+ L S + L++ LQ + I L+ L + HS
Sbjct: 82 GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY---G 905
I H D+K NILL E T ++DFG + L+ + V T +MAPE
Sbjct: 134 HERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAM 186
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
EG K DV+S G+ +E RK P M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 57/288 (19%)
Query: 737 LLGRGSFGLVYKGTLFD------GTNVAIKVFNLQ-LERAFRTFDSECEILRNV-RHRNL 788
LG G+FG V K + VA+K+ E+ SE E+++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMI------- 834
+ + C +V+E+ +G+ +L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 835 -DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
VA +E+L + +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 139 YQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK------PTDEMFTGEMSLRRWV 947
+ +MAPE + + + + DV+S+GVLL E FT P +E+F L+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK---LLKEGY 251
Query: 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
+ P +C + L DC E P QR
Sbjct: 252 RMEKPQ---------------------NCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 30/86 (34%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 204 DNK-FSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPT 262
DN+ G +P +I L L +NL+ N+++G++P ++G++ LE L+L N+ +G +P +
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 263 IFNISTIRLINLIENQLSGHLPLTLG 288
+ ++++R++NL N LSG +P LG
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 738 LGRGSFG--LVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
LG+G+FG +Y+ T D + V K NL E+ R +E IL ++H N++ ++
Sbjct: 8 LGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 794 SCCNIDFKALVLEF-MPNGS--FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+D L++E NG ++K + + L + + + Y+H A
Sbjct: 67 HF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK----A 120
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
I+H D+K NI L + + DFGISK+LG + S+ +T+ + T YM+PE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPELCQGVKY 178
Query: 911 SAKCDVYSYGVLLMETFTRKK 931
+ K D+++ G +L E T K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL-------QLERAFRTFDSECEILR 781
D +G G+FG V+ A+KV + Q + +E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV----HNEKRVLK 56
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
V H ++++F + + F +++E++P G +L + F + ++ LE
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALE 115
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYM 900
YLH IV+ DLKP NILLD+ ++DFG +K L +T T+ T Y+
Sbjct: 116 YLH-SKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYL 165
Query: 901 APE-YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
APE S+G A D ++ G+L+ E P
Sbjct: 166 APEVIQSKGHNKA-VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVK 790
LG+GSFG+VY+G D T VA+K N R F +E +++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMI----DVALVLE 841
+ +V+E M +G + +L S N L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL + VH DL N ++ + T + DFG+++ + E D + + +MA
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFT 928
PE +G+ + D++S+GV+L E +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTN---VAIKVFNLQ-LERAFRTFDSECEILRNVRHRN 787
F + +G+GSFG V+KG D VAIK+ +L+ E E +L
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+ K + S +++E++ GS L LD Q I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEK 121
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE 907
+H D+K N+LL E+ ++DFG++ L D + + + T +MAPE +
Sbjct: 122 K----IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+K D++S G+ +E + P E+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 70/215 (32%), Positives = 99/215 (46%), Gaps = 7/215 (3%)
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGS--IPYYLCHLERLSQLLLNGNNLSGAIPACLGS 491
+ T+ +L L L S L +L L L LN N L I L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-E 114
Query: 492 LTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN 551
LT+L L L +N +T P + ++LS N + LPS +++L L NLDLS N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 552 QLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEA 611
LS D+P +S L +L L L+GN+ + +P L +LE LD+S+N+I ++ SL
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230
Query: 612 LLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGN 646
L L L +S N+LE G N S N
Sbjct: 231 LKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G G++G VYK + G AIKV L+ F E ++++ +H N+V F S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D + +EF GS + +Y L Q + + L YLH +H D
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK----MHRD 131
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-----MATIGYMAPEYGS---EG 908
+K NILL +N ++DFG+S +T TI + T +MAPE + +G
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA-------QITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 909 IVSAKCDVYSYGVLLMETFTRKKP 932
+ CD+++ G+ +E + P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG G+FG VYK + G A KV + E + E EIL H +VK+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDI-LQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+++EF P G+ + + LD L I + +LE L + HS+ I+H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMK-IIHR 134
Query: 856 DLKPNNILLDENMTAHVSDFGIS----KLLGEGDDSVTQTITMATIGYMAPEY-----GS 906
DLK N+LL + ++DFG+S K L D + T +MAPE
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETMK 188
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+ K D++S G+ L+E + P E+
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 738 LGRGSFGLVYKGTLF--------DGTNVAIKVF-NLQLERAFRTFDSECEILRNV-RHRN 787
LG G FG V + VA+K+ + E+ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------YSYNY---------FLDILQR 829
++ + +C +++E+ G+ ++L YSY+ F D++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV-- 140
Query: 830 LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889
+ VA +EYL + +H DL N+L+ EN ++DFG+++ + D
Sbjct: 141 -SCTYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK------PTDEMF 937
T + +MAPE + + + + DV+S+GVL+ E FT P +E+F
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 44/212 (20%)
Query: 740 RGSFGLVY----KGTLFDGTNVAIKVF------------NLQLERAFRTFDSECEILRNV 783
+G+FG VY + T G AIKV N++ ERA I+
Sbjct: 6 KGAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERA---------IMMIQ 53
Query: 784 RHR-NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+ K++ S + D+ LV+E++ G + + + + + +V L +E
Sbjct: 54 GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVED 112
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
LH I+H D+KP N+L+D+ ++DFG+S+ E V T Y+AP
Sbjct: 113 LHQRG----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAP 162
Query: 903 E--YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E G D +S G ++ E P
Sbjct: 163 ETILGVGDD--KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 738 LGRGSFGLVY-------------KGTLFDGTNVAIKVFNLQLE---RAFRTFDSECEILR 781
LG G FG V+ FDG V + V L+ + A F E +I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS---YNYF--------LDILQRL 830
+++ N++++ C + D ++ E+M NG ++L + F + I L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
+ + +A ++YL SL VH DL N L+ + T ++DFG+S+ L GD Q
Sbjct: 133 YMAVQIASGMKYLA---SLN-FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKP----TDEMF---TGE 940
+ I +MA E G + DV+++GV L E FT +++P +DE TGE
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 33/85 (38%), Positives = 51/85 (60%), Gaps = 1/85 (1%)
Query: 52 HRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNE 111
+ ++NLS S+ G IPP LG+++ L LD+S N+F G +P LG+L LR++N N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 112 LSGSFPSWIG-ILSRLQILSFHNNS 135
LSG P+ +G L +F +N+
Sbjct: 502 LSGRVPAALGGRLLHRASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 70/289 (24%), Positives = 112/289 (38%), Gaps = 56/289 (19%)
Query: 738 LGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRT---FDSECEILRNVRHRNL 788
+G+G+FG V++ T VA+K+ L+ E + F E ++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWL--------------------YSYNYF-LDIL 827
VK+ C L+ E+M G ++L N L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 828 QRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
++L I VA + YL VH DL N L+ ENM ++DFG+S+ + D
Sbjct: 131 EQLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLRRW 946
I +M PE + + DV++YGV+L E F+ +P M E+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV----- 241
Query: 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995
+ V D N++ S +C L + +L C + P R
Sbjct: 242 --------IYYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 40/239 (16%)
Query: 736 NLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDS--------------ECEIL 780
LG G++G V K G VAIK + T D E +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 781 RNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
++H N++ + DF LV++ M +K + L Q I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG--DDSVTQTITMA--- 895
LH + +H DL P NI ++ ++DFG+++ G D++++ TM
Sbjct: 133 NVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 896 -------TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRR 945
T+ Y APE G+E A D++S G + E T K +F GE + +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGKP----LFPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G GS G+V T G VA+K +L+ ++ +E I+R+ H N+V +++S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+EF+ G+ + ++ Q + + V L YLH+ ++H D
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHN----QGVIHRD 143
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K ++ILL + +SDFG + + + + + T +MAPE S + D+
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 917 YSYGVLLMETFTRKKPTDEMFTGEMSLR--RWVKESLPHGLTE 957
+S G++++E + P + E L+ R ++++LP + +
Sbjct: 202 WSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 738 LGRGSFG---LVYKGTLFD-GTNVAIKVFN----LQLERAFRTFDSECEILRNVRHRNLV 789
LG G++G LV K D G A+KV +Q + +E ++L VR +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 790 KIFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
D K L+L+++ G LY +F + R+ I ++ L L++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ--- 123
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY---G 905
I++ D+K NILLD ++DFG+SK ++ + TI YMAPE G
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGG 181
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKP 932
S G A D +S GVL E T P
Sbjct: 182 SGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFR-----TFDSECEILRNVRHRNLVKIF 792
+G G FG V G G + A +V +L + F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL------DILQRLNIMIDVALVLEYLHHG 846
C LVLEF P G + +L S + D+LQR+ +VA L +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQA 119
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--- 903
+H DL N L +++ + D+G++ D +T+ + ++APE
Sbjct: 120 D----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 904 -YGSEGIV---SAKCDVYSYGVLLMETFT 928
G + + + K +++S GV + E FT
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 738 LGRGSFGLVYKGTLF--DGTNVAIKVFNLQLERAFRTFD-----SECEILRNV-RHRNLV 789
LG G+FG V + T + ++ +KV L+ + + SE +I+ ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYS-YNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ +C ++ E+ G +L FL + L+ VA + +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
+H DL N+LL + DFG+++ + + V + + +MAPE
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 909 IVSAKCDVYSYGVLLMETFT 928
+ + + DV+SYG+LL E F+
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 737 LLGRGSFGLVYKGTLFDGTN----VAIKVFNLQLERAFRT------FDSECEILRNVRHR 786
+LG+G +G V++ G + A+KV L+ R +E IL V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
+V + + L+LE++ G L F++ + +++L LE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLHQ- 118
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
I++ DLKP NILLD ++DFG+ K + +VT T TI YMAPE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIEYMAPEILM 173
Query: 907 EGIVSAKCDVYSYGVLLMETFT---------RKKPTDEMFTGEMSL 943
D +S G L+ + T RKK D++ G+++L
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 16/202 (7%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKIFS 793
LG+G FG V + G A K + L+ + + +E +IL V R +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHGHSLAPI 852
+ D LV+ M G + +Y+ + + + LE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----I 116
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGYMAPEYGSEGIV 910
V+ DLKP N+LLD++ +SD G++ L G + I T GYMAPE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----KKIKGRAGTPGYMAPEVLQGEVY 171
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
D ++ G L E + P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 39/204 (19%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G GS G+V T G VA+K +L+ ++ +E I+R+ +H N+V+++SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMID-VALV-------LEYLH-HGH 847
D +V+EF+ G+ DI+ + + +A V L +LH G
Sbjct: 87 VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLHAQG- 135
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---- 903
++H D+K ++ILL + +SDFG + + + + + T +MAPE
Sbjct: 136 ----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISR 189
Query: 904 --YGSEGIVSAKCDVYSYGVLLME 925
YG+E D++S G++++E
Sbjct: 190 LPYGTE------VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIF-- 792
++G G++G VYK G VAIK+ ++ + E ILR H N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNIATFYGA 71
Query: 793 ----SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVALVLEY 842
+ N D LV+E GS + +RL I+ + L Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVS--DFGISKLLGEGDDSVTQTITMATIG-- 898
LH ++H D+K NILL +N A V DFG+S L D ++ + T IG
Sbjct: 129 LHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL---DSTLGRRNT--FIGTP 177
Query: 899 -YMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+MAPE + A+ DV+S G+ +E K P +M
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G+ G VY + G VAIK NLQ + +E ++R +H N+V S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+E++ GS + +D Q + + LE+LH ++H D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRD 140
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K +NILL + + ++DFG + + ++ + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 917 YSYGVLLMETFTRKKP 932
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 33/158 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-------HRNLV 789
LG G+FG VY G VAIK ++++ F +++ EC LR V+ H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 790 KIFSSCCNIDFKAL--VLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMIDVALVLEY 842
K+ + L V E+M E LY +I+ + L +
Sbjct: 62 KLKEVF--RENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 843 LH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879
+H HG H DLKP N+L+ ++DFG+++
Sbjct: 115 IHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK---VFNLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
+GRG F VY+ T L D VA+K +F + +A + E ++L+ + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
S + +VLE G + + + ++ + + + H HS ++
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVM 128
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIV 910
H D+KP N+ + + D G+ + S T + +G YM+PE E
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 911 SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970
+ K D++S G LL E + P + +M+L SL + + L E +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF-----SLCQKIEQCDYPPLPTEH--Y 233
Query: 971 SAKTDCLLSIMDLALDCCMESPEQR 995
S K L+S+ C P+QR
Sbjct: 234 SEKLRELVSM------CIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 33/89 (37%), Positives = 51/89 (57%)
Query: 77 FLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSF 136
F+ L + G +PN++ KLR L+ IN + N + G+ P +G ++ L++L NSF
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 137 TDRIPDFLLNLSKLEFLDLMENSLSGSLP 165
IP+ L L+ L L+L NSLSG +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 74/285 (25%), Positives = 126/285 (44%), Gaps = 35/285 (12%)
Query: 732 FNECNLLGRGSFGLV------YKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH 785
F + +LG+G FG V G ++ + K ++ + +E +IL V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK--RIKKRKGESMALNEKQILEKVNS 59
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLH 844
+ +V + + D LVL M G + +Y+ N + + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
+ V+ DLKP NILLD+ +SD G++ + EG+ + + T+GYMAPE
Sbjct: 120 REN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEV 172
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964
+ + D + G L+ E + P F G KE + E VD ++
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR-------KEKVKR---EEVDRRVL 218
Query: 965 GEEQAFSAK-TDCLLSIMDLALDCCMESPEQRIHMTD-AAAELKK 1007
E+ +SAK ++ SI + L + P+QR+ + A E+K+
Sbjct: 219 ETEEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVKR 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 60/231 (25%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERA------FRTFDSECEILRNVR 784
+ E +G G++G VYK L G VA+K + L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 785 ---HRNLVKIFSSCCNIDFK-----ALVLEFMPNGSFEKWLYSYNYFLDILQRL------ 830
H N+V++ C LV E + ++ L +Y L +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATY------LSKCPKPGLP 105
Query: 831 -----NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885
++M + +++LH H IVH DLKP NIL+ + ++DFG++++
Sbjct: 106 PETIKDLMRQLLRGVDFLH-SHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---S 158
Query: 886 DSVTQTITMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ T + T+ Y APE Y + D++S G + E F R+
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 720 TSYLDIQRATDGFNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFR-TFDSEC 777
TSYL++++ LG GS+ VYKG + +G VA+KV +++ E T E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREA 54
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKALVLEFM-----------PNGSFEKWLYSYNYFLDI 826
+L+ ++H N+V + + V E+M P G L+ YN L +
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFM 109
Query: 827 LQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886
Q L L Y+H H I+H DLKP N+L+ ++DFG+++ +
Sbjct: 110 FQLLR-------GLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIP 156
Query: 887 SVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETF 927
S T + + T+ Y P+ G+ S+ D++ G + +E
Sbjct: 157 SQTYSSEVVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 757 VAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEK 815
VA+K+ + R F E +I+ ++ N++++ + C D ++ E+M NG +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 816 WLYSYNY----------FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD 865
+L + + + + +A ++YL S VH DL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164
Query: 866 ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+N T ++DFG+S+ L GD Q + I +M+ E G + DV+++GV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 926 TFT--RKKP----TDEMF---TGE 940
T +++P +DE TGE
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVRHRNLVK 790
+G G++G+VYKG G VA+K L+ E A R E +L+ ++H N+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH------ 844
+ L+ EF+ S + L Y LD L +D LV YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL---SMD--LKKY---LDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 845 ---HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
H ++H DLKP N+L+D ++DFG+++ G T + T+ Y A
Sbjct: 115 LFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRA 169
Query: 902 PE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
PE GS S D++S G + E T+K
Sbjct: 170 PEVLLGSP-RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 40/97 (41%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATI 897
VL +HH HS ++H D+K NILL N + DFG SK+ D V +T T
Sbjct: 152 VLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTD 934
Y+APE S K D++S GVLL E T K+P D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 30/89 (33%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 224 LNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHL 283
L L L+G +P I L+ L+ +NL N++ G +PP++ +I+++ +++L N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 284 PLTLGHSLPNLEFLTLFGNNLIGTIPNSI 312
P +LG L +L L L GN+L G +P ++
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 738 LGRGSFGLVYKGTLFDGTNV--AIKVFNLQLERA-FRTFDSECEILRNVRHRNLVKIFSS 794
LG+G++G VYK L T V A+K L+L+ + F E +IL +V + +
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYNYFL-----DILQRLNIMIDVALVLEYLHHGHSL 849
+ +E+M GS +K LY+ D+L+R I V L++L H+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHN- 123
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGS 906
I+H D+KP N+L++ N + DFG+S G S+ +T IG YMAPE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQSYMAPERIK 174
Query: 907 EGIVSA------KCDVYSYGVLLME 925
G + + DV+S G+ ++E
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 738 LGRGSFGLVYKG---TLFDGTNVAIKVF-NLQLERAFR-TFDSECEILRNVRHRNLVKIF 792
LG G+FG V KG VA+K+ N + A + E +++ + + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
C + LV+E G K+L N + ++ V++ ++YL +
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEETN----F 116
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-TQTITMATIGYMAPEYGSEGIVS 911
VH DL N+LL A +SDFG+SK LG ++ +T + + APE + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMS 942
+K DV+S+GVL+ E F+ +KP M E++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 51/230 (22%)
Query: 738 LGRGSFGLV----YKGTLFDGTNVAIK----VFN--LQLERAFRTFDSECEILRNVR-HR 786
LG+G++G+V T + VAIK VF+ + +RA R E ++LR+ R H+
Sbjct: 8 LGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-- 844
N+ ++ ++ + G+F + LY Y ++ L+ +I L H
Sbjct: 63 NITCLYD-----------MDIVFPGNFNE-LYLYEELMEA--DLHQIIRSGQPLTDAHFQ 108
Query: 845 -----------HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
+ HS A ++H DLKP N+L++ + + DFG+++ E +T
Sbjct: 109 SFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 894 --MATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
+AT Y APE S + DV+S G +L E RK +F G+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFNLQ-LERAFRTFDSECEILRNVRHRNLV 789
F + +G+GSFG VYKG V AIK+ +L+ E E +L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALVLE 841
+ + S +++E++ GS LD+L+ I+ ++ L+
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----------LDLLKPGPLEETYIATILREILKGLD 115
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YLH +H D+K N+LL E ++DFG++ L D + + + T +MA
Sbjct: 116 YLHSERK----IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMA 169
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
PE + K D++S G+ +E + P ++
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVF--NLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
++G G++G+V K G VAIK F + E +T E ++LR +RH N+V +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLAPI 852
+ LV E++ E L + L + + + + Y H H I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-----I 121
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-------YG 905
+H D+KP NIL+ E+ + DFG ++ L S T +AT Y APE YG
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYG 180
Query: 906 SEGIVSAKCDVYSYGVLLMETFT 928
DV++ G ++ E
Sbjct: 181 KP------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G+ G V+ + G VAIK NLQ + +E +++ +++ N+V S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+E++ GS + +D Q + + LE+LH ++H D
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ----VIHRD 140
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K +N+LL + + ++DFG + + ++ + T +MAPE + K D+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 917 YSYGVLLMETFTRKKP 932
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 737 LLGRGSFGLV----YKGT--LFDGTNVAIKVFNLQLERAFRTFDSEC-----EILRNV-R 784
+LG+GSFG V KGT L+ A+KV L+ + + D EC +L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELY-----AVKV--LKKDVILQDDDVECTMTEKRVLALAGK 54
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
H L ++ S D V+E++ G + F + R ++ L L++LH
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLH 113
Query: 845 -HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE 903
G I++ DLK +N+LLD ++DFG+ K G T T T Y+APE
Sbjct: 114 ERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC-GTPDYIAPE 166
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
S D ++ GVLL E + P DE+F
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECE----ILRNV 783
TD + +G+G++G VYK T DG+ A+K+ + D E E IL+++
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75
Query: 784 -RHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLN------ 831
H N+VK + D LVLE GS + + L QRL+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISY 132
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
I+ L L++LH+ I+H D+K NNILL + DFG+S L + +
Sbjct: 133 ILYGALLGLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRN 186
Query: 892 ITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
++ T +MAPE Y A+CDV+S G+ +E P +M
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 9e-10
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 9/196 (4%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G+ G VY + G VAI+ NLQ + +E ++R ++ N+V S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+E++ GS + +D Q + + LE+LH ++H D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ----VIHRD 141
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K +NILL + + ++DFG + + + T +MAPE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKAYGPKVDI 199
Query: 917 YSYGVLLMETFTRKKP 932
+S G++ +E + P
Sbjct: 200 WSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 68/238 (28%), Positives = 107/238 (44%), Gaps = 24/238 (10%)
Query: 732 FNECNLLGRGSFG---LVYKGTLFD-GTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
F +LG G++G LV K + D G A+KV +Q + +E ++L ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 784 RHRNLVKIFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI-DVALVLE 841
R + D K L+L+++ G L F + Q + I ++ L LE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
+LH I++ D+K NILLD N ++DFG+SK E + + TI YMA
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMA 174
Query: 902 PEY--GSEGIVSAKCDVYSYGVLLMETFTRKKP----TDEMFTGEMSLRRWVKESLPH 953
P+ G +G D +S GVL+ E T P ++ E+S RR +K P+
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 732 FNECNLLGRGSFGLVY----KGT--LFDGTNVAIKVFNLQ-------LERAFRTFDSECE 778
F + LLG+G G V+ KGT LF A+KV + + ++R +E E
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLF-----ALKVLDKKEMIKRNKVKRVL----TEQE 53
Query: 779 ILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWL--YSYNYFLDILQRLNIMIDV 836
IL + H L +++S + LV+++ P G + L + + R +V
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLG 882
L LEYLH L IV+ DLKP NILL E+ H+ SDF +SK
Sbjct: 113 LLALEYLH----LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 61/184 (33%), Positives = 89/184 (48%), Gaps = 25/184 (13%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGT--NVAIKVF-------NLQLERAFRTFDSECEIL 780
+ FN LG GSFG V T + VAIK F Q++ F SE +IL
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85
Query: 781 RNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
+ H V ++ S + + LVLEF+ G F +L F + + + L+
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIF 144
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGY 899
EYL SL IV+ DLKP N+LLD++ ++DFG +K++ T+T T+ T Y
Sbjct: 145 EYLQ---SLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEY 194
Query: 900 MAPE 903
+APE
Sbjct: 195 IAPE 198
|
Length = 340 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 738 LGRGSFGLVY--KGTLFDGTNVAIKVFNLQLERAFRTFDSECEI--LRNVRHRNLVKIFS 793
+G GSFG +Y K D + IK +L S+ E+ L ++H N+V F+
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 794 SCCNIDFKALVLEFMPNGSFEKWL-YSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
S +V+E+ G K + Q L+ + ++L L+++H I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD----RKI 122
Query: 853 VHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEYGSEGIV 910
+H D+K NI L +N M A + DFGI++ L +DS+ T T Y++PE
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
+ K D++S G +L E T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G+G+ G VY + G VAIK NLQ + +E ++R ++ N+V S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+E++ GS + +D Q + + L++LH ++H D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ----VIHRD 140
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K +NILL + + ++DFG + + ++ + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 917 YSYGVLLMETFTRKKP 932
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 48/226 (21%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAF-------RTFDSECEILRNVRHRNLV 789
+G G++G+V G VAIK ++ AF RT E +ILR+ +H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67
Query: 790 ---KIFSSCCNIDFKA--LVLEFMPNGSFEKWLYS--------YNYFLDILQRLNIMIDV 836
I DFK +V++ M + ++S YFL L R
Sbjct: 68 AIRDILRPPGA-DFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--M 894
L+Y+H A ++H DLKP+N+L++E+ + DFG+++ L +T +
Sbjct: 119 --GLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 895 ATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939
AT Y APE S + D++S G + E R+ ++F G
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSE--CEILRNVR-----HR--N 787
+G G+ G VYK F T + V ++ RT + E IL ++ H
Sbjct: 22 EIGSGTCGQVYKMR-FKKTGHVMAV-----KQMRRTGNKEENKRILMDLDVVLKSHDCPY 75
Query: 788 LVKIFSSCCNIDFKALV-LEFMPNGSFEKWLYSYNYFL--DILQRLNIMIDVALVLEYLH 844
+VK + D + +E M +K L + DIL ++ + I AL YL
Sbjct: 76 IVKCYG-YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKAL--HYLK 131
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
H ++H D+KP+NILLD + + DFGIS G DS +T + YMAPE
Sbjct: 132 EKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMAPER 185
Query: 905 ----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952
+ DV+S G+ L+E T + P T L + ++E P
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 736 NLLGRGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRTFD---SECEILRNVRHRNL 788
LG GSFG V +KGT G AIK + + E IL + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
V + S + + +LEF+ G L F + + + ++ L EYLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLHS--- 136
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYMAPEY-GS 906
I++ DLKP N+LLD V+DFG +K + + +T T+ T Y+APE S
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQS 189
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP---------TDEMFTGEMSLRRWVKE 949
+G A D ++ GVLL E P +++ G + W
Sbjct: 190 KGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 738 LGRGSFGLV-YKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G GS G+V G VA+K+ +L+ ++ +E I+R+ +H+N+V+++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQ--RLN---IMIDVALVLEYLHHGHSLAP 851
+ +++EF+ G+ DI+ RLN I VL+ L + HS
Sbjct: 89 VGEELWVLMEFLQGGALT----------DIVSQTRLNEEQIATVCESVLQALCYLHSQG- 137
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
++H D+K ++ILL + +SDFG + + D + + T +MAPE S
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 912 AKCDVYSYGVLLMETFTRKKP 932
+ D++S G++++E + P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 725 IQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRT--------FDSE 776
+Q + ++ ++GRG+FG V + KV+ ++L F F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQ----LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 777 CEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
+I+ +V++F + + + +V+E+MP G + +Y D+ ++
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTA 149
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+VL L HS+ ++H D+KP+N+LLD++ ++DFG + E V + T
Sbjct: 150 EVVLA-LDAIHSMG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVGT 206
Query: 897 IGYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
Y++PE G +G +CD +S GV L E P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 732 FNECNLLGRGSFG---LVYKGTLFD-GTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
F +LG G++G LV K T D G A+KV +Q + +E +L +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 784 RHRNLVKIFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
R + + K L+L+++ G LY + F + R ++ L LE+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEH 120
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
LH IV+ D+K NILLD ++DFG+SK + T + TI YMAP
Sbjct: 121 LHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAP 175
Query: 903 E-YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E +G D +S G+L+ E T P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 56/228 (24%)
Query: 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAF-------RTFDSECEILR 781
D + + +G G++G V G VAIK +L R F RT+ E +L+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTY-RELRLLK 69
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD-----IL--QRLN- 831
++ H N++ +D F P S E + +Y + + I+ Q+L+
Sbjct: 70 HMDHENVI------GLLDV------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117
Query: 832 --IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889
I V +L L + HS A I+H DLKP+NI ++E+ + DFG+++ DD +T
Sbjct: 118 DHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMT 173
Query: 890 QTITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ AT Y APE Y + D++S G ++ E T K
Sbjct: 174 GYV--ATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 724 DIQRATDGFNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRT------- 772
D++ + + ++GRG+FG V +K T KV+ ++L F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 88
Query: 773 -FDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN 831
F E +I+ +V++F + + + +V+E+MP G + +Y D+ ++
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWA 144
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
+VL L HS+ +H D+KP+N+LLD++ ++DFG + + + V
Sbjct: 145 RFYTAEVVLA-LDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCD 201
Query: 892 ITMATIGYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+ T Y++PE G +G +CD +S GV L E P
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 738 LGRGSFGLVY--------KGTLFDGTNVAIKVF-NLQLERAFRTFDSECEILRNV-RHRN 787
LG G FG V K VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------YSY------NYFLDILQRLNI 832
++ + +C +++E+ G+ ++L YS+ L ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
VA +EYL + +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK------PTDEMF 937
+ +MAPE + + + + DV+S+GVLL E FT P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAF-RTFDSECEILRNVRHRNLVKIFSSC 795
LG G+ G VYK L +A+KV L + + SE EIL ++ + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV--LEYLHHGHSLAPIV 853
+ ++ EFM GS + + I + + I VA+V L YL SL I+
Sbjct: 69 FVENRISICTEFMDGGSLD-------VYRKIPEHVLGRIAVAVVKGLTYLW---SLK-IL 117
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H D+KP+N+L++ + DFG+S L +S+ +T + T YMAPE S
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGEQYGIH 173
Query: 914 CDVYSYGVLLMETFTRKKPTDEMFTGEMSL 943
DV+S G+ ME + P ++ + SL
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVA---IKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
+G+G F +VYK L DG VA +++F + +A + E ++L+ + H N++K +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 794 SCCNIDFKALVLEFMPNGSFE---KWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
S + +VLE G K + + + LE++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT----MATIGYMAPEYGS 906
I+H D+KP N+ + + D G+ + +T + T YM+PE
Sbjct: 127 -IMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPERIH 179
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSL 943
E + K D++S G LL E + P F G+ M+L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 65/234 (27%)
Query: 738 LGRGSFGLVYKGTLFD---GTNVAIK-VFNLQLERAF-------RTFDSECEILRNVR-H 785
LG+G++G+V+K D VA+K +F+ AF RTF E L+ + H
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD-----AFRNATDAQRTF-REIMFLQELGDH 66
Query: 786 RNLVKIFSSCCNIDFKA-------LVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMID 835
N+VK+ N+ KA LV E+M E L++ N D+ +R IM
Sbjct: 67 PNIVKLL----NV-IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQ 115
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ---TI 892
+ L+Y+H G+ ++H DLKP+NILL+ + ++DFG+++ L E +++ T
Sbjct: 116 LLKALKYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 893 TMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939
+AT Y APE Y ++G+ D++S G +L E KP +F G
Sbjct: 172 YVATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEML-LGKP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 31/279 (11%)
Query: 737 LLGRGSFGLVYKGTLF-DGTN----VAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVK 790
+LG G+FG VYKG DG N VAIKV +A + E ++ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ C + LV + MP G ++ + LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE----V 128
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
+VH DL N+L+ ++DFG+++LL + I +MA E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 911 SAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969
+ + DV+SYGV + E T KP D + E+ +L+ + +
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------------------DLLEKGER 229
Query: 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
C + + + + C M E R + E ++
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G G++G VYK L G A+K+ L+ F E +++ +H N+V F S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ + + +E+ GS + +Y L LQ + + L YLH + H D
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM----HRD 131
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-----MATIGYMAPEYGS---EG 908
+K NILL +N ++DFG++ +T TI + T +MAPE + G
Sbjct: 132 IKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 909 IVSAKCDVYSYGVLLMETFTRKKP 932
+ CD+++ G+ +E + P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 50/217 (23%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVRHRNLVK 790
+G G++G+VYK G VA+K L+ E A R E +L+ + H N+V+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDI-LQRL-----NIMIDVALVLEYLH 844
+ +V E LY FLD+ L++ +D L+ YL+
Sbjct: 63 LLD---------VVHS-------ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 845 ---------HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
H H ++H DLKP N+L+D ++DFG+++ G + T +
Sbjct: 107 QLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-- 161
Query: 896 TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T+ Y APE GS S D++S G + E R+
Sbjct: 162 TLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 55/226 (24%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAF-------RTFDSECEIL 780
T+ + + +G G+FGLV G NVAIK ++ + F RT+ E ++L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK----KIMKPFSTPVLAKRTY-RELKLL 63
Query: 781 RNVRHRNLV---KIF-SSCCNIDFKALVL-----EFMPNGSFEKWLYSYNYFLDILQRLN 831
+++RH N++ IF S +I F +L + + EK Y + IL+
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-FLYQILRG-- 120
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
L+Y+H A +VH DLKP+NIL++EN + DFG++++ D +T
Sbjct: 121 --------LKYVHS----AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGY 165
Query: 892 ITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
++ T Y APE Y E D++S G + E K
Sbjct: 166 VS--TRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 732 FNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDS--ECEILRNVRHRNL 788
F + N +G G++G+VY+ G VA+K + ER S E +L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 789 VK------------IFSSC--CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
V+ IF C D +L L+ MP E Q +M+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASL-LDNMPTPFSES------------QVKCLML 115
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
+ L+YLH I+H DLK +N+LL + ++DFG+++ G +T +
Sbjct: 116 QLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 895 ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T+ Y APE G +A D+++ G +L E K
Sbjct: 171 -TLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 81/256 (31%), Positives = 126/256 (49%), Gaps = 10/256 (3%)
Query: 364 FLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGL 423
SSL+ SL L+ + L + L+ +I E+ L+ L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSE--NLLNLLPLPSLDLNLNRLRSNIS-ELLELTNL 118
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSG 483
L LD+N + P L+ L L DN ++ S+P L +L L L L+ N+LS
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVL 543
+P L +L++L L L N ++ +P + L + ++LS+NS+ L SS+ +LK L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 544 INLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISG 603
L+LS N+L D+P +I L +L TL L+ NQ + S GSL +L LD+S N++S
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291
Query: 604 KIPKSLEALLYLKKLN 619
+P LL L+ L
Sbjct: 292 ALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 53/218 (24%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+G GS G+V T+ G VA+K +L+ ++ +E I+R+ +H N+V++++S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
D +V+EF+ G+ + ++ Q + + V L LH ++H D
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA----QGVIHRD 141
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
+K ++ILL + +SDFG + + + + + T +MAPE S + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 917 YSYGVLLMETFTRKKPTDEMFTGEMSLR--RWVKESLP 952
+S G++++E + P + E L+ + ++++LP
Sbjct: 200 WSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 724 DIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFNL-----QLERAFRTFDSEC 777
++ + F+ ++GRG+FG V V A+K+ + + + AF F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEER 94
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA 837
+I+ + +V++ + + + +V+E+MP G + +Y DI ++
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAE 150
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+VL L HS+ +H D+KP+N+LLD++ ++DFG + + V + T
Sbjct: 151 VVLA-LDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGTP 207
Query: 898 GYMAPEY----GSEGIVSAKCDVYSYGVLLME 925
Y++PE G +G +CD +S GV L E
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 737 LLGRGSFG-LVYKGTLFDGTNVAIKVFNLQL----ERAFRTFDSECEILRNVRHRNLVKI 791
LLG+G+FG ++ G A+K+ ++ + T +E +L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
S D V+E++ G L F + R ++ L+YLH G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK---- 115
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGSEGIV 910
IV+ DLK N++LD++ ++DFG+ K EG D+ T T Y+APE +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
D + GV++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 732 FNECNLLGRGSFGLV------YKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH 785
F + +LG+G FG V G ++ + K + + +E +IL V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL--NEKQILEKVNS 59
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLH 844
R +V + + D LVL M G + +Y + + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGYMAP 902
IV+ DLKP NILLD++ +SD G++ + EG QTI + T+GYMAP
Sbjct: 120 QER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAP 170
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E + D ++ G LL E + P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 68/263 (25%), Positives = 111/263 (42%), Gaps = 53/263 (20%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKI 791
+G+G +G V+ D G VA+K L E R +E +IL + LVK+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+ + ++ L +E++P G F L + + R M ++ ++ LH
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHE----LG 121
Query: 852 IVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMA--TIG---YMAPEY 904
+H DLKP N L+D + H+ +DFG+SK +T A +G YMAPE
Sbjct: 122 YIHRDLKPENFLIDA--SGHIKLTDFGLSK----------GIVTYANSVVGSPDYMAPE- 168
Query: 905 GSEGIVSAK-----CDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLRRWVKESLPHG 954
++ K D +S G +L E P +E + +L+ W KE+L
Sbjct: 169 ----VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRP 220
Query: 955 LTEVVDANLVGEEQAFSAKTDCL 977
+ + NL E A+ T +
Sbjct: 221 VYDDPRFNLSDE--AWDLITKLI 241
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 34/82 (41%), Positives = 49/82 (59%), Gaps = 2/82 (2%)
Query: 275 IENQ-LSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP 333
++NQ L G +P + L +L+ + L GN++ G IP S+ + + L LDLS N F+G IP
Sbjct: 425 LDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 334 HTFGNLRFLRFLNLMFNSLTTE 355
+ G L LR LNL NSL+
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGR 505
|
Length = 623 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 757 VAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEK 815
VA+K+ + R F E +IL ++ N++++ C + D ++ E+M NG +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 816 WLYSYNYFLDILQRLNIMIDVA---LVLEY---LHHGHSLAP---------IVHCDLKPN 860
+L S ++ D + N + A + Y LH +A VH DL
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYG 920
N L+ EN+T ++DFG+S+ L GD Q + I +MA E G + DV+++G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 921 VLLMETFT--RKKP----TDE 935
V L E +++P TDE
Sbjct: 228 VTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 30/239 (12%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN---LQLERAFRTFDSECEILRN 782
F+ +L+GRG FG V K T G A+KV L + F+ E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+ ++ + + D LV+E+ P G L Y D +A ++
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLA 114
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIGYM 900
+H H + VH D+KP N+L+D T H+ +DFG + L + V + + T Y+
Sbjct: 115 IHSVHQMG-YVHRDIKPENVLIDR--TGHIKLADFGSAARL-TANKMVNSKLPVGTPDYI 170
Query: 901 APEY------GSEGIVSAKCDVYSYGVLLMETFTRKKPTDE-----MFTGEMSLRRWVK 948
APE +G +CD +S GV+ E + P E + M+ +R++K
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFNL--QLERAFRT-FDSECEILRNVRH 785
+ F ++GRG+FG V L + V A+K+ N L+RA F E ++L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
+ + + + + + LV+++ G L + L + ++ + ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY- 904
H VH D+KP+NIL+D N ++DFG L E D +V ++ + T Y++PE
Sbjct: 121 LH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEIL 175
Query: 905 ----GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+G +CD +S GV + E + P
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 29/159 (18%)
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H DL NILL EN + DFG+++ + + D V + + +MAPE + + +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 913 KCDVYSYGVLLMETFTR-KKP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
+ DV+S+GVLL E F+ P DE F L+ + P
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--LKEGTRMRAP-------------- 298
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005
E A T + SIM LDC +PE R ++ L
Sbjct: 299 EYA----TPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 57/175 (32%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEI-------LRNVRHRNLV 789
+G+GSFG V DG A+KV ++A + I L+NV+H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ S D VL+++ G L F + R ++A L YLH SL
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPE 903
I++ DLKP NILLD ++DFG+ K EG + S T + T Y+APE
Sbjct: 116 N-IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 737 LLGRGSFGLVYKGTLFDGTN--VAIKVFNLQLERAFRTFDSECEILRN------VRHRNL 788
+LG+GSFG V L GT+ AIKV L+ + + D +C + +H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGH 847
+ D V+E++ G + F + R +V L L +LH HG
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGS 906
+++ DLK +NILLD ++DFG+ K EG + VT T T Y+APE
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
E D ++ GVL+ E + P D++F
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG G+FG VYK + G A KV + + E + E +IL + H N+VK+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ +++EF G+ + + L Q + L YLH I+H D
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK----IIHRD 128
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-----MATIGYMAPEY-----GS 906
LK NIL + ++DFG+S T+TI + T +MAPE
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+ K DV+S G+ L+E + P E+
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 35/105 (33%), Positives = 46/105 (43%), Gaps = 23/105 (21%)
Query: 112 LSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLP 171
L G P+ I L LQ ++ NS IP L +++ LE LDL NS +GS
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS-------- 481
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216
IP SL + T L+ L L N SGR+P +G
Sbjct: 482 ---------------IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 738 LGRGSFGLVYKGTLFDGTN--VAIKVFNL---QLERAFRTFDSECEILRNVRHRNLVKIF 792
+G GSFG VY T TN VA+K + Q ++ E + L+ ++H N ++ +
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-Y 86
Query: 793 SSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV-------LEYLH 844
C + A LV+E+ L S + L++ ++ +++A + L YLH
Sbjct: 87 KGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
H++ +H D+K NILL E ++DFG + + V T +MAPE
Sbjct: 139 -SHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEV 188
Query: 905 ---GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
EG K DV+S G+ +E RK P M
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 49/218 (22%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIK----VFNLQLERAFRTFDSECEILRNVRHRNLVK-- 790
+GRG++G+V + VAIK F+ +++ A RT E ++LR++ H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTL-REIKLLRHLDHENVIAIK 70
Query: 791 -IFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYN--------YFLDILQRLNIMIDVALV 839
I F +V E M + + + S YFL L R
Sbjct: 71 DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR---------G 120
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L+Y+H A ++H DLKP+N+LL+ N + DFG+++ E D +T+ + T Y
Sbjct: 121 LKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV--VTRWY 174
Query: 900 MAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
APE Y DV+S G + E RK
Sbjct: 175 RAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 61/220 (27%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVF-----NLQLER-AFRTFDSECEILRNVRHRNLVK 790
+G GS+G+V+K + G VAIK F + +++ A R E +L+ ++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 791 -------------IFSSCCNIDFKAL-VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
+F C D L LE P G + I+
Sbjct: 65 LIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG------------VPEHLIKKIIWQT 109
Query: 837 ALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+ + H H +H D+KP NIL+ + + DFG +++L D T + A
Sbjct: 110 LQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV--A 162
Query: 896 TIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFT 928
T Y APE YG DV++ G + E T
Sbjct: 163 TRWYRAPELLVGDTQYGP------PVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 737 LLGRGSFG--LVYKGTLFDGTNVAIKVFNLQL---ERAFRTFDSECEIL-RNVRHRNLVK 790
++G+GSFG L+ K L DG A+KV ++ + + +E +L +NV+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ S + VL+F+ G L F + R ++A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS----I 115
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGSEGI 909
IV+ DLKP NILLD ++DFG+ K EG S T T T Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941
D + G +L E P EM
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIM 833
+E IL V R +V + + D LVL M G + +Y+ N D + +
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI- 892
++ LE L IV+ DLKP NILLD+ +SD G++ + EG +T+
Sbjct: 109 AELCCGLEDLQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----ETVR 159
Query: 893 -TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951
+ T+GYMAPE + + D + G L+ EM G+ R+ KE +
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIY----------EMIQGQSPFRKR-KERV 208
Query: 952 PHGLTEVVDANLVGEEQAFSAK-TDCLLSIMDLALDCCMESPEQRIHMT-DAAAELKK 1007
E VD + +++ +S K ++ SI + L ++P++R+ + AA +K+
Sbjct: 209 KR---EEVDRRVKEDQEEYSEKFSEDAKSICRMLL---TKNPKERLGCRGNGAAGVKQ 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRN 787
D F + + LG G+ G+V+K + G +A K+ +L+++ A R E ++L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLD-ILQRLNIMIDVALVLEYLHHG 846
+V + + + ++ +E M GS ++ L + IL +++I + L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 122
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP 932
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 732 FNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILR------ 781
F +LGRG FG V YK T G AIK L++ E E L
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKA----LKKGDIIARDEVESLMCEKRIF 53
Query: 782 ----NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI--- 834
+ RH LV +F+ D V+E+ G +++ D+ +
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAA 108
Query: 835 DVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
V L L+YLH + IV+ DLK +N+LLD ++DFG+ K G G T T
Sbjct: 109 CVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFC 162
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
T ++APE +E + D + GVL+ E + P F G+
Sbjct: 163 -GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 20/199 (10%)
Query: 738 LGRGSFGLVY-----KGTLFDGTNV--AIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
LG+GSFG VY K + V I V L + + E ++L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL---QRLNIMIDVALVLEYLHHGH 847
+S D ++ E+ + L + L Q I + L + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL-GEGDDSVTQTITMATIGYMAPEYGS 906
I+H DLK NI L N+ + DFG+S+LL G D + T T T YM+PE
Sbjct: 127 ----ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALK 178
Query: 907 EGIVSAKCDVYSYGVLLME 925
+K D++S G +L E
Sbjct: 179 HQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 738 LGRGSFGLVY----KGTLFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK 790
LG+G FG V + T G A K N L+ + + E IL V R +V
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV- 56
Query: 791 IFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
S K LV+ M G +Y+ + A ++ L H H
Sbjct: 57 --SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEY-- 904
I++ DLKP N+LLD + +SD G++ L +G ++T A T G+MAPE
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQ 170
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
G E S D ++ GV L E + P
Sbjct: 171 GEEYDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNV-----RHRNLVK 790
+LG+GSFG V+ GTN + L+ + D EC ++ + V H L
Sbjct: 2 MLGKGSFGKVFLAE-LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
++ + + V+E++ G + S + F D+ + ++ L++LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLHS----K 115
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVTQTITMATIGYMAPEYGSEG 908
IV+ DLK +NILLD + ++DFG+ K +LG D+ T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---DAKTCTFC-GTPDYIAPEILLGQ 171
Query: 909 IVSAKCDVYSYGVLLMETFTRKKP 932
+ D +S+GVLL E + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 732 FNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRTFD-----SECEILRN 782
F +LG+G FG V + T G A K L+ +R + +E +IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGEAMALNEKQILEK 56
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLE 841
V R +V + + D LVL M G + +Y+ N D + + ++ LE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGY 899
LH IV+ DLKP NILLD+ +SD G++ + EG +TI + T+GY
Sbjct: 117 DLHRER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-----ETIRGRVGTVGY 167
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
MAPE + D + G L+ E K P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 68/242 (28%), Positives = 118/242 (48%), Gaps = 35/242 (14%)
Query: 724 DIQRATD-GFNECNLLGRGSFGLVYKGTLFDGT-NVAIKVFNLQLERAFRTFDSECEILR 781
DI R+ + + N++G GSFG+VY+ D + VAIK ++ + + + E I++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMK 114
Query: 782 NVRHRNLVKI----FSSCC-----NIDFKALVLEFMPNGSFEKWLYSY---NYFLDILQR 829
N+ H N++ + ++ C NI F +V+EF+P + K++ Y N+ L +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172
Query: 830 LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKLLGEGDDSV 888
+ L Y+H I H DLKP N+L+D N T + DFG +K L G SV
Sbjct: 173 KLYSYQLCRALAYIHSKF----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 889 TQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946
+ + + Y APE G+ + D++S G ++ E +F+G+ S+ +
Sbjct: 229 SY---ICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQL 280
Query: 947 VK 948
V+
Sbjct: 281 VR 282
|
Length = 440 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 732 FNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNL---QLERAFRTFDSECEILRNVRHRN 787
F++ +G GSFG VY + + VAIK + Q ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 788 LVKIFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
++ + C + A LV+E+ GS L + L ++ + L YLH
Sbjct: 77 TIQ-YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY-- 904
H++ +H D+K NILL E + DFG + ++ + V T +MAPE
Sbjct: 134 HNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVIL 184
Query: 905 -GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
EG K DV+S G+ +E RK P M
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-08
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 23/152 (15%)
Query: 740 RGSFGLVY------KGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV----RHRNLV 789
RG+FG VY L+ A+KV + + + + + R+ + +V
Sbjct: 14 RGAFGKVYLGRKKNNSKLY-----AVKVVK-KADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHS 848
++ S + + LV+E++ G + L+ Y YF + + I +VAL L+YLH HG
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG-- 124
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880
I+H DLKP+N+L+ ++DFG+SK+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 33/225 (14%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV------- 783
F L+G G++G VYKG + G AIKV ++ T D E EI + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYS 60
Query: 784 RHRNLVKIFSSCCNI------DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA 837
HRN+ + + D LV+EF GS + N + L+ I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICR 118
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-MAT 896
+L L H H ++H D+K N+LL EN + DFG+S L D +V + T + T
Sbjct: 119 EILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGT 174
Query: 897 IGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
+MAPE + K D++S G+ +E P +M
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFNL--QLERAFRT-FDSECEILRNVRH 785
D F ++GRG+FG V + + A+K+ N L+RA F E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL-DILQRLNIMIDVALVLEYLH 844
+ + + + + ++ LV+++ G L + L + + R I ++ L + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH 119
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE- 903
H VH D+KP+N+LLD N ++DFG S L D +V ++ + T Y++PE
Sbjct: 120 QLH----YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 904 ----------YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
YG E CD +S GV + E + P
Sbjct: 175 LQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 737 LLGRGSFGLVY----KGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIF 792
L+G G FG VY K+ NL+ E T E + N+ + + ++
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL---------DILQRL---------NIMI 834
+ NID + + GSF++ Y + L +I +R+ NIM
Sbjct: 75 KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 835 DVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877
D+ LEY+H HG I H D+KP NI++D N ++ D+GI
Sbjct: 134 DMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 730 DGFNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRN 787
D + + LG GS+ VYKG + +G VA+KV LQ E T E +L+ ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 788 LVKIFSSCCNIDFKALVLEFM-----------PNGSFEKWLYSYNYFLDILQRLNIMIDV 836
+V + + LV E++ P G L+ N L + Q L
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR----- 114
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
L Y+H + I+H DLKP N+L+ + ++DFG+++ + S T + + T
Sbjct: 115 --GLSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVT 166
Query: 897 IGYMAPEYGSEGIVSAKC-DVYSYGVLLME 925
+ Y P+ + C D++ G + +E
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 730 DGFNECNLLGRGSFGLVYK-GTLFDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRN 787
D F + LG G+ G+V K G +A K+ +L+++ A R E ++L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHG 846
+V + + + ++ +E M GS ++ L +IL +++I + L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 122
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HQ---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP 932
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 51/231 (22%), Positives = 104/231 (45%), Gaps = 35/231 (15%)
Query: 738 LGRGSFGLVYKGTLF--------DGTNVAIKVF-NLQLERAFRTFDSECEILRNV-RHRN 787
LG G FG V + + VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-----NYFLDILQR----------LNI 832
++ + C +++E+ G+ ++L + +Y DI + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
VA +EYL +H DL N+L+ E+ ++DFG+++ + + D +
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK------PTDEMF 937
+ +MAPE + + + + DV+S+G+L+ E FT P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 27/76 (35%), Positives = 44/76 (57%)
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H DL NILL EN + DFG+++ + + D V + + +MAPE + + +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 913 KCDVYSYGVLLMETFT 928
+ DV+S+GVLL E F+
Sbjct: 256 QSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 250 LGMNN--LSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
LG++N L G +P I + ++ INL N + G++P +LG S+ +LE L L N+ G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFG 337
IP S+ + L L+L+ N SG +P G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 732 FNECNLLGRGSFGLVY-KGTLFDGTNVAIKVFNL---QLERAFRTFDSECEILRNVRHRN 787
F + +G GSFG VY + VAIK + Q ++ E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 788 LVKIFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV------- 839
++ + C + A LV+E+ L S + L++ ++ +++A +
Sbjct: 87 SIE-YKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L YLH H++ +H D+K NILL E ++DFG + + + V T +
Sbjct: 138 LAYLH-SHNM---IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYW 187
Query: 900 MAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
MAPE EG K DV+S G+ +E RK P M
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G++ VYKG G VA+K +L E T E +++ ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYF--LDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+ LV E+M + +K++ ++ LD + + + + H ++
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR----VL 122
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVS 911
H DLKP N+L+++ ++DFG+++ G ++ + + T+ Y AP+ GS S
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSR-TYS 179
Query: 912 AKCDVYSYGVLLMETFT 928
D++S G ++ E T
Sbjct: 180 TSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L+YLH I+H D+KP N+L++ N + DFG+++ + E D+S T + T Y
Sbjct: 116 LKYLHSAG----ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYY 170
Query: 900 MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
APE GS SA D++S G + E R+
Sbjct: 171 RAPEILMGSRHYTSA-VDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 738 LGRGSFG---LVYKGTLFDGTNVAIKVFNL------QLERAFRTFDSECEILRNVRHRNL 788
+G GSFG LV DG IK N+ + E + + E +L N++H N+
Sbjct: 8 IGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNI 61
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL----QRLNIMIDVALVLEYLH 844
V+ S +V+++ G K + N +L Q L+ + + L L+++H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMA 901
I+H D+K NI L ++ T + DFGI+++L T + IG Y++
Sbjct: 119 D----RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLS 169
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRK 930
PE + K D+++ G +L E T K
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTN-VAIKVF--NLQLERAFRTFDSECEILRNVRHRNL 788
F ++G G++G+V K + VAIK F + + E T E ++LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 789 VKIFSSCCNIDFKALVLEF-----------MPNGSFEKWLYSYNYFLDILQRLNIMIDVA 837
V++ + LV E+ MPNG + + SY Y L
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------------- 109
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
++ +H H IVH D+KP N+L+ N + DFG ++ L EG ++ T +AT
Sbjct: 110 --IKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATR 165
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLME------TFTRKKPTDEMFT 938
Y +PE D++S G +L E F + D++FT
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 27/76 (35%), Positives = 44/76 (57%)
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H DL NILL EN + DFG+++ + + D V + + +MAPE + + +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 913 KCDVYSYGVLLMETFT 928
+ DV+S+GVLL E F+
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 66/254 (25%), Positives = 104/254 (40%), Gaps = 31/254 (12%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI---- 791
++GRG FG VY D G A+K + ++ + E L +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 792 FSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
F C F +L+ M G L + F + R ++ L LE++H+
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNR 116
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
+V+ DLKP NILLDE+ +SD G++ + ++ T GYMAPE
Sbjct: 117 F----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQ 168
Query: 907 EGIV-SAKCDVYSYGVLLME------TFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959
+G + D +S G +L + F + K D+ M+L V LP + +
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFSPEL 226
Query: 960 DANLVGEEQAFSAK 973
+ L G Q +K
Sbjct: 227 KSLLEGLLQRDVSK 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 738 LGRGSFGLVYK-GTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSC 795
+G+G++G V+K +G+ A+K+ + + ++E IL+ + H N+VK +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 796 CNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVALVLEYLH 844
D K LVLE GS + FL +R+ I+ + + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
+ +H D+K NNILL + DFG+S L + + ++ T +MAPE
Sbjct: 142 VNKT----IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEV 195
Query: 905 GS-----EGIVSAKCDVYSYGVLLME 925
+ + A+CDV+S G+ +E
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFNLQLERAFRTFDSECEIL--RNVRH 785
FN +LG+GSFG V KGT AIK+ L+ + + D EC ++ R +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 786 RN----LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
++ L ++ S +D V+E++ G + F + Q + ++++ L
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLF 115
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
+LH I++ DLK +N++LD ++DFG+ K D VT T Y+A
Sbjct: 116 FLHR----RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIA 169
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEM 941
PE + D ++YGVLL E + P DE+F M
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
H HS+ IV+ D+KP N+LLD+ +SD G++ L +G ++TQ T GYMAPE
Sbjct: 110 HLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQ--RAGTNGYMAPEI 165
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E S D ++ G + E + P
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 18/168 (10%)
Query: 771 RTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL 830
+T E +IL+ + HR ++ + + K+ V MP + L++Y +D L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCD--LFTY---VDRSGPL 182
Query: 831 N----IMIDVALV--LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884
I I L+ L YLH I+H D+K NI LDE A + DFG + L
Sbjct: 183 PLEQAITIQRRLLEALAYLHG----RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
D+ T+ +PE + AK D++S G++L E +
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 61/204 (29%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 738 LGRGSFGLVYKGTLFDGTNV-AIKVFNLQL------------ERAF--RTFDSECEILRN 782
+G+G+FG VY+ D + A+KV + + ER RT E +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
++ FS + D LV ++M G L F + + I ++ L LE+
Sbjct: 61 LK-------FSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEH 111
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
LH IV+ DLKP NILLD + DFG+SK D+ T T T Y+AP
Sbjct: 112 LHKYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAP 165
Query: 903 E-YGSEGIVSAKCDVYSYGVLLME 925
E E + D +S GVL+ E
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 824 LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883
L L L+ VA +E+L + VH DL N+LL + + DFG+++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMH 289
Query: 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ V++ T + +MAPE + + + DV+SYG+LL E F+
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 738 LGRGSFGLVYKGTLFD--GTNVAIKVFNLQLERAFRTFDS--ECEILRNVR---HRNLVK 790
+G G++G V+K G VA+K +Q + E +LR++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALVLEY 842
+F C E FE +LD + ++M + L++
Sbjct: 69 LFDVCT---VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
LH +VH DLKP NIL+ + ++DFG++++ + T + T+ Y AP
Sbjct: 126 LHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRK 930
E + + D++S G + E F RK
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLV 789
F ++G G++G VYKG + G AIKV ++ E E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 790 KIF------SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
+ S + D LV+EF GS + N + L+ I +L L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK--NTKGNALKEDWIAYICREILRGL 134
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-MATIGYMAP 902
H H+ ++H D+K N+LL EN + DFG+S L D +V + T + T +MAP
Sbjct: 135 AHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 190
Query: 903 EY-----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
E + + D++S G+ +E P +M
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 737 LLGRGSFGLVYKGTLFDGTNV-AIKVFNLQLERAFRTFDSEC-----EILRNVR-HRNLV 789
+LG+GSFG V L + + A+KV L+ + + D EC IL R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 790 KIFSSCC--NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+++ CC D V+EF+ G + F + R ++ L +LH
Sbjct: 60 QLY--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD-- 114
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGS 906
I++ DLK +N+LLD ++DFG+ K EG + T + T Y+APE
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
E + D ++ GVLL E P D++F
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 732 FNECNLLGRGSFGLVY----KGT--LFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNV- 783
FN +LG+GSFG V KGT L+ AIK+ L+ + + D EC ++ + V
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVIIQDDDVECTMVEKRVL 54
Query: 784 ----RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+ L ++ S +D V+E++ G + F + + ++A+
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-HAVFYAAEIAIG 113
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG--DDSVTQTITMATI 897
L +LH I++ DLK +N++LD ++DFG+ K E T+T T
Sbjct: 114 LFFLHS----KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFC-GTP 165
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEM 941
Y+APE + D +++GVLL E + P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 738 LGRGSFGLVYKGTLFDG-TNVAIKVFNLQLERAFRTFDS----ECEILRNVRHRNLVKIF 792
+G G++G+VYK D TN I + ++LE+ S E +L+ ++H N+V++
Sbjct: 10 IGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA----LVLEYLH---- 844
+ LV E++ LD+ + ++ D A L+ YL+
Sbjct: 68 DVVHSEKRLYLVFEYLD--------------LDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 845 -----HGHSLAPIVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDSVTQTITMATIG 898
H H ++H DLKP N+L+D A ++DFG+++ G + T + T+
Sbjct: 114 GIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLW 168
Query: 899 YMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE GS S D++S G + E +K
Sbjct: 169 YRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 730 DGFNECNLLGRGSFGLV-YKGTLFDGTNVAIKVF------NLQLERAFRTFDSECEILRN 782
D + + +G G++G V G VAIK L +RA+R E +L++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 783 VRHRN---LVKIFSSCCNID-FKA--LVLEFMPN--GSFEKWLYSYNYFLDILQRLNIMI 834
++H N L+ +F+ ++D F LV+ FM G K + L I
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--------HEKLSEDRIQF 122
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
V +L+ L + H+ A I+H DLKP N+ ++E+ + DFG+++ + D +T +
Sbjct: 123 LVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV- 177
Query: 895 ATIGYMAPEYGSEGIVS-----AKCDVYSYGVLLMETFTRK 930
T Y APE I++ D++S G ++ E T K
Sbjct: 178 -TRWYRAPEV----ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 737 LLGRGSFGLVYKGTL-FDGTNVAIKVFN----LQLERAFRTFDSECEILRNVRHRNLVKI 791
++G+GSFG V DG+ A+KV L+ + +L+N++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
S + VL+++ G L FL+ R +VA + YLH SL
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLN- 116
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYMAPEYGSEGIV 910
I++ DLKP NILLD ++DFG+ K EG + T T T Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 911 SAKCDVYSYGVLLME 925
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 737 LLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI---- 791
++GRG FG VY D G A+K + ++ + E L +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 792 FSSCCNIDFK-----ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
F C + F + +L+ M G L + F + R ++ L LE++H+
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNR 116
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT-ITMATIGYMAPEYG 905
+V+ DLKP NILLDE+ +SD G++ D S + ++ T GYMAPE
Sbjct: 117 F----VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVL 167
Query: 906 SEGIV-SAKCDVYSYGVLLMETFTRKKP 932
+G+ + D +S G +L + P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 63/210 (30%), Positives = 87/210 (41%), Gaps = 12/210 (5%)
Query: 737 LLGRGSFGLVY-----KGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
++G+GSFG V F V K L+ + +L+NV+H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
S D VL+++ G L FL+ R ++A L YLH SL
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN- 116
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
IV+ DLKP NILLD ++DFG+ K E + T T T Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941
D + G +L E P T EM
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 737 LLGRGSFGLVYKGTLFDGTN--VAIKVFNLQLERAFRTFDSECEIL-RNV-----RHRNL 788
+LG+GSFG V L GTN AIK L+ + D EC ++ R V H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+F + + V+E++ G + S F + R ++ L++LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG- 116
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVTQTITMATIGYMAPEYGS 906
I++ DLK +N+LLD++ ++DFG+ K + GEG + T Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----KASTFCGTPDYIAPEILK 169
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
+ D +S+GVLL E + P DE+F
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 737 LLGRGSFGLVY----KGTLFDGTNVAIKVFNLQL----ERAFRTFDSECEILRNVRHRNL 788
LLG+G+FG V K T G A+K+ ++ + T +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 57
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ S D V+E+ G L F + R ++ L+YLH S
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---S 113
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGSE 907
+V+ DLK N++LD++ ++DFG+ K EG D T T Y+APE +
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKP 932
D + GV++ E + P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 66/234 (28%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVRHRNLVK 790
LG G+FG VYK + G VA+K + E+ A R E +IL+ ++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEK----------------WLYSYNYFLDILQRLNIMI 834
+ ID + +E ++ L + + L Q M+
Sbjct: 72 L------ID---MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL-----------GE 883
+ + YLH H I+H D+K NIL+D ++DFG+++ G
Sbjct: 123 QLLEGINYLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 884 GDDSVTQTITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
G T + T Y PE Y + D++ G + E FTR+
Sbjct: 179 GTRKYTNLVV--TRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEI-----LRNVRHRNLVKI 791
+G G++G VYK G VA+K +Q + E+ L H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 792 FSSCCNI-----------------DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
C D + + + P G L ++M
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG------------LPAETIKDLMR 115
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
L++LH IVH DLKP NIL+ ++DFG++++ + T +
Sbjct: 116 QFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVV 168
Query: 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 930
T+ Y APE + + D++S G + E F RK
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNV--AIKVFNLQLERAFRT-FDSECEILRNVRHR 786
D F + LG G+ G+V K L + + A K+ +L+++ A R E ++L
Sbjct: 1 DDFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHH 845
+V + + + ++ +E M GS ++ L +IL + I I V L YL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLRE 117
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-- 903
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 118 KHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERL 170
Query: 904 YGSEGIVSAKCDVYSYGVLLME 925
G+ V + D++S G+ L+E
Sbjct: 171 QGTHYTVQS--DIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 51/222 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER---AFRTFDSECEILRNVRHRNLVKIF 792
++G+GS+G+V G VAIK N E A R E ++LR +RH ++V+I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL-REIKLLRLLRHPDIVEIK 65
Query: 793 SSCCNI-------DFKAL--VLEFMPNGSFEKWLYS------------YNYFLDILQRLN 831
+I +FK + V E M E L+ + +FL L R
Sbjct: 66 ----HIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR-- 114
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQ 890
L+Y+H A + H DLKP NIL + + + DFG++++ + ++
Sbjct: 115 -------ALKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163
Query: 891 TITMATIGYMAPEY-GS-EGIVSAKCDVYSYGVLLMETFTRK 930
T +AT Y APE GS + D++S G + E T K
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G++ V+KG + VA+K L+ E A T E +L+N++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
LV E++ + +++L + + + M + L Y H I+H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK----RKILHR 127
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVSAK 913
DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS S
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTE-YSTP 184
Query: 914 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951
D++ G +L E T + MF G VKE L
Sbjct: 185 IDMWGVGCILYEMATGRP----MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 36/150 (24%), Positives = 59/150 (39%), Gaps = 16/150 (10%)
Query: 735 CNLLGRGSFGL----VYKGTLFDGTNVAIKVFNL--QLERAFRTFDSECEILRNVRHRNL 788
L+G+ L + K T VA+K NL + + E R ++H N+
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL---NIMIDVALVLEYLHH 845
+ +S +V M GS E L +F + L L I+ DV L+Y+H
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLK--THFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDF 875
+H +K ++ILL + +S
Sbjct: 120 KG----FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 87/334 (26%), Positives = 136/334 (40%), Gaps = 37/334 (11%)
Query: 224 LNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHL 283
L L ++L + + + + L+ N L+ P++ N + + +S L
Sbjct: 59 LLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL-----NRLRSNISELL 113
Query: 284 PLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIG-LDLSSNLFSGHIPHTFGNLRFL 342
LT SL NN I IP I + LDLS N +P NL L
Sbjct: 114 ELTNLTSL-------DLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNL 165
Query: 343 RFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKF 402
+ L+L FN L+ L+N +L L L+ N + LPP I ++L +
Sbjct: 166 KNLDLSFNDLS---------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEEL 214
Query: 403 EAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP 462
+ + + + NL L L+L +N+L +P ++G L+ L L +N Q S
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISSI 270
Query: 463 YYLCHLERLSQLLLNGNNLSGAIP--ACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYIL 520
L L L +L L+GN+LS A+P A L L L L + +S+ IL
Sbjct: 271 SSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNIL 330
Query: 521 YVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
+S+ P ++ L+ L NL N L
Sbjct: 331 SNGETSS------PEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 41/216 (18%)
Query: 746 VYKGTLFDGTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRNLVKIFS----SCCNI 798
+YKG +F+ V I+ F + + ++E + LR + N++KI+ ++
Sbjct: 36 IYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH------HGHSLAPI 852
+L+LE+ G + L L +L++ ID L L+ + +
Sbjct: 95 PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN----- 148
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS- 911
L + L+ EN K++ G + + + + +M Y S +++
Sbjct: 149 ----LTSVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLND 194
Query: 912 ------AKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941
K D+YS GV+L E FT K P + + T E+
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 737 LLGRGSFGLVY----KGTLFDGTNVAIKVFNLQL----ERAFRTFDSECEILRNVRHRNL 788
LLG+G+FG V K T G A+K+ ++ + T +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFL 57
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ + D V+E+ G L F + R ++ LEYLH
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLHSRD- 115
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGSE 907
+V+ D+K N++LD++ ++DFG+ K EG D T T Y+APE +
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKP 932
D + GV++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTN-----VAIK-VFNLQLERAFRTFDSE 776
+ I R D +LL G+FG ++ G L D V +K V + E E
Sbjct: 1 IAISR--DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQE 58
Query: 777 CEILRNVRHRNLVKIFSSCCNIDFKALVLE-FMPNGSFEKWLYSYNYF-------LDILQ 828
+L + H+N++ I C VL +M G+ + +L L Q
Sbjct: 59 SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118
Query: 829 RLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
+++ I +A + YLH G ++H D+ N ++DE + ++D +S+ L D
Sbjct: 119 LVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MA E S+ DV+S+GVLL E T
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 54/191 (28%), Positives = 75/191 (39%), Gaps = 31/191 (16%)
Query: 757 VAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKW 816
V K L ER SE L H +VK F + D L++E+ G K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK- 154
Query: 817 LYSYNYFLDILQRLN------------IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL 864
I QRL + + L L+ +H ++H DLK NI L
Sbjct: 155 --------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS----RKMMHRDLKSANIFL 202
Query: 865 DENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIVSAKCDVYSYGV 921
+ DFG SK + DSV+ + + G Y+APE S K D++S GV
Sbjct: 203 MPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 922 LLMETFTRKKP 932
+L E T +P
Sbjct: 260 ILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 55/203 (27%), Positives = 79/203 (38%), Gaps = 64/203 (31%)
Query: 739 GRGSFGLVYKG---TLFDGTNVAIKVFNLQLER-------AFRTFDSECEILRNVRHRNL 788
GRG++G VYK DG AIK F E+ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWL---YSYNYFLDIL----QRLNIMIDVALV-- 839
V LV F+ + +L Y+ + I+ Q + I ++V
Sbjct: 65 VS------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 840 --------LEYLHHGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGIS-------KL 880
+ YLH ++H DLKP NIL+ E + D G++ K
Sbjct: 113 LLWQILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 881 LGEGDDSVTQTITMATIGYMAPE 903
L + D V TI Y APE
Sbjct: 169 LADLDPVVV------TIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 9/115 (7%)
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
VH DL N+L+ E + DFG+++ + + +++ T + +MAPE + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 913 KCDVYSYGVLLMETFT------RKKPTDEMFTGEMSLRRWVKESLP-HGLTEVVD 960
DV+S+G+LL E FT + P +E F +++R + + P H E+ +
Sbjct: 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 64/255 (25%), Positives = 105/255 (41%), Gaps = 74/255 (29%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNVAIKVFNLQLERAFRT-----FDSECEILR 781
+ F+ ++G+G+FG LV K G A+K L F+ +E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLA 56
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
+V ++ S + + L++EF+P G L Y+ F + + R M + L +E
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIE 115
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS------------KLLGEGD---- 885
+H +H D+KP+NIL+D +SDFG+S + L +G
Sbjct: 116 AVHK----LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 886 ----------DSVTQTIT--------------MA--TIG---YMAPE------YGSEGIV 910
DS+ T++ MA T+G Y+APE YG E
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE--- 228
Query: 911 SAKCDVYSYGVLLME 925
CD +S G ++ E
Sbjct: 229 ---CDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 727 RATDGFNECNLLGRGSFGLVYKG----TLFDGTNVAIKVFNLQLER------AFRTFDSE 776
R+ D + + N + G++G+VY+ T G VA+K ++ E+ + R E
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKT---GEIVALKKLKMEKEKEGFPITSLR----E 54
Query: 777 CEILRNVRHRNLVKI----FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
IL ++H N+V + S N+D +V+E++ + + + + + +
Sbjct: 55 INILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL 111
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
M+ + + +LH I+H DLK +N+LL+ + DFG+++ G TQ +
Sbjct: 112 MLQLLSGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 893 TMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
T+ Y APE G S D++S G + E KKP +F G+
Sbjct: 168 V--TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFNL--QLERA-FRTFDSECEILRNVRH 785
D F ++GRG+FG V + + V A+K+ N L+RA F E ++L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL-DILQRLNIMIDVALVLEYLH 844
R + + + + + LV+++ G L + L + + R + ++ L ++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVH 119
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
VH D+KP+N+LLD+N ++DFG S L D +V + + T Y++PE
Sbjct: 120 QLG----YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 905 -----GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+G +CD +S GV + E + P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 46/133 (34%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
A +L L + H +++ DLKP NILLD + DFG+ KL + DD T T
Sbjct: 99 TAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-TNTFC-G 155
Query: 896 TIGYMAPEYGSEGIVSAKC-DVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL--P 952
T Y+APE G K D ++ GVLL E T P + EM R+ ++E L P
Sbjct: 156 TPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRFP 213
Query: 953 HGLTEVVDANLVG 965
G L+G
Sbjct: 214 DGFDRDAKDLLIG 226
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 732 FNECNLLGRGSFGLVY----KGT--LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-- 783
FN +LG+GSFG V KGT L+ AIK+ L+ + + D EC ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVVIQDDDVECTMVEKRVL 54
Query: 784 ----RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+ L ++ S +D V+E++ G + F + + ++A+
Sbjct: 55 ALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIAIG 113
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
L +LH I++ DLK +N++LD ++DFG+ K D VT T Y
Sbjct: 114 LFFLHS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEM 941
+APE + D +++GVLL E + P DE+F M
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 46/231 (19%)
Query: 738 LGRGSFGLV---YKGTLFDGTNVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNL 788
+G G+ G+V Y L NVAIK + + RA+R E +++ V H+N+
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD--ILQRLNIMID-------VA 837
+ + + F P S E++ +Y +D + Q + + +D +
Sbjct: 79 ISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+L + H HS A I+H DLKP+NI++ + T + DFG+++ G S T + T
Sbjct: 127 QMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 182
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
Y APE D++S G ++ E K +F G + +W K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 66/313 (21%)
Query: 730 DGFNECNLLGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRN 782
D + + +G G++G VYK G VA+K L+++ A R E +L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 783 VRHRNLVKIFSSCCNIDFKA------LVLEFMPNGSFEKWLYSY----NYFLDILQRLNI 832
+ + +++ K LV E++ + +K++ S L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 833 MIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQ 890
M + + + H HG ++H DLKP N+L+D + ++D G+ + S T
Sbjct: 116 MYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 891 TITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK------------------ 930
I T+ Y APE GS S D++S G + E ++
Sbjct: 171 EIV--TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227
Query: 931 --KPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCC 988
PT++++ G LR W H + +L S + LL M L D
Sbjct: 228 LGTPTEQVWPGVSKLRDW------HEFPQWKPQDLSRAVPDLSPEGLDLLQKM-LRYD-- 278
Query: 989 MESPEQRIHMTDA 1001
P +RI A
Sbjct: 279 ---PAKRISAKAA 288
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 42/211 (19%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF-------RTFDSECEILRNVRHRNLVK 790
+G G++G V FD T ++V +L R F RT+ E +L++++H N++
Sbjct: 25 VGSGAYGSVCAA--FD-TKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVI- 79
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEK----WLYSYNYFLDI-----LQRL---NIMIDVAL 838
L+ F P S E+ +L ++ D+ Q+L ++ +
Sbjct: 80 -----------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+L L + HS A I+H DLKP+N+ ++E+ + DFG+++ DD +T + AT
Sbjct: 129 ILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV--ATRW 182
Query: 899 YMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 928
Y APE + + D++S G ++ E T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 738 LGRGSFGLVYKGTLFDGT---NVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNL 788
+G G+ G+V +D NVAIK + + RA+R E +++ V H+N+
Sbjct: 32 IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD--ILQRLNIMID-------VA 837
+ + + F P S E++ +Y +D + Q + + +D +
Sbjct: 86 IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+L + H HS A I+H DLKP+NI++ + T + DFG+++ G S T + T
Sbjct: 134 QMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 189
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
Y APE D++S G ++ E +F G + +W K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-06
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 824 LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883
LD L+ VA + +L + +H DL NILL + DFG+++ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ V + + +MAPE + + + DV+SYG+LL E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 25/71 (35%), Positives = 40/71 (56%), Gaps = 1/71 (1%)
Query: 372 RSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDN 431
R L + L+ N +RG +PP +G+ + SL + GSIP+ +G L+ L L L+ N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 432 ELNGTIPTTVG 442
L+G +P +G
Sbjct: 501 SLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 738 LGRGSFGLVYKGTLFDGTNVA-IKVFNLQLERAFR---TFDSECEILRNVRHRNLVKIFS 793
+G G FG V ++ T VA + V L+ + + F + + R ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFL---DILQRLNIMIDVALVLEYLHHGHSLA 850
C LV E+ G + +L + +L + ++A + ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE--- 907
+H DL N L ++T V D+GI + D T+ + ++APE E
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 908 GIVSAK----CDVYSYGVLLMETF 927
G+++A+ +V++ GV L E F
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRN------VRHRNLVK 790
+LG+GSFG V L G V L+ + D EC ++ + L
Sbjct: 2 VLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
++ + + V+EF+ G + F D+ + ++ L++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
I++ DLK +N++LD + ++DFG+ K GD+ + T Y+APE
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--GTPDYIAPEILQGLKY 173
Query: 911 SAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLR-------RWV-KES 950
+ D +S+GVLL E + P DE+F S+R RW+ KES
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---SIRVDTPHYPRWITKES 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 737 LLGRGSFGLVYKGTLFDGTN----VAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKI 791
+LG G FG + +G L + VAI ++ R F +E L H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+ +V E+M NG+ + +L + L Q + ++ +A ++YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM---ATIGYMAPEYGSEG 908
VH L + +L++ ++ +S F + D S TM + + + APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 909 IVSAKCDVYSYGVLLME 925
S+ DV+S+G+++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-06
Identities = 35/97 (36%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
L L L G IPN I+ L ++LS N G+IP + G++ L L+L +NS S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-S 481
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIG 393
P SL SL L LN N L G +P +G
Sbjct: 482 IPE-------SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-06
Identities = 62/231 (26%), Positives = 91/231 (39%), Gaps = 44/231 (19%)
Query: 737 LLGRGSFGLVYKGTLFD---GTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVK 790
L+G+G G VY +D VA+K L + F E +I ++ H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 791 IFSSCCNIDFKALVLEFMP--NGSFEKWLYSYNYFLDILQR-----------LNIMIDVA 837
++S C + D V MP G K L + + L + L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG--ISKLLGE---GDDSVTQTI 892
+EY+H ++H DLKP+NILL + D+G I K L E D V +
Sbjct: 124 ATIEYVHS----KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 893 TM-----------ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
T YMAPE S D+Y+ GV+L + T P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 46/199 (23%)
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
+E +IL + +VK++ S + D V++++P G L F + L R I
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA- 108
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI---------SKLLGEGD 885
++ +E +H +H D+KP+NIL+D + ++DFG+ SK +GD
Sbjct: 109 ELTCAIESVHK----MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 886 ----DSVTQTITMATIG----------------------------YMAPEYGSEGIVSAK 913
DS+ + + I Y+APE +
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 914 CDVYSYGVLLMETFTRKKP 932
CD +S GV+L E + P
Sbjct: 225 CDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNLVK 790
+G G++G V+K + VA+K L + A R E +L+ ++H+N+V+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
++ + LV E+ + +K+ S N +D + M + L + H +
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--- 119
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882
++H DLKP N+L+++N ++DFG+++ G
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 737 LLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRNVRHRNL 788
LLG+G+FG V K T G A+K+ + + T +E +L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ S D V+E+ G L F + R ++ L YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLHSCD- 115
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG-DDSVTQTITMATIGYMAPEYGSE 907
+V+ DLK N++LD++ ++DFG+ K EG D T T Y+APE +
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKP 932
D + GV++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 29/155 (18%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER-----AFRTFDSECEILRNVRHRNLVKI 791
LG GS+ VYKG + G VA+K L+ E A R E +L++++H N+V +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV-------LEYLH 844
LV E++ + ++++ L M +V L L Y H
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLS-------MHNVRLFLFQLLRGLAYCH 120
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879
++H DLKP N+L+ E ++DFG+++
Sbjct: 121 QRR----VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 29/185 (15%)
Query: 776 ECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY----NYFLDILQRLN 831
E +L+NV H +++++ + + +VL P+ + LY+Y + L I Q L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PH--YSSDLYTYLTKRSRPLPIDQALI 161
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQ 890
I + L YLH I+H D+K NI +++ + D G ++ +
Sbjct: 162 IEKQILEGLRYLH-AQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF---- 213
Query: 891 TITMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK---------PTDEMFTGE 940
+ +A T+ APE + ++K D++S G++L E P + + +
Sbjct: 214 -LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
Query: 941 MSLRR 945
L +
Sbjct: 273 SHLLK 277
|
Length = 357 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 42/214 (19%)
Query: 732 FNECNLLGRGSFGLVYKGTLFD---GTNVAIKVF------NLQLERAFRTFDSECEILRN 782
+ + +G G+ G+V FD G NVA+K +RA+R E +L+
Sbjct: 23 YQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKC 76
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD--ILQRLNIMID--- 835
V H+N++ + + F P S E++ +Y +D + Q +++ +D
Sbjct: 77 VNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 836 ----VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
+ +L + H HS A I+H DLKP+NI++ + T + DFG+++ + T
Sbjct: 125 MSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMT 180
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925
+ T Y APE D++S G ++ E
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 738 LGRGSFGLVYKGTLFDGTN-VAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G++ VYKG N VA+K L+ E A T E +L++++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA---PI 852
LV E++ +K L Y LD M +V L L L G + +
Sbjct: 74 HTEKSLTLVFEYL-----DKDLKQY---LDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIV 910
+H DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD-Y 182
Query: 911 SAKCDVYSYGVLLMETFT 928
S + D++ G + E T
Sbjct: 183 STQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 46/242 (19%)
Query: 725 IQRATDGFNECNLLGR-----GSFGLVY----KGT--LFDGTNVAIKVFNLQLERAFRTF 773
+ C ++ + G FG V K T LF + K FN +E
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQ- 63
Query: 774 DSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLNI 832
++++ + N +K++ S + L+++++ +G F+ L L + I
Sbjct: 64 -----LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKI 114
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT-AHVSDFGISKLLGEGDDSVTQT 891
+ + L LH + I+H D+K N+L D ++ D+G+ K++G T +
Sbjct: 115 IRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPS 164
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDV----YSYGVLLMETFTRKKP----TDEMFTGEMSL 943
T+ Y +P E I DV ++ GVL E T K P DE E L
Sbjct: 165 CYDGTLDYFSP----EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220
Query: 944 RR 945
+R
Sbjct: 221 KR 222
|
Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 14/193 (7%)
Query: 738 LGRGSFGLVYKGTLFDGTN-VAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G++ V+KG N VA+K L+ E A T E +L++++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
LV E++ +K L Y + +I+ N+ I + +L L + H ++H
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLH 127
Query: 855 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVSA 912
DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YST 184
Query: 913 KCDVYSYGVLLME 925
+ D++ G + E
Sbjct: 185 QIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 56/215 (26%)
Query: 738 LGRGSFGLV---YKGTLFDGTNVAIKVFNLQLERAF-------RTFDSECEILRNVRHRN 787
+G G+ G+V Y G NVAIK +L R F R + E +++ V H+N
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIK----KLSRPFQNVTHAKRAY-RELVLMKLVNHKN 76
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD--ILQRLNIMID-------V 836
++ + + F P S E++ +Y +D + Q + + +D +
Sbjct: 77 IIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL 124
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+L + H HS A I+H DLKP+NI++ + T + DFG+++ G S T + T
Sbjct: 125 YQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 180
Query: 897 IGYMAPE------YGSEGIVSAKCDVYSYGVLLME 925
Y APE Y D++S G ++ E
Sbjct: 181 RYYRAPEVILGMGY------KENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 47/220 (21%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVRHRNLVK 790
+G+G+FG V+K VA+K ++ E+ A R E +IL+ ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 791 IFSSCCNI-----DFKA---LVLEFMPN---GSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+ C +K LV EF + G L S L + ++ + L
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAG-----LLSNKNVKFTLSEIKKVMKMLLN 130
Query: 840 -LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK--LLGEGDDSVTQTITMAT 896
L Y+H I+H D+K NIL+ ++ ++DFG+++ L + T + T
Sbjct: 131 GLYYIH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 897 IGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTR 929
+ Y PE YG D++ G ++ E +TR
Sbjct: 187 LWYRPPELLLGERDYGP------PIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 59/243 (24%), Positives = 97/243 (39%), Gaps = 48/243 (19%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRN 782
D F ++GRG+FG LV K G A+K+ L+ E+ +E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQVAH-IRAERDILVE 57
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+VK+F S + L++EF+P G L + + + I + L ++
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDA 116
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI------------------------- 877
+H +H D+KP+N+LLD +SDFG+
Sbjct: 117 IHQ----LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 878 -----SKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 929
SK E + + +T+G Y+APE + + CD +S GV++ E
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 930 KKP 932
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 65/246 (26%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRN 782
D F ++GRG+FG LV K G A+K L+ E+ +E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHV-RAERDILAE 57
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+ +VK++ S + ++ L++E++P G L + F + R I + L ++
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDS 116
Query: 843 LH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE---------------GDD 886
+H G+ +H D+KP+N+LLD +SDFG+ L + +
Sbjct: 117 IHKLGY-----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 887 SVTQTITM------------------ATIG---YMAPE------YGSEGIVSAKCDVYSY 919
+ M +T+G Y+APE Y E CD +S
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE------CDWWSL 225
Query: 920 GVLLME 925
GV++ E
Sbjct: 226 GVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 49/214 (22%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFD-----SECEILRNVR-HRNLVK 790
+G G+F V K + G AIK +++ F++ + E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 791 IFSSCCNIDFK------ALVLEFMPNGSFEKWLYSY----NYFLDILQRLNIMIDVALVL 840
+ + F ALV E M + LY L + + M + L
Sbjct: 63 L----IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ----TITMA 895
+++H +G I H D+KP NIL+ ++ ++DFG + + T ++
Sbjct: 114 DHMHRNG-----IFHRDIKPENILIKDD-ILKLADFGSCR-------GIYSKPPYTEYIS 160
Query: 896 TIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFT 928
T Y APE ++G K D+++ G + E +
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 44/241 (18%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNV-AIKVFN----LQLERAFRTFDSECEILRNVR 784
+ F ++GRG+FG V D +V A+K+ L+ E+ +E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDILVEAD 59
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
+VK+F S + L++EF+P G L + + + I + L ++ +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH 118
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI--------------------------- 877
+H D+KP+N+LLD +SDFG+
Sbjct: 119 Q----LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 878 ---SKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK 931
SK E + + +T+G Y+APE + + CD +S GV++ E
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 932 P 932
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-05
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 196 HLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL 255
+L++L L++N+ + L L L+L+ NNL P A L L L+L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 46/215 (21%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF-------RTFDSECEILRNVRHRNLVK 790
+G G++G V + +D T + KV +L R F RT+ E +L++++H N++
Sbjct: 23 VGSGAYGSV--CSAYD-TRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVI- 77
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL-----------QRL---NIMIDV 836
L+ F P S E ++ Y + L Q+L ++ +
Sbjct: 78 -----------GLLDVFTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+L L + HS A I+H DLKP+N+ ++E+ + DFG+++ + DD +T + AT
Sbjct: 125 YQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV--AT 178
Query: 897 IGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 930
Y APE + + D++S G ++ E K
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 738 LGRGSFGLVYKGT---LFDG-----TNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV 789
LG+G+F ++KG + D T V +KV + +F ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C D +V E++ GS + +L ++I +L + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---- 118
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT---QTITMATIGYMAPEYGS 906
+ H ++ N+LL + KL G S+T + I + I ++ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG-ISITVLPKEILLERIPWVPPECIE 177
Query: 907 EG-IVSAKCDVYSYGVLLMETFT 928
+S D +S+G L E F+
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 23/76 (30%), Positives = 43/76 (56%)
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H D+ N+LL + A + DFG+++ + + V + + +MAPE + + +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 913 KCDVYSYGVLLMETFT 928
+ DV+SYG+LL E F+
Sbjct: 294 QSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQTIT 893
++ + L +LH I++ DLK +N+LLD + ++D+G+ K LG GD T +
Sbjct: 104 EICIALNFLHE----RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTF 156
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTD 934
T Y+APE D ++ GVL+ E + P D
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 37/238 (15%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIF---- 792
LG GS GLV+ D VA+K L ++ + E +I+R + H N+VK++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 793 --SSCCNIDFKAL--------VLEFMPNG---SFEKWLYSYNYFLDILQRLNIMIDVALV 839
S D +L V E+M E+ S + RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLG-EGDDSVTQTITMATI 897
L+Y+H A ++H DLKP N+ ++ E++ + DFG+++++ + + T
Sbjct: 127 LKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 898 GYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLRRWVKESLP 952
Y +P S + D+++ G + E T K +F G E+ + + ES+P
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVP 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 59/240 (24%), Positives = 91/240 (37%), Gaps = 39/240 (16%)
Query: 426 LKLDDNELNGT----IPTTVGRFQQLQGLSLYDNDLQ------GSIPYYLCHLERLSQLL 475
L+L+ N L + + + L+ L L N+ S+ L L +L
Sbjct: 28 LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87
Query: 476 LNGNNLSGAIPACLGSLT---SLRELHLGSNTLTYSI-----------PSSLWSLEYILY 521
L+ N L L SL SL+EL L +N L P +L L +L
Sbjct: 88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL--VLG 145
Query: 522 VNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD-IPITISGLKD---LATLSLAGNQF 577
N + L +++ + L L+L+ N + I GLK L L L N
Sbjct: 146 RNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205
Query: 578 N----GPIPESFGSLISLESLDVSSNNISGK-IPKSLEALLY----LKKLNVSYNRLEGE 628
+ E+ SL SLE L++ NN++ ALL L L++S N + +
Sbjct: 206 TDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQTIT 893
+++L L YLH I++ DLK +N+LLD ++D+G+ K L GD T +
Sbjct: 104 EISLALNYLHE----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 156
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTD 934
T Y+APE D ++ GVL+ E + P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
+E +IL + +VK++ S + D V++++P G L F ++L R I
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA- 108
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877
++ L +E +H +H D+KP+NIL+D + ++DFG+
Sbjct: 109 ELTLAIESVHK----MGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 26/59 (44%), Positives = 34/59 (57%)
Query: 543 LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNI 601
L +LDLS N+L+ GL +L L L+GN PE+F L SL SLD+S NN+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553
+L+ L L +N LT + L + ++LS N+L+ P + L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL-LGEGDDSVTQTIT 893
+++L L +LH I++ DLK +N+LLD ++D+G+ K + GD T +
Sbjct: 104 EISLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTF 156
Query: 894 MATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKKPTD 934
T Y+APE G + S D ++ GVL+ E + P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 4e-04
Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 8 LTTDQSALLAFKADVIDSRSVLANNWSIS-YPICNWVGISC 47
L D+ ALLAFK+ + S ++W+ S C+W G++C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 50/227 (22%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFNL-------QLERAFRTFDSECE 778
+ F L+ G++G VY K T A+K N Q+++ F E +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF----VERD 53
Query: 779 ILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL 838
IL + +V +F S +V+E++ G L + + R+ + L
Sbjct: 54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARM-YFAETVL 112
Query: 839 VLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL--------LGEG-DDSV 888
LEYLH +G IVH DLKP+N+L+ ++DFG+SK+ L EG +
Sbjct: 113 ALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 889 TQTI----TMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLME 925
T+ T Y+APE YG D ++ G++L E
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 59/266 (22%), Positives = 99/266 (37%), Gaps = 56/266 (21%)
Query: 732 FNECNLLGRGSFGLVYKGTLFD-GTNVAIKVF---NLQLERAFRTFDSECEILRNVRHRN 787
F + LG G+FG V D A+K ++ L +E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+V+++ S + D V++++P G L F + L R I ++ +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK-- 119
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGI---------SKLLGEGD----DSVTQTIT- 893
+H D+KP+NIL+D + ++DFG+ SK GD DS+ +
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 894 -------------------------------MATIGYMAPEYGSEGIVSAKCDVYSYGVL 922
+ T Y+APE + CD +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 923 LMETFTRKKP--TDEMFTGEMSLRRW 946
L E + P +M + W
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 27/128 (21%), Positives = 56/128 (43%), Gaps = 17/128 (13%)
Query: 753 DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV--KIFSSCCNIDFKALVLEFMPN 810
+ +K+ + + A R E IL+ + + L K+ +S + + L++E++
Sbjct: 20 KDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV--HCDLKPNNILLDENM 868
+ ++ + ++ +I +A E L H L +V H DL P NIL+D+
Sbjct: 78 ETLDE--------VSEEEKEDIAEQLA---ELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 869 TAHVSDFG 876
+ D+
Sbjct: 127 ILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 9e-04
Identities = 19/59 (32%), Positives = 33/59 (55%)
Query: 567 LATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
L +L L+ N+ +F L +L+ LD+S NN++ P++ L L+ L++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 41/213 (19%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN--LQLE----RAFRTFDSECEILRNVRHRN-- 787
+G G++G V G VAIK + Q E RA+R E +L++++H N
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 788 -LVKIFSSCCNI----DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
L+ +F+S + DF LV+ +M +K + + D +Q L V +L
Sbjct: 78 GLLDVFTSAVSGDEFQDF-YLVMPYMQT-DLQK-IMGHPLSEDKVQYL-----VYQMLCG 129
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
L + HS A I+H DLKP N+ ++E+ + DFG+++ D +T + T Y AP
Sbjct: 130 LKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV--TRWYRAP 183
Query: 903 EYGSEGIVS-----AKCDVYSYGVLLMETFTRK 930
E I++ D++S G ++ E T K
Sbjct: 184 EV----ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 42/186 (22%)
Query: 172 KLEKLYLGSNDFFG-------------QIPSSLSECTHLQTLWLADNKFSGRLPENIGNL 218
KLEKL+ G + G +IP LS T+L+TL L+D LP +I L
Sbjct: 622 KLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYL 680
Query: 219 SQLTDLNLAQ-NNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST--------- 268
++L DL++++ NL+ +PT I NL+ L LNL + P NIS
Sbjct: 681 NKLEDLDMSRCENLE-ILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE 738
Query: 269 -----IRLINLIENQL----SGHL-----PLT--LGHSLPNLEFLTLFGNNLIGTIPNSI 312
+RL NL E L S L PLT + P+L L L + +P+SI
Sbjct: 739 EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSI 798
Query: 313 TNASKL 318
N KL
Sbjct: 799 QNLHKL 804
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 37/218 (16%)
Query: 732 FNECNLLGRGSFG--LVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV 789
+N ++G GSFG L+ + D ++ + A E +L ++H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------------LNIMID 835
S +V+E+ G D++Q+ L +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGG-------------DLMQKIKLQRGKLFPEDTILQWFVQ 108
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-M 894
+ L ++++H ++H D+K NI L +N + DFG ++LL T +
Sbjct: 109 MCLGVQHIHEKR----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYV 161
Query: 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
T Y+ PE + K D++S G +L E T K P
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY---NYFLDILQRLN 831
+E ILR + H +++++ + F L+L ++ LY Y + I L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILA 186
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
I V ++YLH I+H D+K NI ++ + DFG + D + +
Sbjct: 187 IERSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACF--PVDINANKY 240
Query: 892 ITMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
A TI APE + D++S G++L E T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 18/60 (30%), Positives = 27/60 (45%)
Query: 470 RLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL 529
L L L+ N L+ L +L+ L L N LT P + L + ++LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 21/60 (35%), Positives = 26/60 (43%)
Query: 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
NL+ L L N L + L LDLS N + P F L LR L+L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1022 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.68 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-116 Score=1119.63 Aligned_cols=919 Identities=33% Similarity=0.542 Sum_probs=748.3
Q ss_pred ChhHHHHHHHHHhhccCCCCcccCCCCCCCCCccceeeEEcCCCCcEEEEEcCCCCcccccCCCCCCCCCccEEeccCCc
Q 001710 8 LTTDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENN 87 (1022)
Q Consensus 8 ~~~d~~aLl~~k~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~L~~~~l~~~i~~~l~~l~~L~~L~Ls~n~ 87 (1022)
.+.|+.||++||+++.++...+ .+|+.+.+||.|.||+|+. .++|+.|+|++++++|.+++.+..+++|++|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~-~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYL-SNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccC-CCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 4689999999999997665444 6898888999999999985 4699999999999999999999999999999999999
Q ss_pred ccCCCCCCcc-cccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCccccceeeccCcccccccCC
Q 001710 88 FYGHLPNELG-KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPN 166 (1022)
Q Consensus 88 ~~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 166 (1022)
++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|.
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 9999998765 999999999999999998886 5689999999999999999999999999999999999999988888
Q ss_pred cc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCC
Q 001710 167 DI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245 (1022)
Q Consensus 167 ~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 245 (1022)
.+ .+++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..|+++++|
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 77 68899999999999988888889999999999999999988888888899999999999999988888889999999
Q ss_pred CEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCC
Q 001710 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSS 325 (1022)
Q Consensus 246 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 325 (1022)
++|+|++|++++.+|..+.++++|++|++++|.+.+.+|..+. .+++|++|++++|.+++.+|..+..+++|+.|++++
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 341 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI-QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc-CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcC
Confidence 9999999998888888888888888888888888877776654 577888888888888877777777888888888888
Q ss_pred CccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchhccc
Q 001710 326 NLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAI 405 (1022)
Q Consensus 326 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~ 405 (1022)
|.+.+.+|..++.+++|+.|++++|+++.
T Consensus 342 n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~--------------------------------------------------- 370 (968)
T PLN00113 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTG--------------------------------------------------- 370 (968)
T ss_pred CCCcCcCChHHhCCCCCcEEECCCCeeEe---------------------------------------------------
Confidence 88877777666666666666555554432
Q ss_pred cccccccCCccccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcc
Q 001710 406 KCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485 (1022)
Q Consensus 406 ~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 485 (1022)
.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++.+.+|..|..++.|+.|++++|.+++.+
T Consensus 371 ------~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 444 (968)
T PLN00113 371 ------EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444 (968)
T ss_pred ------eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc
Confidence 34555667778888888888888888888888889999999999998888888899999999999999999888
Q ss_pred cccccCccccceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCcccccccccc
Q 001710 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLK 565 (1022)
Q Consensus 486 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 565 (1022)
|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..+..++
T Consensus 445 ~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 523 (968)
T PLN00113 445 NSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523 (968)
T ss_pred ChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence 8888888999999999999998888765 458899999999999999999999999999999999999999999999999
Q ss_pred ccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCcceeecCCCCCCCCCccccccC
Q 001710 566 DLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSG 645 (1022)
Q Consensus 566 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~ 645 (1022)
+|++|+|++|++++.+|..|..+++|+.|||++|+++|.+|..+..+++|+.|++++|++.|.+|..++|.++...++.|
T Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 603 (968)
T PLN00113 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603 (968)
T ss_pred CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCC-cCCCCCcCCCCCCCCCCcchhhhhhhHHHHHHHHHHHHHh-hhhhccCCC-cc-cCcchhhccc--cccc
Q 001710 646 NYALCGPPR-LQVPPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMF-FIRRQNGNT-KV-PVKEDVLSLA--TWRR 719 (1022)
Q Consensus 646 n~~~c~~p~-~~~~pc~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~-~~~~~~~~~~--~~~~ 719 (1022)
|+.+||++. ...++|..... ....++.+++.++++++++++++++ +++++++.. +. .......... ....
T Consensus 604 n~~lc~~~~~~~~~~c~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (968)
T PLN00113 604 NIDLCGGDTTSGLPPCKRVRK----TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679 (968)
T ss_pred CccccCCccccCCCCCccccc----cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccccccccccc
Confidence 999999653 34667854211 1111222222222222222222222 223222111 11 1100000000 0000
Q ss_pred chHHHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC
Q 001710 720 TSYLDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNI 798 (1022)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 798 (1022)
............|...++||+|+||.||+|+. .++..||||+++.... ...+|++.+++++|||||+++++|.+.
T Consensus 680 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred chhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 11122233345677888999999999999985 5789999998864322 123468899999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
+..++||||+++|+|.++++. ++|..+.+|+.|+++|++|||+.+. .+|+||||||+||+++.++..++. ||.+
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999999964 7899999999999999999996432 689999999999999999988875 6665
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC-cch
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG-LTE 957 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 957 (1022)
...... ....+|+.|+|||+..+..++.++|||||||++|||+||+.||+...........|.+...... ...
T Consensus 830 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 830 GLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred cccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 433211 1235789999999999999999999999999999999999999766555666777776554332 334
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
.+|+.+... ...+.....++.+++.+||+.||++||+|+|+++.|+++.+..
T Consensus 904 ~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 904 WIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred eeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 445444321 1223345667899999999999999999999999999986643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-62 Score=623.98 Aligned_cols=514 Identities=38% Similarity=0.575 Sum_probs=416.1
Q ss_pred CCccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccc-cccccceeeccccccCCCcchhhcCccccceee
Q 001710 76 SFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIG-ILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLD 154 (1022)
Q Consensus 76 ~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 154 (1022)
.+++.|||++|+++|.+|..+..+++|++|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4688899999999888888888889999999998888888887665 788888888888888877775 4577788888
Q ss_pred ccCcccccccCCcc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccC
Q 001710 155 LMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233 (1022)
Q Consensus 155 Ls~N~l~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 233 (1022)
|++|.+++.+|..+ .+++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 88777777666655 46777777777777776777777777777777777777776677777777777777777777776
Q ss_pred CChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccc
Q 001710 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSIT 313 (1022)
Q Consensus 234 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 313 (1022)
.+|..|+++++|++|+|++|++++.+|..+.++++|+.|++++|++.+.+|..+. .+++|++|+|++|++.+.+|..+.
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHc
Confidence 7777777777777777777777666666666666666666666666666655544 356666666666666666666666
Q ss_pred cccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCcccc
Q 001710 314 NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIG 393 (1022)
Q Consensus 314 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 393 (1022)
.+++|+.|++++|.+.+..|..+..+++ |+.|++++|.+.+
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~--------------------------------L~~L~L~~n~l~~------- 346 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPR--------------------------------LQVLQLWSNKFSG------- 346 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCC--------------------------------CCEEECcCCCCcC-------
Confidence 6666666666666665555555554444 4444444444432
Q ss_pred ccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccce
Q 001710 394 NFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQ 473 (1022)
Q Consensus 394 ~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 473 (1022)
.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.
T Consensus 347 ------------------~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~ 408 (968)
T PLN00113 347 ------------------EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408 (968)
T ss_pred ------------------cCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCE
Confidence 35666788899999999999999999999999999999999999999999999999999999
Q ss_pred eecCCccccCcccccccCccccceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccc
Q 001710 474 LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553 (1022)
Q Consensus 474 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 553 (1022)
|++++|.+++..|..|..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. .++|+.|+|++|++
T Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l 487 (968)
T PLN00113 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQF 487 (968)
T ss_pred EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999998887764 58999999999999
Q ss_pred cCccccccccccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCcceeecCCC-
Q 001710 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIK- 632 (1022)
Q Consensus 554 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~- 632 (1022)
++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999863
Q ss_pred CCCCCCccccccCCcccc
Q 001710 633 GPFRNFSAQSFSGNYALC 650 (1022)
Q Consensus 633 ~~~~~~~~~~~~~n~~~c 650 (1022)
..+..+....+.+|...+
T Consensus 568 ~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 568 GNVESLVQVNISHNHLHG 585 (968)
T ss_pred hcCcccCEEeccCCccee
Confidence 445666667777886554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=422.94 Aligned_cols=289 Identities=44% Similarity=0.693 Sum_probs=247.5
Q ss_pred ccccchHHHHHHhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeE
Q 001710 716 TWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795 (1022)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 795 (1022)
..+.|++.+++.+|++|...++||+|+||.||+|...+|+.||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765433135599999999999999999999999
Q ss_pred eeCC-eeEEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEe
Q 001710 796 CNID-FKALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873 (1022)
Q Consensus 796 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~ 873 (1022)
.+.+ +.++|||||++|+|.+++..... .++|.+|++||.++|+||+|||+.+. .+||||||||+|||+|+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 59999999999999999998776 79999999999999999999999664 479999999999999999999999
Q ss_pred eccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccc-ccchhHHHHHHhhcC
Q 001710 874 DFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF-TGEMSLRRWVKESLP 952 (1022)
Q Consensus 874 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 952 (1022)
|||+|+............ ..||.+|+|||+...+..+.|+||||||++++|++||+.|.+... ..+..+..|.+..+.
T Consensus 220 DFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999996543211111111 179999999999999999999999999999999999999887644 455668999887776
Q ss_pred CC-cchhccccccc-hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 953 HG-LTEVVDANLVG-EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 953 ~~-~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
.+ +.+++|+.+.. ... +......+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 64 78899998763 221 11456678999999999999999999999999976644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=384.75 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=211.8
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-eeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNID-FKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e~ 807 (1022)
+.+..+.||+|..|+|||++++ +++-+|+|++....+ ...+++.+|++++++.+||+||.+||+|.... ..+++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4555688999999999999954 688899999965543 34578999999999999999999999999988 49999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
|++|+|++++...+. +++....+|+.+|++||.|||+. ++||||||||+|||+...|.|||||||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~~---~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHEE---RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhc---cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999987754 99999999999999999999963 57999999999999999999999999999877544
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.....+||..|||||.+.+..|+.++||||||++++|+++|+.||........+... +++.-..++.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~------------Ll~~Iv~~pp 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE------------LLCAIVDEPP 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH------------HHHHHhcCCC
Confidence 334467999999999999999999999999999999999999999764222222222 2222222222
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+..+.. .|++++.+++..|+++||.+||+++|+++|
T Consensus 300 P~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 PRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222222 478899999999999999999999999886
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=398.79 Aligned_cols=260 Identities=30% Similarity=0.447 Sum_probs=216.6
Q ss_pred CCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhh--hHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-eeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRNLVKIFSSCCNID-FKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e~ 807 (1022)
+..+.+.+|+|+||+||+|.+.....||||++...... ..+.|.+|+.++.+++|||||+|+|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445669999999999999765445999999765422 2568999999999999999999999999887 78999999
Q ss_pred cCCCCHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCcEEecCCC-cEEEeeccCceecCCC
Q 001710 808 MPNGSFEKWLYS-YNYFLDILQRLNIMIDVALVLEYLHHGHSLAP-IVHCDLKPNNILLDENM-TAHVSDFGISKLLGEG 884 (1022)
Q Consensus 808 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-ivH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~ 884 (1022)
+++|+|.++++. ....+++..+++|+.|||.||+|||+ .+ |||||+||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~----~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS----EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc----CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999988 36679999999999999999999999 56 99999999999999998 9999999999876443
Q ss_pred CCceeeecccCCcccCCccccC--CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGS--EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .......+....
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~----------- 263 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL----------- 263 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC-----------
Confidence 2 2333467999999999999 66999999999999999999999999988655 211111111111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhcc
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQ 1014 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~~ 1014 (1022)
+...+..|+..+..+|.+||+.||++||++.+++..|+.+......
T Consensus 264 ------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 264 ------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1122334788899999999999999999999999999999887654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=399.55 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=219.4
Q ss_pred CCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
.++.++.||+|.||.||.|.++....||+|.++... -..+.|.+|+++|++++|++||+++|+|..++..+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345568899999999999999888899999997652 2336788999999999999999999999998999999999999
Q ss_pred CCHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 811 GSFEKWLYS-YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 811 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
|+|.+|++. .+..+...+.+.++.|||+|++||++ +++||||+.++||||+++..+||+|||+|+....+. +..
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes----~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES----KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTA 360 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh----CCccchhhhhhheeeccCceEEEcccccccccCCCc-eee
Confidence 999999997 55579999999999999999999999 789999999999999999999999999999554433 333
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....-+..|.|||.+..+.++.|+|||||||++|||+| |+.||..+...+ .+ +. ...+.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----v~-~~-------------le~Gy 421 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----VL-EL-------------LERGY 421 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----HH-HH-------------HhccC
Confidence 333446778999999999999999999999999999999 788887754432 11 11 12234
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
+.+.|..|++.++++|..||..+|++||||..+...++++...
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 6778889999999999999999999999999999999887543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.82 Aligned_cols=253 Identities=27% Similarity=0.360 Sum_probs=207.4
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhh-------hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER-------AFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.... ....+.+|+++|++++||+||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567888999999999999997 568999999999765311 12335789999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC---CcEEEeeccC
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN---MTAHVSDFGI 877 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfG~ 877 (1022)
.||||||++||+|.+.+-..+. +.+.....+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~----~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHS----QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHH----cCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999988775 7888889999999999999999 899999999999999755 7899999999
Q ss_pred ceecCCCCCceeeecccCCcccCCccccCCCC---CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
|+..++.. .+...+||+.|.|||++.+.. +..++|+||+|||+|-+++|.+||.+.........+..+.....
T Consensus 326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f- 401 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF- 401 (475)
T ss_pred hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc-
Confidence 99876332 345578999999999887654 34588999999999999999999987544432222221111111
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+...+++..++|.+||..||++||++.|++++
T Consensus 402 --------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 --------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 012345567889999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=389.74 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=213.9
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
.+|+..+.||+|+|+.||.++. .+|..||+|++.+.. ..+.+...+|+++.+.|+|||||+++++|++....|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999996 789999999997643 455678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|+|+.++|..+++. +..+++.++..+++||+.|+.|||+ .+|+|||+|..|++++++.++||+|||+|..+..++
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~----~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHS----LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHh----cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999984 4459999999999999999999999 889999999999999999999999999999986543
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .....+|||.|.|||++....++..+||||+|||+|-|+.|++||+...-.+ .+....
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik------------------ 231 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIK------------------ 231 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHH------------------
Confidence 3 2334789999999999999999999999999999999999999998631111 111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......|...+.+..+||.++|++||.+|||+.+|+.+
T Consensus 232 -~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 -LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233444567778999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=370.58 Aligned_cols=202 Identities=31% Similarity=0.495 Sum_probs=182.3
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecch--hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
..++|...+.||+|+||+||+|++ .++..||||.+... ..+..+....|+.+++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346788889999999999999994 46899999999766 455667788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC------CcEEEeeccCc
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN------MTAHVSDFGIS 878 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~------~~~kl~DfG~a 878 (1022)
||||+||+|.+|++..+. +++..+..++.|+|.|+++||+ ++||||||||+|||++.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~----~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHE----NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999999875 8999999999999999999999 789999999999999854 46899999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccc
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF 937 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~ 937 (1022)
+...++. .....+|++.|||||++....|+.|+|+||+|+++|+|++|+.||+...
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9986443 2344689999999999999999999999999999999999999998643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=404.72 Aligned_cols=263 Identities=29% Similarity=0.447 Sum_probs=226.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
..+....+.||+|+||+||+|+.. +...||||.++...+. ...+|.+|++.++.++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556688999999999999843 3457999999877665 778999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 802 ALVLEFMPNGSFEKWLYSYNY-------------FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
++|+|||..|||.+||+.... .++..+.+.||.|||.||+||-+ +.+||||+.++|+||.++.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~----~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS----HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----Ccccccchhhhhceeccce
Confidence 999999999999999986432 28889999999999999999999 5699999999999999999
Q ss_pred cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH
Q 001710 869 TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 947 (1022)
.|||+|||+++.+...+++.......-+.+|||||.+..++||.++||||||||+||+++ |+.||.+....+. -+.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--Ie~i 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--IECI 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--HHHH
Confidence 999999999998877777665555566789999999999999999999999999999999 8999987544331 1111
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhcc
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQ 1014 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~~ 1014 (1022)
.....++.|++|+.++++||..||+..|++||+++||-..|+++.+.-.+
T Consensus 719 -----------------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 719 -----------------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred -----------------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 11234678899999999999999999999999999999999998765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.65 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=208.8
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEee-eEee-CCeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS-SCCN-IDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~-~~~~~lv 804 (1022)
.+|++.++||+|.||+||+++ ..+|..||.|.+.-+. .........|+.++++++|||||++++ .+.+ ....++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999998 6789999999887443 344567889999999999999999998 3443 4448999
Q ss_pred EEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 805 LEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
||||++|+|...++. .++.+++..+++++.|++.||.++|......-|.||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998864 34479999999999999999999998553234899999999999999999999999999998
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
.+... .....+|||.||+||.+.+..|++|+||||+||++|||+.-.+||.+. ++-...+. +.++
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-I~qg------- 243 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-IEQG------- 243 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-HHcC-------
Confidence 65432 334568999999999999999999999999999999999999999873 22222221 1111
Q ss_pred cccchhhhh-hhh-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 962 NLVGEEQAF-SAK-TDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 962 ~~~~~~~~~-~~~-~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.. +.| ..++.++..+|..|+.+||+.||+...++..+..
T Consensus 244 -------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 -------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 122 5678899999999999999999996555554443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=390.47 Aligned_cols=489 Identities=29% Similarity=0.409 Sum_probs=305.3
Q ss_pred EEEEcCCCCcccccCCCCCCCCCccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeecccc
Q 001710 55 VALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNN 134 (1022)
Q Consensus 55 ~~l~L~~~~l~~~i~~~l~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 134 (1022)
..+.+++|.+. .+.+.+.+|..|++|++++|+++ .+|.+++.+..++.|+.++|+++ .+|+.++.+.+|..|+.++|
T Consensus 48 ~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 48 QKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence 44555555554 33444555555666666665555 55555555555555555555555 45555555555555555555
Q ss_pred ccCCCcchhhcCccccceeeccCcccccccCCccccccccceecccccccccCCccccCCCCCCeeecccccccCCCCcc
Q 001710 135 SFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPEN 214 (1022)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 214 (1022)
.+. .+|+.++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|++....|+.
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~------------------------slp~~~~~~~~l~~l~~~~n~l~~l~~~~ 179 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS------------------------SLPEDMVNLSKLSKLDLEGNKLKALPENH 179 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc------------------------cCchHHHHHHHHHHhhccccchhhCCHHH
Confidence 555 34445555555555555555554 45566666666666777777766444433
Q ss_pred ccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCc
Q 001710 215 IGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294 (1022)
Q Consensus 215 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L 294 (1022)
+. ++.|++||...|.++ .+|..++++.+|+.|||.+|+|. .+| .|.+++.|++|+++.|+++ .+|......++.+
T Consensus 180 i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l 254 (565)
T KOG0472|consen 180 IA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSL 254 (565)
T ss_pred HH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccc
Confidence 33 777777777777776 66777777777777777777776 455 6777777888888888877 7888888788999
Q ss_pred cEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCC-
Q 001710 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRS- 373 (1022)
Q Consensus 295 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~- 373 (1022)
..|||.+|+++ ..|+.++-+.+|.+||+|+|.|+ ..|..++++ .|++|-+.+|.+.++....-.....+-++.+++
T Consensus 255 ~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~ 331 (565)
T KOG0472|consen 255 LVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSK 331 (565)
T ss_pred eeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHh
Confidence 99999999988 77888999999999999999998 467789999 899999999998776533211111111111111
Q ss_pred cceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCccccccccccc---CceE
Q 001710 374 LTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQ---LQGL 450 (1022)
Q Consensus 374 L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L 450 (1022)
.+.=.++.- .|--. ..-............+.+.+.|++++-+++ .+|+......+ ....
T Consensus 332 ~~~dglS~s--e~~~e---------------~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~V 393 (565)
T KOG0472|consen 332 IKDDGLSQS--EGGTE---------------TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSV 393 (565)
T ss_pred hccCCCCCC--ccccc---------------ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEE
Confidence 000000000 00000 000000001112333455666666666666 44544333333 5666
Q ss_pred EeeccCCCCCCCcccccccccce-eecCCccccCcccccccCccccceeeccCceeccccCCccccccccceEeccCCcC
Q 001710 451 SLYDNDLQGSIPYYLCHLERLSQ-LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL 529 (1022)
Q Consensus 451 ~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 529 (1022)
+++.|++. .+|..+..++.+.+ +.+++|.++ .+|..+..+++|..|+|++|-+. .+|..++.+..|+.||+|.|++
T Consensus 394 nfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrF 470 (565)
T KOG0472|consen 394 NFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRF 470 (565)
T ss_pred ecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccc
Confidence 77777776 56666666555444 344444443 66666667777777777777666 5677777777777777777776
Q ss_pred CCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecccceec
Q 001710 530 SGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602 (1022)
Q Consensus 530 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 602 (1022)
. ..|..+..+..++.+-.++|++..+.|+.+.++.+|..|||.+|.|. .+|+.+++|++|+.|+|++|+|.
T Consensus 471 r-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 471 R-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred c-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 6 46666666666777767777777555556777777777777777777 66777777777777777777776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=347.81 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=206.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+.|+.+.++|+|+||+|||++.+ +|+.||||++....+ ...+-.++|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888889999999999999954 699999999965433 334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
||+. ++.+-++..+...+...+.++++|++.|+.|+|+ .++|||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk----~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK----NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh----cCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 9998 5555566666669999999999999999999999 789999999999999999999999999999886422
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHH---hhcCCCcchhcc--
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK---ESLPHGLTEVVD-- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-- 960 (1022)
..++-.+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-++ +-...+ +..++. ..++.
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prh-q~iF~~N 232 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRH-QSIFSSN 232 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHH-HHHhccC
Confidence 23455789999999998776 6799999999999999999999998876322211 111111 111111 11111
Q ss_pred --------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 --------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+......+....-+..+.-+.+++..|++.||++|++.+|++.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111112223345568999999999999999999998864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=388.33 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=221.2
Q ss_pred CCcCCeeecccceEEEEEEEcC----CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++.++||.|.||.||+|+++- ...||||.++... +++..+|+.|+.||.+++||||+++-|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3566899999999999998542 3569999998776 4567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
||++|+|+.||+.+...+++.+...+.++||.|+.||-+ .++||||+.++||||+.+..+|++|||+++.+..+..
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd----m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh----cCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999998889999999999999999999999 7899999999999999999999999999998754431
Q ss_pred -ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 887 -SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 887 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
........-+.+|.|||.+...++|.++||||||+||||.++ |..||.++.+.+. + .. .
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-----I-ka-------------I 847 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----I-KA-------------I 847 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-----H-HH-------------H
Confidence 112222234578999999999999999999999999999888 8999987654431 1 11 1
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
....+++.|.+|+..+++||..||++|-.+||+|.+++..|.++.+
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1234678889999999999999999999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=368.47 Aligned_cols=268 Identities=22% Similarity=0.245 Sum_probs=212.7
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhH-HHHHHHHHHHhhcC-CCcceeEeeeEeeCC-eeEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAF-RTFDSECEILRNVR-HRNLVKIFSSCCNID-FKAL 803 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~-~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~-~~~l 803 (1022)
..++|.++++||.|.||.||+|+ ..+|..||||.++.....+. -.-.+|+..++++. |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45678999999999999999998 55789999999876543321 12367999999998 999999999999988 8999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
|||||+. +|.+.++.+++.+++..+..|++||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk----~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK----HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh----cCcccccCChhheEecccceeEeccccccccccc
Confidence 9999977 9999999999999999999999999999999999 8999999999999999999999999999998755
Q ss_pred CCCceeeecccCCcccCCccc-cCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc---CCCcchh-
Q 001710 884 GDDSVTQTITMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL---PHGLTEV- 958 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~- 958 (1022)
.. .++.++.|.+|+|||+ ++.+.|+.+.|+||+|||++|+.+-++-|.+....+ ++.....-.- ...+.+.
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccchhHH
Confidence 44 3556789999999995 677889999999999999999999999887633222 2222222111 1112211
Q ss_pred -----ccccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -----VDANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -----~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.-.+.. +......-..++.+..++|.+|+.+||++||||+|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0101100 001111223378889999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=357.36 Aligned_cols=243 Identities=27% Similarity=0.311 Sum_probs=202.7
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.++|+++++||+|+||.||.++ .++++-+|+|++++.. ....+....|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999998 4568899999998664 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
+||+.||.|...+++.+. +++..+.-++..|+.||.|||+ .+|||||+||+|||+|.+|+++|+|||+|+..-..
T Consensus 104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~----~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHS----KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHh----CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999998776 7888888899999999999999 89999999999999999999999999999854322
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. ......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||.+....+ +.+......
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----~~~~I~~~k---------- 241 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----MYDKILKGK---------- 241 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----HHHHHhcCc----------
Confidence 2 22334789999999999999999999999999999999999999998633222 111111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 997 (1022)
....+...+.+..+++..+++.||++|..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01112224566789999999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=368.47 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=214.7
Q ss_pred HHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCe
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 800 (1022)
.+...+|...+.||+|+|++||+|+ ..+++.||||++.+.. +...+.+..|...|.+| .||.|+++|..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4456789999999999999999998 4579999999997654 33456778899999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.|+|+||+++|+|.+++.+.+. +++.....++.+|+.|++|||+ .|||||||||+|||+|+||++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~----~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHS----NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHh----cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999999875 8888889999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCc---------ee--eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh
Q 001710 881 LGEGDDS---------VT--QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 881 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 949 (1022)
+...... .. ....+||..|.+||++.+...++.+|+|+|||++|+|+.|.+||.+.. +....+-+..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqkI~~ 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQKIQA 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHHHHH
Confidence 7543222 11 134689999999999999999999999999999999999999998632 2211111111
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
-.+..++++++.+.+|+.+.|..||.+|++.+++.+|
T Consensus 302 ------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 ------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1223445567788999999999999999999888775
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=364.78 Aligned_cols=268 Identities=26% Similarity=0.290 Sum_probs=214.4
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 804 (1022)
+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+. ++......+|+.+|+++.||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777899999999999998 6689999999987765 44456678999999999999999999998876 689999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
+|||++ +|..++...+-.+++.++..+++|++.||+|||+ +||.|||||.+|||||.+|.+||+|||+|+++...
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~----~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS----RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh----cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999998 9999999887789999999999999999999999 89999999999999999999999999999988654
Q ss_pred CCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc-CCC-cchhcc-
Q 001710 885 DDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-PHG-LTEVVD- 960 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~- 960 (1022)
.. ...+..+.|.+|+|||++.| ..|+.++|+||.|||+.||++|++.|.+...-+ ++....+-.- +.. .+.+.+
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccC
Confidence 43 33667789999999997665 469999999999999999999999998743333 2333332211 111 111111
Q ss_pred -------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 -------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.-..+....+.-...+....+|+..+|..||++|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11111111112234456678899999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.74 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=213.2
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|...+++|+|.||.||+|+ ..+|+.||||.++.... .......+|+..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999998 66899999999976542 223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
||+. +|+..++.....++..++..++.++++|++|||+ +.|.||||||.|+|++++|.+||+|||+|+.+.+...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~----~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS----KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh----hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9976 9999999998899999999999999999999999 7899999999999999999999999999999977655
Q ss_pred ceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh---cCCCcch---hc
Q 001710 887 SVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES---LPHGLTE---VV 959 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~---~~ 959 (1022)
.... .+.|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+..+- +++....... .++.|.+ +.
T Consensus 157 ~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccc
Confidence 4433 4789999999977664 5999999999999999999988777653222 2222222211 1111222 21
Q ss_pred cc---cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DA---NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
|- ...........-..++.+..+++..|+..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111111111234566778999999999999999999999875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=378.73 Aligned_cols=492 Identities=28% Similarity=0.391 Sum_probs=376.6
Q ss_pred CCCCCccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCccccce
Q 001710 73 GNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEF 152 (1022)
Q Consensus 73 ~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 152 (1022)
++=..|+.|++++|.+. .+-+.+.++..|.+|++++|+++ ..|++++.+.+++.|+.++|+++ .+|+.++.+.+
T Consensus 42 W~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~--- 115 (565)
T KOG0472|consen 42 WEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLIS--- 115 (565)
T ss_pred hhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhh---
Confidence 33344555666666655 34444555555555555555555 44555555555555555555554 44444555444
Q ss_pred eeccCcccccccCCccccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEecccccc
Q 001710 153 LDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQ 232 (1022)
Q Consensus 153 L~Ls~N~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 232 (1022)
|..|+++.|.+. .+|+.++.+-.|+.|+..+|+++ ..|+.+..+.+|..|++.+|++.
T Consensus 116 --------------------l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~ 173 (565)
T KOG0472|consen 116 --------------------LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK 173 (565)
T ss_pred --------------------hhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh
Confidence 445555555554 67788999999999999999999 78889999999999999999999
Q ss_pred CCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcc-
Q 001710 233 GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNS- 311 (1022)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~- 311 (1022)
...|..+. ++.|++||..+|-++ .+|+.++++.+|..|+|.+|++. .+| .| .++..|.+|+++.|++. .+|..
T Consensus 174 ~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef-~gcs~L~Elh~g~N~i~-~lpae~ 247 (565)
T KOG0472|consen 174 ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EF-PGCSLLKELHVGENQIE-MLPAEH 247 (565)
T ss_pred hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CC-CccHHHHHHHhcccHHH-hhHHHH
Confidence 66666555 999999999999997 89999999999999999999999 788 33 35789999999999998 55554
Q ss_pred cccccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCcc
Q 001710 312 ITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPF 391 (1022)
Q Consensus 312 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 391 (1022)
..+++++..|||.+|++. ..|+.++-+++|..||+|+|.|+..+. +++++ .|+.|.+.+|+++.+-.+.
T Consensus 248 ~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~---------sLgnl-hL~~L~leGNPlrTiRr~i 316 (565)
T KOG0472|consen 248 LKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY---------SLGNL-HLKFLALEGNPLRTIRREI 316 (565)
T ss_pred hcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc---------ccccc-eeeehhhcCCchHHHHHHH
Confidence 459999999999999999 789999999999999999999998764 47788 9999999999998776555
Q ss_pred ccccccc-cchhcc-ccc-cccccCCccccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccc
Q 001710 392 IGNFSAS-LRKFEA-IKC-ELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL 468 (1022)
Q Consensus 392 ~~~~~~~-L~~l~~-~~~-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 468 (1022)
+..-++. |+++.- ..| ++..+ +=+..+ .-+ ... ........+.+.+.|++++-+++ .+|+.+...
T Consensus 317 i~~gT~~vLKyLrs~~~~dglS~s---e~~~e~---~~t----~~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea 384 (565)
T KOG0472|consen 317 ISKGTQEVLKYLRSKIKDDGLSQS---EGGTET---AMT----LPS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEA 384 (565)
T ss_pred HcccHHHHHHHHHHhhccCCCCCC---cccccc---cCC----CCC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHH
Confidence 5443322 344332 011 11000 000000 000 001 11122345678899999999999 566665554
Q ss_pred cc---cceeecCCccccCcccccccCccccc-eeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccc
Q 001710 469 ER---LSQLLLNGNNLSGAIPACLGSLTSLR-ELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLI 544 (1022)
Q Consensus 469 ~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 544 (1022)
.+ .+..+++.|++. .+|..+..+..+. .+.+++|.++ .+|..++.+++|..|+|++|-+.. +|..++.+..|+
T Consensus 385 ~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq 461 (565)
T KOG0472|consen 385 AKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQ 461 (565)
T ss_pred hhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhh
Confidence 44 889999999999 7888888777765 4555666665 899999999999999999999985 788899999999
Q ss_pred eeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCc
Q 001710 545 NLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNR 624 (1022)
Q Consensus 545 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 624 (1022)
.||+|+|++. ..|..+-.+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.|. .+|+.+++|.+|+.|+++||+
T Consensus 462 ~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 462 TLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred eecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCc
Confidence 9999999998 89999888888888888889999777777999999999999999998 999999999999999999999
Q ss_pred ce
Q 001710 625 LE 626 (1022)
Q Consensus 625 l~ 626 (1022)
|+
T Consensus 540 fr 541 (565)
T KOG0472|consen 540 FR 541 (565)
T ss_pred cC
Confidence 99
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=369.25 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=217.2
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
...|...++||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3457777899999999999998 567899999999888777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
|+||+|.|.+.... +++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~----~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHA----RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHh----cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999998776 8999999999999999999999 8999999999999999999999999999998865443
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.....+||++|||||+.....|++|+||||||++++||+-|.+||-. +..+.....- .....
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLI-------------a~ng~ 486 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLI-------------ATNGT 486 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHH-------------hhcCC
Confidence 44567899999999999999999999999999999999999999864 2122111110 01112
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+..++..+..+.+++.+||+.||++|++++|+++|
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2344556678889999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.39 Aligned_cols=267 Identities=23% Similarity=0.403 Sum_probs=219.6
Q ss_pred HHHHhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 724 DIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 724 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
++.+..+++.+.+.||+|.||+||+|+|. ..||||++..+. .+..+.|+.|+..+++-+|.||+-|.|+|..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 44455566778899999999999999975 469999997664 4567899999999999999999999999998887
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
.||+.||+|.+|..+++.....++..+...||+||++|+.|||. ++|||||+|..||++.++++|||+|||++..-
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA----K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA----KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh----hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999999888889999999999999999999999 88999999999999999999999999999865
Q ss_pred CCCCCceeeecccCCcccCCccccCC---CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
............-|...|||||++.. .+|++.+||||||+|+|||++|..||.. ...+..+..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm------------- 604 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM------------- 604 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE-------------
Confidence 44433333334457788999998764 4699999999999999999999999983 222211100
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
+.+.+. .........+|+.++.+|+..||..++++||.+.+++..|+++....
T Consensus 605 VGrG~l-~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 605 VGRGYL-MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred eccccc-CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 001100 11122344678889999999999999999999999999999987643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=354.04 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=208.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC--eeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNID--FKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~lv~e 806 (1022)
.+|...+.||+|+||+||++... +|+..|||.+........+.+.+|+.++++++||+||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999954 58999999987764444667889999999999999999999855544 6899999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeeccCceecCC-C
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKLLGE-G 884 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~-~ 884 (1022)
|+++|+|.+++...+..+++..+..+++||++||+|||+ +|||||||||+|||++. ++.+||+|||.++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs----~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS----KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh----CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999887569999999999999999999999 89999999999999999 79999999999987653 1
Q ss_pred CCceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||.+.... ..+.-........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~~~ig~~~~~------- 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEALLLIGREDSL------- 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHHHHHhccCCC-------
Confidence 112223346799999999998854 3446999999999999999999999874111 1111111000000
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
+ ..+...+.+..++++.|+..||++||||.+++++.--..
T Consensus 242 ----P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 242 ----P--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----C--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0 233446778899999999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.66 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=215.3
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|+..+.||.|..++||+|+ ...++.||||++..+.. ...+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999998 56789999999987753 345888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||.+|++.+.+... ...+++..+..|.+++++||.|||. +|.||||||+.||||+++|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~----~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ----NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh----cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998754 3358999999999999999999999 899999999999999999999999999987654433
Q ss_pred Cce-ee-ecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 886 DSV-TQ-TITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 886 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
... .. ...+||+.|||||++.. ..|+.|+||||||++..|+++|..||..+.+.+.-+....... +......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p-p~~~t~~--- 256 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP-PTLLTSG--- 256 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC-CCccccc---
Confidence 222 12 44589999999998443 3599999999999999999999999998776655444332211 1111111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
........+...+.+++..|+++||.+|||+++++++
T Consensus 257 ------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 ------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1223334556689999999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.77 Aligned_cols=376 Identities=25% Similarity=0.287 Sum_probs=227.6
Q ss_pred CeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccc
Q 001710 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIEN 277 (1022)
Q Consensus 198 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 277 (1022)
+.|++++|+++..-+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+.-++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45666666666666666666666666666666666 55555555555666666666666555556666666666666666
Q ss_pred eeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccccccCCCC
Q 001710 278 QLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESS 357 (1022)
Q Consensus 278 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 357 (1022)
.|+ .+|..-+..-.++++|+|++|+|+..-...|..+.+|..|.|++|+++...+..|.+++.|+.|+|..|+|.....
T Consensus 160 ~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 160 LIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred hhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 666 6666655556788899999999888888888888899999999999988888888888899999988888875432
Q ss_pred CCCccchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCcc
Q 001710 358 PADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTI 437 (1022)
Q Consensus 358 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 437 (1022)
..|..+++|+.|.|..|.+... --..|..+.++++|+|+.|++...-
T Consensus 239 --------ltFqgL~Sl~nlklqrN~I~kL-------------------------~DG~Fy~l~kme~l~L~~N~l~~vn 285 (873)
T KOG4194|consen 239 --------LTFQGLPSLQNLKLQRNDISKL-------------------------DDGAFYGLEKMEHLNLETNRLQAVN 285 (873)
T ss_pred --------hhhcCchhhhhhhhhhcCcccc-------------------------cCcceeeecccceeecccchhhhhh
Confidence 1244555555555555554421 1123555566666666666665555
Q ss_pred cccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccCCcccccc
Q 001710 438 PTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517 (1022)
Q Consensus 438 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 517 (1022)
..++.+++.|+.|+|+.|.|..+.++.+...++|+.|+|++|+|+...+..|..+..|++|+|++|+++..--..|..+.
T Consensus 286 ~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls 365 (873)
T KOG4194|consen 286 EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS 365 (873)
T ss_pred cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence 55555566666666666666555555555555555555555555555555555555555555555555544444444555
Q ss_pred ccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecc
Q 001710 518 YILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVS 597 (1022)
Q Consensus 518 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 597 (1022)
+|+.|||++|.|+..+.+ ....|.+|++|+.|.|.+|+|..+.-.+|.+++.|+.|||.
T Consensus 366 sL~~LdLr~N~ls~~IED---------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~ 424 (873)
T KOG4194|consen 366 SLHKLDLRSNELSWCIED---------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLG 424 (873)
T ss_pred hhhhhcCcCCeEEEEEec---------------------chhhhccchhhhheeecCceeeecchhhhccCcccceecCC
Confidence 555555555554433322 11224445555555555555553333445555555555555
Q ss_pred cceeccccCchhhhcccccEEEccCCcceeecC
Q 001710 598 SNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630 (1022)
Q Consensus 598 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 630 (1022)
+|.|..+-|++|..| .|++|-+..-.+-|.+.
T Consensus 425 ~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 425 DNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred CCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 555555555555555 55555554444444443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=393.22 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=223.0
Q ss_pred cCCCcCCeeecccceEEEEEEEc--CCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF--DGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
+..+....||+|+||.||.|... +|. .||||.++... ......|.+|+.+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 33445678999999999999844 343 48999887664 445678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 803 LVLEFMPNGSFEKWLYSY------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
|++|||++|+|..|+++. ...++....+.++.|||+|+.||++ +++|||||.++|+|+++...|||+|||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~----~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES----KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh----CCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999988 5679999999999999999999999 669999999999999999999999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCc
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGL 955 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 955 (1022)
+|+.+...+++.......-...|||||.+.++.++.|+|||||||++||++| |..||.+..+.+. +..+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~-------- 918 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVL-------- 918 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHH--------
Confidence 9997766665555444345678999999999999999999999999999999 7889876433221 11111
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhccc
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~~~ 1015 (1022)
...+++.|..|++.++++|.+||+.+|++||+|..+++++.++.+.....
T Consensus 919 ----------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 919 ----------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ----------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 12267888999999999999999999999999999999999997766443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.69 Aligned_cols=278 Identities=25% Similarity=0.334 Sum_probs=207.2
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc--CCCcceeEeeeEeeCC----eeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV--RHRNLVKIFSSCCNID----FKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~~l 803 (1022)
...+..+.+|+|.||.||||++. ++.||||++..+.. +.|..|.++++.. +|+||++|+++-...+ .+.+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556688999999999999965 59999999975543 5667787777755 8999999999876555 7899
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH-----GHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
|+||.+.|+|.+|+..+. ++|....+|+..+++||+|||+ .+.+.+|+|||||++||||..|+++.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999877 8999999999999999999997 345678999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCC------CccchhHhHHHHHHHHHcCCCCCC--cccccchhHHHHHHhh
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIV------SAKCDVYSYGVLLMETFTRKKPTD--EMFTGEMSLRRWVKES 950 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~vl~elltg~~p~~--~~~~~~~~~~~~~~~~ 950 (1022)
.++..+.........+||.+|||||++.+..- -.+.||||+|.|+|||+++..-++ +...-+..+..-+..+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 99987766666666899999999998877542 236899999999999999754332 1111111111111110
Q ss_pred cCCC-cchhcc-ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 951 LPHG-LTEVVD-ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 951 ~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
...+ ..+++. .+.....+...........+.+.++.||.+||+.|.|+.=+-+++.++..-..
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0000 000000 00000011111112345678999999999999999999999999999876654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.94 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=211.5
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|.+.+.||+|+||.||||+ .++.+.||+|.+.+.. ++..+.+.+|++++++++|||||.++++|++..+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999998 5578999999987654 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+.| +|..++...+. ++++.+..|+++++.||.|||+ .+|.|||+||+|||++..|++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs----~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHS----NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHh----cCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 9987 99999998776 9999999999999999999999 88999999999999999999999999999987553
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
....+...||+.|||||+..+..|+..+|.||+||++||+++|++||-. ..+.+.++.....+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v----------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPV----------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCC-----------
Confidence 3344556799999999999999999999999999999999999999965 123333332221111
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+...+..+.++++..+.+||.+|.+..+++.|
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1123456778999999999999999999998865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=325.96 Aligned_cols=237 Identities=25% Similarity=0.317 Sum_probs=203.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|+..+.||.|+||.|-+++.+ +|..+|+|+++++. -++.+...+|.++++.+.||.++++++.+.+....|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888899999999999999954 68899999998764 345677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||++||.|..++++.++ +++..+.-+|.||+.|++|||+ .+|++||+||+|||+|++|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~----~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHS----LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHh----cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999999876 8888888999999999999999 78999999999999999999999999999986332
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....+|||.|+|||.+.+..|..++|.|||||++|||+.|.+||.+..+.. .....+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-iY~KI~~----------------- 255 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-IYEKILE----------------- 255 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-HHHHHHh-----------------
Confidence 334689999999999999999999999999999999999999998743321 1111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCC
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRI 996 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 996 (1022)
.....|..++.++.+|+...++.|-.+|.
T Consensus 256 --~~v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 256 --GKVKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred --CcccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 12233455677889999999999999993
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=351.22 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=204.5
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
..++|+.+++||+|+||.||+|+ ..+|..+|+|++++.. ..+.+.+..|-.+|....+|.||++|..|.+.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998 4579999999998764 4567788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||++||++..+|...+. +++..+..++.+++.|++.+|+ .|||||||||+|+|||..|++||+|||+|.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~----~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQ----LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHH----cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999988775 8899999999999999999999 8999999999999999999999999999853211
Q ss_pred ----------------------CCCc----ee-------------------eecccCCcccCCccccCCCCCCccchhHh
Q 001710 884 ----------------------GDDS----VT-------------------QTITMATIGYMAPEYGSEGIVSAKCDVYS 918 (1022)
Q Consensus 884 ----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 918 (1022)
.+.. .. ....+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 00 01246999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCcccccc--hhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC
Q 001710 919 YGVLLMETFTRKKPTDEMFTGE--MSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI 996 (1022)
Q Consensus 919 lG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 996 (1022)
+|||+|||+.|.+||.+....+ ..+..|.... .++....++.+..++|.+|+. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l------------------~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL------------------KFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc------------------cCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999998754433 2223332211 112223345778999999999 999999
Q ss_pred C
Q 001710 997 H 997 (1022)
Q Consensus 997 s 997 (1022)
.
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=364.76 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=215.0
Q ss_pred cCCCcCCeeecccceEEEEEEEcC--C---CEEEEEEecch---hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFD--G---TNVAIKVFNLQ---LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~---~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
++....++||+|+||.||+|++.. + ..||||..+.+ ...+...+.+|+++|+.++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344445899999999999998442 2 23899998853 266778999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++|||+|.||+|.+++++.+..++..++..++.++|.||+|||+ .+++||||.++|+|++.++.+||+|||+++.-
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~----k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS----KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH----CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999999988889999999999999999999999 78999999999999999999999999998753
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH-HhhcCCCcchhc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV-KESLPHGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 959 (1022)
. ..........-+..|+|||.+..+.|++++|||||||++||+++ |..||.++... ....++ ...
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~--------- 379 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNG--------- 379 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcC---------
Confidence 2 11112212345688999999999999999999999999999999 78898875333 233333 211
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
.+...+...+.++..++.+||..+|++||+|.++.+.++.+.....
T Consensus 380 --------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 --------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1222333557788999999999999999999999999999876654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.51 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=207.8
Q ss_pred hhcCCCcCCeeecccceEEEEEEE------cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCC
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNID 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 799 (1022)
+.++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999999973 235689999987543 23346788999999999 8999999999887644
Q ss_pred -eeEEEEEccCCCCHHHHhhhcC---------------------------------------------------------
Q 001710 800 -FKALVLEFMPNGSFEKWLYSYN--------------------------------------------------------- 821 (1022)
Q Consensus 800 -~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 821 (1022)
..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999987532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCc
Q 001710 822 ----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897 (1022)
Q Consensus 822 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~ 897 (1022)
..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...............++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~----~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS----RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH----CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 237788889999999999999999 889999999999999999999999999998654333222223344678
Q ss_pred ccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHH
Q 001710 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDC 976 (1022)
Q Consensus 898 ~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 976 (1022)
.|+|||++.+..++.++|||||||++|||++ |..||......+. ......... ....+..+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGT-----------------RMRAPENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCC-----------------CCCCCCCC
Confidence 8999999988899999999999999999997 9999876432221 111111100 01112345
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 977 LLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 977 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
+.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=361.14 Aligned_cols=368 Identities=26% Similarity=0.281 Sum_probs=245.5
Q ss_pred cceeeccccccCCCcchhhcCccccceeeccCcccccccCCccccccccceecccccccccCCccccCCCCCCeeecccc
Q 001710 126 LQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADN 205 (1022)
Q Consensus 126 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 205 (1022)
-+.||+++|+++..-+..|.++++|+.+++.+|.++ .+|...+...+|+.|+|.+|
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt------------------------~IP~f~~~sghl~~L~L~~N 135 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT------------------------RIPRFGHESGHLEKLDLRHN 135 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh------------------------hcccccccccceeEEeeecc
Confidence 456777777777777777777777777777777665 34443344444555555555
Q ss_pred cccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccc
Q 001710 206 KFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPL 285 (1022)
Q Consensus 206 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 285 (1022)
.|+..-.+.+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+......|.+
T Consensus 136 ~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~-------------------- 195 (873)
T KOG4194|consen 136 LISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDS-------------------- 195 (873)
T ss_pred ccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccc--------------------
Confidence 555444455555555666666666665444444555555666666666665433333333
Q ss_pred cccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchh
Q 001710 286 TLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365 (1022)
Q Consensus 286 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 365 (1022)
+.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|..+...+
T Consensus 196 -----lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~------ 264 (873)
T KOG4194|consen 196 -----LNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA------ 264 (873)
T ss_pred -----cchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc------
Confidence 334444444444444444445555666666666666665333456666666666666666666655543
Q ss_pred ccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCcccccccccc
Q 001710 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ 445 (1022)
Q Consensus 366 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 445 (1022)
|-.|.++++|+|+.|++... -..++.+|+.|+.|+||+|.|..+.++...-.+
T Consensus 265 --Fy~l~kme~l~L~~N~l~~v-------------------------n~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 265 --FYGLEKMEHLNLETNRLQAV-------------------------NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred --eeeecccceeecccchhhhh-------------------------hcccccccchhhhhccchhhhheeecchhhhcc
Confidence 55666777777777766532 235688999999999999999999999988899
Q ss_pred cCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccCCccccccccceEecc
Q 001710 446 QLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525 (1022)
Q Consensus 446 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 525 (1022)
+|+.|+|+.|+|+...+..|..+..|++|+|++|.+...-...|..+.+|++|||++|.|+..+-++
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa------------- 384 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA------------- 384 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc-------------
Confidence 9999999999999999999999999999999999999888889999999999999999999765432
Q ss_pred CCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecc
Q 001710 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVS 597 (1022)
Q Consensus 526 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 597 (1022)
...|.+++.|+.|+|.+|+|+.+...+|.++.+|++|||.+|.|..+-|++|..+ .|+.|-+.
T Consensus 385 --------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 385 --------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred --------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 2334445555555555555554444555555555555555555555555555555 55555443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.28 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=208.7
Q ss_pred CCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
...++-||+|+.|.||+|++. ++.||||+++.-. ..++.-|++|+||||+.|.|+|.....+|||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344577999999999999965 6889999875221 23788999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
-|..+++.... ++....+.|..+||.|+.|||. .+|||||+|.-||||..+..|||+|||-++...... ++-
T Consensus 198 qL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH~----hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkM 269 (904)
T KOG4721|consen 198 QLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLHL----HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKM 269 (904)
T ss_pred cHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHHH----hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhh
Confidence 99999988665 8889999999999999999999 789999999999999999999999999998764432 222
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 971 (1022)
..+||..|||||+++..+.+.|+||||||||+|||+||..||.+...... ++.+ ....-.++
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------IwGV-----GsNsL~Lp 331 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------IWGV-----GSNSLHLP 331 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------------EEec-----cCCccccc
Confidence 35799999999999999999999999999999999999999976322210 1111 11122456
Q ss_pred hhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 972 AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 972 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
.|..|++-+.-||++||+..|..||+|.+++.||+-.....
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 78889999999999999999999999999999998765543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=356.27 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=206.9
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh----h-hhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCC
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL----E-RAFRTFDSECEILRNVR-HRNLVKIFSSCCNID 799 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~ 799 (1022)
...+.|.+.+.||+|+||+|+.|+ ..+++.||+|++.... . ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999998 4578999999876641 1 23456678999999998 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeeccCc
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGIS 878 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG~a 878 (1022)
..++||||+.||+|.+++.. ...+.+..+..+++|+++|++|||+ +||+||||||+|||+|.+ +.+||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~----~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS----RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh----CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999999 4458889999999999999999999 899999999999999999 99999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCC-CC-ccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGI-VS-AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
.... .........+||+.|+|||++.+.. |+ .++||||+|+++|.|++|+.||++... ...... +.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~k-i~---- 236 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRK-IR---- 236 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHH-Hh----
Confidence 8763 1222344568999999999999877 75 889999999999999999999987211 111111 00
Q ss_pred hhccccccchhhhhhhhHHH-HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 957 EVVDANLVGEEQAFSAKTDC-LLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
......+..+ +.++.+++.+|+..||.+|+++.++++
T Consensus 237 ----------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 ----------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0112223333 677899999999999999999999993
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.54 Aligned_cols=269 Identities=24% Similarity=0.299 Sum_probs=209.8
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhh--HHHHHHHHHHHhhcCCCcceeEeeeEe--eCCee
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERA--FRTFDSECEILRNVRHRNLVKIFSSCC--NIDFK 801 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~ 801 (1022)
+..++|+.+++|++|.||.||+|+ .++++.||+|+++.+.+.. .-...+|+.++.+++|||||.+-.+.. +-+..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 345678889999999999999999 4578999999998765332 234678999999999999999988764 45679
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
|+|||||+. +|..++..-++.+...++..++.|+++|++|||. ..|+|||+|++|+|+...|.+||+|||+|+.+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~----~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD----NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh----ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999999988 9999999888889999999999999999999999 78999999999999999999999999999998
Q ss_pred CCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh------cCCC
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES------LPHG 954 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~ 954 (1022)
+... ..++..+.|.+|+|||.+.+ ..|+.+.|+||+|||+.|++++++-|.+....+ ++...++.. ...+
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCC
Confidence 7653 34556678999999997665 459999999999999999999999987743322 222222211 1112
Q ss_pred cchhccc---cccch-----hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEVVDA---NLVGE-----EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~~~---~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+.-.. .+... ...+.. ...++.-++++..++.+||.+|.|+.|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 2211100 00000 011111 1134678899999999999999999998865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.60 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=210.8
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..|...+.||+|+||.||+|. ..+++.||+|++..+. +...+.+.+|+.++..++++||.++|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777899999999999998 4568899999998775 44568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
|.||++.+.++.... +++..+.-|++++..|+.|||. .+.+|||||+.||++..+|.+|++|||.+..+......
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH~----~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLHS----EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhhh----cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999987663 4788888899999999999999 78999999999999999999999999999887654433
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
. ...+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+... .-.++. ...
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------lflIpk-----------~~P 228 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------LFLIPK-----------SAP 228 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------EEeccC-----------CCC
Confidence 2 456899999999999998999999999999999999999999987544210 000011 111
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+.. .++..+.++|..|+++||+.||+|++++++
T Consensus 229 P~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 12222 567789999999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.81 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=202.7
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----eeE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FKA 802 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 802 (1022)
.-.|...+++|+|+||.||+|+.. +++.||||++..+.+ .-.+|..+|+.++|||||++..+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345777899999999999999954 578999998865533 2235999999999999999998886432 234
Q ss_pred EEEEccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeeccCc
Q 001710 803 LVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGIS 878 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG~a 878 (1022)
+|||||+. +|.++++.. +..++...+.-+++||.+|+.|||+ .+|+||||||+|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~----~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS----HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh----cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999988 999998853 4458888899999999999999999 789999999999999965 99999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
+....++.... ...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+ ..+..++...++..-...-++
T Consensus 174 K~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHH
Confidence 99877666543 457899999997666 4699999999999999999999999887 333344444444322222111
Q ss_pred h----------ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 V----------VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+ ..+.+.......-.....+++..+++.++++++|.+|.++.|++++
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 1122222111111234456788999999999999999999998864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=345.05 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=224.5
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+.....++++||+|.||.|..++...+..||||.++.+... ....|.+|+++|.+++||||++++|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34456778999999999999999888899999999887643 45789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||++|+|..|+.++..+ .......+|+.||+.|++||.+ ..+||||+.++|+|+|.++++||+|||+++-+..++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes----~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES----LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh----hchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999987543 3667778899999999999999 779999999999999999999999999999887788
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc--CCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.+..+...+-+.+|||||.+.-++++.++|||+||+++||+++ ...||.++.+.. .+++. .++++.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~-----~~~~~~-- 759 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENA-----GEFFRD-- 759 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhh-----hhhcCC--
Confidence 7777777778899999999999999999999999999999877 678987754332 11111 111110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
.+.......|..|+..++++|.+||..|.++||+++++...|++.
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112234556788999999999999999999999999999998865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.47 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=211.8
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+-|+..+-||.|+.|.|..|+ ..+|+.+|||++.+.. +.....+.+|+-+|+.+.|||++++|+++++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 447777889999999999998 5689999999997663 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|.|.+++...+. +++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~----~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHA----FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhh----hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999988776 8888888999999999999999 679999999999999999999999999998643332
Q ss_pred CceeeecccCCcccCCccccCCCCC-CccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
--...+|.+.|+|||++.|.+| +.++||||.|||+|.++||+.||++ ++++..... +.+
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlK-V~~----------- 226 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLK-VQR----------- 226 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHH-HHc-----------
Confidence 2334689999999999999887 5899999999999999999999984 334443322 212
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+.++.|...+.+..+|+++|+.+||++|.|+.||.+|-
T Consensus 227 ---G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 ---GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 23455566778889999999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.45 Aligned_cols=273 Identities=23% Similarity=0.308 Sum_probs=212.0
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhh--hHHHHHHHHHHHhhcCCCc-ceeEeeeEeeCC-----
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRN-LVKIFSSCCNID----- 799 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~----- 799 (1022)
...|..+++||+|+||+||+|+ ..+|+.||+|++..+.++ ......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999 557899999999876542 4456789999999999999 999999998877
Q ss_pred -eeEEEEEccCCCCHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 800 -FKALVLEFMPNGSFEKWLYSYN---YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 800 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
..++||||++. +|.+++.... ..++...+..+++|++.|++|||+ ++|+|||+||+||+|+++|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~----~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS----HGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh----CCeecccCCcceEEECCCCcEeeecc
Confidence 78899999976 9999998876 357888999999999999999999 89999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-- 952 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 952 (1022)
|+|+.+.-.. ...+..++|..|+|||++.+. .|+...||||+||+++||++++..|.+....++....+..-..|
T Consensus 165 GlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 165 GLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred chHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 9998654222 235556789999999987776 79999999999999999999999988755433222222221112
Q ss_pred CCcchhcc-ccccchhhhhhhhH-------HHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHHh
Q 001710 953 HGLTEVVD-ANLVGEEQAFSAKT-------DCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKI 1008 (1022)
Q Consensus 953 ~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~i 1008 (1022)
..|..+.. +.++...+....+. ....+..+++.+|++++|.+|.|++.++++ +.++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 12222211 11111111111111 112478899999999999999999999987 5555
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=344.05 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=201.9
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhh---hHHHHHHHHHHHhhcCCCcceeEeeeEee----CCeeEEEEEc
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER---AFRTFDSECEILRNVRHRNLVKIFSSCCN----IDFKALVLEF 807 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~ 807 (1022)
...||+|++|.||+|+. +|+.||||+++..... ..+.+.+|+.++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999986 6899999998765322 24678899999999999999999999876 3467899999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++|+|.+++.... .+++.....++.+++.|+.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc---CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999998755 488999999999999999999972 268899999999999999999999999997653321
Q ss_pred eeeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 888 VTQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ........ .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~----~----------- 238 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLIINK----N----------- 238 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhc----C-----------
Confidence 22457899999998876 679999999999999999999999998642211 11111110 0
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
.....+..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 239 --~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 --NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111223467789999999999999999999999999998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.89 Aligned_cols=243 Identities=25% Similarity=0.310 Sum_probs=203.4
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 802 (1022)
..++|...++||+|+||+|++++.+ +++.+|||+++++. ++..+..+.|.+++... +||.++.++.+|.+.++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4567999999999999999999954 68899999998775 45667888899999988 5999999999999999999
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+.||++..+.+. ..+++..+.-++..|+.||.|||+ ++|||||+|.+|||+|.+|++||+|||+++.--
T Consensus 446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~----~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHE----NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHh----cCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999994444333 348999999999999999999999 899999999999999999999999999998642
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
. .....+..+||+.|||||++.+..|+.++|+|||||++|||+.|..||.+. .|.. ++|.-
T Consensus 520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee---------------~FdsI 580 (694)
T KOG0694|consen 520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEE---------------VFDSI 580 (694)
T ss_pred C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHH---------------HHHHH
Confidence 1 122455678999999999999999999999999999999999999999863 2221 12211
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
+.. ....|..++.+..++|++++..+|++|..+
T Consensus 581 ~~d---~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND---EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC---CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 122345567788999999999999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=308.72 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=210.8
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.++|++.+.||+|.||.||.|+ .+++..||+|++.+.. ....+++.+|+++-+.++||||.++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4679999999999999999998 4568889999987654 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 805 LEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
+||.++|++...++..+. .+++.....+++|+|.|+.|+|. +.|+||||||+|+|++.++.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~----k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL----KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc----CCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999985433 48889999999999999999999 789999999999999999999999999987532
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.......+||..|.|||...+..++.++|+|++|++.||++.|.+||.... ....+....+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~-------------- 237 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV-------------- 237 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc--------------
Confidence 233445789999999999999999999999999999999999999998755 22222222221
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+...|...+....++|.+|+.++|.+|.+..|++++-
T Consensus 238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1122344566789999999999999999999998864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.57 Aligned_cols=270 Identities=25% Similarity=0.388 Sum_probs=214.9
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc--CCCcceeEeeeEeeCC----e
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV--RHRNLVKIFSSCCNID----F 800 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~ 800 (1022)
....+....+.||+|.||.||+|++. |+.||||+|....+.+ +.+|.++++.+ +|+||..|++.-..+. .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 34456777899999999999999975 8999999998665543 44577777765 9999999998754432 5
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh----cCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH----GHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
.++|++|.+.|+|.|||.... ++....++++..+|.||+|||- ...+..|+|||||+.||||.+++++.|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 789999999999999999855 8999999999999999999994 1234669999999999999999999999999
Q ss_pred CceecCCCCC--ceeeecccCCcccCCccccCCCCC------CccchhHhHHHHHHHHHcC----------CCCCCcccc
Q 001710 877 ISKLLGEGDD--SVTQTITMATIGYMAPEYGSEGIV------SAKCDVYSYGVLLMETFTR----------KKPTDEMFT 938 (1022)
Q Consensus 877 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~vl~elltg----------~~p~~~~~~ 938 (1022)
+|..+..... .......+||.+|||||++....- -..+||||||.|+||++.+ ..||.+..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9998866532 334556789999999998766431 1358999999999999874 378888887
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
.+.++.+..+..-.+...+.+..+. ....+...+.++|+.||..+|.-|.|+-.+-+.+.++.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW--------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRW--------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCccc--------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 7777776655433333333333222 234456778999999999999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.62 Aligned_cols=269 Identities=23% Similarity=0.263 Sum_probs=208.7
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecc--hhhhhHHHHHHHHHHHhhcCCCcceeEeeeEee-----CC
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL--QLERAFRTFDSECEILRNVRHRNLVKIFSSCCN-----ID 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----~~ 799 (1022)
....|...+.||+|+||.|+.|. ..+|+.||||.+.. +.....++..+|+.+++.++|+||+.+++.+.. ..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34556667899999999999998 45799999998873 334455778899999999999999999998865 45
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
..|+|+|+| +.+|...++.... ++...+..+++|+++|++|+|+ .+|+|||+||.|++++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHS----AnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHS----ANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhc----ccccccccchhheeeccCCCEEecccccee
Confidence 789999999 4599999987664 8999999999999999999999 789999999999999999999999999999
Q ss_pred ecCCCCCceeeecccCCcccCCccc-cCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
...........+..+.|.+|.|||+ +....|+.+.||||.||++.||++|++-|.+... .+.-..+.+.....-.+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEED 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHHH
Confidence 8865433445567889999999995 5567899999999999999999999998876322 122222222222211111
Q ss_pred ------------ccccccchh-hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 ------------VDANLVGEE-QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+...-..+. +-...-+...+...+++.+|+..||.+|+|++|++++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110000000 1111122456678999999999999999999999886
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.10 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=206.2
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC-----------------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCccee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD-----------------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 790 (1022)
.++|++.++||+|+||.||+|...+ +..||+|++.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997432 3369999987653 334467889999999999999999
Q ss_pred EeeeEeeCCeeEEEEEccCCCCHHHHhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 001710 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYN------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852 (1022)
Q Consensus 791 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i 852 (1022)
+++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.|++|||+ .+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~----~~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS----LNF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH----CCc
Confidence 9999999999999999999999999986532 236788899999999999999999 789
Q ss_pred EecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc--CC
Q 001710 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RK 930 (1022)
Q Consensus 853 vH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~ 930 (1022)
+||||||+||++++++.+||+|||+++...............++..|+|||+..++.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999987654433323333456788999999888889999999999999999987 56
Q ss_pred CCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 931 KPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 931 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.||.+.... .....+........... ....+..++..+.+++.+||+.||++||++.|+.+.|++
T Consensus 240 ~p~~~~~~~--~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE--QVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH--HHHHHHHHHhhhccccc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 777653221 11122221111110000 011123456789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.89 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=217.3
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEcC-CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
+....+..+.++||-|.||.||.|.|+. .-.||||.++.+. -..++|..|+.+|+.++|||+|+++|+|..+...|||
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3334566778999999999999999764 5679999997553 3468899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 805 LEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
+|||..|+|.+|+++..+ ..+....+.++.||++|++||.. +.+||||+.++|.||.++-.||++|||+++++..
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk----knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK----KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH----hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999998765 46667778899999999999999 6799999999999999999999999999999865
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
+.+ .......-...|.|||-+....++.|+|||+||+++||+.| |-.||.+.. +.+.. +
T Consensus 418 DTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqVY---------~----- 477 (1157)
T KOG4278|consen 418 DTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVY---------G----- 477 (1157)
T ss_pred Cce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHH---------H-----
Confidence 433 23333345678999999999999999999999999999999 566776532 11111 1
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
+.....+...++.|++.++++|+.||++.|.+||++.|+-+.++.+-
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22233456678899999999999999999999999999999998863
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=307.70 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=213.7
Q ss_pred HHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC-----C
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-----D 799 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~ 799 (1022)
....++|.+.+.||+|+|+.||.++ ..+++.||+|++.....+..+..++|++..++++|||+++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3445789999999999999999999 678999999999888777788899999999999999999999887443 3
Q ss_pred eeEEEEEccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 800 FKALVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
..|++++|...|+|.+.++.. +..+++.+++.|+.+|++||++||+.. .+++||||||.||++.+++.+++.|||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~--~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE--PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC--CcccccCCCcceeEecCCCceEEEecc
Confidence 589999999999999998754 347999999999999999999999954 459999999999999999999999999
Q ss_pred CceecCCCCCce-------eeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHH
Q 001710 877 ISKLLGEGDDSV-------TQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946 (1022)
Q Consensus 877 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 946 (1022)
.++...-..... .......|.-|+|||.+. +...+.++||||+||++|+|+.|..||+........++-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL- 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL- 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-
Confidence 997653211111 112235788999999654 445788999999999999999999999753332111110
Q ss_pred HHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
.+.. ....++....+++.+.+++..|+++||.+||++.+++.+++.+.
T Consensus 254 ----------Av~n-----~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ----------AVQN-----AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------eeec-----cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 11122333347889999999999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=315.60 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=206.2
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
..++|++.+.||+|.|+.||++. ..+|+.+|+|++.... ....+.+.+|+++-+.++|||||++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 35678888999999999999987 4579999999886442 34567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec---CCCcEEEeeccCceec
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLL 881 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfG~a~~~ 881 (1022)
+|+|+|++|..-+-.+ ..+++..+-..++||+.++.|+|. ++|||||+||+|+++- ....+|++|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~----n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS----NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh----cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999987655444 458889999999999999999999 8999999999999995 3346999999999988
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
..+ ......+|||+|||||+++..+|+..+|||+.|+++|-++.|++||.+..... -+.+.....
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~----------- 228 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGA----------- 228 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhccc-----------
Confidence 632 23445789999999999999999999999999999999999999997632211 111111111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+..+ .+.+...+++..+++++|+..||.+|.|+.|++.+
T Consensus 229 -yd~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 -YDYP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -cCCC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1101 11234456778999999999999999999998865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.34 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=207.1
Q ss_pred hhcCCCcCCeeecccceEEEEEEE------cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCC
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNID 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 799 (1022)
..++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345789999999999999999963 235689999987543 23346788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcC----------------------------------------------------------
Q 001710 800 FKALVLEFMPNGSFEKWLYSYN---------------------------------------------------------- 821 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 821 (1022)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 822 ----------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 822 ----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS----KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 136788899999999999999999 889999999999999999999999999998764433
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+++......
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~----------- 336 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM----------- 336 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC-----------
Confidence 2222222345678999999999999999999999999999998 888887643221 222222211100
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+...+.++.+++.+||+.||++||+++|+++.|++.
T Consensus 337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01122355789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.02 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=220.8
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc---CCC--EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF---DGT--NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
...+.....++||+|-||.||+|..- .|+ .||||..+.+. .+..+.|.+|+.+|+.++||||++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 33344555688999999999999832 233 48999988754 34568899999999999999999999999865 4
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.++|||.++-|.|..|++..+..++......+++||..+|+|||+ ...|||||.++||||.+..-||++|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS----krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES----KRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh----hchhhhhhhhhheeecCcceeeecccchhhh
Confidence 689999999999999999999999999999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
+.....+.. +...-+..|||||.+.-..++.++|||.||+.+||+++ |..||.+..+.+ ++
T Consensus 541 ~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI 602 (974)
T KOG4257|consen 541 LEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VI 602 (974)
T ss_pred ccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eE
Confidence 866555443 34456778999999999999999999999999999988 889998744332 11
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
- ....+.+.+.|+.|++.++.+|.+||.+||.+||++.|+...|.++.+
T Consensus 603 ~--~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 G--HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred E--EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1 122345678899999999999999999999999999999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.62 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=207.4
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCC
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNID 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 799 (1022)
..++|++.+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+++++.+ +|+||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4467999999999999999998732 23579999997543 33356788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcC----------------------------------------------------------
Q 001710 800 FKALVLEFMPNGSFEKWLYSYN---------------------------------------------------------- 821 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 821 (1022)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986432
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 822 -----------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 822 -----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
..+++..+.+++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++...........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~----~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS----KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH----CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 136788899999999999999999 88999999999999999999999999999876443322222
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..........+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~----------------- 333 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ----------------- 333 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC-----------------
Confidence 22345678999999988899999999999999999997 999997643322 11111111100
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
...+...+.++.+++.+||+.||++||++.++++.|+++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0011123567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.30 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=206.5
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
..+|++.+.||+|.||.|-+|. ...|+.||||.++++. +...-.+.+|++||..++||||+.+|.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3468888999999999999998 4789999999987654 33445688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||..+|.|.||+.+++. +++.+...+++||++|+.|+|+ .++||||+|.+|||+|.++.+||+|||++-.+..+
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHk----nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHK----NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhh----ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999998876 8999999999999999999999 78999999999999999999999999999877544
Q ss_pred CCceeeecccCCcccCCccccCCCCC-CccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.. -+..+|++-|.+||.+.+.+| ++.+|-||+|+++|.+..|.+||++. ... ..+++.-..
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk----~lvrQIs~G---------- 268 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHK----RLVRQISRG---------- 268 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHH----HHHHHhhcc----------
Confidence 32 334689999999999999887 58899999999999999999999873 111 122211110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
....-+. +.+..-+|+.|+.++|++|.|..++..+-
T Consensus 269 --aYrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 --AYREPET----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --cccCCCC----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 0001111 23346799999999999999999987763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.71 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=202.7
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999984 579999999986543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR----ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh----CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998876533 358999999999999999999999 889999999999999999999999999998754322
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
......||..|+|||++.+..++.++||||+||++|||++|+.||........ .... .......
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~-~~~~~~~----------- 220 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEV-DRRVKED----------- 220 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHH-HHHhhcc-----------
Confidence 12335689999999999999999999999999999999999999976332211 1111 1111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
....+..++.++.+++++||+.||++||+ +++++++
T Consensus 221 ---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 ---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01112234667899999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=349.77 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=219.6
Q ss_pred CCcCCeeecccceEEEEEEE-cCCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
.+..++||+|+||+||+|.+ ..|+ +||+|++.... .++..++.+|+.+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34458899999999999984 3443 68999886543 445678999999999999999999999998776 78999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
+|++.|+|.||++.++..+..+..+.|.+|||+||.|||+ +.+|||||.++||||.+-..+||.|||+|+....++
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~----qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE----QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh----cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999999899999999999999999999999 789999999999999999999999999999887766
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.........-.+.|||-|.+....|+.++|||||||++||++| |..|++++...+. .+ +.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~d-----------------ll 913 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--PD-----------------LL 913 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--hH-----------------HH
Confidence 6555544455678999999999999999999999999999999 8999987544431 11 11
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
....+++.|+.|+.+++.+|.+||..|++.||+|+++...+.+...
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 2233578889999999999999999999999999999999988744
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.73 Aligned_cols=249 Identities=34% Similarity=0.540 Sum_probs=198.3
Q ss_pred cCCeeecccceEEEEEEEc-----CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 734 ECNLLGRGSFGLVYKGTLF-----DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..+.||+|+||.||+|.+. .+..|+||+++... .+..+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999966 25679999996543 33468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++|+|.+++... ...+++..+..|+.||+.||.|||+ .+|+|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS----NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH----TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 5569999999999999999999999 7899999999999999999999999999988744333
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
............|+|||.+.+..++.++||||||+++||+++ |+.||.+.... . ....+.+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-~-~~~~~~~~--------------- 221 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-E-IIEKLKQG--------------- 221 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-H-HHHHHHTT---------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-c-cccccccc---------------
Confidence 333334457788999999988889999999999999999999 67888764221 1 11111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
.....+..++..+.+++.+||..||++||++.++++.|
T Consensus 222 --~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 --QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222344677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.46 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=206.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
..|+.++.||+|.-|+||+++.. ++..+|+|++.++. ++...+...|.+||+.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34677789999999999999965 46889999998765 344567788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC-
Q 001710 806 EFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE- 883 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~- 883 (1022)
|||+||+|....+++.. .+++..+.-++..++-||+|||- .|||+||+||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm----lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM----LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh----hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999886644 78999999999999999999999 8999999999999999999999999999753210
Q ss_pred --------------------------------CCC---------------------ceeeecccCCcccCCccccCCCCC
Q 001710 884 --------------------------------GDD---------------------SVTQTITMATIGYMAPEYGSEGIV 910 (1022)
Q Consensus 884 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 910 (1022)
... .......+||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 001112469999999999999999
Q ss_pred CccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhccc
Q 001710 911 SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCME 990 (1022)
Q Consensus 911 ~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 990 (1022)
+.++|+|+|||++|||+.|..||.+..+.+ .+...+.+.. .++.....+....+||++.|.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l-----------------~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPL-----------------KFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCC-----------------cCCCCCcchhHHHHHHHHHhcc
Confidence 999999999999999999999998854443 2333332221 2222234567789999999999
Q ss_pred CCCCCCC----HHHHHH
Q 001710 991 SPEQRIH----MTDAAA 1003 (1022)
Q Consensus 991 dP~~Rps----~~ell~ 1003 (1022)
||.+|.. +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999998 666544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.44 Aligned_cols=261 Identities=28% Similarity=0.365 Sum_probs=202.7
Q ss_pred HHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh---------h-----hHHHHHHHHHHHhhcCCCccee
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE---------R-----AFRTFDSECEILRNVRHRNLVK 790 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---------~-----~~~~~~~E~~~l~~l~h~~iv~ 790 (1022)
.+..++|++.+.||+|.||.|-+|+ .-+++.||||++.+... . ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4456789999999999999999998 45789999999975431 1 1247889999999999999999
Q ss_pred EeeeEee--CCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 791 IFSSCCN--IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 791 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
++++..+ .+..|||+|||..|.+...=. .+..++..++.+++++++.||+|||. .|||||||||+|+|++++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~----QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHY----QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHh----cCeeccccchhheEEcCCC
Confidence 9999876 457899999999987755322 22238999999999999999999999 7899999999999999999
Q ss_pred cEEEeeccCceecCCCC---CceeeecccCCcccCCccccCCCC----CCccchhHhHHHHHHHHHcCCCCCCcccccch
Q 001710 869 TAHVSDFGISKLLGEGD---DSVTQTITMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~p~~~~~~~~~ 941 (1022)
++||+|||.+.....+. ....-...+||+.|+|||...++. .+.+.||||+||++|.++.|+.||-+.+..+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 99999999998763321 111222367999999999766532 4678999999999999999999997522211
Q ss_pred hHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
.....+.+. + .++..++..+++.++|.+||.+||++|.+..+|..|..--.
T Consensus 327 l~~KIvn~p------------L-----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 327 LFDKIVNDP------------L-----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHhcCc------------c-----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 111111111 1 12222244677899999999999999999999988765443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=332.48 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=207.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc----CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.++|++.+.||+|+||.||+|... .+..||+|+++.... ...+.+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999743 356899999876532 334578899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++|+|.+++......+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~----~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE----MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999998766668999999999999999999999 7899999999999999999999999998765322
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.... ......++..|+|||...+..++.++|||||||++||+++ |..||.+.... .....+.. +.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~----~~------- 225 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED----GF------- 225 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC----CC-------
Confidence 2111 1112235678999999988999999999999999999775 99999764221 11111111 00
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122345677899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.78 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=202.6
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999854 68999999986543 233456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS----KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999998765 48899999999999999999999 889999999999999999999999999998653321
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..+.+...
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i~~~--------------- 213 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKILAG--------------- 213 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhC---------------
Confidence 22468999999999998889999999999999999999999997632211 11111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
....+..++..+.+++.+||+.||.+||+ ++|++++
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 ---KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00112223556889999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=374.83 Aligned_cols=504 Identities=29% Similarity=0.351 Sum_probs=290.3
Q ss_pred EcCCCCcccccCCCCCCCCCccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccC
Q 001710 58 NLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFT 137 (1022)
Q Consensus 58 ~L~~~~l~~~i~~~l~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 137 (1022)
|.+...+. .||..+..-..|+.|+++.|.+....-+.+.+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.+.
T Consensus 4 d~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~ 81 (1081)
T KOG0618|consen 4 DASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR 81 (1081)
T ss_pred ccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence 33444433 34444444444666666666554211223333444666666666665 55666666666666666666665
Q ss_pred CCcchhhcCccccceeeccCcccccccCCcc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCcccc
Q 001710 138 DRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG 216 (1022)
Q Consensus 138 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 216 (1022)
..|....++.+|++|.|..|.+. ..|..+ .+++|++|+++.|++. .+|..+..++.++.+..++|..... ++
T Consensus 82 -~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg 154 (1081)
T KOG0618|consen 82 -SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LG 154 (1081)
T ss_pred -hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hc
Confidence 45566666666666666666665 444444 4566666666666654 5566666666666666666622211 22
Q ss_pred CCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccE
Q 001710 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296 (1022)
Q Consensus 217 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~ 296 (1022)
... ++.++|..|.+.+.++..+..++. .|+|++|.++ -..+..+.+|+.|....|+++.. ....++|+.
T Consensus 155 ~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l-----~~~g~~l~~ 223 (1081)
T KOG0618|consen 155 QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL-----EISGPSLTA 223 (1081)
T ss_pred ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE-----EecCcchhe
Confidence 221 666666666666666666666655 5677777665 22344556666666666666521 123466777
Q ss_pred EEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcce
Q 001710 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTE 376 (1022)
Q Consensus 297 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~ 376 (1022)
|+.++|.++...+.. .-.+|+++|+++|++++ +|++++.+.+|+.++..+|+++.++. .+....+|+.
T Consensus 224 L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~~lp~---------ri~~~~~L~~ 291 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLVALPL---------RISRITSLVS 291 (1081)
T ss_pred eeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhcccceEecccchhHHhhHH---------HHhhhhhHHH
Confidence 777777776333222 22467777777777774 44777777777777777777654321 2333444455
Q ss_pred EecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCcccccccccc-cCceEEeecc
Q 001710 377 LALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ-QLQGLSLYDN 455 (1022)
Q Consensus 377 L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N 455 (1022)
|.+..|.+. -+|+..+.++.|++|+|..|+|....+..+.-.. +|..|+.+.|
T Consensus 292 l~~~~nel~--------------------------yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n 345 (1081)
T KOG0618|consen 292 LSAAYNELE--------------------------YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSN 345 (1081)
T ss_pred HHhhhhhhh--------------------------hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhc
Confidence 555544443 2345555667777777777777633332333222 3566666666
Q ss_pred CCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccCCccccccccceEeccCCcCCCCccc
Q 001710 456 DLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535 (1022)
Q Consensus 456 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 535 (1022)
++.......=...+.|+.|++.+|.++...-..+.++.+|+.|+|++|++.......+.++..|+.|+||+|+++. +|.
T Consensus 346 ~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~ 424 (1081)
T KOG0618|consen 346 KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPD 424 (1081)
T ss_pred cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhH
Confidence 6664333223345566666777777666555556666667777777776664333456666666666666666663 556
Q ss_pred ccccccccceeeccCccccCccccccccccccceecccCcccccC-CCcccccccccceeecccceeccccCchhhhccc
Q 001710 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGP-IPESFGSLISLESLDVSSNNISGKIPKSLEALLY 614 (1022)
Q Consensus 536 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 614 (1022)
.+..++.|+.|...+|+|. ..| ++..++.|+.+|+|.|+|+.. +|..... ++|++|||++|.-.-..-..|..+.+
T Consensus 425 tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~ 501 (1081)
T KOG0618|consen 425 TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKS 501 (1081)
T ss_pred HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhh
Confidence 6666666666666666665 555 666666666666666666632 2332222 56666666666533244455555556
Q ss_pred ccEEEccCC
Q 001710 615 LKKLNVSYN 623 (1022)
Q Consensus 615 L~~L~ls~N 623 (1022)
+...+++-|
T Consensus 502 l~~~~i~~~ 510 (1081)
T KOG0618|consen 502 LSQMDITLN 510 (1081)
T ss_pred hhheecccC
Confidence 666555555
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=336.35 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=204.2
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|++.++||+|+||+||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999854 689999999875432 233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++ +|.+++...+..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~----~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK----RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9985 9999988776668999999999999999999999 8899999999999999999999999999976533221
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--C-Ccchh----
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP--H-GLTEV---- 958 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~-~~~~~---- 958 (1022)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +......... . .+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccch
Confidence 2223467899999998765 5689999999999999999999999976432221 1111111000 0 01000
Q ss_pred -----ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -----VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+.... ..........+.+..+++.+|+++||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRA-QPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCC-CchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00011112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.53 Aligned_cols=269 Identities=22% Similarity=0.266 Sum_probs=203.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999954 689999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++ +++.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ----RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 58888887766668999999999999999999999 889999999999999999999999999997543222
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---cchh----
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEV---- 958 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 958 (1022)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|..||.+.......+........... +...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233568899999998755 45889999999999999999999999865333222222211110000 0000
Q ss_pred -ccc-ccc--c--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -VDA-NLV--G--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -~~~-~~~--~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.++ .+. . ...........+..+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000 0 000000111134567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=341.48 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=207.7
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||.||+++.. ++..||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999954 688999999876533 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++..... +++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhc---CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999987553 88999999999999999999982 259999999999999999999999999997653321
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch---------
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE--------- 957 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 957 (1022)
.....||..|+|||++.+..++.++||||+||++|||++|+.||...... .+..........+...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccc
Confidence 22346899999999999999999999999999999999999999653221 1211111110000000
Q ss_pred ----------------------hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 958 ----------------------VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 958 ----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
..+. +............++.++.+++.+||++||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDY-IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHH-HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000 0000000000113567899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.87 Aligned_cols=242 Identities=22% Similarity=0.258 Sum_probs=198.1
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997643 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~----~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 153 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHS----CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccc
Confidence 9999987655 48999999999999999999999 8899999999999999999999999999875322211 223
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 971 (1022)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ . ...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~---~---------------~~~ 213 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM---E---------------EIR 213 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHc---C---------------CCC
Confidence 356999999999999999999999999999999999999999652211 11111110 0 001
Q ss_pred hhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 972 AKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 972 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1233466789999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.07 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=210.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.+|+..+.||+|+||.||+|++. ++. .||+|+++... ....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 343 48999987543 33456788999999999999999999999765 4679
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
|+||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~----~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh----cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998877678999999999999999999999 8899999999999999999999999999987754
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...........++..|+|||...+..++.++||||||+++||+++ |+.||++.... .+........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----------- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC-----------
Confidence 443333233345678999999999999999999999999999998 99998753221 1122211110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
..+.+..++.++.+++.+||+.+|++||++.+++..+.++..+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11112334567899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=348.56 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeC
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNI 798 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~ 798 (1022)
...++|.+.++||+|+||.||+|+.. .+..||||+++... ....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34578899999999999999999742 13469999997543 233467889999999996 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHhhhcC---------------------------------------------------------
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN--------------------------------------------------------- 821 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 821 (1022)
...++||||+++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999886531
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 001710 822 --------------------------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNIL 863 (1022)
Q Consensus 822 --------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIl 863 (1022)
..+++..+..++.|++.|++|||+ .+|+||||||+||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~----~~ivH~dikp~Nil 269 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS----KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCChHhEE
Confidence 136778889999999999999999 78999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchh
Q 001710 864 LDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 942 (1022)
Q Consensus 864 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 942 (1022)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 99999999999999987644333222333456788999999988899999999999999999997 8999876432221
Q ss_pred HHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 943 LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
....+.. +. ....+..++.++.+++.+||+.||++||++.++.+.|+++.
T Consensus 349 ~~~~~~~----~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKS----GY-------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhc----CC-------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111 00 11122345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.79 Aligned_cols=256 Identities=27% Similarity=0.480 Sum_probs=209.7
Q ss_pred cCCCcCCeeecccceEEEEEEEcC------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFD------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
.+|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998432 2579999987543 233467889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC
Q 001710 803 LVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
++|||+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~----~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS----HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccccccceEEEcCC
Confidence 9999999999999997642 347888999999999999999999 889999999999999999
Q ss_pred CcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHH
Q 001710 868 MTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRW 946 (1022)
Q Consensus 868 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 946 (1022)
+.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999987644433333334456888999999888889999999999999999998 99998764322 12222
Q ss_pred HHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
+.... ....+..++.++.+++.+||+.||++||+++|++++|+++
T Consensus 239 i~~~~-----------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSRQ-----------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCC-----------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11110 0112345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.86 Aligned_cols=246 Identities=25% Similarity=0.273 Sum_probs=202.7
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357889999999999999999954 68999999987543 23346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~----~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLHS----KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999987653 7888999999999999999999 88999999999999999999999999999876432
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ....... .+ .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~-~~-------~-- 231 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKIL-AG-------R-- 231 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHHh-cC-------C--
Confidence 2 1246899999999999999999999999999999999999999653211 1111110 00 0
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
...+..++.++.+++.+||+.||.+||+ +++++++
T Consensus 232 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 -----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111223456889999999999999997 6888765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.57 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=205.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999955 58999999997653 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHE----LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997655 48899999999999999999999 8899999999999999999999999999976533
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ....... .. .... .+...
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~-~~-~~~~---~~~~~- 223 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY-WK-ETLQ---RPVYD- 223 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh-cc-cccc---CCCCC-
Confidence 2233568999999999998899999999999999999999999997632221 1111110 00 0000 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....++.++.+++.+||..+|++||++.+++++
T Consensus 224 -----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 -----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0012346678999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.31 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=214.0
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe-eEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF-KALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv 804 (1022)
.++|..++++|+|+||.++.++. .+++.||+|.+..+. +...+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46788999999999999999984 467899999887654 3344577899999999999999999999999888 9999
Q ss_pred EEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 805 LEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
|+|++||++.+.+.+.+ ..+++..+..++.|++.|+.|||+ ..|+|||||+.||+++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~----~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE----NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh----hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999988766 679999999999999999999998 6799999999999999999999999999999876
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
... .....+||+.|++||.+.+.+|..|+||||+||++|||++-+++|.+.... ..+....+..
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~ki~~~~--------- 222 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILKINRGL--------- 222 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHHHhhcc---------
Confidence 542 234468999999999999999999999999999999999999999863211 1111111110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+.+..++.++..+|..|++.+|+.||++.+++.+
T Consensus 223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 124456678899999999999999999999999987
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.72 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=210.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC----CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.++|++.+.||+|+||+||+|++.. ...||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568899999999999999998642 4579999987554 3344678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++++|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++++|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~----~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE----MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999998766678999999999999999999999 7899999999999999999999999999988753
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...........++..|+|||...+..++.++||||||+++||+++ |..||......+ .........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~----------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGY----------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC-----------
Confidence 222222223345678999999998899999999999999999998 999986532221 111111110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.59 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=207.3
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEee-C
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCN-I 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-~ 798 (1022)
+.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++++ +|+||++++++|.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457999999999999999999632 35789999987543 23345678899999999 89999999998865 4
Q ss_pred CeeEEEEEccCCCCHHHHhhhcC---------------------------------------------------------
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN--------------------------------------------------------- 821 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 821 (1022)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56789999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcc
Q 001710 822 ---YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898 (1022)
Q Consensus 822 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~ 898 (1022)
..+++..+..++.||+.|++|||+ .+|+||||||+||++++++.++|+|||++..+.............++..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~----~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS----RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 147899999999999999999999 8899999999999999999999999999987644333333333456778
Q ss_pred cCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHH
Q 001710 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCL 977 (1022)
Q Consensus 899 y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 977 (1022)
|+|||++.+..++.++||||+||++|||++ |..||.+....+ .+........ . ...+..++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~-------------~~~~~~~~ 302 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----R-------------MRAPEYAT 302 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----C-------------CCCCccCC
Confidence 999999999999999999999999999998 999987532221 1111111100 0 01122345
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 978 LSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 978 ~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
.++.+++.+||+.+|++||++.|++++|+++.+
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=350.52 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=212.3
Q ss_pred cCCCcCCeeecccceEEEEEEEcCC-CEEEEEEecchhhhhHHHHHHHHHHHhhcC-CCcceeEeee-Eee------CCe
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDG-TNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSS-CCN------IDF 800 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~------~~~ 800 (1022)
.++++.++|.+|+|+.||.|+...+ .+||+|++-...+...+.+.+|+++|+.|+ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567779999999999999996655 999999988887888889999999999996 9999999993 221 246
Q ss_pred eEEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
.+|.||||.||.|-|++..+-. .+++.++++|++|+++|+++||... .+|||||||-+|||+..+|..||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~--pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK--PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC--CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 7899999999999999985432 4999999999999999999999854 679999999999999999999999999997
Q ss_pred ecCCCCCcee-------eecccCCcccCCcc---ccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh
Q 001710 880 LLGEGDDSVT-------QTITMATIGYMAPE---YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 880 ~~~~~~~~~~-------~~~~~gt~~y~aPE---~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 949 (1022)
..-....... .-...-|+.|+||| +..+..++.|+|||++||++|-|+....||++...-
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 5422221100 00124689999999 467888999999999999999999999999863111
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
.+++.. ..++..+.++..+.+||+.||++||++||++-+++.++.++..+-+
T Consensus 265 -------aIlng~-----Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 -------AILNGN-----YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -------eEEecc-----ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 112222 2344446788999999999999999999999999999999876544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.50 Aligned_cols=268 Identities=21% Similarity=0.218 Sum_probs=203.4
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999964 68899999987543 2334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++++.+..+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~----~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHK----NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999877765544 33458999999999999999999999 8899999999999999999999999999987643222
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh--hcCCC----------
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE--SLPHG---------- 954 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~---------- 954 (1022)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....... ..+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccch
Confidence 122234689999999999888899999999999999999999999976332211 1111000 00000
Q ss_pred cchhccccccc-hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEVVDANLVG-EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+.... ..........++.++.+++++||++||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 000011112356779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=341.92 Aligned_cols=246 Identities=24% Similarity=0.268 Sum_probs=201.9
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-C-CCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-D-GTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.++|++.+.||+|+||.||+|+.. + +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999844 3 3689999986542 2334567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQS----LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999987654 8899999999999999999999 8899999999999999999999999999987643
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...... .+ .
T Consensus 184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~-----~~-------~- 244 (340)
T PTZ00426 184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKIL-----EG-------I- 244 (340)
T ss_pred Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHh-----cC-------C-
Confidence 21 23468999999999988889999999999999999999999997532211 111111 00 0
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
...+...+..+.+++.+|++.||++|+ ++++++++
T Consensus 245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011222345678999999999999995 89988876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=315.80 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=215.2
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
-|+++.+||+|+||.||+|.+ ..|+.+|+|.+..+. ....+..|+.+|++++.|++|++||.|......++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 377889999999999999984 469999999987653 35678889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
.|+..|.++.+...+++.++..|++..++||+|||. ..-+|||||+.|||+.-+|.+|++|||.|..+.. ....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~----~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK 185 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD----LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK 185 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH----HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence 999999999999999999999999999999999999 5678999999999999999999999999976532 2233
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
.....||+.|||||++..-.|..++||||+|++..||..|++||.+......-+ .--..+.+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----------------MIPT~PPPT 248 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----------------MIPTKPPPT 248 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----------------eccCCCCCC
Confidence 445789999999999999999999999999999999999999998754432100 001123455
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+..|+..+.++.+++++|+-+.|++|-|+-+++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 66778889999999999999999999999998876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.57 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=211.4
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||+|+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457888999999999999999742 34568999987665556678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcE
Q 001710 803 LVLEFMPNGSFEKWLYSYN------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTA 870 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~ 870 (1022)
+||||+++++|.+++...+ ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~----~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS----QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeecccCcceEEEccCCcE
Confidence 9999999999999997543 248999999999999999999999 889999999999999999999
Q ss_pred EEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHh
Q 001710 871 HVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 871 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 949 (1022)
||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999986644332222233445778999999988899999999999999999998 889986543221 1111111
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
.. . ...+..++.++.+++.+||+.||.+||++.|+.+.|+++...
T Consensus 238 ~~---~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 GR---V--------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CC---c--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 0 001122456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=354.74 Aligned_cols=251 Identities=22% Similarity=0.216 Sum_probs=204.8
Q ss_pred CCCcCCeeecccceEEEEEEEc-C-CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-D-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999743 4 6789999876665555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 809 PNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 809 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~----~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS----RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh----CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988642 3358899999999999999999999 889999999999999999999999999998765433
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~~---------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLYGKY---------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCC----------
Confidence 222233456999999999999999999999999999999999999999753221 11111110000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.+..++.++.+++.+||+.||++||++.+++.+
T Consensus 289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01122345678999999999999999999998754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.06 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=203.8
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
++|++.+.||+|+||.||+|+.+++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4588889999999999999998888899999876442 223578889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|+|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+|++|||.++....... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER----NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH----CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 999999998655568999999999999999999999 7899999999999999999999999999986533222 11
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~---------------- 219 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR---------------- 219 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC----------------
Confidence 122335668999999988889999999999999999999 8999865321 111111111100
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
...+...+..+.+++.+||+++|++||+++|+++.|
T Consensus 220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 001112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.82 Aligned_cols=257 Identities=29% Similarity=0.472 Sum_probs=213.1
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++..+|++.++||+|+||.||+|+..+++.+|+|++..........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45567899999999999999999987799999999987665556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|+++++|.+++... +..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~----~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE----QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999764 3458999999999999999999999 889999999999999999999999999998764322
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.. .....++..|+|||...+..++.++||||||+++|+|++ |+.||......+ .........
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~------------- 221 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAGY------------- 221 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhCC-------------
Confidence 21 123346678999999888889999999999999999998 899986533211 111111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++..+.+++.+||+.||++|||++++.+.|+.+
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0112234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.67 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=197.8
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~----~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 153 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence 9999887654 48999999999999999999999 8899999999999999999999999999875322211 222
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 971 (1022)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~-------------------~~ 213 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEE-------------------IR 213 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC-------------------CC
Confidence 346899999999999999999999999999999999999999753211 1111111100 01
Q ss_pred hhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 972 AKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 972 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1233466789999999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.44 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=206.7
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
++|++.+.||+|+||+||+|++. +++ .||+|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56888899999999999999853 454 47888775432 2334667788889999999999999998764 45678
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
++||+++|+|.+++......+++..+..++.||+.|++|||+ .+++||||||+||++++++.+||+|||.++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE----HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH----CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999998776678999999999999999999999 8899999999999999999999999999987644
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...........++..|+|||...++.++.++||||||+++||+++ |..||.+.... ...+++....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGE----------- 228 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC-----------
Confidence 333333334457788999999988899999999999999999998 99998764221 1222221110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
....+..++.++.+++.+||..||++||++.|+++.++.+.++
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0011122455678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.80 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=212.2
Q ss_pred CCCcCCeeecccceEEEEEEEcC--C--CEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFD--G--TNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+....++||+|+||+|++|.|.. | ..||||+++..... ...+|.+|+.+|.+|+|+|++++||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34456889999999999998653 4 35899999877644 56889999999999999999999999987 5678999
Q ss_pred EccCCCCHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 806 EFMPNGSFEKWLYS-YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 806 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|.++.|+|.+.+++ ....+.......++.|||.|+.||.. ++.||||+.++|+++-....|||+|||+.+-++..
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes----krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES----KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh----hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999998 45578889999999999999999999 77999999999999999999999999999988766
Q ss_pred CCceeee-cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 885 DDSVTQT-ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 885 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
+....+. ...-...|+|||.+....++.++|||+|||++|||+| |..||-+..... +.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------IL~~iD-- 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------ILKNID-- 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------HHHhcc--
Confidence 5544433 3345678999999999999999999999999999999 678886632211 111122
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
...+++.++.|+++++++|.+||.++|++||+|..+.+.+-.
T Consensus 330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 334677889999999999999999999999999999855443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.27 Aligned_cols=256 Identities=31% Similarity=0.482 Sum_probs=207.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
..+|.+.+.||+|+||.||+|+.. +++.||+|+++..... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346888899999999999999853 2478999998765443 457889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 802 ALVLEFMPNGSFEKWLYSYN-------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
++||||+++++|.+++...+ ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~----~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS----QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh----CCeeccccccceEEEcCCC
Confidence 99999999999999997643 247888999999999999999999 7899999999999999999
Q ss_pred cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH
Q 001710 869 TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 947 (1022)
.+||+|||++................+++.|+|||++.+..++.++||||+||++|||++ |..||......+ .....
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence 999999999986544332222233446788999999999999999999999999999998 999986532211 11111
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.. +. ....+..++..+.+++++||+.||++||++.|+++.|++
T Consensus 238 ~~----~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQ----GR-------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred Hc----CC-------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 00 001112346678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.12 Aligned_cols=242 Identities=22% Similarity=0.275 Sum_probs=198.1
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 468999999997543 234467788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~----~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHS----GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9999887654 48999999999999999999999 889999999999999999999999999987542221 1223
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 971 (1022)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~---------------~~~ 213 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME---------------DIK 213 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC---------------Ccc
Confidence 356899999999999889999999999999999999999999753211 111111100 001
Q ss_pred hhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 972 AKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 972 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.+..++.++.+++.+||++||++|| ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223456789999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=365.76 Aligned_cols=484 Identities=28% Similarity=0.350 Sum_probs=397.6
Q ss_pred EEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCccccceeeccCcc
Q 001710 80 SLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENS 159 (1022)
Q Consensus 80 ~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 159 (1022)
.+|++..++. .||..+..-..|+.|+++.|.+-...-+.+.+..+|+.|||++|++. ..|..+..+++|+.|++++|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 4688888888 89988877777999999999876433445556667999999999998 789999999999999999999
Q ss_pred cccccCCccccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhh
Q 001710 160 LSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAI 239 (1022)
Q Consensus 160 l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 239 (1022)
+.........+.+|++|.|.+|.+. ..|.++..+.+|++|+++.|++. .+|..+..+..+..+..++|... ..+
T Consensus 80 i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~l 153 (1081)
T KOG0618|consen 80 IRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRL 153 (1081)
T ss_pred HhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhh
Confidence 9855433447899999999999987 78999999999999999999998 78999999999999999999322 223
Q ss_pred cCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccc
Q 001710 240 GNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLI 319 (1022)
Q Consensus 240 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 319 (1022)
+... .+.++|..|.+.+.++..+..+.. .|+|.+|.+. ..... .+++|+.|....|++.... -.-++|+
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dls---~~~~l~~l~c~rn~ls~l~----~~g~~l~ 222 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDLS---NLANLEVLHCERNQLSELE----ISGPSLT 222 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhhh---hccchhhhhhhhcccceEE----ecCcchh
Confidence 3333 888999999999888888888777 7999999987 33332 4678999999999887432 2347889
Q ss_pred eeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCcccccccccc
Q 001710 320 GLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASL 399 (1022)
Q Consensus 320 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L 399 (1022)
.|+.++|.+....+ . ..-.+|+++++++|+++.++ +-...|.+|+.+....|.+.
T Consensus 223 ~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~~lp---------~wi~~~~nle~l~~n~N~l~-------------- 277 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLSNLP---------EWIGACANLEALNANHNRLV-------------- 277 (1081)
T ss_pred eeeeccCcceeecc-c-cccccceeeecchhhhhcch---------HHHHhcccceEecccchhHH--------------
Confidence 99999999883322 2 23467899999999998865 22677889999999888875
Q ss_pred chhccccccccccCCccccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccc-cceeecCC
Q 001710 400 RKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLER-LSQLLLNG 478 (1022)
Q Consensus 400 ~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~ 478 (1022)
.+|..+...++|++|.+.+|.+. -+|.....+++|++|+|..|+|...++..+.-+.. |..|+.+.
T Consensus 278 ------------~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~ 344 (1081)
T KOG0618|consen 278 ------------ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSS 344 (1081)
T ss_pred ------------hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhh
Confidence 46778888999999999999999 67888888999999999999999555544444444 88889999
Q ss_pred ccccCccccccc--CccccceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCc
Q 001710 479 NNLSGAIPACLG--SLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD 556 (1022)
Q Consensus 479 N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 556 (1022)
|++.. .| .++ .+..|+.|++.+|+++...-..+.+...|+.|+|++|+|...+...+.++..|++|+||+|+|+ .
T Consensus 345 n~l~~-lp-~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~ 421 (1081)
T KOG0618|consen 345 NKLST-LP-SYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T 421 (1081)
T ss_pred ccccc-cc-cccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence 99984 34 333 4678999999999999888888999999999999999999877778899999999999999998 8
Q ss_pred cccccccccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCcc
Q 001710 557 IPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625 (1022)
Q Consensus 557 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 625 (1022)
+|.++..+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+-..-.....-++|++|||+||..
T Consensus 422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8999999999999999999999 677 799999999999999999854333333338999999999974
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.23 Aligned_cols=255 Identities=22% Similarity=0.403 Sum_probs=208.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 467899999999999999999987888999998865432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++++|.+++... ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||.+.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~----~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER----KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998754 3458899999999999999999999 78999999999999999999999999999876433221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||+..+..++.++|||||||++|||++ |+.||.+.... .....+....+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR-------------- 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1222335678999999988889999999999999999998 99998653221 11121111110
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
.+....++.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=336.61 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=204.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|++.++||+|+||.||+|+.. ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999854 68899999887653 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++...+. +++..+..++.|++.|+.|||+. .+|+||||||+||++++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999987553 88999999999999999999972 369999999999999999999999999987653221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc----------
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT---------- 956 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 956 (1022)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...............
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccCC
Confidence 22346899999999999888999999999999999999999999753221 111111100000000
Q ss_pred -------------------hhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 -------------------EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+.......+.. ....++.++.+++.+||++||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000000 001135678999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=327.25 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=206.5
Q ss_pred cCCCcCCeeecccceEEEEEEE-----cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-----FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
++|++.+.||+|+||+||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999973 246789999987543 3344678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC
Q 001710 804 VLEFMPNGSFEKWLYSYN----------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~----~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS----HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh----cCeehhccccceEEEcCC
Confidence 999999999999985322 247888999999999999999999 789999999999999999
Q ss_pred CcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHH
Q 001710 868 MTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRW 946 (1022)
Q Consensus 868 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 946 (1022)
+.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.+... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999987644333233333446778999999988889999999999999999999 8889865321 112222
Q ss_pred HHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
+..... ...+..++.++.+++.+||+.||++||++.++.++|+++
T Consensus 239 ~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 239 VRKRQL-----------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 211110 112234566789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=327.89 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=211.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.+|.+.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345699999876655555778899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 804 VLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+ ++|+||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~----~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS----QHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh----CCeeecccCcceEEEccCC
Confidence 999999999999997542 247899999999999999999999 8899999999999999999
Q ss_pred cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH
Q 001710 869 TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 947 (1022)
.++|+|||++................++..|+|||...+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999976544333222334456788999999988899999999999999999999 999986533221 11111
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
.... .. ..+..++..+.+++.+||+.||++||+++++++.|+++...
T Consensus 239 ~~~~---~~--------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGR---VL--------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCC---CC--------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1100 00 01122456789999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.44 Aligned_cols=248 Identities=27% Similarity=0.438 Sum_probs=200.2
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
++||+|+||.||+|+. .+++.||+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 478999999876443 33456788999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~----~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES----KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99998766668999999999999999999999 88999999999999999999999999998765432211111122
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSA 972 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 972 (1022)
..+..|+|||.+.++.++.++||||+|+++|||++ |..||....... ......... ....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~-----------------~~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGV-----------------RLPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCC-----------------CCCC
Confidence 23567999999988889999999999999999998 888886532211 111111100 0111
Q ss_pred hHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
+..++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2344667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.69 Aligned_cols=240 Identities=24% Similarity=0.250 Sum_probs=195.3
Q ss_pred eecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999854 68899999987542 23345678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHK----FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 99997754 48999999999999999999999 889999999999999999999999999997542222 122345
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
.||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .......... ...+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~---------------~~~~ 213 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEP---------------LRFP 213 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCC---------------CCCC
Confidence 6899999999999999999999999999999999999999753211 1111111100 1112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIH---MTDAAAE 1004 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 1004 (1022)
..++.++.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 334567899999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.24 Aligned_cols=257 Identities=28% Similarity=0.335 Sum_probs=209.8
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--------hhhHHHHHHHHHHHhhc-CCCcceeEeeeEe
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--------ERAFRTFDSECEILRNV-RHRNLVKIFSSCC 796 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~ 796 (1022)
..-..|...+.+|.|..++|.++. ..+|..+|+|++.... .+..+.-.+|+.+++++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 334567888999999999999887 4578999999986443 12234556799999999 6999999999999
Q ss_pred eCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 797 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
.+...++|+|.|+.|.|.|++...-. +++....+|++|+..|++|||. +.|||||+||+|||+|++..+||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylHa----~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLHA----RNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHHH----hhhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999999987654 8999999999999999999999 789999999999999999999999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCC------CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSE------GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
+|+.+.++.. -...+||++|+|||.+.- ..|+..+|+|+.|+++|.++.|.+||.- +....+-..+.+.
T Consensus 169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~ImeG 243 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIMEG 243 (411)
T ss_pred eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHHhc
Confidence 9998866543 344689999999996542 3588899999999999999999999864 2222222222221
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
..+ -..+.+.+.+....++|.+|+++||.+|.|++|++++=--
T Consensus 244 kyq--------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 244 KYQ--------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred ccc--------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 111 1223455677889999999999999999999999987443
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.44 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=209.2
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
..+|++.++||+|+||+||+|++ .+++ .||+|+++... ....+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35688899999999999999984 3454 48999986543 33456788899999999999999999998754 467
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
++|||+++|+|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~----~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH----CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999998766668999999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
............++..|+|||...+..++.++|||||||++||+++ |..||+.... .....++....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~---------- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE---------- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC----------
Confidence 4332222222345678999999988889999999999999999998 8899875322 22222222111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
..+.+..++.++.+++.+||+.||++||++.++++.++++..+.
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 -------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01112335667899999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=341.60 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=209.0
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcC-CCcceeEeeeEe
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVR-HRNLVKIFSSCC 796 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~ 796 (1022)
.+...++|.+.++||+|+||.||+|++. .+..||+|+++... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445567888999999999999999853 24679999997543 233457889999999997 999999999999
Q ss_pred eCCeeEEEEEccCCCCHHHHhhhcC-------------------------------------------------------
Q 001710 797 NIDFKALVLEFMPNGSFEKWLYSYN------------------------------------------------------- 821 (1022)
Q Consensus 797 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 821 (1022)
.....++||||+++|+|.++++..+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999996532
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 001710 822 ------------------------------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKP 859 (1022)
Q Consensus 822 ------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~ 859 (1022)
..+++..+..++.|++.|++|||+ .+|+||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~----~~ivHrdlkp 267 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS----KNCVHRDLAA 267 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc----CCcCcccCCc
Confidence 135777888999999999999999 7899999999
Q ss_pred CcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccc
Q 001710 860 NNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFT 938 (1022)
Q Consensus 860 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~ 938 (1022)
+||++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986543322222223356788999999988889999999999999999998 8889875432
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
.+. ....+.. +. +...+..++.++.+++.+||+.+|++||+++|+++.|+++.
T Consensus 348 ~~~-~~~~~~~----~~-------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ-FYNAIKR----GY-------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH-HHHHHHc----CC-------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 221 1111111 10 01122345678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=326.75 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=204.8
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998742 24679999886432 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEE
Q 001710 801 KALVLEFMPNGSFEKWLYSYNY---------FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH 871 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~k 871 (1022)
.++||||+++|+|.+++..... ..++..+..++.|++.|++|||+ .+++||||||+||++++++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA----NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999875321 35778899999999999999999 7899999999999999999999
Q ss_pred EeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhh
Q 001710 872 VSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 872 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.+.... .....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~- 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME- 236 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc-
Confidence 999999976544333222223345788999999988889999999999999999999 68888653221 11111111
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
... ...+..++..+.+++.+||+.||++||++.|+++.+++
T Consensus 237 --~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 --GGL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --CCc--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 01122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.15 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=204.5
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
++|++.+.||+|+||+||+|+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999997777789999887443 223568899999999999999999999999888999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|+|.+++......+++..++.++.||+.|++|||+ .+++|+||||+||+++.++.+||+|||.++....... ..
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES----KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 999999998765568999999999999999999999 8899999999999999999999999999986543321 11
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....++..|+|||...+..++.++||||||+++|||++ |..||...... ...........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---------------- 219 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR---------------- 219 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC----------------
Confidence 222335678999999988889999999999999999999 99998753321 11111111100
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
...+...+..+.+++.+||+++|++||++.++++.++
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=353.22 Aligned_cols=258 Identities=24% Similarity=0.284 Sum_probs=207.3
Q ss_pred HHHHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-
Q 001710 724 DIQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID- 799 (1022)
Q Consensus 724 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~- 799 (1022)
+.+...++|.+.+.||+|+||+||+|+ ..+|+.||||++.... ......+.+|+.++..++|++++++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 334456789999999999999999998 4579999999986542 334566788999999999999999988765432
Q ss_pred -------eeEEEEEccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc
Q 001710 800 -------FKALVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 800 -------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~----~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS----KHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEEeCCCC
Confidence 367999999999999998753 2358899999999999999999999 88999999999999999999
Q ss_pred EEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 949 (1022)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..++..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~ 256 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHK 256 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH
Confidence 999999999876543322233345799999999999999999999999999999999999999975321 112221
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...... .+.+..++.++.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~~--------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRY--------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCC--------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111100 01223456778999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.90 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=208.1
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..++|++.+.||+|+||.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3466888999999999999999977788999999875432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA----QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997654 458999999999999999999999 7899999999999999999999999999987653221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .......+..|+|||+..+..++.++||||||+++|||++ |+.||.+..... ....+....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~-------------- 221 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGY-------------- 221 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC--------------
Confidence 1 1111223457999999998899999999999999999999 999987532211 111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.47 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|+.+++.++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999985 468999999997653 234456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~----~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ----MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998875669999999999999999999999 889999999999999999999999999998765433
Q ss_pred CceeeecccCCcccCCccccC------CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 886 DSVTQTITMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.. ......||+.|+|||++. ...++.++||||+||++|||++|+.||.+....+ ........ ..
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~----- 226 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QR----- 226 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CC-----
Confidence 22 223346899999999876 4567899999999999999999999997532211 11111100 00
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+....++.++.+++..|++ +|++||++.+++++
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 -------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00011112345678999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=327.69 Aligned_cols=271 Identities=27% Similarity=0.403 Sum_probs=207.5
Q ss_pred cCCCcCCeeecccceEEEEEEE-----cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCeeE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-----FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFKA 802 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~ 802 (1022)
.+|++.+.||+|+||+||+|+. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999973 3578999999876666666788999999999999999999998754 34678
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~----~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS----KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH----CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999998766568999999999999999999999 889999999999999999999999999998764
Q ss_pred CCCCceee-ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC-CCc-chhc
Q 001710 883 EGDDSVTQ-TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-HGL-TEVV 959 (1022)
Q Consensus 883 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~-~~~~ 959 (1022)
........ ....++..|+|||...+..++.++||||+|+++|||++|..|+...... .......... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHH
Confidence 43322111 1122345699999998888999999999999999999987765432110 0000000000 000 0000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
+ .+ ......+.+..++.++.+++.+||.++|++|||+.|+++.|++++
T Consensus 237 ~-~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 E-LL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred H-HH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0 00 001112233456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.68 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=208.6
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|+. .+++.||||.++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999984 478999999875422 333456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 806 EFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
||+++|+|.+++.. ....+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||.+..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS----RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh----CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988853 23357899999999999999999999 889999999999999999999999999998764
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.... ......++..|+|||...+..++.++||||+|+++|||++|+.||.............+... ...
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~------ 226 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---DYP------ 226 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---CCC------
Confidence 3322 12234588899999998888899999999999999999999999865322211121111110 000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
......++..+.+++.+||+.+|++||++.++++.+++++
T Consensus 227 -------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 -------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011234567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=342.60 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=198.7
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.|++++.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588889999999999999984 568899999997543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||+++.++++||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH~----~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK----MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh----CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999977554 8888999999999999999999 8899999999999999999999999999864321000
Q ss_pred c---------------------------------------------eeeecccCCcccCCccccCCCCCCccchhHhHHH
Q 001710 887 S---------------------------------------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGV 921 (1022)
Q Consensus 887 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 921 (1022)
. ......+||+.|+|||.+.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0011246999999999998888999999999999
Q ss_pred HHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHh--hcccCCCCCCCHH
Q 001710 922 LLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALD--CCMESPEQRIHMT 999 (1022)
Q Consensus 922 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~ 999 (1022)
++|||++|+.||......+... .... ... .+ ..+....++.++.+++.+ |+..+|..||++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-~i~~--~~~--------~~-----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL-KVIN--WEN--------TL-----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH-HHHc--ccc--------cc-----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999997633221111 1000 000 00 011112245667888888 4556666799999
Q ss_pred HHHHH
Q 001710 1000 DAAAE 1004 (1022)
Q Consensus 1000 ell~~ 1004 (1022)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=336.91 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=198.0
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC-----CeeE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-----DFKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~~ 802 (1022)
+|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999984 468999999986432 22345678899999999999999999988543 2479
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||++ ++|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 589998876553 8999999999999999999999 889999999999999999999999999997653
Q ss_pred CCCC-ceeeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCc----
Q 001710 883 EGDD-SVTQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL---- 955 (1022)
Q Consensus 883 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 955 (1022)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ....+........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHH
Confidence 3221 112234568999999998765 678999999999999999999999997532211 1111111110000
Q ss_pred --------chhccccccch-hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 --------TEVVDANLVGE-EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 --------~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+....... .........++.++.+++.+||+.||++||+++|++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000111245678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.09 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=196.6
Q ss_pred CCeeecccceEEEEEEE----cCCCEEEEEEecchh----hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 735 CNLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQL----ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+++||+|+||.||+++. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999974 357899999987542 2233567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++...+. +.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 81 YLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQ----QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999999977654 7888888999999999999999 8899999999999999999999999999875432221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~~------------- 215 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILKG------------- 215 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcC-------------
Confidence 1223468999999999998889999999999999999999999997532211 11111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0111223456789999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.36 Aligned_cols=266 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred cCCCcCCeeecccceEEEEEEE-c-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhc---CCCcceeEeeeEee-----
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-F-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNV---RHRNLVKIFSSCCN----- 797 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~----- 797 (1022)
.+|++.+.||+|+||+||+|+. . +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 3 468899998865432 2234556677777766 69999999998852
Q ss_pred CCeeEEEEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 798 IDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~----~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS----HRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 446889999997 58999887543 358999999999999999999999 889999999999999999999999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc---CC
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL---PH 953 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~ 953 (1022)
+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|++||.+.... ..+........ +.
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 99876433 1223356899999999998888999999999999999999999999764322 12222221110 00
Q ss_pred Ccchhc---cccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 954 GLTEVV---DANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 954 ~~~~~~---~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.... ...+.. ..........++..+.+++.+|++.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 110000 000000 000001112356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.86 Aligned_cols=263 Identities=19% Similarity=0.208 Sum_probs=200.0
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..+|++.+.||+|+||.||+|+. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999984 568999999653 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+.......
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~----~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHE----NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 95 68888887654 48899999999999999999999 7899999999999999999999999999975432211
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccc------cchhHHHHHHhhc------CCCc
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT------GEMSLRRWVKESL------PHGL 955 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~------~~~~~~~~~~~~~------~~~~ 955 (1022)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+..+...+.... +...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 122234699999999999999999999999999999999999988643211 1111222211110 0000
Q ss_pred chhccccc----------cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 TEVVDANL----------VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 ~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..+ ......+......+.++.+++.+||+.||++|||++|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 00001111122356678999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.78 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=202.0
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999995 468999999997542 234456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~----~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK----LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999998755 48999999999999999999999 889999999999999999999999999997653221
Q ss_pred Cce------------------------------------eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcC
Q 001710 886 DSV------------------------------------TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 929 (1022)
Q Consensus 886 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg 929 (1022)
... .....+||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100 01123689999999999888999999999999999999999
Q ss_pred CCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 001710 930 KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH---MTDAAAE 1004 (1022)
Q Consensus 930 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 1004 (1022)
..||......+. ..... . .... + ..+....+++++.+++.+|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~~~~~~~-~~~i~-~-~~~~--------~-----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQET-YRKII-N-WKET--------L-----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHH-HHHHH-c-CCCc--------c-----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975322111 11110 0 0000 0 001111235678899999997 9999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.14 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=207.4
Q ss_pred CCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 235799998875542 334678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 804 VLEFMPNGSFEKWLYSYN-----------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
||||+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----~~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE----MKLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH----CCeehhhhhhh
Confidence 999999999999986431 247889999999999999999999 88999999999
Q ss_pred cEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCccccc
Q 001710 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTG 939 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~ 939 (1022)
||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999986543333222233345678999999888889999999999999999998 9999865321
Q ss_pred chhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 940 EMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
..+..+..... ....+..++.++.+++.+||+.+|++||+++|+++.|+++..+
T Consensus 236 -~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 -ERLFNLLKTGY-----------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHHHhCCC-----------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11222222111 0111234556789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.34 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=195.6
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHH---hhcCCCcceeEeeeEeeCCeeEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEIL---RNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66789999999999999985 468999999997543 22345566676665 466799999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++|+|..++... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~----~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHE----NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh----CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999988654 48999999999999999999999 88999999999999999999999999998753222
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. .......|++.|+|||.+.+..++.++||||+||++|||++|+.||......+ ........
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~--------------- 216 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVND--------------- 216 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC---------------
Confidence 1 12233568999999999999999999999999999999999999997532211 11111100
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 217 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ----EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011223466789999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.87 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=206.3
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.+|.+.++||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++|++|+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4578889999999999999985 458899999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~----~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK----KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999987643 358999999999999999999999 88999999999999999999999999999876443221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++|||||||++|||++ |..||...... ........ ..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~----~~----------- 222 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK----GY----------- 222 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC----CC-----------
Confidence 1112234568999999988899999999999999999998 88998653211 11111111 00
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
....+..++.++.+++.+||+.||++||++.++.+.|+.+
T Consensus 223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=337.98 Aligned_cols=248 Identities=27% Similarity=0.343 Sum_probs=195.4
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999854 689999999865433 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++|+|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHR----RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHH----CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999986532 25677888999999999999999 7899999999999999999999999999987643221
Q ss_pred eeeecccCCcccCCccccCC-----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 888 VTQTITMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+ ...........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~--------- 291 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS--------- 291 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc---------
Confidence 1223468999999997643 334578999999999999999999997322111 11111110000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+..++.++.++|.+||+.||++||++.|++++
T Consensus 292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123456678999999999999999999999986
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=326.23 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=205.8
Q ss_pred CC-CcCCeeecccceEEEEEEE-----cCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--Cee
Q 001710 731 GF-NECNLLGRGSFGLVYKGTL-----FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFK 801 (1022)
Q Consensus 731 ~~-~~~~~Lg~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 801 (1022)
+| ++.+.||+|+||+||++.. .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988652 3578899999876532 3346788899999999999999999988653 357
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++++|.+++.... +++.++..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++..+
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~----~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHS----QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHHH----CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 89999999999999997654 8999999999999999999999 78999999999999999999999999999876
Q ss_pred CCCCCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC-CCcchhc
Q 001710 882 GEGDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-HGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 959 (1022)
........ .....++..|+|||...+..++.++||||||+++|||++|..||............+...... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 54322111 112235667999999888889999999999999999999999986532221111110000000 0001111
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
+... ..+.+..++.++.+++.+||+++|++||+++++++.|+++.
T Consensus 238 ~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 11223456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=338.54 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=198.0
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|+.++++++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999984 468999999997543 233456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~----~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ----LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999998755 48999999999999999999999 889999999999999999999999999997653211
Q ss_pred Cc---------------------------------eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCC
Q 001710 886 DS---------------------------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932 (1022)
Q Consensus 886 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p 932 (1022)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001234699999999999999999999999999999999999999
Q ss_pred CCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcc--cCCCCCCCHHHHHHH
Q 001710 933 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCM--ESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~ell~~ 1004 (1022)
|.+....+ ....... . ... + ..+.....+.+..+++.+++. .++..||++.|++++
T Consensus 236 f~~~~~~~-~~~~i~~-~-~~~--------~-----~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQE-TYKKVMN-W-KET--------L-----IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHH-HHHHHHc-C-cCc--------c-----cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 97532221 1111110 0 000 0 001111234566778877554 233456899999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.76 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=206.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.+|...++||+|+||.||+++.. ++..+|+|.+........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 356899999876665666789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc
Q 001710 804 VLEFMPNGSFEKWLYSYN--------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
||||+++++|.+++...+ ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~----~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS----LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH----CCeecccccHhhEEEcCCCC
Confidence 999999999999997653 247899999999999999999999 88999999999999999999
Q ss_pred EEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHH
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 948 (1022)
+||+|||++..+.............+++.|+|||...+..++.++|||||||++|||++ |..||......+ ......
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH
Confidence 99999999976543332222223345778999999988899999999999999999998 889986532221 111111
Q ss_pred hhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
... ....+..++..+.+++.+||+.||.+||++.|+.+.|++
T Consensus 239 ~~~-----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGR-----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCc-----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 011123356678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.35 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=209.6
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEee
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCN 797 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 797 (1022)
....++|++.+.||+|+||.||+|+.. ....+|+|++.... .+....+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567889999999999999999853 23679999987543 33446688999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 001710 798 IDFKALVLEFMPNGSFEKWLYSY---------------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNI 862 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NI 862 (1022)
....++||||+++|+|.+++... ...+++..++.++.|++.|++|||+ .+|+||||||+||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~----~~ivH~dlkp~Ni 163 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS----KKCIHRDLAARNV 163 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH----CCccccccceeeE
Confidence 99999999999999999998642 2358899999999999999999999 8899999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccch
Q 001710 863 LLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 941 (1022)
Q Consensus 863 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 941 (1022)
+++.++.+||+|||.++.+.............++..|+|||...+..++.++|||||||++||+++ |..||......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 999999999999999987654433222223345678999999888899999999999999999998 889986532211
Q ss_pred hHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
......... ....+..++.++.+++.+||++||++|||+.|+++.|+++.
T Consensus 243 -~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGY-----------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111100 01112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=321.09 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
.+|++.+.||+|+||.||+|+..++..+|+|++..... ....+.+|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999977777899999864322 23467889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+++|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.++........ .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES----NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH----CCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 999999998766668999999999999999999999 88999999999999999999999999999865432211 1
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....++..|+|||...+..++.++||||||+++||+++ |+.||......+ ....+....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~----------------- 218 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGY----------------- 218 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCC-----------------
Confidence 111223457999999988899999999999999999999 789987532221 111111110
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
....+..++.++.+++.+||+.+|++||++.|+++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111223567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.33 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=211.3
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcC-----CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEee-CCe
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFD-----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDF 800 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~ 800 (1022)
..++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999998654 6889999887543 3345678899999999999999999998766 567
Q ss_pred eEEEEEccCCCCHHHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEe
Q 001710 801 KALVLEFMPNGSFEKWLYSYN-------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~ 873 (1022)
.++++||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK----RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH----CCEeecccCHhhEEEcCCCcEEEC
Confidence 899999999999999987642 358899999999999999999999 789999999999999999999999
Q ss_pred eccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcC
Q 001710 874 DFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLP 952 (1022)
Q Consensus 874 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 952 (1022)
|||+++.+.............++..|+|||...+..++.++||||+|+++||+++ |+.||..... ..+..+.....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~- 236 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY- 236 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC-
Confidence 9999986644332222223346778999999988889999999999999999999 9999975322 22222222111
Q ss_pred CCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 953 HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
....+..++.++.+++.+||+.||++||++.++++.|+++..+
T Consensus 237 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ----------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ----------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0111223456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.26 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=202.2
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.|++.++||+|+||+||++.. .+++.||+|++..... .....+.+|++++++++||+|+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999985 4689999999865431 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR----ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH----CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999886543 358999999999999999999999 789999999999999999999999999998754322
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+ .......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~-~~~~~~~----------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV-ERRVKED----------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-HHHhhhc-----------
Confidence 2 12346899999999998888999999999999999999999999753221 111111 1111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+..++..+.+++.+||+.||++|| ++.+++++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111233566789999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.42 Aligned_cols=252 Identities=23% Similarity=0.262 Sum_probs=199.6
Q ss_pred CCCcCCeeecccceEEEEEEE----cCCCEEEEEEecchh----hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCee
Q 001710 731 GFNECNLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQL----ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 801 (1022)
+|++.+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|+.+++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999974 357899999987542 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~----~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999876543 8899999999999999999999 88999999999999999999999999999865
Q ss_pred CCCCCceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ........... +
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~ 227 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------D 227 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------C
Confidence 433222 12234689999999988765 478999999999999999999999974322111 11111111000 0
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
...+...+..+.+++.+||+.||++|| ++++++++
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011223456788999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=332.69 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=198.0
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCC-CcceeEeeeEeeCCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRH-RNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+++++.++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888899999999999999854 57899999987643 2344667889999999976 56888999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~----~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHS----KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999876554 7899999999999999999999 889999999999999999999999999987532222
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+...
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~--------------- 216 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIMEH--------------- 216 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHcC---------------
Confidence 1 2233568999999999999999999999999999999999999997532211 11111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM-----TDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~ 1004 (1022)
....+...+.++.+++.+||++||.+|++. .++.++
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001112345678899999999999999976 565543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=342.00 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=205.6
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999954 68999999997543 234467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~----~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVHK----LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999998763 48999999999999999999999 899999999999999999999999999998764432
Q ss_pred ---------------------------CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccc
Q 001710 886 ---------------------------DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT 938 (1022)
Q Consensus 886 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~ 938 (1022)
.........||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00122335689999999999999999999999999999999999999976432
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-HHHHHHH
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-MTDAAAE 1004 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~~ 1004 (1022)
.+ ....... .... + ..+....++.++.+++.+|+. ||++||+ +.|++++
T Consensus 236 ~~-~~~~i~~--~~~~--------~-----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE-TYNKIIN--WKES--------L-----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HHHHHhc--cCCc--------c-----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 1111110 0000 0 011111146778999999998 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.50 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=204.7
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
.+++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467899999999999999999854 35679999886543 2334568889999999999999999999999889
Q ss_pred eEEEEEccCCCCHHHHhhhcCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC---cEE
Q 001710 801 KALVLEFMPNGSFEKWLYSYNY------FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM---TAH 871 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~---~~k 871 (1022)
.++||||+++++|.+++...+. .+++..+.+++.||+.|++|||+ .+++||||||+||+++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~----~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE----NHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEeecccchheEEEeccCCCcceE
Confidence 9999999999999999976532 48999999999999999999999 7899999999999998655 599
Q ss_pred EeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhh
Q 001710 872 VSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 872 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
|+|||+++................+..|+|||+..+..++.++|||||||++|||++ |..||......+ ....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~ 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGG 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence 999999987643322222222234568999999988899999999999999999997 999987532221 11111110
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
. ....+..++..+.+++.+||+.+|++||++.+++++|++
T Consensus 238 ~-----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 238 G-----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred C-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0 011123346678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.02 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=208.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEc--------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF--------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 798 (1022)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 457999999999999999999742 23569999997643 33456788899999999 799999999999999
Q ss_pred CeeEEEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNIL 863 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIl 863 (1022)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~----~gi~H~dlkp~Nil 172 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS----KKCIHRDLAARNVL 172 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH----CCcccccccHHheE
Confidence 99999999999999999997642 247889999999999999999999 88999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchh
Q 001710 864 LDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 942 (1022)
Q Consensus 864 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 942 (1022)
+++++.+||+|||.+................++..|+|||...+..++.++||||+||++|||++ |+.||..... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999976543222222222234568999999988889999999999999999998 8888865321 11
Q ss_pred HHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 943 LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
....+.... ....+..++.++.+++.+||..+|++||++.++++.|+++....
T Consensus 251 ~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHcCC-----------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111100 11122345678899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=339.61 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=202.7
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
..++|++.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456799999999999999999985 468899999986532 2233457789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++|+|.+++.... ++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH~----~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999987654 7888899999999999999999 8899999999999999999999999999987643
Q ss_pred CCCceeeecccCCcccCCccccCCC----CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~-------- 264 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKN-------- 264 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCC--------
Confidence 322 122345699999999987543 4789999999999999999999999753211 11111110000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~ 1004 (1022)
....+....++.++.+++.+|++.+|++ ||++.|++++
T Consensus 265 -------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0001111234667899999999999998 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.37 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=203.7
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999985 57889999998765544556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++.... .+++..+..++.|++.|++|||+ .+|+|||+||+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHS----KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987654 48999999999999999999999 8899999999999999999999999999987643221
Q ss_pred eeeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 888 VTQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
......++..|+|||.+. ...++.++||||+||++|||++|+.||......+. ...+... .+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~------------~~~ 227 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKS------------NFQ 227 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecC------------CCC
Confidence 122345888999999764 44578899999999999999999999864322111 0000000 000
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
. ........++..+.+++.+||+.+|++||+++++++++
T Consensus 228 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 P--PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00111123456789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.36 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=192.1
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999997653 22334456677777654 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~----~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK----KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999987655 48999999999999999999999 889999999999999999999999999997643322 222
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .... +... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~-i~~~------------------~~ 213 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDS-ILND------------------RP 213 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHcC------------------CC
Confidence 34568999999999999899999999999999999999999997532211 1111 1000 00
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMT-DAAA 1003 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~ 1003 (1022)
..+..++.++.+++.+||+.||++||++. ++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11223456788999999999999999875 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=335.19 Aligned_cols=243 Identities=22% Similarity=0.255 Sum_probs=196.9
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999997653 233456778999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 489999999999999999999962 5799999999999999999999999999875422221 122
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 971 (1022)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. . ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~---~---------------~~~ 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM---E---------------EIR 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhc---C---------------CCC
Confidence 346899999999999989999999999999999999999999753211 11111100 0 001
Q ss_pred hhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 972 AKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 972 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.+..++.++.+++.+||+.||++|+ ++++++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223456789999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=352.33 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=206.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.++||+|+||.||+|+.. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999854 68999999987542 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 806 EFMPNGSFEKWLYSY----------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
||++||+|.+++... ....++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs----~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS----KGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH----CCccccCCchheEEEcCCCCEEEEec
Confidence 999999999998642 1235677889999999999999999 88999999999999999999999999
Q ss_pred cCceecCCCCCc----------------eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccccc
Q 001710 876 GISKLLGEGDDS----------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939 (1022)
Q Consensus 876 G~a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~ 939 (1022)
|+++........ ......+||+.|+|||...+..++.++||||+||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999876211100 0111246899999999999999999999999999999999999999752221
Q ss_pred chhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhhHh
Q 001710 940 EMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-HMTDAAAELKKIRVK 1011 (1022)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~i~~~ 1011 (1022)
+.... ..... .........++..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 238 ki~~~----~~i~~-------------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYR----DVILS-------------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh----hhccC-------------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11100 00000 000111124456789999999999999996 567788888877554
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.70 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=203.3
Q ss_pred CCcCCeeecccceEEEEEEEc-C---CCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe-----
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-D---GTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF----- 800 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 800 (1022)
|++.+.||+|+||.||+|+.. + +..||+|+++.+. ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999853 2 3679999987543 2334678899999999999999999998866544
Q ss_pred -eEEEEEccCCCCHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEee
Q 001710 801 -KALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 801 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~----~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN----RNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh----CCeeccccchheEEECCCCeEEECC
Confidence 78999999999999988543 2358999999999999999999999 7899999999999999999999999
Q ss_pred ccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCC
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 875 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||.+.... ....+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~-- 232 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGN-- 232 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--
Confidence 999987654433222223345678999999988899999999999999999999 88888653222 1112111110
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
....+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234567889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.33 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=204.6
Q ss_pred hcCCCcCCeeecccceEEEEEEE------cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC-C
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI-D 799 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 799 (1022)
.++|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45799999999999999999973 346789999997543 23346788899999999 689999999988654 4
Q ss_pred eeEEEEEccCCCCHHHHhhhcC----------------------------------------------------------
Q 001710 800 FKALVLEFMPNGSFEKWLYSYN---------------------------------------------------------- 821 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 821 (1022)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 822 --------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 822 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS----RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 136788889999999999999999 88999999999999999999999999999865433222222223
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSA 972 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 972 (1022)
.++..|+|||...+..++.++||||||+++|||++ |..||......+. .......... ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~-----------------~~~ 303 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR-----------------MRA 303 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCC-----------------CCC
Confidence 45678999999888899999999999999999997 8899875322211 1111111000 011
Q ss_pred hHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
+..++.++.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 112345689999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.81 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=195.8
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 468899999997643 23345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~----~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence 99999887654 48999999999999999999999 8899999999999999999999999999875322111 12
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccccc---chhHHHHHHhhcCCCcchhccccccchh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG---EMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+..+.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------------- 220 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------------- 220 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-------------
Confidence 2356899999999999999999999999999999999999999642211 111111211111000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHM------TDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~ell~~ 1004 (1022)
....+..++.++.+++.+||+.||++||++ .+++++
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011223445678899999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=340.88 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=199.1
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999984 578999999986542 233466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~----~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHK----LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997654 48889999999999999999999 889999999999999999999999999996432110
Q ss_pred Cc---------------------------------------------eeeecccCCcccCCccccCCCCCCccchhHhHH
Q 001710 886 DS---------------------------------------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYG 920 (1022)
Q Consensus 886 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 920 (1022)
.. ......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124689999999999888999999999999
Q ss_pred HHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCC---CC
Q 001710 921 VLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR---IH 997 (1022)
Q Consensus 921 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps 997 (1022)
|++|||++|..||......+ ....... .... + ..+....++.++.+++.+|+. +|.+| ++
T Consensus 236 vil~elltG~~Pf~~~~~~~-~~~~i~~--~~~~--------~-----~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE-TYRKIIN--WRET--------L-----YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH-HHHHHHc--cCCc--------c-----CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999997532211 1111110 0000 0 001111235678899999998 67765 59
Q ss_pred HHHHHHH
Q 001710 998 MTDAAAE 1004 (1022)
Q Consensus 998 ~~ell~~ 1004 (1022)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.84 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=199.3
Q ss_pred CcCCeeecccceEEEEEEEcC-CC--EEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC------Cee
Q 001710 733 NECNLLGRGSFGLVYKGTLFD-GT--NVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI------DFK 801 (1022)
Q Consensus 733 ~~~~~Lg~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~ 801 (1022)
.+.++||+|+||.||+|+..+ +. .||+|.++... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998653 33 68999886542 34456788999999999999999999987432 246
Q ss_pred EEEEEccCCCCHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 802 ALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS----KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH----CCeeccccchhheEEcCCCCEEECCCC
Confidence 8999999999999987432 2347899999999999999999999 789999999999999999999999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCc
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGL 955 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 955 (1022)
+++.+.............+++.|+|||...+..++.++||||||+++|||++ |..||...... .....+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~---~- 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQG---N- 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC---C-
Confidence 9987654332222233346778999999999999999999999999999999 78888653221 111111110 0
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
....+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 232 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 -------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.91 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=210.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEE--------cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEee
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL--------FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCN 797 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 797 (1022)
..++|.+.+.||+|+||.||+|+. .++..||+|...... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 346688889999999999999973 124579999987543 34456788999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 001710 798 IDFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNI 862 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NI 862 (1022)
....++||||+++|+|.+++.... ..+++.++..++.||+.|++|||+ .+|+||||||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~----~givH~dlkp~Ni 168 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS----QKCIHRDLAARNV 168 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH----CCeeecccccceE
Confidence 999999999999999999997642 247888999999999999999999 8899999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccch
Q 001710 863 LLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 941 (1022)
Q Consensus 863 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 941 (1022)
++++++.+||+|||.++...............++..|+|||...+..++.++||||||+++||+++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 999999999999999987654333323333446678999999988889999999999999999998 78887653211
Q ss_pred hHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
.....+.... ....+..++..+.+++.+||+.+|++||++.|+++.|+++..-
T Consensus 247 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELFKLLKEGH-----------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHcCC-----------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111100 0111234567889999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.55 Aligned_cols=236 Identities=24% Similarity=0.296 Sum_probs=191.8
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 68899999987543 23445677888888877 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH~----~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLHD----KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT 153 (320)
T ss_pred chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence 999999876654 8999999999999999999999 8899999999999999999999999999875422211 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~---~~---------------~ 213 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILN---DE---------------V 213 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhc---CC---------------C
Confidence 3346899999999999989999999999999999999999999753221 11111110 00 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
..+..++.++.+++.+|++.||++||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1112245678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.67 Aligned_cols=245 Identities=25% Similarity=0.335 Sum_probs=205.1
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHH
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFE 814 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~ 814 (1022)
-+||+|.||+||.|+.. +...+|||-+.....+......+|+...++++|+|||+++|.+.+.++.-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999954 56678999988776777788999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec-CCCcEEEeeccCceecCCCCCceeee
Q 001710 815 KWLYSYNYFL--DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQT 891 (1022)
Q Consensus 815 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~ 891 (1022)
+.++..-.++ .+.+.-.+.+||++||.|||+ ..|||||||-+||||. -.|.+||+|||-+++...- ..-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe----n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE----NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh----cceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9999876656 778888899999999999999 6799999999999996 6789999999999876332 22233
Q ss_pred cccCCcccCCccccCCCC--CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 892 ITMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
...||..|||||++..++ |+.++|||||||++.||.||++||.++......+.+.-.-. ..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----------------vH 797 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----------------VH 797 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----------------cC
Confidence 456999999999887654 89999999999999999999999988655543332211100 12
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
-+.|+..+.+..++|.+|+.+||.+||+++++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2345677888999999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.83 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=196.7
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|+||.||+|+. .+++.||+|+++... ....+.+.+|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 468899999997643 23345678899999998 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHE----RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence 99999887654 48999999999999999999999 8899999999999999999999999999875322111 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccc---hhHHHHHHhhcCCCcchhccccccchh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE---MSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+ .....+..+.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------- 220 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------------- 220 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------------
Confidence 33568999999999999999999999999999999999999997422111 11111211111000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCC------HHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIH------MTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~ell~~ 1004 (1022)
....+..++.++.+++.+||+.||.+||+ +.+++++
T Consensus 221 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 -QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 01112334567899999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.17 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=207.0
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CC---CEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DG---TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.+|++.+.||+|+||.||+|+.. ++ ..||||+++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35778899999999999999854 33 369999987653 34456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+|++|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~----~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE----MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999998766668999999999999999999999 88999999999999999999999999998766443
Q ss_pred CCceeeeccc---CCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 885 DDSVTQTITM---ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 885 ~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
.......... .+..|+|||...+..++.++||||+||++||+++ |..||..... .....++....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~--------- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY--------- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC---------
Confidence 2221111111 2457999999998899999999999999999886 9999875322 12222221110
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+.+++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112234567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.12 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=196.1
Q ss_pred eecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||+||+++. .+++.||+|++..... ...+.+..|+++++.++|++|+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 4789999999875432 2335677899999999999999999999999999999999999999
Q ss_pred HHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 814 EKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 814 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+..+...... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ----RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 988753 23358999999999999999999999 88999999999999999999999999999876443221 2
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ............ ..
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~---------------~~ 218 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND---------------SV 218 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc---------------CC
Confidence 23468999999999999999999999999999999999999997532211 111111110000 01
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
..+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12234567789999999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.84 Aligned_cols=242 Identities=23% Similarity=0.259 Sum_probs=195.5
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.++++.+ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 57899999987653 23345677889998876 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHR----HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT 153 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence 99999987655 38899999999999999999999 8899999999999999999999999999976432221 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~----~~---------------~ 213 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILH----DD---------------V 213 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHc----CC---------------C
Confidence 33468999999999998899999999999999999999999997632211 1111110 00 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCC-------CHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRI-------HMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~ell~~ 1004 (1022)
..+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01122356788999999999999999 77887765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.77 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=204.2
Q ss_pred CCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
+|++.+.||+|+||.||+|+.. ++..||+|+++..... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677789999999999999843 2478999999755432 34568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 804 VLEFMPNGSFEKWLYSY---------------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
++||+++++|.+++... ...+++..+..++.|++.|++|+|+ .+|+||||||+||++++++
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~----~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS----HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH----cCccccccchhheEecCCC
Confidence 99999999999998532 1247888899999999999999999 8899999999999999999
Q ss_pred cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH
Q 001710 869 TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 947 (1022)
.+||+|||+++...............+++.|+|||...++.++.++||||+||++|||++ |..||.+.... .+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 999999999886644333222333456788999999888889999999999999999998 77887653221 111
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
....... ....+.+++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 237 ~~i~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ--------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC--------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111110 011234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.20 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=211.8
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhh---hHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER---AFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 802 (1022)
....|++.+.||+|.||.||+++.+ +|+.+|+|++.+.... ..+.+.+|+++|+++. |||||.+++++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999955 5999999999766432 3467889999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC----CCcEEEeeccCc
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE----NMTAHVSDFGIS 878 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~----~~~~kl~DfG~a 878 (1022)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+ .||+|||+||+|+|+.. ++.+|++|||+|
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~----~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS----LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh----CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999887 38999999999999999999999 89999999999999963 357999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
.+... .......+||++|+|||++....|+.++||||+|+++|.|++|.+||.+....+... ....... +
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~~-----~- 256 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGDF-----D- 256 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCCC-----C-
Confidence 98765 224455789999999999999999999999999999999999999998744333222 1111100 0
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+.....+....++++.|+..||.+|+++.++++|
T Consensus 257 ---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 ---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1112334557788999999999999999999999996
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.99 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=197.5
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.|+++++||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999984 468899999987543 3345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~----~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK----MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997754 47888899999999999999999 7899999999999999999999999999753311000
Q ss_pred ---------------------------------------------ceeeecccCCcccCCccccCCCCCCccchhHhHHH
Q 001710 887 ---------------------------------------------SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGV 921 (1022)
Q Consensus 887 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 921 (1022)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011246899999999999989999999999999
Q ss_pred HHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC---H
Q 001710 922 LLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH---M 998 (1022)
Q Consensus 922 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~ 998 (1022)
++|||++|+.||......+. ...... ... .. ..+.....+++..+++.+|+ .+|++|++ +
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~--~~~--------~~-----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-QMKVIN--WQT--------SL-----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-HHHHHc--cCC--------Cc-----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999976332211 111110 000 00 01111223556778888876 59999997 8
Q ss_pred HHHHHH
Q 001710 999 TDAAAE 1004 (1022)
Q Consensus 999 ~ell~~ 1004 (1022)
.|++++
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=341.63 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=198.9
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999984 468999999986542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+|..+.....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~----~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK----MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999998765 37888889999999999999999 8899999999999999999999999999853311000
Q ss_pred -----------------------------------------ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHH
Q 001710 887 -----------------------------------------SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 925 (1022)
Q Consensus 887 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~e 925 (1022)
.......+||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112469999999999999999999999999999999
Q ss_pred HHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC---CHHHHH
Q 001710 926 TFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI---HMTDAA 1002 (1022)
Q Consensus 926 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ell 1002 (1022)
|++|+.||......+... . +. ..... + ..+....++.++.+++.+|+ .+|.+|+ ++.|++
T Consensus 237 ll~G~~Pf~~~~~~~~~~-~-i~-~~~~~--------~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAETQL-K-VI-NWETT--------L-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHHHHH-H-Hh-ccCcc--------c-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999997643221111 0 00 00000 0 00111224556788888876 5999999 899998
Q ss_pred HH
Q 001710 1003 AE 1004 (1022)
Q Consensus 1003 ~~ 1004 (1022)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.06 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=201.9
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999954 68899999986532 22345678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++|+|.+++.... +++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH~----~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHS----MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999997654 7889999999999999999999 88999999999999999999999999999876
Q ss_pred CCCCCceeeecccCCcccCCccccCCC----CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~----- 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNS----- 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCcc-----
Confidence 43222 122345699999999987653 3788999999999999999999999753221 111111110000
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~ 1004 (1022)
+ ..+.....+..+.+++..|+..+|.+ |+++.|++++
T Consensus 266 -----~-----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 -----L-----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----c-----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01111234566789999999865544 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.98 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=195.7
Q ss_pred eecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 4689999999865321 1234456799999999999999999999999999999999999999
Q ss_pred HHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeec
Q 001710 814 EKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892 (1022)
Q Consensus 814 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 892 (1022)
.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS----MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH----CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98886543 358899999999999999999999 899999999999999999999999999998764332 2223
Q ss_pred ccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhh
Q 001710 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSA 972 (1022)
Q Consensus 893 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 972 (1022)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...... .............. .. ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~------~~ 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------VK------FE 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------cc------cc
Confidence 46899999999998888999999999999999999999999753221 11111111111100 00 00
Q ss_pred hHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
...++.++.+++.+||++||++||+++|+++.+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1234567899999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.82 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=195.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--------
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-------- 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-------- 798 (1022)
...+|++.++||+|+||.||+|+. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999985 468999999885432 2335699999999999999998876432
Q ss_pred CeeEEEEEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-cEEEee
Q 001710 799 DFKALVLEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSD 874 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~D 874 (1022)
...++||||+++ ++.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~----~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS----KFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCEecCCcCHHHEEEcCCCCceeeec
Confidence 246789999986 67776653 33468999999999999999999999 8899999999999999665 799999
Q ss_pred ccCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCC
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 875 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
||+|+.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+....+ .+..........
T Consensus 215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTP 290 (440)
T ss_pred cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Confidence 999987643322 123468999999998765 468999999999999999999999997643221 222222111100
Q ss_pred Ccchh--cc--------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 954 GLTEV--VD--------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 954 ~~~~~--~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..... .. +......-....+...+.++.+++.+||++||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 00 00111111111223356788999999999999999999999866
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.53 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=195.1
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999854 57899999987643 22334566788888877 5899999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999876554 8899999999999999999999 889999999999999999999999999997543222
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~---~----------- 217 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEH---N----------- 217 (323)
T ss_pred C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---C-----------
Confidence 1 223356899999999999999999999999999999999999999763221 111111110 0
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
...+...+.++.+++.+|++.||++|+++
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.44 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=208.6
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999984 579999999876432 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 806 EFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
||+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++++|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS----RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864 23358999999999999999999999 889999999999999999999999999987664
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
..... .....++..|+|||...+..++.++||||+|+++|||++|..||....... ..+.+....... +
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~- 226 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEQCDY-----P- 226 (267)
T ss_pred cCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhhhhcCCC-----C-
Confidence 33221 223458889999999988889999999999999999999999986432221 111111100000 0
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
......++.++.+++.+||+.||++|||+.+|++.++++.
T Consensus 227 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 -------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0011235667999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.46 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=205.8
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
..++|++.++||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 245799998764432 233467889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEE
Q 001710 801 KALVLEFMPNGSFEKWLYSYN---------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH 871 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~k 871 (1022)
.++||||+++|+|.+++.... ...++..+..++.|++.|+.|||+ ++|+||||||+||++++++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA----KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999997532 234677888999999999999999 8899999999999999999999
Q ss_pred EeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhh
Q 001710 872 VSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 872 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
++|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||...... ++.+..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~ 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFV 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence 999999986544332222223345678999999988899999999999999999999 78888653221 111111
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
..... ...+..++..+.+++.+||+.||++||++.++++.+++...
T Consensus 235 ~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 235 MDGGY--------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HcCCC--------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11100 01122345679999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.52 Aligned_cols=267 Identities=18% Similarity=0.271 Sum_probs=203.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999854 688899999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++ ++.+++...+..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR----RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 8888887776668999999999999999999999 8899999999999999999999999999976533221
Q ss_pred eeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--CC-cchh-----
Q 001710 888 VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP--HG-LTEV----- 958 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~-~~~~----- 958 (1022)
......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ........... .. +...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223457899999997754 568899999999999999999999997643221 11111111000 00 0000
Q ss_pred -ccccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -VDANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+..... ..........++.++.+++.+|++.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 000011122356678999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.76 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=205.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCC--EEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT--NVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 804 (1022)
++|++.+.||+|+||.||+|... ++. .+|+|.++... ....+.+.+|+.+++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999854 333 47888887432 33456788999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc
Q 001710 805 LEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~----~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE----KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCcCCcceEEECCCCe
Confidence 99999999999997532 247889999999999999999999 88999999999999999999
Q ss_pred EEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHH
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 948 (1022)
+||+|||++..... .........+..|+|||...+..++.++|||||||++|||++ |..||......+ +..
T Consensus 158 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYE 229 (297)
T ss_pred EEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH
Confidence 99999999864321 111111223567999999988889999999999999999998 999987532211 111
Q ss_pred hhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
. ...+. ....+..++.++.+++.+||+.+|.+||++.++++.|+.+..+.
T Consensus 230 ~-~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 K-LPQGY-------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred H-HhcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 11110 01112335667899999999999999999999999999998766
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.76 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=207.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 800 (1022)
.++|.+.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456888999999999999999732 34579999987543 33456788999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
.++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+|+|+||||+||+++.++.++++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~----~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS----KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999997643 348999999999999999999999 789999999999999999999999999998
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
...............++..|+|||.+.+..++.++||||+||++|||++ |..||......+. .........+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~----- 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYRM----- 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCcC-----
Confidence 6644332222222346778999999988899999999999999999998 9999876432221 11111111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+...+.++.+++.+||+.+|++||++.|+++.|++.
T Consensus 264 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.02 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=204.6
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.++|++.++||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456899999999999999999977767899999875432 23568889999999999999999998754 5578999999
Q ss_pred CCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~----~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH----CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999997643 357899999999999999999999 88999999999999999999999999999876443322
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++||||+|+++||+++ |..||.+....+. . ... ....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~----~~~-~~~~----------- 220 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-L----DQV-ERGY----------- 220 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-H----HHH-hcCC-----------
Confidence 1122346678999999988889999999999999999999 7888865432211 1 100 0000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++..+.+++.+||+.||++||+++++.+.|++.
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=326.09 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=192.9
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+.. +++.||+|+++... ......+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999997653 23345566788888765 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~----~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHS----KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence 99999997654 38899999999999999999999 8899999999999999999999999999875422221 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~---------~--------- 213 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDN---------P--------- 213 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------C---------
Confidence 2346899999999999889999999999999999999999999753221 1111111000 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMT-DAAA 1003 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~ 1003 (1022)
..+..++.++.+++.+||+.||++||++. ++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01122355678999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=323.17 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=207.2
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC-----------------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCccee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD-----------------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 790 (1022)
..+|++.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987432 2458999987654 334567889999999999999999
Q ss_pred EeeeEeeCCeeEEEEEccCCCCHHHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYN----------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 791 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
+++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~----~~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES----LNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH----cCccccccchh
Confidence 9999999999999999999999999997654 258999999999999999999999 78999999999
Q ss_pred cEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc--CCCCCCcccc
Q 001710 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKPTDEMFT 938 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~ 938 (1022)
||+++.++.++|+|||++................++..|+|||...+..++.++|||||||++|||++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986544433333334456788999999888889999999999999999998 6778765322
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
.+ .............. ......+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus 240 ~~--~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ--VIENAGHFFRDDGR----------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH--HHHHHHhccccccc----------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 11111111100000 0001122335578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.05 Aligned_cols=240 Identities=22% Similarity=0.280 Sum_probs=192.5
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999854 68899999997653 22345566788888765 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHS----KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99999987654 38899999999999999999999 889999999999999999999999999987532211 122
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~------------------~ 213 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT------------------P 213 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC------------------C
Confidence 345689999999999999999999999999999999999999975321 11111111100 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMT-DAA 1002 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell 1002 (1022)
..+..++.++.+++.+||+.||++||++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01122456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.38 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=205.8
Q ss_pred CCCcCCeeecccceEEEEEEE-----cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-----FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 802 (1022)
-|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357889999987553 33446788999999999999999999998775 5688
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+++++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~----~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS----RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH----CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999997765568999999999999999999999 889999999999999999999999999998764
Q ss_pred CCCCce-eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccccc----------chhHHHHHHhhc
Q 001710 883 EGDDSV-TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG----------EMSLRRWVKESL 951 (1022)
Q Consensus 883 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~----------~~~~~~~~~~~~ 951 (1022)
...... ......++..|+|||...+..++.++||||||+++||+++++.|+...... +.....++...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 433211 122344667899999988888999999999999999999987764321110 00111111000
Q ss_pred CCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
. .....+.+..++.++.+++.+||+.+|++||+++++++.++++
T Consensus 240 --------~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 --------E-----EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred --------H-----cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 0011122334677899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.84 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=203.7
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-----hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
++|++.+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999984 468999999886432 1234568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++++|.+++...+. +++..+..++.|++.|+.|||+ .+|+||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH~----~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHS----NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999876553 7889999999999999999999 8899999999999999999999999999986543
Q ss_pred CCCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...... .....++..|+|||...+..++.++||||+|+++||+++|+.||......+. ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~------- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIAT----QPT------- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHHhc----cCC-------
Confidence 221111 1234577899999999998899999999999999999999999875322111 111000 000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++.++.+++.+||..+|++||++.|++++
T Consensus 225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011223356678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.24 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=198.3
Q ss_pred eeecccceEEEEEEE---cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 737 LLGRGSFGLVYKGTL---FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999964 357889999986543 2345678899999999999999999998864 4678999999999
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee-e
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT-Q 890 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~ 890 (1022)
+|.+++.... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++........... .
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~----~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE----TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997654 48999999999999999999999 7899999999999999999999999999987654332211 1
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
....++..|+|||......++.++|||||||++|||++ |..||...... .....+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~-----------------~ 216 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE-----------------R 216 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-----------------C
Confidence 22234578999999888889999999999999999998 99999763222 1112121100 0
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
.+.+..++.++.++|.+||++||++||++.+|++.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112234567789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.25 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=206.3
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
...+|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+|++++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346789999999999999999984 4689999999876655556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++++|.+++.... +++.++..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~i~~ql~~aL~~LH~----~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 98 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHS----NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ccCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999987543 7899999999999999999999 8899999999999999999999999999876533221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......+++.|+|||...+..++.++|||||||++|+|++|+.||....... .+.... ....
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~-~~~~----------- 233 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA-TNGT----------- 233 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh-cCCC-----------
Confidence 1223468889999999888889999999999999999999999996532211 111100 0000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+...+..+.+++.+||.+||++||++.|++++
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 -PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011123345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=318.46 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=210.9
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCC----EEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.+|++.++||+|+||.||+|... +|+ .||+|+..... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888899999999999999853 333 58999887554 3345678899999999999999999999987 77899
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++|+|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~----~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE----KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh----CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998876679999999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...........++..|+|||......++.++||||||+++||+++ |+.||...... .+.+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE----------- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC-----------
Confidence 333222222234568999999888889999999999999999999 99998763221 1222222110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
..+.+..++.++.+++.+||..||.+||++.++++.++++.++..
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 111223345678999999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=313.41 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=198.9
Q ss_pred eeecccceEEEEEEEc---CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCC
Q 001710 737 LLGRGSFGLVYKGTLF---DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS 812 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 812 (1022)
.||+|+||.||+|.+. ++..||+|+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999743 355799999876543 334668899999999999999999998864 56789999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce-eee
Q 001710 813 FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-TQT 891 (1022)
Q Consensus 813 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~ 891 (1022)
|.+++......+++..+.+++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG----KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999998766678999999999999999999999 789999999999999999999999999998654332211 112
Q ss_pred cccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 892 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
...++..|+|||...+..++.++||||||+++||+++ |..||......+ ....+.... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~-----------------~~ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGK-----------------RL 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCC-----------------CC
Confidence 2234578999999888889999999999999999996 999997643221 111111110 01
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+..++.++.+++.+||+.||++||++.++.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=316.71 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=207.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-C---CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-D---GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.+|++.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999853 2 3479999987543 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||.+..+...
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~----~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD----MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999998776668999999999999999999999 88999999999999999999999999999876443
Q ss_pred CCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 885 DDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 885 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
..... .....++..|+|||...+..++.++||||||+++||+++ |..||.+.... ..........
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY----------- 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC-----------
Confidence 22111 111223567999999988889999999999999999887 99998764221 1111111110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.46 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=196.1
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+.. +++.||+|+++... ......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 57899999997653 23345677889999888 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHE----RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT 153 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence 99999987664 48999999999999999999999 8899999999999999999999999999875322211 12
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ . ..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~~---~---------------~~ 213 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSILE---D---------------EV 213 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHc---C---------------CC
Confidence 2346899999999999999999999999999999999999999753211 11111110 0 00
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHM-----TDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~ 1004 (1022)
..+..++.++.+++.+||+.||++||++ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122345678999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.93 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC---------------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD---------------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIF 792 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~ 792 (1022)
..+|++.+.||+|+||.||+++... ...||+|+++... ......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999987432 2358999987653 33345788999999999999999999
Q ss_pred eeEeeCCeeEEEEEccCCCCHHHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 001710 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYN-----------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNN 861 (1022)
Q Consensus 793 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~N 861 (1022)
+++......++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~----~~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS----LNFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh----cCeeccccChhh
Confidence 99999999999999999999999986532 136889999999999999999999 889999999999
Q ss_pred EEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc--CCCCCCccccc
Q 001710 862 ILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKPTDEMFTG 939 (1022)
Q Consensus 862 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~~ 939 (1022)
|++++++.+||+|||++................++..|+|||...++.++.++|||||||++|||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543322222223345678999999888889999999999999999998 56777653221
Q ss_pred chhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 940 EMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
...... .+......... ....+..++..+.+++++||+.||++||++.++++.|++
T Consensus 240 -~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENT-GEFFRNQGRQI----------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHH-HHhhhhccccc----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111 11111000000 001112245679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.13 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=209.6
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999965 79999999886422 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 806 EFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
||+++|+|.+++... ...+++..+..++.+++.|++|||+ .+|+||||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS----KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh----CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998642 3358899999999999999999999 889999999999999999999999999987654
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
..... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... .....+..........
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~------ 226 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYP------ 226 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCC------
Confidence 33211 122457889999999888889999999999999999999999986432 1122221111000000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
. .....++.++.+++.+||..+|++||++.++++.+++++
T Consensus 227 ------~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 ------P-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------C-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 011245667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.85 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=208.2
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|+..++||+|+||.||+|+.. +++.||+|.+..... .+.+.+|++++++++|+||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 367899999999999999999965 488999999876533 57889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++......+++..+..++.|++.|+.|||+ .+|+||||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~----~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS----NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999998766778999999999999999999999 7899999999999999999999999999987644321
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........... .. . ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~----~-----------~~~ 216 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IP----N-----------KPP 216 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hc----c-----------CCC
Confidence 22234578899999999888999999999999999999999999875322211000 00 0 000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+..++..+.+++.+||+.||++||+++|++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1112233456678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.86 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=208.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc--------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF--------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 798 (1022)
.++|.+.++||+|+||.||+|+.. ....||+|+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999732 24569999987543 33456788899999999 699999999999998
Q ss_pred CeeEEEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNIL 863 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIl 863 (1022)
...++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~----~gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES----RRCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH----CCeeeccccceeEE
Confidence 99999999999999999997532 247889999999999999999999 88999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchh
Q 001710 864 LDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 942 (1022)
Q Consensus 864 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 942 (1022)
+++++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999986643322222222234567999999888889999999999999999999 888886532211
Q ss_pred HHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 943 LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
......... ....+..++.++.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 245 ~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 245 LFKLLREGH-----------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 111111100 011123456678999999999999999999999999999976553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.22 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=204.1
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-----------------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCccee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-----------------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 790 (1022)
.++|++.++||+|+||.||+++.. ++..||+|++.... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 23468999987553 334567889999999999999999
Q ss_pred EeeeEeeCCeeEEEEEccCCCCHHHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYN----------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 791 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
+++++...+..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~----~~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS----LNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH----CCeecccCChh
Confidence 9999999999999999999999999987643 136778899999999999999999 88999999999
Q ss_pred cEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc--CCCCCCcccc
Q 001710 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKKPTDEMFT 938 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~ 938 (1022)
||++++++.++++|||++..+.............++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986644332222222345678999998888889999999999999999998 6788865322
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.+. ... .......... ....+.+..++..+.+++.+||+.||++||++.|+.+.|++
T Consensus 240 ~~~-~~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQV-IEN-TGEFFRDQGR----------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH-HHH-HHHHHhhccc----------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211 110 0000000000 00111223456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.38 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=211.3
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+=|+..+-||+|.|++|-+|+ ..+|..||||++.+.. .-....+.+|++.|+.++|||||++|++.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 447777889999999999998 6789999999998764 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe-cCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL-DENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll-~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
.-++|+|.||+-++...+.+....+++.||+.|+.|+|+.| +||||+||+||.+ ..-|-||++|||++-.+.++.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh----hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999988888999999999999999999999954 9999999999877 467889999999998775544
Q ss_pred CceeeecccCCcccCCccccCCCCCC-ccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.-+..+|...|-|||.+.|..|+ +++||||+|+++|-+.+|++||++....|... -++|=
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-------------mImDC--- 234 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-------------MIMDC--- 234 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-------------hhhcc---
Confidence 33456899999999999998886 68999999999999999999999865554311 11221
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+..|...+.+..++|..|+..||.+|.+..|++..
T Consensus 235 ----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 124456677888999999999999999999998754
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=316.03 Aligned_cols=257 Identities=25% Similarity=0.456 Sum_probs=207.1
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CC---CEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DG---TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
..+|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+.+.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999854 33 379999987553 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||++++++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD----MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999998766668999999999999999999999 7899999999999999999999999999987643
Q ss_pred CCCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 884 GDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 884 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
...... ......+..|+|||+.....++.++|||||||++||+++ |+.||...... .....+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~---------- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF---------- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC----------
Confidence 322111 111223457999999888889999999999999999997 99998653221 1111111100
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+.+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223566789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.36 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=208.5
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .+++.+|+|++........+.+.+|++++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46789999999999999999985 46788999999876655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++......+++..+..++.|++.|++|||+ .+|+|+||+|+||++++++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~----~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE----TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh----CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999999998765568999999999999999999999 7899999999999999999999999999976543221
Q ss_pred eeeecccCCcccCCccccCCC---CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 888 VTQTITMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
......++..|+|||...+. .++.++||||+|+++|||++|+.||.+....+. ...........
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~----------- 223 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP----------- 223 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC-----------
Confidence 12234678899999988776 789999999999999999999999976432221 11111110000
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.........+.++.+++++||+.+|.+||++++++.+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 ---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0111223456678999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.81 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=207.5
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .++..||+|++........+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45688999999999999999985 46899999999876666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++...+..+++..+..++.|++.|+.|||+ .+|+|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~----~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS----HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999998876679999999999999999999999 7899999999999999999999999999876432221
Q ss_pred eeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 888 VTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
......++..|+|||... +..++.++||||+|+++|||++|+.||......+ ....+.. .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----~-------- 223 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK-----S-------- 223 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc-----C--------
Confidence 223345889999999764 4457889999999999999999999997642211 1111110 0
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.......+..++.++.+++.+||+.+|++||++.+++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001111223456678999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.11 Aligned_cols=344 Identities=27% Similarity=0.370 Sum_probs=186.7
Q ss_pred CCccccCCCCCCeeecccccccCCCCccccCCCcccEEEecccccc-CCChhhhcCcCCCCEEEccCccccCcCCccccc
Q 001710 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQ-GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN 265 (1022)
Q Consensus 187 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 265 (1022)
+|+.++.+.+|++|.+++|++. .+-..++.++.|+.+++..|++. .-+|..+..+..|..||||+|+++ +.|..+..
T Consensus 47 vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~ 124 (1255)
T KOG0444|consen 47 VPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY 124 (1255)
T ss_pred ChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhh
Confidence 3344444444444444444433 22233344444444444444442 123334444444444444444444 34444444
Q ss_pred ccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCcccccccccccc
Q 001710 266 ISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFL 345 (1022)
Q Consensus 266 l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 345 (1022)
-+++-+|+||+|+|. .||..++.++..|-+||||+|++. .+|+....+..|++|+|++|.+....-..+..|++|+.|
T Consensus 125 AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL 202 (1255)
T KOG0444|consen 125 AKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVL 202 (1255)
T ss_pred hcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence 444444444444444 566666666777777777777776 556667777778888888877765444445555555556
Q ss_pred ccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceE
Q 001710 346 NLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425 (1022)
Q Consensus 346 ~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~ 425 (1022)
++++.+-+- ..+|..+..+.+|..
T Consensus 203 hms~TqRTl--------------------------------------------------------~N~Ptsld~l~NL~d 226 (1255)
T KOG0444|consen 203 HMSNTQRTL--------------------------------------------------------DNIPTSLDDLHNLRD 226 (1255)
T ss_pred hcccccchh--------------------------------------------------------hcCCCchhhhhhhhh
Confidence 555543221 134555666667777
Q ss_pred EEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccCcee
Q 001710 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTL 505 (1022)
Q Consensus 426 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 505 (1022)
+|+|.|.+. .+|+.+.++++|+.|+|++|+|+ .. ....+.+.+|++|+||+|++
T Consensus 227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL------------------------~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-EL------------------------NMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred ccccccCCC-cchHHHhhhhhhheeccCcCcee-ee------------------------eccHHHHhhhhhhccccchh
Confidence 777777766 55665555555555555555555 22 22333344445555555554
Q ss_pred ccccCCccccccccceEeccCCcCC-CCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcc
Q 001710 506 TYSIPSSLWSLEYILYVNLSSNSLS-GPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPES 584 (1022)
Q Consensus 506 ~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 584 (1022)
+ .+|.+++.++.|+.|.+.+|+++ .-+|..++.+.+|+.+..++|++. .+|..+..+..|+.|.|++|++- .+|.+
T Consensus 281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPea 357 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEA 357 (1255)
T ss_pred c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhh
Confidence 4 34444444444444444444433 125666666677777777777775 66777777777777777777766 56667
Q ss_pred cccccccceeecccceeccccCchhhhcccccEEE
Q 001710 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLN 619 (1022)
Q Consensus 585 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 619 (1022)
+.-|+.|+.|||..|.=.-..|+--..-++|+.-+
T Consensus 358 IHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYN 392 (1255)
T KOG0444|consen 358 IHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYN 392 (1255)
T ss_pred hhhcCCcceeeccCCcCccCCCCcchhhhcceeee
Confidence 76677777777777754324443322223444433
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.15 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=206.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467889999999999999999853 24689999986543 23345688899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEE
Q 001710 802 ALVLEFMPNGSFEKWLYSYN---------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV 872 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl 872 (1022)
++||||+++|+|.+++.... ..+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA----KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh----CCccccccChheEEEcCCCCEEE
Confidence 99999999999999987532 236788999999999999999999 78999999999999999999999
Q ss_pred eeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhc
Q 001710 873 SDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESL 951 (1022)
Q Consensus 873 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 951 (1022)
+|||+++.+.............++..|+|||...++.++.++|||||||++||+++ |..||.+.... ....+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcCC
Confidence 99999986644333222333456789999999888889999999999999999998 88898653221 1222221100
Q ss_pred CCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
....+..++.++.+++.+||+.+|++|||+.++++.|++
T Consensus 239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 -----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 011122346678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.14 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=204.9
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.+.|++.++||+|+||.||+|+.. ++..||+|++........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356889999999999999999954 5889999999876666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|..++.+....+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||.+.......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~----~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS----MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc----CCeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 99999999887666668999999999999999999999 789999999999999999999999999987543221
Q ss_pred eeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 888 VTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.......++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----~-------- 231 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS----E-------- 231 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcC----C--------
Confidence 1122345788999999874 345788999999999999999999998653211 111111100 0
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+....+..++.++.+++.+||+.||++||++.|++++
T Consensus 232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 ----PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111223345678999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=314.27 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=204.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 457889999999999999999988888899999875433 23568899999999999999999998854 5678999999
Q ss_pred CCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++++|.+++.... ..+++.++..++.+++.|++|||+ .+|+||||||+||++++++.++|+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER----MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999997643 358999999999999999999999 78999999999999999999999999999876433221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++||||||+++|||++ |..||.+....+ .........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~--------------- 220 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGY--------------- 220 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC---------------
Confidence 1122235668999999888889999999999999999999 888986532211 111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
..+.+..++..+.+++.+||.++|++|||+.++.+.|++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011123445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.12 Aligned_cols=238 Identities=27% Similarity=0.302 Sum_probs=193.5
Q ss_pred CeeecccceEEEEEEE----cCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 736 NLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999873 3578999999976532 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS----LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 999999997654 48999999999999999999999 8899999999999999999999999999976533221 2
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ . ....... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~---~~~i~~~---------------~ 214 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--T---MTMILKA---------------K 214 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--H---HHHHHcC---------------C
Confidence 223568999999999988889999999999999999999999997532211 1 1111000 0
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTD 1000 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 1000 (1022)
...+..++.++.+++++||++||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112234567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.33 Aligned_cols=247 Identities=33% Similarity=0.492 Sum_probs=200.7
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHH
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFE 814 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~ 814 (1022)
++||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999987889999999875542 33456889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeeccc
Q 001710 815 KWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894 (1022)
Q Consensus 815 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 894 (1022)
+++......+++..+..++.|++.++.|+|+ .+++||||||+||++++++.+|++|||++......... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 155 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES----KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ 155 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence 9998766668999999999999999999999 88999999999999999999999999999764332211 111223
Q ss_pred CCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 895 gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
++..|+|||+..+..++.++||||||+++||+++ |..||....... ....+.. .. ....+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~----~~-------------~~~~~ 216 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEK----GY-------------RMSCP 216 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc----CC-------------CCCCC
Confidence 4567999999988889999999999999999998 899987542211 1111111 00 00111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
..++.++.+++.+||+.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.86 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=204.7
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999985 468999999986532 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++... ...+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~----~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS----KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999875 4468999999999999999999999 8899999999999999999999999999987654322
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
. .....+++.|+|||+..+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---~----------- 218 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGV---F----------- 218 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC---C-----------
Confidence 1 22345788999999999888999999999999999999999999754311 1111111100 0
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++++||+.+|++||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=320.05 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=202.1
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
|++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+.+++.++|||++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999954 5788999998766555567788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||++........ ..
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~----~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE----NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR 160 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCcccEEEccCCCEEEcccccccccccccc--cc
Confidence 99999887655568999999999999999999999 8899999999999999999999999999876532211 22
Q ss_pred ecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 891 TITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....++..|+|||++. +..++.++||||+||++|||++|+.||......+ ..........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~-------------- 225 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEP-------------- 225 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCC--------------
Confidence 3346889999999863 4557889999999999999999999987532211 1111111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+..++.++.+++.+||+.||++||++.+++++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 --PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123345678999999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.88 Aligned_cols=248 Identities=33% Similarity=0.498 Sum_probs=202.6
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHH
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFE 814 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~ 814 (1022)
++||+|+||.||+|...+++.||+|++...... ..+.+.+|++++++++|++|+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeeccc
Q 001710 815 KWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894 (1022)
Q Consensus 815 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 894 (1022)
+++......+++..+..++.+++.|++|||+ .+++||||||+||+++.++.+||+|||.+................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~----~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES----KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9998766568999999999999999999999 789999999999999999999999999997654322222212223
Q ss_pred CCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 895 gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
.+..|+|||...++.++.++||||+|+++|||++ |..||...... .......... ....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-----------------~~~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-----------------RMPAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC-----------------CCCCC
Confidence 4567999999888889999999999999999999 78888653221 1111111100 01122
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 344667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.88 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=206.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4567899999999999999999988889999999875433 2457889999999999999999999874 4568999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.++++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~----~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER----KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc----CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999987543 368999999999999999999999 7899999999999999999999999999987643222
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......++..|+|||+..+..++.++||||||+++||+++ |+.||.+....+ ..........
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------------- 221 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYR------------- 221 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCC-------------
Confidence 1 1222345678999999988889999999999999999999 999997643221 1111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.+.+..++.++.+++.+||+.+|++||+++++...|+.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.15 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=206.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999985 488999999976644 4567889999999999999999999999989999999999
Q ss_pred CCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++++|.+++..... .+++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~----~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE----KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999976553 58999999999999999999999 8899999999999999999999999999986632211
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
....+..|+|||...++.++.++||||+|+++||+++ |..||...... .+...+....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~--------------- 216 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGY--------------- 216 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCC---------------
Confidence 2235668999999988889999999999999999997 99998653211 1111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
....+..++.++.+++++||..+|++||++.|+++.|+++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0011223467789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.47 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=204.7
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
++.+++++.....||+|+||.||+|+. .+++.||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566777778999999999999984 4678899999876665566788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeeccCcee
Q 001710 804 VLEFMPNGSFEKWLYSYNYFL--DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKL 880 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG~a~~ 880 (1022)
|+||+++++|.+++......+ ++..+..++.|++.|++|||+ .+|+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD----NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH----CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999998754435 788889999999999999999 88999999999999986 67999999999976
Q ss_pred cCCCCCceeeecccCCcccCCccccCCCC--CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
...... ......++..|+|||+..+.. ++.++||||+|+++|+|++|+.||.+....... .+.....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~------- 227 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMF------- 227 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhh-------
Confidence 543221 122235788999999876543 788999999999999999999998753221111 1100000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.. ....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 228 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KI--HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------cc--CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 011123455678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=314.98 Aligned_cols=248 Identities=31% Similarity=0.508 Sum_probs=206.0
Q ss_pred CeeecccceEEEEEEEcC----CCEEEEEEecchhhhh-HHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQLERA-FRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|+||.||+|+... +..||+|+++...... .+.+.+|++.++.++|++++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998543 7889999998665433 67888999999999999999999999999999999999999
Q ss_pred CCHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 811 GSFEKWLYSY--------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 811 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
++|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS----KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc----CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999886 4569999999999999999999999 889999999999999999999999999998775
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
............++..|+|||...+..++.++||||+|+++|||++ |..||..... ......... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~----~------- 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK----G------- 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc----C-------
Confidence 5433233334557889999999888889999999999999999999 5899876421 111111111 0
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
.....+..++.++.+++.+||+.+|++||++.|++++|+
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.33 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=208.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCC----EEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGT----NVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
.++|+..+.||+|+||.||+|+.. +|. .||+|++..... .....+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356888899999999999999853 444 578998865432 2334688899999999999999999998754 467
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+++||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~----~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE----RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh----cCeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999998776678999999999999999999999 789999999999999999999999999998764
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
............++..|+|||...+..++.++||||||+++||+++ |+.||.+... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~---------- 228 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE---------- 228 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC----------
Confidence 4332222223445778999999988889999999999999999997 8899865321 22222222110
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
..+.+..++.++.+++.+||..+|++||+++++++.++++.....
T Consensus 229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 229 -------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 011122345678999999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=332.84 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=203.3
Q ss_pred HHHHhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC
Q 001710 724 DIQRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID 799 (1022)
Q Consensus 724 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 799 (1022)
++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 44556689999999999999999999854 68899999986432 223456788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
..++||||+++|+|.+++.... ++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHS----MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHH----CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999987654 7888899999999999999999 889999999999999999999999999998
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCC----CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCc
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 955 (1022)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~---- 264 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKN---- 264 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC----
Confidence 7643221 122345699999999987643 3789999999999999999999999752211 11111111000
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHHH
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAEL 1005 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~L 1005 (1022)
....+....++..+.+++..|+..++.+ |+++.|++++.
T Consensus 265 -----------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 -----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0011122245667889999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.84 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=205.5
Q ss_pred hcCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
.++|++.+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 467899999875542 3346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 802 ALVLEFMPNGSFEKWLYSYN---------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~----~~i~H~dl~p~ 159 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE----RKFVHRDLATR 159 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh----CCeecccccHh
Confidence 99999999999999997432 136788899999999999999999 88999999999
Q ss_pred cEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCccccc
Q 001710 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTG 939 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~ 939 (1022)
||++++++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543332222222345677999999888899999999999999999998 77888653221
Q ss_pred chhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 940 EMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
+ +........ ..+.+..++.++.+++.+||+.||++||++.|+++.|++
T Consensus 240 ~-----~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E-----VIYYVRDGN--------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-----HHHHHhcCC--------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 111111000 011123356778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.64 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=208.1
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC----CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3457888999999999999998533 3469999887654 4455688999999999999999999999876 45689
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++|+|.+++......+++..+..++.+++.|++|||+ .+++||||||+||+++.++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES----KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999998766668999999999999999999999 7899999999999999999999999999987644
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.... ......++..|+|||......++.++||||||+++||+++ |..||......+. ........
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~~----------- 225 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENGE----------- 225 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcCC-----------
Confidence 3221 1222334567999999888889999999999999999986 9999976432211 11111100
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
....+..++..+.+++.+||.++|++||++.++++.|+++...
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112234567899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.51 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=205.4
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.++||+|+||.||+++. .++..||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688999999999999999984 4688899999875532 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++...+ .+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh---CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999998764 488999999999999999999972 379999999999999999999999999987553221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc-----------
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT----------- 956 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 956 (1022)
.....++..|+|||...+..++.++||||||+++|||++|+.||.... ......+..........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence 223468899999999888889999999999999999999999986432 11122222111100000
Q ss_pred ----------hhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 957 ----------EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 957 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+..+.......+.. ....++.++.+++.+||+.||++||++.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000000 1112566789999999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.12 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=191.5
Q ss_pred CeeecccceEEEEEEEcC-------------CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 736 NLLGRGSFGLVYKGTLFD-------------GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
+.||+|+||.||+|+..+ ...||+|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998432 2358999987665555667888999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc-------EEEeec
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT-------AHVSDF 875 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~-------~kl~Df 875 (1022)
+||||+++|+|..++......+++..+.+++.||+.|++|||+ .+|+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED----KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh----CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999988766668999999999999999999999 88999999999999987664 899999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHH-cCCCCCCcccccchhHHHHHHhhcCC
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETF-TRKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
|.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+. ......
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~---- 224 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYEG---- 224 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHhc----
Confidence 998754321 2245788899999876 567899999999999999998 58888765321110 010000
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
. . ........++.++|.+||+.||++||++.++++.+
T Consensus 225 ~--------~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 Q--------C-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred C--------c-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0 00011245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=321.71 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=206.6
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
...+|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346799999999999999999984 5799999999876655555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++++|.+++.... +++.++..++.|++.|+.|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 97 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH~----~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 97 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHS----NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ccCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999987643 7899999999999999999999 7899999999999999999999999999986543322
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
. .....+++.|+|||...+..++.++||||+|+++|++++|+.||............ . ...
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~------------~~~ 231 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----A------------TNG 231 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----c------------cCC
Confidence 1 22345888999999998888999999999999999999999999653221100000 0 000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223345668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.51 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=199.6
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|+.+++.++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999985 468999999987532 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ----LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999998766668999999999999999999999 889999999999999999999999999997664332
Q ss_pred CceeeecccCCcccCCccccCC-----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 886 DSVTQTITMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ....... .....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~~---~~~~~--- 228 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNH---KEHFQ--- 228 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHcC---CCccc---
Confidence 2 12223468999999998753 4578899999999999999999999975322111 1111000 00000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~ 1004 (1022)
+ ......++.++.+++++|+..++++ ||++.+++++
T Consensus 229 --~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 --F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0011224567889999988654443 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.39 Aligned_cols=253 Identities=30% Similarity=0.414 Sum_probs=201.1
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhH--HHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAF--RTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
|++.+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999955 567899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
++++|.+++...+ .+++..+..++.|++.||++||+ .+|+|+||||+||++++++.++|+|||.+..+. ....
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~----~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHS----KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHH----TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred ccccccccccccc-ccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999998433 38999999999999999999999 889999999999999999999999999998652 2222
Q ss_pred eeecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 889 TQTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||+.. +..++.++||||+|+++|+|++|..||.+.. .................
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~~----------- 220 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRPLP----------- 220 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTHHH-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccccccc-----------
Confidence 344467899999999988 8889999999999999999999999998641 11111111111000000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
............+.+++.+||+.||++||++.+++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011113678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=317.23 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=203.0
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34678889999999999999984 46899999998766555556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++...+ .+++.++..++.|++.|+.|||+ .+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS----KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999999987655 48999999999999999999999 789999999999999999999999999997664322
Q ss_pred eeeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 888 VTQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.......|+..|+|||++. ...++.++||||+||++|||++|..||........ ........... +.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~-------~~-- 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQP-------PK-- 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCC-------Cc--
Confidence 1223346899999999864 45688999999999999999999999865322211 11111100000 00
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......++..+.+++.+||+.+|++||++++++++
T Consensus 231 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 -----LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -----ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00111234568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.29 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=194.3
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+|+..+.||+|+||+||+|+. .+|+.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477789999999999999985 468999999987543 233456778899998885 577888999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++..... +++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~----~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHR----RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999876554 8999999999999999999999 889999999999999999999999999987543221
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. ..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~---~~----------- 217 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIME---HN----------- 217 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh---CC-----------
Confidence 1 122345899999999999889999999999999999999999999763221 11111111 00
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
...+..++.++.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.87 Aligned_cols=237 Identities=26% Similarity=0.291 Sum_probs=188.7
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHH-HHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECE-ILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 4789999999875431 22234444544 56788999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS----LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99999987654 48899999999999999999999 889999999999999999999999999987532221 122
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~---------------~ 213 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKP---------------L 213 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCC---------------C
Confidence 3346899999999999999999999999999999999999999753211 1111111000 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 999 (1022)
..+...+.++.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11122356789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=332.80 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=199.8
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----eeE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 802 (1022)
+|++.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999985 478999999886432 233467889999999999999999999998776 789
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~----~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 57888776544 48999999999999999999999 889999999999999999999999999998654
Q ss_pred CCCCceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh---
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV--- 958 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 958 (1022)
.... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .+...............
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHh
Confidence 3221 122334678999999987764 57899999999999999999999997643221 11111110000000000
Q ss_pred -------cccc-cc--chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -------VDAN-LV--GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -------~~~~-~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+... .. ............+.++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 00 0000001112335678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=318.80 Aligned_cols=271 Identities=26% Similarity=0.364 Sum_probs=209.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc-----CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEee--CCee
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-----DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFK 801 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~ 801 (1022)
++|+..+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999843 3678999999766543 45788999999999999999999999877 5578
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS----QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998877679999999999999999999999 88999999999999999999999999999877
Q ss_pred CCCCCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
........ .....++..|+|||...+..++.++||||||+++|||++|+.|+......... +............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHH
Confidence 53322211 11233556799999988888999999999999999999999997653222110 000000000000000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..+. .....+.+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 0011222344567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.30 Aligned_cols=239 Identities=22% Similarity=0.300 Sum_probs=190.6
Q ss_pred eeecccceEEEEEEEcC-------------------------CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeE
Q 001710 737 LLGRGSFGLVYKGTLFD-------------------------GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l 791 (1022)
+||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997321 13589999876655555678889999999999999999
Q ss_pred eeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC---
Q 001710 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM--- 868 (1022)
Q Consensus 792 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~--- 868 (1022)
++++.+....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED----KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc----CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999998766668999999999999999999999 8899999999999997644
Q ss_pred ----cEEEeeccCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHH-cCCCCCCcccccchh
Q 001710 869 ----TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETF-TRKKPTDEMFTGEMS 942 (1022)
Q Consensus 869 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~ell-tg~~p~~~~~~~~~~ 942 (1022)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 4899999988643221 12346788999997765 56899999999999999985 6899987543221
Q ss_pred HHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 943 LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
...+..... ..+.....++.+++.+||+.+|++||++.++++.|+
T Consensus 230 ~~~~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH-------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc-------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111100 001112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.13 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=201.6
Q ss_pred CeeecccceEEEEEEEcC--C--CEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLFD--G--TNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|++|.||+|++.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998543 3 3699999987655 556788999999999999999999999988 888999999999
Q ss_pred CCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce-
Q 001710 811 GSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV- 888 (1022)
Q Consensus 811 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 888 (1022)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~----~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES----KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh----CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999998765 468999999999999999999999 889999999999999999999999999998775432221
Q ss_pred eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||...+..++.++|||||||++|||++ |+.||......+ ........ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~----~------------- 217 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKE----G------------- 217 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhc----C-------------
Confidence 1223456788999999988899999999999999999999 999986532221 11111110 0
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
.....+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.30 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=201.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEe-eCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC-NIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .|+.||+|..+... ..+.+.+|+.++++++|++++++++++. .....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788899999999999999984 48889999986443 2457889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++..... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+|++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA----NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999986543 47899999999999999999999 889999999999999999999999999987643322
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ......+.... .
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~----~--------- 217 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY----K--------- 217 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC----C---------
Confidence 12234568999999988889999999999999999997 9999864211 11111111100 0
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
...+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011223567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.69 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=208.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..++|.+.++||+|+||.||+|...+++.||||.+..... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578999999999999999999987788999999875432 346788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++.... ..+++..+..++.+++.|++|||+ .+++|+||||+||++++++.+|++|||.+........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~----~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES----RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999997654 468999999999999999999999 7899999999999999999999999999987643221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......++..|+|||...+..++.++||||+|+++||+++ |+.||.+.... ..... .....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~-~~~~~-------------- 221 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ-VERGY-------------- 221 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHcCC--------------
Confidence 1 1112234568999999988889999999999999999998 99998653221 11111 11100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
..+.+..++.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011122335678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=317.54 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=199.4
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999984 578999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|..+. .+++..+..++.|++.|++|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS----LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH----CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997652 26788899999999999999999 889999999999999999999999999997653322
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchh--HHHHHHhhcCCCcchhccccccc
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMS--LRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.....+|..|+|||.+.+..++.++||||+|+++|+|++|+.||......... ...+........ ...+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 22346899999999999889999999999999999999999999753322111 011111000000 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+.++.+++.+||+.+|++||++.|++++
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234568999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=325.32 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=192.7
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 467899999997653 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++...+ .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~----~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHE----RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT 153 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence 99999887654 48999999999999999999999 8899999999999999999999999999875322111 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccc-hhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+........ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~ 219 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------------P 219 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------C
Confidence 33568999999999999999999999999999999999999996432211 11111111111000 0
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
...+...+..+.+++.+||+.||++|+++
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122345667899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.30 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=192.0
Q ss_pred CeeecccceEEEEEEEcC---CCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTLFD---GTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+|+..+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 45799998875542 23356888999999999999999999999999999999999999
Q ss_pred CHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 812 SFEKWLYSYN----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 812 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+|.+++.... ...++..+..++.|++.|++|||+ .+++||||||+||++++++++|++|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK----NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH----CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999997533 245677888999999999999999 88999999999999999999999999999754433322
Q ss_pred eeeecccCCcccCCccccCCC-------CCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 888 VTQTITMATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.......++..|+|||+..+. .++.++||||||+++|||++ |+.||......+. ...-+.. ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~----~~~~~~ 231 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE----QQLKLP 231 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc----ccCCCC
Confidence 222334577889999987532 35789999999999999996 9999975432221 1110110 000011
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
++.+ ...++..+.+++..|| .+|++||+++|+++.|+
T Consensus 232 ~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRL---------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCcc---------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1110 1123456788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=321.42 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=204.4
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCC--EEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGT--NVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 803 (1022)
.++|++.+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999854 454 45777765432 33456788899999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC
Q 001710 804 VLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM 868 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~ 868 (1022)
||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||++++++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~----~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ----KQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh----CCccccccchheEEecCCC
Confidence 999999999999997543 247899999999999999999999 8899999999999999999
Q ss_pred cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHH
Q 001710 869 TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 869 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 947 (1022)
.+||+|||++..... ........++..|+|||...+..++.++|||||||++|||+| |..||......+ . .
T Consensus 162 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~---~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L---Y 233 (303)
T ss_pred cEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H---H
Confidence 999999999864211 111122234667999999888889999999999999999998 999986532211 1 1
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhhc
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~~ 1013 (1022)
. ..+... ....+..++.++.+++.+||+.+|++||++.++++.++++...-.
T Consensus 234 ~-~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 234 E-KLPQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred H-HHhcCC-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 111110 001112245678999999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.54 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=210.8
Q ss_pred CCcCCeeecccceEEEEEEEcC-CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 732 FNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
|.++.-||.|+||.||+|+.++ +-..|.|++.....+..+.|.-|++|+..++||+||++++.|...+..+|..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4445669999999999998553 445688999888888889999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|-++.++-.-+..+++.++.-+++|++.||.|||+ ..|||||+|+.|||++-+|.++++|||.+.... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs----~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS----QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR 187 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh----cchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence 99999998888889999999999999999999999 779999999999999999999999999986532 223334
Q ss_pred ecccCCcccCCccc-----cCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 891 TITMATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~-----~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....||++|||||+ ....+|++++||||||+++.||..+.+|..+..... ..++- -+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR----VllKi-------------aKS 250 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKI-------------AKS 250 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH----HHHHH-------------hhc
Confidence 55789999999995 456789999999999999999999999977643322 11111 122
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+.+-.|...+..+.+++.+|+.+||..||++.+++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 334445566778889999999999999999999999875
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.95 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=206.9
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
...+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345699999999999999999984 5789999999876655556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++++|.+++.... +++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~----~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHA----NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999999987643 8999999999999999999999 8899999999999999999999999999876543322
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++|||||||++|++++|+.||......+. ... ......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~-~~~~~~-------------- 232 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IATNGT-------------- 232 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHhcCC--------------
Confidence 12234588899999999888899999999999999999999999975322111 111 110000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+..++..+.+++.+||..||++||++.+++++
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 -PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111223455678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.14 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=203.3
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
++|.+.++||+|+||.||+|....+..+|+|++.... ...+.+.+|++++++++|++++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999997777789999876543 23356888999999999999999999875 456789999999
Q ss_pred CCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 810 NGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 810 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
+++|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER----MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999997643 357899999999999999999999 78999999999999999999999999999876433221
Q ss_pred eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||...+..++.++||||+|+++|||++ |..||.+....+ ...+......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------- 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR--------------- 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC---------------
Confidence 1122345678999999988889999999999999999999 899987643221 1111111100
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
...+...+..+.+++.+||.+||++||+++++++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.08 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=196.1
Q ss_pred CeeecccceEEEEEEEc----CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEe-eCCeeEEEEEccC
Q 001710 736 NLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCC-NIDFKALVLEFMP 809 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~~ 809 (1022)
+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 24579999885432 334567888999999999999999999775 4556789999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce-
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV- 888 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 888 (1022)
+|+|.+++.......++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS----KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999998766567888889999999999999999 789999999999999999999999999997653322111
Q ss_pred -eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcC-CCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 889 -TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 889 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++|||||||++|||++| .+||..... ......+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~--------------- 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGR--------------- 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC---------------
Confidence 11123456789999998888899999999999999999996 455543211 11111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
....+..++..+.+++.+||+.+|++||++.|+++.++++..
T Consensus 220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011122345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=327.27 Aligned_cols=242 Identities=26% Similarity=0.279 Sum_probs=189.9
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchhh---hhHHHHHHHH-HHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE---RAFRTFDSEC-EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 578899999875431 1223334444 456788999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~----~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLHS----LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 999999987554 7788888899999999999999 8899999999999999999999999999975422211 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~---~~---------------~ 213 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNILN---KP---------------L 213 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHHHHh---CC---------------c
Confidence 33568999999999999999999999999999999999999997532211 1111110 00 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+...+..+.+++.+|++.||.+||++.+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1112345678999999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.78 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=202.8
Q ss_pred CCcCCeeecccceEEEEEE-EcCCCEEEEEEecch---hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ---LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
|..++-||.|+||.||.|+ ..+.+.||||.+... ..+.|.++..|++++++++|||++.+-|+|-.+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556679999999999998 457889999998654 345678999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
|-| +-.|++...+.++.+..+..|..+.+.||+|||+ .+.||||||+.|||+++.|.||++|||.|..+.+.
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS----~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS----HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH----hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 955 8888888888889999999999999999999999 78999999999999999999999999999876432
Q ss_pred eeeecccCCcccCCcccc---CCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 888 VTQTITMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
...+|||+|||||++ ..+.|+-++||||+|++..|+..+++|.-.|.... ....-. +.-.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----ALYHIA--QNes-------- 242 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIA--QNES-------- 242 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----HHHHHH--hcCC--------
Confidence 235799999999964 46789999999999999999999999976543322 111100 0000
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+.+ .....+..+.+++..|+++-|.+|||..+++++-
T Consensus 243 ---PtL-qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 243 ---PTL-QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---CCC-CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 011 1234567789999999999999999999998763
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.87 Aligned_cols=194 Identities=28% Similarity=0.381 Sum_probs=170.7
Q ss_pred CCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcC-C-----CcceeEeeeEeeCCeeEE
Q 001710 731 GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-H-----RNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~~~~~~l 803 (1022)
+|++.+.||+|+||.|.+|. ..+++.||||+++... ....+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999998 5579999999998653 33456678999999996 4 489999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC--CCcEEEeeccCcee
Q 001710 804 VLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE--NMTAHVSDFGISKL 880 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~--~~~~kl~DfG~a~~ 880 (1022)
|+|.++. +|.++++.... .++...+..|+.||+.||.+||+ .+|||+|+||+|||+.+ ...+||+|||.|.+
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~----l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE----LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999965 99999987664 58899999999999999999999 89999999999999974 34799999999987
Q ss_pred cCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCc
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
...... ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 644332 35578899999999999999999999999999999999887765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.11 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=202.9
Q ss_pred CCCcCCeeecccceEEEEEEEcCCCEEEEEEecchh------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
+|++.+.||+|+||.||+|...+++.+|+|.++... .+....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998789999999886432 23345688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++++|.+++.... .+++..+..++.|++.|++|||+ .+|+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN----NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997654 37899999999999999999999 78999999999999999999999999998765321
Q ss_pred CC----ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 885 DD----SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 885 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
.. ........++..|+|||+..+..++.++||||+|+++||+++|+.||......+. ... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~-~~~~--~~~----- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFY-IGAH--RGL----- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHH-hhhc--cCC-----
Confidence 11 1111234588899999999988899999999999999999999999975322211 111 0000 000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++.++.+++++||+.+|++||++.|++++
T Consensus 227 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 --------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 001122356678999999999999999999998763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.40 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=207.1
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecch--hhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
...|+++++||+|+.+.||++...+.+.||+|++... .......|..|+..|.++ .|.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568899999999999999999777788888866433 244567899999999999 4999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||=+. +|..++++.....+...+..+.+|++.++.++|+ .||||.|+||.|.|+ -+|.+||+|||.|..+..+.
T Consensus 440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~----~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ----HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH----hceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 98654 9999999888766656888999999999999999 899999999999998 45799999999999998888
Q ss_pred CceeeecccCCcccCCccccCCCC-----------CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGI-----------VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
........+||+.||+||.+.... .++++||||+||++|+|+.|+.||+..... |.+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aK------ 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAK------ 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHH------
Confidence 888888899999999999754432 567899999999999999999999763222 211
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+....++....+++..+.. .++.++|..||..||++||+..|++++
T Consensus 582 l~aI~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1122333322222222222 228899999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=329.22 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=197.9
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID----- 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----- 799 (1022)
..++|++.+.||+|+||.||+|+. .+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999985 468999999986542 233466788999999999999999999886543
Q ss_pred -eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 800 -FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 800 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
..++||||+++ ++.+.+.. .++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~----~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46899999976 56665543 37888999999999999999999 88999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
+...... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ......... ......+.
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~-~~~~~~~~ 245 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQ-LGTPSAEF 245 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh-cCCCcHHH
Confidence 7543221 223346899999999999999999999999999999999999999753221 111111111 00000000
Q ss_pred c-----------cc--cccc-----hh------hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 959 V-----------DA--NLVG-----EE------QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 959 ~-----------~~--~~~~-----~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
. .. .... .. .........+.++.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 00 0000 00 00001112345689999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=332.92 Aligned_cols=265 Identities=18% Similarity=0.204 Sum_probs=199.9
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
...|.+.+.||+|+||.||+|+.. +++.||||... ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346899999999999999999854 57899999643 23456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+. ++|.+++......+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~----~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG----EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 68999887765569999999999999999999999 88999999999999999999999999999876433222
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccccc------chhHHHHHHhhcCC--Ccchhc
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG------EMSLRRWVKESLPH--GLTEVV 959 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~------~~~~~~~~~~~~~~--~~~~~~ 959 (1022)
.......||..|+|||++.+..++.++|||||||++|||++|..|+-..... ...+...+...... ......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2223356999999999999999999999999999999999987654321111 11222222221100 000000
Q ss_pred ccccc-----------c---hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLV-----------G---EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~-----------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+. . ....+........++.+++.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0 000011111234468899999999999999999999976
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=332.78 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=198.6
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999985 468999999987543 234467788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH~----~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQ----LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHH----CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999976553 8899999999999999999999 899999999999999999999999999987543211
Q ss_pred Cc---------------------------------eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCC
Q 001710 886 DS---------------------------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932 (1022)
Q Consensus 886 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p 932 (1022)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001124699999999999999999999999999999999999999
Q ss_pred CCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 001710 933 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH---MTDAAAE 1004 (1022)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 1004 (1022)
|......+. ...... ... .+ ..+.....+.++.+++.+|+. ||++|++ +.|+.++
T Consensus 236 f~~~~~~~~-~~~i~~--~~~--------~~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQET-YRKVMN--WKE--------TL-----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHH-HHHHHc--CCC--------ce-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 976332211 111000 000 00 001111235567888888764 9999995 6676665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.90 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=199.8
Q ss_pred CeeecccceEEEEEEEc-C---CCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-D---GTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|+||.||+|+.. . +..||+|.+..... ...+.+.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999742 2 36899999875543 34467889999999999999999999876 4467999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee-
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT- 889 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~- 889 (1022)
|+|.+++.... .+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~----~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES----KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh----cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998766 58999999999999999999999 7899999999999999999999999999987644332211
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....++..|+|||...+..++.++||||||+++||+++ |..||..... .....+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~----------------- 215 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE----------------- 215 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC-----------------
Confidence 111223567999999988889999999999999999998 9999876422 12222222111
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
....+..++..+.+++.+||+++|++||++.++++.|+++.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122335667899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.62 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=200.7
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
|+..++||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67778999999999999984 468999999886543 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++...+ ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ----ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh----CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886543 358999999999999999999999 8899999999999999999999999999976533221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
.....|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... ..... ..... ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~~-~~~---------- 221 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLVK-EVQ---------- 221 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhhh-hhh----------
Confidence 123468999999999998899999999999999999999999997632211 00010 00000 000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
...+..++.++.+++.+||+.||++||+ +.|++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0112234567899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=323.41 Aligned_cols=258 Identities=23% Similarity=0.404 Sum_probs=206.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc--------CCCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF--------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNID 799 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 799 (1022)
.+|++.+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999732 12368999887543 33456788999999999 7999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe
Q 001710 800 FKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL 864 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll 864 (1022)
..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~----~givH~dlkp~Nill 167 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS----QKCIHRDLAARNVLV 167 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH----CCeeccccccceEEE
Confidence 9999999999999999987532 247889999999999999999999 889999999999999
Q ss_pred cCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhH
Q 001710 865 DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSL 943 (1022)
Q Consensus 865 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~ 943 (1022)
++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+....+ .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--H
Confidence 9999999999999987644332222222334567999999999999999999999999999998 888886532111 1
Q ss_pred HHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 944 RRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
...+.... ....+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 246 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 FKLLKEGH-----------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111100 011123445678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=332.13 Aligned_cols=265 Identities=22% Similarity=0.184 Sum_probs=202.6
Q ss_pred hcCCCcCCeeecccceEEEEEEEc---CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF---DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
..+|.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 3578999987643 23457999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|++. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~----~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHG----RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9996 5888888543 358999999999999999999999 889999999999999999999999999998765544
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccccc--chhHHHHHHhhcCCC------cc-
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLRRWVKESLPHG------LT- 956 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~------~~- 956 (1022)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ...+....+...... ..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 333333457999999999999999999999999999999999999999764322 112222222111000 00
Q ss_pred h---hccc---cccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 E---VVDA---NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~---~~~~---~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. .+.. .... ..+.......++.++.++|.+||..||++||++.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000 0000 000000111235578899999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.14 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=190.8
Q ss_pred eeecccceEEEEEEEcC---CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCC
Q 001710 737 LLGRGSFGLVYKGTLFD---GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS 812 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 812 (1022)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|+..++.++|+||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888776443 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 813 FEKWLYSYNY----FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 813 L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
|.+++..... ..++.....++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ----ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh----cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999976542 24677888999999999999999 889999999999999999999999999987543332222
Q ss_pred eeecccCCcccCCccccC-------CCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 889 TQTITMATIGYMAPEYGS-------EGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
......++..|+|||+.. ...++.++||||+||++|||++ |..||......+ .......... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~----~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD----IKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC----ccCCC
Confidence 223344677899999753 3456889999999999999999 778886532221 1111111110 01111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
+ ..+..++..+.+++..|| .||++||+++||++.|.
T Consensus 233 ~---------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 P---------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C---------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 112234566788999999 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.49 Aligned_cols=267 Identities=20% Similarity=0.272 Sum_probs=202.9
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 356899999999999999999854 688999999875432 233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++ ++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~----~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR----RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 997 58999988766668999999999999999999999 8899999999999999999999999999976432221
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC----CCcchhccc
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP----HGLTEVVDA 961 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 961 (1022)
......+++.|+|||...+ ..++.++||||+||++|||++|+.||......+ .. ........ ..+......
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QL-HFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHcCCCChhhchhhhcc
Confidence 1223356889999997655 457889999999999999999999997543221 11 11111111 111111110
Q ss_pred ------cccchhh--hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 ------NLVGEEQ--AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+..... .......++.++.+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 001112356678999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.37 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=200.3
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
|+..++||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++|++|+++++++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999985 468999999986543 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++...+ ..+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~----~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR----ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999886543 358999999999999999999999 8899999999999999999999999999976533221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
.....|+..|+|||.+.+..++.++|+||+||++||+++|..||....... ....+.. ......
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~-~~~~~~----------- 221 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDR-RVLETE----------- 221 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hhhccc-----------
Confidence 223468999999999988899999999999999999999999997532211 1111111 111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
...+..++.++.+++..||+.||++||+ +.+++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0011234566889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.00 Aligned_cols=241 Identities=26% Similarity=0.312 Sum_probs=190.1
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHH-HHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECE-ILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||+||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 478999999987542 122344455554 56778999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~----~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS----INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT 153 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence 99999887654 48999999999999999999999 8899999999999999999999999999875322211 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~~~--------~------- 213 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILHKP--------L------- 213 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHcCC--------c-------
Confidence 33568999999999999999999999999999999999999997532111 111111100 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
..+...+.++.+++.+|++.+|.+||++.+.++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 011123556789999999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.65 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=202.5
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
+|++.++||+|+||.||+++.. ++..||+|.++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999854 68999999886432 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++|+|.+++... ...++...+..++.|++.|+.|||+ .+|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~----~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE----KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh----CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988653 3457899999999999999999999 8899999999999999999999999999976643221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||+..+..++.++|+||+|+++|+|++|..||...... ............
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~----------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGSYK----------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCCCC-----------
Confidence 122345888999999998888999999999999999999999999753211 111111000000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+..++.++.+++.+||+.||++||++.|++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.85 Aligned_cols=372 Identities=30% Similarity=0.404 Sum_probs=277.9
Q ss_pred CCCCCeeeccccccc-CCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCccccccccccee
Q 001710 194 CTHLQTLWLADNKFS-GRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLI 272 (1022)
Q Consensus 194 l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 272 (1022)
++-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 344455666666666 455666666666666666666665 56666666666666666666665 344445555666666
Q ss_pred ecccceeee-eccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCcccccccccccccccccc
Q 001710 273 NLIENQLSG-HLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351 (1022)
Q Consensus 273 ~Ls~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 351 (1022)
.+.+|++.. -+|..++. +..|+.||||+|++. ..|..+...+++..|+||+|+|..++...|-++.-|-+||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 666665532 34555553 666666666666665 556666666677777777777765544556666666666666666
Q ss_pred ccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCC
Q 001710 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDN 431 (1022)
Q Consensus 352 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N 431 (1022)
+..+ |+.+..+..|++|+|++|
T Consensus 162 Le~L----------------------------------------------------------PPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 162 LEML----------------------------------------------------------PPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred hhhc----------------------------------------------------------CHHHHHHhhhhhhhcCCC
Confidence 6543 334455555566666666
Q ss_pred CCCCcccccccccccCceEEeeccCCC-CCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccC
Q 001710 432 ELNGTIPTTVGRFQQLQGLSLYDNDLQ-GSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIP 510 (1022)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 510 (1022)
.+...--..+..+++|+.|.+++.+=+ ..+|..+..+.+|..+|||.|.+. ..|+++.++.+|+.|+||+|+|+ .+.
T Consensus 184 PL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~ 261 (1255)
T KOG0444|consen 184 PLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELN 261 (1255)
T ss_pred hhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eee
Confidence 554333334445667777777766533 357888999999999999999998 89999999999999999999999 566
Q ss_pred CccccccccceEeccCCcCCCCcccccccccccceeeccCccccC-ccccccccccccceecccCcccccCCCccccccc
Q 001710 511 SSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSG-DIPITISGLKDLATLSLAGNQFNGPIPESFGSLI 589 (1022)
Q Consensus 511 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 589 (1022)
.....-.+|+.|+||.|+++ .+|.++..++.|+.|.+.+|+++- -+|..++.|.+|+.+..++|.+. ..|..++.+.
T Consensus 262 ~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~ 339 (1255)
T KOG0444|consen 262 MTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCV 339 (1255)
T ss_pred ccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhH
Confidence 66777789999999999999 589999999999999999999973 47999999999999999999999 8899999999
Q ss_pred ccceeecccceeccccCchhhhcccccEEEccCCcceeecCCC
Q 001710 590 SLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIK 632 (1022)
Q Consensus 590 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 632 (1022)
.|+.|.|++|++. .+|+.+.-|+.|+.||+..|+=--.+|..
T Consensus 340 kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 340 KLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred HHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 9999999999998 89999999999999999999876666643
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.56 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=203.6
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
.+|++.+.||+|+||.||+|...+++.+|+|++..... ....+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999977788999998865432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+++|.+++......+++..+..++.+++.|++|||+ .+++||||||+||+++.++.++|+|||.+......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES----SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH----CCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 999999998766668999999999999999999999 78999999999999999999999999999865432211 1
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....++.+|+|||...++.++.++||||+|+++|||++ |..||...... ....... .+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~----~~~~------------ 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETIN----AGFR------------ 219 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHh----CCCC------------
Confidence 122335678999999988889999999999999999998 89998753221 1111111 1000
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
...+...+..+.+++.+||+.+|++||++.|++++|
T Consensus 220 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 -LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 001112356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.42 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=200.0
Q ss_pred HhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC------
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI------ 798 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~------ 798 (1022)
.+.+.|++.+.||+|+||.||+|+. .+++.||+|++..... ....+.+|+.+++++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567788899999999999999985 4688999999875532 235678899999999 699999999998753
Q ss_pred CeeEEEEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccC
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~ 877 (1022)
...++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~----~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ----HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH----CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 45789999999999999988743 358999999999999999999999 7899999999999999999999999999
Q ss_pred ceecCCCCCceeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 952 (1022)
+....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||.+...... ..... .
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~~~-~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLIP-R 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHHHh-c
Confidence 98653322 1223356889999999875 34588899999999999999999999965322111 11000 0
Q ss_pred CCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.. .. ...+..++.++.+++.+||+.+|.+||++.|++++
T Consensus 231 ~~-----~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP-----AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC-----CC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 00 00112345678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=337.78 Aligned_cols=267 Identities=21% Similarity=0.234 Sum_probs=193.7
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCC------CcceeEeeeEee
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH------RNLVKIFSSCCN 797 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~ 797 (1022)
+....++|++.++||+|+||+||+|+. .+++.||||+++... ...+.+..|+.+++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344568899999999999999999985 468889999986432 223445667777777754 458888888876
Q ss_pred C-CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC--------
Q 001710 798 I-DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-------- 868 (1022)
Q Consensus 798 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-------- 868 (1022)
. .+.++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 678998887654 489999999999999999999972 3899999999999998765
Q ss_pred --------cEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccc
Q 001710 869 --------TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940 (1022)
Q Consensus 869 --------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~ 940 (1022)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864321 2234579999999999999999999999999999999999999997633211
Q ss_pred hhHHHHHHhhc---CCCc---------chhccc------cccchh------hhhhhhHHHHHHHHHHHHhhcccCCCCCC
Q 001710 941 MSLRRWVKESL---PHGL---------TEVVDA------NLVGEE------QAFSAKTDCLLSIMDLALDCCMESPEQRI 996 (1022)
Q Consensus 941 ~~~~~~~~~~~---~~~~---------~~~~~~------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 996 (1022)
.+.. +.... +..+ ..+++. ...... ............+.++|.+||++||++||
T Consensus 353 -~~~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 353 -HLHL-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHH-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 1111 11110 0000 000000 000000 00000011235678999999999999999
Q ss_pred CHHHHHHH
Q 001710 997 HMTDAAAE 1004 (1022)
Q Consensus 997 s~~ell~~ 1004 (1022)
|++|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=323.36 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=199.9
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.++||+|+||+||+++.. +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999854 57889999986432 223345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~----~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ----LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999998765568999999999999999999999 889999999999999999999999999997653322
Q ss_pred CceeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 886 DSVTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ...........
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~---- 226 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKER---- 226 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCcc----
Confidence 2 2223356999999999875 3468899999999999999999999997532111 11111100000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~ 1004 (1022)
. ........++.++.+++++|+..+|++ |+++.|++++
T Consensus 227 --~----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 --F----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --c----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000111234667899999988765554 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.68 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=196.4
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhc---CCCcceeEeeeEee-----CC
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNV---RHRNLVKIFSSCCN-----ID 799 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~-----~~ 799 (1022)
+|++.+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999854 689999999875432 1223456677777766 69999999998864 34
Q ss_pred eeEEEEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 800 FKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA----NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 8888887643 348999999999999999999999 88999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc-CC--Cc
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-PH--GL 955 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~ 955 (1022)
........ .....+|..|+|||++.+..++.++||||+||++|||++|++||...... ..+........ +. .+
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence 87643221 22345789999999998888999999999999999999999998653222 11222211110 00 00
Q ss_pred chhc---cccccch--hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 TEVV---DANLVGE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 ~~~~---~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.... ...+... .........++.++.+++.+|+++||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000000 00011112356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.05 Aligned_cols=254 Identities=23% Similarity=0.405 Sum_probs=205.8
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 456789999999999999999997778889999887543 234678889999999999999999999887 778999999
Q ss_pred cCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++... ....++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~----~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ----RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh----CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999764 3357889999999999999999999 7899999999999999999999999999976543221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.......++..|+|||+.....++.++|+||||+++|++++ |+.||..... .....+......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~------------- 221 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR------------- 221 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC-------------
Confidence 11222345677999999988889999999999999999999 8999875322 112222211100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.+.+...+.++.+++.+||+++|++||++.++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=314.18 Aligned_cols=240 Identities=22% Similarity=0.358 Sum_probs=192.1
Q ss_pred CeeecccceEEEEEEEcC--------CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 736 NLLGRGSFGLVYKGTLFD--------GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997432 234888988766555567788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc--------EEEeeccCce
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT--------AHVSDFGISK 879 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~--------~kl~DfG~a~ 879 (1022)
+++|+|.++++..+..+++..+..++.||+.|++|||+ .+|+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED----KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999998776678999999999999999999999 88999999999999987765 6999999986
Q ss_pred ecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCC-CCCCcccccchhHHHHHHhhcCCCcch
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
..... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....... .......
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~-------- 220 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED-------- 220 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc--------
Confidence 54322 22357888999998876 45799999999999999999985 5554321111 1111110
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
....+.....++.+++.+||+.||++||+++++++.|+
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00111223456899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.95 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=199.7
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999854 68899999986532 223445788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~----~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ----LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998765568999999999999999999999 889999999999999999999999999998764432
Q ss_pred CceeeecccCCcccCCccccCC-----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 886 DSVTQTITMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
. .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||......+ ....... ...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~----~~~----- 225 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN----HEE----- 225 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHc----CCC-----
Confidence 2 12233569999999998765 567889999999999999999999997532211 1111110 000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ--RIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~ell~~ 1004 (1022)
.+. .......++.++.+++.+|+..++.+ |+++.+++++
T Consensus 226 -~~~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 -RFQ----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -ccc----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 00001224567889999999876554 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=321.22 Aligned_cols=266 Identities=19% Similarity=0.254 Sum_probs=197.1
Q ss_pred cCCeeecc--cceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 734 ECNLLGRG--SFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 734 ~~~~Lg~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
+.++||+| +|++||+++. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999984 578999999987653 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH----MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999754 2348999999999999999999999 78999999999999999999999999876443211110
Q ss_pred e-----eeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc----
Q 001710 888 V-----TQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT---- 956 (1022)
Q Consensus 888 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 956 (1022)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||............ .....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccch
Confidence 0 0112346778999998865 45889999999999999999999999764322211111 1111100000
Q ss_pred -----------hhcccccc------------chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 -----------EVVDANLV------------GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 -----------~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..+. ......+....++..+.+++.+||++||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000111223456688999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.78 Aligned_cols=237 Identities=24% Similarity=0.285 Sum_probs=187.6
Q ss_pred CeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHH-HHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSEC-EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 68899999987543 12233444454 467889999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~----~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHS----LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 99999887654 47888899999999999999999 889999999999999999999999999987532221 122
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~---------------~ 213 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKP---------------L 213 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCC---------------C
Confidence 335689999999999988999999999999999999999999975321 11111111000 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 999 (1022)
..+...+.++.+++.+|++.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11123355688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.14 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=199.1
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCe
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDF 800 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~ 800 (1022)
....++|.+.+.||+|+||+||+|+.. ++..||+|++.... ......+..|+.+++.++||||+++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445678999999999999999999854 57789999886542 3345678899999999999999999998854 456
Q ss_pred eEEEEEccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC---CCCCeEecCCCCCcEEecC--------
Q 001710 801 KALVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGH---SLAPIVHCDLKPNNILLDE-------- 866 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~~~ivH~Dik~~NIll~~-------- 866 (1022)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+.. ...+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998753 235899999999999999999999832 0135999999999999964
Q ss_pred ---------CCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCc
Q 001710 867 ---------NMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 867 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 33589999999986543221 223468999999998754 4588999999999999999999999975
Q ss_pred ccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 936 MFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
... ...++..... . +.+ ....++.++.++|..||+.+|++||++.|++.+
T Consensus 246 ~~~----~~qli~~lk~-~------p~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANN----FSQLISELKR-G------PDL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCc----HHHHHHHHhc-C------CCC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 322 1122111110 0 000 011235678999999999999999999999853
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.42 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=204.8
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||+|+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34777889999999999999854 68899999987543 34457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++|+|.+++.... +++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~~--l~~~~~~~~~~~l~~~l~~lh~----~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHS----EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHh----CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999987643 7899999999999999999999 7899999999999999999999999999977643321
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||+..+..++.++||||||+++|||++|..||.+...... ... .....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-~~~~~------------ 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFL-IPKNN------------ 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhh-hhcCC------------
Confidence 12234578899999999888899999999999999999999999876432211 000 00000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011233466788999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.80 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=196.1
Q ss_pred CeeecccceEEEEEEEc-CCC--EEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF-DGT--NVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|+.+++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999864 343 46888887432 33456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 811 GSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 811 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
|+|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.+|++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~----~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ----KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH----CCEeecccccceEEEcCCCeEEECCC
Confidence 99999987543 247899999999999999999999 88999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCC
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
|++..... .........+..|+|||+.....++.++||||||+++|||++ |..||...... ...... +..
T Consensus 157 gl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~-~~~ 227 (270)
T cd05047 157 GLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL-PQG 227 (270)
T ss_pred CCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH-hCC
Confidence 99853211 111112234567999999888889999999999999999997 99998653221 111111 111
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
. ....+..++.++.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 228 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 00111234567899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.03 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=201.3
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh---------hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---------RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
+|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477789999999999999985 4688999998864321 223568889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.++||||+++++|.+++...+ .+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~----~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN----RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHh----cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999998764 47889999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc----eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc
Q 001710 881 LGEGDDS----VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 881 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
....... .......++..|+|||...+..++.++||||+|+++|+|++|+.||.+..... .... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-~~~~~----- 228 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFK-IGENA----- 228 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHH-HhccC-----
Confidence 6432111 11122357889999999988889999999999999999999999997632211 1110 00000
Q ss_pred hhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++..+.+++.+||+.||.+||++.|++++
T Consensus 229 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 ------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 001122345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.28 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=202.0
Q ss_pred HHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEe----
Q 001710 723 LDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCC---- 796 (1022)
Q Consensus 723 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---- 796 (1022)
.++..+.++|++.+.||+|+||.||+|+. .+++.||+|+..... .....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44556788999999999999999999985 468899999876432 2235677899999999 6999999999874
Q ss_pred -eCCeeEEEEEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEE
Q 001710 797 -NIDFKALVLEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV 872 (1022)
Q Consensus 797 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl 872 (1022)
..+..++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.+|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV----NKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh----CCccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998763 23357889999999999999999999 78999999999999999999999
Q ss_pred eeccCceecCCCCCceeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHH
Q 001710 873 SDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 873 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 947 (1022)
+|||++..+..... ......|+..|+|||++. +..++.++||||+||++|||++|+.||....... .+.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----ALF 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HHh
Confidence 99999987643221 222346899999999864 3457889999999999999999999987532211 111
Q ss_pred HhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
.. . .. .......+..++.++.+++.+||+.||++||++.|++++.
T Consensus 240 ~~-~-~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KI-P-RN-----------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hc-c-cc-----------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0 00 0000111222355689999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.14 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=205.3
Q ss_pred CCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|+..+.||+|+||.||.++ ..+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999998 4568899999876542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK----AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh----CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999875 3458999999999999999999999 7899999999999999999999999999987644332
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......+++.|+|||...+..++.++||||+|+++|||++|..||...... ............
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~---------- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQGNYT---------- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCC----------
Confidence 223346889999999988888999999999999999999999998653221 111111111000
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
..+..++.++.+++.+||+.+|++||+++|++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11133456789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=323.11 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=199.0
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeC---
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--- 798 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--- 798 (1022)
.....++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 344567899999999999999999984 5688999999875432 2345677899999999999999999887543
Q ss_pred ---CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 799 ---DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 799 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
...++++|++ +++|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~----~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH----CCeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 679998876543 8999999999999999999999 88999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+..+.......
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~- 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTP- 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCC-
Confidence 999865432 223468999999998766 56899999999999999999999999753211 1112211111000
Q ss_pred cchhcc-----------ccccchh-hh-hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEVVD-----------ANLVGEE-QA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~~-----------~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+... ..+.... .. ........+.+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000 00 00001234457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.24 Aligned_cols=266 Identities=24% Similarity=0.290 Sum_probs=199.6
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999854 68999999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 808 MPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS----RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh----CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58988886533 458999999999999999999999 889999999999999999999999999997653322
Q ss_pred CceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCC---Cc---chh
Q 001710 886 DSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH---GL---TEV 958 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 958 (1022)
.......+++.|+|||...+ ..++.++||||+||++|||++|+.||.+....... .......... .+ ...
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL-FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhcchhh
Confidence 12223457889999997765 45788999999999999999999999753221111 1111100000 00 000
Q ss_pred cc--ccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 VD--ANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ~~--~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+ ..... ..........++.++.+++++||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00000 000001122356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.26 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=204.4
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999854 68899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++++|||.++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~----~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE----EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999999875 48999999999999999999999 7899999999999999999999999999987754321
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......++..|+|||...+..++.++||||||+++|||++|+.||......+. ...... ... +.+
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~----~~~----~~~---- 218 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFLIPK----NNP----PSL---- 218 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHHhhh----cCC----CCC----
Confidence 22234678899999999888899999999999999999999999975332111 000000 000 000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. ...++.++.+++.+||..+|++||++++++++
T Consensus 219 ---~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 ---E-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---c-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 01145678999999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.92 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=199.2
Q ss_pred CeeecccceEEEEEEEcC-------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 736 NLLGRGSFGLVYKGTLFD-------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2579999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-----cEEEeecc
Q 001710 808 MPNGSFEKWLYSY------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-----TAHVSDFG 876 (1022)
Q Consensus 808 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-----~~kl~DfG 876 (1022)
+++++|.+++... ...+++..+..++.|++.|++|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ----MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh----CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999753 2347889999999999999999999 7899999999999999887 89999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCc
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGL 955 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 955 (1022)
++................++..|+|||++.++.++.++|||||||++|||++ |+.||...... .....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~----- 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAG----- 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcC-----
Confidence 9976644333222233346788999999999999999999999999999998 99998653221 111111110
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.....+..++..+.+++.+||+.+|++||+++++.+.|++
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111223456778999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=323.74 Aligned_cols=263 Identities=19% Similarity=0.193 Sum_probs=196.3
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999854 5788999975432 23469999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+. ++|.+++......+++..+..|+.||+.||.|||+ .+||||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA----QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 995 58999888766679999999999999999999999 889999999999999999999999999997532221
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCC-Ccccccc--------hhHHHHHHhhc--CCCc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPT-DEMFTGE--------MSLRRWVKESL--PHGL 955 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~-~~~~~~~--------~~~~~~~~~~~--~~~~ 955 (1022)
......||..|+|||++.+..++.++|||||||++|||+++..|+ ....... ..+........ +...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 122346899999999999999999999999999999999865554 3211110 11111111100 0000
Q ss_pred c---------hhccccc--cchhhh--hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 T---------EVVDANL--VGEEQA--FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 ~---------~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. ..++..- ...... ......++.+..++|.+||+.||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 0000000 000000 00111334567789999999999999999999875
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.02 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=201.0
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999854 689999999865432 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++ +|.+++......+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~----~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS----HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 8888887655568999999999999999999999 7899999999999999999999999999986543221
Q ss_pred eeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---c---chhcc
Q 001710 888 VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---L---TEVVD 960 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~ 960 (1022)
......++..|+|||.+.+. .++.++||||+||++|||++|+.|+......+.......+...... + ....+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578899999987664 4789999999999999999999986543332222222111110000 0 00000
Q ss_pred c----cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 A----NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. ..............++.++.+++.+||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0000000011122356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=308.51 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=197.5
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-----hhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCee
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFK 801 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~ 801 (1022)
.+|+..+.||+|+||.||+|.. .+++.||+|++.... .+....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999985 468999999886432 2334568889999999999999999998865 3567
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
+++|||+++++|.+++..... +++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH~----~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHS----NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999987554 7899999999999999999999 78999999999999999999999999999765
Q ss_pred CCCCCc-eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDDS-VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
...... .......++..|+|||...+..++.++||||+||++||+++|+.||......+. . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~----~~~~~~~~----- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-I----FKIATQPT----- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-H----HHHhcCCC-----
Confidence 332111 111224578899999999888899999999999999999999999976422111 1 11100000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..+...+.+++ +||..+|++||+++|++++
T Consensus 227 --------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 --------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0011223445667777 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.30 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=206.1
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46799999999999999999984 46889999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++.+.. +++..+..++.|++.|+.|||+ .+++|||+||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~----~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHS----NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHh----CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999997654 7899999999999999999999 8899999999999999999999999999876543322
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......+++.|+|||...+..++.++||||||+++|++++|+.||......+. ...+. ....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~----------------~~~~ 232 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIA----------------TNGT 232 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehh----------------cCCC
Confidence 12234588899999998888899999999999999999999999975322111 00000 0001
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+...+..+.+++++||..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112223345678999999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=325.08 Aligned_cols=265 Identities=20% Similarity=0.224 Sum_probs=197.7
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC------
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI------ 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 798 (1022)
..++|++.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999984 468899999987543 23346678899999999999999999988643
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~----~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999976 66666643 37888999999999999999999 88999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC------
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP------ 952 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 952 (1022)
+...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||.+....+ ...........
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 8653321 2233468999999999998899999999999999999999999997532111 11111110000
Q ss_pred ----CCcchhcccc--cc---------ch--hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 ----HGLTEVVDAN--LV---------GE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ----~~~~~~~~~~--~~---------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.......+.. .. .. ............++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 00 00 00000111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.17 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=204.3
Q ss_pred cCCCcCCeeecccceEEEEEEEc------CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 802 (1022)
++|++.+.||+|+||.||+|+.. +...||+|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999853 2467999988755433 4567899999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEee
Q 001710 803 LVLEFMPNGSFEKWLYSYN--------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~----~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN----ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh----cCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999997654 148999999999999999999999 7899999999999999999999999
Q ss_pred ccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCC
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 875 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
||++........ .......++..|+|||...+..++.++||||+|+++|++++ |..||...... .........
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~~--- 234 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQAG--- 234 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHcC---
Confidence 999875432221 12223346778999999888889999999999999999999 77888643221 111111110
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
.. ....+..++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 235 ~~-------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KL-------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred Cc-------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 011122356678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.75 Aligned_cols=238 Identities=23% Similarity=0.391 Sum_probs=190.9
Q ss_pred CeeecccceEEEEEEEcC-C----------CEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 736 NLLGRGSFGLVYKGTLFD-G----------TNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~-~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
++||+|+||.||+|...+ + ..||+|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999998653 3 25788887655433 5778899999999999999999999988 778999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-------cEEEeeccC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-------TAHVSDFGI 877 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-------~~kl~DfG~ 877 (1022)
|||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+|++|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED----KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh----CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999998776568999999999999999999999 8899999999999999888 799999999
Q ss_pred ceecCCCCCceeeecccCCcccCCccccCCC--CCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCC
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
+..... .....++..|+|||++.+. .++.++||||+|+++||+++ |..||......+ ...+... ..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~~---~~ 223 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQD---QH 223 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHhc---CC
Confidence 986533 1223466789999988776 78999999999999999999 577776532111 1111110 00
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
. .+.+ ....+.+++.+||..+|++||++.|+++.|+
T Consensus 224 --------~------~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 --------R------LPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------C------CCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0000 0156889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.50 Aligned_cols=258 Identities=23% Similarity=0.286 Sum_probs=206.1
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5688889999999999999984 468899999886553 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++...+ .+++..+..++.+++.|+.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh---cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999987754 489999999999999999999973 369999999999999999999999999986542221
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccch------hHHHHHHhhcCCCcchhccc
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM------SLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 961 (1022)
.....++..|+|||++.+..++.++|||||||++||+++|+.||......+. ....+.......
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 228 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------- 228 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc--------
Confidence 1234688999999998888899999999999999999999999986433211 011111111100
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
..... ....++.++.+++.+||++||++||++.|++++..-+
T Consensus 229 ----~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 229 ----PPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ----cCCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 00000 1112566789999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=320.00 Aligned_cols=194 Identities=21% Similarity=0.266 Sum_probs=159.5
Q ss_pred CCeeecccceEEEEEEEc---CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCeeEEEEEccC
Q 001710 735 CNLLGRGSFGLVYKGTLF---DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFKALVLEFMP 809 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~ 809 (1022)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999854 46789999986442 22456789999999999999999998854 456789999996
Q ss_pred CCCHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe----cCCCcEEEeeccC
Q 001710 810 NGSFEKWLYSY--------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGI 877 (1022)
Q Consensus 810 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfG~ 877 (1022)
+ +|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~----~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA----NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh----CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 888877532 1248889999999999999999999 889999999999999 4667899999999
Q ss_pred ceecCCCCCc-eeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCc
Q 001710 878 SKLLGEGDDS-VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 878 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
|+.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9876433221 12234568999999998766 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=312.66 Aligned_cols=270 Identities=22% Similarity=0.276 Sum_probs=200.4
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++++|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999984 46899999998655322 2345678999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||++ +++.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~----~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG----QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67777776555557888899999999999999999 789999999999999999999999999987643222
Q ss_pred CceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh-hcCCC---------
Q 001710 886 DSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE-SLPHG--------- 954 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--------- 954 (1022)
. ......++..|+|||...+ ..++.++||||+|+++|||++|..||+........+...... ..+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 1223457889999998765 357889999999999999999999997644322222211110 00000
Q ss_pred ---cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 ---LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+...................+.++.+++.+|+..||.+|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000001124568899999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=311.87 Aligned_cols=267 Identities=20% Similarity=0.234 Sum_probs=202.5
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999865 689999998864432 223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++++.+..+..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHK----HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888766544 48999999999999999999999 8899999999999999999999999999987644332
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--CCcchhcc---
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP--HGLTEVVD--- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--- 960 (1022)
......++..|+|||...+ ..++.++||||+|+++|||++|+.||.+....+. .......... .......+
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhccccc
Confidence 1223457888999998765 5678999999999999999999999976433221 1111110000 00000000
Q ss_pred -------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 -------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+...............+..+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000001112346778999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.86 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=188.3
Q ss_pred CeeecccceEEEEEEEcCC---CEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 736 NLLGRGSFGLVYKGTLFDG---TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999985443 345677665443 234567899999999999999999999999999999999999999
Q ss_pred CHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 812 SFEKWLYSYN---YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 812 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
+|.+++.... ...+...+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~----~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK----HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH----CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999997643 235677788999999999999999 789999999999999999999999999986432222111
Q ss_pred eeecccCCcccCCccccCC-------CCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 889 TQTITMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
......++..|+|||+... ..++.++||||||+++|||++ |..||...... .......... .....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~----~~~~~~ 231 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQ----QVKLFK 231 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhc----ccccCC
Confidence 2223457889999998643 245789999999999999997 46677643221 1111111111 111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
+.+ +..+...+.+++..|| .+|++||+++++++.|.
T Consensus 232 ~~~---------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL---------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc---------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 1123556788999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=293.08 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=205.4
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
..++|+.+++||+|.||.|-+++ ..+|+.||+|+++++. ++....-..|-++++..+||.+..+-..|...+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 35789999999999999999998 4579999999998775 3445566789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+.||.|.-.+.+.+. +++.....+...|+.||.|||+ ++||+||+|.+|.++|.||++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLHs----~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLHS----RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhhh----CCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999999988887654 6777777789999999999999 889999999999999999999999999997532
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.........+||+.|+|||++....|+.++|+|.+|+|+|||++|+.||..... .-+...+..
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl~-------------- 382 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELILM-------------- 382 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHHh--------------
Confidence 222344567899999999999999999999999999999999999999976321 112111110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.....|...+++...++...+.+||.+|. .++|+.++
T Consensus 383 ----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 ----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 01122344466778999999999999997 56666654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=341.24 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=217.4
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEc----C----CCEEEEEEecchh-hhhHHHHHHHHHHHhhc-CCCcceeEeeeE
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF----D----GTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSC 795 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~ 795 (1022)
+...++..+.+.+|+|+||.||+|..+ . ...||||.++... ....+.+..|+.+|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334455566679999999999999732 1 3569999987654 34567899999999999 699999999999
Q ss_pred eeCCeeEEEEEccCCCCHHHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 796 CNIDFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 796 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
......++|+||+..|+|.++++..+ ..++....+.+++|||.|++||++ .++||||+.++
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~----~~~vHRDLAaR 447 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS----VPCVHRDLAAR 447 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh----CCccchhhhhh
Confidence 99999999999999999999999887 348899999999999999999999 78999999999
Q ss_pred cEEecCCCcEEEeeccCceecCCCCCceee-ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccc
Q 001710 861 NILLDENMTAHVSDFGISKLLGEGDDSVTQ-TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFT 938 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~ 938 (1022)
|||+.++..+||+|||+|+.......+... +...-...|||||.+....|+.++||||||+++||++| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976655544422 21113557999999999999999999999999999999 7889876321
Q ss_pred cchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhH
Q 001710 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~ 1010 (1022)
.+ .+.++++ .+.+...|..|+.+++++|+.||+.+|++||++.++++.++....
T Consensus 528 ~~-~l~~~l~-----------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TE-ELLEFLK-----------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH-HHHHHHh-----------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 21 1122222 233556778899999999999999999999999999999999543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=311.60 Aligned_cols=267 Identities=20% Similarity=0.218 Sum_probs=204.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999985 468999999987654 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+ +++|.+++......+++.++..++.|++.|++|||+ .+|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA----NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999998766679999999999999999999999 8899999999999999999999999999987644322
Q ss_pred eeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---cchhcc---
Q 001710 888 VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEVVD--- 960 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 960 (1022)
.......++..|+|||...+. .++.++||||+|+++|||++|.+||...... .............. +.+..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcch
Confidence 122334688999999987654 4689999999999999999998887653221 11111111110000 000000
Q ss_pred c---cccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 A---NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~---~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. .... ...........+.++.+++++|++++|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000 000001112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=323.67 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=198.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC------
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI------ 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 798 (1022)
..++|++.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999984 468899999987542 23345678899999999999999999987543
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
...++||||+++ ++.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~----~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh----CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999976 67776643 37888999999999999999999 88999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch-
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE- 957 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 957 (1022)
+...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||.+....+ ........ ......+
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ-LGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCCHHH
Confidence 8653322 2233468999999999999999999999999999999999999997532211 11111110 0000000
Q ss_pred ----------hcccc--ccch-----------hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 ----------VVDAN--LVGE-----------EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ----------~~~~~--~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..... +... ............++.+++.+|++.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000 00000011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=311.60 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=201.3
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 78999999887543 33356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 808 MPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
+++++|.+++... ...+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE---HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc---CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998764 22589999999999999999999962 479999999999999999999999999997653221
Q ss_pred CceeeecccCCcccCCccccCCCC------CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.....++..|+|||...+.. ++.++||||+||++|||++|+.||....... ...........
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~------ 225 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIVDG------ 225 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHhhc------
Confidence 12245788999999875543 5889999999999999999999996532111 11100000000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. ....+..++.++.+++.+||+.+|++||++.+++.+
T Consensus 226 ------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 ------D--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------C--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 011223356778999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.17 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=200.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee-CCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e 806 (1022)
+|++.+.||+|++|.||+++. .+++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999984 457899999986543 2345668889999999999999999998764 446789999
Q ss_pred ccCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|+++++|.+++... ...+++.++..++.+++.|++|||+ .+|+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~----~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE----KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999864 3358999999999999999999999 889999999999999999999999999998764322
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......+++.|+|||+..+..++.++||||+|+++||+++|+.||...... .+.........
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~---------- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIEGKL---------- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcCC----------
Confidence 2 122345788999999999999999999999999999999999998753211 11111100000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++..+.+++.+||+.+|++||++.+++++
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.45 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=201.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.|+..+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 366678899999999999985 467899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~----~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLHS----ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc----CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999999998754 38899999999999999999999 7899999999999999999999999999976543221
Q ss_pred eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
......++..|+|||+..+..++.++||||||+++|||++|+.||........ ..+... ... +
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~----~~~----~------- 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPK----NSP----P------- 219 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhhhc----CCC----C-------
Confidence 12224578899999999888899999999999999999999999875322211 111110 000 0
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+..++.++.+++.+||+.+|++||++.+++++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112345678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.60 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=200.1
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh----------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL----------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID 799 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 799 (1022)
+|...+.||+|+||.||+|.. .+|+.||+|.++... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999984 468999999875421 112346788999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
..++||||+++++|.++++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++++|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS----KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh----CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998765 48899999999999999999999 789999999999999999999999999997
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCCC--CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
...............++..|+|||...... ++.++|+||+|+++||+++|..||...... ..+.. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~ 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFK-LGNKRSAP 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHH-hhccccCC
Confidence 653322222222345788999999876654 789999999999999999999998642221 11111 00000000
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.. .....++.++.+++.+||+++|++||++.+++++
T Consensus 232 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPP---------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCc---------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 1112346778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.39 Aligned_cols=245 Identities=22% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCCeeecccceEEEEEEE-cCCCEEEEEEecch----hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe--eEEEEE
Q 001710 734 ECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQ----LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF--KALVLE 806 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--~~lv~e 806 (1022)
...+||+|+|-+||+|.+ .+|..||--.++.. ..+..++|..|+.+|+.|+||||+++|.+|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 347899999999999984 45777875333222 23445789999999999999999999999987665 678999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec-CCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~ 885 (1022)
.+..|+|..|+.+.+. .....+..|++||++||.|||+++ .+|||||||-+||+|. ..|.|||+|+|+|+......
T Consensus 124 L~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~--PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQD--PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCC--CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999886 889999999999999999999976 7899999999999997 57899999999998764332
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....+|||.|||||... ..|...+||||||+.++||+|+..||.+-....+-+........|.....+-
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~------ 269 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK------ 269 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC------
Confidence 22268999999999876 6799999999999999999999999987655444333333222222222222
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+++.++|.+|+.. ..+|||+.|++++
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 23578999999999 9999999999864
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.11 Aligned_cols=250 Identities=31% Similarity=0.512 Sum_probs=203.0
Q ss_pred CCcCCeeecccceEEEEEEEcC-----CCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTLFD-----GTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
+++.+.||+|+||.||+++..+ +..||+|++...... ..+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998543 388999999765433 5678889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 806 EFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
||+++++|.+++...... +++..+..++.|++.|++|||+ .+++||||||+||++++++.++++|||.+......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~----~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES----KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc----CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999875544 8999999999999999999999 78999999999999999999999999999877554
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
...... ...++..|+|||...+..++.++||||+|+++|||++ |..||..... ....+.+.....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~----------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYR----------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC-----------
Confidence 322211 2336789999999888889999999999999999998 7888765211 111111111100
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
...+..++.++.+++.+||+.||++|||+.|+++.|
T Consensus 223 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=286.15 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=203.7
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++.+.+.-||.|..|.||+++. .+|+..|||.+.... .+..+++...++++..-. +|.||+.+|+|......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445567799999999999984 468999999987654 444567777777776664 8999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
.|.. .++..++.-..++++.-.-++...+++||.||.+.| +|+|||+||+|||+|+.|.+|+||||.+.++..
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--- 244 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--- 244 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeec---
Confidence 9844 677888777777899889999999999999999865 799999999999999999999999999987633
Q ss_pred ceeeecccCCcccCCccccCC---CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
+...+..+|-+.|||||.+.. ..|+..+||||||+.++|+.||..||..-......+.....+
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-------------- 310 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-------------- 310 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--------------
Confidence 334555678999999997654 468889999999999999999999998744443333332221
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+.++....+++++.+++..|+++|+.+||...+++++
T Consensus 311 --ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 --EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 112233334467889999999999999999999999875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=312.13 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=203.1
Q ss_pred hHHHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEee-
Q 001710 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCN- 797 (1022)
Q Consensus 721 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~- 797 (1022)
+..++..+.+.|++.+.||+|+||.||+|+. .+++.||+|++..... ....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4445556678899999999999999999985 4688999999865533 335678899999999 69999999999853
Q ss_pred -----CCeeEEEEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEE
Q 001710 798 -----IDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH 871 (1022)
Q Consensus 798 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~k 871 (1022)
....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~----~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA----HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEE
Confidence 457899999999999999987643 357888899999999999999999 7899999999999999999999
Q ss_pred EeeccCceecCCCCCceeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHH
Q 001710 872 VSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946 (1022)
Q Consensus 872 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 946 (1022)
|+|||++........ ......++..|+|||.+. +..++.++||||+||++|||++|+.||......+... .
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L- 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-
Confidence 999999876532211 122346889999999765 3568889999999999999999999997532221110 0
Q ss_pred HHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..... .. ......++.++.++|.+||+.||++||++.|++++
T Consensus 238 ~~~~~--------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 IPRNP--------PP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HhhCC--------CC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00000 00 01112356679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.97 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=206.2
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|+||+||+|.. .++..+|+|++.... ....+.+.+|+..++.++|+|++++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999984 468899999986543 23457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 808 MPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
+++++|.++++... ..+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~----~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS----NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999997642 358999999999999999999999 889999999999999999999999999997765433
Q ss_pred Cce--eeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 886 DSV--TQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 886 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
... ......++..|+|||.+... .++.++|+||||+++|||++|+.||......+ ......... +. .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~--------~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-PP--------S 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-CC--------C
Confidence 221 12234588999999987766 78999999999999999999999997643321 111111110 00 0
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+. .......++..+.+++.+||+.||++||++.+++++
T Consensus 227 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LE----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cC----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000112456778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.42 Aligned_cols=248 Identities=27% Similarity=0.352 Sum_probs=202.2
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-----hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
+|+..+.||+|+||.||+|... +++.||+|.+.... ++..+.+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999965 78999999886543 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++++|.+++.... .+++..+..++.|++.|++|||+ .+|+|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD----RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999998765 37899999999999999999999 78999999999999999999999999999875433
Q ss_pred CCceeeecccCCcccCCccccCCCC-CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
. ......++..|+|||...... ++.++|+||+|+++|++++|+.||......+ ....+... ..
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~--------- 219 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KE--------- 219 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---cc---------
Confidence 2 123345888999999877666 8999999999999999999999997643111 11111100 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++.++.+++.+||+.+|++||++.+++++
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 001122345678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.05 Aligned_cols=246 Identities=29% Similarity=0.500 Sum_probs=199.5
Q ss_pred cCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
++|++.+.||+|+||.||+++ .+++.||+|..+... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 458889999999999999997 568889999986543 235788899999999999999999998764 4689999999
Q ss_pred CCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 810 NGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 810 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
+++|.+++..... .+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES----KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999976543 57899999999999999999999 889999999999999999999999999987643221
Q ss_pred eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.....+..|+|||...+..++.++||||+|+++|||++ |+.||......+ ...... .+.
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~~~------------ 214 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVE----KGY------------ 214 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh----CCC------------
Confidence 11234567999999988899999999999999999998 899987532211 111111 110
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
....+..++..+.+++.+||+.+|++||+++++++.+++
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011123456778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.14 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=200.1
Q ss_pred CCcCCeeecccceEEEEEEEc----CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC------
Q 001710 732 FNECNLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID------ 799 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 799 (1022)
|.+.+.||+|+||.||+|... ++..||||++..+. ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999742 36889999987543 334567889999999999999999999886532
Q ss_pred eeEEEEEccCCCCHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEee
Q 001710 800 FKALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
..++++||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+|++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~----~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS----KNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCEeecccchhhEEEcCCCCEEECc
Confidence 347899999999999887532 1247889999999999999999999 7899999999999999999999999
Q ss_pred ccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhcCC
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 875 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
||.++...............++..|++||......++.++|||||||++|||++ |+.||..... .....+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~-- 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN-- 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC--
Confidence 999987644332222223345678999999888889999999999999999999 8888865322 11112111100
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
....+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ---------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=313.85 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=199.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999854 57899999987553 233457788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.+++...+ .+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN----YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997765 48899999999999999999999 889999999999999999999999999986421100
Q ss_pred C-------------ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC
Q 001710 886 D-------------SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952 (1022)
Q Consensus 886 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 952 (1022)
. ........++..|+|||.+.+..++.++|+||||+++||+++|..||.+.... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC
Confidence 0 00111234778899999988888999999999999999999999998753221 111111111000
Q ss_pred CCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 953 HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
. ......++.++.+++.+||+.||++||++.++.+.++
T Consensus 235 ~----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 235 W----------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred C----------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 0011134667899999999999999998644444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=305.66 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=203.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.++||+|+||.||+++. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999984 468999999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+++++|.+++.... ..+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD----RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999987643 357899999999999999999999 7899999999999999999999999999987643322
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
. .....++..|+|||+..+..++.++|||||||++|++++|+.||..... ...+........
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~----------- 218 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSY----------- 218 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCC-----------
Confidence 1 1224578899999999888899999999999999999999999864211 111111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++.+||+.+|++||++.|++++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01123346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=311.95 Aligned_cols=260 Identities=26% Similarity=0.328 Sum_probs=203.4
Q ss_pred hHHHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC
Q 001710 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 721 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 798 (1022)
...++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3345666788999999999999999999985 468899999986432 2235677899999999 799999999998754
Q ss_pred -----CeeEEEEEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcE
Q 001710 799 -----DFKALVLEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTA 870 (1022)
Q Consensus 799 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~ 870 (1022)
...++||||+++++|.++++. ....+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN----NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHEEEcCCCCE
Confidence 357999999999999998863 23458999999999999999999999 889999999999999999999
Q ss_pred EEeeccCceecCCCCCceeeecccCCcccCCccccCCC-----CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHH
Q 001710 871 HVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG-----IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRR 945 (1022)
Q Consensus 871 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~ 945 (1022)
||+|||++........ ......++..|+|||.+... .++.++||||+||++|||++|+.||...... .....
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK 244 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH
Confidence 9999999886543222 12234588899999986543 3688999999999999999999998764221 11111
Q ss_pred HHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 946 WVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 946 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+..... . ....+......+.+++.+||+.+|++||++.|++++
T Consensus 245 ~~~~~~----~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNPP----P------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCCC----C------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111100 0 011122334568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=313.37 Aligned_cols=267 Identities=24% Similarity=0.292 Sum_probs=202.6
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999965 589999998764432 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++++++.++..... .+++..+..++.|++.|++|||+ .+|+|||++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~----~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS----HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999988766543 38999999999999999999999 7899999999999999999999999999987643322
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHH--hhcCCCcchhcc---
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK--ESLPHGLTEVVD--- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--- 960 (1022)
......++..|+|||...+ ..++.++||||||+++|||++|+.||......+ ....... ...........+
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence 2223457889999998765 457889999999999999999999986532211 1111110 000000000000
Q ss_pred -------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 -------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+............+.++..+.+++.+||+++|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00110111111223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.96 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=200.3
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
|.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+|++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456799999999999985 46889999998765555567788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
++|.+++... .+++..+..++.||+.|++|||+ .+|+||||||+||++++++.++|+|||++........ ..
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~----~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLHN----QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH----CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 9999988654 38899999999999999999999 7899999999999999999999999999876533221 12
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....++..|+|||...+..++.++||||+|+++|||++|+.||...... ..... .....+. ..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~-~~~~~~~--------~~------- 238 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRR-IRDNLPP--------RV------- 238 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHhcCCC--------cc-------
Confidence 2345889999999988888999999999999999999999998753211 11111 1111111 00
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+..+.+++.+||..||.+||++.|++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112235568899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.52 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=194.3
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHH-HhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEI-LRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|+||.||+|+.. +|+.||+|+++.... .....+..|... ++..+||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999854 699999999875432 222345556554 566689999999999999999999999
Q ss_pred ccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 807 FMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLA-PIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 807 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
|++ |+|.+++.. ....+++..+..++.|++.|++|||+ . +++||||||+||++++++.+||+|||.+..+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS----KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh----cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 588887754 23468999999999999999999998 5 79999999999999999999999999998653
Q ss_pred CCCCceeeecccCCcccCCccccCC----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1022)
... ......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||.........+........+
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 226 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP------ 226 (283)
T ss_pred ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC------
Confidence 221 1223457889999998754 446889999999999999999999997533222222221111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+ ....++.++.+++.+||..+|++||++.+++++
T Consensus 227 ---~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 ---QL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011246678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.00 Aligned_cols=240 Identities=24% Similarity=0.243 Sum_probs=186.5
Q ss_pred eecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc---CCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV---RHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
||+|+||+||+|+. .+++.||||++.... ......+..|..++.+. +||+|+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999985 468999999986542 12233455567777665 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~----~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHK----YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 99999987654 48999999999999999999999 8899999999999999999999999999875432221 12
Q ss_pred ecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 891 TITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
....||..|+|||.+.+. .++.++||||+||++|||++|+.||......+ ...... .+.. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i~-~~~~-----~~------ 216 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNIA-FGKV-----RF------ 216 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHHH-cCCC-----CC------
Confidence 335689999999987654 48999999999999999999999997532111 111110 0000 00
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCC----CHHHHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRI----HMTDAAA 1003 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~ell~ 1003 (1022)
+ ...++.++.+++.+||+.||++|| ++.++++
T Consensus 217 -~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 -P-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -C-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 012355678999999999999998 4566655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.08 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=200.7
Q ss_pred CCCcCCeeecccceEEEEEEEcC--CCEEEEEEecchh----------hhhHHHHHHHHHHHhh-cCCCcceeEeeeEee
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFD--GTNVAIKVFNLQL----------ERAFRTFDSECEILRN-VRHRNLVKIFSSCCN 797 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~ 797 (1022)
+|++.+.||+|+||.||+|+... ++.+|+|.+.... ......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999654 6889999875321 2234557778888875 699999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEee
Q 001710 798 IDFKALVLEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+. .+++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC---CceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998753 344689999999999999999999952 5799999999999999999999999
Q ss_pred ccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 875 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
||.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||...... .....+.. ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~---~~ 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVE---AV 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHhh---cc
Confidence 99998764432 223456888999999998888999999999999999999999998642111 11111111 00
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
.... ....++.++.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPL-------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcC-------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 01123567899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.93 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=200.7
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999854 6899999998654322 23456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++ +|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~----~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ----RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9985 9999988766678999999999999999999999 7899999999999999999999999999875432211
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--CC-cchhcc--
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP--HG-LTEVVD-- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~-- 960 (1022)
......++..|+|||...+ ..++.++||||+|+++|||++|+.||.+................. .. +.....
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122346788999998765 458899999999999999999999997543222222111111000 00 000000
Q ss_pred ----ccc--cchhhhhhhhHHH--HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ----ANL--VGEEQAFSAKTDC--LLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ----~~~--~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
... ............. ..++.+++++|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0000000000011 2567899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.93 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=201.9
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|+..+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|++++++++||+++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999984 468899999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeeccCceecCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~ 885 (1022)
+++++|.+++.... ..+++..+.+++.+++.|++|||+ .+|+||||+|+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~----~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT----KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999998753 358999999999999999999999 789999999999999855 468999999998764432
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||....... ..........
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~~~~---------- 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMSGTF---------- 218 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHhcCC----------
Confidence 2 122457889999999988889999999999999999999999987532211 1111110000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++.+||+++|++||++.|++++
T Consensus 219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01112345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=344.71 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=206.7
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.+-+|....+||.|.||.||.|. ..+|+-.|+|-++... ....+.+.+|+.++..++|||+|++||+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456777899999999999998 5679999999776554 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
||||++|+|.+.++..+. .++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|..+.+.
T Consensus 1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH~----~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLHE----HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHHh----cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999887653 5666666788999999999999 88999999999999999999999999999988665
Q ss_pred CCc--eeeecccCCcccCCccccCCCC---CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 885 DDS--VTQTITMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 885 ~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
... .......||+.|||||++.+.. ...++||||+|||+.||+||+.||.++.....-+-.....+.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~-------- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK-------- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC--------
Confidence 322 2233567999999999876643 567899999999999999999999875444322222111111
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
-..|+..+.+-.+++..|++.||++|.++.|++++
T Consensus 1460 ----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12234467778999999999999999998877664
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=314.50 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=200.1
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
|+....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999985 46899999998765444456788899999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++..+..... ..
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~----~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLHS----QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9999988653 38899999999999999999999 7899999999999999999999999999875533221 22
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....++..|+|||++.+..++.++||||+||++|||++|+.||...... .... ......... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~-~~~~~~~~~---------------~ 237 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMK-RLRDSPPPK---------------L 237 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHhccCCCC---------------c
Confidence 2356889999999998888999999999999999999999998642211 1111 111110000 0
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+.++.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.47 Aligned_cols=248 Identities=26% Similarity=0.304 Sum_probs=205.4
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.+.|..-++||+|+||.||-++. .+|+-||.|.+.+..- ........|..++.++..+.||.+-.+|++++..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35577788999999999999984 5799999998865432 2234567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 805 LEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
+..|.||+|.-++...+. .++++.+..++.+|+.||++||. ..||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~----~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR----RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh----cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998887653 58999999999999999999999 8899999999999999999999999999998865
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
+.. ....+||.+|||||++..+.|+...|+||+||++|||+.|+.||...... .-.+.+|++.
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEvdrr~ 402 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEVDRRT 402 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHHHHHH
Confidence 543 33458999999999999999999999999999999999999999752211 1112233333
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 999 (1022)
.... ...+..++++..++.+..++.||++|....
T Consensus 403 ~~~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LEDP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcch--hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3222 223356788899999999999999998543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.92 Aligned_cols=266 Identities=24% Similarity=0.266 Sum_probs=202.1
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhh-----hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER-----AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
+|+..+.||+|+||.||+|... +++.||+|.++..... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999854 6899999998755322 334567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+ +|+|.+++......+++..+..++.|+++||+|||+ .+|+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS----NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 889999998765468999999999999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---cc---h
Q 001710 885 DDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LT---E 957 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~ 957 (1022)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+........... +. .
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 22 1222346788999997754 46789999999999999999998877653221 11212111110000 00 0
Q ss_pred hccc---cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 VVDA---NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+. ...............+.++.+++.+||++||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0000001111123346778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.53 Aligned_cols=251 Identities=24% Similarity=0.276 Sum_probs=198.1
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-----hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--Cee
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFK 801 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 801 (1022)
.+|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999985 468999999875332 23346788899999999999999999988763 467
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++++|.+++..... +++..+.+++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||.+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~----~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHS----NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999876543 7888999999999999999999 78999999999999999999999999999765
Q ss_pred CCCCCc-eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDDS-VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
...... .......++..|+|||...+..++.++||||||+++|||++|+.||....... .... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~~----- 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFK----IATQPT----- 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHH----HhcCCC-----
Confidence 332111 11222458889999999888889999999999999999999999997532111 1111 110000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+...+..+.+++.+|+. +|++||+++|++++
T Consensus 227 --------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011123345567889999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.44 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=203.9
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 4789999999876544 3567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++.... .+++..+..++.+++.|++|||+ .+|+|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~----~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHS----HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998754 37889999999999999999999 88999999999999999999999999999876443322
Q ss_pred ee--eecccCCcccCCccccCCCC---CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 888 VT--QTITMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 888 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.. .....++..|+|||++.+.. ++.++||||||+++||+++|+.||.+...... .........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~----------- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAGH----------- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcCC-----------
Confidence 11 11245788999999887766 88999999999999999999999975322111 111111100
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+....++..+.+++++||+.+|++||++.|++.+
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 ----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00111112235667899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.95 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=205.9
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999865 68999999987654 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++......++...+.+++.|++.|++|||+. .+++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK---HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC---CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999987655689999999999999999999982 47999999999999999999999999998765322111
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
...++..|+|||...+..++.++||||+|+++|++++|+.||..................... .
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 221 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------P 221 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------------C
Confidence 155788999999998889999999999999999999999999764322222222222111110 0
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.... ...++.++.++|.+||..||++||++.+++.+
T Consensus 222 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 11156678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.97 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=202.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 578999999986533 2234678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-cEEEeeccCceecC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKLLG 882 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfG~a~~~~ 882 (1022)
||||+++++|.+++...+ .+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~----~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE----NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997655 48899999999999999999999 8899999999999998776 59999999998765
Q ss_pred CCCCc--eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 883 EGDDS--VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 883 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
..... .......++..|+|||...+..++.++||||+|+++|++++|..||....... ... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~-~~~~~~~~~------ 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLA-LIFKIASAT------ 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHH-HHHHHhccC------
Confidence 43211 11123457889999999888889999999999999999999999986422111 111 111100000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+...+.++.+++.+||+.+|++||++.|++++
T Consensus 228 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 -------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0111223456778999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.95 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=202.2
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCC-----
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNID----- 799 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~----- 799 (1022)
.++++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999964 678999999876543 346788999999999 6999999999997644
Q ss_pred -eeEEEEEccCCCCHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 800 -FKALVLEFMPNGSFEKWLYSYN---YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 800 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~----~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE----NKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc----CCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999887533 468999999999999999999999 78999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCC-----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
|.+........ ......++..|+|||.+.. ..++.++||||+|+++|+|++|+.||....... ...+....
T Consensus 158 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~- 233 (275)
T cd06608 158 GVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRN- 233 (275)
T ss_pred ccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhcc-
Confidence 99987543221 2233458889999997643 346789999999999999999999997532211 11111110
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.......+..++.++.+++.+||..||++|||+.|++++
T Consensus 234 ---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 ---------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000111223356778999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.34 Aligned_cols=262 Identities=19% Similarity=0.195 Sum_probs=187.5
Q ss_pred CeeecccceEEEEEEEc---CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTLF---DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~ 810 (1022)
.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999854 45789999886542 22457789999999999999999998853 5577899999875
Q ss_pred CCHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe----cCCCcEEEeeccCc
Q 001710 811 GSFEKWLYSY--------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGIS 878 (1022)
Q Consensus 811 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfG~a 878 (1022)
+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA----NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh----CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 777776432 1247889999999999999999999 889999999999999 56779999999999
Q ss_pred eecCCCCCc-eeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccc--------hhHHHHHH
Q 001710 879 KLLGEGDDS-VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--------MSLRRWVK 948 (1022)
Q Consensus 879 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~--------~~~~~~~~ 948 (1022)
+........ .......+|+.|+|||.+.+ ..++.++||||+||++|||+||++||....... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876543221 12233468999999998766 458999999999999999999999996432110 11111111
Q ss_pred hhcCC---Ccchh------------c-cccccchhh--h-hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 949 ESLPH---GLTEV------------V-DANLVGEEQ--A-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 949 ~~~~~---~~~~~------------~-~~~~~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..... .+... . ......... . ..........+.+++.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 10000 00000 0 000000000 0 00001123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.94 Aligned_cols=245 Identities=25% Similarity=0.296 Sum_probs=201.5
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999854 68999999986543 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~----~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHS----LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999998764 48999999999999999999999 88999999999999999999999999999876433
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.....+++.|+|||...+..++.++||||+|+++|+|++|+.||..... ........ .+
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~-----~~----------- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKIL-----EG----------- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh-----cC-----------
Confidence 2234588999999998888889999999999999999999999875321 11111100 00
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+...+..+.+++.+||..||.+|+ +++|++++
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0011222356788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.29 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=201.5
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee--CCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~ 805 (1022)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 468899999886432 3345678889999999999999999998754 45678999
Q ss_pred EccCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 806 EFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGH-SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
||+++++|.+++... ...+++..++.++.|++.|++|||..+ ...+|+|+||+|+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998764 346899999999999999999999210 0078999999999999999999999999999876
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
...... .....++..|+|||...+..++.++||||||+++|+|++|+.||.... .....+.+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~--------- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKF--------- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCC---------
Confidence 443321 223468899999999988889999999999999999999999997632 1111111111100
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++.+|++.+|++||++.+++++
T Consensus 228 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=290.78 Aligned_cols=272 Identities=21% Similarity=0.239 Sum_probs=199.2
Q ss_pred hcCCCcCCeeecccceEEEEEEE-c--C--CCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEee-CCe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-F--D--GTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDF 800 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~--~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~ 800 (1022)
...|+.+..||+|.||.||+|.- + + ...+|+|.++.+.+ ......-+|+..++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 34688999999999999999952 2 2 23789999976632 233456789999999999999999999877 778
Q ss_pred eEEEEEccCCCCHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC----CcEEE
Q 001710 801 KALVLEFMPNGSFEKWLYSYN----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN----MTAHV 872 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~----~~~kl 872 (1022)
.++++||++. +|...++.++ ..++...+..|++||+.|+.|||+ .=|.|||+||.||+|..+ |.|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~----NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS----NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh----hheeeccCCcceEEEeccCCccCeeEe
Confidence 8999999998 8888887543 368999999999999999999999 459999999999999877 89999
Q ss_pred eeccCceecCCCCCce-eeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCccccc-----chh---
Q 001710 873 SDFGISKLLGEGDDSV-TQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTG-----EMS--- 942 (1022)
Q Consensus 873 ~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~-----~~~--- 942 (1022)
+|||+|+.+.+.-... .....+.|.+|+|||++.|. .||.+.||||.||++.||+|-.+.|...... ...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999886543332 33446789999999977665 5999999999999999999988877542111 111
Q ss_pred HHHHHHhhc-CC--Ccchhc----------ccc--ccc---hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 943 LRRWVKESL-PH--GLTEVV----------DAN--LVG---EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 943 ~~~~~~~~~-~~--~~~~~~----------~~~--~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.....-.- |. .|..+. +.+ ... -....+....-++..++++..++++||.+|.|+++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111000 00 011110 000 000 000111111122337899999999999999999999886
Q ss_pred H
Q 001710 1005 L 1005 (1022)
Q Consensus 1005 L 1005 (1022)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 4
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=309.16 Aligned_cols=247 Identities=26% Similarity=0.295 Sum_probs=198.6
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
...|+..+.||+|+||+||+|+.. +++.||+|++.... .+..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999854 68999999886432 23346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||++ |++.+++......+++..+..++.|++.|+.|||+ .+|+||||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~----~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS----HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99997 57878776655568999999999999999999999 78999999999999999999999999998765322
Q ss_pred CCceeeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
....++..|+|||.+. ...++.++||||||+++|||++|..||........ ......... +
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~-----~ 232 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNDS-----P 232 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcCCC-----C
Confidence 1235788999999763 45688999999999999999999999865321110 000000000 0
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......++..+.+++.+||+.||++||++.+++.+
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 --------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00112356678999999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=304.85 Aligned_cols=256 Identities=24% Similarity=0.255 Sum_probs=201.1
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 805 (1022)
++|+..+.||.|++|.||+|.. .+++.||+|++..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688889999999999999996 4688999999875433 3456788999999999999999999988653 4689999
Q ss_pred EccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 806 EFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
||+++++|.+++.. ....++...+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~----~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS----RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988653 33458899999999999999999999 889999999999999999999999999987653
Q ss_pred CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccc---cchhHHHHHHhhcCCCcchhc
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT---GEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.... ....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .......+..........
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK--- 229 (287)
T ss_pred cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc---
Confidence 2221 123477889999999888999999999999999999999999976422 111222222211100000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. ........+..+.+++.+||+.+|++|||+.|++++
T Consensus 230 -~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 -D-------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -c-------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 001011235678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.52 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=200.7
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
|...++||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 55567999999999999984 57889999998755544556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
++|.+++... .+++..+..++.|++.|++|||+ .+|+||||+|+||+++.++.++++|||.+........ ..
T Consensus 101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~----~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLHA----QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 9999999873 38899999999999999999999 8899999999999999999999999998875533221 12
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....|+..|+|||...+..++.++||||+|+++|||++|+.||...... ..... .....+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~-~~~~~~~---------------~~ 235 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR-IRDNLPP---------------KL 235 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-HHhcCCC---------------CC
Confidence 2345889999999998888999999999999999999999998652211 11111 1110000 00
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+..++..+.+++.+||+++|++||++.+++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1112245678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.58 Aligned_cols=250 Identities=29% Similarity=0.391 Sum_probs=206.5
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
+|+..+.||+|++|.||++... ++..||+|++..........+.+|++.+++++|++++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999964 688999999987655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+++|.+++......+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~----~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS----NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc----CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999998875568999999999999999999999 7899999999999999999999999999987654432
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||........ ... ... .... .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~---~~~~------------~ 216 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFK-IAT---NGPP------------G 216 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-HHh---cCCC------------C
Confidence 2234578899999998888899999999999999999999999875321111 000 110 0000 0
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......++..+.+++.+||+.||++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111235678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.23 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=208.1
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
..++.|+..+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++.++.++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888899999999999999965 688999999976544 4567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.+++......+++..+..++.|++.|++|||+ .+|+|+|++|+||+++.++.++|+|||.+.......
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~----~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS----QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999876469999999999999999999999 889999999999999999999999999987654322
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......++..|+|||...+..++.++||||||+++|+|++|+.||...... .....+... ..
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~----~~---------- 233 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTK----GI---------- 233 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc----CC----------
Confidence 1 112234788999999988888999999999999999999999998653221 111111110 00
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
........++..+.+++.+||+.+|.+||++.+++++
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 --PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111223356678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.32 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=201.6
Q ss_pred hhcCCCcC-CeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEee----CCe
Q 001710 728 ATDGFNEC-NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCN----IDF 800 (1022)
Q Consensus 728 ~~~~~~~~-~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----~~~ 800 (1022)
.+++|.+. ++||-|-.|.|-.+. ..+++++|+|++... ....+|++..... .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 689999999999987 457999999988522 3456788887777 69999999999865 345
Q ss_pred eEEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec---CCCcEEEeecc
Q 001710 801 KALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFG 876 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfG 876 (1022)
..+|||.|+||.|...++.++. .+++.++..|++||+.|+.|||+ ..|.|||+||+|+|.. .+..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~----~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS----MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh----cchhhccCChhheeeecCCCCcceEecccc
Confidence 6799999999999999987665 69999999999999999999999 7899999999999997 46679999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
+|+.-.. .......+-|+.|.|||++...+|+..+|+||+|+++|-|++|.+||...... .+..-.+..+..+..
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHhHhhccCc
Confidence 9986432 33344567899999999999999999999999999999999999999864331 111111111111111
Q ss_pred hhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
++ ..+.+...+++..++|+.++..+|.+|.|+.|++.+
T Consensus 285 ~F----------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EF----------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cC----------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 123456678899999999999999999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.71 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=201.9
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
-|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999985 468899999886443 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLHS----EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc----CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999998754 38899999999999999999999 8899999999999999999999999999876543221
Q ss_pred eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
......++..|+|||...+..++.++||||+||++|+|++|..||....... ....+. ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~----~~~~------------ 218 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP----KNNP------------ 218 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh----cCCC------------
Confidence 1223457889999999888888999999999999999999999987532211 111111 0000
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++.+||+.+|++||++.+++++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112345678999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.95 Aligned_cols=268 Identities=22% Similarity=0.235 Sum_probs=201.4
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 803 (1022)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888999999999999999965 688999999875432 2234567899999999999999999998877 88999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+.....
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD----NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH----CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9999975 9999988766678999999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc-CCC--cchhc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-PHG--LTEVV 959 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 959 (1022)
... ......++..|+|||...+. .++.++|+||+|+++|||++|+.||...... ........... +.. +....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhh
Confidence 321 12234578899999987654 4689999999999999999999999753321 11111111100 000 00000
Q ss_pred c------cc---ccchhhhhhhhHH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 D------AN---LVGEEQAFSAKTD-CLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~------~~---~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. .. ..........+.. .+..+.+++++||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00 0000000001111 36678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=307.00 Aligned_cols=268 Identities=24% Similarity=0.280 Sum_probs=203.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999854 58899999886543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|++++.+..+.... ..+++..+..++.|++.|++|||+ .+++|||++|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHS----HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987776665543 348999999999999999999999 7899999999999999999999999999987654432
Q ss_pred ceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHH--hhcCCCcchhc--cc
Q 001710 887 SVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK--ESLPHGLTEVV--DA 961 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~ 961 (1022)
.......++..|+|||+..+. .++.++||||+|+++|+|++|+.||......+ ....... ...+....... +.
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCc
Confidence 122234578899999998887 88999999999999999999999987532211 1111000 00000000000 00
Q ss_pred cccc---------hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVG---------EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.. .......+..++.++.+++++||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000011122347789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=331.92 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=193.3
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEe----------
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCC---------- 796 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---------- 796 (1022)
..+|+..++||+|+||.||+++. -||+.||||++.... +.....+.+|+..+++++|||||+++..|.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35688889999999999999994 489999999987664 445677889999999999999999872110
Q ss_pred --------------------------------------------------------e-----------------------
Q 001710 797 --------------------------------------------------------N----------------------- 797 (1022)
Q Consensus 797 --------------------------------------------------------~----------------------- 797 (1022)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 001710 798 ----------------------I--------DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847 (1022)
Q Consensus 798 ----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 847 (1022)
+ ...||-||||+..++.++++.....-.....++++++|+.|++|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-- 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-- 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh--
Confidence 0 23578999999988888888766433577889999999999999999
Q ss_pred CCCCeEecCCCCCcEEecCCCcEEEeeccCceecC----------------CCCCceeeecccCCcccCCccccCCC---
Q 001710 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG----------------EGDDSVTQTITMATIGYMAPEYGSEG--- 908 (1022)
Q Consensus 848 ~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~--- 908 (1022)
.|||||||||.||++|++..|||+|||+|+... .+......+..+||.-|+|||++.+.
T Consensus 716 --~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 --QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred --CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 889999999999999999999999999998721 11223345667899999999987665
Q ss_pred CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhc
Q 001710 909 IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCC 988 (1022)
Q Consensus 909 ~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 988 (1022)
.|+.|+|+||+|+|++||+. ||...+.....+....+..+|.. ..+.+.. ...-..+|+.|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~--------------~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE--------------HPEEASLIRWLL 855 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc--------------chHHHHHHHHHh
Confidence 49999999999999999996 56543332222222222222222 1112211 123468999999
Q ss_pred ccCCCCCCCHHHHHH
Q 001710 989 MESPEQRIHMTDAAA 1003 (1022)
Q Consensus 989 ~~dP~~Rps~~ell~ 1003 (1022)
++||.+||||.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.31 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=200.1
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcC---CCcceeEeeeEeeCCeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVR---HRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
.|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++ ||+++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 578999999987543 334567888999999996 999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.++++.. .+++..+..++.|++.|+.|||+ .+|+||||+|+||++++++.++++|||.+..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~----~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998764 48999999999999999999999 889999999999999999999999999998765433
Q ss_pred CceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. ......|+..|+|||...+ ..++.++||||||+++|+|++|..||.+..... +....... ..+.+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~-----~~~~~~ 223 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKS-----KPPRLE 223 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccC-----CCCCCC
Confidence 2 2233468889999998765 447899999999999999999999997532211 11100000 000000
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...++.++.+++.+||+.||++||++.|++++
T Consensus 224 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 --------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01145678999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.58 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=199.3
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|+..+.||+|++|.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999854 68999999887543 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
+. ++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~----~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS----HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 58988886543 358999999999999999999999 7899999999999999999999999999876543221
Q ss_pred ceeeecccCCcccCCccccCCCC-CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC--cchhcc---
Q 001710 887 SVTQTITMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG--LTEVVD--- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 960 (1022)
......++..|+|||...+.. ++.++||||||+++|||+||+.||...... ....+......... ......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 122334688999999776544 688999999999999999999998653221 12222221111000 000000
Q ss_pred ---ccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ---ANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+.. ...........+.++.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.81 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=208.7
Q ss_pred hHHHHHHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC
Q 001710 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 721 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 798 (1022)
.+.|+.+.++ ++||+|+|+.|-.+. .++|.+||||++.+.......++.+|++++... .|+||+.++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4556666554 689999999999998 789999999999988777778899999999999 599999999999999
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC---cEEEeec
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM---TAHVSDF 875 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~---~~kl~Df 875 (1022)
+..|+|||-|.||+|...+.++.. +++.++.++.++|+.||+|||. +||.|||+||+|||-.+.. -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~----kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHT----KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhh----cCcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999988765 8899999999999999999999 9999999999999997544 4899999
Q ss_pred cCceecCCC-----CCceeeecccCCcccCCcccc-----CCCCCCccchhHhHHHHHHHHHcCCCCCCcccccc-----
Q 001710 876 GISKLLGEG-----DDSVTQTITMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE----- 940 (1022)
Q Consensus 876 G~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~----- 940 (1022)
.++.-+... .....-...+|+..|||||+. ....|+.++|.||+|+|+|-|++|.+||.+.-..+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 997644221 122233456789999999953 23458999999999999999999999998753321
Q ss_pred -hhH---HHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 941 -MSL---RRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 941 -~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
... ..-.-+.+..+..++.| ..+...+.+..+++...+..||.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPd----------kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPD----------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCCh----------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 11111122222222222 123456778899999999999999999998887
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=309.97 Aligned_cols=253 Identities=27% Similarity=0.349 Sum_probs=202.2
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999854 589999999876532 24567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 806 EFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL----LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH----CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987643 458999999999999999999999 88999999999999999999999999998765322
Q ss_pred CCce---------------------------eeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCccc
Q 001710 885 DDSV---------------------------TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF 937 (1022)
Q Consensus 885 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~ 937 (1022)
.... ......||..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1110 0112357889999999988889999999999999999999999997533
Q ss_pred ccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC----HHHHHHH
Q 001710 938 TGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH----MTDAAAE 1004 (1022)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~ 1004 (1022)
... ...... ... . ..+.....+.++.+++.+||..||++||+ +.|++++
T Consensus 237 ~~~-~~~~~~----~~~--------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-TFSNIL----KKE--------V-----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-HHHHHh----cCC--------c-----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 221 111111 000 0 01111114667899999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.15 Aligned_cols=262 Identities=21% Similarity=0.227 Sum_probs=196.2
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcC-CCcceeEeeeEeeC--CeeEEEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVR-HRNLVKIFSSCCNI--DFKALVLE 806 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv~e 806 (1022)
|++.++||+|+||.||+|+. .+++.||+|+++.... .......+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999984 4689999999875422 22233457888999885 99999999999887 88999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++ ++.+++......+++..+..++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||.+........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~----~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR----NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH----CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9974 8888887765568999999999999999999999 88999999999999999 9999999999987643322
Q ss_pred ceeeecccCCcccCCcccc-CCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch---hccc-
Q 001710 887 SVTQTITMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE---VVDA- 961 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 961 (1022)
. ....++..|+|||.. .+..++.++||||+||++|||++|..||...... ....+........... ....
T Consensus 155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 223578899999965 4456789999999999999999999999753221 1111111111110000 0000
Q ss_pred -----cccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 -----NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 -----~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.. ..........++.++.+++.+||+++|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 000011123457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.74 Aligned_cols=248 Identities=26% Similarity=0.310 Sum_probs=203.1
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999854 68999999987543 2345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++++|.+++... ..+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~----~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS----KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999876 358999999999999999999999 789999999999999999999999999998764432
Q ss_pred ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccch
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
......++..|+|||...+..++.++|+||+|+++|+|++|..||...... ...... ......
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~------------ 217 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIR-AKQETA------------ 217 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHH-HHhccc------------
Confidence 223345788999999988888999999999999999999999999764321 111111 111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH--HHHHH
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHM--TDAAA 1003 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~ell~ 1003 (1022)
....+...+.++.+++.+||+.||++||++ +|+.+
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 011222345778999999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=305.09 Aligned_cols=259 Identities=19% Similarity=0.196 Sum_probs=188.0
Q ss_pred hcCCCcCCeeecccceEEEEEEEcC----CCEEEEEEecchhhhh-----------HHHHHHHHHHHhhcCCCcceeEee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQLERA-----------FRTFDSECEILRNVRHRNLVKIFS 793 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~l~~ 793 (1022)
.++|++.++||+|+||+||+|+..+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999998543 4567777643322111 011223444556678999999999
Q ss_pred eEeeCC----eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc
Q 001710 794 SCCNID----FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 794 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
++.... ..++++|++.. ++.+.+.... ..++..+..|+.|++.|++|||+ .+|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~----~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHE----HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCc
Confidence 776543 44688888754 6666665433 25788889999999999999999 88999999999999999999
Q ss_pred EEEeeccCceecCCCCCc-----eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHH
Q 001710 870 AHVSDFGISKLLGEGDDS-----VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR 944 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~ 944 (1022)
++|+|||+|+.+...... .......||+.|+|||...+..++.++||||+||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 112234699999999999999999999999999999999999999987533221111
Q ss_pred HHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 945 RWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
....+.. ....... .....++..+.+++..||+.+|++||++.++.+.+
T Consensus 245 ~~~~~~~----~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFI----KRLHEGK--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHH----HHhhhhh--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000 0000000 01123467799999999999999999999999876
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=308.67 Aligned_cols=268 Identities=24% Similarity=0.269 Sum_probs=200.5
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhh--hHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKA 802 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 802 (1022)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++..... ....+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 356799999999999999999985 46899999998754322 223456799999999999999999998754 4689
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+++ +|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE----NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99999975 8999888765668999999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---cchh
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEV 958 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 958 (1022)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.... ...... ....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPG 235 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchh
Confidence 4321 1222345788999998765 557899999999999999999999997532211 111111 111100 0000
Q ss_pred ccc-----cccchhh----hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 VDA-----NLVGEEQ----AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 ~~~-----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+. .+..... ........+.++.++|.+|+++||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000 000011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=312.42 Aligned_cols=267 Identities=22% Similarity=0.277 Sum_probs=198.9
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC-----Cee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-----DFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~ 801 (1022)
.++|++.++||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 578999999986432 23445678899999999999999999987654 357
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++|+||+++ ++.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~----~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 899999975 888877654 38999999999999999999999 88999999999999999999999999999876
Q ss_pred CCCCCce-eeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC----c
Q 001710 882 GEGDDSV-TQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG----L 955 (1022)
Q Consensus 882 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 955 (1022)
....... ......++..|+|||...+ ..++.++||||+||++|+|++|+.||.+... .............. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence 4332211 1123468899999997544 5688999999999999999999999965321 11111111111111 1
Q ss_pred chhccccccc------hhhh---hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 TEVVDANLVG------EEQA---FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 ~~~~~~~~~~------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..... .... ....+..+.++.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111100000 0000 00112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=304.96 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=200.2
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.|+..+.||+|+||.||+|+. .++..||+|++.... .+....+.+|++++++++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999985 468899999986432 3344678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++ ++.+++......+++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~----~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS----HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 8888877666668999999999999999999999 88999999999999999999999999998754322
Q ss_pred ceeeecccCCcccCCcccc---CCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 887 SVTQTITMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
....++..|+|||++ .++.++.++|||||||++|||++|+.||...... .....+.....+.
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~---------- 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPT---------- 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCC----------
Confidence 223578899999986 3456889999999999999999999998653211 1111221111100
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
.....++..+.+++.+||+.+|.+||++.+++++....
T Consensus 244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11123456689999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.81 Aligned_cols=248 Identities=19% Similarity=0.245 Sum_probs=195.2
Q ss_pred HHHhhcCCCcCCee--ecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCe
Q 001710 725 IQRATDGFNECNLL--GRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 725 ~~~~~~~~~~~~~L--g~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 800 (1022)
.....++|++.+.+ |+|+||.||+++. .++..+|+|++........ |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677777776 9999999999984 4688999999865422111 22222222 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-cEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfG~a~ 879 (1022)
.++||||+++++|.+++.... .+++..+..++.|+++|++|||+ .+++||||||+||+++.++ .++|+|||.+.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHK----HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999998765 58999999999999999999999 8899999999999999988 99999999987
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... ...++..|+|||++.+..++.++||||+|+++|||++|+.||......+.....+.... ..
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------ 225 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------ 225 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------
Confidence 653221 23578899999999888899999999999999999999999985433333333332211 00
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-HHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-MTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~~ 1004 (1022)
....+..++..+.+++.+||+++|++||+ ++|++++
T Consensus 226 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 01112245677899999999999999996 6888753
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.67 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=207.1
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKALVL 805 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 805 (1022)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999965 689999999876642 4567888999999999999999999999988 8899999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~----~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS----NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998766 58999999999999999999999 889999999999999999999999999998875543
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.........++..|+|||...+..++.++||||+|+++|++++|..||...... .... .....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~-~~~~~------------- 218 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAAL-YKIGS------------- 218 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHH-Hhccc-------------
Confidence 311223356888999999988888999999999999999999999999764311 1111 10000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.......+...+..+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000111223346778999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.84 Aligned_cols=269 Identities=19% Similarity=0.226 Sum_probs=198.6
Q ss_pred CCCcCCeeecccceEEEEEEEc---CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF---DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 802 (1022)
+|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999954 47899999998643 33346678899999999999999999999888 7899
Q ss_pred EEEEccCCCCHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC----CCcEEEee
Q 001710 803 LVLEFMPNGSFEKWLYSYN----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE----NMTAHVSD 874 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~----~~~~kl~D 874 (1022)
+||||+++ ++.+++.... ..++...+..++.|++.|++|||+ .+|+||||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh----CCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999976 6766664322 258899999999999999999999 88999999999999999 99999999
Q ss_pred ccCceecCCCCC-ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccc--------hhHH
Q 001710 875 FGISKLLGEGDD-SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--------MSLR 944 (1022)
Q Consensus 875 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~--------~~~~ 944 (1022)
||++........ ........++..|+|||...+ ..++.++|||||||++|||++|+.||....... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987643322 122233467889999997665 457899999999999999999999997543322 1111
Q ss_pred HHHHhhcCC------------Ccchhcc----ccccch--hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 945 RWVKESLPH------------GLTEVVD----ANLVGE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 945 ~~~~~~~~~------------~~~~~~~----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.++...... ......+ ...... ..........+.++.+++.+|+++||++|||+.|++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110000 0000000 000000 00001111345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.32 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=188.5
Q ss_pred eeecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHHHHhh---cCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 737 LLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECEILRN---VRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~---l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
+||+|+||.||++.. .+++.||+|.+..... .....+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 4689999998865421 112233445444443 479999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|+|.+++...+. +++..+..++.|++.|++|||+ .+|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~----~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHH----CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 9999999876554 8999999999999999999999 789999999999999999999999999997653322
Q ss_pred eecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....|+..|+|||... +..++.++||||+||++|||++|..||......... ........ .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~---------------~ 214 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT---------------V 214 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhc---------------C
Confidence 12346899999999875 456889999999999999999999999754322111 11000000 0
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+..++.++.+++.+||+.||++|| +++|++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112234567789999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.64 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=198.7
Q ss_pred CCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 735 CNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
..+||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999985 47899999998655444556788999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
.+++.... +++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~----~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 105 TDIVTHTR--MNEEQIAAVCLAVLKALSVLHA----QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 99876543 7899999999999999999999 7899999999999999999999999999876543221 12234
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
.++..|+|||...+..++.++|+||+|+++|||++|..||..... ...........+... ...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~---------------~~~ 239 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKL---------------KNL 239 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCccc---------------CCc
Confidence 588999999998888899999999999999999999999864211 111111221111111 011
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..++.++.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1234567899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.74 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=206.9
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++.+++++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999855 589999999876643 4457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++.... .+++..+..++.|++.|++|||+. .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTK---RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcc---CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999998753 489999999999999999999972 46999999999999999999999999999876443322
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccc-cchhHHHHHHhhcCCCcchhccccccch
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT-GEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
. ....++..|+|||...+..++.++||||||+++|||++|+.||..... .......+... ...
T Consensus 157 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~----------- 220 (264)
T cd06623 157 C--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP----------- 220 (264)
T ss_pred c--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC-----------
Confidence 1 223578899999999888999999999999999999999999976532 11111111111 000
Q ss_pred hhhhhhhHH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 967 EQAFSAKTD-CLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 967 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+.. ++..+.+++.+||+.+|++||++.|++++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 56778999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=307.31 Aligned_cols=270 Identities=21% Similarity=0.266 Sum_probs=197.5
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNID----- 799 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----- 799 (1022)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999854 689999998865432 22345667999999999999999999987654
Q ss_pred ---eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeecc
Q 001710 800 ---FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876 (1022)
Q Consensus 800 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 876 (1022)
..++||||+.+ ++.+++......+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~----~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR----NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 8888887765568999999999999999999999 789999999999999999999999999
Q ss_pred CceecCCCCCc--eeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh---h
Q 001710 877 ISKLLGEGDDS--VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE---S 950 (1022)
Q Consensus 877 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~---~ 950 (1022)
++..+...... .......++..|+|||...+. .++.++||||+|+++|||++|+.||....... ... .... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~-~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLT-LISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHhCC
Confidence 99876433221 112234578889999977654 47889999999999999999999987532211 111 1111 1
Q ss_pred cCCCcch------hcc-ccccchhh-hh---hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 951 LPHGLTE------VVD-ANLVGEEQ-AF---SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 951 ~~~~~~~------~~~-~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+....+ ..+ ..+..... .. ..+......+.++|.+||+.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1111000 000 00000000 00 0000123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.62 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=208.6
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEE
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 803 (1022)
.....|.+...||+|.|+.|..|+ ..++..||+|.+++..- .....+.+|+++|+.++|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 445678999999999999999998 45799999999987652 233458899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
||||+.+|.+.+++.+++. ..+..+..++.|+.++++|||+ +.|||||+|++||+++.+..+||+|||++.++..
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~----k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS----KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh----cceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999999887 4448888899999999999999 7899999999999999999999999999998864
Q ss_pred CCCceeeecccCCcccCCccccCCCCC-CccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
... -...+|++.|+|||+..+..| ++++|+||+|+++|-++.|..||++..-.+ +-++.
T Consensus 208 ~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rv 267 (596)
T KOG0586|consen 208 GLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRV 267 (596)
T ss_pred ccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchh
Confidence 332 334679999999999888765 689999999999999999999998732221 11111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+.+ .+..+...+.+..+++++++-.+|.+|++.+++.++-
T Consensus 268 l~g---k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRG---KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eee---eecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111 1122233445678999999999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=310.41 Aligned_cols=275 Identities=28% Similarity=0.345 Sum_probs=209.8
Q ss_pred CCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC------eeE
Q 001710 731 GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID------FKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~~~ 802 (1022)
.|...+.||+|+||.||+|+ ..+|+.||||.+.... ....+...+|++++++++|+|||+++++-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35567889999999999999 5689999999997654 233466788999999999999999999866543 567
Q ss_pred EEEEccCCCCHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec--CCCc--EEEeecc
Q 001710 803 LVLEFMPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD--ENMT--AHVSDFG 876 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~--~~~~--~kl~DfG 876 (1022)
+|||||.||+|...+++.. ..+++.+...+..+++.||.|||+ .+||||||||.||++- ++|+ -||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE----n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE----NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH----cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999998653 369999999999999999999999 8899999999999984 4444 6999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhH-HHHHH-hhcCC
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL-RRWVK-ESLPH 953 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~-~~~~~-~~~~~ 953 (1022)
.|+....+. .....+||..|.+||... .+.|+..+|.|||||++||++||..||.......... ..|.. ...+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999875544 445578999999999888 4889999999999999999999999997654443211 12221 11222
Q ss_pred Ccchhccccccch---hhhhhh----hHHHHHHHHHHHHhhcccCCCCCC--CHHHHHHHHHHhhHhh
Q 001710 954 GLTEVVDANLVGE---EQAFSA----KTDCLLSIMDLALDCCMESPEQRI--HMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 954 ~~~~~~~~~~~~~---~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rp--s~~ell~~L~~i~~~~ 1012 (1022)
+......+...++ ...++. .......+-.++..++..+|.+|- .+.+..+.+..|.+.-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 2222222211111 111111 222334567788899999999999 8888888888886653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.16 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=203.8
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
|++.+.||+|++|.||+|+.. +++.+|+|+++.... .....+.+|++++++++|++|+++++++.+....++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999854 688999999875532 24467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
++ ++.+++......+++..+..++.|++.|++|||+ .+|+|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS----HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH----CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 76 8888888765668999999999999999999999 789999999999999999999999999998775443 1
Q ss_pred eeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC----cchhcc---
Q 001710 889 TQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG----LTEVVD--- 960 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~--- 960 (1022)
......++..|+|||...+. .++.++||||+|+++|+|++|+.||......+ .+..... ..... +....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFR-TLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HcCCCchHhcccchhhhh
Confidence 22234578889999987766 78999999999999999999999986532211 1111111 11110 000000
Q ss_pred ---ccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ---ANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+.. ........+.++.++.+++.+||++||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 000111234567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=306.18 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=194.6
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh-hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|+..+.||+|+||.||+++. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455668899999999999985 468999999987543 234457888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHh---hh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 808 MPNGSFEKWL---YS-YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 808 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
+.. ++.++. .. ....+++..+..++.+++.|++|||+. .+|+||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc---CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 865 555433 22 224589999999999999999999972 3799999999999999999999999999976533
Q ss_pred CCCceeeecccCCcccCCccccCCC---CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
... .....++..|+|||.+.+. .++.++||||+||++|||++|+.||..... ......+..... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-----~ 228 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGD-----P 228 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCC-----C
Confidence 221 1223578899999988766 689999999999999999999999875321 111111111000 0
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+.+. ...+..++.++.+++.+||+.||++||++.+++++
T Consensus 229 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01112356778999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.22 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=199.6
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
|++.+.||+|++|.||+|+. .+|..||+|++.... ....+.+.+|+++++.++||+++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999985 479999999987553 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~----~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS----HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 58999987655 358999999999999999999999 7899999999999999999999999999976533221
Q ss_pred eeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---c---chhcc
Q 001710 888 VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---L---TEVVD 960 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~ 960 (1022)
......++..|+|||+..+. .++.++||||+|+++|||++|+.||....... ............. + ....+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence 12223568899999977654 57889999999999999999999987532211 1112111111000 0 00000
Q ss_pred --ccccch--hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 --ANLVGE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 --~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+... ..........+.++.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00011122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=255.98 Aligned_cols=266 Identities=22% Similarity=0.251 Sum_probs=202.7
Q ss_pred CCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|+..++||+|.||+||+|+ ..+++.||+|+++.+.. .......+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 55688999999876653 3345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
|+. +|..|.......++.+.+..++.|+++|+.++|+ +.+.|||+||+|.++..+|++|++|||+|+.++-...
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs----hnvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS----HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh----hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 977 8999998888889999999999999999999999 6799999999999999999999999999987754332
Q ss_pred eeeecccCCcccCCccccCCCC-CCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHhhc------CCCcchhc
Q 001710 888 VTQTITMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESL------PHGLTEVV 959 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 959 (1022)
-.+..+.|..|.+|.++.+.. |+...|+||.||++.|+.. |++.|.+.... .++....+..- ...+..+.
T Consensus 157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCC
Confidence 233456799999999887765 8899999999999999998 45555543222 22333222111 11122222
Q ss_pred cccccchhhhhhhh----HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLVGEEQAFSAK----TDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
|-......+..... +.....-.++++..+.-+|.+|.++.+++++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 21111111111111 1222335678889999999999999998764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.06 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=197.4
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCe-----
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDF----- 800 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~----- 800 (1022)
++|++.+.||+|+||.||+|+.. +++.||+|+.+.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999854 689999998865432 22356788999999995 6999999999877665
Q ss_pred eEEEEEccCCCCHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeec
Q 001710 801 KALVLEFMPNGSFEKWLYSYN----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDF 875 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~Df 875 (1022)
.++||||+++ ++.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~----~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK----HGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 7888876532 347999999999999999999999 88999999999999998 899999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh-cCC
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES-LPH 953 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~ 953 (1022)
|.+..+..... ......+++.|+|||...+ ..++.++||||||+++|||++|..||......+... ...... .+.
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (295)
T cd07837 156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPT 232 (295)
T ss_pred ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCC
Confidence 99986533221 1222356888999997754 457899999999999999999999987532222111 111110 000
Q ss_pred C--cchhcccc----ccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 954 G--LTEVVDAN----LVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 954 ~--~~~~~~~~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. +....+.. ... ........+..+.++.++|.+||++||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000 000 000001112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.93 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=198.7
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcC-CCEEEEEEecchh-hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQL-ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv 804 (1022)
..++|++.+.||+|+||.||+|+..+ ++.||||+++... ......+.+|+.++.+.. ||||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678899999999999999999654 8999999987543 223345666777776664 99999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+.+ ++.++.......+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh---CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999854 78887776555789999999999999999999972 37999999999999999999999999999765432
Q ss_pred CCceeeecccCCcccCCccccCCCC----CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||............+.....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------- 236 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--------- 236 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC---------
Confidence 22 12235778999999876554 788999999999999999999999653222211222111110
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
...+....++.++.+++.+||+.||++||++.+++++-
T Consensus 237 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 -------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00111113456789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.32 Aligned_cols=266 Identities=22% Similarity=0.307 Sum_probs=201.4
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
+|++.++||+|++|.||+|+.. +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999964 688999999876543 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 809 PNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 809 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
++ +|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.++++|||.+........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE----NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888887644 358999999999999999999999 7899999999999999999999999999976533221
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc-C--CCcchhcc--
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-P--HGLTEVVD-- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~-- 960 (1022)
......++..|+|||...+ ..++.++||||+|+++||+++|+.||.+....+ .......... + ..+.....
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCc
Confidence 1223457889999997755 457889999999999999999999997643221 1111111100 0 00000000
Q ss_pred ---ccccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ---ANLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ---~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+.. ........+.++.++.+++.+|++.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 000111122346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.18 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=195.3
Q ss_pred Ceeecc--cceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRG--SFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
..||+| +||+||+|+. .+|+.||+|++.... .+..+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999985 479999999987543 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce-
Q 001710 811 GSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV- 888 (1022)
Q Consensus 811 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 888 (1022)
+++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~----~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ----NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999988643 358899999999999999999999 789999999999999999999999998654332111110
Q ss_pred ----eeecccCCcccCCccccCCC--CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc-CCC-------
Q 001710 889 ----TQTITMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-PHG------- 954 (1022)
Q Consensus 889 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~------- 954 (1022)
......++..|+|||++.+. .++.++||||+||++|||++|+.||.................. +..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345679999988764 4789999999999999999999999764332221111100000 000
Q ss_pred cchh---------------cc----ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 LTEV---------------VD----ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~---------------~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.... .. ..........+....++..+.+++++||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 00 00000111122344577889999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=309.45 Aligned_cols=265 Identities=21% Similarity=0.222 Sum_probs=198.5
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC------
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI------ 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 798 (1022)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357799999999999999999984 478999999986432 23345677899999999999999999988643
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
...++||||+++ +|.+.+... ++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~----~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 888877643 7889999999999999999999 78999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCC-----
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH----- 953 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 953 (1022)
........ .....++..|+|||...+..++.++||||+||++|+|++|+.||...... .............
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 87643221 22345788999999999889999999999999999999999999753211 1111111100000
Q ss_pred -----Ccchhccccccc--------------hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 954 -----GLTEVVDANLVG--------------EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 954 -----~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+..... ...........+..+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 000000012345668899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.10 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=196.3
Q ss_pred eecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||.|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999954 58999999986543 23446788999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
.+++..... ++...+..++.|+++|++|||+ .+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH~----~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLHN----RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh----CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999987543 8899999999999999999999 889999999999999999999999999998764432 12234
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
.++..|+|||...+..++.++|+||+|+++|||++|..||....... ........... .....+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------------~~~~~~ 216 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGN-------------GKLEFP 216 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccC-------------CCCCCC
Confidence 57889999999888889999999999999999999999997643211 11111111000 011112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIH-----MTDAAA 1003 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~ 1003 (1022)
..++.++.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 223567899999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.09 Aligned_cols=271 Identities=24% Similarity=0.254 Sum_probs=202.0
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC----
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNID---- 799 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---- 799 (1022)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999964 588999999875432 22346778999999999999999999987654
Q ss_pred ------eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEe
Q 001710 800 ------FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873 (1022)
Q Consensus 800 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~ 873 (1022)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK----KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 7777777655568999999999999999999999 789999999999999999999999
Q ss_pred eccCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC
Q 001710 874 DFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952 (1022)
Q Consensus 874 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 952 (1022)
|||.+........ .......++..|+|||...+ ..++.++||||+||++|||++|+.||..... ...+.........
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence 9999987644332 11122346778999997654 4578999999999999999999999975321 1222222221111
Q ss_pred C---Ccchhccc--------cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 H---GLTEVVDA--------NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ~---~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. .+..+... .-............++..+.+++.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 01111000 0000000001112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.60 Aligned_cols=266 Identities=23% Similarity=0.247 Sum_probs=201.7
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--CeeEEEEE
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFKALVLE 806 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~e 806 (1022)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999865 58899999998663 33345678899999999999999999999888 88999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
|+++ +|.+++......+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~----~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS----NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH----CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8999887765568999999999999999999999 7899999999999999999999999999987654332
Q ss_pred ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC---cchhcc--
Q 001710 887 SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEVVD-- 960 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 960 (1022)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||...... .............. +....+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 12233456788999997654 45789999999999999999999999763321 11222111111000 000000
Q ss_pred ------ccccchhhhhhhhHH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ------ANLVGEEQAFSAKTD-CLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
............... ++.++.+++++||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000001111 36788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=327.71 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=210.3
Q ss_pred HHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC
Q 001710 723 LDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI 798 (1022)
Q Consensus 723 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 798 (1022)
.+++-..++|.++++||+|+||.|..++. .+++.||+|++.+-. ......|..|-++|.--..+=|+.++.+|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34555678999999999999999999995 568899999987632 23345688899999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
.+.|+|||||+||+|...+.+.+ .+++..+..++..|+-||+.+|+ .|+|||||||+|||+|..|++||+|||.|
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~----mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS----MGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh----ccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999988 69999999999999999999999 89999999999999999999999999999
Q ss_pred eecCCCCCceeeecccCCcccCCccccC----C-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCC
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGS----E-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
-.+..+. .......+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||.+..-.+. +......
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-Y~KIm~h---- 296 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-YGKIMNH---- 296 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-HHHHhch----
Confidence 8886543 45566778999999999653 3 6799999999999999999999999976221111 1111100
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH---MTDAAAE 1004 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ell~~ 1004 (1022)
. ..-.++.....+....++|++.+. +|+.|.. +.|+..|
T Consensus 297 --k---------~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 297 --K---------ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred --h---------hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 0 000122223467788999998877 6888887 8777654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=286.15 Aligned_cols=265 Identities=20% Similarity=0.308 Sum_probs=220.1
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEEcC------CCEEEEEEecchh-hhhHHHHHHHHHHHhhcCCCcceeEeeeEee
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTLFD------GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 797 (1022)
+.....+++..-.+.+|.||.||.|.+.+ .+.|-||.++... +-+...+..|.-.+..+.|||+..+.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33444567777789999999999996543 3457778776554 3356778899999999999999999999865
Q ss_pred -CCeeEEEEEccCCCCHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc
Q 001710 798 -IDFKALVLEFMPNGSFEKWLYSY-------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 798 -~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
.+.+++++.++.-|+|..|+... .+.++..+...++.|++.|++|||+ .+|||.||.++|.++|+.-.
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~----~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN----HGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh----cCcccchhhhhcceehhhee
Confidence 55788999999999999999832 2357788889999999999999999 89999999999999999999
Q ss_pred EEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHH
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 948 (1022)
+||+|=.+++..-+.++..-......+..||+||.+....|+.++||||||+++|||+| |+.||.+..+.|+ ..+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~ylk 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYLK 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHHh
Confidence 99999999998877766655555567788999999999999999999999999999999 8999887543331 22222
Q ss_pred hhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
.+.++..|-+|+++++.+|..||..+|++||++++++.-|.+...+.
T Consensus 513 -----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 513 -----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 23456678899999999999999999999999999999999987665
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.62 Aligned_cols=264 Identities=19% Similarity=0.188 Sum_probs=195.2
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecch--hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
+.+|.|+++.||+++ .+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344555555555554 47999999998755 244557889999999999999999999999999999999999999999
Q ss_pred HHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc-----
Q 001710 814 EKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS----- 887 (1022)
Q Consensus 814 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~----- 887 (1022)
.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+..+......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~----~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS----KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999864 3358899999999999999999999 78999999999999999999999999998765322211
Q ss_pred eeeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCc----chhcc-
Q 001710 888 VTQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL----TEVVD- 960 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~- 960 (1022)
.......++..|+|||.+.+ ..++.++||||+||++|||++|+.||............. ....+... .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCccccccCchhhhcC
Confidence 11122346778999998765 358899999999999999999999997643322211111 11110000 00000
Q ss_pred ----------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 961 ----------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 961 ----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
................+.++.+++.+||++||++||++++++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000011112223344567889999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=293.67 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=205.7
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999954 689999999876532 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 808 MPNGSFEKWLYSYN---YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
+++++|.+++.... ..+++..+..++.+++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~----~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS----RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh----CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999998753 568999999999999999999999 78999999999999999999999999999876443
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.. ......+++.|+|||...+..++.++||||+|+++|+|++|+.||..... .............
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 221 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYP-------- 221 (258)
T ss_pred cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCC--------
Confidence 31 22234688899999998888899999999999999999999999865321 1111111111100
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+..++.++.+++.+||..+|++||++.|++++
T Consensus 222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.67 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=201.2
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999854 68899999986542 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCc-EEEeeccCceecCCCC
Q 001710 808 MPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT-AHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~-~kl~DfG~a~~~~~~~ 885 (1022)
+++++|.+++..... .+++..+..++.|++.|++|||+ .+++|+||||+||++++++. +|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD----RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH----CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876443 57999999999999999999999 78999999999999998864 6999999998764332
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. ......|++.|+|||+..+..++.++||||+|+++||+++|+.||..... .+++.........
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFA--------- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCC---------
Confidence 2 12224588899999998888899999999999999999999999865321 2222221111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......+.++.+++.+||+.+|++||++.|++++
T Consensus 221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.73 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=199.5
Q ss_pred cCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecch-----hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC--Cee
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQ-----LERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--DFK 801 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 801 (1022)
.+|++.+.||+|+||.||+|+. .++..||+|++... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999984 46899999987532 123456788999999999999999999998764 457
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++++|.+++..... +++..+..++.|++.|+.|||+ .+|+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH~----~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHS----NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999886554 7899999999999999999999 78999999999999999999999999999865
Q ss_pred CCCCC-ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDD-SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
..... ........++..|+|||...+..++.++|||||||++||+++|+.||.+....+. ..+.. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~~---- 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIA----TQPTK---- 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHH----cCCCC----
Confidence 32111 1111234588899999999888899999999999999999999999976322211 11111 11100
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+...++.+.+++.+||+ +|.+||++.+++.+
T Consensus 228 ---------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ---------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11233456678999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.80 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=193.6
Q ss_pred eecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||+||+|.. .+|+.||+|++.... ......+..|+.++++++||+|+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999986542 22234567899999999999999999999999999999999999999
Q ss_pred HHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeec
Q 001710 814 EKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892 (1022)
Q Consensus 814 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 892 (1022)
.+++.... ..+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~----~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ----RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99987654 358999999999999999999999 889999999999999999999999999987653321 1223
Q ss_pred ccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhh
Q 001710 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSA 972 (1022)
Q Consensus 893 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 972 (1022)
..++..|+|||...+..++.++||||+|+++|+|++|+.||...... ............. ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~ 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM---------------AVEY 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc---------------cccC
Confidence 45788999999988888999999999999999999999999753221 1111111110000 0111
Q ss_pred hHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 973 KTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
+..++..+.+++.+||+.||++|| ++.+++.+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 223466789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=307.56 Aligned_cols=269 Identities=21% Similarity=0.244 Sum_probs=200.4
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee----CCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN----IDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~ 801 (1022)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36799999999999999999984 469999999987543 2334567789999999999999999988753 3467
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+. ++|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 589998876554 8999999999999999999999 78999999999999999999999999999766
Q ss_pred CCCCCce--eeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc--CCC--
Q 001710 882 GEGDDSV--TQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL--PHG-- 954 (1022)
Q Consensus 882 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-- 954 (1022)
....... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+..... .+........ +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhh
Confidence 4332211 1123468889999998655 568899999999999999999999997632211 1111111000 000
Q ss_pred -------cchhcccc-ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 -------LTEVVDAN-LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 -------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+.. ..............+.++.+++.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 000000001112346789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=292.90 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=204.3
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|++++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999854 678999999876653 4557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++++|.+++.... .+++..+..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhh----CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999998764 48999999999999999999999 88999999999999999999999999999877543321
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ......... ..
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~~------------- 215 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-DD------------- 215 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-cC-------------
Confidence 2234578899999998888889999999999999999999999875321 111111100 00
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 001122345678999999999999999999998753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=320.94 Aligned_cols=271 Identities=16% Similarity=0.149 Sum_probs=190.0
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcC--CCEEEEEE--------------ecc---hhhhhHHHHHHHHHHHhhcCCCcc
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFD--GTNVAIKV--------------FNL---QLERAFRTFDSECEILRNVRHRNL 788 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vAvK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~~i 788 (1022)
..++|++.+.||+|+||+||++.... +..+++|. +.. ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987432 22222221 100 112234567889999999999999
Q ss_pred eeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe
Q 001710 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYN----YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL 864 (1022)
Q Consensus 789 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll 864 (1022)
+++++++...+..++|+|++.+ ++.+++.... .......+..|+.|++.||+|||+ .+||||||||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~----~gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD----KKLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEE
Confidence 9999999999999999999954 7777765432 123456677899999999999999 889999999999999
Q ss_pred cCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCC-CCccccc-chh
Q 001710 865 DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-TDEMFTG-EMS 942 (1022)
Q Consensus 865 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-~~~~~~~-~~~ 942 (1022)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+ +...... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876543222 12234689999999999999999999999999999999998764 4322111 122
Q ss_pred HHHHHHh------hcCCCcch---hccc-cccc---hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 943 LRRWVKE------SLPHGLTE---VVDA-NLVG---EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 943 ~~~~~~~------~~~~~~~~---~~~~-~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+...... ..+..... .++. .+.. ...........+.++.+++.+|+++||.+||++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2222111 01110000 0000 0000 000011111234567889999999999999999999875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=292.70 Aligned_cols=247 Identities=27% Similarity=0.315 Sum_probs=203.1
Q ss_pred CCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+|++.++||+|+||.||+++. .+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999984 468899999987543 33346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 808 MPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 808 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
+++++|.+++... ...+++..++.++.|++.|++|||+ .+++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~----~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE----QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh----CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998762 2358999999999999999999999 88999999999999999999999999999876543
Q ss_pred CCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. .....++..|+|||...+..++.++|+||+|+++||+++|+.||...... .....+... ..
T Consensus 157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~---~~--------- 218 (256)
T cd08530 157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQRG---KY--------- 218 (256)
T ss_pred C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcC---CC---------
Confidence 1 12245788999999998888999999999999999999999999753221 111111110 00
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+..++.++.+++.+||+.+|++||++.|++++
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01122456778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.69 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=195.8
Q ss_pred eecccceEEEEEEEc-CCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999875543 4456788899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC------c
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD------S 887 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~------~ 887 (1022)
.+++...+ .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~----~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS----NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998765 48999999999999999999999 8899999999999999999999999999876533221 1
Q ss_pred eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchh
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.......++..|+|||...+..++.++||||+|+++||+++|..||......+ ....... ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~---~~~------------ 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQNILN---GKI------------ 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc---CCc------------
Confidence 12233457889999999888889999999999999999999999997532111 1111110 000
Q ss_pred hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
..+.....+..+.+++.+||+.+|++||+++++.+.+
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0000111256789999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=299.30 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=197.1
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|++|+||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999854 689999998865432 233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeeccCceecCCC
Q 001710 807 FMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~ 884 (1022)
|+++ ++.+++..... ..++..+..++.||+.||+|||+ .+|+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~----~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS----HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 78877755433 36788888999999999999999 78999999999999985 567999999999765332
Q ss_pred CCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh---cCCCcchh--
Q 001710 885 DDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES---LPHGLTEV-- 958 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 958 (1022)
.. ......+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||......+ ......... ....+...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhcccccc
Confidence 11 1223457889999997765 457899999999999999999999997532221 111111100 00000000
Q ss_pred -ccc--cccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -VDA--NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -~~~--~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+. .... ...........+.++.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 000001112345678999999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=299.77 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=198.5
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecch---hhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQ---LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
..|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999954 6788999988642 2334467788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
||+. |++.+++......+++.++..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~----~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS----HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9997 58888876655668999999999999999999999 78999999999999999999999999998765332
Q ss_pred CceeeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 886 DSVTQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
....++..|+|||... ...++.++|||||||++|||++|+.||......+ ....+.....+
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC----------
Confidence 1235788999999764 3567889999999999999999999986532211 11111111000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
......++..+.++|.+||+.+|++||++.+++++-..
T Consensus 233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00112345678999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=293.75 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=187.7
Q ss_pred eeecccceEEEEEEE-cCCCEEEEEEecchhh---hhHHHHHHHHH---HHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 737 LLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTFDSECE---ILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~---~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
.||+|+||.||+|+. .+++.||+|++..... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 4689999998865421 11122334443 3444579999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|+|.+++...+ .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~----~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999887654 48999999999999999999999 789999999999999999999999999987653221
Q ss_pred eecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhh
Q 001710 890 QTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....|+..|+|||...++ .++.++||||+|+++|||++|+.||..................
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 214 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------------- 214 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-----------------
Confidence 1234689999999987654 6899999999999999999999999764222111100000000
Q ss_pred hhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
....+..++.++.+++.+|+..+|.+|| ++.+++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0111223456789999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=305.53 Aligned_cols=268 Identities=23% Similarity=0.299 Sum_probs=199.6
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC--Cee
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI--DFK 801 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--~~~ 801 (1022)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567889999999999999999854 68899999885432 23345677899999999 999999999998653 367
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++ +|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~----~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999999974 999988765 48899999999999999999999 88999999999999999999999999999866
Q ss_pred CCCCCc---eeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC-CC--
Q 001710 882 GEGDDS---VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-HG-- 954 (1022)
Q Consensus 882 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~-- 954 (1022)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 443221 12223468899999997654 5678999999999999999999999965322211 1111111000 00
Q ss_pred --------cchhccccccch--hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 955 --------LTEVVDANLVGE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 --------~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....++ .+... .........++.++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 00000 00001112256788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=277.54 Aligned_cols=271 Identities=20% Similarity=0.260 Sum_probs=201.3
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee--------C
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN--------I 798 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------~ 798 (1022)
..|+...+||+|.||.||+|+ .++|+.||+|++-.+. +.......+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 446667889999999999998 4568889998764432 2233567889999999999999999988854 2
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCc
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a 878 (1022)
...|+||++|+. +|...+......++..++.++++++.+||.|+|. ..|+|||+||.|+||+.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr----~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR----NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH----hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 357899999988 8999998887779999999999999999999999 77999999999999999999999999999
Q ss_pred eecCCCCC--ceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccch--hHHHHHHhhcCC
Q 001710 879 KLLGEGDD--SVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM--SLRRWVKESLPH 953 (1022)
Q Consensus 879 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~ 953 (1022)
+.+..... ...++.++.|..|++||.+.| ..|+++.|||+.|||+.||+||.+-+++.....+ .++......-+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76644332 233556778999999996554 5699999999999999999999998876332211 122222211111
Q ss_pred Ccchhcc----ccccch---hhhhhhhHHH------HHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 954 GLTEVVD----ANLVGE---EQAFSAKTDC------LLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 954 ~~~~~~~----~~~~~~---~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
.|.++.. +.+..+ ......-++. .++..+++..++..||.+|+++++++.+-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1211111 001000 0001111111 23578999999999999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=304.99 Aligned_cols=272 Identities=22% Similarity=0.252 Sum_probs=202.5
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC-----Ce
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-----DF 800 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 800 (1022)
..+|.+.+.||+|+||+||+|+. .+++.||||.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999984 468999999986532 23345677899999999999999999987643 34
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.++||||+. ++|.+++...+ .+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~----~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 68998887654 48999999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh---cCCCc-
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES---LPHGL- 955 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~- 955 (1022)
...... ......++..|+|||.... ..++.++|||||||++|+|++|+.||.+.... .......... .+..+
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhh
Confidence 643321 1223457889999997654 56889999999999999999999999753211 1111111000 00000
Q ss_pred -------chhcccccc-chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHHhh
Q 001710 956 -------TEVVDANLV-GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKIR 1009 (1022)
Q Consensus 956 -------~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~i~ 1009 (1022)
.......-. .........+.++.++.+++++||+.+|++||+++|++++ ++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 0000011123467788999999999999999999999998 66553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=294.08 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=198.4
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhh--hhHHHHHHHHHHHhhc---CCCcceeEeeeEeeCCe-----
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE--RAFRTFDSECEILRNV---RHRNLVKIFSSCCNIDF----- 800 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~----- 800 (1022)
|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999965 489999999874432 2234566788777766 59999999999988776
Q ss_pred eEEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
.+++|||+++ +|.+++..... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~----~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH----CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 89988876433 58999999999999999999999 789999999999999999999999999998
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.+...... ....++..|+|||...+..++.++|||||||++|||++|.+||..... ......+.............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcC
Confidence 76443221 223478889999999888899999999999999999999999875332 22233332221111000000
Q ss_pred ------cccccchh--hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 ------DANLVGEE--QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ------~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
...+.... .........+..+.+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 0011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=303.03 Aligned_cols=272 Identities=23% Similarity=0.271 Sum_probs=206.3
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----eeE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 802 (1022)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999954 58999999987643 334567889999999999999999999988765 789
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
+||||+++ +|.+++.... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||.+....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~----~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999984 8999887655 58999999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCc-eeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCc-----
Q 001710 883 EGDDS-VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL----- 955 (1022)
Q Consensus 883 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 955 (1022)
..... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.+....+ .... +........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNL-IVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH-HHHhcCCCChhHhh
Confidence 43210 112234578899999998877 78999999999999999999999997643211 1111 111110000
Q ss_pred -------chhccc-cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHHhhH
Q 001710 956 -------TEVVDA-NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKIRV 1010 (1022)
Q Consensus 956 -------~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~i~~ 1010 (1022)
...+.. ...............+..+.+++++||+++|++||++.+++.+ ++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000 0000000011112246778999999999999999999999986 555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=291.60 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=186.9
Q ss_pred CeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHH-hhcCCCcceeEeeeEeeCCeeEEEEEccCC
Q 001710 736 NLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEIL-RNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 468999999986543 12223344455444 445899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ----RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997654 48899999999999999999999 7899999999999999999999999999875432 1
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
....++..|+|||...+..++.++||||+|+++|||++|..||......+ .......... .. ..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~-------------~~ 214 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRI--NW-------------PE 214 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc--CC-------------CC
Confidence 22457889999999888889999999999999999999999997532211 1111110000 00 00
Q ss_pred hhhHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 001710 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAA 1002 (1022)
Q Consensus 971 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 1002 (1022)
.....++..+.+++.+||+.+|++||++.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 11123567789999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=298.36 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=203.3
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv 804 (1022)
++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999854 78999999987532 233467788999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCC
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 884 (1022)
|||+++++|.+++...+ .+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~----~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHS----KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998765 48999999999999999999999 78999999999999999999999999999876443
Q ss_pred CCc------------------eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHH
Q 001710 885 DDS------------------VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946 (1022)
Q Consensus 885 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 946 (1022)
... .......++..|+|||...+..++.++||||+|++++++++|+.||...... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence 221 1222345788999999988888999999999999999999999999753211 11111
Q ss_pred HHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCH----HHHHHH
Q 001710 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM----TDAAAE 1004 (1022)
Q Consensus 947 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~ell~~ 1004 (1022)
... .....+...+..+.+++.+||+.+|++||++ .+++++
T Consensus 234 ~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 ILK------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHh------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 110 0011122335668999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=285.79 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=200.5
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCee
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 801 (1022)
....+|..+.+||+|+||.|-+|+.+ +.+.||||+++++. .+..+--+.|.++++.- +-|.++++..++.+.+..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457999999999999999999843 56789999998764 23334445688888777 578899999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
|+||||+.||+|.-.+++.+. +.+..+..+|..||-||-+||+ +||++||+|..||++|.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~----kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhc----CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999988876 6667777899999999999999 89999999999999999999999999999753
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
- ....+....+||+.|+|||.+...+|+.++|+||||+++|||+.|.+||++. ++..+.+.+.++
T Consensus 501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~eh----------- 565 (683)
T KOG0696|consen 501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEH----------- 565 (683)
T ss_pred c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHc-----------
Confidence 2 2223344578999999999999999999999999999999999999999873 333333333322
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 997 (1022)
....|...+.+..++....+.+.|.+|..
T Consensus 566 -------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 22344556777889999999999999974
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=296.96 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=195.0
Q ss_pred CCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 732 FNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
|...+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 468899999986432 23446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+. |++.+++......+++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~----~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS----HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 58888887666668999999999999999999999 7899999999999999999999999999864321
Q ss_pred eeeecccCCcccCCccccC---CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccccc
Q 001710 888 VTQTITMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.....++..|+|||++. +..++.++||||||+++|||++|..||........ .........+.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~----------- 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSPT----------- 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCC-----------
Confidence 12345788999999863 45688899999999999999999999865322111 11100000000
Q ss_pred chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....++..+.+++.+||+++|.+||++.+++++
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012234568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=301.15 Aligned_cols=265 Identities=24% Similarity=0.298 Sum_probs=199.4
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee-CCee
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDFK 801 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~ 801 (1022)
...+++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 45678899999999999999999984 478999999876432 2234667789999999999999999998865 5578
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+ +++|.+++.... +++..+..++.|+++|++|||+ .+|+||||+|+||++++++.++|+|||.+...
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH~----~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHS----AGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 8999998 568998887543 7888888999999999999999 88999999999999999999999999998754
Q ss_pred CCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
.... ....++..|+|||...+ ..++.++||||+|+++|||++|+.||...... .....+. +.......++..
T Consensus 159 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~ 231 (328)
T cd07856 159 DPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIIT-DLLGTPPDDVIN 231 (328)
T ss_pred CCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCCCCHHHHH
Confidence 3211 22357888999998655 56899999999999999999999999753221 1111111 111000000000
Q ss_pred ----c-------cccc--hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 961 ----A-------NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 ----~-------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. .+.. ..+.......++.++.++|.+||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 000011112346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=295.11 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=197.8
Q ss_pred CCCcCCeeecccceEEEEEEE----cCCCEEEEEEecchhh----hhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCee
Q 001710 731 GFNECNLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQLE----RAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 801 (1022)
+|++.+.||+|+||.||+|+. .+|..||+|+++.... ...+.+.+|+++++++ +|++|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999984 3689999999875431 2335678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~----~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999998654 47889999999999999999999 88999999999999999999999999999875
Q ss_pred CCCCCceeeecccCCcccCCccccCCC--CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... ......|+..|+|||...+. .++.++||||+|+++|+|++|+.||..... ......+........
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE----- 228 (290)
T ss_pred cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-----
Confidence 433221 12234588899999987653 467899999999999999999999864211 111112111111000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~ 1004 (1022)
.+.+..++..+.+++++||+.||++|| ++.+++.+
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011223456789999999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=295.73 Aligned_cols=255 Identities=24% Similarity=0.274 Sum_probs=199.6
Q ss_pred CCCcCCeeecccceEEEEEEE----cCCCEEEEEEecchh----hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCee
Q 001710 731 GFNECNLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQL----ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 801 (1022)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++++ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999973 357889999987532 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++++|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~----~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQ----LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987654 48899999999999999999999 88999999999999999999999999998765
Q ss_pred CCCCCceeeecccCCcccCCccccCCCC--CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... ......++..|+|||...+.. .+.++||||+|+++|||++|..||...... .....+.+.....
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKS------ 227 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHcc------
Confidence 433221 122345788999999877655 788999999999999999999998642111 1111111111100
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
....+..++..+.+++.+||+.||++|||++++.+.++.
T Consensus 228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011122345678999999999999999998877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=295.33 Aligned_cols=243 Identities=25% Similarity=0.350 Sum_probs=200.0
Q ss_pred CeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCC
Q 001710 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS 812 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 812 (1022)
++||+|.||+||-|+ .++|+.||||++.+.. .+......+|+.|++.++||.||.+-..|++.+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 789999999999998 5689999999997654 3334678889999999999999999999999999999999998877
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC---CcEEEeeccCceecCCCCCcee
Q 001710 813 FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN---MTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 813 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
|+-.+......+++.....++.||+.||.|||. ++|||+|+||+|||+.+. -.+||||||+|+.+++....
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~----knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-- 723 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF----KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-- 723 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh----cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--
Confidence 888888777779999999999999999999999 889999999999999643 36999999999999766543
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
...+||+.|+|||++..+.|...-|+||.|+++|--++|..||.+...- .+.+. ...+..+.
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----ndQIQ-----------NAaFMyPp-- 785 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----NDQIQ-----------NAAFMYPP-- 785 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch----hHHhh-----------ccccccCC--
Confidence 3368999999999999999999999999999999999999999763221 11111 11111111
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
..+...+....++|...+++.-.+|-+....+.
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 123345566789999999999999998876544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=302.46 Aligned_cols=272 Identities=19% Similarity=0.231 Sum_probs=201.7
Q ss_pred hHHHHHHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEee
Q 001710 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797 (1022)
Q Consensus 721 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 797 (1022)
.-.++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677889999999999999999999984 578999999987542 2234567789999999999999999998864
Q ss_pred C------CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEE
Q 001710 798 I------DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH 871 (1022)
Q Consensus 798 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~k 871 (1022)
. ...+++++++ +++|.+++.... +++..+..++.|++.|++|||+ .+|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS----ADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH----CCeeecCCChHHEEEcCCCCEE
Confidence 3 3467888877 779998887543 8999999999999999999999 8899999999999999999999
Q ss_pred EeeccCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh
Q 001710 872 VSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 872 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
|+|||++...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 9999998764321 123457889999998765 56889999999999999999999998653221 1111111111
Q ss_pred cCC--Ccchhccc----cc----cc-hhhh-hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 951 LPH--GLTEVVDA----NL----VG-EEQA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 951 ~~~--~~~~~~~~----~~----~~-~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
... .....+.. .+ .. .... ......++.++.++|.+|++.||++||++.+++.+=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000 00000000 00 00 0000 000112356789999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.75 Aligned_cols=269 Identities=22% Similarity=0.241 Sum_probs=198.2
Q ss_pred hcCCCc-CCeeecccceEEEEEEE-cCCCEEEEEEecchhhhh--------------HHHHHHHHHHHhhcCCCcceeEe
Q 001710 729 TDGFNE-CNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERA--------------FRTFDSECEILRNVRHRNLVKIF 792 (1022)
Q Consensus 729 ~~~~~~-~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~iv~l~ 792 (1022)
.++|.. .+.||+|+||+||+|+. .+++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 46799999999999985 468999999886543211 12467899999999999999999
Q ss_pred eeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEE
Q 001710 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV 872 (1022)
Q Consensus 793 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl 872 (1022)
+++...+..++||||++ |+|.+++.... .+++.....++.|++.|++|||+ .+|+||||+|+||+++.++.+++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~----~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHK----WYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCeecccccHHHeEECCCCCEEE
Confidence 99999999999999997 58999887644 38999999999999999999999 88999999999999999999999
Q ss_pred eeccCceecCCCCC------------ceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCccccc
Q 001710 873 SDFGISKLLGEGDD------------SVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939 (1022)
Q Consensus 873 ~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~ 939 (1022)
+|||.+........ ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987642110 1112223467889999987664 4789999999999999999999999754322
Q ss_pred chhHHHHHHhh---cCCCcchhcccc----c-c-chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 940 EMSLRRWVKES---LPHGLTEVVDAN----L-V-GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 940 ~~~~~~~~~~~---~~~~~~~~~~~~----~-~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+ .+....... ....+....+.. + . ...........++.++.+++.+||+.+|++||++.|++.+
T Consensus 241 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 D-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 111111110 000011000000 0 0 0000111122346778999999999999999999999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=305.47 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=196.9
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC---------
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNI--------- 798 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--------- 798 (1022)
..+|.+.+.||+|+||.||+|+. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999985 46899999998766555667788999999999999999999776543
Q ss_pred -----CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec-CCCcEEE
Q 001710 799 -----DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHV 872 (1022)
Q Consensus 799 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-~~~~~kl 872 (1022)
...++||||++ ++|.+++... .+++..+..++.||+.|++|||+ .+|+||||||+||+++ +++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~----~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHS----ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 4898888654 38899999999999999999999 7899999999999998 4567899
Q ss_pred eeccCceecCCCCCce-eeecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh
Q 001710 873 SDFGISKLLGEGDDSV-TQTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES 950 (1022)
Q Consensus 873 ~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 950 (1022)
+|||.+.......... ......++..|+|||.+. +..++.++||||+||++|||++|+.||......+. ...... .
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~-~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILE-S 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-h
Confidence 9999997653321111 112235788999999654 45688999999999999999999999975432221 111111 0
Q ss_pred cCCCcc----hh---cccccc-----chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 951 LPHGLT----EV---VDANLV-----GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 951 ~~~~~~----~~---~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+.... .. ...... ............+.++.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 100000 00 000000 0000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=302.29 Aligned_cols=266 Identities=22% Similarity=0.238 Sum_probs=199.6
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC--
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID-- 799 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-- 799 (1022)
+....++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 44567889999999999999999998 4578999999986432 223456788999999999999999999886543
Q ss_pred ----eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 800 ----FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 800 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
..++||||+ +++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++++||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~----~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHA----AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 67999888753 38999999999999999999999 88999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC--
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-- 952 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 952 (1022)
|++....... ....+++.|+|||...+ ..++.++|+||+|+++|++++|+.||...... .......+....
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 9997653321 22357889999998765 45889999999999999999999999753221 111111110000
Q ss_pred ---------CCcchhccc--cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 ---------HGLTEVVDA--NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ---------~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
......... .... .........++.++.+++.+|++.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRK-KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCc-chHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000 00011123456678999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=293.34 Aligned_cols=264 Identities=21% Similarity=0.236 Sum_probs=196.3
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEEEcc
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER-AFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
|++.+.||+|+||+||+|+.. +++.||+|++...... ......+|+..+++++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999964 5789999998654321 2234457999999998 999999999999999999999999
Q ss_pred CCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 809 PNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+|+|.+++.... ..+++..+..++.|++.++.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~----~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK----HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 779998887654 458999999999999999999999 7899999999999999999999999999987643322
Q ss_pred eeeecccCCcccCCccccC-CCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHH---hhcCCCcc------h
Q 001710 888 VTQTITMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK---ESLPHGLT------E 957 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~------~ 957 (1022)
.....++..|+|||... ...++.++|+||||+++|||++|+.||......+. ...... ......+. .
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhc
Confidence 12345788999999764 45578999999999999999999999865322111 111000 00000000 0
Q ss_pred hccccccchhh--hhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 VVDANLVGEEQ--AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..+..+..... ........+.++.+++++||+.||++||+++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 000011124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.88 Aligned_cols=268 Identities=21% Similarity=0.264 Sum_probs=197.5
Q ss_pred hcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC------
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID------ 799 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 799 (1022)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999986532 222356788999999999999999999986542
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
..++|+||+.. ++.++.. ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~----~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS----AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 45899999965 7777653 248899999999999999999999 789999999999999999999999999987
Q ss_pred ecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhh-cCC-Ccc
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES-LPH-GLT 956 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~ 956 (1022)
..... .....++..|+|||...+ ..++.++|||||||++|||++|+.||.+..... .+....... .+. ...
T Consensus 166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence 64321 122357888999998766 468899999999999999999999997532111 111111100 000 000
Q ss_pred h---------hccc-cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHHhhH
Q 001710 957 E---------VVDA-NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKIRV 1010 (1022)
Q Consensus 957 ~---------~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~i~~ 1010 (1022)
+ .... ............+..+.++.+++.+||+.||++||+++|++.+ ++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 0000 0000000000112245678899999999999999999999976 766644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.75 Aligned_cols=270 Identities=22% Similarity=0.232 Sum_probs=196.9
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhh--hHHHHHHHHHHHhhcCCCcceeEeeeEeeCC------
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER--AFRTFDSECEILRNVRHRNLVKIFSSCCNID------ 799 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 799 (1022)
.++|++.++||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999854 6899999988654322 2345678999999999999999999875433
Q ss_pred --eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccC
Q 001710 800 --FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 800 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~ 877 (1022)
..++||||+++ ++.+.+......+++.++..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~----~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE----NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999975 7777777655569999999999999999999999 8899999999999999999999999999
Q ss_pred ceecCCCCCce---------eeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHH
Q 001710 878 SKLLGEGDDSV---------TQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWV 947 (1022)
Q Consensus 878 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 947 (1022)
+.......... ......+++.|+|||...+ ..++.++||||+||++|||++|++||....... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 97654322211 1122356788999997655 458899999999999999999999987532221 111111
Q ss_pred HhhcC---CCcc------hhcccccc--chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 948 KESLP---HGLT------EVVDANLV--GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 948 ~~~~~---~~~~------~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..... ..+. ...+.... ..............++.+++.+|++.||++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000 0000 00000000 0000000112233678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=276.72 Aligned_cols=250 Identities=24% Similarity=0.254 Sum_probs=193.0
Q ss_pred CCeeecccceEEEEEEE-cCCCEEEEEEecchhh-hhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 735 CNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
...||.|+||+|+|-.. ..|+..|||+++.... ...+++..|.+...+- +.|+||++||++..++..++.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 46799999999999984 5799999999987653 4456677777765555 799999999999999999999999965
Q ss_pred CHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCc
Q 001710 812 SFEKWLYS----YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 812 ~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 887 (1022)
+++.+-.. ....+++.-.-.|....+.||+||-+. ..|||||+||+|||++..|.+|+||||.+..+ ..+
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~---lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL---v~S 221 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE---LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL---VDS 221 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH---hhhhhccCChhheEEecCCCEeeecccchHhH---HHH
Confidence 66554321 223588888888999999999999975 46999999999999999999999999999765 344
Q ss_pred eeeecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 888 VTQTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
...+..+|-..|||||.+.. ..|+.++||||+|+++||+.||..||.....-.+++.+.+....+.- ...
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l-----~~~--- 293 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL-----LFD--- 293 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee-----cCc---
Confidence 55666788999999997654 34889999999999999999999998764332222333222111111 100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....++..+..+|.-|+.+|-..||.+.++.++
T Consensus 294 -----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 -----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0112356788999999999999999999998764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.23 Aligned_cols=264 Identities=25% Similarity=0.284 Sum_probs=200.6
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++++++|++++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999954 58999999987653 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCce
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 888 (1022)
++ +|.+++......+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS----HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 84 8999998875569999999999999999999999 7899999999999999999999999999987643322
Q ss_pred eeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhc---CCCcchh-----c
Q 001710 889 TQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL---PHGLTEV-----V 959 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~ 959 (1022)
......++..|+|||...+. .++.++||||+|+++||+++|+.||......+ .......... +..+... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 22223467789999987766 78999999999999999999999986532211 1111111000 0000000 0
Q ss_pred ccccc---chhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 960 DANLV---GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+..+. ..... ...+..+.++.+++.+||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 00000 0111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=322.12 Aligned_cols=146 Identities=29% Similarity=0.475 Sum_probs=131.6
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
.++|.+.++||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999955 68999999987542 23346788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
|||+++++|.+++...+ .+++..+..|+.||+.||+|||. .+||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~----~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHR----HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh----CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997655 37889999999999999999999 789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=301.40 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=198.8
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe---
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF--- 800 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--- 800 (1022)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999954 68899999986532 2334567789999999999999999988766554
Q ss_pred ---eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccC
Q 001710 801 ---KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 801 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~ 877 (1022)
.++|+||+ +++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~----~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 56999988764 38999999999999999999999 7899999999999999999999999999
Q ss_pred ceecCCCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
+...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||...... ..+..... .......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~-~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN-LVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-hcCCCCH
Confidence 9865332 223457888999997654 46789999999999999999999999653221 11111111 1100000
Q ss_pred h------------hccccccchhhh-hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 957 E------------VVDANLVGEEQA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
. +........... ......++.++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000000000000 01112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=296.08 Aligned_cols=267 Identities=21% Similarity=0.227 Sum_probs=193.2
Q ss_pred CCCcCCeeecccceEEEEEEEc-C--CCEEEEEEecchhh--hhHHHHHHHHHHHhhc-CCCcceeEeeeEeeC----Ce
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-D--GTNVAIKVFNLQLE--RAFRTFDSECEILRNV-RHRNLVKIFSSCCNI----DF 800 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~ 800 (1022)
+|++.+.||+|+||.||+++.. + +..||+|++..... ...+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999854 4 77899998865322 2245678899999999 599999999875432 45
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~----~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999986 58999887544 48999999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCCc--eeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC-----
Q 001710 881 LGEGDDS--VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP----- 952 (1022)
Q Consensus 881 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 952 (1022)
....... .......||..|+|||...+ ..++.++||||+|+++|++++|+.||..... .......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 6432211 11223468899999997655 4689999999999999999999999875321 1111111110000
Q ss_pred ------CCcchhccccccchhhh-hhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 ------HGLTEVVDANLVGEEQA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ------~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
..........-...... ......++.++.+++.+|+++||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000 00111235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=296.63 Aligned_cols=243 Identities=23% Similarity=0.244 Sum_probs=196.6
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+++|.....+|.|+|+.|-++. ..+++..|||++.... ..-.+|+.++.+. +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4567777789999999998887 4578899999997652 2234577676666 69999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEe-cCCCcEEEeeccCceecCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL-DENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll-~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
++.|+-+.+.+...+. .. ..+..|+.+|+.++.|||+ .||||||+||+|||+ ++.++++|+|||.++...+.
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~----~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHE----QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHh----cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887776654 22 7777899999999999999 789999999999999 59999999999999876544
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....+-|..|.|||++....|+.++||||+|+++|+|++|+.||.....+. .+..-+ ...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei~~~i---~~~------------ 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EIHTRI---QMP------------ 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HHHHhh---cCC------------
Confidence 223456889999999999999999999999999999999999998744441 111100 000
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
......++..++|+.+||+.||.+||++.++..+=-.
T Consensus 530 -----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 -----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 0114456778999999999999999999999876433
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=286.34 Aligned_cols=248 Identities=23% Similarity=0.236 Sum_probs=194.5
Q ss_pred CCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh-----hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 804 (1022)
+|.+.++||+|+||.||+++.. .+..+++|+.+... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999854 34556666654321 12234566799999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 805 LEFMPNGSFEKWLYS---YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
|||+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++. +.++++|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~----~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ----RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH----cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998864 23468999999999999999999999 88999999999999975 56999999999876
Q ss_pred CCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
..... ......++..|+|||...+..++.++|+||+|+++|+|++|..||...... ..........
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~------- 221 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGP------- 221 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCC-------
Confidence 43322 122345788999999888888899999999999999999999998642111 1111111000
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+..++.++.++|.+||+.+|++||++.|++++
T Consensus 222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 001123456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=277.14 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=200.4
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcC-CC-----cceeEeeeEeeCCee
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HR-----NLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~l~~~~~~~~~~ 801 (1022)
+++|.++..+|+|.||.|-.+... .+..||||+++.- ....+..+-|+++++++. +. -+|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999998743 4789999998643 444566777999999993 22 377888889999999
Q ss_pred EEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC--------------
Q 001710 802 ALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-------------- 866 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-------------- 866 (1022)
|+|+|.+ |.++.+++..... +++...+..|++|++++++|||+ .+++|-|+||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~----~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD----LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh----cceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 5599999988655 78999999999999999999999 88999999999999931
Q ss_pred ------CCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccc
Q 001710 867 ------NMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940 (1022)
Q Consensus 867 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~ 940 (1022)
...++++|||.|++-.+.. +..+.|..|.|||++.+-.++..+||||+|||++|+.||...|+...+.|
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3358999999998754433 34568999999999999999999999999999999999999887643222
Q ss_pred -hhHHHHHHhhcCCC-----------------cchhcccc--------ccchhhhhhhhHHHHHHHHHHHHhhcccCCCC
Q 001710 941 -MSLRRWVKESLPHG-----------------LTEVVDAN--------LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQ 994 (1022)
Q Consensus 941 -~~~~~~~~~~~~~~-----------------~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1022)
..+.+-+....|.. |.+....+ .+..............++++|+++|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 11111111111111 00000000 00000111112223456999999999999999
Q ss_pred CCCHHHHHHH
Q 001710 995 RIHMTDAAAE 1004 (1022)
Q Consensus 995 Rps~~ell~~ 1004 (1022)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=281.67 Aligned_cols=236 Identities=28% Similarity=0.309 Sum_probs=193.5
Q ss_pred eecccceEEEEEEEc-CCCEEEEEEecchhh---hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCH
Q 001710 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
||+|+||.||++... +++.||+|++..... .....+..|+.++++++|+|++++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999854 589999999876532 2456788899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecc
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 893 (1022)
.+++.... .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~----~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHS----LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99998765 38999999999999999999999 789999999999999999999999999998764332 122334
Q ss_pred cCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 894 ~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
.++..|+|||...+...+.++|+||||+++||+++|..||..... .......... ....+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~---------------~~~~~ 213 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD---------------PLRFP 213 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC---------------CCCCC
Confidence 578899999998888889999999999999999999999965322 1111111100 11122
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIHMTD 1000 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps~~e 1000 (1022)
...+.++.+++.+||..||++||++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 223567899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=281.59 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=200.1
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--h-----hhHHHHHHHHHHHhhcCCCcceeEeeeEee-CCe
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--E-----RAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDF 800 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~ 800 (1022)
++|-.++.||+|+|+.||+|. +...+.||||+-.... + ...+...+|.+|.+.+.||.||++|+++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457778999999999999998 5568899999864332 1 123456789999999999999999999965 456
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec---CCCcEEEeeccC
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGI 877 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfG~ 877 (1022)
.|-|+|||+|.+|+-|+..++- +++.++..|+.||+.||.||.+.. .+|||-|+||.|||+- .-|.+||+|||+
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEik--pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEIK--PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhccC--CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 7899999999999999988765 899999999999999999999854 7799999999999995 457899999999
Q ss_pred ceecCCCCCce-----eeecccCCcccCCccccC-C---CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHH
Q 001710 878 SKLLGEGDDSV-----TQTITMATIGYMAPEYGS-E---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 878 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 948 (1022)
++.+..+.+.. -.+...||.+|++||.+. + ...+.|+||||+||++|+++.|+.||...... .++ ..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdI---Lq 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDI---LQ 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHH---Hh
Confidence 99986554332 233457999999999543 2 34789999999999999999999999752211 111 11
Q ss_pred hhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
+. .+ +......++..+..+.+..++|++|+.+.-++|.+..++..
T Consensus 696 eN------TI----lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 EN------TI----LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hh------ch----hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 10 01 11112233444556677899999999999999998888754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=279.98 Aligned_cols=220 Identities=20% Similarity=0.168 Sum_probs=177.6
Q ss_pred ccceEEEEEEE-cCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHHHHhhh
Q 001710 741 GSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS 819 (1022)
Q Consensus 741 G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 819 (1022)
|.||.||+++. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999984 578999999987543 223455555566799999999999999999999999999999999876
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCccc
Q 001710 820 YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899 (1022)
Q Consensus 820 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y 899 (1022)
.. .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH~----~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALHR----EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 54 38999999999999999999999 889999999999999999999999999886653321 123456789
Q ss_pred CCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHH
Q 001710 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLS 979 (1022)
Q Consensus 900 ~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 979 (1022)
+|||...+..++.++||||+|+++|||++|..|+....... ... .....+..++..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~---------~~~~~~~~~~~~ 204 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTH---------TTLNIPEWVSEE 204 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccc---------cccCCcccCCHH
Confidence 99999888889999999999999999999998865321100 000 001122234567
Q ss_pred HHHHHHhhcccCCCCCCCHH
Q 001710 980 IMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 980 l~~li~~cl~~dP~~Rps~~ 999 (1022)
+.+++.+|++.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 89999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=295.80 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=210.8
Q ss_pred HHhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEee-----C
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCN-----I 798 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-----~ 798 (1022)
...++.|++.+.||.|.+|.||+++ .++|+.+|+|+.....+.. +++..|.++++.. .|||++.++|++.- +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3456778999999999999999998 6689999999988765443 5667799999988 69999999999853 5
Q ss_pred CeeEEEEEccCCCCHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccC
Q 001710 799 DFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~ 877 (1022)
+..++|||||.+|+..|+++.. +..+.|..+..|++.++.|+.|||. ..++|||||-.|||++.++.||++|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~----nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN----NKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh----cceeeecccCceEEEeccCcEEEeeeee
Confidence 6889999999999999988754 4469999999999999999999999 6799999999999999999999999999
Q ss_pred ceecCCCCCceeeecccCCcccCCccccCC-----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcC
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 952 (1022)
+...... .......+||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+-++.+....+
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF--------- 238 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF--------- 238 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---------
Confidence 9876433 233445679999999997654 347788999999999999999999987765442100
Q ss_pred CCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 953 HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.....+.+.+..++..+.++.++|..|+.+|-++||++.+++++
T Consensus 239 --------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 --------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01122334455567778899999999999999999999998865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=249.71 Aligned_cols=218 Identities=27% Similarity=0.362 Sum_probs=178.8
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhh-hhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE-RAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
.++......||+|+||.|-+.+ .++|...|+|.+..... +..++..+|+.+..+. .+|.+|+|||........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3444555779999999998887 46899999999876543 3345667777776655 7999999999999999999999
Q ss_pred EccCCCCHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 806 EFMPNGSFEKWLY---SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
|.|+- +|..+-+ ..+..+++.-.-+|+..++.||.|||++ ..|+|||+||+|||++.+|++|+||||.+..+.
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k---L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK---LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH---hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99965 7777654 3455689999999999999999999985 569999999999999999999999999998763
Q ss_pred CCCCceeeecccCCcccCCccccCC----CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCC
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 953 (1022)
.+...+...|-..|||||.+.. ..|+.++||||+|+.+.||.+++.||+......+++.+.+++.-|+
T Consensus 201 ---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 201 ---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred ---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 3344555668888999996543 4689999999999999999999999998877777787777765544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=265.22 Aligned_cols=248 Identities=20% Similarity=0.262 Sum_probs=199.3
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 803 (1022)
-.+|..+.+||+|+|+.|-.++ .++.+.||+|+++++. ++.......|..+..+. +||.+|.+..+|.++...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4679999999999999999998 4578889999998764 34445566788888777 69999999999999999999
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
|.||++||+|.-.+++.+. ++++.+..+...|.-||.|||+ +|||+||+|..|||+|..|++|++|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~----rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHE----RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhh----cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999887776665 8888888899999999999999 9999999999999999999999999999976322
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCc--ccccchhHHHHHHhhcCCCcchhccc
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE--MFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
. ....+..+||+.|.|||.+.+..|++.+|+|++|++++||+.|+.||+- +.+.+++..++.-+.+- ..
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------ek 474 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------EK 474 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------hh
Confidence 2 2234457899999999999999999999999999999999999999984 33334443333322210 00
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 997 (1022)
....|...+-....+++.-+++||.+|..
T Consensus 475 -------qiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 -------QIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11122233344567888999999999873
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=285.28 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=205.3
Q ss_pred cCCCcCCeeecccceEEEEEEEcCC-CEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDG-TNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
.+++.+.-||-|+||.|=+++.+.. ..+|+|++++.. .++.+.+..|.++|...+.|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566667799999999999985543 348999887543 455677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|-|-||.++..++.++. ++......++..+++|++|||. ++||+||+||+|.++|.+|.+||.|||+|+.++.+.
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~----k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHR----KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHh----cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998876 7788888899999999999999 889999999999999999999999999999987655
Q ss_pred CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccc
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .-..+||+.|.|||.+.....+.++|.||+|+++||+++|.+||.+..+..... ...+ ++
T Consensus 575 K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-~ILk-----Gi---------- 635 (732)
T KOG0614|consen 575 K---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-LILK-----GI---------- 635 (732)
T ss_pred c---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-HHHh-----hh----------
Confidence 4 334689999999999999999999999999999999999999998754432111 1111 11
Q ss_pred hhhhhhhhHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~ell~~ 1004 (1022)
..+..|...+....++|++.+..+|.+|.. ..|+-+|
T Consensus 636 --d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 --DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred --hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 122334455666789999999999999985 5566555
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=253.56 Aligned_cols=260 Identities=21% Similarity=0.368 Sum_probs=201.1
Q ss_pred hhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCC--eeEE
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSCCNID--FKAL 803 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~--~~~l 803 (1022)
..++|++.+++|+|.|+.||.|. ..+.++++||++++-. .+.+.+|+.+++.++ ||||+++++...++. .+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999998 5678899999997553 356788999999997 999999999997754 5679
Q ss_pred EEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeeccCceecC
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKLLG 882 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG~a~~~~ 882 (1022)
|+||+.+.+....-.. ++...+...+.+++.||.|+|+ .||.|||+||.||++|. .-.++|+|+|+|.++.
T Consensus 113 iFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS----~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHS----MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHh----cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999999887776544 6777888899999999999999 89999999999999995 5579999999999997
Q ss_pred CCCCceeeecccCCcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchh---
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV--- 958 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 958 (1022)
++.. ...++.+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||-- +..+..+.++-...-+..++
T Consensus 185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh---G~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH---GHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC---CCCCHHHHHHHHHHhChHHHHHH
Confidence 6654 445678889999997654 5689999999999999999999999743 34444444432221121111
Q ss_pred -------ccccccc---hh-----hhhh---hhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 959 -------VDANLVG---EE-----QAFS---AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 959 -------~~~~~~~---~~-----~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+|+.+.+ .. ..+- ...-.+++..+++...+.+|-.+|+|++|++++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2222111 00 0000 011134678999999999999999999999876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.84 Aligned_cols=217 Identities=24% Similarity=0.380 Sum_probs=179.7
Q ss_pred chHHHHHHhhc---CCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEe
Q 001710 720 TSYLDIQRATD---GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIF 792 (1022)
Q Consensus 720 ~~~~~~~~~~~---~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~ 792 (1022)
..|..++++.- -|..++.||-|+||+|.+++ ..+...||+|.+++.. +.+...++.|.+||.....+=||++|
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 34555555443 36677889999999999998 4456779999987664 45566788899999999999999999
Q ss_pred eeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEE
Q 001710 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV 872 (1022)
Q Consensus 793 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl 872 (1022)
..|.+++..|+||||++||++..+|-+-+- +++..+..++..+..|+++.|+ .|+|||||||+|||||.||++||
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHk----mGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHK----MGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHh----ccceecccCccceEEccCCceee
Confidence 999999999999999999999999887665 6666666678889999999999 89999999999999999999999
Q ss_pred eeccCceecC---------CCCCc-------------------------------eeeecccCCcccCCccccCCCCCCc
Q 001710 873 SDFGISKLLG---------EGDDS-------------------------------VTQTITMATIGYMAPEYGSEGIVSA 912 (1022)
Q Consensus 873 ~DfG~a~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 912 (1022)
+|||+|+-+. +++-. ......+||+.|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 9999995331 10000 0011236999999999999999999
Q ss_pred cchhHhHHHHHHHHHcCCCCCCcccccch
Q 001710 913 KCDVYSYGVLLMETFTRKKPTDEMFTGEM 941 (1022)
Q Consensus 913 ~~DvwslG~vl~elltg~~p~~~~~~~~~ 941 (1022)
.+|+||.|+|+|||+.|++||......+.
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 99999999999999999999988766654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=302.32 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=169.9
Q ss_pred hhcCCCcCCeeecccceEEEEEEEc-C----CCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeee------Ee
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLF-D----GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSS------CC 796 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~------~~ 796 (1022)
..++|++.++||+|+||.||+|+.. + +..||+|++...... +....| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999854 4 689999987543211 111111 1112222222222211 24
Q ss_pred eCCeeEEEEEccCCCCHHHHhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 001710 797 NIDFKALVLEFMPNGSFEKWLYSYNYF-------------------LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL 857 (1022)
Q Consensus 797 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Di 857 (1022)
.....++||||+++++|.+++...... .....+..++.|++.||+|||+ .+|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~----~gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS----TGIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH----CCEEeCcC
Confidence 566789999999999999998754321 1123456799999999999999 78999999
Q ss_pred CCCcEEecC-CCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCC----------------------CCCccc
Q 001710 858 KPNNILLDE-NMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG----------------------IVSAKC 914 (1022)
Q Consensus 858 k~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 914 (1022)
||+|||++. ++.+||+|||+|+.+...... ......+|+.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 689999999999865433222 22335689999999954321 234567
Q ss_pred hhHhHHHHHHHHHcCCCCCCcccc--------cchhHHHHHHhhcCCCcchhccccccch-hhhhhhhHHHHHHHHHHHH
Q 001710 915 DVYSYGVLLMETFTRKKPTDEMFT--------GEMSLRRWVKESLPHGLTEVVDANLVGE-EQAFSAKTDCLLSIMDLAL 985 (1022)
Q Consensus 915 DvwslG~vl~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 985 (1022)
||||+||++|||+++..|++.... .......|... ........ ...+...........+++.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccccchhhhhhhhhccccchHHHHHHH
Confidence 999999999999998776543110 00111122111 11110000 0000111111234568999
Q ss_pred hhcccCCCCCCCHHHHHHH
Q 001710 986 DCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 986 ~cl~~dP~~Rps~~ell~~ 1004 (1022)
+|++.||++|||++|+++|
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=297.38 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=190.2
Q ss_pred cCCeeecccceE-EEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 734 ECNLLGRGSFGL-VYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 734 ~~~~Lg~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
..+++|.|+.|+ ||+|. .+|+.||||++-.+ ......+|+..++.- +|||||++|+.-.++.+.||+.|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV-YEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEe-eCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 346789999985 79998 57899999987533 334667899999988 699999999999999999999999966
Q ss_pred CHHHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC---C--CcEEEeeccCceecCC
Q 001710 812 SFEKWLYSYNY---FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE---N--MTAHVSDFGISKLLGE 883 (1022)
Q Consensus 812 ~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~---~--~~~kl~DfG~a~~~~~ 883 (1022)
+|+++++.... .........+..|+++|++|||+ .+|||||+||+||||+. + .+++|+|||+++.+..
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs----l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS----LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh----cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999988421 11224456789999999999999 78999999999999975 3 4699999999999876
Q ss_pred CCCcee-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcC-CCCCCcccccchhHHHHHHhhcCCCcchhccc
Q 001710 884 GDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 884 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
+..+.. .....||.+|+|||++....-+.++||||+|||+|+.++| .+||......+.++-. +...+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~-- 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLV-- 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Ccccee--
Confidence 654433 3456799999999999999989999999999999999996 8999864333221110 100000
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+....+| +..++|.+|+++||..||++.+|+.|
T Consensus 734 -------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 -------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11111222 67899999999999999999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=287.89 Aligned_cols=258 Identities=23% Similarity=0.259 Sum_probs=183.4
Q ss_pred hhcCCCcCCeeecccceEEEEEEE-----------------cCCCEEEEEEecchhhhhH--------------HHHHHH
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-----------------FDGTNVAIKVFNLQLERAF--------------RTFDSE 776 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~--------------~~~~~E 776 (1022)
..++|++.++||+|+||+||+|.. ..++.||||++........ +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 2356899999865432222 233457
Q ss_pred HHHHhhcCCCcc-----eeEeeeEee--------CCeeEEEEEccCCCCHHHHhhhcCC---------------------
Q 001710 777 CEILRNVRHRNL-----VKIFSSCCN--------IDFKALVLEFMPNGSFEKWLYSYNY--------------------- 822 (1022)
Q Consensus 777 ~~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 822 (1022)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778866554 667777653 3567999999999999999874311
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccC
Q 001710 823 --FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900 (1022)
Q Consensus 823 --~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~ 900 (1022)
..++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.+||+|||++..+...... ......+|+.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~----~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR----IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 24567788999999999999999 78999999999999999999999999999765432211 112233578999
Q ss_pred CccccCCCC--------------------C--CccchhHhHHHHHHHHHcCCC-CCCcccccch-------hHHHHHHhh
Q 001710 901 APEYGSEGI--------------------V--SAKCDVYSYGVLLMETFTRKK-PTDEMFTGEM-------SLRRWVKES 950 (1022)
Q Consensus 901 aPE~~~~~~--------------------~--~~~~DvwslG~vl~elltg~~-p~~~~~~~~~-------~~~~~~~~~ 950 (1022)
|||.+.... | ..+.||||+||++|||+++.. ||........ ....|...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~- 456 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY- 456 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence 999765322 1 124799999999999999875 6653211111 11111110
Q ss_pred cCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCC---CCCCCHHHHHHH
Q 001710 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESP---EQRIHMTDAAAE 1004 (1022)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~ell~~ 1004 (1022)
......++.....+....+++.+|+..+| .+|+|++|+++|
T Consensus 457 -------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 -------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00111122233346678999999999876 689999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=266.07 Aligned_cols=238 Identities=30% Similarity=0.349 Sum_probs=194.5
Q ss_pred cceEEEEEEEc-CCCEEEEEEecchhhhh-HHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHHHHhhh
Q 001710 742 SFGLVYKGTLF-DGTNVAIKVFNLQLERA-FRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYS 819 (1022)
Q Consensus 742 ~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 819 (1022)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999997665443 67889999999999999999999999999999999999999999999887
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCccc
Q 001710 820 YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899 (1022)
Q Consensus 820 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y 899 (1022)
... +++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~----~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHS----NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHH----cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 654 8899999999999999999999 789999999999999999999999999998765432 22334578899
Q ss_pred CCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHH
Q 001710 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLS 979 (1022)
Q Consensus 900 ~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 979 (1022)
+|||...+..++.++||||+|+++|++++|..||......+ ...++........ ......++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~ 216 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPPF---------------PPPEWKISPE 216 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCC---------------ccccccCCHH
Confidence 99999888888999999999999999999999987532221 1111111110000 0000014567
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHH
Q 001710 980 IMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 980 l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=261.90 Aligned_cols=265 Identities=21% Similarity=0.235 Sum_probs=196.3
Q ss_pred cCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcC--------CCcceeEeeeEee---
Q 001710 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR--------HRNLVKIFSSCCN--- 797 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~~--- 797 (1022)
.+|.+.++||.|.|++||+|. ..+.+.||+|+.+.. +...+....|+.++++++ ..+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678899999999999999997 567889999999755 334466788999999994 3579999999864
Q ss_pred -CCeeEEEEEccCCCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC--------
Q 001710 798 -IDFKALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-------- 867 (1022)
Q Consensus 798 -~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-------- 867 (1022)
+.+.|||+|++ |.+|..++....+ .++...+.+|++||+.||.|||..+ ||||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeeeccccchhhhh
Confidence 56899999999 6689888876544 6999999999999999999999864 79999999999999210
Q ss_pred --------------------------------------------------------------------------------
Q 001710 868 -------------------------------------------------------------------------------- 867 (1022)
Q Consensus 868 -------------------------------------------------------------------------------- 867 (1022)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 001710 868 ------------------------------------------------------------------------------MT 869 (1022)
Q Consensus 868 ------------------------------------------------------------------------------~~ 869 (1022)
..
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCc-----ccccchhHH
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE-----MFTGEMSLR 944 (1022)
Q Consensus 870 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~-----~~~~~~~~~ 944 (1022)
|||+|||-|.-+.. ..+..+.|..|+|||++.+..|++.+||||++|++|||+||...|+. ..+++..++
T Consensus 393 vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 23333333322111 11122457889999999999999999999999999999999988863 234455566
Q ss_pred HHHHhh--cCC-----C--cchhccccccch--------------hhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 001710 945 RWVKES--LPH-----G--LTEVVDANLVGE--------------EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001 (1022)
Q Consensus 945 ~~~~~~--~~~-----~--~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 1001 (1022)
..+.-. +|+ + ..++++.+-... ...+..+.....++.+++.-|++.+|++||||.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 554321 111 1 223333211000 01233345567789999999999999999999999
Q ss_pred HHH
Q 001710 1002 AAE 1004 (1022)
Q Consensus 1002 l~~ 1004 (1022)
+++
T Consensus 548 l~h 550 (590)
T KOG1290|consen 548 LKH 550 (590)
T ss_pred hcC
Confidence 865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=254.01 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=195.4
Q ss_pred cCCeeecccceEEEEEEE-cCCCEEEEEEecchhh--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCC-----eeEEEE
Q 001710 734 ECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNID-----FKALVL 805 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~lv~ 805 (1022)
..+.||.|+||+||.+.. .+|+.||+|++..-.. ...+++.+|..++...+|.|+...++...... +.|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 347899999999999984 5799999998864332 34577889999999999999999888765432 467888
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|.|.. +|...+-... .++...+.-+.+||++||+|||+ .+|.||||||.|.|+.++-.+||||||+|+....+
T Consensus 137 ELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHs----A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHT----ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHhh----cchhhccCCCccEEeccCceEEecccccccccchh-
Confidence 98854 8888776544 48888899999999999999999 88999999999999999999999999999875443
Q ss_pred CceeeecccCCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch-------
Q 001710 886 DSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE------- 957 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 957 (1022)
....++..+.|.+|+|||.+.|. .|+.+.||||.||++.|++-++..|+....-+ .-+.+.+.+-....+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhh
Confidence 34445666789999999988775 59999999999999999999998887532211 111122111111000
Q ss_pred -----hccccccchh----hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 001710 958 -----VVDANLVGEE----QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 958 -----~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 1007 (1022)
++....+.+. ..+..+..-..+...+.+.++..||++|.+..+.+.++-.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111000 0111122233456788999999999999999998877543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=265.58 Aligned_cols=198 Identities=24% Similarity=0.326 Sum_probs=171.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---h-----hhHHHHHHHHHHHhhcC---CCcceeEeeeEe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---E-----RAFRTFDSECEILRNVR---HRNLVKIFSSCC 796 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~-----~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~ 796 (1022)
..+|...+.+|+|+||.|+.|..+ +...|+||.+.++. + +....+-.|++||.+++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356899999999999999999855 46789999887664 1 12234667999999997 999999999999
Q ss_pred eCCeeEEEEEcc-CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeec
Q 001710 797 NIDFKALVLEFM-PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDF 875 (1022)
Q Consensus 797 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 875 (1022)
+.+.+|++||-. ++.+|.+++...+. +++.....|++||+-|+++||+ .+|||||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~----~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHD----QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccccc----cCceecccccccEEEecCCeEEEeec
Confidence 999999999985 45589999987765 8999999999999999999999 88999999999999999999999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCCCCC-CccchhHhHHHHHHHHHcCCCCCCc
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
|.|....++.. ...+||.+|.|||++.|..| +..-|||++|+++|.++....||..
T Consensus 715 gsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99987655443 34579999999999999887 5668999999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=269.26 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=206.3
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
...++|+.++.+|+|.||.||||+ ..+++..|+|+++.+....+....+|+-+++..+|||||.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 345789999999999999999999 4578999999999988888888899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCC
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 885 (1022)
|||.+|+|++.-+..+ .+++.++..+++...+|++|||+ .|-+|||||-.||++++.|.+|++|||.+..++..-
T Consensus 92 EycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs----~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHS----QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhc----CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999999766655 48999999999999999999999 778999999999999999999999999997765432
Q ss_pred CceeeecccCCcccCCccc---cCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhcccc
Q 001710 886 DSVTQTITMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
. +.....||+.|||||+ .+.+.|..++|||+.|+...|+-.-++|--...... .-........+
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~q--------- 233 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQ--------- 233 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCC---------
Confidence 2 2334579999999995 456678999999999999999988887743221111 11111111111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 1003 (1022)
.+....+....+.+-++++.|+.++|++||++..+++
T Consensus 234 ----pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 ----PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0111222334566889999999999999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=240.01 Aligned_cols=211 Identities=35% Similarity=0.492 Sum_probs=184.4
Q ss_pred eecccceEEEEEEEc-CCCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHHH
Q 001710 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEK 815 (1022)
Q Consensus 738 Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~ 815 (1022)
||+|++|.||+++.. +++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999866443 34678899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-CCcEEEeeccCceecCCCCCceeeeccc
Q 001710 816 WLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGISKLLGEGDDSVTQTITM 894 (1022)
Q Consensus 816 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 894 (1022)
++......+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS----NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 998764458999999999999999999999 78999999999999999 89999999999987644321 122345
Q ss_pred CCcccCCccccCCC-CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhh
Q 001710 895 ATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973 (1022)
Q Consensus 895 gt~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 973 (1022)
+...|++||..... .++.+.|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999988777 888999999999999999
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 974 TDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 974 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-28 Score=242.53 Aligned_cols=257 Identities=22% Similarity=0.260 Sum_probs=197.3
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeC------C
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI------D 799 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 799 (1022)
..+|..++.+|.|+- .|..|. .-.++.||+|...... ...+++..+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999998 666665 2358899999875442 33457788999999999999999999998643 3
Q ss_pred eeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
..|+|||+|+. +|...+.. .++...+..|.+|++.|+.|||+ .+|+|||+||+||++..+..+||.|||+|+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs----~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHS----AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh----cceeecccCcccceecchhheeeccchhhc
Confidence 57899999966 88887773 26788899999999999999999 899999999999999999999999999998
Q ss_pred ecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC--cch
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG--LTE 957 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 957 (1022)
.-.. ....+..+.|..|.|||++.+..|...+||||.||++.||++|+.-|. ++..+.+|.+-....+ -..
T Consensus 167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHH
Confidence 6432 245666789999999999998889999999999999999999998765 5566666644211110 000
Q ss_pred h---------------------------ccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 V---------------------------VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~---------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
+ .|..+.. .....+--.....+++.+|+-.||++|.+++++++|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~---~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV---VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccc---cccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0000000 011111123457899999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=254.32 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=203.4
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcC------CCcceeEeeeEeeCC
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVR------HRNLVKIFSSCCNID 799 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~~ 799 (1022)
....+|.+....|+|-|++|..|... .|..||||++.... ...+.=+.|+++|++|. .-|+++++..|....
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34567888899999999999999844 47899999997653 23344567999999994 458999999999999
Q ss_pred eeEEEEEccCCCCHHHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeecc
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNY--FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFG 876 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG 876 (1022)
+.|+|||-+.- +|.+++.+.+. .+...++..+++|+.-||..|-. -+|+|.||||.||||.+. ..+||||||
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~----c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK----CGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh----cCeeecccCccceEeccCcceeeeccCc
Confidence 99999998854 99999998776 57778899999999999999998 789999999999999864 568999999
Q ss_pred CceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchh-H------------
Q 001710 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMS-L------------ 943 (1022)
Q Consensus 877 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-~------------ 943 (1022)
.|.+....+. +.+..+..|.|||++.|-+|+...|+||.||.+||+.||+..|.+.....+. +
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9988754433 2234567799999999999999999999999999999999988764433221 0
Q ss_pred ---HHHHHhhcCCCcc---hhcc---------------------ccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCC
Q 001710 944 ---RRWVKESLPHGLT---EVVD---------------------ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI 996 (1022)
Q Consensus 944 ---~~~~~~~~~~~~~---~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 996 (1022)
.++..+++.+.+. ...| ..+.+..............+.+|+..|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0111122221100 0000 011111111122334566799999999999999999
Q ss_pred CHHHHHHH
Q 001710 997 HMTDAAAE 1004 (1022)
Q Consensus 997 s~~ell~~ 1004 (1022)
|..++++|
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=229.35 Aligned_cols=252 Identities=18% Similarity=0.266 Sum_probs=189.4
Q ss_pred cCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeee-EeeCCeeEEEEE
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSS-CCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~-~~~~~~~~lv~e 806 (1022)
+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+...... .++|.+|...--.+ .|.||+.-|+. |+..+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 56888899999999999999854 5788999988766433 46788887765566 58999988764 677788889999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec--CCCcEEEeeccCceecCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~--~~~~~kl~DfG~a~~~~~~ 884 (1022)
|++.|+|..-+...+ +.+....+++.|+++|++|||+ ..+||||||.+||||- +...+|+||||..+..+..
T Consensus 103 ~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHs----knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHS----KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhc----cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999999888766 7889999999999999999999 7899999999999994 3447999999998865433
Q ss_pred CCceeeecccCCcccCCccccCC---C--CCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhc
Q 001710 885 DDSVTQTITMATIGYMAPEYGSE---G--IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.... .-+..|.|||.... + ...+.+|||.||+++|.++||+.||+...-.......|..=..+. .
T Consensus 177 V~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk--~--- 246 (378)
T KOG1345|consen 177 VKYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK--N--- 246 (378)
T ss_pred ehhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc--C---
Confidence 2222 23456899995332 2 246789999999999999999999997666665555554321111 1
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 1005 (1022)
+++.... ..+++.+..+.++-+.++|++|-...++.+..
T Consensus 247 -~~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 -PALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -ccCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 0111111 12355677888999999999995555544443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=244.26 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=201.0
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEc----CCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCe
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 800 (1022)
....+.|..+++||+|.|++||+|... ..+.||+|.+...... .++..|++++..+ .+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567899999999999999999843 4678999998766443 5688999999999 59999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec-CCCcEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfG~a~ 879 (1022)
..+|+||++..+..++... ++...+..+++.+..||+++|+ .|||||||||.|++.+ ..+.-.|+|||+|.
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~----~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK----NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc----cCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999998876 6688889999999999999999 8999999999999998 56788999999997
Q ss_pred ecCCC------------------------------------------CCceeeecccCCcccCCccccC-CCCCCccchh
Q 001710 880 LLGEG------------------------------------------DDSVTQTITMATIGYMAPEYGS-EGIVSAKCDV 916 (1022)
Q Consensus 880 ~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv 916 (1022)
.+... .........+||+||.|||++. .+..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 22100 0000122346999999999754 4567899999
Q ss_pred HhHHHHHHHHHcCCCCCCcccccchhHHHHHHh----------hcCCC--cch---------h------cc-ccc-cchh
Q 001710 917 YSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE----------SLPHG--LTE---------V------VD-ANL-VGEE 967 (1022)
Q Consensus 917 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~--~~~---------~------~~-~~~-~~~~ 967 (1022)
||.|+++..+++++.||-....+-..+.+.+.- ..+.. +.+ . ++ ..+ ....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999986544444444333221 00000 000 0 00 000 0000
Q ss_pred ---hhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 968 ---QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.........+..+++++.+|+..||.+|.|++|++++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111112234478999999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=234.93 Aligned_cols=199 Identities=29% Similarity=0.394 Sum_probs=173.5
Q ss_pred CCcCCeeecccceEEEEEEEcC-CCEEEEEEecchhhh-hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 732 FNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLER-AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
|...+.||+|++|.||+++..+ ++.+|+|.+...... ..+.+.+|++.+++++|++++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999999654 899999999876544 56788899999999999999999999999899999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+++|.+++......+++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS----LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 999999998765447899999999999999999999 78999999999999999999999999999877543211 1
Q ss_pred eecccCCcccCCcccc-CCCCCCccchhHhHHHHHHHHHcCCCCCCc
Q 001710 890 QTITMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
.....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2234577889999987 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-28 Score=248.13 Aligned_cols=387 Identities=23% Similarity=0.258 Sum_probs=241.4
Q ss_pred CCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccC-ccccCcCCcccccccccceeecc
Q 001710 197 LQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGM-NNLSGPVPPTIFNISTIRLINLI 275 (1022)
Q Consensus 197 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls 275 (1022)
-..++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+.|++|.++.+|.+|-+.+ |+|+...-..|.+|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 34556666666655555666666666666666666666666666666655554443 56654333445555555555555
Q ss_pred cceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCcc------------CccCCcccccccccc
Q 001710 276 ENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLF------------SGHIPHTFGNLRFLR 343 (1022)
Q Consensus 276 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------------~~~~~~~~~~l~~L~ 343 (1022)
-|++. -++...+..+++|..|.+.+|.+...--..|..+..++.+.+..|.+ ....|-.++..+...
T Consensus 149 an~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 149 ANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred hhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 55555 33333334455555555555555533333555555555555555552 122233344444444
Q ss_pred ccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCC-ccccCCCc
Q 001710 344 FLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP-QEIGNLSG 422 (1022)
Q Consensus 344 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p-~~l~~l~~ 422 (1022)
-..|.++++..+.+.. +..-..++..-....|...+.-| ..|..+++
T Consensus 228 p~rl~~~Ri~q~~a~k--------------------------------f~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARK--------------------------------FLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred hHHHHHHHhcccchhh--------------------------------hhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 4445555554443221 11111122222233444444444 34889999
Q ss_pred ceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccC
Q 001710 423 LMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGS 502 (1022)
Q Consensus 423 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 502 (1022)
|+.|+|++|+|+++-+.+|.+..+++.|.|..|+|..+....|.++..|+.|+|.+|+|+..-|.+|..+.+|.+|+|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 99999999999999999999999999999999999988889999999999999999999999999999999999999988
Q ss_pred ceeccc-----cCCcccc-----------ccccceEeccCCcCCC---Cccccccc---------ccccc-eeeccCccc
Q 001710 503 NTLTYS-----IPSSLWS-----------LEYILYVNLSSNSLSG---PLPSSIQH---------LKVLI-NLDLSRNQL 553 (1022)
Q Consensus 503 N~l~~~-----~p~~~~~-----------l~~L~~L~ls~N~l~~---~~p~~~~~---------l~~L~-~L~Ls~N~l 553 (1022)
|.+--. +-+|+.+ =..++.+.++.+.+.. ..|++... .+-+. ...-|++.+
T Consensus 356 Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~l 435 (498)
T KOG4237|consen 356 NPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLL 435 (498)
T ss_pred CcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccch
Confidence 866410 0111110 1123445555544332 12222221 11222 233454455
Q ss_pred cCccccccccccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCC
Q 001710 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYN 623 (1022)
Q Consensus 554 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 623 (1022)
+ .+|..+. ..-..|+|.+|.++ .+|.. .+.+| .+|+++|+|+..--..|.+|++|.+|-||+|
T Consensus 436 k-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 436 K-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred h-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4 5555543 34568899999999 67776 67788 8999999999777788999999999999987
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-27 Score=241.80 Aligned_cols=291 Identities=24% Similarity=0.211 Sum_probs=205.7
Q ss_pred CccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccc-cccCCCcchhhcCccccceeec
Q 001710 77 FLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHN-NSFTDRIPDFLLNLSKLEFLDL 155 (1022)
Q Consensus 77 ~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L 155 (1022)
.-+.++|..|+|+...|.+|+.+++|++||||+|.|+-+-|++|.++.+|..|-+.+ |+|+......|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 346788888999866667888888999999998888888888888888877765555 8888666667888888888888
Q ss_pred cCcccccccCCcc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCC
Q 001710 156 MENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234 (1022)
Q Consensus 156 s~N~l~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 234 (1022)
.-|.+.-.....+ .+++|..|.+..|.+...--..|..+.+++++.+..|.+-. ..+++.+.. +...
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-------~~a~ 215 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-------DLAM 215 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-------HHhh
Confidence 8888775544444 46777777777777653333366666777777766665321 122222111 1112
Q ss_pred ChhhhcCcCCCCEEEccCccccCcCCccccc-ccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccc
Q 001710 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN-ISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSIT 313 (1022)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 313 (1022)
.|..+++.....-..+.++++..+-+..|.. +..+..=-.+.+..-+..|..-+..+++|++|+|++|+++++-+.+|.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe 295 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE 295 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence 3344455555555555555555333333322 223333233344444567777788899999999999999999999999
Q ss_pred cccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccc
Q 001710 314 NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGI 387 (1022)
Q Consensus 314 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 387 (1022)
.+..++.|.|..|+|..+....|.++..|+.|+|.+|+|+.+...+ |..+.+|.+|.|-.|++...
T Consensus 296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~a--------F~~~~~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGA--------FQTLFSLSTLNLLSNPFNCN 361 (498)
T ss_pred chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccc--------ccccceeeeeehccCcccCc
Confidence 9999999999999999888889999999999999999999876544 77788999999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=214.83 Aligned_cols=171 Identities=19% Similarity=0.153 Sum_probs=133.6
Q ss_pred CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceee
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 890 (1022)
|+|.++++..+..+++..+..|+.|++.||+|||+ .+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~----~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR----QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999998776679999999999999999999999 44 999999999999999 99998754321
Q ss_pred ecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhh
Q 001710 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970 (1022)
Q Consensus 891 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 970 (1022)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............+.....+.... ..
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 129 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR------------DR 129 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc------------cc
Confidence 2588999999999999999999999999999999999999976443333333333222111000 00
Q ss_pred hhhHHHHH--HHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 971 SAKTDCLL--SIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 971 ~~~~~~~~--~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
..+..... ++.+++.+||+.+|++||++.|+++++..+....
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 01122223 6899999999999999999999999998875543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=268.11 Aligned_cols=197 Identities=19% Similarity=0.259 Sum_probs=139.5
Q ss_pred hcCC-CcceeEeeeE-------eeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 001710 782 NVRH-RNLVKIFSSC-------CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853 (1022)
Q Consensus 782 ~l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~iv 853 (1022)
.++| +||+++++++ ...+..+.++||+ +++|.+++......+++.+++.+++||+.||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~----~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS----QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh----CCee
Confidence 3445 5777777776 2234566788887 559999998766669999999999999999999999 8899
Q ss_pred ecCCCCCcEEecC-------------------CCcEEEeeccCceecCCCCC--------------ceeeecccCCcccC
Q 001710 854 HCDLKPNNILLDE-------------------NMTAHVSDFGISKLLGEGDD--------------SVTQTITMATIGYM 900 (1022)
Q Consensus 854 H~Dik~~NIll~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y~ 900 (1022)
||||||+|||++. ++.+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965 44556666666653211000 00111235788999
Q ss_pred CccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHH
Q 001710 901 APEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSI 980 (1022)
Q Consensus 901 aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 980 (1022)
|||++.+..|+.++|||||||++|||++|..|+.... .....+.....+ +. ........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~--------~~----------~~~~~~~~ 241 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP--------PQ----------ILLNWPKE 241 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC--------hh----------hhhcCHHH
Confidence 9999999999999999999999999999888865311 111111111000 00 00112335
Q ss_pred HHHHHhhcccCCCCCCCHHHHHHH
Q 001710 981 MDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 981 ~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.+++.+||+++|.+||++.|++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678899999999999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=262.94 Aligned_cols=363 Identities=20% Similarity=0.232 Sum_probs=231.1
Q ss_pred CcEEEEEcCCCCccc-cc-CCCCCCCCCccEEeccCCc------ccCCCCCCccccc-ccccccccccccCCCCCccccc
Q 001710 52 HRVVALNLSSFSLGG-II-PPHLGNLSFLVSLDISENN------FYGHLPNELGKLR-RLRLINFAYNELSGSFPSWIGI 122 (1022)
Q Consensus 52 ~~v~~l~L~~~~l~~-~i-~~~l~~l~~L~~L~Ls~n~------~~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~ 122 (1022)
.+|..+.|.-..+.. .+ +.+|.++.+|+.|.+..+. +...+|..+..++ +|+.|++.++.+. .+|..+ .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 456665555433321 12 3457888999999887653 3345777777765 6888998888876 677776 4
Q ss_pred ccccceeeccccccCCCcchhhcCccccceeeccCcccccccCCccccccccceecccccccccCCccccCCCCCCeeec
Q 001710 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWL 202 (1022)
Q Consensus 123 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 202 (1022)
+.+|++|+|++|.+. .+|..+..+++|+.|+|++|...+.+|....+++|+.|+|++|.....+|..++.+++|+.|++
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 688889999988887 5777788888888888888765566776556788888888887766777888888888888888
Q ss_pred ccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeee
Q 001710 203 ADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGH 282 (1022)
Q Consensus 203 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 282 (1022)
++|..-+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|+|++|.++ .+|..+ .+++|+.|++.++... .
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~ 761 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-K 761 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-h
Confidence 8765444566554 6777888888877655455532 346777777777765 445443 4556666655543321 0
Q ss_pred ccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccc-cccCCCCCCCc
Q 001710 283 LPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFN-SLTTESSPADQ 361 (1022)
Q Consensus 283 ~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~ 361 (1022)
+.. .+....+..+...++|+.|+|++|...+.+|..++++++|+.|++++| .++.++.
T Consensus 762 l~~-----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~---- 820 (1153)
T PLN03210 762 LWE-----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT---- 820 (1153)
T ss_pred ccc-----------------cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC----
Confidence 000 001111111122345555555555555555555555666666666554 2333221
Q ss_pred cchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCcccccc
Q 001710 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV 441 (1022)
Q Consensus 362 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 441 (1022)
...+++|+.|++++|..-. .+|. ..++|++|+|++|.+. .+|.++
T Consensus 821 ------~~~L~sL~~L~Ls~c~~L~-------------------------~~p~---~~~nL~~L~Ls~n~i~-~iP~si 865 (1153)
T PLN03210 821 ------GINLESLESLDLSGCSRLR-------------------------TFPD---ISTNISDLNLSRTGIE-EVPWWI 865 (1153)
T ss_pred ------CCCccccCEEECCCCCccc-------------------------cccc---cccccCEeECCCCCCc-cChHHH
Confidence 1134556666666553221 1221 1256778888888887 577788
Q ss_pred cccccCceEEeeccCCCCCCCcccccccccceeecCCcc
Q 001710 442 GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNN 480 (1022)
Q Consensus 442 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 480 (1022)
..+++|+.|+|++|+--..+|..+..+++|+.|++++|.
T Consensus 866 ~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 866 EKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred hcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 888888888888844333567777888888888887763
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=262.66 Aligned_cols=336 Identities=21% Similarity=0.302 Sum_probs=176.0
Q ss_pred ccccCCCcccEEEecccc------ccCCChhhhcCcC-CCCEEEccCccccCcCCcccccccccceeecccceeeeeccc
Q 001710 213 ENIGNLSQLTDLNLAQNN------LQGDMPTAIGNLQ-MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPL 285 (1022)
Q Consensus 213 ~~l~~l~~L~~L~L~~N~------l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 285 (1022)
.+|.++.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..+ ...+|+.|++++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345555556655554432 2223444454443 4666666666554 444444 3456666666666655 3444
Q ss_pred cccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccc-cccCCCCCCCccch
Q 001710 286 TLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFN-SLTTESSPADQWSF 364 (1022)
Q Consensus 286 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~ 364 (1022)
.+. .+++|+.|+|++|.....+|. +..+++|+.|+|++|.....+|..++++++|+.|++++| .++.++..
T Consensus 629 ~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~------ 700 (1153)
T PLN03210 629 GVH-SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG------ 700 (1153)
T ss_pred ccc-cCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc------
Confidence 432 466666666666554444443 556666666666666555566666666666666666664 33333211
Q ss_pred hccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCccccccccc
Q 001710 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRF 444 (1022)
Q Consensus 365 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 444 (1022)
.++++|+.|++++|...+ .+|. ..++|++|++++|.+. .+|..+ .+
T Consensus 701 ----i~l~sL~~L~Lsgc~~L~-------------------------~~p~---~~~nL~~L~L~~n~i~-~lP~~~-~l 746 (1153)
T PLN03210 701 ----INLKSLYRLNLSGCSRLK-------------------------SFPD---ISTNISWLDLDETAIE-EFPSNL-RL 746 (1153)
T ss_pred ----CCCCCCCEEeCCCCCCcc-------------------------cccc---ccCCcCeeecCCCccc-cccccc-cc
Confidence 134556666665553221 1221 1245666667776665 444443 45
Q ss_pred ccCceEEeeccCCC-------CCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccCCcccccc
Q 001710 445 QQLQGLSLYDNDLQ-------GSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517 (1022)
Q Consensus 445 ~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 517 (1022)
++|++|++.++... ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|... .++
T Consensus 747 ~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~ 825 (1153)
T PLN03210 747 ENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLE 825 (1153)
T ss_pred cccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccc
Confidence 66666666553322 1112222233456666666665555566666666666666666554333455444 455
Q ss_pred ccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccC-cccccCCCcccccccccceeec
Q 001710 518 YILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAG-NQFNGPIPESFGSLISLESLDV 596 (1022)
Q Consensus 518 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L 596 (1022)
+|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|++
T Consensus 826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l 900 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDF 900 (1153)
T ss_pred ccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeec
Confidence 5666666655433333322 234555566666555 4555555555555555555 3333 34444555555555555
Q ss_pred ccc
Q 001710 597 SSN 599 (1022)
Q Consensus 597 s~N 599 (1022)
++|
T Consensus 901 ~~C 903 (1153)
T PLN03210 901 SDC 903 (1153)
T ss_pred CCC
Confidence 554
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-24 Score=209.93 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=194.5
Q ss_pred CCcCCeeecccceEEEEEEEcCCCEEEEEEecchh--hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccC
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
.....+|.+...|..|+|+++ |..+++|++.... ....+.|.+|.-.++-..||||..++|.|..+....++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567899999999999986 5567777775443 2344678889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEe--eccCceecCCCCC
Q 001710 810 NGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS--DFGISKLLGEGDD 886 (1022)
Q Consensus 810 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~--DfG~a~~~~~~~~ 886 (1022)
.|+|...+++... ..+..++.+++.++++|++|||+.. +-|-.--+.++.|++|++.+++|+ |--++
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs-------- 340 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS-------- 340 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee--------
Confidence 9999999987654 5788899999999999999999854 224445688999999999988774 32222
Q ss_pred ceeeecccCCcccCCccccCCCCC---CccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIV---SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
.......-.+.||+||.+...+. -.++|+|||++++||+-|+..||.+....+..+....
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------- 403 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------- 403 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------------
Confidence 12222334678999998877654 3579999999999999999999998766654332221
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
+.-+...|+..+..+..+|.-|++.||.+||.+..++-.|+++.
T Consensus 404 --eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 --EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11223344555677889999999999999999999999998864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=201.99 Aligned_cols=264 Identities=15% Similarity=0.170 Sum_probs=208.6
Q ss_pred hcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeEEEEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
.-.|++.++||+|+||+.|.|+ +.+++.||||.-.... ...++..|.+.++.| ..++|..+|.+..++.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4569999999999999999998 7789999999754332 235677799999998 57999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-----CcEEEeeccCceec
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-----MTAHVSDFGISKLL 881 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-----~~~kl~DfG~a~~~ 881 (1022)
.+ |.+|+|...-+++.++..+++.||.|++.-++|+|+ +..|+|||||+|.||..- ..+.++|||+|+.+
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~----k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE----KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh----cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 98 779999999888889999999999999999999999 679999999999999743 35899999999988
Q ss_pred CCCCC-----ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcc
Q 001710 882 GEGDD-----SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 882 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
..... +.......||.+||+-....+.+.+...|+-|+|-|+++.+.|..||++..... ....+.+-....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeKIGe~K--- 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEKIGETK--- 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHHHhcccc---
Confidence 55432 222334569999999999999999999999999999999999999999854321 111211100000
Q ss_pred hhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
...+.....+.++.++..-++..-..+=++-|+..-+..-+..+..+
T Consensus 256 --------r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 256 --------RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred --------ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 00111223445677778888888888889999988877777776554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=196.37 Aligned_cols=261 Identities=17% Similarity=0.182 Sum_probs=202.2
Q ss_pred HhhcCCCcCCeeecccceEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCC-CcceeEeeeEeeCCeeEEE
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH-RNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv 804 (1022)
...++|.++++||+|+||.+|.|. ..+|..||+|+-+..... .....|..+++.+++ ..|..+..+..+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 668999999986544332 456779999999975 7888888888999999999
Q ss_pred EEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC---CCcEEEeeccCceec
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE---NMTAHVSDFGISKLL 881 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfG~a~~~ 881 (1022)
||.. |.+|++...-+.+.++..+++..+-|++.-++|+|. +++|||||||+|.|+.- -..+.++|||+|+.+
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~----r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL----RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh----hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9988 779999999888889999999999999999999999 78999999999999963 346899999999987
Q ss_pred CCCCCc-----eeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchh--HHHHHHhhcCCC
Q 001710 882 GEGDDS-----VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMS--LRRWVKESLPHG 954 (1022)
Q Consensus 882 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~ 954 (1022)
...... .......||.+|++-....+.+.+...|+-|+|.++.+.-.|..||++....... ..........
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-- 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-- 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC--
Confidence 543221 1223346999999999888888899999999999999999999999986443211 1111111110
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
.........+|.++.-.+..|-..-=++-|+..-+.+.+.-+
T Consensus 243 ------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 ------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred ------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 011122334566677778888877777888777666665554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-22 Score=219.64 Aligned_cols=262 Identities=18% Similarity=0.166 Sum_probs=199.1
Q ss_pred CCCcCCeeecccceEEEEEEEcCC--CEEEEEEecchhhhhHHHHHHHHHHHhhcCC----CcceeEeeeE-eeCCeeEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFDG--TNVAIKVFNLQLERAFRTFDSECEILRNVRH----RNLVKIFSSC-CNIDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~l~~~~-~~~~~~~l 803 (1022)
+|++.++||+|+||.||.+..... ..+|+|+...........+..|..++..+.. +++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999985443 4789998765543322367789999999973 6899999998 57788999
Q ss_pred EEEccCCCCHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-----CcEEEeeccC
Q 001710 804 VLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-----MTAHVSDFGI 877 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-----~~~kl~DfG~ 877 (1022)
||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++|+ .|++||||||.|+.+... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~----~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS----KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh----cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 779999886655 679999999999999999999999 899999999999999854 4699999999
Q ss_pred ce--ecCCCCC---c-e-e-eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHh
Q 001710 878 SK--LLGEGDD---S-V-T-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 878 a~--~~~~~~~---~-~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 949 (1022)
|+ .+..... . . . .....||..|+++....+...+++.|+||+++++.|+..|..||........ .......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~ 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence 98 3322211 1 1 1 2235699999999999999999999999999999999999999966432211 1111111
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHhh
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~~ 1012 (1022)
...... .. .....+..+.++...+-..+..++|....+...+++.....
T Consensus 253 ~~~~~~----~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLT----DR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhcc----cc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000 00 11123445667777777789999999999999988876553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=221.16 Aligned_cols=166 Identities=22% Similarity=0.207 Sum_probs=129.3
Q ss_pred HhhcCCCcCCeeecccceEEEEEEEc--CCCEEEEEEecch-----hhhhHHHHHHHHHHHhhcCCCccee-EeeeEeeC
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLF--DGTNVAIKVFNLQ-----LERAFRTFDSECEILRNVRHRNLVK-IFSSCCNI 798 (1022)
Q Consensus 727 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~~~~ 798 (1022)
...++|.+.+.||+|+||+||+|+.. +++.||||+.... .....+.+.+|++++++++|+++++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34577999999999999999999854 5778899986533 1223456899999999999999985 4432
Q ss_pred CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEecCCCcEEEeeccC
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL-KPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Di-k~~NIll~~~~~~kl~DfG~ 877 (1022)
+..++||||++|++|... ... . ...++.+++++|+|||+ .||+|||| ||+||+++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~----~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHR----AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHH----CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999732 111 1 14678999999999999 89999999 99999999999999999999
Q ss_pred ceecCCCCCcee------eecccCCcccCCccccCCC
Q 001710 878 SKLLGEGDDSVT------QTITMATIGYMAPEYGSEG 908 (1022)
Q Consensus 878 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 908 (1022)
|+.+........ .....+++.|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997754432111 1234678889999976543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=240.35 Aligned_cols=181 Identities=29% Similarity=0.396 Sum_probs=108.6
Q ss_pred cceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeecc
Q 001710 422 GLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLG 501 (1022)
Q Consensus 422 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 501 (1022)
+|+.|++++|+++ .+|.. .++|+.|+|++|+|.+ +|.. ...|+.|++++|+|++ +|.. ..+|+.|+|+
T Consensus 283 ~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS 350 (788)
T PRK15387 283 GLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVS 350 (788)
T ss_pred hcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecC
Confidence 3445555555555 23321 2455566666666553 2221 1235556666666653 3321 1356666666
Q ss_pred CceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCC
Q 001710 502 SNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI 581 (1022)
Q Consensus 502 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 581 (1022)
+|+|+ .+|... .+|+.|++++|+|+. +|.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++ +
T Consensus 351 ~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-I 417 (788)
T PRK15387 351 DNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-L 417 (788)
T ss_pred CCccC-CCCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-C
Confidence 66666 344322 345666677777764 3432 245777777777776 34543 2467777888888773 5
Q ss_pred CcccccccccceeecccceeccccCchhhhcccccEEEccCCcceeecCC
Q 001710 582 PESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPI 631 (1022)
Q Consensus 582 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 631 (1022)
|..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|.
T Consensus 418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 6433 35677888888887 6777788888888888888888877663
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=238.22 Aligned_cols=269 Identities=28% Similarity=0.374 Sum_probs=171.7
Q ss_pred CCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceee
Q 001710 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLD 322 (1022)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 322 (1022)
..-..|+|+.|.|+ .+|..+. .+|+.|++++|+++ .+|. ..++|++|+|++|+++. +|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc-ccCc---ccccceee
Confidence 45667888888887 5676664 36777777777777 4553 24667777777776663 3322 24566666
Q ss_pred CCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchh
Q 001710 323 LSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKF 402 (1022)
Q Consensus 323 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l 402 (1022)
+++|.+.. +|..+ .+|+.|++++|+|+.++.
T Consensus 269 Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~--------------------------------------------- 299 (788)
T PRK15387 269 IFSNPLTH-LPALP---SGLCKLWIFGNQLTSLPV--------------------------------------------- 299 (788)
T ss_pred ccCCchhh-hhhch---hhcCEEECcCCccccccc---------------------------------------------
Confidence 66666653 33222 334455555555544321
Q ss_pred ccccccccccCCccccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCcccc
Q 001710 403 EAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS 482 (1022)
Q Consensus 403 ~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 482 (1022)
.+++|++|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+
T Consensus 300 ----------------~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls 355 (788)
T PRK15387 300 ----------------LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA 355 (788)
T ss_pred ----------------cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccC
Confidence 12345555555555553 23211 245556666666653 3321 135667777777776
Q ss_pred CcccccccCccccceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccc
Q 001710 483 GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITIS 562 (1022)
Q Consensus 483 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 562 (1022)
+ +|... .+|+.|++++|+|+ .+|... .+|+.|++++|+|++ +|.. .++|+.|++++|+|+ .+|..+
T Consensus 356 ~-LP~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~- 421 (788)
T PRK15387 356 S-LPTLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP- 421 (788)
T ss_pred C-CCCCC---cccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch-
Confidence 3 44322 45667777777777 355432 467788888888885 4433 257888999999998 466543
Q ss_pred cccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcc
Q 001710 563 GLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL 613 (1022)
Q Consensus 563 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 613 (1022)
.+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+..+.
T Consensus 422 --~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 422 --SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred --hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 46788999999998 7899999999999999999999998888775553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=231.44 Aligned_cols=292 Identities=20% Similarity=0.315 Sum_probs=141.1
Q ss_pred CCChhHHHHHHHHHhhccCCCCc--ccCCCCCCCCCcccee----------------eEEcCCCCcEEEEEcCCCCcccc
Q 001710 6 NNLTTDQSALLAFKADVIDSRSV--LANNWSISYPICNWVG----------------ISCGARHHRVVALNLSSFSLGGI 67 (1022)
Q Consensus 6 ~~~~~d~~aLl~~k~~~~~~~~~--~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~L~~~~l~~~ 67 (1022)
.....|...+++..+.+.-|+.. ....|..+++.|-=.. |.|.. ..|+.+..-+......
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQASS 136 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccccccccc
Confidence 35677889999999999766422 2345998889896443 55532 3455544433211111
Q ss_pred cC--CCCCCCCCccEEeccCCcccCC----------CCCCcccccccccccccccccCCCCCcccccccccceeeccccc
Q 001710 68 IP--PHLGNLSFLVSLDISENNFYGH----------LPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNS 135 (1022)
Q Consensus 68 i~--~~l~~l~~L~~L~Ls~n~~~~~----------~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 135 (1022)
-. ....+....-. +=..+.-.+. +.+++ -.+...|+++++.++ .+|..+. ++|+.|+|++|.
T Consensus 137 ~~~~~~~~~~~~~w~-~w~~~~~~~~~~~r~~a~~r~~~Cl--~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~ 210 (754)
T PRK15370 137 ASGSKDAVNYELIWS-EWVKEAPAKEAANREEAVQRMRDCL--KNNKTELRLKILGLT-TIPACIP--EQITTLILDNNE 210 (754)
T ss_pred CCCCCChhhHHHHHH-HHHhcCCCCccccHHHHHHHHHhhc--ccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCC
Confidence 00 00000000000 0000000000 01111 134566777777776 4555443 467777777777
Q ss_pred cCCCcchhhcCccccceeeccCcccccccCCccccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccc
Q 001710 136 FTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI 215 (1022)
Q Consensus 136 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 215 (1022)
++ .+|..+. ++|+.|+|++|++++ +|..+ .++|+.|+|++|++. .+|..+. ++|+.|++++|+|+ .+|..+
T Consensus 211 Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l-~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l 281 (754)
T PRK15370 211 LK-SLPENLQ--GNIKTLYANSNQLTS-IPATL-PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENL 281 (754)
T ss_pred CC-cCChhhc--cCCCEEECCCCcccc-CChhh-hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccccc
Confidence 77 4555443 467777777777763 33322 134566666666655 3444443 35666666666665 345433
Q ss_pred cCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCcc
Q 001710 216 GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLE 295 (1022)
Q Consensus 216 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~ 295 (1022)
. ++|+.|+|++|+|++ +|..+. .+|+.|++++|+++. +|..+. ++|+.|++++|.++ .+|..+ .++|+
T Consensus 282 ~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l---~~sL~ 349 (754)
T PRK15370 282 P--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASL---PPELQ 349 (754)
T ss_pred C--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhh---cCccc
Confidence 2 356666666666653 333222 245555555555552 332221 34444444444444 233322 13444
Q ss_pred EEEccCcccCccCCcccccccccceeeCCCCccC
Q 001710 296 FLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329 (1022)
Q Consensus 296 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 329 (1022)
.|+|++|+++ .+|..+. ++|+.|+|++|+|+
T Consensus 350 ~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 350 VLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred EEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 4444444444 2232221 34444444444444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=233.78 Aligned_cols=254 Identities=20% Similarity=0.198 Sum_probs=191.0
Q ss_pred cCCeeecccceEEEEEEE-cCCCEEEEEEec-----chhhhh-HHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 734 ECNLLGRGSFGLVYKGTL-FDGTNVAIKVFN-----LQLERA-FRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
...++|.|++|.|+.+.. .....++.|.+. ...... ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887763 334444444332 122222 2226678888888999999888887777666666699
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
||++ +|..++.... .+....+-.+++|+..|++|+|+ .||.|||+|++|++++.+|.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~----~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHS----MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHh----cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999988763 37888888999999999999999 8999999999999999999999999999987755444
Q ss_pred c--eeeecccCCcccCCccccCCCCCCc-cchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccc
Q 001710 887 S--VTQTITMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 887 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
. ......+|+..|+|||+..+..|.+ ..||||.|+++..|.+|+.||......+..+ .+ .......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~-------~~~~~~~ 544 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KT-------NNYSDQR 544 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hh-------hcccccc
Confidence 3 4455667999999999999998875 5899999999999999999997644433322 00 0000111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
....+........+.....+|.+|+++||.+|.|+++|++.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11122233344556678899999999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-20 Score=205.00 Aligned_cols=258 Identities=29% Similarity=0.392 Sum_probs=200.3
Q ss_pred CCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhh---hHHHHHHHHHHHhhcCCC-cceeEeeeEeeCCeeEEEEEc
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER---AFRTFDSECEILRNVRHR-NLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++++++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999865 88999998766533 367789999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC-cEEEeeccCceecCCC
Q 001710 808 MPNGSFEKWLYSYNY--FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKLLGEG 884 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~ 884 (1022)
+.++++.+++..... .++......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~----~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS----KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999987776652 58999999999999999999999 7899999999999999988 7999999999866444
Q ss_pred CCce----eeecccCCcccCCccccCC---CCCCccchhHhHHHHHHHHHcCCCCCCccccc--chhHHHHHHhhcCCCc
Q 001710 885 DDSV----TQTITMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLRRWVKESLPHGL 955 (1022)
Q Consensus 885 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 955 (1022)
.... ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .......+........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 3221 2345679999999998887 57889999999999999999999997654321 1122222221111100
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
........ .......+.+++..|+..+|..|.+..+....
T Consensus 236 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN---------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc---------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 02223567899999999999999999988775
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=222.66 Aligned_cols=138 Identities=28% Similarity=0.405 Sum_probs=64.8
Q ss_pred CCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccccceeeccc
Q 001710 197 LQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276 (1022)
Q Consensus 197 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 276 (1022)
...|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|++|++++|+++ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 345555555555 3444332 34555666666555 3333332 35566666666555 2343322 2344455555
Q ss_pred ceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccCCcccccccccccccccccccc
Q 001710 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353 (1022)
Q Consensus 277 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 353 (1022)
|++. .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|++ +|..+. ++|+.|++++|+++
T Consensus 251 N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 251 NRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc
Confidence 5544 3443332 24555555555555 2343332 245555555555553 232221 24455555555444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=190.85 Aligned_cols=171 Identities=13% Similarity=0.123 Sum_probs=133.5
Q ss_pred hhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhH---H------HHHHHHHHHhhcCCCcceeEeeeEeeC
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF---R------TFDSECEILRNVRHRNLVKIFSSCCNI 798 (1022)
Q Consensus 728 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~---~------~~~~E~~~l~~l~h~~iv~l~~~~~~~ 798 (1022)
..++|+..+++|.|+||.||.+.. ++..+|+|++........ . .+.+|++.+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999765 577899999976543221 2 267899999999999999998886543
Q ss_pred --------CeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcE
Q 001710 799 --------DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTA 870 (1022)
Q Consensus 799 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~ 870 (1022)
...++||||++|.+|.++.. ++. ....+++.++..+|+ .|++|||+||.||+++++| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~----~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ----HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH----cCCccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 346699999999999 8999999999999999988 9
Q ss_pred EEeeccCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHH
Q 001710 871 HVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 927 (1022)
Q Consensus 871 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ell 927 (1022)
+++|||........... ..+.....|..++|+|++|+.+....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654211110 11334445667899999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=185.07 Aligned_cols=139 Identities=18% Similarity=0.184 Sum_probs=108.5
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhh--h------------------------HHHHHHHHHHHhhcCCCcc
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER--A------------------------FRTFDSECEILRNVRHRNL 788 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~~i 788 (1022)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999778999999999754211 0 0122359999999988776
Q ss_pred eeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCcEEecCC
Q 001710 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL-HHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 789 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
.....+.. ...++||||++++++....... ..++......++.|++.++.|+ |+ .+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~----~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQD----CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEEE-C
Confidence 44333222 2238999999998776553332 3488999999999999999999 57 7899999999999998 5
Q ss_pred CcEEEeeccCceec
Q 001710 868 MTAHVSDFGISKLL 881 (1022)
Q Consensus 868 ~~~kl~DfG~a~~~ 881 (1022)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=217.47 Aligned_cols=249 Identities=20% Similarity=0.220 Sum_probs=179.4
Q ss_pred CCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhh----hHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEE
Q 001710 731 GFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER----AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 731 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 806 (1022)
+|...+.||++.|=.|.+|+..+|. |+||++-+..+. ...+..+|++ ...++|||.+++--+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777789999999999999987777 999998766522 2233344455 556699999999888777888889999
Q ss_pred ccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecC-CCC
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG-EGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~-~~~ 885 (1022)
|+.+ +|.|.+..++. +...+.+-|+.|++.|+..+|+ .||+|||||.+||||++-.-+.|+||..-+... +.+
T Consensus 102 yvkh-nLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH~----~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCHK----LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccchH-HHHHHHHHHHHHHHHHHHHHHH----cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9976 99999887664 7788888899999999999999 899999999999999999999999997654321 111
Q ss_pred Cceeee----cccCCcccCCccccCC----------CC-CCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHHh
Q 001710 886 DSVTQT----ITMATIGYMAPEYGSE----------GI-VSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKE 949 (1022)
Q Consensus 886 ~~~~~~----~~~gt~~y~aPE~~~~----------~~-~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 949 (1022)
.....+ ....-..|.|||.+.. .. .+++-||||+|||++|+++ |++||.- .+...-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAY 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhH
Confidence 111111 1122346999994322 12 5778999999999999998 6777752 111110
Q ss_pred hcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 950 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
. .+-. .++ ...+. .-....+.+++..|++.||++|.++.+.++.-.
T Consensus 248 r--~~~~--~~~-----e~~Le--~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 R--SGNA--DDP-----EQLLE--KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred h--ccCc--cCH-----HHHHH--hCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0 0000 000 00000 001225789999999999999999999998833
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=200.27 Aligned_cols=217 Identities=26% Similarity=0.378 Sum_probs=167.5
Q ss_pred HhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCC
Q 001710 780 LRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI-VHCDLK 858 (1022)
Q Consensus 780 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i-vH~Dik 858 (1022)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.|.+......+++.....++++|+.|++|+|. .+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~----s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN----SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc----Ccceeeeeec
Confidence 467899999999999999999999999999999999999988889999999999999999999998 344 899999
Q ss_pred CCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCC-------CCccchhHhHHHHHHHHHcCCC
Q 001710 859 PNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGI-------VSAKCDVYSYGVLLMETFTRKK 931 (1022)
Q Consensus 859 ~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~vl~elltg~~ 931 (1022)
+.|.++|..+.+|++|||+.................-..-|.|||.+.... .+.++||||||++++|+++++.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764311111222222344699999876642 4677999999999999999999
Q ss_pred CCCcccccchh--HHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 001710 932 PTDEMFTGEMS--LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 932 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~ 1009 (1022)
||+.....+.. +...++. +....+.+.+. ......+++..++.+||..+|++||+++++-..++.+.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~----~~~~~~rP~i~-------~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK----GGSNPFRPSIE-------LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHHh----cCCCCcCcchh-------hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99875444332 2222222 11111222111 11133447899999999999999999999999988875
Q ss_pred Hh
Q 001710 1010 VK 1011 (1022)
Q Consensus 1010 ~~ 1011 (1022)
..
T Consensus 226 ~~ 227 (484)
T KOG1023|consen 226 KG 227 (484)
T ss_pred cc
Confidence 53
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=174.32 Aligned_cols=186 Identities=16% Similarity=0.094 Sum_probs=140.3
Q ss_pred CcCCeeecccceEEEEEEEcCCCEEEEEEecchhhh----hHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEEEc
Q 001710 733 NECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER----AFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 733 ~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++++++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998774 7888888877644321 1235789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEecCCCcEEEeeccCceecCCCCC
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL-KPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Di-k~~NIll~~~~~~kl~DfG~a~~~~~~~~ 886 (1022)
++|.+|.+.... ....++.|++.+++++|+ .||+|||| ||+||++++++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~----~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHR----CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHH----CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998764321 123578899999999999 89999999 79999999999999999999986544331
Q ss_pred c----ee-------eecccCCcccCCccccCC--CCCCccchhHhHHHHHHHHHcCCCCCCc
Q 001710 887 S----VT-------QTITMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKKPTDE 935 (1022)
Q Consensus 887 ~----~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~ 935 (1022)
. .. ......++.|++|+...- ..--...+.++-|+-+|.++|++.|+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 1 00 112335777888873221 1222567999999999999999998654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=184.35 Aligned_cols=230 Identities=20% Similarity=0.271 Sum_probs=148.8
Q ss_pred CCcCCeeecccceEEEEEEEc-CCCEEEEEEecchh---hhhHHHHHHHHHHHhhcC----------CCcceeEeeeEe-
Q 001710 732 FNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQL---ERAFRTFDSECEILRNVR----------HRNLVKIFSSCC- 796 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~~iv~l~~~~~- 796 (1022)
+...+.||.|+++.||.++.. +++++|||++.... ....+.+.+|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999965 58999999886543 234566666765555532 212222222211
Q ss_pred --------eC---C-----eeEEEEEccCCCCHHHHhhh---cCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 001710 797 --------NI---D-----FKALVLEFMPNGSFEKWLYS---YNY---FLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854 (1022)
Q Consensus 797 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH 854 (1022)
.. . ..+++|+-+. ++|.+++.. ... ......+..+..|+++.+++||+ .|+||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~----~GlVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS----YGLVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH----TTEEE
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh----cceEe
Confidence 11 1 2357888774 488887542 222 24456667788999999999999 89999
Q ss_pred cCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCC--------CCCCccchhHhHHHHHHHH
Q 001710 855 CDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE--------GIVSAKCDVYSYGVLLMET 926 (1022)
Q Consensus 855 ~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~vl~el 926 (1022)
+||+|+|++++++|.++|+||+.....+... .....+..|.|||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887653211 11345678999996433 3578899999999999999
Q ss_pred HcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCC
Q 001710 927 FTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQR 995 (1022)
Q Consensus 927 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 995 (1022)
+++..||+......... . .+....+.++.+..+|+.+++++|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~-----------------~-------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE-----------------W-------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG-----------------G-------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc-----------------c-------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999998642221100 0 122223667889999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.4e-19 Score=181.75 Aligned_cols=196 Identities=21% Similarity=0.244 Sum_probs=139.4
Q ss_pred CCCcceeEeeeEee---------------------------CCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHH
Q 001710 784 RHRNLVKIFSSCCN---------------------------IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836 (1022)
Q Consensus 784 ~h~~iv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 836 (1022)
+|||||++.++|.+ ....|+||...+. +|.+++.... .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999877643 2356899998876 9999998766 4556666699999
Q ss_pred HHHHHHHHhcCCCCCeEecCCCCCcEEec--CCC--cEEEeeccCceecCCCC---Cc-eeeecccCCcccCCccccCCC
Q 001710 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLD--ENM--TAHVSDFGISKLLGEGD---DS-VTQTITMATIGYMAPEYGSEG 908 (1022)
Q Consensus 837 ~~~l~~LH~~~~~~~ivH~Dik~~NIll~--~~~--~~kl~DfG~a~~~~~~~---~~-~~~~~~~gt~~y~aPE~~~~~ 908 (1022)
++|+.|||+ .||.|||+|++|||+. +|+ .+.++|||++---.... .+ ...-..-|...-||||+....
T Consensus 351 LEav~hL~~----hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLHK----HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH----ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 8999999999999994 444 47899999985322211 01 111112366778999975543
Q ss_pred C------CCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHH
Q 001710 909 I------VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMD 982 (1022)
Q Consensus 909 ~------~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 982 (1022)
+ --.|+|.|+.|.+.||++....||.......-+.+.+.... .-..++.|+..+.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q------------------LPalp~~vpp~~rq 488 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ------------------LPALPSRVPPVARQ 488 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh------------------CCCCcccCChHHHH
Confidence 2 12479999999999999999999976222211122221111 11234567888999
Q ss_pred HHHhhcccCCCCCCCHHHHHHH
Q 001710 983 LALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 983 li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
++...++.||.+|+++.-....
T Consensus 489 lV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHhcCCccccCCccHHHhH
Confidence 9999999999999987654433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=175.52 Aligned_cols=140 Identities=20% Similarity=0.189 Sum_probs=110.3
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhh--------------------------hHHHHHHHHHHHhhcCCCcc
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER--------------------------AFRTFDSECEILRNVRHRNL 788 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~~i 788 (1022)
...||+|+||.||+|+..+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999768999999998764211 01223578999999999987
Q ss_pred eeEeeeEeeCCeeEEEEEccCCCCHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC
Q 001710 789 VKIFSSCCNIDFKALVLEFMPNGSFEKW-LYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 789 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
.....+... ..++||||++|+++... +... .++......++.|++.++.++|+. .||+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQE---AGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHh---CCEecCCCChhhEEEE-C
Confidence 544443332 24899999998855433 4332 377888999999999999999973 4799999999999999 8
Q ss_pred CcEEEeeccCceecC
Q 001710 868 MTAHVSDFGISKLLG 882 (1022)
Q Consensus 868 ~~~kl~DfG~a~~~~ 882 (1022)
+.++|+|||+|....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 999999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=206.11 Aligned_cols=253 Identities=19% Similarity=0.206 Sum_probs=186.9
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcC---CCcceeEeeeEeeCCeeE
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR---HRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~ 802 (1022)
+...+.|.+.+.+|+|+||.||+|...+|+.||+|+-+...... |.-=.+++.||+ -+.|..+..++.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 33456788889999999999999997789999999977654321 111233444554 345666666666677789
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEec-------CCCcEEEeec
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-------ENMTAHVSDF 875 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-------~~~~~kl~Df 875 (1022)
+|+||.+.|+|.+++...+ .+++.-++.++.|++..+++||. .+|||+||||+|.++. ....++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~----~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHA----MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHh----cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999999444 59999999999999999999999 7899999999999994 3446999999
Q ss_pred cCceecCCCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCc
Q 001710 876 GISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955 (1022)
Q Consensus 876 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 955 (1022)
|.+..+.--.........++|-.+-.+|...|..+++..|.|.++.+++-|+.|+.-= +..+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~~g~ 908 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------VKNGS 908 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hcCCc
Confidence 9998775444444555677899999999999999999999999999999999987431 11111
Q ss_pred chhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhHh
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i~~~ 1011 (1022)
...++..+ ++... .+ ...++...+|+.|=..=|...++...++++..+
T Consensus 909 ~~~~~~~~----~Ry~~-~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 909 SWMVKTNF----PRYWK-RD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ceeccccc----hhhhh-HH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 11111111 11111 11 234556666666666777888888888877554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-20 Score=172.44 Aligned_cols=167 Identities=35% Similarity=0.594 Sum_probs=137.0
Q ss_pred CCCCCCCCccEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCccc
Q 001710 70 PHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSK 149 (1022)
Q Consensus 70 ~~l~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 149 (1022)
+.+.++++.+.|.||+|.++ .+|..+..+.+|+.|++++|++. .+|.+++.+++|++|+++-|++. ..|..|+.++.
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred ccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 34667888999999999999 78888999999999999999999 89999999999999999999998 89999999999
Q ss_pred cceeeccCccccc-ccCCcc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEec
Q 001710 150 LEFLDLMENSLSG-SLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLA 227 (1022)
Q Consensus 150 L~~L~Ls~N~l~~-~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 227 (1022)
|+.|||+.|+++. .+|..+ .+..|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- ..|..++.+.+|++|.+.
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 9999999999874 455554 6777777788777775 67777777777777777777776 567777777777777777
Q ss_pred cccccCCChhhhcCc
Q 001710 228 QNNLQGDMPTAIGNL 242 (1022)
Q Consensus 228 ~N~l~~~~~~~~~~l 242 (1022)
+|+++ .+|..++++
T Consensus 182 gnrl~-vlppel~~l 195 (264)
T KOG0617|consen 182 GNRLT-VLPPELANL 195 (264)
T ss_pred cceee-ecChhhhhh
Confidence 77777 555555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.1e-20 Score=202.84 Aligned_cols=225 Identities=26% Similarity=0.282 Sum_probs=180.5
Q ss_pred eeecccceEEEEEE----EcCCCEEEEEEecchhhh--hHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEEEEEccC
Q 001710 737 LLGRGSFGLVYKGT----LFDGTNVAIKVFNLQLER--AFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVLEFMP 809 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~----~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 809 (1022)
.+|+|+||.|+.++ ...|+.+|+|+.++.... .......|..++..++ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 334778899988765421 1124566889999997 9999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCcee
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 889 (1022)
+|++...+..... ++..........++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~----l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHK----LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcch----hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999998877665 5666666778889999999999 8999999999999999999999999999986533222
Q ss_pred eecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcchhccccccchhhh
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 969 (1022)
.+||..|||||++. ....++|.||||++++||+||..||.. .......+. .
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~-------------------~ 203 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA-------------------E 203 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh-------------------c
Confidence 27999999999988 567789999999999999999999976 111111111 1
Q ss_pred hhhhHHHHHHHHHHHHhhcccCCCCCCCH
Q 001710 970 FSAKTDCLLSIMDLALDCCMESPEQRIHM 998 (1022)
Q Consensus 970 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 998 (1022)
...+...+....+++.+++..+|..|...
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23345556678889999999999999866
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-20 Score=208.92 Aligned_cols=105 Identities=24% Similarity=0.184 Sum_probs=56.0
Q ss_pred EEcCCCCcc-cccCCCCCCCCCccEEeccCCcccC----CCCCCcccccccccccccccccCC------CCCcccccccc
Q 001710 57 LNLSSFSLG-GIIPPHLGNLSFLVSLDISENNFYG----HLPNELGKLRRLRLINFAYNELSG------SFPSWIGILSR 125 (1022)
Q Consensus 57 l~L~~~~l~-~~i~~~l~~l~~L~~L~Ls~n~~~~----~~p~~l~~l~~L~~L~Ls~n~l~~------~~p~~~~~l~~ 125 (1022)
|+|.++.++ ......+..+..|++|+++++.++. .++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666665 2333344555667777777766643 244445555666666666665552 12233444555
Q ss_pred cceeeccccccCCCcchhhcCccc---cceeeccCcccc
Q 001710 126 LQILSFHNNSFTDRIPDFLLNLSK---LEFLDLMENSLS 161 (1022)
Q Consensus 126 L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~Ls~N~l~ 161 (1022)
|++|+|++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 555566555555444444444443 555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-20 Score=205.87 Aligned_cols=273 Identities=22% Similarity=0.255 Sum_probs=183.9
Q ss_pred EEeccCCccc-CCCCCCcccccccccccccccccCCC----CCcccccccccceeeccccccCC------CcchhhcCcc
Q 001710 80 SLDISENNFY-GHLPNELGKLRRLRLINFAYNELSGS----FPSWIGILSRLQILSFHNNSFTD------RIPDFLLNLS 148 (1022)
Q Consensus 80 ~L~Ls~n~~~-~~~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~ 148 (1022)
.|+|+.+.++ +..+..+..+.+|++|++++|.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777777 34556667777788888888887542 44555566778888888887762 2345666777
Q ss_pred ccceeeccCcccccccCCcc-cccc---ccceecccccccc----cCCccccCC-CCCCeeecccccccCC----CCccc
Q 001710 149 KLEFLDLMENSLSGSLPNDI-RLPK---LEKLYLGSNDFFG----QIPSSLSEC-THLQTLWLADNKFSGR----LPENI 215 (1022)
Q Consensus 149 ~L~~L~Ls~N~l~~~~~~~~-~l~~---L~~L~L~~n~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~l 215 (1022)
+|+.|++++|.+.+..+..+ .+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 88888888888875444444 3333 8888888888762 233345566 7888888888887743 23345
Q ss_pred cCCCcccEEEeccccccCC----ChhhhcCcCCCCEEEccCccccCcC----Ccccccccccceeecccceeeeeccccc
Q 001710 216 GNLSQLTDLNLAQNNLQGD----MPTAIGNLQMLEHLNLGMNNLSGPV----PPTIFNISTIRLINLIENQLSGHLPLTL 287 (1022)
Q Consensus 216 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 287 (1022)
..+.+|++|++++|.+++. ++..+..+++|++|+|++|.+++.. +..+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 5667788888888888742 3344556668888888888876432 3344556778888888888875333332
Q ss_pred cC----CCCCccEEEccCcccCc----cCCcccccccccceeeCCCCccCccC----Ccccccc-ccccccccccccc
Q 001710 288 GH----SLPNLEFLTLFGNNLIG----TIPNSITNASKLIGLDLSSNLFSGHI----PHTFGNL-RFLRFLNLMFNSL 352 (1022)
Q Consensus 288 ~~----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l-~~L~~L~L~~N~l 352 (1022)
.. ..+.|++|++++|.++. .+...+..+++|+++++++|.+.... ...+... +.|+.+++.+|.+
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 22 23789999999998862 23345566688999999999998553 3333334 6788888888753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=167.99 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=106.8
Q ss_pred CCcCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-----CCCcceeEeeeEeeCC---eeE-
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-----RHRNLVKIFSSCCNID---FKA- 802 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~---~~~- 802 (1022)
+...+.||+|+||.||. ...++. .+||++........+.+.+|+.+++.+ .||||++++|++.+.. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 323344 479988765444556789999999999 5799999999998864 333
Q ss_pred EEEEc--cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCeEecCCCCCcEEecC----CCcEEEeec
Q 001710 803 LVLEF--MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL-EYLHHGHSLAPIVHCDLKPNNILLDE----NMTAHVSDF 875 (1022)
Q Consensus 803 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~~ivH~Dik~~NIll~~----~~~~kl~Df 875 (1022)
+|+|| +++|+|.+++.+.. +++. ..++.+++.++ +|||+ .+|+||||||+||+++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~----~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLD----NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHH----CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 55799999997643 5554 35678888777 99999 78999999999999974 347999995
Q ss_pred cCc
Q 001710 876 GIS 878 (1022)
Q Consensus 876 G~a 878 (1022)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-19 Score=167.10 Aligned_cols=167 Identities=28% Similarity=0.484 Sum_probs=116.4
Q ss_pred ccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccc
Q 001710 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLR 496 (1022)
Q Consensus 417 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 496 (1022)
+.++++++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456677777778888887 56666777777777777777776 56666666777777777666666 5666666666666
Q ss_pred eeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcc
Q 001710 497 ELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576 (1022)
Q Consensus 497 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 576 (1022)
.|||..|++.. ..+|+.|-.++.|+.|+|++|.+. .+|..++.+++|+.|.+..|.
T Consensus 106 vldltynnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhcccccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 66666666542 135566666667777777777775 667777777777777777777
Q ss_pred cccCCCcccccccccceeecccceeccccCchhhhc
Q 001710 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEAL 612 (1022)
Q Consensus 577 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 612 (1022)
+- .+|..++.++.|++|.+.+|+++ .+|.+++.+
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 76 67777777777888888888877 666666654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=168.66 Aligned_cols=142 Identities=18% Similarity=0.104 Sum_probs=112.1
Q ss_pred cCCCcCCeeecccceEEEEEE--EcCCCEEEEEEecchhhh------------------------hHHHHHHHHHHHhhc
Q 001710 730 DGFNECNLLGRGSFGLVYKGT--LFDGTNVAIKVFNLQLER------------------------AFRTFDSECEILRNV 783 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l 783 (1022)
.-|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 568999999998754210 112356799999999
Q ss_pred CCC--cceeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCC
Q 001710 784 RHR--NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP-IVHCDLKPN 860 (1022)
Q Consensus 784 ~h~--~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-ivH~Dik~~ 860 (1022)
.+. .+.+++++ ...++||||++++++..+..... .........++.|++.++.+||+ .+ |+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~----~g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYK----EGELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHh----cCCEEeCCCChh
Confidence 753 34445543 23589999999988877653322 35666678899999999999999 88 999999999
Q ss_pred cEEecCCCcEEEeeccCceec
Q 001710 861 NILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~ 881 (1022)
||+++ ++.++++|||.|...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=160.45 Aligned_cols=142 Identities=18% Similarity=0.138 Sum_probs=111.3
Q ss_pred HHHhhcCCCcCCeeecccceEEEEEEEcCCCEEEEEEecchhh----------------------hhHHHHHHHHHHHhh
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE----------------------RAFRTFDSECEILRN 782 (1022)
Q Consensus 725 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~ 782 (1022)
+.+....|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3344444778899999999999999987899999998764320 011235678999999
Q ss_pred cCCC--cceeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 001710 783 VRHR--NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN 860 (1022)
Q Consensus 783 l~h~--~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~ 860 (1022)
+.|+ .++..++. ...++||||++|++|.+.... .....++.+++.++.++|+ .+|+||||||+
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~----~gi~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK----HGIIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH----CCCCcCCCCcc
Confidence 9877 44444442 345899999999999775431 2345788999999999999 88999999999
Q ss_pred cEEecCCCcEEEeeccCceec
Q 001710 861 NILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 861 NIll~~~~~~kl~DfG~a~~~ 881 (1022)
||++++++.++|+|||.+...
T Consensus 155 Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cEEEcCCCcEEEEECCccccC
Confidence 999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=162.40 Aligned_cols=134 Identities=20% Similarity=0.303 Sum_probs=113.7
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhh--------hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE--------RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
+.||+|++|.||+|+. +|..|++|+...... .....+.+|++++..++|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999986 678899998653221 1224577899999999999988777777777788999999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
++|++|.+++.... + .+..++.+++.++.++|+ .+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~----~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS----AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh----CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987543 2 788899999999999999 8899999999999999 78999999998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-16 Score=189.50 Aligned_cols=151 Identities=28% Similarity=0.494 Sum_probs=126.6
Q ss_pred CChhHHHHHHHHHhhccCCCCcccCCCCCCCCCc----cceeeEEcCC--C--CcEEEEEcCCCCcccccCCCCCCCCCc
Q 001710 7 NLTTDQSALLAFKADVIDSRSVLANNWSISYPIC----NWVGISCGAR--H--HRVVALNLSSFSLGGIIPPHLGNLSFL 78 (1022)
Q Consensus 7 ~~~~d~~aLl~~k~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~L~~~~l~~~i~~~l~~l~~L 78 (1022)
..+.|..||++||+++.++. . .+|.. .+|| .|.||.|+.. . .+|+.|+|+++++.|.+|+.++.|++|
T Consensus 369 t~~~~~~aL~~~k~~~~~~~-~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPL-R--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cCchHHHHHHHHHHhcCCcc-c--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 46779999999999996553 2 37964 3443 7999999532 2 369999999999999999999999999
Q ss_pred cEEeccCCcccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCc-cccceeeccC
Q 001710 79 VSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNL-SKLEFLDLME 157 (1022)
Q Consensus 79 ~~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~ 157 (1022)
+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.++.+++|++|+|++|.++|.+|..++.+ .++..+++++
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 999999999999999999999999999999999999999999999999999999999999999888764 4566777777
Q ss_pred cccc
Q 001710 158 NSLS 161 (1022)
Q Consensus 158 N~l~ 161 (1022)
|...
T Consensus 525 N~~l 528 (623)
T PLN03150 525 NAGL 528 (623)
T ss_pred Cccc
Confidence 6543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=181.17 Aligned_cols=137 Identities=20% Similarity=0.272 Sum_probs=111.3
Q ss_pred hcCCCcCCeeecccceEEEEEEEcCCCEEEEEEe-cchh-------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCe
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVF-NLQL-------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 800 (1022)
...|...+.||+|+||+||+|.+... .+++|+. .... ....+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999985443 3444432 1111 1123568899999999999999988877777777
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.++||||+++++|.+++. ....++.+++.++.|||+ .+|+|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~----~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK----AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh----CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999875 346799999999999999 889999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.7e-17 Score=179.09 Aligned_cols=242 Identities=20% Similarity=0.256 Sum_probs=158.9
Q ss_pred CCcCCeeecccceEEEEEEEcCC----CEEEEEEecchhhhhHHHHHHHHHHHhhcC-CCcceeEe------eeE-----
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDG----TNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIF------SSC----- 795 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~----~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~------~~~----- 795 (1022)
..+.+..+.++++.++..+...+ ..++.|..+.+.-.......+++..+.... |+..+..- ...
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 44556677777777776653322 334455444333122233333444444443 44333221 011
Q ss_pred eeCCeeEEEEEccCCCCHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEe
Q 001710 796 CNIDFKALVLEFMPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873 (1022)
Q Consensus 796 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~ 873 (1022)
......||.|++|...+|.+|+...+ ...++.....++.|++.|++| . +.+|||+||.||+...+..+||.
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y--k-----~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY--K-----GLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh--c-----cchhhhccccccccccchhhhhh
Confidence 11235789999999999999996443 367888899999999999999 3 58999999999999999999999
Q ss_pred eccCceecCCCC----CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc-CCCCCCcccccchhHHHHHH
Q 001710 874 DFGISKLLGEGD----DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 874 DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 948 (1022)
|||+........ ....++..+||..||+||.+.+..|+.|+||||+|++++|+++ =..+++.. ..+...
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~-- 472 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDI-- 472 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhhh--
Confidence 999998765544 2334556789999999999999999999999999999999998 22222211 001110
Q ss_pred hhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAA 1002 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 1002 (1022)
+ | ....+.... +++ .-+.++.+++...|.+||++.+..
T Consensus 473 ---r-------~-g~ip~~~~~----d~p-~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 473 ---R-------D-GIIPPEFLQ----DYP-EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ---h-------c-CCCChHHhh----cCc-HHHHHHHHhcCCCcccCchHHHHh
Confidence 0 1 011000011 111 225799999999999999555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=185.69 Aligned_cols=212 Identities=23% Similarity=0.255 Sum_probs=146.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEc-CCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..+|..++.|..|+||.||.++++ +.+.+|+|+-+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 357889999999999999999855 4667888653211 11110 22222333333
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCC-
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD- 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~- 886 (1022)
|+-.+.+..-+. ++... +.+++|+|+ .||+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 ---gDc~tllk~~g~-lPvdm--------vla~Eylh~----ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVDM--------VLAVEYLHS----YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC-Ccchh--------hHHhHhhcc----CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 344444444332 33222 778999999 8999999999999999999999999999865321100
Q ss_pred ------------ceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCC
Q 001710 887 ------------SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 887 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
.......+||+.|+|||++....|+..+|+|++|+++||.+.|+.||.+.. .|..+.+.+...+...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhcccc
Confidence 001123479999999999999999999999999999999999999998742 3333444443322111
Q ss_pred cchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHH
Q 001710 955 LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 999 (1022)
+.++..+.+..+++.+.++.+|..|--..
T Consensus 279 ----------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 ----------------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----------------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 11223456778999999999999998544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=156.94 Aligned_cols=130 Identities=23% Similarity=0.351 Sum_probs=106.7
Q ss_pred eeecccceEEEEEEEcCCCEEEEEEecchh--------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEcc
Q 001710 737 LLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 737 ~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 808 (1022)
.||+|+||.||+|. .+|..|++|+..... .....++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 37999999999998 467889999864321 112356778999999999887665555555666778999999
Q ss_pred CCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
+|++|.+++..... .++.+++.++.++|+ .+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~----~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK----AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH----CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998765321 789999999999999 8999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.4e-17 Score=188.65 Aligned_cols=257 Identities=20% Similarity=0.243 Sum_probs=200.8
Q ss_pred hcCCCcCCeeecccceEEEEEEEc--CCCEEEEEEecchh--hhhHHHHHHHHHHHhhcC-CCcceeEeeeEeeCCeeEE
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF--DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l 803 (1022)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456778888999999999888743 34556777665443 333455566888888886 9999999999999999999
Q ss_pred EEEccCCCCHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCcEEecCCC-cEEEeeccCcee
Q 001710 804 VLEFMPNGSFEKWL-YSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKL 880 (1022)
Q Consensus 804 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfG~a~~ 880 (1022)
++||.+++++.+.+ .......+......+..|+..++.|+| + .+++|||+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~----~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE----NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc----cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999988 544434667777789999999999999 7 7899999999999999999 999999999998
Q ss_pred cCC-CCCceeeecccC-CcccCCccccCC-CCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch
Q 001710 881 LGE-GDDSVTQTITMA-TIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 881 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
+.. ..........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..||+...........|........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 251 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT--- 251 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc---
Confidence 876 444555556678 999999998877 45678899999999999999999999876655555555544432111
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
............+++..++..+|..|.+.+++...
T Consensus 252 ------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 ------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 11112223456788899999999999998887543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-14 Score=144.39 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=97.7
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhh--hHHH----------------------HHHHHHHHhhcCCCc--c
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER--AFRT----------------------FDSECEILRNVRHRN--L 788 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~~--i 788 (1022)
.+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999778999999998754211 1111 135666666664433 4
Q ss_pred eeEeeeEeeCCeeEEEEEccCCCCHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC
Q 001710 789 VKIFSSCCNIDFKALVLEFMPNGSFEK-WLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 789 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
.+.+++ ...++||||++++.+.. .+.... . ......++.+++.++.++|.. .+|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~---~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYRE---AGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhc---cCcCcCCCChhhEEEE-C
Confidence 444443 23589999999954321 111111 1 156678999999999999973 4699999999999999 9
Q ss_pred CcEEEeeccCceec
Q 001710 868 MTAHVSDFGISKLL 881 (1022)
Q Consensus 868 ~~~kl~DfG~a~~~ 881 (1022)
+.++++|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.4e-14 Score=138.08 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=114.1
Q ss_pred cCCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCC--CcceeEeeeEeeCCeeEEEEEccCCC
Q 001710 734 ECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH--RNLVKIFSSCCNIDFKALVLEFMPNG 811 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~g 811 (1022)
+++.||+|.++.||++...+ ..+++|+...... ...+.+|+..++.++| ..+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999644 7899999865533 4568889999999976 58999999888888899999999988
Q ss_pred CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 812 SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 812 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.+..+ +......++.+++++++++|..+. .+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~-~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPL-LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCc-eEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 456677889999999999998432 4699999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=145.65 Aligned_cols=134 Identities=17% Similarity=0.182 Sum_probs=105.1
Q ss_pred Ceee-cccceEEEEEEEcCCCEEEEEEecchh-------------hhhHHHHHHHHHHHhhcCCCcc--eeEeeeEeeCC
Q 001710 736 NLLG-RGSFGLVYKGTLFDGTNVAIKVFNLQL-------------ERAFRTFDSECEILRNVRHRNL--VKIFSSCCNID 799 (1022)
Q Consensus 736 ~~Lg-~G~~g~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~ 799 (1022)
..|| .|+.|+||+++.. +..+|||++.... ......+.+|++++..++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5688 8999999999864 7789999885321 1123467889999999998875 66776644322
Q ss_pred ----eeEEEEEccCC-CCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEee
Q 001710 800 ----FKALVLEFMPN-GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 800 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
..++||||++| .+|.+++.... ++.. .+.+++.++.+||+ .||+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH~----~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFHD----AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHHH----CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 68999886532 4443 36789999999999 8999999999999999999999999
Q ss_pred ccCcee
Q 001710 875 FGISKL 880 (1022)
Q Consensus 875 fG~a~~ 880 (1022)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-16 Score=166.44 Aligned_cols=179 Identities=30% Similarity=0.455 Sum_probs=150.2
Q ss_pred ccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCccccceeeccCceeccccCCccccccccceE
Q 001710 443 RFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYV 522 (1022)
Q Consensus 443 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 522 (1022)
.+..-...||+.|++. .+|..++.+-.|+.+.|.+|.+. .+|..++++..|..|||+.|+++ ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445556788888887 67888888888888888888887 77888888888888888888888 6788888776 8888
Q ss_pred eccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecccceec
Q 001710 523 NLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602 (1022)
Q Consensus 523 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 602 (1022)
-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..++.| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 88888888 47778888889999999999997 78888999999999999999998 567778866 5889999999998
Q ss_pred cccCchhhhcccccEEEccCCcceeecC
Q 001710 603 GKIPKSLEALLYLKKLNVSYNRLEGEIP 630 (1022)
Q Consensus 603 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p 630 (1022)
.+|-.|..|..|++|-|.+|+|..++.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCChH
Confidence 899999999999999999999987544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-14 Score=171.57 Aligned_cols=117 Identities=40% Similarity=0.662 Sum_probs=83.5
Q ss_pred cceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccC
Q 001710 543 LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSY 622 (1022)
Q Consensus 543 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 622 (1022)
++.|+|++|.+++.+|..+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CcceeecCCC--CCCCCCccccccCCccccCCCCcCCCCCc
Q 001710 623 NRLEGEIPIK--GPFRNFSAQSFSGNYALCGPPRLQVPPCK 661 (1022)
Q Consensus 623 N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~p~~~~~pc~ 661 (1022)
|+++|.+|.. ..+..+....+.+|+.+|+.|. .++|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 7777777743 1122334556788889998764 34675
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.6e-13 Score=153.13 Aligned_cols=140 Identities=21% Similarity=0.253 Sum_probs=102.0
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhhhhH----------------------------------------HHHHH
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF----------------------------------------RTFDS 775 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 775 (1022)
+.||+|++|.||+|++.+|+.||||+.++...+.. -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865421110 02555
Q ss_pred HHHHHhhcC----CCcceeEeeeEe-eCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhcCCC
Q 001710 776 ECEILRNVR----HRNLVKIFSSCC-NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL-VLEYLHHGHSL 849 (1022)
Q Consensus 776 E~~~l~~l~----h~~iv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~~ 849 (1022)
|++.+.+++ |..-+.+-.++. .....++||||++|+++.++........ .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~---- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR---- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh----
Confidence 666666663 333333333332 2345689999999999988765432212 23456666666 4678888
Q ss_pred CCeEecCCCCCcEEecCCCcEEEeeccCceecC
Q 001710 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 850 ~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 882 (1022)
.|++|+|+||.||++++++.++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 789999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.5e-15 Score=158.92 Aligned_cols=195 Identities=30% Similarity=0.483 Sum_probs=170.5
Q ss_pred CCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCcccccccCcccccee
Q 001710 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLREL 498 (1022)
Q Consensus 419 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 498 (1022)
.++.-++.||+.|++. .+|..+..+..|+.+.|+.|.|. .+|..++++..|+.|||+.|+++ ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4666778999999999 88999999999999999999999 78999999999999999999999 7788787765 8999
Q ss_pred eccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccc
Q 001710 499 HLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578 (1022)
Q Consensus 499 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 578 (1022)
-+++|+++ .+|..++.+..|..||.+.|.|.. +|..++++.+|+.|.+..|++. .+|.++..| .|..||+|+|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 99999999 799999999999999999999984 7888999999999999999998 778888854 5889999999999
Q ss_pred cCCCcccccccccceeecccceeccccCchhhhccc---ccEEEccCC
Q 001710 579 GPIPESFGSLISLESLDVSSNNISGKIPKSLEALLY---LKKLNVSYN 623 (1022)
Q Consensus 579 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~ls~N 623 (1022)
.+|-.|.+|..|++|-|.+|.|. ..|..+...-. .++|+..-+
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 89999999999999999999998 77776654433 345554444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.8e-13 Score=152.41 Aligned_cols=198 Identities=33% Similarity=0.482 Sum_probs=109.2
Q ss_pred EEeccCCcccCCCCCCcccccccccccccccccCCCCCccccccc-ccceeeccccccCCCcchhhcCccccceeeccCc
Q 001710 80 SLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILS-RLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158 (1022)
Q Consensus 80 ~L~Ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 158 (1022)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .+|+..+.+. +|++|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 22233444556666666666666 5555555553 6666666666666 44455666666666666666
Q ss_pred ccccccCCccccccccceecccccccccCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCChhh
Q 001710 159 SLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTA 238 (1022)
Q Consensus 159 ~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 238 (1022)
+++...+....++.|+.|++++|++. .+|..+.....|++|++++|.+. ..+..+..+.++..|.+.+|++. ..+..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 66632222225566666666666665 34444444455666666666432 34445555566666666666665 23455
Q ss_pred hcCcCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccc
Q 001710 239 IGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPL 285 (1022)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 285 (1022)
++.+++|+.|++++|.++.. +. +..+.+++.|++++|.+....|.
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hccccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence 56666666666666666532 22 55555555555555555544443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-12 Score=150.58 Aligned_cols=199 Identities=35% Similarity=0.540 Sum_probs=154.9
Q ss_pred EEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCccccccc-ccceeecCCccccCcccccccCccccceeeccCc
Q 001710 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE-RLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSN 503 (1022)
Q Consensus 425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 503 (1022)
.++++.|.+. .....+..++.++.|++.+|.+. .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5777777775 23344555677888888888888 5666666664 8888888888888 55666788888888888888
Q ss_pred eeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCc
Q 001710 504 TLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPE 583 (1022)
Q Consensus 504 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 583 (1022)
+++ .+|......++|+.|++++|+++. +|........|++|.+++|++. ..+..+..+..+..|.+++|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 888 566666678888888899988885 4555455566889999999654 67777888888999999999888 4467
Q ss_pred ccccccccceeecccceeccccCchhhhcccccEEEccCCcceeecCCC
Q 001710 584 SFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIK 632 (1022)
Q Consensus 584 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 632 (1022)
.++.+.++++|++++|+++ .++. +..+.+++.|++++|.+....|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 7888888999999999998 4444 888889999999999888877743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-12 Score=145.37 Aligned_cols=248 Identities=20% Similarity=0.189 Sum_probs=185.0
Q ss_pred CCCcCCeeec--ccceEEEEEEE---cCCCEEEEEEecchhh--hhHHHHHHHHHHHhhc-CCCcceeEeeeEeeCCeeE
Q 001710 731 GFNECNLLGR--GSFGLVYKGTL---FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 731 ~~~~~~~Lg~--G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 802 (1022)
.|.+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+...+.+ .|++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556788999 99999999974 4688899998543322 2222334577777777 4999999999999999999
Q ss_pred EEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeeccC
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL----VLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGI 877 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG~ 877 (1022)
+-+|++. .++.++.......++....+.+..+... |+.++|. ..++|-|+||.||+...+ ..++++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs----~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS----NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC----CcccccccchhheecccccceeecCCcce
Confidence 9999995 6899998888777888899999999999 9999999 779999999999999999 8899999999
Q ss_pred ceecCCCCCceeee--cc-cCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCCCCc-ccccchhHHHHHHhhcCC
Q 001710 878 SKLLGEGDDSVTQT--IT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDE-MFTGEMSLRRWVKESLPH 953 (1022)
Q Consensus 878 a~~~~~~~~~~~~~--~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~ 953 (1022)
...++......... .. .|...|++||...+ .++.++|+|++|.++.+..++-.++.. ....+..++.+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 99887665322211 12 46778999997654 678899999999999999988655432 112221111111
Q ss_pred CcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 001710 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 1004 (1022)
.. .+....-..++...+..|++.+|-.|++++.+...
T Consensus 343 ----------ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 343 ----------IP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----------Cc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00 00111123345558999999999999999887653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.2e-13 Score=134.08 Aligned_cols=206 Identities=25% Similarity=0.240 Sum_probs=145.2
Q ss_pred cccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCC-ccccCcccccccCccc
Q 001710 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNG-NNLSGAIPACLGSLTS 494 (1022)
Q Consensus 416 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~ 494 (1022)
.+..+.+|..+.++.+.-.. +-+-...-+.|+++......++. .|. +-....+....-+. --..|..-.....+..
T Consensus 209 ~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~ 285 (490)
T KOG1259|consen 209 NLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADTWQE 285 (490)
T ss_pred chHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecchHhh
Confidence 34445566666666654431 22222233567777777666652 221 11112222111111 1122333344556688
Q ss_pred cceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccC
Q 001710 495 LRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAG 574 (1022)
Q Consensus 495 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 574 (1022)
|+++||++|.|+ .+.++..-++.++.|++|+|.|..+ +.++.+++|+.||||+|.++ .+..+-..|.+.+.|+|++
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 999999999999 6778888899999999999999854 34889999999999999998 6666667889999999999
Q ss_pred cccccCCCcccccccccceeecccceeccccC-chhhhcccccEEEccCCcceeecC
Q 001710 575 NQFNGPIPESFGSLISLESLDVSSNNISGKIP-KSLEALLYLKKLNVSYNRLEGEIP 630 (1022)
Q Consensus 575 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p 630 (1022)
|.|... ..+.+|-+|..||+++|+|..... ..++++|-|+.+.|.+||+++.+.
T Consensus 362 N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 362 NKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999843 457888999999999999984322 568899999999999999998654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.6e-12 Score=143.39 Aligned_cols=144 Identities=19% Similarity=0.217 Sum_probs=94.9
Q ss_pred cCCCcCCeeecccceEEEEEEEcC-CCEEEEEEecchhhhh----------------------------------HH---
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERA----------------------------------FR--- 771 (1022)
Q Consensus 730 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~~--- 771 (1022)
.+|+. +.||+|++|.||+|+.++ |+.||||+.++...+. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999877 9999999997542110 11
Q ss_pred ---HHHHHHHHHhhcC----CCcceeEeeeEee-CCeeEEEEEccCCCCHHHHh--hhcCCCCCHHHHHHHHHHHHH-HH
Q 001710 772 ---TFDSECEILRNVR----HRNLVKIFSSCCN-IDFKALVLEFMPNGSFEKWL--YSYNYFLDILQRLNIMIDVAL-VL 840 (1022)
Q Consensus 772 ---~~~~E~~~l~~l~----h~~iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~-~l 840 (1022)
++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- ...+ .+... ++...+. -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~---la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKL---LAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHH---HHHHHHHHHH
Confidence 2344555555552 3333443333332 34567999999999998753 2222 22221 1221111 12
Q ss_pred HHHHhcCCCCCeEecCCCCCcEEecCCC----cEEEeeccCceecCC
Q 001710 841 EYLHHGHSLAPIVHCDLKPNNILLDENM----TAHVSDFGISKLLGE 883 (1022)
Q Consensus 841 ~~LH~~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfG~a~~~~~ 883 (1022)
..+.. .|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 274 ~Qif~----~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFR----DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHh----CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23334 6899999999999999888 999999999987754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7e-12 Score=128.09 Aligned_cols=203 Identities=20% Similarity=0.265 Sum_probs=141.0
Q ss_pred HHhhcCCCcceeEeeeEeeCC-----eeEEEEEccCCCCHHHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001710 779 ILRNVRHRNLVKIFSSCCNID-----FKALVLEFMPNGSFEKWLYSYNY---FLDILQRLNIMIDVALVLEYLHHGHSLA 850 (1022)
Q Consensus 779 ~l~~l~h~~iv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 850 (1022)
-+-.+.|-|+|+++.|+.+.. ...+++|||..|++..+|++..+ .+....-.+|+.||.+||.|||+.. .
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~--P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD--P 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC--C
Confidence 344557999999999986543 46789999999999999986543 5677777889999999999999865 6
Q ss_pred CeEecCCCCCcEEecCCCcEEEeeccCceecC--CCCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHc
Q 001710 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLG--EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928 (1022)
Q Consensus 851 ~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt 928 (1022)
+|+|+++.-+-|++..+|-+|+.--.-..... ............+-++|.|||.......+.++|||+||+...||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 79999999999999999988874222111110 0011112223346789999998888888889999999999999998
Q ss_pred CCCC-CCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 001710 929 RKKP-TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 929 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 1006 (1022)
+..- .......+ +.+. +..+ +.+- .. ..-..++..|++..|..||+|.+++.|.-
T Consensus 278 lEiq~tnseS~~~------~ee~----ia~~----i~~l----en-----~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 278 LEIQSTNSESKVE------VEEN----IANV----IIGL----EN-----GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heeccCCCcceee------hhhh----hhhh----eeec----cC-----ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 8654 22111110 0000 0000 0000 00 00135788999999999999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=130.89 Aligned_cols=168 Identities=15% Similarity=0.165 Sum_probs=130.4
Q ss_pred EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHH
Q 001710 751 LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL 830 (1022)
Q Consensus 751 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 830 (1022)
..++.+|.|..++...........+-+..++.++||+|+++++.+...+..|+|+|.+. .|..++.+.+ ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 45688888888876655555667788999999999999999999999999999999984 6777777643 66777
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCCCCCceeeecccCCcccCCccccCCCCC
Q 001710 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910 (1022)
Q Consensus 831 ~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 910 (1022)
..++||+.||.|||+. .+++|++|.-.-|+|++.|..||++|.++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d---~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDD---CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHhcc---CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 7999999999999964 4699999999999999999999999998865432221 111111223466677544332
Q ss_pred CccchhHhHHHHHHHHHcCCC
Q 001710 911 SAKCDVYSYGVLLMETFTRKK 931 (1022)
Q Consensus 911 ~~~~DvwslG~vl~elltg~~ 931 (1022)
-..|.|.|||+++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.8e-11 Score=121.30 Aligned_cols=131 Identities=18% Similarity=0.181 Sum_probs=96.8
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcce-eEeeeEeeCCeeEEEEEccCCCCH
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV-KIFSSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~lv~e~~~~g~L 813 (1022)
++.++.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999854 78899999765432 123467899999999655544 455443 2345799999999887
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCcEEecCCCcEEEeeccCce
Q 001710 814 EKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS-LAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~ 879 (1022)
.+. . .....++.+++.+++.||.... +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 653 0 1123457889999999998321 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-12 Score=138.46 Aligned_cols=213 Identities=25% Similarity=0.334 Sum_probs=129.9
Q ss_pred ccccccccccccccccCCCCC-cccccccccceeeccccccCCC--cchhhcCccccceeeccCcccccccCCcc--ccc
Q 001710 97 GKLRRLRLINFAYNELSGSFP-SWIGILSRLQILSFHNNSFTDR--IPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLP 171 (1022)
Q Consensus 97 ~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~l~ 171 (1022)
+++.+|+...|.++.+..... .....|++++.||||.|-|..- +-.....|++|+.|+|+.|++.-...... .++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 357778888888877763221 3456688888888888887752 33455678888888888888764433333 467
Q ss_pred cccceecccccccc-cCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCCh--hhhcCcCCCCEE
Q 001710 172 KLEKLYLGSNDFFG-QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP--TAIGNLQMLEHL 248 (1022)
Q Consensus 172 ~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L 248 (1022)
+|+.|.|++|.++. .+...+..+++|+.|+|..|..-..-.....-++.|++|||++|++-. .+ ...+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence 78888888887762 222334567788888888875332333344456678888888877752 33 456677777777
Q ss_pred EccCccccCcC-CcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCcc-CCcccccccccceeeCCCC
Q 001710 249 NLGMNNLSGPV-PPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT-IPNSITNASKLIGLDLSSN 326 (1022)
Q Consensus 249 ~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N 326 (1022)
+++.+.+...- |+. .. ......+++|++|+++.|++..- --..+..+.+|..|.+..|
T Consensus 277 nls~tgi~si~~~d~-~s-------------------~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDV-ES-------------------LDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred hccccCcchhcCCCc-cc-------------------hhhhcccccceeeecccCccccccccchhhccchhhhhhcccc
Confidence 77777776321 111 00 00012355666666666665311 1123444566677777777
Q ss_pred ccCc
Q 001710 327 LFSG 330 (1022)
Q Consensus 327 ~l~~ 330 (1022)
.+..
T Consensus 337 ~ln~ 340 (505)
T KOG3207|consen 337 YLNK 340 (505)
T ss_pred cccc
Confidence 7763
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.5e-12 Score=134.47 Aligned_cols=193 Identities=25% Similarity=0.224 Sum_probs=127.4
Q ss_pred cCCCCCCeeecccccccCCCC-ccccCCCcccEEEeccccccCC--ChhhhcCcCCCCEEEccCccccCcCCccc-cccc
Q 001710 192 SECTHLQTLWLADNKFSGRLP-ENIGNLSQLTDLNLAQNNLQGD--MPTAIGNLQMLEHLNLGMNNLSGPVPPTI-FNIS 267 (1022)
Q Consensus 192 ~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~ 267 (1022)
+++.+|+...|.+..+....- .....|++++.||||+|-+... +-.....|++|+.|+|+.|++........ ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 456667777777776652211 2455678888888888887643 23446778888888888888864433332 2467
Q ss_pred ccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCccC-Cccccccccccccc
Q 001710 268 TIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHI-PHTFGNLRFLRFLN 346 (1022)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ 346 (1022)
.|+.|.|+.|.++..--......+|+|+.|+|..|.....-......+..|+.|||++|++.... ....+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 78888888888876544444456788888888888644444445556778888888888876332 14567788888888
Q ss_pred cccccccCCCCCCCccchhccccccCCcceEecccCCCcc
Q 001710 347 LMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRG 386 (1022)
Q Consensus 347 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 386 (1022)
++.+.|+++..+.. .........++|++|++..|++..
T Consensus 278 ls~tgi~si~~~d~--~s~~kt~~f~kL~~L~i~~N~I~~ 315 (505)
T KOG3207|consen 278 LSSTGIASIAEPDV--ESLDKTHTFPKLEYLNISENNIRD 315 (505)
T ss_pred ccccCcchhcCCCc--cchhhhcccccceeeecccCcccc
Confidence 88888877654331 112223455667777777776653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.2e-10 Score=112.54 Aligned_cols=135 Identities=20% Similarity=0.203 Sum_probs=98.1
Q ss_pred CeeecccceEEEEEEEcC-------CCEEEEEEecchh------------h----------hhHHH----HHHHHHHHhh
Q 001710 736 NLLGRGSFGLVYKGTLFD-------GTNVAIKVFNLQL------------E----------RAFRT----FDSECEILRN 782 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~------------~----------~~~~~----~~~E~~~l~~ 782 (1022)
..||.|.-+.||.|...+ +..+|||+.+... + ...+. ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998442 4799999875321 0 00112 2379999999
Q ss_pred cCC--CcceeEeeeEeeCCeeEEEEEccCCCCHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCC
Q 001710 783 VRH--RNLVKIFSSCCNIDFKALVLEFMPNGSFEK-WLYSYNYFLDILQRLNIMIDVALVLEYL-HHGHSLAPIVHCDLK 858 (1022)
Q Consensus 783 l~h--~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~~ivH~Dik 858 (1022)
+.. -++...+++ ...++||||+.++.+.. .++.. .++......+..+++.++.++ |+ .+|||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~----~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKE----CNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHh----CCeecCCCC
Confidence 953 455666654 45689999998753322 22221 244556677889999999999 77 789999999
Q ss_pred CCcEEecCCCcEEEeeccCceec
Q 001710 859 PNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 859 ~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
+.||+++ ++.+.++|||-|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.5e-12 Score=144.88 Aligned_cols=247 Identities=27% Similarity=0.272 Sum_probs=142.6
Q ss_pred cccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccccCccccccccccchhccccccccccCCcc
Q 001710 337 GNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQE 416 (1022)
Q Consensus 337 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~ 416 (1022)
..+..++.+++..|.|..+ ...+..+.+|+.|++.+|.|..+. ..
T Consensus 69 ~~l~~l~~l~l~~n~i~~~---------~~~l~~~~~l~~l~l~~n~i~~i~--------------------------~~ 113 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKI---------LNHLSKLKSLEALDLYDNKIEKIE--------------------------NL 113 (414)
T ss_pred HHhHhHHhhccchhhhhhh---------hcccccccceeeeeccccchhhcc--------------------------cc
Confidence 3455566666666666541 122455666777777777666431 11
Q ss_pred ccCCCcceEEEeeCCCCCCcccccccccccCceEEeeccCCCCCCCcccccccccceeecCCccccCccc-ccccCcccc
Q 001710 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIP-ACLGSLTSL 495 (1022)
Q Consensus 417 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L 495 (1022)
+..+++|++|++++|+|+.+. .+..++.|+.|++++|.|... ..+..++.|+.+++++|.+....+ . ...+.++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISL 188 (414)
T ss_pred hhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence 455667777777777776433 244555577777777777632 234446777777777777764433 1 3566677
Q ss_pred ceeeccCceeccccCCccccccccceEeccCCcCCCCccccccccc--ccceeeccCccccCccccccccccccceeccc
Q 001710 496 RELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLK--VLINLDLSRNQLSGDIPITISGLKDLATLSLA 573 (1022)
Q Consensus 496 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 573 (1022)
+.+++++|.+. ....+..+..+..+++..|.++...+ +..+. .|+.+++++|++. ..+..+..+..+..|+++
T Consensus 189 ~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 189 EELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLS 263 (414)
T ss_pred HHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchh
Confidence 77777777776 33444455555555677777664322 11222 2677777777775 444556666777777777
Q ss_pred CcccccCCCcccccccccceeecccceecc---ccCch-hhhcccccEEEccCCcceeecC
Q 001710 574 GNQFNGPIPESFGSLISLESLDVSSNNISG---KIPKS-LEALLYLKKLNVSYNRLEGEIP 630 (1022)
Q Consensus 574 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~-~~~l~~L~~L~ls~N~l~~~~p 630 (1022)
.|++... ..+.....+..+.+..|.+.. ..... ....+.++.+.+.+|+.....+
T Consensus 264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 264 SNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 7776633 223445556666666666552 11111 3445566666666666555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-12 Score=135.39 Aligned_cols=199 Identities=23% Similarity=0.268 Sum_probs=110.9
Q ss_pred CcEEEEEcCCCCccc----ccCCCCCCCCCccEEeccCCcccC----CCCCCcccccccccccccccccCCCCCcccccc
Q 001710 52 HRVVALNLSSFSLGG----IIPPHLGNLSFLVSLDISENNFYG----HLPNELGKLRRLRLINFAYNELSGSFPSWIGIL 123 (1022)
Q Consensus 52 ~~v~~l~L~~~~l~~----~i~~~l~~l~~L~~L~Ls~n~~~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 123 (1022)
..++.|+|++|.++. .|.+.+.+.+.|+..++|+- ++| .+|+.+.. +.+.+-..
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~-----------------l~~aL~~~ 91 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKM-----------------LSKALLGC 91 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHH-----------------HHHHHhcC
Confidence 346777777777653 33444556666666666652 222 23332211 11233445
Q ss_pred cccceeeccccccCCCcchh----hcCccccceeeccCcccccccCCcc-cc-ccccceecccccccccCCccccCCCCC
Q 001710 124 SRLQILSFHNNSFTDRIPDF----LLNLSKLEFLDLMENSLSGSLPNDI-RL-PKLEKLYLGSNDFFGQIPSSLSECTHL 197 (1022)
Q Consensus 124 ~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~~~~~-~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L 197 (1022)
++|++||||+|.|....+.. +.++..|++|.|.+|.+. |... .+ ..|.+|. .| ...+.-+.|
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~--~~-------kk~~~~~~L 159 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFELA--VN-------KKAASKPKL 159 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHH--HH-------hccCCCcce
Confidence 67888888888877554443 455677888888888765 1111 11 1233332 11 122334567
Q ss_pred CeeecccccccCCCC----ccccCCCcccEEEeccccccC----CChhhhcCcCCCCEEEccCccccCcCC----ccccc
Q 001710 198 QTLWLADNKFSGRLP----ENIGNLSQLTDLNLAQNNLQG----DMPTAIGNLQMLEHLNLGMNNLSGPVP----PTIFN 265 (1022)
Q Consensus 198 ~~L~L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~ 265 (1022)
+++...+|++..... ..|...+.|+.+.++.|.|.. .+...|..+++|+.|||..|-++.... ..+..
T Consensus 160 rv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s 239 (382)
T KOG1909|consen 160 RVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS 239 (382)
T ss_pred EEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc
Confidence 777777777764332 335556777778888777752 234567777788888888887764322 22333
Q ss_pred ccccceeecccceee
Q 001710 266 ISTIRLINLIENQLS 280 (1022)
Q Consensus 266 l~~L~~L~Ls~N~l~ 280 (1022)
+++|+.|++++|.++
T Consensus 240 ~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 240 WPHLRELNLGDCLLE 254 (382)
T ss_pred cchheeecccccccc
Confidence 444444555444443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-12 Score=134.68 Aligned_cols=221 Identities=26% Similarity=0.284 Sum_probs=101.6
Q ss_pred cEEEEEcCCCC---cccccCCC-------CCCCCCccEEeccCCcccCCCCCC----cccccccccccccccccCCCCCc
Q 001710 53 RVVALNLSSFS---LGGIIPPH-------LGNLSFLVSLDISENNFYGHLPNE----LGKLRRLRLINFAYNELSGSFPS 118 (1022)
Q Consensus 53 ~v~~l~L~~~~---l~~~i~~~-------l~~l~~L~~L~Ls~n~~~~~~p~~----l~~l~~L~~L~Ls~n~l~~~~p~ 118 (1022)
..+..++++.. +...+|+. +-..++|++||||+|-|.-..+.. |.++..|++|.|.+|.++-.--.
T Consensus 59 ~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~ 138 (382)
T KOG1909|consen 59 ELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGG 138 (382)
T ss_pred cceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHH
Confidence 45666666542 22344443 444556777777777666443332 23344555555555544411111
Q ss_pred ccccccccceeeccccccCCCcchhhcCccccceeeccCcccccccCCc----c-ccccccceecccccccc----cCCc
Q 001710 119 WIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPND----I-RLPKLEKLYLGSNDFFG----QIPS 189 (1022)
Q Consensus 119 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~-~l~~L~~L~L~~n~l~~----~~p~ 189 (1022)
.++. .|.+|. .| .-.+.-++|+++...+|++....... + ..+.|+.+.+..|.+.. .+..
T Consensus 139 ~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~e 207 (382)
T KOG1909|consen 139 RLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAE 207 (382)
T ss_pred HHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHH
Confidence 1110 011111 00 01122345566666666554221111 1 23445555555554421 1223
Q ss_pred cccCCCCCCeeecccccccCCC----CccccCCCcccEEEeccccccCCChhhh-----cCcCCCCEEEccCccccCcCC
Q 001710 190 SLSECTHLQTLWLADNKFSGRL----PENIGNLSQLTDLNLAQNNLQGDMPTAI-----GNLQMLEHLNLGMNNLSGPVP 260 (1022)
Q Consensus 190 ~l~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~ 260 (1022)
+|..+++|++|||.+|-|+... ...+..+++|++|++++|.++..-..+| ...++|++|.|.+|.++....
T Consensus 208 al~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~ 287 (382)
T KOG1909|consen 208 ALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAA 287 (382)
T ss_pred HHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHH
Confidence 4555666666666666555321 2334445556666666666653332222 224555555555555542111
Q ss_pred cccccccccceeecccceeeeeccccccCCCCCccEEEccCcccC
Q 001710 261 PTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305 (1022)
Q Consensus 261 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 305 (1022)
. .+...+. ..|.|+.|+|++|.+.
T Consensus 288 ~--------------------~la~~~~-ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 288 L--------------------ALAACMA-EKPDLEKLNLNGNRLG 311 (382)
T ss_pred H--------------------HHHHHHh-cchhhHHhcCCccccc
Confidence 1 1112222 3678888888888873
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.1e-10 Score=106.07 Aligned_cols=131 Identities=22% Similarity=0.324 Sum_probs=103.2
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecch-h-----h--hhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEEEc
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ-L-----E--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~-~-----~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 807 (1022)
..+++|+-+.+|.+.+. |.++.+|.-.+. . + -..++-.+|++++.+++--.|...+=+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999764 444666643221 1 1 1234567899999999877776666666777888899999
Q ss_pred cCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
++|..|.+++... ...++..+-.-+.-||. .||||+|+.++||.+..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~----~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK----AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh----cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988765 24677888888899999 8999999999999998765 99999999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.1e-11 Score=116.59 Aligned_cols=122 Identities=30% Similarity=0.374 Sum_probs=38.8
Q ss_pred cccceeeccCceeccccCCccc-cccccceEeccCCcCCCCcccccccccccceeeccCccccCcccccc-cccccccee
Q 001710 493 TSLRELHLGSNTLTYSIPSSLW-SLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITI-SGLKDLATL 570 (1022)
Q Consensus 493 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L 570 (1022)
.++++|+|.+|.|+. + +.+. .+.+|+.|+|++|.|+.+ +.+..++.|+.|++++|+|+ .+...+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 345566666666652 2 2333 345556666666666543 23555666666666666666 333333 346666666
Q ss_pred cccCcccccCC-CcccccccccceeecccceeccccCc----hhhhcccccEEEc
Q 001710 571 SLAGNQFNGPI-PESFGSLISLESLDVSSNNISGKIPK----SLEALLYLKKLNV 620 (1022)
Q Consensus 571 ~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l 620 (1022)
+|++|+|.... -..+..+++|+.|+|.+|+++. .+. .+..+|+|+.||-
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 66666665322 1345667777777777777763 232 3556777777653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-09 Score=103.41 Aligned_cols=142 Identities=20% Similarity=0.239 Sum_probs=108.6
Q ss_pred cCCeeecccceEEEEEEEcCCCEEEEEEe-cchh-------hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCeeEEEE
Q 001710 734 ECNLLGRGSFGLVYKGTLFDGTNVAIKVF-NLQL-------ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 734 ~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 805 (1022)
....+.+|+-+.|+++.+ .|+.+.||.- .+.. +-..++..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999984 5777777742 2211 122456788999999997666665555666777778999
Q ss_pred EccCC-CCHHHHhhhcCCCCC-HHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCC---cEEEeeccCcee
Q 001710 806 EFMPN-GSFEKWLYSYNYFLD-ILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM---TAHVSDFGISKL 880 (1022)
Q Consensus 806 e~~~~-g~L~~~l~~~~~~~~-~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~---~~kl~DfG~a~~ 880 (1022)
||++| .++.+++......-. ......+++.|-+.+.-||. .+|||+|+..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~----ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD----NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh----CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 478888876554333 33337899999999999999 7799999999999997555 468999999853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.6e-11 Score=132.03 Aligned_cols=250 Identities=18% Similarity=0.131 Sum_probs=178.7
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEE--cCCCEEEEEEecchhhhhHH--HHHHHHHHHhhc-CCCcceeEeeeEeeCCe
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTL--FDGTNVAIKVFNLQLERAFR--TFDSECEILRNV-RHRNLVKIFSSCCNIDF 800 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 800 (1022)
.....+|..+..||.|.|+.||+... .++..||+|........... .-..|+.+...+ .|.++++.+..|...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34567889999999999999998863 45788999977544322222 224566666666 59999998888888888
Q ss_pred eEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC-CcEEEeeccCce
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGISK 879 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG~a~ 879 (1022)
.|+--||+++++..... .....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.++
T Consensus 341 ~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s----~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS----KLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc----hhhhcccccccceeeccchhhhhcccccccc
Confidence 88999999999887766 333357888889999999999999998 789999999999999886 888999999986
Q ss_pred ecCCCCCceeeecccCCcccC--CccccCCCCCCccchhHhHHHHHHHHHcCCCCCCcccccchhHHHHHHhhcCCCcch
Q 001710 880 LLGEGDDSVTQTITMATIGYM--APEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
.+.- .......+.++. +++......+..+.|++|||.-+.|.+++..--.. ... |. .
T Consensus 416 ~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~------~~---------~ 474 (524)
T KOG0601|consen 416 RLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQ------SL---------T 474 (524)
T ss_pred ccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc-ccc------ce---------e
Confidence 4211 111112233344 56666677788999999999999999998653221 000 00 0
Q ss_pred hccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~i 1008 (1022)
+ .....+........+..+...+..+++..||.+.++..+.+..
T Consensus 475 i-------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 I-------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred e-------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 0000111112224567788889999999999999887766544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-11 Score=140.16 Aligned_cols=193 Identities=30% Similarity=0.333 Sum_probs=97.9
Q ss_pred CccEEEccCcccCccCCcccccccccceeeCCCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccC
Q 001710 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCR 372 (1022)
Q Consensus 293 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~ 372 (1022)
.++.+++..|.+.. +-..+..+.+|+.|++.+|+|... ...+..+++|++|++++|.|+.+. .+..+.
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~----------~l~~l~ 140 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE----------GLSTLT 140 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc----------chhhcc
Confidence 34444444444432 223344555666666666666532 222555666666666666666543 244455
Q ss_pred CcceEecccCCCccccCccccccccccchhccccccccccCCccccCCCcceEEEeeCCCCCCccc-ccccccccCceEE
Q 001710 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIP-TTVGRFQQLQGLS 451 (1022)
Q Consensus 373 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 451 (1022)
.|+.|++++|+|+.+ ..+..++.|+.+++++|.+...-+ . ...+.+++.++
T Consensus 141 ~L~~L~l~~N~i~~~---------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~ 192 (414)
T KOG0531|consen 141 LLKELNLSGNLISDI---------------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELD 192 (414)
T ss_pred chhhheeccCcchhc---------------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHh
Confidence 566666666665532 123335666666666666663333 1 34555666666
Q ss_pred eeccCCCCCCCcccccccccceeecCCccccCcccccccCccc--cceeeccCceeccccCCccccccccceEeccCCcC
Q 001710 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTS--LRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL 529 (1022)
Q Consensus 452 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 529 (1022)
+.+|.+.. ...+..+..+..+++..|.++..-+ +..+.. |+.+++++|++. ..+..+..+..+..|++++|++
T Consensus 193 l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 193 LGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred ccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence 66666652 2233344444555666666653222 112222 566666666665 2223444444444455555544
Q ss_pred C
Q 001710 530 S 530 (1022)
Q Consensus 530 ~ 530 (1022)
.
T Consensus 268 ~ 268 (414)
T KOG0531|consen 268 S 268 (414)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.1e-10 Score=116.13 Aligned_cols=143 Identities=20% Similarity=0.204 Sum_probs=111.5
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhh-hhHHHHHHHHHHHhhcCCC--cceeEeeeEeeCC---eeEEEEEccC
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHR--NLVKIFSSCCNID---FKALVLEFMP 809 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~---~~~lv~e~~~ 809 (1022)
+.++.|.++.||+++..+|+.+++|+...... .....+..|+++++.+++. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999876678999999765432 1345778899999999763 4566777766542 5689999999
Q ss_pred CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 001710 810 NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH------------------------------------------ 847 (1022)
Q Consensus 810 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------ 847 (1022)
|.++.+.+.. ..++......++.++++++.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988776542 23677788888999999999998521
Q ss_pred ----------CCCCeEecCCCCCcEEecC--CCcEEEeeccCcee
Q 001710 848 ----------SLAPIVHCDLKPNNILLDE--NMTAHVSDFGISKL 880 (1022)
Q Consensus 848 ----------~~~~ivH~Dik~~NIll~~--~~~~kl~DfG~a~~ 880 (1022)
.+..++|+|+++.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1355899999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-11 Score=121.75 Aligned_cols=136 Identities=27% Similarity=0.289 Sum_probs=83.9
Q ss_pred ccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcCCCCEEEccCccccCcCCcccccccc
Q 001710 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST 268 (1022)
Q Consensus 189 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 268 (1022)
..+...+.|++||||+|.|+ .+.+++.-++.++.|++|+|.|... ..+..|.+|+.||||+|.++ .+..+-.
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~---- 349 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL---- 349 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh----
Confidence 33444556677777777776 5566666667777777777777632 23666667777777777665 2222222
Q ss_pred cceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeCCCCccCcc-CCcccccccccccccc
Q 001710 269 IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGH-IPHTFGNLRFLRFLNL 347 (1022)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L 347 (1022)
.+-++++|.|++|.+... ..+..+.+|..||+++|+|... -...+++++.|+.+.|
T Consensus 350 ---------------------KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L 406 (490)
T KOG1259|consen 350 ---------------------KLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRL 406 (490)
T ss_pred ---------------------hhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhh
Confidence 345556666666655422 3455666777777777777532 2245777788888888
Q ss_pred ccccccCC
Q 001710 348 MFNSLTTE 355 (1022)
Q Consensus 348 ~~N~l~~~ 355 (1022)
.+|.|...
T Consensus 407 ~~NPl~~~ 414 (490)
T KOG1259|consen 407 TGNPLAGS 414 (490)
T ss_pred cCCCcccc
Confidence 88877654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=114.37 Aligned_cols=126 Identities=33% Similarity=0.318 Sum_probs=43.8
Q ss_pred cccccceeecCCccccCccccccc-CccccceeeccCceeccccCCccccccccceEeccCCcCCCCcccccccccccce
Q 001710 467 HLERLSQLLLNGNNLSGAIPACLG-SLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545 (1022)
Q Consensus 467 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 545 (1022)
+..++++|+|.+|.|+. +. .++ .+.+|+.|+|++|.|+. + +.+..++.|+.|++++|+|+.+.+.....+++|++
T Consensus 17 n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred ccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 33455666666666653 22 333 35666677777777663 2 24666677777777777777543322245677777
Q ss_pred eeccCccccCcc-ccccccccccceecccCcccccCC---Ccccccccccceeec
Q 001710 546 LDLSRNQLSGDI-PITISGLKDLATLSLAGNQFNGPI---PESFGSLISLESLDV 596 (1022)
Q Consensus 546 L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~L 596 (1022)
|+|++|+|.... -..++.+++|+.|+|.+|+++... ...+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 777777776422 244667888888888888887432 123567888888873
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-10 Score=139.67 Aligned_cols=270 Identities=23% Similarity=0.276 Sum_probs=172.7
Q ss_pred CCccEEeccCCc--ccCCCCCCcccccccccccccccccCCCCCcccccccccceeeccccccCCCcchhhcCcccccee
Q 001710 76 SFLVSLDISENN--FYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFL 153 (1022)
Q Consensus 76 ~~L~~L~Ls~n~--~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 153 (1022)
+.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|..|+.|-+|++|+|+++.++ .+|..+++|++|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 368888888886 44333445778999999999988766788999999999999999999988 788999999999999
Q ss_pred eccCcccccccCCcc-ccccccceeccccccc--ccCCccccCCCCCCeeecccccccCCCCccccCCCccc----EEEe
Q 001710 154 DLMENSLSGSLPNDI-RLPKLEKLYLGSNDFF--GQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLT----DLNL 226 (1022)
Q Consensus 154 ~Ls~N~l~~~~~~~~-~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L 226 (1022)
++..+.-...+|... .+.+|++|.+..-... ...-..+.++.+|+.+....... .+-..+..+..|. .+.+
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence 998887666666666 4889999888766522 22223344455555555433222 1112222333332 3343
Q ss_pred ccccccCCChhhhcCcCCCCEEEccCccccCcCCccccccc------ccceeecccceeeeeccccccCCCCCccEEEcc
Q 001710 227 AQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIS------TIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300 (1022)
Q Consensus 227 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~ 300 (1022)
.++... ..+..+..+.+|+.|.+.++.++........... ++..+...++.....+-.. .-.++|+.|++.
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~--~f~~~L~~l~l~ 778 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWL--LFAPHLTSLSLV 778 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchh--hccCcccEEEEe
Confidence 333333 4566788889999999998888644333322211 2222222222111111111 235899999999
Q ss_pred CcccCccCCcccccccccceeeCCCCccCcc-CCcccccccccccccccccc
Q 001710 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGH-IPHTFGNLRFLRFLNLMFNS 351 (1022)
Q Consensus 301 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~ 351 (1022)
++.....+.+....+..+..+-+..+.+.+. .-...+.++++..+.+.+=.
T Consensus 779 ~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~ 830 (889)
T KOG4658|consen 779 SCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLK 830 (889)
T ss_pred cccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCccc
Confidence 9988877777777777787777778877766 34555666666666555433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-08 Score=108.56 Aligned_cols=267 Identities=12% Similarity=0.057 Sum_probs=173.9
Q ss_pred CCeeecccceEEEEEEEcCCCEEEEEEecchhhhhHHHHHHHHHHHhhc-CCCcceeEeee------E-eeCCeeEEEEE
Q 001710 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSS------C-CNIDFKALVLE 806 (1022)
Q Consensus 735 ~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~------~-~~~~~~~lv~e 806 (1022)
...||+|+-+.+|..- .-+..+.|++......... +.+..|... .||-+-.-+.+ . .......+.|.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4679999999999753 1223455766544322111 123333333 45544331111 1 12233678888
Q ss_pred ccCCC-CHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCcee
Q 001710 807 FMPNG-SFEKWLYS-----YNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 807 ~~~~g-~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~ 880 (1022)
.+.+- ...++... .-....|...+++++.++.+.+.||+ .|.+-+|+.++|+||.+++.+.+.|=+.-..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~----~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE----HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh----cCCcccccCccceeeecCceEEEEcccceee
Confidence 88764 23333321 11257899999999999999999999 7899999999999999999999998765443
Q ss_pred cCCCCCceeeecccCCcccCCccccC-----CCCCCccchhHhHHHHHHHHHcC-CCCCCcccccc-------hhHHHHH
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGE-------MSLRRWV 947 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~-------~~~~~~~ 947 (1022)
.. ........+|...|.+||.-. +...+...|-|.+|+++++++.| ++||.+..... ..+..-
T Consensus 167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g- 242 (637)
T COG4248 167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG- 242 (637)
T ss_pred cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc-
Confidence 32 222344567899999999533 44456789999999999999986 89998753321 111110
Q ss_pred HhhcCCCcchhcccccc-chhhhhhhhHHHHHHHHHHHHhhcccC--CCCCCCHHHHHHHHHHhhHhhccccccCC
Q 001710 948 KESLPHGLTEVVDANLV-GEEQAFSAKTDCLLSIMDLALDCCMES--PEQRIHMTDAAAELKKIRVKFLQQSSVAG 1020 (1022)
Q Consensus 948 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~ell~~L~~i~~~~~~~~~~~~ 1020 (1022)
. .....++... ...+........+.++..+..+|+... +.-||+++-.+..|.++.++..++.+-||
T Consensus 243 --~----f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~ 312 (637)
T COG4248 243 --R----FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAM 312 (637)
T ss_pred --e----eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccc
Confidence 0 0000011100 011222333445677888999999863 56899999999999999999999888766
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-10 Score=137.15 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=172.0
Q ss_pred HHhhcCCCcCCeeecccceEEEEEEE-cCCCEEEEEEecchh---hhhHHHHHHHHHHHhhcCCCcceeEeeeEeeCCee
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 726 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 801 (1022)
+...+.+.+.+.+.+|+++.++.++- ..|...+.|+..... ....+....+-.+.-..++|-+++....+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34556778888899999999998872 245445555443221 11223333344444445667777776665666778
Q ss_pred EEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceec
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~ 881 (1022)
++|++|..++++..-++..+. .+..........+..+.+|||. ..+.|||++|.|++...+++.+++|||.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s----~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHS----SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcccc----chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998887664 3333334456668889999998 66899999999999999999999999843322
Q ss_pred CC---------------------CC--------CceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCCC
Q 001710 882 GE---------------------GD--------DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932 (1022)
Q Consensus 882 ~~---------------------~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p 932 (1022)
+- .. .........+|+.|.+||...+......+|+|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 00 00112234689999999999999999999999999999999999999
Q ss_pred CCcccccchhHHHHHHhhcCCCcchhccccccchhhhhhhhHHHHHHHHHHHHhhcccCCCCCCCHH
Q 001710 933 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 999 (1022)
|........ + ... ....+ .....+...+....+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~-f----~ni--------~~~~~----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI-F----ENI--------LNRDI----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh-h----hcc--------ccCCC----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 976433211 1 111 11101 11112223345567888899999999998876
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-09 Score=80.45 Aligned_cols=40 Identities=35% Similarity=0.750 Sum_probs=30.0
Q ss_pred hhHHHHHHHHHhhccCCCCcccCCCCCC--CCCccceeeEEc
Q 001710 9 TTDQSALLAFKADVIDSRSVLANNWSIS--YPICNWVGISCG 48 (1022)
Q Consensus 9 ~~d~~aLl~~k~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 48 (1022)
++|++||++||+++.+++.....+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 6799999999999996555556799976 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-08 Score=99.99 Aligned_cols=125 Identities=22% Similarity=0.254 Sum_probs=82.7
Q ss_pred EEEEEEEcCCCEEEEEEecchh--------------h------------hhHHHHHHHHHHHhhcCCC--cceeEeeeEe
Q 001710 745 LVYKGTLFDGTNVAIKVFNLQL--------------E------------RAFRTFDSECEILRNVRHR--NLVKIFSSCC 796 (1022)
Q Consensus 745 ~Vy~~~~~~~~~vAvK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~ 796 (1022)
.||.|...+|..+|||+.+... . -......+|++.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999875321 0 0123467899999999765 456666542
Q ss_pred eCCeeEEEEEccC--CCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCCcEEecCCCcEEEe
Q 001710 797 NIDFKALVLEFMP--NGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY-LHHGHSLAPIVHCDLKPNNILLDENMTAHVS 873 (1022)
Q Consensus 797 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~ 873 (1022)
...+||||++ |..+..+.... ++......++.+++..+.. +|. .||||+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~----~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK----AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC----TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh----cCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 65554433322 1133445677788885555 467 789999999999999987 99999
Q ss_pred eccCceec
Q 001710 874 DFGISKLL 881 (1022)
Q Consensus 874 DfG~a~~~ 881 (1022)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-10 Score=130.04 Aligned_cols=181 Identities=29% Similarity=0.290 Sum_probs=119.7
Q ss_pred cccccccccCceEEeeccCCCCCCCcccccc-cccceeecCCcccc----------CcccccccCccccceeeccCceec
Q 001710 438 PTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL-ERLSQLLLNGNNLS----------GAIPACLGSLTSLRELHLGSNTLT 506 (1022)
Q Consensus 438 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~l~~L~~L~L~~N~l~ 506 (1022)
|-.+..+.+|+.|.|.++.|.. ...+..+ ..|++|... |.+. |.+-.++ .+..|...+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence 4455566777777777777763 1111111 233333322 2111 1111111 1246778888888888
Q ss_pred cccCCccccccccceEeccCCcCCCCcccccccccccceeeccCccccCccccccccccccceecccCcccccCCCcccc
Q 001710 507 YSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFG 586 (1022)
Q Consensus 507 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 586 (1022)
....++.-++.|+.|||++|+++... .+..++.|++|||++|.++.+.--...++. |..|++++|.++.. ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 56677888888888888888888653 677788888888988888844333344555 88888888888743 3467
Q ss_pred cccccceeecccceeccccC-chhhhcccccEEEccCCcceee
Q 001710 587 SLISLESLDVSSNNISGKIP-KSLEALLYLKKLNVSYNRLEGE 628 (1022)
Q Consensus 587 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~ 628 (1022)
+|.+|+-|||++|-|++--. ..++.|..|+.|+|.|||+.+.
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 88888888999988875332 3356778888889999988875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.2e-08 Score=102.38 Aligned_cols=140 Identities=15% Similarity=0.085 Sum_probs=101.0
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhhh-hHH----------HHHHHHHHHhhcCCCcce--eEeeeEee-----
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER-AFR----------TFDSECEILRNVRHRNLV--KIFSSCCN----- 797 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~~iv--~l~~~~~~----- 797 (1022)
+.+-+-....|++.+. +|+.|.||........ ..+ .+.+|.+.+.++...+|. ..+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455667664 5788999977443211 111 377899999998544443 34455433
Q ss_pred CCeeEEEEEccCCC-CHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecC-------CC
Q 001710 798 IDFKALVLEFMPNG-SFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-------NM 868 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-------~~ 868 (1022)
....++|||++++. +|.+++... ....+...+..++.+++..+..||. .||+|+|+++.|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~----~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA----AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH----CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 799988642 2235566777899999999999999 89999999999999975 46
Q ss_pred cEEEeeccCcee
Q 001710 869 TAHVSDFGISKL 880 (1022)
Q Consensus 869 ~~kl~DfG~a~~ 880 (1022)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.4e-08 Score=101.48 Aligned_cols=134 Identities=22% Similarity=0.196 Sum_probs=98.5
Q ss_pred CCcCCeeecccceEEEEEEEcCCCEEEEEEecchhh----------------------hhHHHHHHHHHHHhhcCCC--c
Q 001710 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE----------------------RAFRTFDSECEILRNVRHR--N 787 (1022)
Q Consensus 732 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--~ 787 (1022)
..+..+||.|.-+.||.|..++|.++|||.-+.... -......+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445689999999999999988999999996432110 0123467899999999654 6
Q ss_pred ceeEeeeEeeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCC
Q 001710 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDEN 867 (1022)
Q Consensus 788 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~ 867 (1022)
+.+.+++ +...+||||++|-.|...- ++......++..|+.-+...-. .||||+|+.+-||++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~----~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR----RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH----cCccccCCchheEEEecC
Confidence 7777765 4567999999997665532 1233344455555555555555 789999999999999999
Q ss_pred CcEEEeeccCce
Q 001710 868 MTAHVSDFGISK 879 (1022)
Q Consensus 868 ~~~kl~DfG~a~ 879 (1022)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999996554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.6e-09 Score=85.14 Aligned_cols=60 Identities=37% Similarity=0.588 Sum_probs=35.6
Q ss_pred ccceecccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCcc
Q 001710 566 DLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625 (1022)
Q Consensus 566 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 625 (1022)
+|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445566666666666666666655555666666666666666653
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.8e-09 Score=84.98 Aligned_cols=60 Identities=40% Similarity=0.559 Sum_probs=33.0
Q ss_pred ccceeeccCccccCccccccccccccceecccCcccccCCCcccccccccceeeccccee
Q 001710 542 VLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNI 601 (1022)
Q Consensus 542 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 601 (1022)
+|++|++++|+|+...+..|.++++|++|++++|+|+...|.+|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555555555555555555555555543
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-08 Score=125.41 Aligned_cols=209 Identities=23% Similarity=0.252 Sum_probs=104.5
Q ss_pred cCCccccccccceecccccccccCCccccCCCCCCeeeccccc--ccCCCCccccCCCcccEEEeccccccCCChhhhcC
Q 001710 164 LPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNK--FSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGN 241 (1022)
Q Consensus 164 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 241 (1022)
.|........+...+-+|.+.. ++... ..+.|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..++.
T Consensus 516 ~~~~~~~~~~rr~s~~~~~~~~-~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~ 593 (889)
T KOG4658|consen 516 IPQVKSWNSVRRMSLMNNKIEH-IAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGE 593 (889)
T ss_pred cccccchhheeEEEEeccchhh-ccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhh
Confidence 3333334455555555555542 22222 22356666666664 44333344556666666666666555566666666
Q ss_pred cCCCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccC--ccCCcccccccccc
Q 001710 242 LQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI--GTIPNSITNASKLI 319 (1022)
Q Consensus 242 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~ 319 (1022)
|-+|++|+|++..++ .+|..+.++.+|.+|++..+.-...+|. ....+++|++|.+..-... ...-..+..+..|+
T Consensus 594 Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~-i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~ 671 (889)
T KOG4658|consen 594 LVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPG-ILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE 671 (889)
T ss_pred hhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccc-hhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence 666666666666665 5666666666666666666655433332 2224666666666554311 11112223333444
Q ss_pred eeeCCCCccCccCCcccccccccc----ccccccccccCCCCCCCccchhccccccCCcceEecccCCCccc
Q 001710 320 GLDLSSNLFSGHIPHTFGNLRFLR----FLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGI 387 (1022)
Q Consensus 320 ~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 387 (1022)
.+....... .+-..+..+..|. .+.+.++.. .....++..+.+|+.|.+.+..+..+
T Consensus 672 ~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~---------~~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 672 NLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSK---------RTLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred hheeecchh--HhHhhhhhhHHHHHHhHhhhhccccc---------ceeecccccccCcceEEEEcCCCchh
Confidence 443322221 1112223333333 222222111 11234566777788888877776543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-09 Score=98.13 Aligned_cols=135 Identities=24% Similarity=0.260 Sum_probs=99.6
Q ss_pred ccceeeccCceeccccCCc---cccccccceEeccCCcCCCCcccccccccccceeeccCccccCcccccccccccccee
Q 001710 494 SLRELHLGSNTLTYSIPSS---LWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATL 570 (1022)
Q Consensus 494 ~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 570 (1022)
.+..++|+++++- .+++. +.....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|.+++.++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 3455666666655 23333 334455666788888888654444455668999999999998 889999999999999
Q ss_pred cccCcccccCCCcccccccccceeecccceeccccCchhhhcccccEEEccCCcceeecCCC
Q 001710 571 SLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIK 632 (1022)
Q Consensus 571 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 632 (1022)
|++.|.|. ..|..+..|.+|..||..+|.+. .+|-.+-.-...-..++.+++|.+..+.+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 99999998 77888888999999999999987 66655433233334456788888888764
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.1e-09 Score=105.96 Aligned_cols=224 Identities=24% Similarity=0.269 Sum_probs=123.6
Q ss_pred CCCCCCcccccccccccccccccCCCCC-ccc-ccccccceeeccccccCC--CcchhhcCccccceeeccCcccccccC
Q 001710 90 GHLPNELGKLRRLRLINFAYNELSGSFP-SWI-GILSRLQILSFHNNSFTD--RIPDFLLNLSKLEFLDLMENSLSGSLP 165 (1022)
Q Consensus 90 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~~-~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 165 (1022)
|..+-.+..++-++.|.+.++.|....- ..| ...+.+++|||.+|++++ .+...+.+|+.|+.|+|+.|++...|-
T Consensus 35 g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~ 114 (418)
T KOG2982|consen 35 GLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK 114 (418)
T ss_pred ccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc
Confidence 3334344444555666666665543221 122 235678888888888885 556667788899999999998886554
Q ss_pred Cc-cccccccceecccccccc-cCCccccCCCCCCeeecccccccCCCCccccCCCcccEEEeccccccCCChhhhcCcC
Q 001710 166 ND-IRLPKLEKLYLGSNDFFG-QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQ 243 (1022)
Q Consensus 166 ~~-~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 243 (1022)
.. ..+.+|+.|-|.+..+.- ...+.+..++.+++|.++.|.+. .+.+..|-++...|
T Consensus 115 ~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~------- 173 (418)
T KOG2982|consen 115 SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWST------- 173 (418)
T ss_pred cCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccch-------
Confidence 44 356677777777776642 22233445555555555555322 12222222221111
Q ss_pred CCCEEEccCccccCcCCcccccccccceeecccceeeeeccccccCCCCCccEEEccCcccCccCCcccccccccceeeC
Q 001710 244 MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDL 323 (1022)
Q Consensus 244 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 323 (1022)
.+.+|.+-. .+..++++-|++.. -+|++..+.+..|.+...
T Consensus 174 ~v~tlh~~~---------------c~~~~w~~~~~l~r--------~Fpnv~sv~v~e~PlK~~---------------- 214 (418)
T KOG2982|consen 174 EVLTLHQLP---------------CLEQLWLNKNKLSR--------IFPNVNSVFVCEGPLKTE---------------- 214 (418)
T ss_pred hhhhhhcCC---------------cHHHHHHHHHhHHh--------hcccchheeeecCcccch----------------
Confidence 111111111 11122222222221 134444444444443311
Q ss_pred CCCccCccCCccccccccccccccccccccCCCCCCCccchhccccccCCcceEecccCCCccc
Q 001710 324 SSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGI 387 (1022)
Q Consensus 324 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 387 (1022)
..-+.+..++.+-.|+|+.|+|. .|..++.+.++++|..|.++.|++.+.
T Consensus 215 -------s~ek~se~~p~~~~LnL~~~~id-------swasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 215 -------SSEKGSEPFPSLSCLNLGANNID-------SWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred -------hhcccCCCCCcchhhhhcccccc-------cHHHHHHHcCCchhheeeccCCccccc
Confidence 11133444556667888888775 477788899999999999999998754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-07 Score=108.91 Aligned_cols=140 Identities=19% Similarity=0.200 Sum_probs=95.0
Q ss_pred CeeecccceEEEEEEEcCCCEEEEEEecchhhhhH----------------------------------------HHHHH
Q 001710 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAF----------------------------------------RTFDS 775 (1022)
Q Consensus 736 ~~Lg~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 775 (1022)
+.|+.++-|.||+|++++|+.||||+.++..++.. -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999875431110 02445
Q ss_pred HHHHHhhcC-----CCcceeEeeeE-eeCCeeEEEEEccCCCCHHHHhhhcCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 001710 776 ECEILRNVR-----HRNLVKIFSSC-CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV-LEYLHHGHS 848 (1022)
Q Consensus 776 E~~~l~~l~-----h~~iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~ 848 (1022)
|+..+.+++ .+.+ .+-.++ +-.....++|||++|..+.+...-.....+... ++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~--- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR--- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh---
Confidence 666666552 2332 222222 334456799999999988887433333355333 33333333 222223
Q ss_pred CCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 849 ~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
.|++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5799999999999999999999999999977644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-06 Score=95.33 Aligned_cols=165 Identities=19% Similarity=0.213 Sum_probs=124.5
Q ss_pred eEEEEEE-EcCCCEEEEEEecchhhhhHHHHHHHHHHHhhcCCCcceeEeeeEee----CCeeEEEEEccCCC-CHHHHh
Q 001710 744 GLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN----IDFKALVLEFMPNG-SFEKWL 817 (1022)
Q Consensus 744 g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~~~~g-~L~~~l 817 (1022)
.+.|++. ..||..|++|+++............-++.++++.|+|+|+|.+++.. +...++||+|.++. +|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5779997 45899999999955443333333456889999999999999988863 34678999998864 677654
Q ss_pred hhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEecCCCcEEEeeccCceecCC
Q 001710 818 YSY--------------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 818 ~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 883 (1022)
... +...++...+.++.|+..||.++|+ .|..-+-+.+.+|+++.+.+++|+.-|.......
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs----sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS----SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh----cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 321 1246778999999999999999999 7888899999999999999999988777655433
Q ss_pred CCCceeeecccCCcccCCccccCCCCCCccchhHhHHHHHHHHHcCCC
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKK 931 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~ 931 (1022)
+.. |.+.+ -.+-|.-.+|.+++.+.||..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 220 11111 135789999999999999854
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-08 Score=102.73 Aligned_cols=112 Identities=21% Similarity=0.282 Sum_probs=68.1
Q ss_pred ccCCCCCCeeecccccccCCCC-cccc-CCCcccEEEeccccccC--CChhhhcCcCCCCEEEccCccccCcCCcccccc
Q 001710 191 LSECTHLQTLWLADNKFSGRLP-ENIG-NLSQLTDLNLAQNNLQG--DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNI 266 (1022)
Q Consensus 191 l~~l~~L~~L~L~~N~l~~~~p-~~l~-~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 266 (1022)
++....++.|.+.++.|..... ..|+ .++.+++|||.+|+|+. .+...+.+++.|++|+|+.|++...+-..-..+
T Consensus 41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~ 120 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL 120 (418)
T ss_pred eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence 3344455566666666543221 1233 35778889999998873 455667889999999999999875443221345
Q ss_pred cccceeecccceeeeeccccccCCCCCccEEEccCc
Q 001710 267 STIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302 (1022)
Q Consensus 267 ~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~~L~L~~N 302 (1022)
.+|+.|-|.+..+...-..++...+|.++.|.++.|
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N 156 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDN 156 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccc
Confidence 566666666655554444444444555555555555
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-09 Score=122.07 Aligned_cols=123 Identities=29% Similarity=0.349 Sum_probs=53.8
Q ss_pred cceeeccCcccccccCCcc-ccccccceecccccccccCCccccCCCCCCeeecccccccCCCCc-cccCCCcccEEEec
Q 001710 150 LEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPE-NIGNLSQLTDLNLA 227 (1022)
Q Consensus 150 L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~ 227 (1022)
|...+.+.|.+. .....+ -++.|+.|+|+.|+++.. +.+..++.|++|||++|.+. .+|. ....+ +|..|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 444455555554 222222 244555555555555432 24445555555555555554 2222 11122 25555555
Q ss_pred cccccCCChhhhcCcCCCCEEEccCccccCcCC-cccccccccceeeccccee
Q 001710 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVP-PTIFNISTIRLINLIENQL 279 (1022)
Q Consensus 228 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l 279 (1022)
+|.++.. ..+.+|++|+.|||++|-|.+--. ..+..|..|+.|+|.+|.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 5555422 234455555555555555442111 1122334444444444444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-06 Score=89.55 Aligned_cols=106 Identities=24% Similarity=0.279 Sum_probs=84.7
Q ss_pred HHHHHHHHHHhhcCCCc--ceeEeeeEeeC----CeeEEEEEccCCC-CHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 001710 771 RTFDSECEILRNVRHRN--LVKIFSSCCNI----DFKALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843 (1022)
Q Consensus 771 ~~~~~E~~~l~~l~h~~--iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L 843 (1022)
....+|.+.+.++...+ .++.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45778888888885433 34555555442 2458999999985 79999887443 56677888999999999999
Q ss_pred HhcCCCCCeEecCCCCCcEEecCCC---cEEEeeccCceec
Q 001710 844 HHGHSLAPIVHCDLKPNNILLDENM---TAHVSDFGISKLL 881 (1022)
Q Consensus 844 H~~~~~~~ivH~Dik~~NIll~~~~---~~kl~DfG~a~~~ 881 (1022)
|+ .||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H~----~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HD----AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH----CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 8999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1022 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 2e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 547 bits (1411), Expect = 0.0
Identities = 188/635 (29%), Positives = 285/635 (44%), Gaps = 26/635 (4%)
Query: 45 ISCGARHHRVVALNLSSFSLGGIIPPHL---GNLSFLVSLDISENNFYGHLPNELGKLRR 101
+S G + + + L+LS+ S+ G L L IS N G + + +
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 102 LRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS 161
L ++ + N S P +G S LQ L N + + ++L+ L++ N
Sbjct: 202 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260
Query: 162 GSLPNDIRLPKLEKLYLGSNDFFGQIPSSLS-ECTHLQTLWLADNKFSGRLPENIGNLSQ 220
G +P L L+ L L N F G+IP LS C L L L+ N F G +P G+ S
Sbjct: 261 GPIPPLP-LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 221 LTDLNLAQNNLQGDMPT-AIGNLQMLEHLNLGMNNLSGPVPPTIFNIST-IRLINLIENQ 278
L L L+ NN G++P + ++ L+ L+L N SG +P ++ N+S + ++L N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 279 LSGHLPLTLGHS-LPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFG 337
SG + L + L+ L L N G IP +++N S+L+ L LS N SG IP + G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 338 NLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSA 397
+L LR L L N L L ++L L L+ N L G +P + N +
Sbjct: 440 SLSKLRDLKLWLNMLE--------GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT- 490
Query: 398 SLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDL 457
+L L G IP+ IG L L LKL +N +G IP +G + L L L N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 458 QGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYS--IPSSLWS 515
G+IP + + N ++G + + +E H N L + L
Sbjct: 551 NGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 516 LEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGN 575
L N++S G + + ++ LD+S N LSG IP I + L L+L N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 576 QFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPF 635
+G IP+ G L L LD+SSN + G+IP+++ AL L ++++S N L G IP G F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 636 RNFSAQSFSGNYALCGPPRLQVPPCKEDKGKGSKK 670
F F N LCG P + P D ++
Sbjct: 727 ETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = e-168
Identities = 189/661 (28%), Positives = 309/661 (46%), Gaps = 38/661 (5%)
Query: 2 ATVINNLTTDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSS 61
A+ +L + L++FK + D ++L + WS + C + G++C R +V +++LSS
Sbjct: 4 ASPSQSLYREIHQLISFKDVLPDK-NLLPD-WSSNKNPCTFDGVTC--RDDKVTSIDLSS 59
Query: 62 FSL---GGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPS 118
L + L +L+ L SL +S ++ G + L ++ + N LSG +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT 118
Query: 119 --WIGILSRLQILSFHNNSFTDRIPD-FLLNLSKLEFLDLMENSLSGSLPNDIR----LP 171
+G S L+ L+ +N+ L L+ LE LDL NS+SG+
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
+L+ L + N G + +S C +L+ L ++ N FS +P +G+ S L L+++ N L
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSL 291
GD AI L+ LN+ N GP+PP + +++ ++L EN+ +G +P L +
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGAC 293
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP-HTFGNLRFLRFLNLMFN 350
L L L GN+ G +P + S L L LSSN FSG +P T +R L+ L+L FN
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 351 SLTTESSPADQWSFLSSLTNCR-SLTELALNVNPLRGILPPFIGNFSA-SLRKFEAIKCE 408
+ SLTN SL L L+ N G + P + +L++
Sbjct: 354 EFSG--------ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL 468
G IP + N S L+ L L N L+GTIP+++G +L+ L L+ N L+G IP L ++
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
+ L L+L+ N+L+G IP+ L + T+L + L +N LT IP + LE + + LS+NS
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
SG +P+ + + LI LDL+ N +G IP + + +A N G +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKND 581
Query: 589 ISLESLDVSSN--NISGKIPKSLEALLYLKKLNVSYNRLEGEIPIK-GPFRNFSAQSFSG 645
+ + N G + L L N++ G + S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 646 N 646
N
Sbjct: 642 N 642
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-105
Identities = 90/627 (14%), Positives = 192/627 (30%), Gaps = 83/627 (13%)
Query: 27 SVLANNWSISYPICNWV---GISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDI 83
+ NW+ + + W G+S + RV L+L F G +P +G L+ L L +
Sbjct: 54 TQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 84 SENNFYG----HLPNELGKLRRLRLINFAYNELSGSFPSWIG--ILSRLQILSFHNNSFT 137
+ P + +F + S L +++
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 138 DRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTH 196
I K + + N+++ + + RL KL + Y+G++ F + E +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
Query: 197 LQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL- 255
+ + NL LTD+ + +PT + L ++ +N+ N
Sbjct: 232 SEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 256 -------SGPVPPTIFNISTIRLINLIENQL-SGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
I++I + N L + + +L + L L N L G
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK-MKKLGMLECLYNQLEGK 345
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
+P + + KL L+L+ N + + G + L+ N L +
Sbjct: 346 LP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNI-------FD 397
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
+ ++ + + N + + + + +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDP------------------LDPTPFKGINVSSIN 439
Query: 428 LDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG-------SIPYYLCHLERLSQLLLNGNN 480
L +N+++ L ++L N L + L+ + L N
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 481 LSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQH 539
L+ +L L + L N+ + P+ + S+++
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNS------------------STLKG 540
Query: 540 LKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSN 599
+ D N+ + P I+ L L + N + E ++ LD+ N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 600 NISGKIPKSLEALLYLKKLNVSYNRLE 626
+ + + Y++ +
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 32/239 (13%), Positives = 78/239 (32%), Gaps = 12/239 (5%)
Query: 407 CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG----SIP 462
+ + + L L+ +G +P +G+ +L+ L+L + + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 463 YYLCHLERLSQLLLNGNNLSGAIPACLG--SLTSLRELHLGSNTLTYSIPSSLWSLEYIL 520
+ Q + + L + + S+ SI S
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 521 YVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGP 580
+ SN+++ + ++ L L + + + ++
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-----YKT 240
Query: 581 IPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
+ +L L ++V + K+P L+AL ++ +NV+ NR +K ++ +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-103
Identities = 132/613 (21%), Positives = 216/613 (35%), Gaps = 28/613 (4%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
+P L + + L+++ N + +L ++ +N +S P L L+
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEKLYLGSNDFFGQ 186
+L+ +N + + L L LM NS+ N L L L N
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIG--NLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
+ + +LQ L L++NK E + S L L L+ N ++ P +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
Query: 245 LEHLNLGMNNLSGPVPPTIF---NISTIRLINLIENQLSGHLPLTLGH-SLPNLEFLTLF 300
L L L L + + ++IR ++L +QLS T NL L L
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
NNL +S +L L N H+ L +R+LNL + S A
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 361 QWSF-LSSLTNCRSLTELALNVNPLRGILPPFIGNFSA----SLRKFEAIKCELKGSIPQ 415
S + L L + N + GI SL L
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY-LCHLERLSQL 474
+ + S L L L N+++ L+ L L N++ + LE + ++
Sbjct: 377 SLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSNTLTY--SIPSSLWSLEYILYVNLSSNSLSGP 532
L+ N + SL+ L L L S PS L + ++LS+N+++
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 533 LPSSIQHLKVLINLDLSRNQLS--------GDIPITISGLKDLATLSLAGNQFNGPIPES 584
++ L+ L LDL N L+ G + GL L L+L N F+ E
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP--IKGPFRNFSAQS 642
F L L+ +D+ NN++ + LK LN+ N + FRN +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 643 FSGNYALCGPPRL 655
N C +
Sbjct: 616 MRFNPFDCTCESI 628
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = 6e-98
Identities = 116/603 (19%), Positives = 201/603 (33%), Gaps = 43/603 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L++ ++ + P L L L++ N L ++ N +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR---LPKL 173
+ L L +N + + L L+ L L N + ++ L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 174 EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIG---NLSQLTDLNLAQNN 230
+KL L SN P L L+L + + L E + + + +L+L+ +
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 231 LQGDMPTAIGNLQM--LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
L T L+ L L+L NNL+ + + + L N + +L
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL- 292
Query: 289 HSLPNLEFLTLFGN---------NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNL 339
H L N+ +L L + +L S L L++ N G + F L
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 340 RFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASL 399
L++L+L + + + + + L+ L L L N + I L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAH----SPLHILNLTKNKISKIESDAFSWLG-HL 407
Query: 400 RKFEAIKCELKGSIP-QEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQ 458
+ E+ + QE L + + L N+ + LQ L L L+
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 459 G--SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
S P L L+ L L+ NN++ L L L L L N L
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR--------- 518
Query: 517 EYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
L ++ G ++ L L L+L N L +L + L N
Sbjct: 519 -------LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLY-LKKLNVSYNRLEGEIPIKGPF 635
N F + +SL+SL++ N I+ K L +L++ +N + F
Sbjct: 572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631
Query: 636 RNF 638
N+
Sbjct: 632 VNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 9e-83
Identities = 108/523 (20%), Positives = 192/523 (36%), Gaps = 31/523 (5%)
Query: 125 RLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDF 183
++ + T ++PD L + + L+L N L + R +L L +G N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 184 FGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQ 243
P + L+ L L N+ S + + LT+L+L N++Q +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 244 MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH-SLPNLEFLTLFGN 302
L L+L N LS T + ++ + L N++ L + +L+ L L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 303 NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFG---NLRFLRFLNLMFNSLTTESSPA 359
+ P +L GL L++ + +R L+L + L+T S+
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 360 DQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGN 419
L +LT L L+ N L + L F ++ +
Sbjct: 242 -----FLGL-KWTNLTMLDLSYNNLNVVGNDSFAWLP-QLEYFFLEYNNIQHLFSHSLHG 294
Query: 420 LSGLMFLKLDDN---------ELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLER 470
L + +L L + L + + L+ L++ DND+ G L
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354
Query: 471 LSQLLLNGNNLSGA--IPACLGSL--TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSS 526
L L L+ + S SL + L L+L N ++ + L ++ ++L
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 527 NSLSGPLP-SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG--PIPE 583
N + L + L+ + + LS N+ + + + L L L P
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 584 SFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
F L +L LD+S+NNI+ LE L L+ L++ +N L
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-39
Identities = 73/318 (22%), Positives = 118/318 (37%), Gaps = 27/318 (8%)
Query: 29 LANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNF 88
L+N+++ + N +S H + LNL+ + I L L LD+ N
Sbjct: 360 LSNSFTSLRTLTNETFVSLA--HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 89 YGHLP-NELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFT--DRIPDFLL 145
L E L + I +YN+ + ++ LQ L + D P
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 146 NLSKLEFLDLMENSLSGSLPNDIR-LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLAD 204
L L LDL N+++ + + L KLE L L N +L LW
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN--------------NLARLW--K 521
Query: 205 NKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF 264
+ G + LS L LNL N +L L+ ++LG+NNL+
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 265 NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPN-----SITNASKLI 319
N +++ +NL +N ++ G + NL L + N T + + N +
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTN 641
Query: 320 GLDLSSNLFSGHIPHTFG 337
+LSS+ PH G
Sbjct: 642 IPELSSHYLCNTPPHYHG 659
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-38
Identities = 51/265 (19%), Positives = 93/265 (35%), Gaps = 11/265 (4%)
Query: 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNE 432
S + L + P + ++ +L+ S L L + N
Sbjct: 5 SHEVADCSHLKLTQV-PD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 433 LNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSL 492
++ P + L+ L+L N+L L++L L N++
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 493 TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQ--HLKVLINLDLSR 550
+L L L N L+ + + LE + + LS+N + + L L+LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 551 NQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFG---SLISLESLDVSSNNISGKIPK 607
NQ+ P + L L L Q + E + S+ +L +S++ +S
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 608 SLEALLY--LKKLNVSYNRLEGEIP 630
+ L + L L++SYN L
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGN 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-30
Identities = 46/196 (23%), Positives = 72/196 (36%), Gaps = 7/196 (3%)
Query: 446 QLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTL 505
+ L +P L ++ L L N L A + L L +G NT+
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 506 TYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLK 565
+ P L + +NL N LS + L L L N + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 566 DLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEAL--LYLKKLNVSYN 623
+L TL L+ N + + L +L+ L +S+N I + L+ LKKL +S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 624 RLEGEIPIKGPFRNFS 639
+++ P G F
Sbjct: 182 QIKEFSP--GCFHAIG 195
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 5e-92
Identities = 117/587 (19%), Positives = 194/587 (33%), Gaps = 57/587 (9%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
IP +L +LD+S N L++++ + E+ LS L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEKLYLGSNDF-FG 185
L N LS L+ L +E +L+ I L L++L + N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
++P S T+L+ L L+ NK ++ L Q+ LNL
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL------------------- 180
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN--- 302
L+L +N ++ + P F + + L N S ++ T L LE L
Sbjct: 181 -SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 303 ---NLIGTIPNSITNASKLIGLDLSSN---LFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
NL +++ L + + I F L + +L+ ++
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-- 296
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQE 416
+ + L L + + L KG
Sbjct: 297 --------VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK-RLT-----FTSNKGGNAFS 342
Query: 417 IGNLSGLMFLKLDDNELN--GTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
+L L FL L N L+ G + L+ L L N + + LE+L L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 401
Query: 475 LLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPL 533
+NL SL +L L + + L + + ++ NS
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 534 -PSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLE 592
P L+ L LDLS+ QL P + L L L+++ N F + L SL+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 593 SLDVSSNNISGKIPKSLEALLY-LKKLNVSYNRLEGEIPIKGPFRNF 638
LD S N+I + L+ L LN++ N + F +
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ-SFLQW 567
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 7e-73
Identities = 111/520 (21%), Positives = 178/520 (34%), Gaps = 48/520 (9%)
Query: 154 DLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPE 213
ME + +P+++ + L L N S LQ L L+ +
Sbjct: 13 QCMELNFY-KIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 214 NIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLIN 273
+LS L+ L L N +Q A L L+ L NL+ I ++ T++ +N
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 274 LIENQL-SGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKL----IGLDLSSNLF 328
+ N + S LP + L NLE L L N + + ++ + LDLS N
Sbjct: 131 VAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 329 SGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGIL 388
+ P F +R L L L N + + + L L L G L
Sbjct: 190 NFIQPGAFKEIR-LHKLTLRNNFDSLNVMK----TCIQGLAGLEVH-RLVLGEFRNEGNL 243
Query: 389 PPFIGNFSASLRKFEAIKCELK------GSIPQEIGNLSGLMFLKLDDNELNGTIPTTVG 442
F + L + L I L+ + L +
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FS 301
Query: 443 RFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNL--------------------- 481
Q L L + L L+RL+ G N
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 482 SGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI-QHL 540
G TSL+ L L N + ++ S+ LE + +++ ++L S+ L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 541 KVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI-PESFGSLISLESLDVSSN 599
+ LI LD+S +GL L L +AGN F P+ F L +L LD+S
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 600 NISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
+ P + +L L+ LN+S+N P++ +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-45
Identities = 67/338 (19%), Positives = 108/338 (31%), Gaps = 23/338 (6%)
Query: 58 NLSSFSLGGIIPPHLGNLSFLVSLDISENN------FYGHLPNELGKLRRLRLINFAYNE 111
+ G + L L +L I E + + + L + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 112 LSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLP 171
+ Q L N F L +L +L F + + LP
Sbjct: 294 IERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD----LP 347
Query: 172 KLEKLYLGSND--FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
LE L L N F G S T L+ L L+ N + N L QL L+ +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 230 NLQGDMPT-AIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
NL+ +L+ L +L++ + +S++ ++ + N + +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 289 HSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLM 348
L NL FL L L P + + S L L++S N F + L L+ L+
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 349 FNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRG 386
N + T L SL L L N
Sbjct: 527 LNHIMTSKK-----QELQHF--PSSLAFLNLTQNDFAC 557
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 7e-85
Identities = 104/306 (33%), Positives = 153/306 (50%), Gaps = 16/306 (5%)
Query: 718 RRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSEC 777
R +D++ AT+ F+ L+G G FG VYKG L DG VA+K + + F++E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLY---SYNYFLDILQRLNIMI 834
E L RH +LV + C + L+ ++M NG+ ++ LY + QRL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
A L YLH I+H D+K NILLDEN ++DFGISK E D + T+
Sbjct: 147 GAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMF-TGEMSLRRWVKESLPH 953
T+GY+ PEY +G ++ K DVYS+GV+L E + + ++L W ES +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 954 G-LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012
G L ++VD NL + + + L D A+ C S E R M D +L+
Sbjct: 263 GQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR-- 315
Query: 1013 LQQSSV 1018
LQ+S +
Sbjct: 316 LQESVI 321
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-83
Identities = 85/298 (28%), Positives = 128/298 (42%), Gaps = 32/298 (10%)
Query: 366 SSLTNCRSLTELALNVNPLRG--ILPPFIGNFSASLRKFE-AIKCELKGSIPQEIGNLSG 422
+ T + L L+ L +P + N L L G IP I L+
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 423 LMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS 482
L +L + ++G IP + + + L L N L G++P + L L + +GN +S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 483 GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKV 542
GAIP GS + L + +S N L+G +P + +L
Sbjct: 163 GAIPDSYGSFSKLFT-----------------------SMTISRNRLTGKIPPTFANLN- 198
Query: 543 LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602
L +DLSRN L GD + K+ + LA N + G +L LD+ +N I
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257
Query: 603 GKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPC 660
G +P+ L L +L LNVS+N L GEIP G + F +++ N LCG P +P C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 7e-71
Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 34/307 (11%)
Query: 10 TDQSALLAFKADVIDSRSVLANNWSISYPICNWVGISCGARHH--RVVALNLSSFSLG-- 65
D+ ALL K D+ + ++ + + W+G+ C RV L+LS +L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 66 -------------------------GIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLR 100
G IPP + L+ L L I+ N G +P+ L +++
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 101 RLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKL-EFLDLMENS 159
L ++F+YN LSG+ P I L L ++F N + IPD + SKL + + N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 160 LSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLS 219
L+G +P L + L N G + Q + LA N + L + +G
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK 244
Query: 220 QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQL 279
L L+L N + G +P + L+ L LN+ NNL G + P N+ + N+
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKC 303
Query: 280 --SGHLP 284
LP
Sbjct: 304 LCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-63
Identities = 79/335 (23%), Positives = 129/335 (38%), Gaps = 58/335 (17%)
Query: 129 LSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIP 188
N ++ + D ++ LDL +L P IP
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP---------------------IP 69
Query: 189 SSLSECTHLQTLWLAD-NKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEH 247
SSL+ +L L++ N G +P I L+QL L + N+ G +P + ++ L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 248 LNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
L+ N LSG +PP+I ++ + I N++SG +P + G +T+ N L G
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
IP + N + L +DLS N+ G FG+ + + ++L NSL + L
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD---------LGK 239
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
+ ++L L L N G++PQ + L L L
Sbjct: 240 VGLSKNLNGLDLRNN-----------RIY--------------GTLPQGLTQLKFLHSLN 274
Query: 428 LDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP 462
+ N L G IP G Q+ + +N P
Sbjct: 275 VSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 4/156 (2%)
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTL--TYSIPSSLWSLEYILYVNLSS-NSLSGPLPS 535
G + + L L L Y IPSSL +L Y+ ++ + N+L GP+P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLD 595
+I L L L ++ +SG IP +S +K L TL + N +G +P S SL +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 596 VSSNNISGKIPKSLEALLYL-KKLNVSYNRLEGEIP 630
N ISG IP S + L + +S NRL G+IP
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-82
Identities = 115/314 (36%), Positives = 160/314 (50%), Gaps = 22/314 (7%)
Query: 705 VPVKED-VLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFN 763
VP +ED + L +R S ++Q A+D F+ N+LGRG FG VYKG L DGT VA+K
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 764 LQ----LERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLY- 818
+ E F+T E E++ HRNL+++ C + LV +M NGS L
Sbjct: 64 EERTQGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 819 --SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG 876
LD +R I + A L YLH H I+H D+K NILLDE A V DFG
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 877 ISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
++KL+ D VT T TIG++APEY S G S K DV+ YGV+L+E T ++ D
Sbjct: 180 LAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 937 FTGE---MSLRRWVKESLPHG-LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESP 992
+ L WVK L L +VD +L G + + + ++ +AL C SP
Sbjct: 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN---YKDE--EVEQLIQVALLCTQSSP 293
Query: 993 EQRIHMTDAAAELK 1006
+R M++ L+
Sbjct: 294 MERPKMSEVVRMLE 307
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 284 bits (727), Expect = 7e-82
Identities = 103/671 (15%), Positives = 191/671 (28%), Gaps = 110/671 (16%)
Query: 10 TDQSALLAFKA----------DVIDSRSVLANNWSISYPICNWVGISCGARHH--RVVAL 57
D AL A + ++ + NW+ + + W + RV L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 58 NLSSFSLGGIIPPHLGNLSFLVSLDISENN-------FYGHLPNELGKLRRLRLINFAYN 110
+L+ F G +P +G L+ L L ++ F R I Y
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 111 ELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-R 169
++ + + + LQ N D ++L + +L N ++ + I R
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL-TNRIT-FISKAIQR 446
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
L KL+ +Y ++ F + + + K + NL LTD+ L
Sbjct: 447 LTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 230 NLQGDMPTAIGNLQMLEHLNLGMNNLSGP---------VPPTIFNISTIRLINLIENQLS 280
+P + +L L+ LN+ N + I++ + N L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 281 G-HLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNL 339
+L + L L N + + KL L L N
Sbjct: 562 EFPASASLQK-MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFT 618
Query: 340 RFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASL 399
+ L N L + + + + + + N +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIF-------NAKSVYVMGSVDFSYNKIGSEGR---------- 661
Query: 400 RKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG 459
S + + L NE+ + + L +N +
Sbjct: 662 ----------NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT- 710
Query: 460 SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSL--WSLE 517
SIP N + L + L N LT S+ +L
Sbjct: 711 SIP----------------ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
Query: 518 YILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQF 577
Y+ +++S N S P+ + L + GN+
Sbjct: 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ------------------RDAEGNRI 794
Query: 578 NGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL-EGEIPIKGPFR 636
P + SL L + SN+I K+ + L L L+++ N ++ P+
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851
Query: 637 NFSAQSFSGNY 647
+
Sbjct: 852 EAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 4e-64
Identities = 83/609 (13%), Positives = 191/609 (31%), Gaps = 65/609 (10%)
Query: 73 GNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFH 132
+ L + ++ N + I A + + P+ + +
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTT---Y 224
Query: 133 NNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPK----------LEKLYLGSND 182
+ S R ++ F +++N L+ I+L + L+ ++ +
Sbjct: 225 SQSGIKRSELETQSVRGESF-TVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDG 283
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFS---GRLPENIGNLSQLTDLNLAQNNLQGDMPTAI 239
+ S T W + + + ++ N ++T L+LA +G +P AI
Sbjct: 284 KNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAI 343
Query: 240 GNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTL 299
G L L+ L+ G ++ + T + ++++ H L L
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403
Query: 300 FGN-----NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
+ + I + K + +N + I L L+ + + T
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT- 461
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP 414
+ + N L E C +P
Sbjct: 462 ------------YDNIAVDWEDANSDYAKQYENEELSWSNLK-DLTDVELYNCPNMTQLP 508
Query: 415 QEIGNLSGLMFLKLDDNELNG---------TIPTTVGRFQQLQGLSLYDNDLQG-SIPYY 464
+ +L L L + N + ++Q + N+L+
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 465 LCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVN 523
L + +L L N + + A G+ L +L L N + IP + + + +
Sbjct: 569 LQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 524 LSSNSLSG-PLPSSIQHLKVLINLDLSRNQLSGDIP-----ITISGLKDLATLSLAGNQF 577
S N L P + + + V+ ++D S N++ + + + +T++L+ N+
Sbjct: 626 FSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 578 NGPIPESFGSLISLESLDVSSNNIS-------GKIPKSLEALLYLKKLNVSYNRLEGEIP 630
E F + + ++ +S+N ++ + + L +++ +N+L +
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744
Query: 631 IKGPFRNFS 639
Sbjct: 745 DDFRATTLP 753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-79
Identities = 120/584 (20%), Positives = 196/584 (33%), Gaps = 52/584 (8%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
IP L + L+ S N +L L ++ ++ RL
Sbjct: 27 IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEKLYLGSNDFFGQ 186
L N L L+ L ++ +S + LE LYLGSN
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLT--DLNLAQNNLQGDMPTAIGNLQM 244
L+ L +N E++ +L Q T LNL N++ G + + +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAV 203
Query: 245 LEHLNLGMNNLSGPVPPTIFN--ISTIRLINLIENQLSGHLPLTL-GHSLPNLEFLTLFG 301
+ LN G + + N I ++ L + P G ++E + L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 302 NNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ 361
+ N+ S L LDL++ S +P L L+ L L N
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ---- 318
Query: 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLS 421
S +N SLT L++ N R L + NL
Sbjct: 319 ----ISASNFPSLTHLSIKGNTKRLELGTGC------------------------LENLE 350
Query: 422 GLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNG 478
L L L +++ T + + LQ L+L N+ +L L L
Sbjct: 351 NLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 479 NNLSGAIP-ACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG---PLP 534
L + +L L+ L+L + L S L + ++NL N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 535 SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
+S+Q L L L LS LS + LK + + L+ N+ E+ L + L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNF 638
+++SN+IS +P L L + +N+ N L+ F +
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI-YFLEW 571
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 8e-76
Identities = 112/558 (20%), Positives = 185/558 (33%), Gaps = 45/558 (8%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L S L I L L LD++ Y + RL + N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEK 175
+ + L+ L F + L N LE L L N +S KL+
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKV 157
Query: 176 LYLGSNDFFGQIPSSLSECTHLQ--TLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233
L +N +S +L L N +G + + + LN
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLL 216
Query: 234 DMPTAIGN--LQMLEHLNLGMNNLSGPVPPTIFNISTIRL--INLIENQLSGHLPLTLGH 289
+ + N +Q L + P + + + INL ++ T
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMF 349
L+ L L + + +P+ + S L L LS+N F + N L L++
Sbjct: 277 -FSGLQELDLTATH-LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
N+ E L N +L EL L+ + +
Sbjct: 335 NTKRLELGT-------GCLENLENLRELDLSHDDIETS---------------------- 365
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY-LCHL 468
++ NLS L L L NE QL+ L L L+ +L
Sbjct: 366 -DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSI---PSSLWSLEYILYVNLS 525
L L L+ + L + L +L+ L+L N +SL +L + + LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF 585
LS + LK++ ++DLS N+L+ +S LK + L+LA N + +P
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLL 543
Query: 586 GSLISLESLDVSSNNISG 603
L ++++ N +
Sbjct: 544 PILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-71
Identities = 106/515 (20%), Positives = 174/515 (33%), Gaps = 23/515 (4%)
Query: 127 QILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFG 185
+ + N IP L + E L+ N L RL L L L +
Sbjct: 15 KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+ L TL L N + L L Q + + N + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTL-FGNNL 304
E L LG N++S P F +++++ N + + L L+L N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQATNLSLNLNGND 190
Query: 305 IGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRF--LRFLNLMFNSLTTESSPADQW 362
I I +++ L+ I N L S
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV--- 247
Query: 363 SFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSG 422
L S+ + L + I FS L++ + L +P + LS
Sbjct: 248 --FEGLCEM-SVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-ELPSGLVGLST 302
Query: 423 LMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY-LCHLERLSQLLLNGNNL 481
L L L N+ + F L LS+ N + + L +LE L +L L+ +++
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362
Query: 482 --SGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG-PLPSSIQ 538
S L +L+ L+ L+L N + + ++L+ L S Q
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 539 HLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI---PESFGSLISLESLD 595
+L +L L+LS + L GL L L+L GN F S +L LE L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 596 VSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
+S ++S + +L + +++S+NRL
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-51
Identities = 91/462 (19%), Positives = 170/462 (36%), Gaps = 27/462 (5%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFL--VSLDISENNFYGHLPNELGKLRRLRLINFAYNELSG 114
L+ + ++ + + +L +SL+++ N+ + + +NF +
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLL 216
Query: 115 SFPSWIGI--LSRLQILSFHNNSFTDRIPDFLLNLSK--LEFLDLMENSLSGSLPNDIR- 169
+ + L + +F + D P L + +E ++L ++ N
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
L++L L + ++PS L + L+ L L+ NKF + N LT L++ N
Sbjct: 277 FSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 230 NLQGD-MPTAIGNLQMLEHLNLGMNNL--SGPVPPTIFNISTIRLINLIENQLSGHLPLT 286
+ + + NL+ L L+L +++ S + N+S ++ +NL N+ L
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTE 394
Query: 287 LGHSLPNLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFL 345
P LE L L L S N L L+LS +L F L L+ L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
Query: 346 NLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAI 405
NL N + +SL L L L+ L I + + +
Sbjct: 455 NLQGNHFPKGN-----IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK-MMNHVDLS 508
Query: 406 KCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYL 465
L S + + +L G+ +L L N ++ +P+ + Q + ++L N L +
Sbjct: 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT----- 562
Query: 466 CHLERLSQ-LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLT 506
C + N L + LR + L TL+
Sbjct: 563 CSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-43
Identities = 71/314 (22%), Positives = 115/314 (36%), Gaps = 11/314 (3%)
Query: 48 GARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINF 107
G V ++NL I S L LD++ + LP+ L L L+ +
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVL 308
Query: 108 AYNELSGSFPSWIGILSRLQILSFHNNSFTDRI-PDFLLNLSKLEFLDLMENSLSGSLPN 166
+ N+ L LS N+ + L NL L LDL + + S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 167 DI---RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLT 222
++ L L+ L L N+ + EC L+ L LA + + ++ NL L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 223 DLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG--PVPPTIF-NISTIRLINLIENQL 279
LNL+ + L L L+HLNL N+ + + ++ L L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 280 SGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNL 339
S L + + L N L + ++++ + L+L+SN S +P L
Sbjct: 489 SSIDQHAFTS-LKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPIL 546
Query: 340 RFLRFLNLMFNSLT 353
R +NL N L
Sbjct: 547 SQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 44/237 (18%), Positives = 81/237 (34%), Gaps = 9/237 (3%)
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHL 468
L L L FL L ++ T +L L L N L L
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
+ L L +S L + +L L+LGSN ++ + E + ++ +N+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 529 LSGPLPSSIQHLKVL--INLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPE--S 584
+ + L+ ++L+L+ N ++G I +L+ G Q I +
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEAL--LYLKKLNVSYNRLEGEIPIKGPFRNFS 639
++ SL + P E L + ++ +N+ + F FS
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS--NTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 41/216 (18%), Positives = 69/216 (31%), Gaps = 6/216 (2%)
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
++ LN IP T+ + L N L L L+ L L +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
S L L L +N L + ++L + + ++ +S + + K L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLE--SLDVSSNNISG 603
L L N +S + L L N + E SL SL+++ N+I+G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 604 KIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
I + LN + I
Sbjct: 194 -IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 40/207 (19%), Positives = 71/207 (34%), Gaps = 5/207 (2%)
Query: 450 LSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSI 509
+ + L IP L L + N L L +L L L + +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 510 PSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLAT 569
+ S + + L++N L +++ K L +L + +S I + K L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 570 LSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEAL--LYLKKLNVSYNRLEG 627
L L N + L+ LD +N I + + +L LN++ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 628 EIPIKGPFRNFSAQSFSGNYALCGPPR 654
P F + +F G L +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-75
Identities = 105/579 (18%), Positives = 179/579 (30%), Gaps = 42/579 (7%)
Query: 66 GIIPPHLGNLSFLVSLDISENNFYGHLPNELGK-LRRLRLINFAYNELSGSFPSWIGILS 124
G + P + + + + + +P+++ + + L ++N L S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSSTKNIDL---SFNPLKILKSYSFSNFS 56
Query: 125 RLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEKLYLGSNDF 183
LQ L L L L L N + P L LE L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 184 FGQIPSSLSECTHLQTLWLADNKFSG-RLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNL 242
+ + L+ L +A N +LP NL+ L ++L+ N +Q + L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 243 QML----EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLT 298
+ L++ +N + + F + + L N S ++ T +L L
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 299 LFGNNLIGTIPNSITNASKLIGL--------DLSSNLFSGHIPHTFGNLRFLRFLNLMFN 350
L I S + GL L+ F L + ++L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 351 SLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELK 410
S+ L + L++ L+ + L+ K
Sbjct: 296 SIKY----------LEDVPKHFKWQSLSIIRCQLKQFPTLDLPF----LKSLTL--TMNK 339
Query: 411 GSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ--QLQGLSLYDNDLQGSIPYYLCHL 468
GSI + L L +L L N L+ + + L+ L L N + L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 469 ERLSQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
E L L + L SL L L + L + + ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 528 SLSGPLPSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFG 586
S S++ + L LDLS+ QL L L L+++ N +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 587 SLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
L SL +LD S N I L N++ N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 7e-66
Identities = 109/528 (20%), Positives = 187/528 (35%), Gaps = 26/528 (4%)
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPK 172
GS I ++ + + + ++PD + S + +DL N L +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 173 LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQ 232
L+ L L + + HL L L N P + L+ L +L + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 233 GDMPTAIGNLQMLEHLNLGMNNLSG-PVPPTIFNISTIRLINLIENQLSGHLPLTLGHSL 291
IG L L+ LN+ N + +P N++ + ++L N + + + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFL 176
Query: 292 PNLEFLTL---FGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP-HTFGNLRFLRFLNL 347
+ L N I I + KL L L N S +I NL L L
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 348 MFNSLTTESSPAD-QWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIK 406
+ E + + S + L + ++ E L + ++
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVKFHCLA-NVSAMSLAG 294
Query: 407 CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC 466
+ +++ L + +L L+ L+L N +GSI +
Sbjct: 295 VSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMN--KGSISFKKV 347
Query: 467 HLERLSQLLLNGNNLSGAIPACL--GSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNL 524
L LS L L+ N LS + SLR L L N + ++ LE + +++
Sbjct: 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDF 406
Query: 525 SSNSLSG-PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPE 583
++L S+ L+ L+ LD+S D GL L TL +AGN F
Sbjct: 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
Query: 584 S-FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
+ F + +L LD+S + + L L+ LN+S+N L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 61/332 (18%), Positives = 106/332 (31%), Gaps = 20/332 (6%)
Query: 59 LSSFSLGGIIPPHLGNLSFLV--SLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
+L P + L + ++ N + + L + ++ A +
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YL 300
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
+ Q LS P L+L L+ L L N S + LP L L
Sbjct: 301 EDVPK-HFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS-ISFKKVALPSLSYL 355
Query: 177 YLGSN--DFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG- 233
L N F G S L+ L L+ N + N L +L L+ + L+
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
+A +L+ L +L++ N ++++ + + N + + + N
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
L FL L L +L L++S N + L L L+ FN +
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 354 TESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
T +SL L N +
Sbjct: 535 TSKG--------ILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 5/157 (3%)
Query: 483 GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKV 542
G++ C+ + ++ L+ +P + ++LS N L S +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 543 LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602
L LDLSR ++ GL L+ L L GN P SF L SLE+L ++
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 603 GKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
+ L+ LKKLNV++N + + F N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 8e-71
Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 27/302 (8%)
Query: 721 SYLDIQRATDGFNE------CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERA----F 770
S+ +++ T+ F+E N +G G FG+VYKG + + T VA+K ++
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 771 RTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF--LDILQ 828
+ FD E +++ +H NLV++ + D LV +MPNGS L + L
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 829 RLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888
R I A + +LH +H D+K NILLDE TA +SDFG+++ + +V
Sbjct: 135 RCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
+ + T YMAPE G ++ K D+YS+GV+L+E T DE L +
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKE 248
Query: 949 ESL--PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
E + + +D + + + ++ +A C E +R + L+
Sbjct: 249 EIEDEEKTIEDYIDKKMND----ADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 1007 KI 1008
++
Sbjct: 303 EM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-60
Identities = 62/306 (20%), Positives = 116/306 (37%), Gaps = 22/306 (7%)
Query: 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEIL 780
++ + + RG FG V+K VA+K+F +Q +++++ + E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 781 RNVRHRNLVKIFSSCCNIDFKA----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
++H N+++ + L+ F GS +L + + +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETM 130
Query: 837 ALVLEYLH------HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
A L YLH I H D+K N+LL N+TA ++DFG++ G +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 891 TITMATIGYMAPEYGSEGI-----VSAKCDVYSYGVLLMETFTRKKPTDEMFTG-EMSLR 944
+ T YMAPE I + D+Y+ G++L E +R D +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 945 RWVKE--SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAA 1002
+ + SL VV + + K + + + +C E R+
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 1003 AELKKI 1008
+ ++
Sbjct: 311 ERITQM 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-57
Identities = 111/488 (22%), Positives = 183/488 (37%), Gaps = 19/488 (3%)
Query: 148 SKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNK 206
+ LDL N L P+L+ L L + + +HL TL L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 207 FSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL-SGPVPPTIFN 265
LS L L + NL IG+L+ L+ LN+ N + S +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 266 ISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTL---FGNNLIGTIPNSITNASKLIGLD 322
++ + ++L N++ + T L + L L N + I +L L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 323 LSSNLFSGHIPHT-FGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNV 381
L +N S ++ T L L L+ + + S+L +LT +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF--RNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 382 NPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV 441
L L I F+ + ++ G L+L + + PT
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPT-- 321
Query: 442 GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS--GAIPACLGSLTSLRELH 499
+ + L+ L+ N + L L L L+ N LS G TSL+ L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 500 LGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG-PLPSSIQHLKVLINLDLSRNQLSGDIP 558
L N + ++ S+ LE + +++ ++L S L+ LI LD+S
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 559 ITISGLKDLATLSLAGNQF-NGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKK 617
+GL L L +AGN F +P+ F L +L LD+S + P + +L L+
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 618 LNVSYNRL 625
LN++ N+L
Sbjct: 499 LNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-56
Identities = 111/587 (18%), Positives = 191/587 (32%), Gaps = 81/587 (13%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
IP +L +LD+S N L++++ + E+ LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDF-F 184
L N LS L+ L +E +L+ SL N L L++L + N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138
Query: 185 GQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
++P S T+L+ L L+ NK ++ L Q+ LNL
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL------------------ 180
Query: 245 LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFG--- 301
L+L +N ++ + P F + + L N S ++ T L LE L
Sbjct: 181 --SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 302 ---NNLIGTIPNSITNASKLIGLDLSSN---LFSGHIPHTFGNLRFLRFLNLMFNSLTTE 355
NL +++ L + + I F L + +L+ ++
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER- 296
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ 415
+ + L L P +
Sbjct: 297 ---------VKDFSYNFGWQHLELVNCKFGQF--PTL----------------------- 322
Query: 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQ--GSIPYYLCHLERLSQ 473
L L L N+ + V L+ L L N L G L
Sbjct: 323 ---KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 474 LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLW-SLEYILYVNLSSNSLSGP 532
L L+ N + + + L L L + L S++ SL ++Y+++S
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 533 LPSSIQHLKVLINLDLSRNQLSGDI-PITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
L L L ++ N + P + L++L L L+ Q P +F SL SL
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNF 638
+ L+++SN + + L L+K+ + N + P +
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-48
Identities = 101/520 (19%), Positives = 169/520 (32%), Gaps = 59/520 (11%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+LS + I +LS L +L ++ N L L+ + L+
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 117 PSWIGILSRLQILSFHNNSFTD-RIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLE 174
IG L L+ L+ +N ++P++ NL+ LE LDL N + D+R L ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 175 ----KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPEN-IGNLSQLTDLNLA-- 227
L L N I + L L L +N S + + I L+ L L
Sbjct: 177 LLNLSLDLSLN-PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 228 ----QNNLQGDMPTAIGNLQML--EHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLS 280
+ NL+ +A+ L L E L + +F ++ + +L+ +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 281 GHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLR 340
+ +LE + S L L +SN + +L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKS------LKRLTFTSNKGGNAF--SEVDLP 347
Query: 341 FLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLR 400
L FL+L N L+ + + S SL L L+ N +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQ------SDFGTTSLKYLDLSFNGVI--------------- 386
Query: 401 KFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQG 459
++ L L L + L +V + L L + +
Sbjct: 387 -----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 460 SIPYYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEY 518
+ L L L + GN+ L +L L L L P++ SL
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 519 ILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIP 558
+ +N++SN L L L + L N P
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-21
Identities = 43/174 (24%), Positives = 65/174 (37%), Gaps = 7/174 (4%)
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS 530
L L+ N L S L+ L L + + SL ++ + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 531 GPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN-GPIPESFGSLI 589
+ L L L L+ I LK L L++A N +PE F +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 590 SLESLDVSSNNISGKIPKSLEALLYLK----KLNVSYNRLEGEIPIKGPFRNFS 639
+LE LD+SSN I L L + L++S N + I G F+
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ-PGAFKEIR 201
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-15
Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 10/144 (6%)
Query: 499 HLGSNTLTY---SIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSG 555
++P S +L +LS N L S L LDLSR ++
Sbjct: 13 QCMELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 556 DIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYL 615
L L+TL L GN +F L SL+ L N++ + L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 616 KKLNVSYNRLEGEIPIKGPFRNFS 639
K+LNV++N ++ + F N +
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-57
Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 738 LGRGSFGLVYKGTLF-DGTNVAIKVFNLQ-------LERAFRTFDSECEILRNVRHRNLV 789
+G+G FGLV+KG L D + VAIK L + F+ F E I+ N+ H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
K++ + +V+EF+P G L + + +L +M+D+AL +EY+ + +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 850 APIVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE- 903
PIVH DL+ NI L + A V+DFG+S+ + + + +MAPE
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPET 197
Query: 904 -YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE-----SLPHGLTE 957
E + K D YS+ ++L T + P DE G++ ++E ++P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP----- 252
Query: 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DC + ++ C P++R H + EL ++
Sbjct: 253 ----------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-56
Identities = 75/285 (26%), Positives = 111/285 (38%), Gaps = 45/285 (15%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
+GRG+FG+V K + +VAIK + ER + F E L V H N+VK C
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK-LYGACL 71
Query: 798 IDFKALVLEFMPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
LV+E+ GS L+ + ++ + + + YLH ++H
Sbjct: 72 NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS-MQPKALIHR 129
Query: 856 DLKPNNILLDENMT-AHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIVS 911
DLKP N+LL T + DFG + + QT G +MAPE S
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI--------QTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE----SLPHGLTEVVDANLVGEE 967
KCDV+S+G++L E TR+KP DE+ + V L
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI--------------- 226
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012
+ I L C + P QR M + + + F
Sbjct: 227 ------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-55
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 29/276 (10%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G GSFG V++ + G++VA+K+ Q F E I++ +RH N+V +
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYN--YFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
++V E++ GS + L+ LD +RL++ DVA + YLH+ + PIV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP--PIV 161
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H +LK N+L+D+ T V DFG+S+L S T +MAPE + + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEK 219
Query: 914 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA-FSA 972
DVYS+GV+L E T ++P + ++ VG +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQV-------------------VAAVGFKCKRLEI 260
Query: 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ + + C P +R L+ +
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G GSFG VYKG + G VA+K+ N+ + + F +E +LR RH N++ F
Sbjct: 32 IGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL-FMGY 88
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
A+V ++ S L++ ++ + ++I A ++YLH I+H
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA----KSIIHR 144
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---YGSEGIVSA 912
DLK NNI L E+ T + DFG++ S +I +MAPE S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 913 KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSA 972
+ DVY++G++L E T + P + + + + SL L++V
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS------------ 252
Query: 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+C + L +C + ++R AE++++
Sbjct: 253 --NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-55
Identities = 103/516 (19%), Positives = 199/516 (38%), Gaps = 53/516 (10%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGS 180
G L I + D L++ L + +++ + L ++ L
Sbjct: 1 GPLGSATIT--QDTPINQIFTD--TALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADR 55
Query: 181 NDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG 240
+ + +L + ++N+ + + NL++L D+ + N + T +
Sbjct: 56 LGI--KSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIAD--ITPLA 109
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
NL L L L N ++ + N++ + + L N +S L+ L +L+ L+
Sbjct: 110 NLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISALS---GLTSLQQLSF- 163
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
GN + P + N + L LD+SSN S L L L N ++
Sbjct: 164 GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD------ 213
Query: 361 QWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNL 420
++ L +L EL+LN N L+ I + + + +L + ++ P + L
Sbjct: 214 ----ITPLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQISNLAP--LSGL 264
Query: 421 SGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNN 480
+ L LKL N+++ P + L L L +N L+ P + +L+ L+ L L NN
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 481 LSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHL 540
+S P + SLT L+ L +N ++ SSL +L I +++ N +S + + +L
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL--TPLANL 374
Query: 541 KVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI-PESFGSLISLESLDVSSN 599
+ L L+ + + +++ + N I P + S D++ N
Sbjct: 375 TRITQLGLNDQAWTNAPV---NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
Query: 600 NISGKIPKSLEALLYLKKLNVSYNRLEGEI--PIKG 633
S + + G + P+K
Sbjct: 432 LPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-54
Identities = 115/512 (22%), Positives = 190/512 (37%), Gaps = 71/512 (13%)
Query: 72 LGNLSFLVSLDISENNFYGHLP-NELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILS 130
L+ + + + N + +L ++ L+ + G + L+ L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQIN 74
Query: 131 FHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSS 190
F NN TD P L NL+KL + + N ++ + L L L L +N P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP-- 129
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNL 250
L T+L L L+ N S + L+ L L+ N + + NL LE L++
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDI 184
Query: 251 GMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPN 310
N +S + ++ + + NQ+S PL L NL+ L+L GN L
Sbjct: 185 SSNKVSDI--SVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQL--KDIG 237
Query: 311 SITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTN 370
++ + + L LDL++N S P L L L L N ++ +S L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN----------ISPLAG 285
Query: 371 CRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDD 430
+LT L LN N L I P I NL L +L L
Sbjct: 286 LTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTLYF 318
Query: 431 NELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLG 490
N ++ P V +LQ L Y+N + L +L ++ L N +S P L
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LA 372
Query: 491 SLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSR 550
+LT + +L L T + + ++ V + +L P++I D++
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITW 430
Query: 551 NQLSGDIPITISGLKDLATLSLAGNQFNGPIP 582
N S T+ F+G +
Sbjct: 431 NLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 15/224 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+L+ L I L +L+ L LD++ N P L L +L + N++S
Sbjct: 226 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 281
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
P + L+ L L + N D P + NL L +L L N++S + L KL++L
Sbjct: 282 P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRL 336
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
+ +N SSL+ T++ L N+ S + NL+++T L L
Sbjct: 337 FFYNNKV--SDVSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPV 392
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS 280
N+ + + L P TI + + ++ N S
Sbjct: 393 NYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 26/157 (16%), Positives = 55/157 (35%), Gaps = 28/157 (17%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L L ++ I P + +L+ L L N + L L + ++ +N++S
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLS----------------------KLEFLD 154
P + L+R+ L ++ ++T+ ++ N+S D
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPD 427
Query: 155 LMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSL 191
+ N S + + + G+ F G + L
Sbjct: 428 ITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 48/288 (16%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSC 795
L G ++KG + G ++ +KV ++ R R F+ EC LR H N++
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP-VLGA 75
Query: 796 CN---IDFKALVLEFMPNGSFEKWLYSY-----NYFLDILQRLNIMIDVALVLEYLHHGH 847
C L+ +MP GS LY+ N+ +D Q + +D+A + +LH
Sbjct: 76 CQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---Y 904
I L ++++DE+MTA +S + S M ++APE
Sbjct: 132 P--LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQK 182
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964
E D++S+ VLL E TR+ P ++ E+ V
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------------------GMKV 223
Query: 965 GEEQA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011
E + + L C E P +R L+K++ K
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-52
Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 50/289 (17%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQ----LERAFRTFDSECEILRNVRHRNLVKIFS 793
+G G FG VY+ + G VA+K + + E ++ ++H N++ +
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C LV+EF G L + +N + +A + YLH ++ P
Sbjct: 74 VCLKEPNLCLVMEFARGGP----LNRVLSGKRIPPDILVNWAVQIARGMNYLHD-EAIVP 128
Query: 852 IVHCDLKPNNILLDE--------NMTAHVSDFGISKLLGEGDDSVTQTITMA---TIGYM 900
I+H DLK +NIL+ + N ++DFG+++ +T M+ +M
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-------WHRTTKMSAAGAYAWM 181
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960
APE + S DV+SYGVLL E T + P + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------------------- 222
Query: 961 ANLVGEEQA-FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
A V + + C L DC P R T+ +L I
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-52
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 37/333 (11%)
Query: 720 TSYLDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEI 779
+ + D L+GRG +G VYKG+L D VA+KVF+ + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNI 58
Query: 780 --LRNVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
+ + H N+ + + LV+E+ PNGS K+L + D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 833 MIDVALVLEYLH-----HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
V L YLH H I H DL N+L+ + T +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 888 VTQTITMA------TIGYMAPEYGSEGI-------VSAKCDVYSYGVLLMETFTRKK--- 931
A TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 932 PTDEMFTGEMSLRRWVKE--SLPHGLTEVVDANLVGE-EQAFSAKTDCLLSIMDLALDCC 988
P + + +M+ + V + V + +A+ + + S+ + DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 989 MESPEQRIHMTDAAAELKKIRVKFLQQSSVAGT 1021
+ E R+ A + ++ + + + SV+ T
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-51
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
L+G+G FG VY G + G VAI++ +++ E + F E R RH N+V
Sbjct: 39 ELIGKGRFGQVYHGR-WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+C + A++ + + LD+ + I ++ + YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA----KGIL 152
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA---TIGYMAPE------- 903
H DLK N+ D N ++DFG+ + G + + ++APE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 904 --YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
+ S DV++ G + E R+ P ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----------------PAEAIIWQ 254
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQS 1016
G + S + I D+ L C E+R T L+K+ + + S
Sbjct: 255 MGTGMKPNLS-QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-51
Identities = 99/537 (18%), Positives = 184/537 (34%), Gaps = 41/537 (7%)
Query: 103 RLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSG 162
R+ + + L+ P +L+ + L N L +L+ L+L
Sbjct: 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 163 SLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRL--PENIGNL 218
++ + LP L L LGS+ + P + HL L L S + NL
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 219 SQLTDLNLAQNNLQG-DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRL--INLI 275
LT L+L++N ++ + + G L L+ ++ N + + + L +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 276 ENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHT 335
N L + + G + + L ++ G N + SN S +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFS 235
Query: 336 FGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNF 395
+ F+++ + + L S+ L L+ + +
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQ-----NTFAGLAR-SSVRHLDLSHGFVFSLNSRVFETL 289
Query: 396 SASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDN 455
L+ ++ + L L L L N L + ++ + L N
Sbjct: 290 K-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 456 DLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS 515
+ LE+L L L N L+ + + S+ ++ L N L ++P +
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLT 402
Query: 516 LEYILYVNLSSNSLSG-PLPSSIQHLKVLINLDLSRNQLSG-DIPITISGLKDLATLSLA 573
I +LS N L + + + L L L++N+ S T S L L L
Sbjct: 403 ANLI---HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 574 GNQFNGPI-----PESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
N + F L L+ L ++ N ++ P L L+ L+++ NRL
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-50
Identities = 125/654 (19%), Positives = 225/654 (34%), Gaps = 59/654 (9%)
Query: 74 NLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF-PSWIGILSRLQILSFH 132
L+ L +S N + L +L+L+ + L L+IL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 133 NNSFTDRIPDFLLNLSKLEFLDLMENSLS-GSLPNDI--RLPKLEKLYLGSNDFFG-QIP 188
++ PD L L L L LS L + L L +L L N +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQ--LTDLNLAQNNLQGDMPTAIGN-LQML 245
S + L+++ + N+ + L L+ +LA N+L + G +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
++ L + ++SG N T+ + N +S +L ++ +N+
Sbjct: 202 RNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSL-ILAHHIMGAGFGFHNIK 253
Query: 306 GTIPNSITN--ASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWS 363
N+ S + LDLS F L+ L+ LNL +N + +
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD------ 307
Query: 364 FLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGL 423
+ +L L L+ N L + + + K + Q L L
Sbjct: 308 --EAFYGLDNLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSG 483
L L DN L TT+ + + L N L ++P + L+ N L
Sbjct: 365 QTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIH---LSENRLEN 415
Query: 484 -AIPACLGSLTSLRELHLGSNTLTY-SIPSSLWSLEYILYVNLSSNSLSGPLPSSI---- 537
I L + L+ L L N + S + + + L N L + +
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 538 -QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDV 596
+ L L L L+ N L+ P S L L LSL N+ + +LE LD+
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDI 533
Query: 597 SSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKG--PFRNFSAQSFSGNY------- 647
S N + P + + L L++++N+ E + + N + + +G
Sbjct: 534 SRNQLLAPNP---DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVY 590
Query: 648 --ALCGPPRLQVPPCKEDKGKGSKKAPFALKFILPLIISIVLIAIVIMFFIRRQ 699
+ G + D+ + K F+L + + +++ L+ I+ + R
Sbjct: 591 PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-40
Identities = 83/462 (17%), Positives = 159/462 (34%), Gaps = 66/462 (14%)
Query: 194 CTHLQTLWLADNKFSG--RLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLG 251
C+ + A +F ++P+ L+ L L+ N ++ ++ L+ L+ L LG
Sbjct: 2 CSFDGRI--AFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56
Query: 252 MNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI-- 308
+ F N+ +R+++L +++ L L +L L L+ L +
Sbjct: 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 309 PNSITNASKLIGLDLSSN-LFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
N L LDLS N + S ++ +FG L L+ ++ N + L
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE-----LEP 170
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
L ++L+ +L N L + G R L L
Sbjct: 171 LQG-KTLSFFSLAANSLYSRVSVDWGKCMNPFR-------------------NMVLEILD 210
Query: 428 LDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPA 487
+ N I + N + S + L + +N+
Sbjct: 211 VSGNGWTVDIT------------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 488 CLGSL--TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
L +S+R L L + +L+ + +NL+ N ++ + L L
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV 318
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
L+LS N L GL +A + L N ++F L L++LD+ N ++
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNY 647
++ + + + +S N+L + + N
Sbjct: 376 --TIHFIPSIPDIFLSGNKL----------VTLPKINLTANL 405
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-29
Identities = 92/449 (20%), Positives = 146/449 (32%), Gaps = 49/449 (10%)
Query: 57 LNLSSFSLGGIIPPHLGNLSF--LVSLDISENNFYGHLPNELGKL------RRLRLINFA 108
++ SS + + L L L ++ N+ Y + + GK L +++ +
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212
Query: 109 YN------------ELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNL--SKLEFLD 154
N +S S + + + F ++ D + L S + LD
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 155 LMENSLSGSLPNDIR-LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPE 213
L + L L+ L L N + +LQ L L+ N
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 214 NIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLIN 273
N L ++ ++L +N++ L+ L+ L+L N L+ TI I +I I
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIF 387
Query: 274 LIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIG-TIPNSITNASKLIGLDLSSNLFSG-H 331
L N+L TL + L N L I + L L L+ N FS
Sbjct: 388 LSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442
Query: 332 IPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPF 391
T L L L N L W L++ L L LN N L + PP
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH---LQVLYLNHNYLNSL-PPG 498
Query: 392 IGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLS 451
+ + +LR L + + L L + N+L P F L L
Sbjct: 499 VFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLD 553
Query: 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNN 480
+ N C L L + N
Sbjct: 554 ITHNKFICE-----CELSTFINWLNHTNV 577
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-17
Identities = 50/230 (21%), Positives = 87/230 (37%), Gaps = 19/230 (8%)
Query: 52 HRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNE 111
+V ++L + I L L +LD+ +N + + + I + N+
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNK 392
Query: 112 LSGSFPSWIGILSRLQILSFHNNSFTD-RIPDFLLNLSKLEFLDLMENSLSGSLPNDI-- 168
L + ++ N + I FLL + L+ L L +N S +
Sbjct: 393 LVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 169 RLPKLEKLYLGSNDFFGQIPSSLSE-----CTHLQTLWLADNKFSGRLPENIGNLSQLTD 223
P LE+L+LG N + L +HLQ L+L N + P +L+ L
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 224 LNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLIN 273
L+L N L + LE L++ N L P P ++S + + +
Sbjct: 509 LSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITH 556
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 42/295 (14%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG+G FG K T + G + +K E RTF E +++R + H N++K
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ E++ G+ + S + QR++ D+A + YLH + I+H D
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN----IIHRD 133
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA------------TIGYMAPEY 904
L +N L+ EN V+DFG+++L+ + ++ +MAPE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL----PHGLTEVVD 960
+ K DV+S+G++L E R + M V+ L P
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP------- 246
Query: 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015
+C S + + CC PE+R L+ +R+
Sbjct: 247 --------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-50
Identities = 67/299 (22%), Positives = 122/299 (40%), Gaps = 38/299 (12%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEI--LRNVRHRNLVKIFS 793
+G+G +G V++G+ + G NVA+K+F+ + E+++ E E+ +RH N++ +
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIA 69
Query: 794 SCCNIDFKA----LVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLH--- 844
S + L+ + GS LY Y LD + L I++ +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGS----LYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 845 -HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA--TIGYMA 901
I H DLK NIL+ +N ++D G++ + + + + T YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 902 PE------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
PE + D++++G++L E R + + V P+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV----PNDP 241
Query: 956 TEVVDANLVGEEQ------AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ +V +Q L S+ L +C ++P R+ L KI
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 34/297 (11%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G+G +G V+ G + G VA+KVF E ++ ++E +RH N++ ++
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100
Query: 796 CNIDFK----ALVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLH----H 845
L+ ++ NGS LY Y + LD L + L +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGS----LYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA--TIGYMAPE 903
I H DLK NIL+ +N T ++D G++ + V T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 904 --YGSEGIVSA----KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957
S D+YS+G++L E R + ++ V P +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV----PSDPSY 272
Query: 958 VVDANLVGEEQ------AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+V ++ + +CL + L +C +P R+ L K+
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-47
Identities = 97/531 (18%), Positives = 191/531 (35%), Gaps = 39/531 (7%)
Query: 80 SLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDR 139
D +F +P+ L ++ ++ ++N+++ + + LQ+L ++
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 140 IPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFG-QIPSSLSECTH 196
D +L LE LDL +N LS SL + L L+ L L N + + S T+
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 197 LQTLWLADNKFSGRLPEN-IGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL 255
LQTL + + + + L+ L +L + +L+ ++ +++ + HL L ++
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 256 SGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNA 315
+ + +S++R + L + L+ + + S
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 316 SKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLT 375
KL+ L L + F + N L + ++
Sbjct: 244 LKLLRYILE--------------LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 376 ELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNG 435
L + L L +++ ++ +L L FL L +N +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLE-KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 436 TIPTT---VGRFQQLQGLSLYDNDLQ--GSIPYYLCHLERLSQLLLNGNNLSGAIPACLG 490
G + LQ L L N L+ L L+ L+ L ++ N +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 491 SLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSR 550
+R L+L S + +LE + ++S+N+L + L+ L +SR
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIPQTLEVL---DVSNNNLDS-FSLFLPRLQEL---YISR 460
Query: 551 NQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNI 601
N+L +P S L + ++ NQ F L SL+ + + +N
Sbjct: 461 NKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-46
Identities = 93/499 (18%), Positives = 185/499 (37%), Gaps = 31/499 (6%)
Query: 145 LNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLAD 204
L+ D S + S+P+ + ++ L L N L C +LQ L L
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 205 NKFSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG-PVPPT 262
++ + + + +L L L+L+ N+L + G L L++LNL N V
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 263 IFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLD 322
N++ ++ + + + + L +L L + +L S+ + + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 323 LSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVN 382
L + + + L +R+L L +L +SS + L
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 383 PLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ-EIGNLSGLMFLK--------LDDNEL 433
+L S +F+ G E +S L ++ + L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGAI---PACL 489
+ T ++++ +++ ++ + +P HL+ L L L+ N + AC
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 490 GSLTSLRELHLGSNTLTY--SIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLD 547
G+ SL+ L L N L L +L+ + +++S N+ P+P S Q + + L+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 548 LSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPK 607
LS + + + L L ++ N + L L+ L +S N + +P
Sbjct: 417 LSSTGIRV---VKTCIPQTLEVLDVSNNN----LDSFSLFLPRLQELYISRNKLK-TLPD 468
Query: 608 SLEALLYLKKLNVSYNRLE 626
+ L + +S N+L+
Sbjct: 469 AS-LFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-45
Identities = 92/534 (17%), Positives = 172/534 (32%), Gaps = 66/534 (12%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
IP L + + SLD+S N +L L+++ + ++ L L+
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFG 185
L +N + + LS L++L+LM N + L L+ L +G+ + F
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 186 QIP-SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
+I + T L L + +++ ++ + L L + + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 245 LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH---------SLPNLE 295
+ +L L NL+ + + + + S + L +E
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 296 FLTLFGNNLIGTIPNSITNASKLI--------GLDLSSNLFSGHIPHTFGNLRFLRFLNL 347
F N L P+ S+L L + + + L ++ + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 348 MFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKC 407
+ + + +SL L L+ N +
Sbjct: 318 ENSKVFLVPCSF--------SQHLKSLEFLDLSENLMV---------------------- 347
Query: 408 ELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYY 464
E G L L L N L ++ T L L + N +P
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405
Query: 465 LCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNL 524
E++ L L+ + + C+ +L L + +N L S L L+ + +
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQEL---YI 458
Query: 525 SSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
S N L LP + VL+ + +SRNQL L L + L N ++
Sbjct: 459 SRNKLKT-LPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-33
Identities = 74/450 (16%), Positives = 133/450 (29%), Gaps = 70/450 (15%)
Query: 194 CTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
C F+ +P + + + L+L+ N + + L+ L L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 254 NLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSIT 313
++ + F +SL +LE L L N+L +
Sbjct: 61 RINT-IEGDAF------------------------YSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 314 NASKLIGLDLSSNLFSG-HIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCR 372
S L L+L N + + F NL L+ L + +E
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR-------IDFAGLT 148
Query: 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNE 432
SL EL + LR Q + ++ + L L +E
Sbjct: 149 SLNELEIKALSLRNY-------------------------QSQSLKSIRDIHHLTLHLSE 183
Query: 433 LNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSL 492
+ ++ L L D +L L E S + S L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 493 TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQ 552
L L + + + +L + N S + + L + L + +
Sbjct: 244 LKLLRYILELSEVEFDD----CTLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFY 297
Query: 553 LSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKS---L 609
L D+ S L+ + +++ ++ L SLE LD+S N + + K+
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 610 EALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
A L+ L +S N L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 76/432 (17%), Positives = 137/432 (31%), Gaps = 82/432 (18%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L + + SL L ++ + L + + L L +R + L+
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 117 PSWIG---ILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
S + + S ++ L+F + TD + LL L + L+L E D L L
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY-ILELSEVEFD-----DCTLNGL 266
Query: 174 EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233
+D ++ E ++ L + L L ++ + + + +
Sbjct: 267 GDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
+ +L+ LE L+L N + L N + P+
Sbjct: 325 VPCSFSQHLKSLEFLDLSEN-----------LMVEEYLKNSACK-----------GAWPS 362
Query: 294 LEFLTLFGNNL--IGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
L+ L L N+L + + L LD+S N F +P + +RFLNL
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 352 LTTESSPADQWSFLSSLTNC--RSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
+ + C ++L L ++ N L
Sbjct: 422 IR-------------VVKTCIPQTLEVLDVSNNNLD------------------------ 444
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE 469
S L L L + N+L T+P F L + + N L+ L
Sbjct: 445 --SFSL---FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLT 497
Query: 470 RLSQLLLNGNNL 481
L ++ L+ N
Sbjct: 498 SLQKIWLHTNPW 509
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-47
Identities = 62/295 (21%), Positives = 114/295 (38%), Gaps = 30/295 (10%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEI--LRNVRHRNLVKIFS 793
+G+G FG V++G + G VA+K+F+ + ER++ E EI +RH N++ +
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHENILGFIA 103
Query: 794 SCCNIDFKA----LVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLH--- 844
+ + LV ++ +GS L+ Y Y + + + + + A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 845 -HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA--TIGYMA 901
I H DLK NIL+ +N T ++D G++ D++ T YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 902 PE------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE--SLPH 953
PE + D+Y+ G++ E R ++ V S+
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 954 GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
V + L + L + + +C + R+ L ++
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-46
Identities = 85/407 (20%), Positives = 160/407 (39%), Gaps = 63/407 (15%)
Query: 221 LTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS 280
L + P +L L +++ T + +I + + +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVA 57
Query: 281 GHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLR 340
+ L NLE+L L GN + P ++N KL L + +N + NL
Sbjct: 58 SIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 341 FLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLR 400
LR L L ++++ +S L N + L L N
Sbjct: 111 NLRELYLNEDNISD----------ISPLANLTKMYSLNLGANHNL--------------- 145
Query: 401 KFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGS 460
S + N++GL +L + ++++ P + L LSL N ++
Sbjct: 146 -----------SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192
Query: 461 IPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIP-SSLWSLEYI 519
P L L L N ++ P + ++T L L +G+N +T P ++L L ++
Sbjct: 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWL 248
Query: 520 LYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG 579
+ +N +S ++++ L L L++ NQ+S DI + ++ L L +L L NQ
Sbjct: 249 ---EIGTNQISDI--NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGN 301
Query: 580 PIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
E G L +L +L +S N+I+ P L +L + + + ++
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 82/414 (19%), Positives = 155/414 (37%), Gaps = 83/414 (20%)
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
++ L + L +T L +A + I L LE+L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYL 71
Query: 249 NLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI 308
NL N ++ P + N+ + + + N+++ L +L NL L L +N+
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ---NLTNLRELYLNEDNISDIS 126
Query: 309 PNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSL 368
P + N +K+ L+L +N + N+ L +L + + + ++ +
Sbjct: 127 P--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD----------VTPI 173
Query: 369 TNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKL 428
N L L+LN N + I P + +L+ L +
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP---------------------------LASLTSLHYFTA 206
Query: 429 DDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPAC 488
N++ P + ++ RL+ L + N ++ P
Sbjct: 207 YVNQITDITP--------------------------VANMTRLNSLKIGNNKITDLSP-- 238
Query: 489 LGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDL 548
L +L+ L L +G+N ++ +++ L + +N+ SN +S S + +L L +L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 549 SRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602
+ NQL + I GL +L TL L+ N P SL ++S D ++ I
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-44
Identities = 79/429 (18%), Positives = 149/429 (34%), Gaps = 84/429 (19%)
Query: 126 LQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFG 185
L+ P +L++ L + S++ + L + KL +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKV-- 56
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+ T+L+ L L N+ + + NL +LT+L + N + +A+ NL L
Sbjct: 57 ASIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNL 112
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
L L +N+S + L +L + L L N+ +
Sbjct: 113 RELYLNEDNISD-------------ISPL--------------ANLTKMYSLNLGANHNL 145
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
+ + ++N + L L ++ + P NL L L+L +N + +
Sbjct: 146 -SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED----------I 192
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
S L + SL VN + I P + N++ L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP---------------------------VANMTRLNS 225
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
LK+ +N++ P + QL L + N + I + L +L L + N +S
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDIS 281
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
L +L+ L L L +N L + L + + LS N ++ + L + +
Sbjct: 282 V--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDS 337
Query: 546 LDLSRNQLS 554
D + +
Sbjct: 338 ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 79/380 (20%), Positives = 145/380 (38%), Gaps = 58/380 (15%)
Query: 54 VVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
+ L S+ ++ L + L ++ + + L L +N N+++
Sbjct: 24 GIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASIQ-GIEYLTNLEYLNLNGNQIT 79
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
P + L +L L N TD L NL+ L L L E+++S + L K+
Sbjct: 80 DISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLANLTKM 134
Query: 174 EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233
L LG+N S LS T L L + ++K I NL+ L L+L N ++
Sbjct: 135 YSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED 191
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
+ + +L L + +N ++ P + N++ + + + N+++ PL +L
Sbjct: 192 --ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA---NLSQ 244
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
L +L + N + + N++ + +KL L++ SN S NL L L L N L
Sbjct: 245 LTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 354 TESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSI 413
E + + +LT L L+ N + I P
Sbjct: 301 NED--------MEVIGGLTNLTTLFLSQNHITDIRP------------------------ 328
Query: 414 PQEIGNLSGLMFLKLDDNEL 433
+ +LS + + +
Sbjct: 329 ---LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 80/426 (18%), Positives = 149/426 (34%), Gaps = 84/426 (19%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L + I P +L+ + + + + + +L + + A +++
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
I L+ L+ L+ + N TD P L NL KL L + N ++ + L L +L
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLREL 115
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
YL ++ S L+ T + +L L N + N++ L L + ++ ++
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--V 170
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
T I NL L L+L N + + L SL +L +
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-------------ISPL--------------ASLTSLHY 203
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
T + N + P + N ++L L + +N + P NL L +L + N ++
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-- 257
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQE 416
++++ + L L + N + I
Sbjct: 258 --------INAVKDLTKLKMLNVGSNQISDI---------------------------SV 282
Query: 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476
+ NLS L L L++N+L +G L L L N + P L L ++
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 477 NGNNLS 482
+
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 63/329 (19%), Positives = 123/329 (37%), Gaps = 33/329 (10%)
Query: 302 NNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ 361
I I + ++ I L + + L + L + + +
Sbjct: 9 PAPINQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS------- 58
Query: 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLS 421
+ + +L L LN N + I + N L ++ + + NL+
Sbjct: 59 ---IQGIEYLTNLEYLNLNGNQITDI--SPLSNLV-KLTNLYIGTNKI--TDISALQNLT 110
Query: 422 GLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNL 481
L L L+++ ++ P + ++ L+L N + L ++ L+ L + + +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKV 167
Query: 482 SGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLK 541
P + +LT L L L N + P L SL + Y N ++ + + ++
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMT 221
Query: 542 VLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNI 601
L +L + N+++ P+ + L L L + NQ + + L L+ L+V SN I
Sbjct: 222 RLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277
Query: 602 SGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
S L L L L ++ N+L E
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDM 304
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 57/260 (21%), Positives = 105/260 (40%), Gaps = 20/260 (7%)
Query: 374 LTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNEL 433
LA P+ I P + + + K + + L + L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLA-EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLT 493
+ L+ L+L N + P L +L +L+ L + N ++ + L +LT
Sbjct: 57 --ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553
+LREL+L + ++ P L +L + +NL +N S + ++ L L ++ +++
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL 613
PI + L DL +LSL NQ P SL SL N I+ P + +
Sbjct: 168 KDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 614 YLKKLNVSYNRLEGEIPIKG 633
L L + N++ P+
Sbjct: 222 RLNSLKIGNNKITDLSPLAN 241
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-46
Identities = 110/535 (20%), Positives = 188/535 (35%), Gaps = 84/535 (15%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
I P + +FL +N +P E ++ A++E + P G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQI 187
+ R+ D L + L+L LS SLP P LE L N ++
Sbjct: 62 VS---------RLRDCLDR--QAHELELNNLGLS-SLPELP--PHLESLVASCNS-LTEL 106
Query: 188 PSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEH 247
P L S LP L L ++ N L+ +P + N L+
Sbjct: 107 PELPQSLKSLLVDNNNLKALSD-LPPL------LEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 248 LNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
+++ N+L +P + + I NQL LP L + LP L + NN +
Sbjct: 158 IDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELP-ELQN-LPFLTAIYA-DNNSLKK 209
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
+P+ + L + +N+ NL FL + N L +
Sbjct: 210 LPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK---------TLPDL 255
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
+ L L + N L LP + L + + + + NL +L
Sbjct: 256 PPS---LEALNVRDNYLTD-LPELPQS----LTFLDVSENIFS-GLSELPPNLY---YLN 303
Query: 428 LDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPA 487
NE+ ++ L+ L++ +N L +P LERL + N+L+ +P
Sbjct: 304 ASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 354
Query: 488 CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLD 547
+L++LH+ N L P S+E +L NS +P Q+LK L
Sbjct: 355 ---LPQNLKQLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQ---LH 402
Query: 548 LSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602
+ N L + P ++D L + + P + + LE ++
Sbjct: 403 VETNPLR-EFPDIPESVED---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-43
Identities = 104/475 (21%), Positives = 173/475 (36%), Gaps = 83/475 (17%)
Query: 165 PNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLS----- 219
P ++ L++ S++ ++P + A +++ P G
Sbjct: 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 220 --------QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRL 271
Q +L L L +P + LE L N+L+ +P ++ ++ +
Sbjct: 64 RLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLV 118
Query: 272 INLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGH 331
N LS P LE+L + N L +P + N+S L +D+ +N
Sbjct: 119 DNNNLKALSD--------LPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-K 167
Query: 332 IPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPF 391
+P + L F+ N L L L N LT + + N L+ LP
Sbjct: 168 LPDLPPS---LEFIAAGNNQLEE----------LPELQNLPFLTAIYADNNSLKK-LPDL 213
Query: 392 IGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLS 451
+ L A L E+ NL L + D+N L T+P L+ L+
Sbjct: 214 PLS----LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALN 263
Query: 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS 511
+ DN L +P L L + LS +L L+ SN + S+
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCD 314
Query: 512 SLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLS 571
SLE + N+S+N L LP+ L+ L S N L+ ++P LK L
Sbjct: 315 LPPSLEEL---NVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQNLK---QLH 363
Query: 572 LAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
+ N P+ S+ L N+ ++P+ + LK+L+V N L
Sbjct: 364 VEYNPLRE-FPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 94/477 (19%), Positives = 168/477 (35%), Gaps = 85/477 (17%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLR-------------RLRLINFAYNELSG 114
+P N+ + + + + P G+ R + + LS
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLE 174
S P L+ L NS T+ +P+ +L L + +LS P LE
Sbjct: 85 SLPELPP---HLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL------LE 134
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L + +N ++P L + L+ + + +N +LP+ +L + N L+ +
Sbjct: 135 YLGVSNNQL-EKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQLE-E 187
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+P + NL L + N+L +P ++ +I N N L LP L + LP L
Sbjct: 188 LPE-LQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGN---NILE-ELP-ELQN-LPFL 239
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
+ NNL+ T+P+ + L L++ N + +P +L FL +F+ L+
Sbjct: 240 TTIYA-DNNLLKTLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294
Query: 355 ESSPADQWSFLSSLTN--------CRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIK 406
+L++ +N SL EL ++ N L LP L + A
Sbjct: 295 L---PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASF 346
Query: 407 CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGR----------------FQQLQGL 450
L +P+ NL L ++ N L P Q L+ L
Sbjct: 347 NHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQL 401
Query: 451 SLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTY 507
+ N L+ P +E L +N + + L + + +
Sbjct: 402 HVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 58/323 (17%), Positives = 110/323 (34%), Gaps = 28/323 (8%)
Query: 49 ARHHRVVALNLSSFSLGGI-----IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLR 103
+ HH + + G L + D + H +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQ 59
Query: 104 LINFAYNELSGSFPSWIGILSR--LQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS 161
+ L + + ++ L + + PD LS L+ + + L
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 162 GSLPNDI-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGN--- 217
LP+ + + LE L L N +P+S++ L+ L + LPE + +
Sbjct: 118 -ELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 218 ------LSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRL 271
L L L L ++ +P +I NLQ L+ L + + LS + P I ++ +
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233
Query: 272 INLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGH 331
++L + P G L+ L L + + T+P I ++L LDL +
Sbjct: 234 LDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 332 IPHTFGNLRFLRFLNLMFNSLTT 354
+P L + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 58/333 (17%), Positives = 111/333 (33%), Gaps = 31/333 (9%)
Query: 69 PPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQI 128
H + S +L + + L + +R + + + + QI
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 129 LSFHNNSFTDRIPDFL--LNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFG 185
+ + D L L+L L P+ RL L+ + + +
Sbjct: 61 ETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG-LM 117
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL---------QGDMP 236
++P ++ + L+TL LA N LP +I +L++L +L++ D
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
L L+ L L + +P +I N+ ++ + + + LS L + H LP LE
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHH-LPKLEE 233
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
L L G + P + L L L +P L L L+L +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS-- 291
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
S + + + + + +
Sbjct: 292 ------RLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 57/347 (16%), Positives = 111/347 (31%), Gaps = 35/347 (10%)
Query: 209 GRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST 268
G + + S +L + + Q + + + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 269 IRLINLIENQLSGHLPLTLGH-SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNL 327
++ L L + P L L L P+ S L + + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 328 FSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGI 387
+P T L L L N L + +S+ + L EL++ P
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR---------ALPASIASLNRLRELSIRACPELTE 165
Query: 388 LPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQL 447
LP + + E L L L+L+ + ++P ++ Q L
Sbjct: 166 LPEPLASTD----------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 448 QGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTY 507
+ L + ++ L ++ + HL +L +L L G P G L+ L L +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 508 SIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
++P + L + ++L LPS I L + + + +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 55/333 (16%), Positives = 106/333 (31%), Gaps = 33/333 (9%)
Query: 289 HSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLM 348
H E L G+ + + ++ + D + H N +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRT 64
Query: 349 FNSLTTESSPADQWSFLSSLTNCRS--LTELALNVNPLRGILPPFIGNFSASLRKFEAIK 406
+L + L + L L PL P S L+
Sbjct: 65 GRALK---------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDA 113
Query: 407 CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDL--------- 457
L +P + +GL L L N L +P ++ +L+ LS+
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 458 QGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517
L L L L + ++PA + +L +L+ L + ++ L+ ++ ++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 518 YILYVNLSSNSLSGPLPSSIQHLKVLINLDLS-RNQLSGDIPITISGLKDLATLSLAGNQ 576
+ ++L + P L L L + L +P+ I L L L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 577 FNGPIPESFGSLISLESLDVSSNNISGKIPKSL 609
+P L + + V ++ ++ +
Sbjct: 289 NLSRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-39
Identities = 52/330 (15%), Positives = 106/330 (32%), Gaps = 15/330 (4%)
Query: 190 SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLN 249
+ + L+ + + + + + + + + N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 250 LGMNNLSGPVPPTIFNISTIRLI--NLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
L + + + + L L P L +L+ +T+ L+
Sbjct: 63 RTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-E 118
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLM-FNSLTTESSPADQWSFLS 366
+P+++ + L L L+ N +P + +L LR L++ LT P
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 367 SLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFL 426
+L L L +R LP I N +L+ + L ++ I +L L L
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQ-NLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 427 KLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIP 486
L P G L+ L L D ++P + L +L +L L G +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 487 ACLGSLTSLRELHLGSNTLTYSIPSSLWSL 516
+ + L + + + + +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 61/375 (16%), Positives = 110/375 (29%), Gaps = 60/375 (16%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
S + L F ++ D L + D + N ++ +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGR 66
Query: 183 FFGQIPSSLSECTH--LQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG 240
L + T L L + P+ LS L + + L ++P +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
LE L L N L LP ++ L L L++
Sbjct: 125 QFAGLETLTLARNPLR-------------------------ALPASIAS-LNRLRELSIR 158
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
+ +P + + L L+ L L + +
Sbjct: 159 ACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR------- 196
Query: 361 QWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNL 420
S +S+ N ++L L + +PL L P I + L + + C + P G
Sbjct: 197 --SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP-KLEELDLRGCTALRNYPPIFGGR 252
Query: 421 SGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNN 480
+ L L L D T+P + R QL+ L L +P + L +L+ +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 481 LSGAIPACLGSLTSL 495
+ + +
Sbjct: 313 QAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 60/327 (18%), Positives = 110/327 (33%), Gaps = 34/327 (10%)
Query: 305 IGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSF 364
+G+ + ++S L + + + ++W
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR------------NRWHS 48
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNF-SASLRKFEAIKCELKGSIPQEIGNLSGL 423
N + L+ + + E L P + LS L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSG 483
+ +D L +P T+ +F L+ L+L N L+ ++P + L RL +L +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVL 543
+P L S + E L +L+ + L + LP+SI +L+ L
Sbjct: 165 ELPEPLASTDASGEH------------QGLVNLQSL---RLEWTGIRS-LPASIANLQNL 208
Query: 544 INLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISG 603
+L + + LS + I L L L L G P FG L+ L + +
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 604 KIPKSLEALLYLKKLNVSYNRLEGEIP 630
+P + L L+KL++ +P
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 55/246 (22%), Positives = 85/246 (34%), Gaps = 16/246 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L L S L P LS L + I LP+ + + L + A N L +
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-AL 142
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPD---------FLLNLSKLEFLDLMENSLSGSLPND 167
P+ I L+RL+ LS +P+ L L+ L L + SLP
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 168 I-RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNL 226
I L L+ L + ++ + ++ L+ L L P G + L L L
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 227 AQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLT 286
+ +P I L LE L+L +P I + +I + L L
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQH 319
Query: 287 LGHSLP 292
+ P
Sbjct: 320 RPVARP 325
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-43
Identities = 66/463 (14%), Positives = 135/463 (29%), Gaps = 57/463 (12%)
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
+ + + + + S +++ L L+ N S ++ ++L LNL+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 230 NLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH 289
L + +L L L+L N + + +I ++ N +S + +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--- 117
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSG-HIPHTFGNLRFLRFLNLM 348
+ + L N + S++ LDL N + + L LNL
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 349 FNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCE 408
+N + + L L L+ N L
Sbjct: 178 YNFIYD----------VKGQVVFAKLKTLDLSSNKLA----------------------- 204
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQ-GSIPYYLCH 467
+ E + +G+ ++ L +N+L I + Q L+ L N G++ +
Sbjct: 205 ---FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
+R+ + T H G+ L + +
Sbjct: 261 NQRVQTVAKQTVKKLTGQN--EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 528 SLSG----PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPE 583
S G L ++ +D + Q I + TL + +
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 584 SFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
+ L+ + ++ + E L+ L R E
Sbjct: 379 GRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-40
Identities = 68/496 (13%), Positives = 157/496 (31%), Gaps = 46/496 (9%)
Query: 73 GNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFH 132
N + +++++ L + ++ ++ + N LS + + ++L++L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 133 NNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLS 192
+N + D +LS L LDL N + L P +E L+ +N ++ S
Sbjct: 67 SNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANN-NISRVSCSR- 118
Query: 193 ECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG-DMPTAIGNLQMLEHLNLG 251
+ ++LA+NK + + G S++ L+L N + + + LEHLNL
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 252 MNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNS 311
N + V + + ++ ++L N+L+ + + +++L NN + I +
Sbjct: 178 YNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISL-RNNKLVLIEKA 232
Query: 312 ITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNC 371
+ + L DL N F + R + ++ + ++ C
Sbjct: 233 LRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE--------EC 283
Query: 372 RSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDN 431
T + PF A L +
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIAL--------------------KRKEHALLSGQGS 323
Query: 432 ELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGS 491
E + + + + + I + L L + +
Sbjct: 324 ETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382
Query: 492 LTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN 551
L + ++ L + + + + D+ ++
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442
Query: 552 QLSGDIPITISGLKDL 567
+ + + + LK L
Sbjct: 443 KET-QLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 56/414 (13%), Positives = 122/414 (29%), Gaps = 30/414 (7%)
Query: 211 LPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIR 270
+ E N ++ + ++L+ + + + ++ L+L N LS + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 271 LINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSG 330
L+NL N L L L SL L L L N + + + L ++N S
Sbjct: 62 LLNLSSNVLYETLDL---ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 331 HIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPP 390
+ + + + L N +T + L L +N + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRD--------LDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 391 FIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGL 450
+ S +L + + ++ + L L L N+L + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 451 SLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS-GAIPACLGSLTSLRELHLGSNTLTYSI 509
SL +N L I L + L L GN G + ++ + +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 510 PSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD----IPITISGLK 565
++ + + + L L + + G +
Sbjct: 279 NEEECTVPTLG--HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 566 DLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLN 619
+ Q+ I + + +L+ + ++ A L
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 13/216 (6%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+I + N + K+ D+ L + + ++ L L N L L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
L L+ N L + L SL++LR L L +N + L I ++ ++N++S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG-PIPESFGSLIS 590
+ S + N+ L+ N+++ + + L L N+ + E S +
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 591 LESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
LE L++ N I + + LK L++S N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 37/337 (10%), Positives = 87/337 (25%), Gaps = 40/337 (11%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+ ++ ++ + ++ ++ N + G R++ ++ NE+
Sbjct: 104 LHAANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--- 157
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
T + + LE L+L N + + + KL+ L
Sbjct: 158 --------------------TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTL 196
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
L SN + + + L +NK + + + L +L N
Sbjct: 197 DLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
+ + + + L + LP L L+
Sbjct: 255 RDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKR 312
Query: 297 LTL----FGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
+ + N ++ +D + I + L +L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
+ S + + A+ L+
Sbjct: 373 DEQVSNG-----RRAHAELDGTLQQAVGQIELQHATE 404
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 13/70 (18%), Positives = 26/70 (37%)
Query: 564 LKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYN 623
+ + + S +++ LD+S N +S L L+ LN+S N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 624 RLEGEIPIKG 633
L + ++
Sbjct: 69 VLYETLDLES 78
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-39
Identities = 96/495 (19%), Positives = 175/495 (35%), Gaps = 48/495 (9%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
+ + IL+ N ++ +L+LSKL L + N + L + +LE L L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDL 76
Query: 179 GSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRLPEN--IGNLSQLTDLNLAQNNLQGDM 235
N ++ S +L+ L L+ N F LP GN+SQL L L+ +L+
Sbjct: 77 SHN----KLVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 236 PTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRL-INLIENQLSGHLPLTLGHSLPN 293
I +L + + L + P + +T L I N+ + ++ N
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHT----FGNLRFLRFLNLMF 349
LE + ++ +KL SNL +I T L+ + + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
S++ + SL L+++ P +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGT-SLKALSIHQVVSDVFGFPQSYIYE------------- 297
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE 469
S + + + L +N L ++ HL
Sbjct: 298 ---------IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348
Query: 470 RLSQLLLNGNNLSGAIPACLG---SLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLS 525
L L+L N L + + SL++L + N+++Y S + +L +N+S
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF 585
SN L+ + + + LDL N++ IP + L+ L L++A NQ F
Sbjct: 408 SNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464
Query: 586 GSLISLESLDVSSNN 600
L SL+ + + +N
Sbjct: 465 DRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 86/467 (18%), Positives = 161/467 (34%), Gaps = 25/467 (5%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+P LS L ++ N S +I +LS+L L ++ N +Q + Q L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
E+L+L N L + ++ ++L N ++ L+FL L +L
Sbjct: 72 EYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ-WSF 364
+ I + + L + + L+ +L T + S
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 365 LSSLTNCRSLTELALNVNPLRGIL-PPFIGNFSASLRKFEAIKCELKGSIPQEIGNL--- 420
+ S + L N L + L E + I L
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 421 SGLMFLKLDDNELNGTIPTTVGRF-----QQLQGLSLYDNDLQGSIPYYLCHLERLSQLL 475
+ + + + + +L G + + + L + + Y ++
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS--GPL 533
+ C ++ L +N LT ++ + L + + L N L +
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 534 PSSIQHLKVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLE 592
+K L LD+S+N +S D S K L +L+++ N I ++
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIK 424
Query: 593 SLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
LD+ SN I IPK + L L++LNV+ N+L+ +P G F +
Sbjct: 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 81/466 (17%), Positives = 158/466 (33%), Gaps = 56/466 (12%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL-SGS 115
L +S + + L LD+S N + L+ L L ++N +
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDL---SFNAFDALP 106
Query: 116 FPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS-----GSLPNDIRL 170
G +S+L+ L + +L+ + L ++ + L +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD-FNT 165
Query: 171 PKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLS------QLTDL 224
L ++ + +F + S+ +L+ + + + L+ +L++L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 225 NLAQNNLQGDMPTAIGNLQM---LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSG 281
L + I L + + ++ L G + F+ S L L +Q+
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 282 H----LPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFG 337
+ N+ + + S + LD S+NL + + G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 338 NLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSA 397
+L L L L N L S A+ + + SL +L ++ N + G+ S
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQ------QLDISQNSVSYDEKK--GDCS- 396
Query: 398 SLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDL 457
L+ L + N L TI + +++ L L+ N +
Sbjct: 397 ---------------------WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433
Query: 458 QGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSN 503
+ SIP + LE L +L + N L LTSL+++ L +N
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 74/426 (17%), Positives = 127/426 (29%), Gaps = 63/426 (14%)
Query: 57 LNLSSFSLGGI-IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGS 115
L+LS + + I GN+S L L +S + + L +++
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG-- 152
Query: 116 FPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSG------------S 163
L S H T++ F+L++S +L +++
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 164 LPNDIRLPKLEKLYLGSNDFFGQIPSSLSEC---THLQTLWLADNKFSGRLPENIGNLS- 219
L PKL L L + + + + T + +++ K G+L + S
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 220 ----QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLI 275
L+ + + + N ++ IS ++
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 276 ENQLSGHLPLTLGHSLPNLEFLTLFGNNL--IGTIPNSITNASKLIGLDLSSNLFSGHIP 333
N L+ L LE L L N L + I T L LD+S N S
Sbjct: 333 NNLLT-DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 334 H-TFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFI 392
+ L LN+ N LT L + L L+ N ++
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIF--------RCLP--PRIKVLDLHSNKIK------- 434
Query: 393 GNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSL 452
SIP+++ L L L + N+L R LQ + L
Sbjct: 435 -------------------SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWL 475
Query: 453 YDNDLQ 458
+ N
Sbjct: 476 HTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 49/240 (20%), Positives = 93/240 (38%), Gaps = 16/240 (6%)
Query: 51 HHRVVALNLSSFSLGGIIPPHLGNLSF-----LVSLDISENNFYGHLPNELGKLRRLRLI 105
H V ++S+ L G + + S L + + F + +
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
Query: 106 NFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLP 165
NF + +S L F NN TD + + +L++LE L L N L L
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 166 NDI----RLPKLEKLYLGSNDF-FGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQ 220
++ L++L + N + + S L +L ++ N + + + +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422
Query: 221 LTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQL 279
+ L+L N ++ +P + L+ L+ LN+ N L VP IF +++++ I L N
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 30/277 (10%)
Query: 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+GRG+FG V+ G L D T VA+K L F E IL+ H N+V++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V+E + G F +L + L + L ++ D A +EYL +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC----CIHR 237
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ E +SDFG+S+ +G + + + + + APE + G S++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 916 VYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHG--LTEVVDANLVGEEQAFSA 972
V+S+G+LL ETF+ P + + +E + G L
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRL---------------PC 336
Query: 973 KTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
C ++ L C P QR + EL+ IR
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-38
Identities = 74/419 (17%), Positives = 139/419 (33%), Gaps = 55/419 (13%)
Query: 236 PTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLE 295
+ + + +++ M ++ +++ + + LP L S +E
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 296 FLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTE 355
L L + + A + L + N PH F N+ L L L N L++
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ 415
N LT L+++ N L I
Sbjct: 133 PR--------GIFHNTPKLTTLSMSNNNLE--------------------------RIED 158
Query: 416 EI-GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
+ + L L+L N L + + L ++ N L L + +L
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 210
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLP 534
+ N+++ + L L L N LT + L + ++ V+LS N L +
Sbjct: 211 DASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY 265
Query: 535 SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
++ L L +S N+L + + + L L L+ N + + LE+L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENL 323
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPP 653
+ N+I + L LK L +S+N + ++ FRN + + C
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-36
Identities = 79/432 (18%), Positives = 145/432 (33%), Gaps = 58/432 (13%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
I S+L + + L+ + + ++ + + + +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 247 HLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
LNL + + F TI+ + + N + +LP + ++P L L L N +
Sbjct: 73 LLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL-ERNDL 129
Query: 306 GTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSF 364
++P I N KL L +S+N TF L+ L L N LT
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---------- 179
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLM 424
L+ SL ++ N L + +
Sbjct: 180 -VDLSLIPSLFHANVSYNLL------------------------------STLAIPIAVE 208
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGA 484
L N +N + V +L L L N+L +L + L ++ L+ N L
Sbjct: 209 ELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKI 263
Query: 485 IPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLI 544
+ + L L++ +N L ++ + + ++LS N L + + L
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 321
Query: 545 NLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGK 604
NL L N + + +S L L+L+ N ++ + ++ V + K
Sbjct: 322 NLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCK 376
Query: 605 IPKSLEALLYLK 616
I LE L K
Sbjct: 377 IDYQLEHGLCCK 388
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 71/414 (17%), Positives = 133/414 (32%), Gaps = 59/414 (14%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
+++ + L+ + + L R++ L+N ++
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLE 174
+Q L N+ P N+ L L L N LS SLP I PKL
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L + +N+ + T LQ L L+ N+ + + + + L N++ N L
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL--- 198
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ + +E L+ N+++ V + + ++ L N L+ + P L
Sbjct: 199 --STLAIPIAVEELDASHNSINV-VRGPVN--VELTILKLQHNNLT---DTAWLLNYPGL 250
Query: 295 EFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
+ L N + I +L L +S+N + + L+ L+L N L
Sbjct: 251 VEVDL-SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 354 TESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSI 413
+ L L L+ N + +
Sbjct: 309 ---------HVERNQPQFDRLENLYLDHNSIVTL-------------------------- 333
Query: 414 PQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCH 467
++ L L L N+ + + F+ + ++ D D I Y L H
Sbjct: 334 --KLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-34
Identities = 76/425 (17%), Positives = 145/425 (34%), Gaps = 65/425 (15%)
Query: 122 ILSRLQILSFHNNSFTDRIPDFL--LNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLY 177
+ H + T + + L+ + + +++ LP + ++E L
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 75
Query: 178 LGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQGDMP 236
L + + +Q L++ N LP ++ N+ LT L L +N+L
Sbjct: 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLE 295
N L L++ NNL + F ++++ + L N+L+ H+ L+L +P+L
Sbjct: 135 GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLF 189
Query: 296 FLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTE 355
+ N L +++ + LD S N + + L L L N+LT
Sbjct: 190 HANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD- 240
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ 415
+ L N L E+ L+ N L I
Sbjct: 241 ---------TAWLLNYPGLVEVDLSYNELE--------------------------KIMY 265
Query: 416 EI-GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
+ L L + +N L + L+ L L N L + +RL L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLP 534
L+ N++ + L + +L+ L L N + +L + + +
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKID 378
Query: 535 SSIQH 539
++H
Sbjct: 379 YQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 57/321 (17%), Positives = 103/321 (32%), Gaps = 48/321 (14%)
Query: 307 TIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLS 366
I +++ + + + L + + +++ + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA--------A 63
Query: 367 SLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI-GNLSGLMF 425
L + R + L LN + I +
Sbjct: 64 LLDSFRQVELLNLNDLQIE--------------------------EIDTYAFAYAHTIQK 97
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
L + N + P L L L NDL + +L+ L ++ NNL
Sbjct: 98 LYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
+ TSL+ L L SN LT+ S + SL + N+S N LS ++ +
Sbjct: 158 DDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS-----TLAIPIAVEE 209
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
LD S N ++ + +L L L N + L +D+S N + +
Sbjct: 210 LDASHNSINV---VRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM 264
Query: 606 PKSLEALLYLKKLNVSYNRLE 626
+ L++L +S NRL
Sbjct: 265 YHPFVKMQRLERLYISNNRLV 285
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 55/335 (16%), Positives = 106/335 (31%), Gaps = 49/335 (14%)
Query: 287 LGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLN 346
+ + + + ++L + + +A + LDLS N S L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 347 LMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIK 406
L N L L + +L L LN N +
Sbjct: 65 LSSNVLYE----------TLDLESLSTLRTLDLNNNYV---------------------- 92
Query: 407 CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC 466
QE+ + L +N ++ + R Q + + L +N +
Sbjct: 93 --------QELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEG 141
Query: 467 HLERLSQLLLNGNNLSG-AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525
R+ L L N + S +L L+L N + + + + ++LS
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLS 199
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN-GPIPES 584
SN L+ + Q + + L N+L I + ++L L GN F+ G + +
Sbjct: 200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLN 619
F ++++ + + + L
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 53/303 (17%), Positives = 122/303 (40%), Gaps = 16/303 (5%)
Query: 74 NLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHN 133
N + +++++ L + ++ ++ + N LS + + ++L++L+ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 134 NSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSE 193
N + D +LS L LDL N + L P +E L+ +N ++ S
Sbjct: 68 NVLYE-TLDL-ESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANN-NISRVSCSR-- 118
Query: 194 CTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG-DMPTAIGNLQMLEHLNLGM 252
+ ++LA+NK + + G S++ L+L N + + + LEHLNL
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 253 NNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI 312
N + V + + ++ ++L N+L+ + + +++L NN + I ++
Sbjct: 179 NFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISL-RNNKLVLIEKAL 233
Query: 313 TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCR 372
+ L DL N F + R + ++ + ++ + +L +
Sbjct: 234 RFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 373 SLT 375
+
Sbjct: 293 AYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 50/346 (14%), Positives = 109/346 (31%), Gaps = 53/346 (15%)
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
+ + + + + S +++ L L+ N S ++ ++L LNL+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 230 NLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH 289
L + +L L L+L N + + +I ++ N +S + +
Sbjct: 69 VLY--ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSN-LFSGHIPHTFGNLRFLRFLNLM 348
+ + L N + S++ LDL N + + + + L LNL
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 349 FNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCE 408
+N + + L L L+ N L
Sbjct: 178 YNFIYD----------VKGQVVFAKLKTLDLSSNKLA----------------------- 204
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQ-GSIPYYLCH 467
+ E + +G+ ++ L +N+L I + Q L+ L N G++ +
Sbjct: 205 ---FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSL 513
+R+ + + ++ L +P+
Sbjct: 261 NQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 58/349 (16%), Positives = 108/349 (30%), Gaps = 49/349 (14%)
Query: 195 THLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNN 254
+ + D+ L + + +L+L+ N L + LE LNL N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 255 LSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITN 314
L + ++ST+R ++L N + L P++E L NN I + S
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHA-ANNNISRVSCSR-- 118
Query: 315 ASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSL 374
+ L++N + G +++L+L N + T + +S L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE----LAASSDT---L 171
Query: 375 TELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELN 434
L L N + + ++ + L L L N+L
Sbjct: 172 EHLNLQYNFIY--------------------------DVKGQV-VFAKLKTLDLSSNKLA 204
Query: 435 GTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS-GAIPACLGSLT 493
+ + +SL +N L I L + L L GN G +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYIL-YVNLSSNSLSGPLPSSIQHLK 541
++ + + ++ + Y L P + L
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 44/283 (15%), Positives = 90/283 (31%), Gaps = 19/283 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+LS L I L + L L++S N Y +L L LR ++ N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQE-- 94
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LPKLEK 175
+ + ++ L NN+ + R+ + + L N ++ D +++
Sbjct: 95 ---LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 176 LYLGSNDFFG-QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L L N+ + L+ L L N + + ++L L+L+ N L
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-F 205
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
M + + ++L N L + + + +L N +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFG 337
+ + + + + L +P F
Sbjct: 265 QTVA---KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 40/233 (17%), Positives = 81/233 (34%), Gaps = 24/233 (10%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+I + N + K+ D+ L + + ++ L L N L L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 472 SQLLLNGNNLSGAIP-----------------ACLGSLTSLRELHLGSNTLTYSIPSSLW 514
L L+ N L + L S+ LH +N ++ S
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 515 SLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSG-DIPITISGLKDLATLSLA 573
+ I L++N ++ + LDL N++ + + L L+L
Sbjct: 121 GKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 574 GNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
N + L++LD+SSN ++ + ++ + +++ N+L
Sbjct: 178 YNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 31/178 (17%), Positives = 68/178 (38%), Gaps = 11/178 (6%)
Query: 460 SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYI 519
+I + R + ++L A+ + S +++EL L N L+ + L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 520 LYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG 579
+NLSSN L ++ L L LDL+ N + + + TL A N +
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 580 PIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRN 637
+ +++ +++N I+ ++ L++ N ++ + +
Sbjct: 114 -VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 36/227 (15%), Positives = 74/227 (32%), Gaps = 17/227 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSG-S 115
L+ ++ ++ + ++ ++ N + G R++ ++ NE+ +
Sbjct: 104 LHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 116 FPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLE 174
F L+ L+ N D + + +KL+ LDL N L+ + + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFS-GRLPENIGNLSQLTDLNLAQNNLQG 233
+ L +N I +L +L+ L N F G L + ++ +
Sbjct: 218 WISLRNNK-LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS 280
+ L H P F RLI L +
Sbjct: 277 GQNEEECTVPTLGHY----GAYCCEDLPAPFA---DRLIALGHHHHH 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 21/283 (7%)
Query: 738 LGRGSFGLVYKGTLF-----DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIF 792
LG+G+FG V G VA+K E R F+ E EIL++++H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 793 SSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
C + + L++E++P GS +L + +D ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGI 909
+H DL NIL++ + DFG++K+L + + + + I + APE +E
Sbjct: 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEVVDANLVGE 966
S DV+S+GV+L E FT + + M + + G + +++ L+
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQMIVFHLIE--LLKN 247
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
C I + +C + QR D A + +IR
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-36
Identities = 75/421 (17%), Positives = 143/421 (33%), Gaps = 57/421 (13%)
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ + + + +++ M ++ +++ + + LP L S +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 295 EFLTLFGNNLIGTIP-NSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
E L L + I I + A + L + N PH F N+ L L L N L+
Sbjct: 78 ELLNL-NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 354 TESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSI 413
+ N LT L+++ N L I
Sbjct: 137 SLPR--------GIFHNTPKLTTLSMSNNNLE--------------------------RI 162
Query: 414 PQEI-GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLS 472
+ + L L+L N L + + L ++ N L ++ +
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLA----IPIAVE 214
Query: 473 QLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGP 532
+L + N+++ + L L L N LT + L + ++ V+LS N L
Sbjct: 215 ELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKI 269
Query: 533 LPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLE 592
+ ++ L L +S N+L + + + L L L+ N + + LE
Sbjct: 270 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 327
Query: 593 SLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGP 652
+L + N+I + L LK L +S+N + ++ FRN + + C
Sbjct: 328 NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKI 383
Query: 653 P 653
Sbjct: 384 D 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 80/438 (18%), Positives = 148/438 (33%), Gaps = 58/438 (13%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
I S+L + + L+ + + ++ + + + +E
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 247 HLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
LNL + + F TI+ + + N + +LP + ++P L L L N +
Sbjct: 79 LLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL-ERNDL 135
Query: 306 GTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSF 364
++P I N KL L +S+N TF L+ L L N LT
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---------- 185
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLM 424
L+ SL ++ N L + +
Sbjct: 186 -VDLSLIPSLFHANVSYNLL------------------------------STLAIPIAVE 214
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGA 484
L N +N + V +L L L N+L +L + L ++ L+ N L
Sbjct: 215 ELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKI 269
Query: 485 IPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLI 544
+ + L L++ +N L ++ + + ++LS N L + + L
Sbjct: 270 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 327
Query: 545 NLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGK 604
NL L N + + +S L L+L+ N ++ + ++ V + K
Sbjct: 328 NLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCK 382
Query: 605 IPKSLEALLYLKKLNVSY 622
I LE L K+ + Y
Sbjct: 383 IDYQLEHGLCCKESDKPY 400
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 90/539 (16%), Positives = 164/539 (30%), Gaps = 98/539 (18%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
+++ + L+ + + L R++ L+N ++
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLE 174
+Q L N+ P N+ L L L N LS SLP I PKL
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 150
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L + +N+ + T LQ L L+ N+ + + + + L N++ N L
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL--- 204
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ + +E L+ N+++ V + L
Sbjct: 205 --STLAIPIAVEELDASHNSINV-VRGPVN---------------------------VEL 234
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
L L NNL T + N L+ +DLS N + H F ++ L L + N L
Sbjct: 235 TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 292
Query: 355 ESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP 414
+ +L L L+ N L +
Sbjct: 293 LN---------LYGQPIPTLKVLDLSHNHLL--------------------------HVE 317
Query: 415 QEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
+ L L LD N + T+ + L+ L+L ND + L +++
Sbjct: 318 RNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARP 372
Query: 475 LLNGNNLSGAIP-------ACLGSLTSLRELHLGSNTLTYSI---------PSSLWSLEY 518
++ + I C S + L LT + S+ ++
Sbjct: 373 AVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS 432
Query: 519 ILYVNLSSNSLSGPLPSSIQHLKVLIN-LDLSRNQLSGDIPITISGLKDLATLSLAGNQ 576
+ ++ G + L+ +N L QL+ + L+ L +
Sbjct: 433 VQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLR 491
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 40/192 (20%), Positives = 72/192 (37%), Gaps = 5/192 (2%)
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
I + + + + + L + + + A L S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 496 RELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSG 555
L+L + + I + + N++ P Q++ +L L L RN LS
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 556 DIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLY 614
+P I L TLS++ N ++F + SL++L +SSN ++ + L +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 193
Query: 615 LKKLNVSYNRLE 626
L NVSYN L
Sbjct: 194 LFHANVSYNLLS 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 21/283 (7%)
Query: 738 LGRGSFGLVYKGTLF-----DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIF 792
LG+G+FG V G VA+K E R F+ E EIL++++H N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 793 SSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
C + + L++E++P GS +L + +D ++ L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGI 909
+H DL NIL++ + DFG++K+L + + + + I + APE +E
Sbjct: 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEVVDANLVGE 966
S DV+S+GV+L E FT + + M + + G + +++ L+
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQMIVFHLIE--LLKN 278
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
C I + +C + QR D A + +IR
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 17/280 (6%)
Query: 738 LGRGSFGLVYKGTLF-----DGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G FG V G VA+K E EILRN+ H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 792 FSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
C L++EF+P+GS +++L +++ Q+L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEG 908
VH DL N+L++ + DFG++K + + + + + + APE +
Sbjct: 147 --YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 909 IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
DV+S+GV L E T + + + T +V+ + E +
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--TRLVN--TLKEGK 260
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+C + L C P R + + +
Sbjct: 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 738 LGRGSFGLVYKGTLFDG-----TNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKG VAIK +A + E ++ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C L+ + MP G ++ + + LN + +A + YL
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---- 137
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+VH DL N+L+ ++DFG++KLLG + I +MA E I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEM 936
+ DV+SYGV + E T KP D +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 20/281 (7%)
Query: 738 LGRGSFGLVYKGTLF-----DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIF 792
LG+G+FG V G VA+K R F E +IL+ + +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 793 SSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
++ LV+E++P+G +L + LD + L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGI 909
VH DL NIL++ ++DFG++KLL D V + + I + APE S+ I
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 910 VSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLP-HGLTEVVDANLVGEE 967
S + DV+S+GV+L E FT K + R + L+ +++ L+ E
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLE--LLEEG 260
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
Q A C + +L C SP+ R + +L +
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-34
Identities = 77/392 (19%), Positives = 128/392 (32%), Gaps = 61/392 (15%)
Query: 194 CTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
L + ++ + LP+ + +T L + NNL +P L+ L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91
Query: 254 NLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSIT 313
L+ +P + + + + L L L +FGN L ++P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPA--------LPSGLCKLWIFGNQLT-SLPVLPP 141
Query: 314 NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRS 373
L L +S N + +P L L N N LT S +
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT---------SLPMLPSG--- 182
Query: 374 LTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNEL 433
L EL+++ N L LP L K A L S+P L L + N L
Sbjct: 183 LQELSVSDNQLA-SLPTLPSE----LYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRL 233
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLT 493
++P +L+ L + N L S+P L LS + N L+ +P L L+
Sbjct: 234 T-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLS 284
Query: 494 SLRELHLGSN---TLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSR 550
S ++L N T + S + + P + L + L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344
Query: 551 NQLSGDIPIT----ISGLKDLATLSLAGNQFN 578
+ P + SL ++ +
Sbjct: 345 AREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 81/359 (22%), Positives = 137/359 (38%), Gaps = 78/359 (21%)
Query: 272 INLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGH 331
+N+ E+ L+ LP L ++ L + NNL ++P L L++S N +
Sbjct: 45 LNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT-S 95
Query: 332 IPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPF 391
+P L L + L S L +L + N L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPS---------------GLCKLWIFGNQLT------ 134
Query: 392 IGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLS 451
S+P L L + DN+L ++P +L L
Sbjct: 135 --------------------SLPVLPPGLQ---ELSVSDNQLA-SLPALPS---ELCKLW 167
Query: 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS 511
Y+N L S+P L+ LS ++ N L+ ++P L L + N LT S+P+
Sbjct: 168 AYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPA 218
Query: 512 SLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLS 571
L+ + +S N L+ LP LK L +S N+L+ +P+ SGL +LS
Sbjct: 219 LPSGLKEL---IVSGNRLTS-LPVLPSELK---ELMVSGNRLT-SLPMLPSGLL---SLS 267
Query: 572 LAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
+ NQ +PES L S ++++ N +S + ++L + + R +
Sbjct: 268 VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-31
Identities = 80/425 (18%), Positives = 132/425 (31%), Gaps = 103/425 (24%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
+ +L+ + T +PD L + L + +N+L+ SLP
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALP-------------- 80
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNL 242
L+TL ++ N+ + LP L +L+ + +L P L
Sbjct: 81 ------------PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGL 123
Query: 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
L + N L+ +P + + + + NQL+ +L L L + N
Sbjct: 124 C---KLWIFGNQLTS-LPVLPPGLQELSVSD---NQLA-----SLPALPSELCKLWAYNN 171
Query: 303 NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQW 362
L ++P + L L +S N + +P L L N SL
Sbjct: 172 QLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPAL------- 219
Query: 363 SFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSG 422
L EL ++ N L S+P L
Sbjct: 220 --------PSGLKELIVSGNRLT--------------------------SLPVLPSELKE 245
Query: 423 LMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLS 482
LM + N L ++P L LS+Y N L +P L HL + + L GN LS
Sbjct: 246 LM---VSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 483 GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKV 542
L +TS + G +S L+ +++ L
Sbjct: 298 ERTLQALREITSA-PGYSGPIIRFDMAGASAPRETRALH-LAAADWLVPAREGEPAPADR 355
Query: 543 LINLD 547
Sbjct: 356 WHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-29
Identities = 73/340 (21%), Positives = 121/340 (35%), Gaps = 60/340 (17%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
LN+ L +P L + +L I +NN LP +LR L + + N+L+ S
Sbjct: 45 LNVGESGLT-TLPDCLPAH--ITTLVIPDNNL-TSLPALPPELRTLEV---SGNQLT-SL 96
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
P L L I S S L L + N L+ SLP P L++L
Sbjct: 97 PVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVLP--PGLQEL 146
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
+ N +P+ S L LW +N+ + LP L +L+++ N L +P
Sbjct: 147 SVSDN-QLASLPALPS---ELCKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLP 197
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH------- 289
T L L N + +L S ++ + + N+L+ LP+
Sbjct: 198 TLPSELYKLWAYNNRLTSLPA-------LPSGLKELIVSGNRLT-SLPVLPSELKELMVS 249
Query: 290 ---------SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLR 340
L L++ N + +P S+ + S ++L N S T LR
Sbjct: 250 GNRLTSLPMLPSGLLSLSV-YRNQLTRLPESLIHLSSETTVNLEGNPLS---ERTLQALR 305
Query: 341 FLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
+ + + S+ R+L A +
Sbjct: 306 EITSAPGYSGPIIR-----FDMAGASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 27/247 (10%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L++S L + P L L N LP L+ L + + N+L+ S
Sbjct: 146 LSVSDNQLASL-PALPSEL---CKLWAYNNQL-TSLPMLPSGLQELSV---SDNQLA-SL 196
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
P+ L +L NN T +P S L+ L + N L+ SLP +L++L
Sbjct: 197 PTLPSELYKLWAY---NNRLT-SLPA---LPSGLKELIVSGNRLT-SLPVLP--SELKEL 246
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
+ N +P + L +L + N+ + RLPE++ +LS T +NL N L
Sbjct: 247 MVSGN-RLTSLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301
Query: 237 TAIGNLQMLEHLNLG---MNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
A+ + + + P + L+ + P H
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361
Query: 294 LEFLTLF 300
+ F
Sbjct: 362 EDNADAF 368
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 32/267 (11%)
Query: 738 LGRGSFGLVYKGTL----FDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK 790
LG GSFG+V +G +VA+K L A F E + ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
++ K +V E P GS L + + + VA + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGI 909
+H DL N+LL + DFG+ + L + DD V Q + APE
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 910 VSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
S D + +GV L E FT ++P + ++++ + E +
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGL-----------------NGSQILHK-IDKEGE 242
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQR 995
DC I ++ + C PE R
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDR 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG+G FG V+ GT T VAIK F E ++++ +RH LV++++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+ + +V E+M GS +L +L + Q +++ +A + Y+ + V
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YV 302
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL+ NIL+ EN+ V+DFG+++L+ E ++ + I + APE G + K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 914 CDVYSYGVLLMETFT 928
DV+S+G+LL E T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-34
Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG G FG V+ T T VA+K + F +E +++ ++H LVK+ +
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+ ++ EFM GS +L S + + ++ +A + ++ + +
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YI 306
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL+ NIL+ ++ ++DFG+++++ E ++ + I + APE + G + K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 914 CDVYSYGVLLMETFT 928
DV+S+G+LLME T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 738 LGRGSFGLVYKGTLFDG---TNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
LG G+FG V +G +VAIKV + E +I+ + + +V++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
C LV+E G K+L + + ++ V++ ++YL + V
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 132
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGIVSA 912
H DL N+LL A +SDFG+SK LG D ++ + + APE + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 913 KCDVYSYGVLLMETFTR-KKPTDEM 936
+ DV+SYGV + E + +KP +M
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 36/291 (12%)
Query: 736 NLLGRGSFGLVYKGTLFDG----TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
++GRG FG VY GTL D + A+K N F +E I+++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 791 IFSSCCNIDFKAL-VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C + L VL +M +G ++ + + + + + VA ++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD--DSVTQTITMATIGYMAPEYGSE 907
VH DL N +LDE T V+DFG+++ + + + +T + +MA E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH-GLT--EVVDANLV 964
+ K DV+S+GVLL E TR G P+ + ++ +
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR---------GAP----------PYPDVNTFDIT--VYL 245
Query: 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015
+ + C + ++ L C E R ++ + + I F+ +
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVF--NLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G G FGLV+ G + VAIK E F E E++ + H LV+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGVC 72
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
LV EFM +G +L + L + +DV + YL ++H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHR 128
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ EN VSDFG+++ + D + T T + + +PE S S+K D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 916 VYSYGVLLMETFTR-KKPTDEM 936
V+S+GVL+ E F+ K P +
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENR 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 32/290 (11%)
Query: 736 NLLGRGSFGLVYKGTLFDG----TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
++GRG FG VY GTL D + A+K N F +E I+++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 791 IFSSCCNIDFKAL-VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C + L VL +M +G ++ + + + + + VA +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT--IGYMAPEYGSE 907
VH DL N +LDE T V+DFG+++ + + + T A + +MA E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 908 GIVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
+ K DV+S+GVLL E TR P ++ T + + L G
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQG------------ 312
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQS 1016
+ C + ++ L C E R ++ + + I F+ +
Sbjct: 313 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 735 CNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG+G FG V+ GT T VAIK F E ++++ +RH LV++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+ + +V E+M GS +L +L + Q +++ +A + Y+ + V
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YV 385
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL+ NIL+ EN+ V+DFG+++L+ E ++ + I + APE G + K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 914 CDVYSYGVLLMETFT 928
DV+S+G+LL E T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVF--NLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G FG+V G +VA+K+ E F E + + + H LVK + C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFF---QEAQTMMKLSHPKLVKFYGVC 72
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V E++ NG +L S+ L+ Q L + DV + +L +H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ----FIHR 128
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+D ++ VSDFG+++ + D V+ T + + APE S+K D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 916 VYSYGVLLMETFTR-KKPTDEM 936
V+++G+L+ E F+ K P D
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLY 209
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 76/338 (22%), Positives = 124/338 (36%), Gaps = 41/338 (12%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
L L N + + + L L+L+ N+ S P F NL LR L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
L T +LT+L ++ N + +L F
Sbjct: 92 LKLIPL--------GVFTGLSNLTKLDISENKIVILLD---YMFQ--------------- 125
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYY-LCH 467
+L L L++ DN+L I F L+ L+L +L SIP L H
Sbjct: 126 -------DLYNLKSLEVGDNDLV-YISH--RAFSGLNSLEQLTLEKCNLT-SIPTEALSH 174
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
L L L L N++ L L+ L + ++ + + ++++
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 528 SLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGS 587
+L+ +++HL L L+LS N +S + L L + L G Q P +F
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294
Query: 588 LISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
L L L+VS N ++ ++ L+ L + N L
Sbjct: 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 72/336 (21%), Positives = 117/336 (34%), Gaps = 38/336 (11%)
Query: 53 RVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL 112
L+L + + + L L+++EN + +
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI--------------VSAVE------ 72
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RL 170
G+F + L L+ L +N LS L LD+ EN + L + + L
Sbjct: 73 PGAFNN----LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL 127
Query: 171 PKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNN 230
L+ L +G ND + S L+ L L + E + +L L L L N
Sbjct: 128 YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 231 LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHS 290
+ + L L+ L + + P + +++ L+ +P
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
Query: 291 LPNLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMF 349
L L FL L N I TI S+ +L + L + P+ F L +LR LN+
Sbjct: 247 LVYLRFLNL-SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
N LTT S + +L L L+ NPL
Sbjct: 306 NQLTTLEE--------SVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 79/373 (21%), Positives = 131/373 (35%), Gaps = 49/373 (13%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
GI + ++L N D + LE L+L EN +S ++ L L L L
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGL 87
Query: 179 GSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPT 237
SN IP + ++L L +++NK L +L L L + N+L
Sbjct: 88 RSN-RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146
Query: 238 AIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
A L LE L L NL+ +P ++ + ++ L ++ + L L+
Sbjct: 147 AFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSF-KRLYRLKV 204
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPH-TFGNLRFLRFLNLMFNSLTTE 355
L + + T+ + L L ++ + +P+ +L +LRFLNL +N ++T
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ 415
S L L E+ L L + P F
Sbjct: 264 EG--------SMLHELLRLQEIQLVGGQLAVVEP---YAFR------------------- 293
Query: 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLL 475
L+ L L + N+L + L+ L L N L C L + +
Sbjct: 294 ---GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD-----CRLLWVFR-R 344
Query: 476 LNGNNLSGAIPAC 488
N + P C
Sbjct: 345 RWRLNFNRQQPTC 357
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-32
Identities = 83/369 (22%), Positives = 134/369 (36%), Gaps = 46/369 (12%)
Query: 192 SECT---HLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
C + + +F +PE I ++ L+L +N ++ + LE L
Sbjct: 5 PRCECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 249 NLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT 307
L N +S V P F N+ +R + L N+L +PL + L NL L + N I
Sbjct: 62 ELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI-SENKIVI 118
Query: 308 IPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLS 366
+ + + + L L++ N F L L L L +LT+ + A
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA------- 171
Query: 367 SLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFL 426
L++ L L L + I +F L L L
Sbjct: 172 -LSHLHGLIVLRLRHLNINAIRD---YSFK----------------------RLYRLKVL 205
Query: 427 KLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGAI 485
++ T+ L LS+ +L ++PY HL L L L+ N +S
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIE 264
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
+ L L L+E+ L L P + L Y+ +N+S N L+ S + L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 546 LDLSRNQLS 554
L L N L+
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 62/321 (19%), Positives = 102/321 (31%), Gaps = 61/321 (19%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
LDL N F + L L L N ++ A N +L L L
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA--------FNNLFNLRTLGLR 88
Query: 381 VNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI-GNLSGLMFLKLDDNELNGTIPT 439
N L+ IP + LS L L + +N++ +
Sbjct: 89 SNRLK--------------------------LIPLGVFTGLSNLTKLDISENKIV-ILLD 121
Query: 440 TVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELH 499
+ FQ L L L + N+L L SL +L
Sbjct: 122 YM--FQ---------------------DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT 158
Query: 500 LGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPI 559
L LT +L L ++ + L +++ S + L L L++S +
Sbjct: 159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 560 TISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLN 619
+L +LS+ + L+ L L++S N IS L LL L+++
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278
Query: 620 VSYNRLEGEIPIKGPFRNFSA 640
+ +L + FR +
Sbjct: 279 LVGGQLA-VVE-PYAFRGLNY 297
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 46/219 (21%), Positives = 78/219 (35%), Gaps = 3/219 (1%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++P+ I + L L N + F L+ L L +N + P +L L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
L L N L L++L +L + N + + L + + + N L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
+ L L L L + L+ +S L L L L N SF L L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
+ L++S + + L L L++++ L +P
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 738 LGRGSFGLVYKGTLFDGTN----VAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKIF 792
+G G G V G L VAIK ER R F SE I+ H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
+V E+M NGS + +L +++ I+Q + ++ V + YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG----Y 172
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-TQTITMATIGYMAPEYGSEGIVS 911
VH DL N+L+D N+ VSDFG+S++L + D+ T T I + APE + S
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEM 936
+ DV+S+GV++ E ++P M
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-33
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVK 790
F ++LG G+ G + +FD +VA+K + F D E ++LR H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSL 849
F + + F+ + +E + ++++ ++ L+ + ++ L +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138
Query: 850 APIVHCDLKPNNILLDE-----NMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPE 903
IVH DLKP+NIL+ + A +SDFG+ K L G S ++ + T G++APE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 904 Y---GSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+ + D++S G + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 738 LGRGSFGLVYKGTL----FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIF 792
+G G FG V G L +VAIK + E+ R F E I+ H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
+V E+M NGS + +L ++ ++Q + ++ +A ++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG----Y 168
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-TQTITMATIGYMAPEYGSEGIVS 911
VH DL NIL++ N+ VSDFG+ ++L + ++ T I + +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970
+ DV+SYG++L E + ++P EM +V+ A V E
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGYRL 269
Query: 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DC ++ L LDC + R + L K+
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 35/267 (13%)
Query: 738 LGRGSFGLVYKGTLFDG-----TNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG VYKG VAIK +A + E ++ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C L+ + MP G ++ + + LN + +A + YL
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---- 137
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+VH DL N+L+ ++DFG++KLLG + I +MA E I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE--EQ 968
+ DV+SYGV + E T KP D + +E+ GE Q
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI-----------------PASEISSILEKGERLPQ 240
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQR 995
C + + + + C M + R
Sbjct: 241 P----PICTIDVYMIMVKCWMIDADSR 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 6/191 (3%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG+V G +VAIK+ + F E +++ N+ H LV+++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDL 857
++ E+M NG +L + Q L + DV +EYL +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRDL 146
Query: 858 KPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVY 917
N L+++ VSDFG+S+ + D+ + + + + PE S+K D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 918 SYGVLLMETFT 928
++GVL+ E ++
Sbjct: 206 AFGVLMWEIYS 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 67/291 (23%), Positives = 116/291 (39%), Gaps = 23/291 (7%)
Query: 738 LGRGSFGLVYKGTL-----FDGTNVAIKVFNLQ---LERAFRTFDSECEILRNVRHRNLV 789
LG G FG V G VA+K L+ + + E +ILR + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 790 KIFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
K C + + LV+E++P GS +L ++ + + Q L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGS 906
+H DL N+LLD + + DFG++K + EG + + + + + APE
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
E DV+S+GV L E T + T + L + + + + L+
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV--LRLTE--LLER 266
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQSS 1017
+ C + L +C R + LK + K+ Q+
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-33
Identities = 98/500 (19%), Positives = 175/500 (35%), Gaps = 60/500 (12%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
+ R + LS NS ++ + LS+L L L N + SL + LE L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 179 GSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRLPEN--IGNLSQLTDLNLAQNNLQGDM 235
N ++ + S L+ L L+ N F LP GNL++LT L L+ +
Sbjct: 108 SHN----RLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 236 PTAIGNLQ-MLEHLNLGMNNLSGPVPPTIFNISTIRL-INLIENQLSGHLPLTLGHSLPN 293
+ +L L+L ++ G ++ +T L + N L ++L +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222
Query: 294 LEFLTL---------FGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRF 344
L+ + L L ++ + F R + +
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEY 280
Query: 345 LNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEA 404
LN+ ++T ++ + +L L + + L +S
Sbjct: 281 LNIYNLTIT------ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS-------- 326
Query: 405 IKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY 464
+ + L ++ L+ N S+
Sbjct: 327 --------------VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 465 LCHLERLSQLLLNGNNLS--GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSL-EYILY 521
L+RL L+L N L + +++SL L + N+L + E IL
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 522 VNLSSNSLSGPLPSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGP 580
+NLSSN L+G + + +KVL DL N++ IP ++ L+ L L++A NQ
Sbjct: 433 LNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488
Query: 581 IPESFGSLISLESLDVSSNN 600
F L SL+ + + N
Sbjct: 489 PDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 90/465 (19%), Positives = 169/465 (36%), Gaps = 23/465 (4%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+P L + L L+ N S +I LS+L L L+ N ++ Q L
Sbjct: 45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG-HSLPNLEFLTLFGNNL 304
E+L++ N L + +++R ++L N LP+ +L L FL L
Sbjct: 103 EYLDVSHNRLQN-ISCCPM--ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 305 IGTIPNSITNAS-KLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWS 363
+ + I LDL S G + L+L+F+ + S +
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV-LHLVFHPNSLFSVQVNMSV 217
Query: 364 FLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIP-QEIGNLSG 422
++ N L L + + I+ K S+ +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 423 LMFLKLDDNELNGTIPTTVGRF-----QQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN 477
+ +L + + + I + + L + + S ++ +L+
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 478 GNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS--GPLPS 535
++ C S +S L+ N T S+ +L+ + + L N L +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
Query: 536 SIQHLKVLINLDLSRNQL-SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
+++ L LD+S N L S T + + + L+L+ N G + ++ L
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVL 455
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFS 639
D+ +N I IPK + L L++LNV+ N+L+ +P G F +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 8e-19
Identities = 68/351 (19%), Positives = 126/351 (35%), Gaps = 30/351 (8%)
Query: 51 HHRVVALNLSSFSLGGIIPPHL--GNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFA 108
H + L+L S+ + G L N + L + + F + + L L+L N
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 109 YNELSG----SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNL---SKLEFLDLMENSLS 161
N+ + +F S + L ++ + T + L +E+L++ +++
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 162 GSLPNDI------RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI 215
+ + L L ++ + F + S + L+ +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 216 GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF---NISTIRLI 272
+ S T LN QN + L+ L+ L L N L N+S++ +
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETL 408
Query: 273 NLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHI 332
++ N L+ H ++ L L N L G++ + K+ LDL +N I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SI 465
Query: 333 PHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNP 383
P +L+ L+ LN+ N L S P SL + L+ NP
Sbjct: 466 PKDVTHLQALQELNVASNQLK--SVPD------GVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 11/157 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPN---ELGKLRRLRLINFAYNEL- 112
LN + + L L +L + N + + L ++ + N L
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLN 416
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLP 171
S ++ + +L+ +N T + L K++ LDL N + S+P D+ L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 172 KLEKLYLGSNDFFGQIP-SSLSECTHLQTLWLADNKF 207
L++L + SN +P T LQ +WL DN +
Sbjct: 474 ALQELNVASN-QLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 725 IQRATDGFNECNLLGRGSFGLVYKGTLFDG----TNVAIKVFN-LQLERAFRTFDSECEI 779
I + ++G+G FG+VY G D AIK + + + F E +
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 780 LRNVRHRNLVKIFSSCCNID-FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL 838
+R + H N++ + + ++L +M +G +++ S + ++ + VA
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT-- 896
+EYL VH DL N +LDE+ T V+DFG+++ + + + Q A
Sbjct: 136 GMEYLAEQK----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 929
+ + A E + K DV+S+GVLL E TR
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 35/267 (13%)
Query: 738 LGRGSFGLVYKGTLFDG-----TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKI 791
LG G FG V+KG V IKV + ++F+ + ++ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
C LV +++P GS + + L LN + +A + YL
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---- 135
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+VH +L N+LL V+DFG++ LL D + + I +MA E G +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE--EQ 968
+ DV+SYGV + E T +P + L EV D GE Q
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGL-----------------RLAEVPDLLEKGERLAQ 238
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQR 995
C + + + + C M R
Sbjct: 239 P----QICTIDVYMVMVKCWMIDENIR 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH 785
R F E +LG+G+FG V K D AIK E T SE +L ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 786 RNLVKIFSSCCNIDFKA-------------LVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
+ +V+ +++ + +E+ NG+ ++S N + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
+ L Y+H I+H DLKP NI +DE+ + DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 893 TMAT---------IG---YMAPE-YGSEGIVSAKCDVYSYGVLLME 925
IG Y+A E G + K D+YS G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 738 LGRGSFGLVYKGTLFDGTN-----VAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKI 791
+G G FG VYKG L + VAIK E+ F E I+ H N++++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
++ E+M NG+ +K+L + +LQ + ++ +A ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---- 167
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT---IGYMAPEYGSEG 908
VH DL NIL++ N+ VSDFG+S++L DD T I + APE S
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 909 IVSAKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967
++ DV+S+G+++ E T ++P + +S EV+ A + +
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP----YWE-LSNH------------EVMKA--INDG 266
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DC +I L + C + +R D + L K+
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/265 (25%), Positives = 107/265 (40%), Gaps = 32/265 (12%)
Query: 738 LGRGSFGLVYKGTL---FDGTNVAIKVF--NLQLERAFRTFDSECEILRNVRHRNLVKIF 792
LG G+FG V KG VA+K+ +E +++ + + +V++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
C + LV+E G K+L N + + ++ V++ ++YL +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN----F 138
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGIVS 911
VH DL N+LL A +SDFG+SK L ++ QT + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 912 AKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970
+K DV+S+GVL+ E F+ +KP M E V L G +
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKG-------------ERM 239
Query: 971 SAKTDCLLSIMDLALDCCMESPEQR 995
C + DL C E R
Sbjct: 240 GCPAGCPREMYDLMNLCWTYDVENR 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 738 LGRGSFGLVYKGTLFDG----TNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKI 791
LG G FG V +G L VA+K L +R F SE +++ H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 792 FSSCCNIDFKA-----LVLEFMPNGSFEKWL-----YSYNYFLDILQRLNIMIDVALVLE 841
C + + ++L FM G +L + + + L M+D+AL +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL + + +H DL N +L ++MT V+DFG+SK + GD I + ++A
Sbjct: 162 YLSNRN----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTR 929
E ++ + ++K DV+++GV + E TR
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 81/430 (18%), Positives = 144/430 (33%), Gaps = 72/430 (16%)
Query: 122 ILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLG 179
+ + + + NS + L L+FL + + + + N+ L L L L
Sbjct: 28 LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 180 SNDFFGQIPSS-LSECTHLQTLWLADNKF-SGRLPENI-GNLSQLTDLNLAQNNLQGDMP 236
N F Q+ + + +L+ L L L N L+ L L L NN++ P
Sbjct: 88 YNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 237 TAI-GNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ N++ L+L N + + N L L ++
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLL---------------RLSSI 190
Query: 295 EFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRF---LRFLNLMFNS 351
+ L + + + LDLS N F + F + ++ L L +
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 352 LTTESSPADQWSFLSSLT----NCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKC 407
S + + T + L+ + +
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF---------------------- 288
Query: 408 ELKGSIPQEI-GNLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYL 465
++ + + + + L L L NE+N I L L+L N L SI +
Sbjct: 289 ----ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRM 342
Query: 466 CH-LERLSQLLLNGNNLSGAIPACL-GSLTSLRELHLGSNTLTYSIP----SSLWSLEYI 519
L++L L L+ N++ A+ L +L+EL L +N L S+P L SL+ I
Sbjct: 343 FENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKI 400
Query: 520 LYVNLSSNSL 529
L +N
Sbjct: 401 ---WLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 80/413 (19%), Positives = 134/413 (32%), Gaps = 43/413 (10%)
Query: 195 THLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPT-AIGNLQMLEHLNLGMN 253
H+ + L+ N + + L L L + Q + L L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 254 NLSGPVPPTIF-NISTIRLINLIENQL-SGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNS 311
+ F ++ + ++ L + L L L +LE L L NN+ P S
Sbjct: 90 QFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 312 I-TNASKLIGLDLSSNLFSGHIPHTFGNL--RFLRFLNLMFNSLTTESSPADQWSFLSSL 368
N + LDL+ N N + L L +L + W +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 369 TNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKL 428
S+T L L+ N + + F ++ + L + + F
Sbjct: 209 FKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLILS-NSYNMGSSFGHTNFKDP 264
Query: 429 DDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGAIPA 487
D+ G + ++ L + + ++ + H L QL L N ++
Sbjct: 265 DNFTFKGLEAS------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDN 317
Query: 488 CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLD 547
LT L +L+L N L SI ++L L LD
Sbjct: 318 AFWGLTHLLKLNLSQNFLG-SID-----------------------SRMFENLDKLEVLD 353
Query: 548 LSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNN 600
LS N + + GL +L L+L NQ F L SL+ + + +N
Sbjct: 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 74/377 (19%), Positives = 123/377 (32%), Gaps = 63/377 (16%)
Query: 267 STIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIP-NSITNASKLIGLDLSS 325
+ + ++L N ++ L T L +L+FL + I N+ S LI L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 326 NLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
N F F L L L L +L + SL L L N ++
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGN------FFKPLTSLEMLVLRDNNIK 142
Query: 386 GILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ 445
I P F N+ L L N++ +I
Sbjct: 143 KIQP--ASFFL----------------------NMRRFHVLDLTFNKVK-SICE--EDLL 175
Query: 446 QLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTL 505
QG L ++ +N L TS+ L L N
Sbjct: 176 NFQGKHFTLLRLS-----------SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224
Query: 506 TYSIPSSLWSL-------------EYILYVNLSSNSLSGPLPSSIQHLKV--LINLDLSR 550
S+ + Y + + + P + + L+ + DLS+
Sbjct: 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK 284
Query: 551 NQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSL 609
+++ + ++ S DL L+LA N+ N +F L L L++S N + +
Sbjct: 285 SKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF 343
Query: 610 EALLYLKKLNVSYNRLE 626
E L L+ L++SYN +
Sbjct: 344 ENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 71/368 (19%), Positives = 132/368 (35%), Gaps = 57/368 (15%)
Query: 57 LNLSSFSLGGIIPPHL-GNLSFLVSLDISENNFYGHLPNE-LGKLRRLRLINFAYNELS- 113
L + + G +I + LS L+ L + N F L L L ++ L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 114 -----GSFPSWIGILSRLQILSFHNNSFTDRIPD-FLLNLSKLEFLDLMENSLSGSLPND 167
F L+ L++L +N+ P F LN+ + LDL N + S+ +
Sbjct: 118 AVLSGNFFKP----LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEE 172
Query: 168 I------------RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI 215
RL + + + + + T + TL L+ N F + +
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 216 GNLSQLTDL-----NLAQNNLQGDMPTAIGNLQM----------LEHLNLGMNNLSGPVP 260
+ T + + + N T + ++ +L + + +
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LL 291
Query: 261 PTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI-TNASKL 318
++F + + + + L +N+++ + L +L L L N +G+I + + N KL
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNL-SQNFLGSIDSRMFENLDKL 349
Query: 319 IGLDLSSNLFSGHIPH-TFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTEL 377
LDLS N + +F L L+ L L N L + LT SL ++
Sbjct: 350 EVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGI-----FDRLT---SLQKI 400
Query: 378 ALNVNPLR 385
L+ NP
Sbjct: 401 WLHTNPWD 408
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 738 LGRGSFGLVYKGTLFDG---TNVAIKVF-NLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
LG G+FG V +G +VAIKV + E +I+ + + +V++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
C LV+E G K+L + + ++ V++ ++YL + V
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FV 458
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMAPEYGSEGIVSA 912
H +L N+LL A +SDFG+SK LG D ++ + + APE + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 913 KCDVYSYGVLLMETFTR-KKPTDEM 936
+ DV+SYGV + E + +KP +M
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-32
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 15/223 (6%)
Query: 735 CNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFS 793
+ LG G +G VY+G VA+K F E +++ ++H NLV++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
C ++ EFM G+ +L N + + L + ++ +EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----F 339
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
+H +L N L+ EN V+DFG+S+L+ GD I + APE + S
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 913 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHG 954
K DV+++GVLL E T P + + V E L
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD 435
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 20/209 (9%)
Query: 738 LGRGSFGLVYKGTLFDGTN----VAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIF 792
+G G FG V++G N VAIK + F E +R H ++VK+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 793 SSCCN----IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
I ++E G +L Y LD+ + ++ L YL
Sbjct: 83 GVITENPVWI-----IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
VH D+ N+L+ N + DFG+S+ + E + I +MAPE +
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR 192
Query: 909 IVSAKCDVYSYGVLLMETFTR-KKPTDEM 936
++ DV+ +GV + E KP +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 738 LGRGSFGLVYKGTLFDG----TNVAIKVF--NLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG+G FG V + L VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 792 FSSCCNIDFKA------LVLEFMPNGSFEKWL-----YSYNYFLDILQRLNIMIDVALVL 840
K ++L FM +G +L + L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
EYL + +H DL N +L E+MT V+DFG+S+ + GD + + ++
Sbjct: 151 EYLSSRN----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFTR 929
A E ++ + + DV+++GV + E TR
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 51/192 (26%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
LG G FG V+ G T VA+K F +E +++ ++H+ LV++++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 798 IDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856
+ ++ E+M NGS +L + + L I + L++ +A + ++ + +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDV 916
L+ NIL+ + ++ ++DFG+++L+ E ++ + I + APE + G + K DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 917 YSYGVLLMETFT 928
+S+G+LL E T
Sbjct: 194 WSFGILLTEIVT 205
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 29/229 (12%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR 784
+R F E L+G G FG V+K DG IK E+A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 785 HRNLVKIFSSCCNIDFKA----------------LVLEFMPNGSFEKWLYSYN-YFLDIL 827
H N+V D+ + +EF G+ E+W+ LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 828 QRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
L + + ++Y+H +++ DLKP+NI L + + DFG+ L
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
T+ YM+PE S + D+Y+ G++L E E
Sbjct: 179 TRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 55/270 (20%), Positives = 119/270 (44%), Gaps = 17/270 (6%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
+ +L NN T+ NL L L L+ N +S + L KLE+LYL
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYL 107
Query: 179 GSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQGDM-- 235
N ++P + LQ L + +N+ + ++ +++ L+Q+ + L N L+
Sbjct: 108 SKNQ-LKELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 236 PTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLE 295
A ++ L ++ + N++ +P + ++ ++L N+++ + L NL
Sbjct: 164 NGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLA 219
Query: 296 FLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTE 355
L L N++ S+ N L L L++N +P + ++++ + L N+++
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-- 276
Query: 356 SSPADQWSFLSSLTNCRSLTELALNVNPLR 385
+ ++ + T S + ++L NP++
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 59/282 (20%), Positives = 106/282 (37%), Gaps = 21/282 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+L + + I NL L +L + N P L +L + + N+L
Sbjct: 57 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 115
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSL-SGSLPNDI--RLPK 172
P + LQ L H N T ++ + L+++ ++L N L S + N + K
Sbjct: 116 PE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 173 LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNL 231
L + + + IP L L L L NK + ++ L+ L L L+ N++
Sbjct: 173 LSYIRIADTN-ITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSI 228
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS-----GHLPLT 286
++ N L L+L N L VP + + I+++ L N +S P
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 287 LGHSLPNLEFLTLFGNNLIGTI--PNSITNASKLIGLDLSSN 326
+ ++LF N + P++ + L +
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 66/341 (19%), Positives = 114/341 (33%), Gaps = 70/341 (20%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
P+ L L N + N L L L +N S P F L L L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
L ++L EL ++ N + + F+
Sbjct: 112 LKELPEKM----P-------KTLQELRVHENEITKVRK---SVFN--------------- 142
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
L+ ++ ++L N L+ + + QG +++L
Sbjct: 143 -------GLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKL 173
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
S + + N++ IP G SL ELHL N +T +SL L + + LS NS+S
Sbjct: 174 SYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG------PIPESF 585
S+ + L L L+ N+L +P ++ K + + L N + P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 586 GSLISLESLDVSSNNISGKI--PKSLEALLYLKKLNVSYNR 624
S + + SN + P + + + + +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 66/327 (20%), Positives = 118/327 (36%), Gaps = 53/327 (16%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
+P L L L +NK + + NL L L L N + P A L LE
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 247 HLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL-I 305
L L N L +P + T++ + + EN+++ + ++ + L + + L N L
Sbjct: 104 RLYLSKNQLKE-LPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 306 GTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSF 364
I N KL + ++ + IP G L L+L N +T +
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDA------- 209
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLM 424
+SL +L +L L+ N + + G+ + N L
Sbjct: 210 -ASLKGLNNLAKLGLSFNSISAVDN---GSLA----------------------NTPHLR 243
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG------SIPYYLCHLERLSQLLLNG 478
L L++N+L +P + + +Q + L++N++ P Y S + L
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 479 NNLS-GAIPACL-GSLTSLRELHLGSN 503
N + I + + LG+
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 13/222 (5%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+P+++ L L +N++ + L L L +N + P L +L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSSNSL- 529
+L L+ N L +P +L+EL + N +T + S+++ L ++ V L +N L
Sbjct: 103 ERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 530 SGPLPSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
S + + Q +K L + ++ ++ I L L L GN+ S L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGL 215
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
+L L +S N+IS SL +L++L+++ N+L ++P
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 30/153 (19%), Positives = 56/153 (36%), Gaps = 22/153 (14%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS----GSFPSWIGIL 123
IP L L L + N L L L + ++N +S GS +
Sbjct: 186 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN----T 239
Query: 124 SRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--------RLPKLEK 175
L+ L +NN ++P L + ++ + L N++S ++ ++ +
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 297
Query: 176 LYLGSNDF-FGQIPSSLSEC-THLQTLWLADNK 206
+ L SN + +I S C + L + K
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
+ S L +P + D A L L N+ F +L +L +L + +N IS
Sbjct: 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIPIKGPFRN 637
P + L+ L++L +S N+L+ E+P + +
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELP-EKMPKT 122
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 738 LGRGSFGLVYKGTLFDG----TNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKIF 792
LG G FG VY+G + NVA+K F SE I++N+ H ++VK+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
+ +++E P G +L L +L + + + + YL +
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----C 134
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
VH D+ NIL+ + DFG+S+ + E +D ++T I +M+PE + +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 913 KCDVYSYGVLLMETFTR-KKPTDEM 936
DV+ + V + E + K+P +
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 18/236 (7%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNL--QLERAFRTFDSECEILRNVRHRNLVKIFS 793
+GRGSF VYKG VA + + F E E+L+ ++H N+V+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 794 SCCNIDFKA----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
S + LV E M +G+ + +L + I + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLHTRTP- 150
Query: 850 APIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEYGSE 907
PI+H DLK +NI + + + D G++ L + + T +MAPE E
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYEE 204
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963
DVY++G+ ++E T + P E RR P +V +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 14/193 (7%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC- 796
+G+G FG V G + G VA+K ++ + + F +E ++ +RH NLV++
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+V E+M GS +L S L L +DV +EYL + VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHR 313
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N+L+ E+ A VSDFG++K + S TQ + + APE E S K D
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 916 VYSYGVLLMETFT 928
V+S+G+LL E ++
Sbjct: 369 VWSFGILLWEIYS 381
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 27/219 (12%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
+G GS+G K DG + K + E + SE +LR ++H N+V+ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 794 SCCNIDFKAL--VLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ L V+E+ G + +LD L +M + L L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 849 LA-PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---- 903
++H DLKP N+ LD + DFG++++L D S +T T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 904 --YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
Y K D++S G LL E P FT
Sbjct: 191 MSYNE------KSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-30
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 11/196 (5%)
Query: 738 LGRGSFGLVYKGTLFDGTN----VAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIF 792
+G G FG V++G N VAIK + F E +R H ++VK+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
+ +++E G +L + LD+ + ++ L YL
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR----F 512
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSA 912
VH D+ N+L+ N + DFG+S+ + E + I +MAPE + ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 913 KCDVYSYGVLLMETFT 928
DV+ +GV + E
Sbjct: 572 ASDVWMFGVCMWEILM 587
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 8/194 (4%)
Query: 738 LGRGSFGLVYKGTLFDG-TNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG G +G VY+G VA+K F E +++ ++H NLV++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 797 NIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
++ EFM G+ +L N + + L + ++ +EYL + +H
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHR 135
Query: 856 DLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCD 915
DL N L+ EN V+DFG+S+L+ GD I + APE + S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 916 VYSYGVLLMETFTR 929
V+++GVLL E T
Sbjct: 195 VWAFGVLLWEIATY 208
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 24/213 (11%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL--VKI 791
+G G V++ AIK NL+ + ++ +E L ++ + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLA 850
+ + +V+E N WL D +R + ++ + +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE------- 903
IVH DLKP N L+ + M + DFGI+ + SV + + T+ YM PE
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 904 ----YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
S+ +S K DV+S G +L K P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 64/299 (21%), Positives = 121/299 (40%), Gaps = 44/299 (14%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
LG+GSFG+VY+G T VAIK N R F +E +++ ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL---------YSYNYFLDILQRLNIMIDVALVLE 841
+ +++E M G + +L + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YL+ VH DL N ++ E+ T + DFG+++ + E D + + +M+
Sbjct: 153 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH-GLT--EV 958
PE +G+ + DV+S+GV+L E T E P+ GL+ +V
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PYQGLSNEQV 249
Query: 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQSS 1017
+ V E +C + +L C +P+ R + + +K+ ++ S
Sbjct: 250 LR--FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVK 790
LG G+FG VY+G + VA+K + E+ F E I+ H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL------YSYNYFLDILQRLNIMIDVALVLEYLH 844
+ +++E M G + +L S L +L L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 845 HGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
H +H D+ N LL A + DFG+++ + M + +M
Sbjct: 158 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFT 928
PE EGI ++K D +S+GVLL E F+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 737 LLGRGSFGLVYKGTLFD---GTNVAIKVFNLQLER--AFRT-FDSECEILRNVRHRNLVK 790
L+GRG G VY+ D VA+K+ + L FRT E ++ ++V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 791 IFSSCCNIDFKA------LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
I DF + + + L L + + I+ + L+ H
Sbjct: 99 IH------DFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAH 151
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT-ITMATIGYMAPE 903
H D+KP NIL+ + A++ DFGI+ D+ +TQ T+ T+ YMAPE
Sbjct: 152 AAG----ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPE 205
Query: 904 YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
SE + + D+Y+ +L E T P + G+
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 13/210 (6%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIK---VFNLQLERAFRTFDSECEILRNVRH 785
F +GRG F VY+ L DG VA+K +F+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEY 842
N++K ++S + +VLE G + + + + + + LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
+H ++H D+KP N+ + + D G+ + + ++ T YM+P
Sbjct: 152 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E E + K D++S G LL E + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
+G GSFG DG IK N+ + E +L N++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
S +V+++ G K + + Q L+ + + L L+++H I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----I 146
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE------YGS 906
+H D+K NI L ++ T + DFGI+++L + + T Y++PE Y +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP 932
K D+++ G +L E T K
Sbjct: 205 ------KSDIWALGCVLYELCTLKHA 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVR 784
R F LGRG FG+V++ D N AIK L E A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 785 HRNLVKIFSSCCNIDFKA------------LVLEFMPNGSFEKWL--YSYNYFLDILQRL 830
H +V+ F++ + + ++ + + W+ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
+I + +A +E+LH ++H DLKP+NI + V DFG+ + + ++ T
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 891 TITMATIG----------YMAPEYGSEGIVSAKCDVYSYGVLLME 925
M YM+PE S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G+G FG V G G VA+K ++ + + F +E ++ +RH NLV++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 796 C-NIDFKALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
+V E+M GS +L S L L +DV +EYL + V
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FV 139
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
H DL N+L+ E+ A VSDFG++K + S TQ + + APE E S K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 914 CDVYSYGVLLMETFT 928
DV+S+G+LL E ++
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-30
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 41/229 (17%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQ-LERAFRTFDSECEILR-NV 783
Q + +LG GS G V F G VA+K + + A E ++L +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESD 66
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRL------NIMIDVA 837
H N+++ + S F + LE N + + + S N + L+ +++ +A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 838 LVLEYLH-HGHSLAPIVHCDLKPNNILLD-------------ENMTAHVSDFGISKLLGE 883
+ +LH I+H DLKP NIL+ EN+ +SDFG+ K L
Sbjct: 126 SGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 884 GDDSVTQTITMA--TIGYMAPE-------YGSEGIVSAKCDVYSYGVLL 923
G S + T G+ APE ++ ++ D++S G +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-30
Identities = 79/473 (16%), Positives = 151/473 (31%), Gaps = 58/473 (12%)
Query: 163 SLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLT 222
S + + + S + L +L ++ + I L+ LT
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLT 67
Query: 223 DLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGH 282
L NN+ + + L +L N L+ + ++ + +N N+L+
Sbjct: 68 KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-K 120
Query: 283 LPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFL 342
L ++ P L +L N + I +++ ++L LD N + L
Sbjct: 121 LDVS---QNPLLTYLNC-ARNTLTEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQL 172
Query: 343 RFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKF 402
L+ FN +T ++ + L L + N + + N L
Sbjct: 173 TTLDCSFNKITE-----------LDVSQNKLLNRLNCDTNNITKL--DLNQN--IQLTFL 217
Query: 403 EAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP 462
+ +L I + L+ L + N L + V +L L DL I
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID 270
Query: 463 YYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYV 522
L H +L G + + T L L + +T S L Y+
Sbjct: 271 --LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQNPKLVYL--- 323
Query: 523 NLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIP 582
L++ L+ L + H L +L + D ++ + L A Q
Sbjct: 324 YLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPK 378
Query: 583 ESFGSL-----ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
E+ + +S + LD N ++ I + +++ L + P
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 78/488 (15%), Positives = 148/488 (30%), Gaps = 80/488 (16%)
Query: 74 NLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHN 133
N + V+ +L L L N + +++G I L+ L L +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG-----IEKLTGLTKLICTS 73
Query: 134 NSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSE 193
N+ T + L + L +L N L+ +L L KL L +N +S+
Sbjct: 74 NNITT-LD--LSQNTNLTYLACDSNKLT-NLDVT-PLTKLTYLNCDTNKL---TKLDVSQ 125
Query: 194 CTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
L L A N + + + + +QLT+L+ N + L L+ N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFN 180
Query: 254 NLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSIT 313
++ + + +N N ++ L L L FL N L I +T
Sbjct: 181 KITE---LDVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VT 230
Query: 314 NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRS 373
++L D S N + + L L L+ + L LT+
Sbjct: 231 PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE-----------IDLTHNTQ 276
Query: 374 LTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNEL 433
L L ++ + + L L +
Sbjct: 277 LIYFQAEGCRKIKEL---------------------------DVTHNTQLYLLDCQAAGI 309
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLT 493
+ + + +L L L + +L + + H +L L ++ + +G +
Sbjct: 310 T-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIP 361
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG---PLPSSIQHLKVLINLDLSR 550
+L +L + + V+ G + + ++
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITW 421
Query: 551 NQLSGDIP 558
LS D P
Sbjct: 422 ENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 58/347 (16%), Positives = 114/347 (32%), Gaps = 52/347 (14%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L S L + + L+ L L+ N ++ + L +N A N L+
Sbjct: 90 LACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EI 142
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSG-SLPNDIRLPKLEK 175
+ ++L L H N ++ + ++L LD N ++ + L +
Sbjct: 143 D--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQ---NKLLNR 195
Query: 176 LYLGSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L +N I L++ L L + NK + ++ L+QLT + + N L +
Sbjct: 196 LNCDTN----NITKLDLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-E 247
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG--HSLP 292
+ + L L L+ +L I LI Q G +
Sbjct: 248 LD--VSTLSKLTTLHCIQTDLL--------EIDLTHNTQLIYFQAEGCRKIKELDVTHNT 297
Query: 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
L L I + ++ KL+ L L++ + + + L+ L+ + +
Sbjct: 298 QLYLLDC-QAAGITELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI 351
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASL 399
SS+ +L + + N S ++
Sbjct: 352 QD----------FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 34/214 (15%), Positives = 69/214 (32%), Gaps = 20/214 (9%)
Query: 72 LGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSF 131
+ L+ L D S N + L KL L I E+ + ++L
Sbjct: 229 VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTH------NTQLIYFQA 282
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPS-S 190
+ + + ++L LD ++ L + PKL LYL + ++
Sbjct: 283 EGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLS-QNPKLVYLYLNNT----ELTELD 334
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNL 250
+S T L++L + +G + L + A+ + N + ++
Sbjct: 335 VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392
Query: 251 GMNNLSG---PVPPTIFNISTIRLINLIENQLSG 281
+ + G + P + + LS
Sbjct: 393 DLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 24/213 (11%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL--VKI 791
+G G V++ AIK NL+ + ++ +E L ++ + +++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLA 850
+ + +V+E N WL D +R + ++ + +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE------- 903
IVH DLKP N L+ + M + DFGI+ + SV + + T+ YM PE
Sbjct: 129 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 904 ----YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
S+ +S K DV+S G +L K P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+LG+G++G+VY G L + +AIK + R + E + ++++H+N+V+ S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSY------------NYFLDILQRLNIMIDVALVLEYL 843
F + +E +P GS L S Y IL+ L+YL
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----------LKYL 138
Query: 844 HHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMA 901
H IVH D+K +N+L++ + +SDFG SK L T T T+ YMA
Sbjct: 139 HDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMA 191
Query: 902 PE--YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE D++S G ++E T K P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER--AFRT-FDSECEILRNVRHRNLVKIF 792
LG G VY VAIK + F+ E + H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPI 852
D LV+E++ + +++ S + L + +N + +++ H I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR----I 132
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT-ITMATIGYMAPEYGSEGIVS 911
VH D+KP NIL+D N T + DFGI+K L + S+TQT + T+ Y +PE
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
D+YS G++L E + P F GE
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG V+ ++ VA+K A + F E E+L N++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNIMIDV 836
+ C + D +V E+M +G K+L L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
A + YL H VH DL N L+ N+ + DFG+S+ + D TM
Sbjct: 143 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
I +M PE + + DV+S+GV+L E FT
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVK 790
LG G+FG VY+G + VA+K + E+ F E I+ H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL------YSYNYFLDILQRLNIMIDVALVLEYLH 844
+ ++LE M G + +L S L +L L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 845 HGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
H +H D+ N LL A + DFG+++ + M + +M
Sbjct: 199 ENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFT 928
PE EGI ++K D +S+GVLL E F+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 44/202 (21%), Positives = 77/202 (38%), Gaps = 15/202 (7%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
+GRGSFG V++ G A+K L++ R E + +V ++ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
+ + +E + GS + + + + LEYLH I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLHTRR----ILH 173
Query: 855 CDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSEGIV 910
D+K +N+LL + A + DFG + L + G +MAPE
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 911 SAKCDVYSYGVLLMETFTRKKP 932
AK D++S +++ P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 24/213 (11%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL--VKI 791
+G G V++ AIK NL+ + ++ +E L ++ + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLA 850
+ + +V+E N WL D +R + ++ + +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE------- 903
IVH DLKP N L+ + M + DFGI+ + SV + + + YM PE
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 904 ----YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
S+ +S K DV+S G +L K P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 738 LGRGSFGLVYKGTL--------FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV 789
LG+G+F ++KG T V +KV + +F ++ + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C D LV EF+ GS + +L ++IL +L + +A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 850 APIVHCDLKPNNILLD--------ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
++H ++ NILL +SD GIS + D I I ++
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVP 185
Query: 902 PE---YGSEGIVSAKCDVYSYGVLLMETFTR-KKP 932
PE ++ D +S+G L E + KP
Sbjct: 186 PECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G+FG V+ + VA+K E A + F E E+L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWL--------------YSYNYFLDILQRLNIMIDVA 837
F C +V E+M +G ++L L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
+ YL H VH DL N L+ + + + DFG+S+ + D TM I
Sbjct: 169 AGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+M PE + + DV+S+GV+L E FT
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 41/292 (14%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G F V L DG A+K ++ E ++ R H N++++ + C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 796 CNIDFKA----LVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHS 848
L+L F G+ + FL Q L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-------TIGYMA 901
H DLKP NILL + + D G + Q +T+ TI Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 902 PE----YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957
PE I + DV+S G +L + P D +F S+ V+ L
Sbjct: 212 PELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS----- 265
Query: 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ + S+ LL+ M + +D P QR H+ ++L+ ++
Sbjct: 266 ------IPQSPRHSSALWQLLNSM-MTVD-----PHQRPHIPLLLSQLEALQ 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 57/275 (20%), Positives = 85/275 (30%), Gaps = 38/275 (13%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS-GSLPND--IRLP 171
S P+ GI S L +N L++L L L N LS +
Sbjct: 21 SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNN 230
L+ L L N + S+ L+ L + ++ +L L L+++ +
Sbjct: 79 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 231 LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHS 290
+ L LE L + N+ P IF
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF------------------------TE 173
Query: 291 LPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFN 350
L NL FL L L P + + S L L++S N F + L L+ L+ N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 351 SLTTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
+ T L SL L L N
Sbjct: 234 HIMTSKKQE-----LQHFP--SSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 51/234 (21%), Positives = 91/234 (38%), Gaps = 15/234 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENN--FYGHLPNELGKLRRLRLINFAYNELSG 114
L L S L + L+ L L +S N F G L+ ++ ++N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPD--FLLNLSKLEFLDLMENSLSGSLPNDI--RL 170
+ S L +L+ L F +++ ++ + L+L L +LD+ N I L
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGL 149
Query: 171 PKLEKLYLGSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQ 228
LE L + N F +E +L L L+ + +L +LS L LN++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208
Query: 229 NNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN--ISTIRLINLIENQLS 280
NN L L+ L+ +N++ S++ +NL +N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 7/219 (3%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDL--QGSIPYYLCHLE 469
S+P I S L+L+ N+L + QL LSL N L +G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 470 RLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSL-WSLEYILYVNLSSNS 528
L L L+ N + + + L L L + L S+ SL ++Y+++S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGS 587
L L L ++ N + I + L++L L L+ Q P +F S
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 588 LISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
L SL+ L++S NN + L L+ L+ S N +
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 55/274 (20%), Positives = 85/274 (31%), Gaps = 41/274 (14%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
IP+S T L+L SN F L L L+L N L+ + + +S
Sbjct: 26 IPSSATR------LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
L L L+ N + ++ L L L
Sbjct: 80 LK------YLDLSFNGVI--------------------------TMSSNFLGLEQLEHLD 107
Query: 428 LDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIP 486
+ L +V + L L + + + L L L + GN+
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 487 A-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
L +L L L L P++ SL + +N+S N+ + L L
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 546 LDLSRNQLSGDIPITISGL-KDLATLSLAGNQFN 578
LD S N + + LA L+L N F
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 16/269 (5%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
I +L NN ++ D L L L L+ N +S + L KL+KLY+
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYI 109
Query: 179 GSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDM--P 236
N +IP +L + L L + DN+ L + + + N L+ P
Sbjct: 110 SKNH-LVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
A L+ L +L + L+G +P + T+ ++L N++ + L L
Sbjct: 167 GAFDGLK-LNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
L L N + S++ L L L +N S +P +L+ L+ + L N++T
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT--K 278
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLR 385
+ + + ++L NP+
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 53/284 (18%), Positives = 100/284 (35%), Gaps = 20/284 (7%)
Query: 54 VVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
L+L + + + L L +L + N LR+L+ + + N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSL-SGSLPNDI-RL 170
P + S L L H+N ++P + L + +++ N L +
Sbjct: 116 -EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
Query: 171 PKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQN 229
KL L + IP L L L L NK + S+L L L N
Sbjct: 172 LKLNYLRISEA-KLTGIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHN 227
Query: 230 NLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS-----GHLP 284
++ ++ L L L+L N LS VP + ++ ++++ L N ++ P
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286
Query: 285 LTLGHSLPNLEFLTLFGNNL-IGTIPNSI-TNASKLIGLDLSSN 326
+ G ++LF N + + + + + + +
Sbjct: 287 VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 64/327 (19%), Positives = 113/327 (34%), Gaps = 54/327 (16%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
+P +S L L +N S ++ L L L L N + A L+ L+
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 247 HLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL-I 305
L + N+L +PP + S++ + + +N++ +P + L N+ + + GN L
Sbjct: 106 KLYISKNHLVE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
+ KL L +S + IP L L+L N +
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIEL-------- 210
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
L L L L N +R I G+ S L L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIEN---GSLS----------------------FLPTLRE 245
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP-------YYLCHLERLSQLLLNG 478
L LD+N+L+ +P + + LQ + L+ N++ + + + + L
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 479 NNLSGAI--PACLGSLTSLRELHLGSN 503
N + PA +T + G+
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 65/357 (18%), Positives = 112/357 (31%), Gaps = 57/357 (15%)
Query: 282 HLPLTLGHSLP-----NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTF 336
LP T P +L + L +P I+ LDL +N S F
Sbjct: 18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDF 74
Query: 337 GNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
L+ L L L+ N ++ A + R L +L ++ N L
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKA--------FSPLRKLQKLYISKNHLV----------- 115
Query: 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDND 456
IP + S L+ L++ DN + + + + + N
Sbjct: 116 ---------------EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158
Query: 457 LQ-GSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS 515
L+ +L+ L ++ L+ IP +L ELHL N + L
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLR 215
Query: 516 LEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGN 575
+ + L N + S+ L L L L N+LS +P + LK L + L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 576 QFNGPIPESFGSL------ISLESLDVSSNNISGKI--PKSLEALLYLKKLNVSYNR 624
F + + + +N + P + + + +
Sbjct: 275 NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 12/221 (5%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++P+EI L L +N+++ Q L L L +N + L +L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL-S 530
+L ++ N+L IP +SL EL + N + L + + + N L +
Sbjct: 105 QKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 531 GPLPSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLI 589
LK L L +S +L+G I + L L L N+ E
Sbjct: 162 SGFEPGAFDGLK-LNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQAIELEDLLRYS 217
Query: 590 SLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
L L + N I SL L L++L++ N+L +P
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 31/168 (18%), Positives = 61/168 (36%), Gaps = 26/168 (15%)
Query: 57 LNLSSFSLGG----IIPPHLGNLSFLVSLDISENNFYGHLPNE-LGKLRRLRLINFAYNE 111
L L+ + IP L L L + N + E L + +L + +N+
Sbjct: 172 LKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQ 228
Query: 112 LS----GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS------ 161
+ GS L L+ L NN + R+P L +L L+ + L N+++
Sbjct: 229 IRMIENGSLSF----LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 162 -GSLPNDIRLPKLEKLYLGSNDF-FGQIPSSLSEC-THLQTLWLADNK 206
+ ++ + L +N + ++ + C T + + K
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 27/85 (31%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
+ S L +P IS D L L N + + F L L +L + +N IS
Sbjct: 38 VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIP 630
K+ L L+KL +S N L EIP
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIP 118
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER--AFRT-FDSECEILRNVRHRNLVKIF 792
+LG G V+ L D +VA+KV L R +F F E + + H +V ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 793 ------SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
+ + + +V+E++ G + + + + + ++ D L + H
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT-ITMATIGYMAPEYG 905
I+H D+KP NI++ V DFGI++ + + +SVTQT + T Y++PE
Sbjct: 136 G----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
V A+ DVYS G +L E T + P FTG+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
LG FG VYKG LF VAIK + F E + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNIMID 835
+ +++ + +G ++L + L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+A +EYL H +VH DL N+L+ + + +SD G+ + + D ++
Sbjct: 137 IAAGMEYLSSHH----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
I +MAPE G S D++SYGV+L E F+
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVKIFS- 793
+LG+G+ V++G G AIKVFN + R E E+L+ + H+N+VK+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 794 -SCCNIDFKALVLEFMPNGSFEKWLYS--YNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
K L++EF P GS L Y L + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 851 PIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMATI----GYMAP 902
IVH ++KP NI+ D ++DFG ++ L + + ++ Y+ P
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYGTEEYLHP 184
Query: 903 EYGSEGIV--------SAKCDVYSYGVLL 923
+ ++ A D++S GV
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 33/215 (15%)
Query: 737 LLGRGSFGLVYKG--TLFDGTNVAIKVFNLQLERAFRT-FDSECEILRNVRHRNLVKIF- 792
+ G G +Y +G V +K + + +E + L V H ++V+IF
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 793 ------SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
+ + +V+E++ S ++ L + + + ++++ L YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS- 200
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT-ITMATIGYMAPEYG 905
+V+ DLKP NI+L E + D G + T G+ APE
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-------RINSFGYLYGTPGFQAPEI- 248
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
+ D+Y+ G L G
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 52/215 (24%), Positives = 78/215 (36%), Gaps = 23/215 (10%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNV 783
F + LG GS+G V+K DG A+K + +E V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 784 -RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+H V++ + L E S ++ ++ L Q + D L L +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
LH +VH D+KP NI L + DFG+ LG Q YMAP
Sbjct: 173 LHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAP 225
Query: 903 E-----YGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
E YG+ DV+S G+ ++E +
Sbjct: 226 ELLQGSYGT------AADVFSLGLTILEVACNMEL 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLV 789
LGRG+FG V + F VA+K+ R SE +IL ++ H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 790 KIFSSCCNIDFKALV-LEFMPNGSFEKWL---------------YSYNYFLDILQRLNIM 833
+ +C +V +EF G+ +L Y FL + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
VA +E+L +H DL NILL E + DFG+++ + + D V +
Sbjct: 155 FQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 738 LGRGSFGLVYKGTLFD--------GTNVAIKVFN-LQLERAFRTFDSECEILRNV-RHRN 787
LG G+FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNI 832
++ + +C +++E+ G+ ++L + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
+A +EYL +H DL N+L+ EN ++DFG+++ + D T
Sbjct: 163 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVK 790
LG G FG V K T F T VA+K+ R SE +L+ V H +++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL-----------------------YSYNYFLDIL 827
++ +C L++E+ GS +L + L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 828 QRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
++ ++ ++YL +VH DL NIL+ E +SDFG+S+ + E D
Sbjct: 151 DLISFAWQISQGMQYLAEMK----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
V ++ + +MA E + I + + DV+S+GVLL E T
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-27
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 28/203 (13%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLVKI 791
LG G FG V + G VAIK +L ER E +I++ + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL----EIQIMKKLNHPNVVSA 77
Query: 792 F------SSCCNIDFKALVLEFMPNGSFEKWL--YSYNYFLDILQRLNIMIDVALVLEYL 843
D L +E+ G K+L + L ++ D++ L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 844 HHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
H I+H DLKP NI+L + + + D G +K L +G+ + T+ Y+
Sbjct: 138 HENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYL 190
Query: 901 APEYGSEGIVSAKCDVYSYGVLL 923
APE + + D +S+G L
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLA 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVKIFS- 793
+LG+G+ V++G G AIKVFN + R E E+L+ + H+N+VK+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 794 -SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--LNIMIDVALVLEYLH-HGHSL 849
K L++EF P GS L + + + L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 850 APIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
IVH ++KP NI+ D ++DFG ++ L + + V+ T Y+ P+
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMY 187
Query: 906 SEGIV--------SAKCDVYSYGVLL 923
++ A D++S GV
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 736 NLLGRGSFGLVYKGTLFD------GTNVAIKVFNLQ-LERAFRTFDSECEILRNV-RHRN 787
LG G+FG V + T F VA+K+ SE +I+ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL-------------YSYNYFLDILQRLNIMI 834
+V + +C + ++ E+ G +L N L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM 894
VA + +L + +H D+ N+LL A + DFG+++ + + + +
Sbjct: 172 QVAQGMAFLASKN----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 895 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + + DV+SYG+LL E F+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 42/298 (14%), Positives = 89/298 (29%), Gaps = 68/298 (22%)
Query: 709 EDVLSLATWRRTSYLDIQRATDG----FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFN 763
+ ++S + W ++ +LG+ + T G + + V
Sbjct: 53 DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 112
Query: 764 LQLE---RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE------FMPNGSFE 814
A + E LR +R K F +++ + E
Sbjct: 113 FTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE 172
Query: 815 KWLYSYNYF--------------------------LDILQRLNIMIDVALVLEYLH-HGH 847
+ ++ + F L RL + + V +L LH +G
Sbjct: 173 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY--- 904
+VH L+P +I+LD+ ++ F G ++ G+ PE
Sbjct: 232 ----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIGRGFAPPETTAE 281
Query: 905 -------GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLRRWVKESLPH 953
+++ D ++ G+ + + P T + + W+ S +
Sbjct: 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWIFRSCKN 335
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 29/216 (13%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIKVFNLQ-LERAFRTFDSECEILRNV-RHRNLV 789
LG G+FG V + T + VA+K+ SE ++L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWL-----------------YSYNYFLDILQRLNI 832
+ +C ++ E+ G +L LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
VA + +L + +H DL NILL + DFG+++ + + V +
Sbjct: 151 SYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + DV+SYG+ L E F+
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 34/221 (15%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVK 790
+G G+FG V++ T VA+K+ F E ++ + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWL-----------------------YSYNYFLDIL 827
+ C L+ E+M G ++L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 828 QRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887
++L I VA + YL VH DL N L+ ENM ++DFG+S+ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
I +M PE + + DV++YGV+L E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 42/248 (16%), Positives = 77/248 (31%), Gaps = 25/248 (10%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGTLFDGTN------VAIKVFNLQLERAFRTFDSE 776
+ Q + +LLG G+F VY+ T D + +KV F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 777 CEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF----LDILQRLNI 832
E L+ +K +S+ + LV E G+ + Y + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH-----------VSDFGISKLL 881
+ + ++E +H I+H D+KP+N +L + D G S +
Sbjct: 178 AMRMLYMIEQVHDCE----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941
T T G+ E S + + D + + + GE
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 942 SLRRWVKE 949
+
Sbjct: 294 KPEGLFRR 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 20/270 (7%)
Query: 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTF-DSECEILRNVRHRN 787
D F + + LG G+ G+V+K + G +A K+ +L+++ A R E ++L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 788 LVK-----IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+V +I +E M GS ++ + + + I V L Y
Sbjct: 93 IVGFYGAFYSDGEISI-----CMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTY 146
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
L H I+H D+KP+NIL++ + DFG+S G+ DS+ + T YM+P
Sbjct: 147 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV-GTRSYMSP 199
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962
E S + D++S G+ L+E + P E+ L + T
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESP 992
F + ++I +L E P
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 28/254 (11%), Positives = 63/254 (24%), Gaps = 46/254 (18%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKIF 792
L G +V+ + + A+KVF + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 793 SSC-CNIDFKALVLEFMPN----GSFEKWLYSYNYFL----------------------- 824
+ A+ ++ P + NY L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 825 ---DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881
IL + + + L +VH P+N+ + + + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 882 GEGDDSVTQTITMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG 939
G + + Y E+ S + + + G+ + + P + G
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 940 EMSLRRWVKESLPH 953
+ +P
Sbjct: 300 IKGSWKRPSLRVPG 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 736 NLLGRGSFGLVYKGTLFDG---TNVAIKVFNLQL-----ERAFRTFDSECEILRNV-RHR 786
+++G G+FG V K + + AIK ++ + R F E E+L + H
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIK----RMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLN 831
N++ + +C + + L +E+ P+G+ +L S L Q L+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
DVA ++YL +H DL NIL+ EN A ++DFG+S+ + V +T
Sbjct: 147 FAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ + +MA E + + + DV+SYGVLL E +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 38/266 (14%), Positives = 86/266 (32%), Gaps = 63/266 (23%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNL----------------QLERAFRTFDSECEI 779
+LG+ + T G + + V R R ++ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 780 LRNVR------------HRNLVKIFSSCCNIDFKALVLEFM----PNGSFEKWLYSY--- 820
++R + ++++ ++ + + +F + L S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 821 NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880
+ L RL + + V +L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 881 LGEGDDSVTQTITMATIGYMAPEY-----------GSEGIVSAKCDVYSYGVLLMETFTR 929
G S + G+ PE +++ D ++ G+++ +
Sbjct: 256 DGARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 930 KKPTDEMFTGE--MSLRRWVKESLPH 953
P T + + W+ S +
Sbjct: 310 DLP----ITKDAALGGSEWIFRSCKN 331
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 738 LGRGSFGLVYKGTLFD--------GTNVAIKVFN-LQLERAFRTFDSECEILRNV-RHRN 787
LG G FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNI 832
++ + +C +++E+ G+ ++L + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
+A +EYL +H DL N+L+ EN ++DFG+++ + D T
Sbjct: 209 TYQLARGMEYLASQK----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 738 LGRGSFGLVYKGTLFD--------GTNVAIKVFN-LQLERAFRTFDSECEILRNV-RHRN 787
LG G+FG V T VA+K+ E+ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWL---------------YSYNYFLDILQRLNI 832
++ + +C +++E+ G+ ++L ++ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
VA +EYL +H DL N+L+ E+ ++DFG+++ + D T
Sbjct: 197 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + I + + DV+S+GVLL E FT
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 69/246 (28%)
Query: 719 RTSYLDIQRATDGFNE----CNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTF 773
R + L +T GF E +LGRG +V + A+K+ ++ +F
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 774 D---------SECEILRNV-RHRNLVKIFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNY 822
+ E +ILR V H N++++ + F LV + M G F+
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY------- 114
Query: 823 FLDILQR--------LNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVS 873
+ ++ IM + V+ LH IVH DLKP NILLD++M ++
Sbjct: 115 ---LTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLT 166
Query: 874 DFGISKLLGEGDDSVTQTITMATI----GYMAPE------------YGSEGIVSAKCDVY 917
DFG S L G+ + + Y+APE YG E D++
Sbjct: 167 DFGFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMW 213
Query: 918 SYGVLL 923
S GV++
Sbjct: 214 STGVIM 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKI 791
LG+G FG VY +A+KV L+ E EI ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 792 ---FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
F + L+LE+ P G+ + L + F + + ++A L Y H
Sbjct: 75 YGYFHDATRV---YLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR- 129
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
++H D+KP N+LL ++DFG S S T+ Y+ PE
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGTLDYLPPEMIEGR 182
Query: 909 IVSAKCDVYSYGVLLME 925
+ K D++S GVL E
Sbjct: 183 MHDEKVDLWSLGVLCYE 199
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 54/225 (24%), Positives = 84/225 (37%), Gaps = 42/225 (18%)
Query: 738 LGRGSFGLVYKGTLFDG------TNVAIKVFNLQL-----ERAFRTFDSECEILRNV-RH 785
LG G+FG V T + VA+K L SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWL----------------------YSYNYF 823
N+V + +C L+ E+ G +L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 824 LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883
L L VA +E+L VH DL N+L+ + DFG+++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ V + + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-26
Identities = 57/315 (18%), Positives = 105/315 (33%), Gaps = 34/315 (10%)
Query: 75 LSFLVSLDISENNFYGHLPN-------ELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
L + +S+N+FY + K + L NE ++++
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQI 187
L + + + +PD L ++ L++ +N+L SLP LE L N +
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELP--ASLEYLDACDNRL-STL 115
Query: 188 PSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEH 247
P + L+ L + +N+ + LPE L +N N L +P +L E
Sbjct: 116 PELPA---SLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSL---EV 164
Query: 248 LNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG--HSLPNLEFLTLFGNNLI 305
L++ N L+ +P ++ +++ N L LP H E N I
Sbjct: 165 LSVRNNQLTF-LPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
IP +I + + L N S I + + + +
Sbjct: 220 THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 366 SSLTNCRSLTELALN 380
+ E +
Sbjct: 280 LADAVTAWFPENKQS 294
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 68/322 (21%), Positives = 115/322 (35%), Gaps = 61/322 (18%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNC--RSLTELA 378
LS N F I T+ + F + +L E+ + +S L C +EL
Sbjct: 11 FSLSQNSFYNTISGTYADY-FSAWDKWEKQALPGEN----RNEAVSLLKECLINQFSELQ 65
Query: 379 LNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIP 438
LN L LP + + E + L S+P+ +L +L DN L+ T+P
Sbjct: 66 LNRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLP 116
Query: 439 TTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLREL 498
L+ L + +N L +P LE ++ + N L+ +P TSL L
Sbjct: 117 EL---PASLKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPE---LPTSLEVL 165
Query: 499 HLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHL----KVLINLDLSRNQLS 554
+ +N LT +P SLE + ++S+N L LP+ + I N+++
Sbjct: 166 SVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 555 GDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLY 614
IPE+ SL ++ + N +S +I +SL
Sbjct: 221 H-------------------------IPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 615 LKKLNVSYNRLEGEIPIKGPFR 636
+ +
Sbjct: 256 QPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-19
Identities = 62/397 (15%), Positives = 111/397 (27%), Gaps = 100/397 (25%)
Query: 168 IRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLA 227
I LP L N F+ I + ++ +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYAD-----------------YFSAWDKWEKQALPGEN 45
Query: 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTL 287
+N + + + L L NLS +P + I ++ + +N L LP
Sbjct: 46 RNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--- 96
Query: 288 GHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNL 347
+LE+L N L T+P + L LD+ +N + +P L ++ N
Sbjct: 97 -ELPASLEYLDACDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYI---NA 147
Query: 348 MFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKC 407
N LT T+ L L++ N L
Sbjct: 148 DNNQLT---------MLPELPTS---LEVLSVRNNQLT---------------------- 173
Query: 408 ELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCH 467
+P+ +L L + N L ++P R + ++
Sbjct: 174 ----FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIF-------------- 211
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
N ++ IP + SL + L N L+ I SL +
Sbjct: 212 ------FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT--AQPDYHGP 262
Query: 528 SLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGL 564
+ + Q+ D + +S +
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 14/204 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNL----SFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL 112
L++S+ L + P + EN H+P + L I N L
Sbjct: 185 LDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPL 242
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR-LP 171
S + + F+ N D + + +D+ +
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQ--QNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
+ +N F LS+ + F ++ + LS +L +
Sbjct: 301 HAFEHEEHANTFS-AFLDRLSDTVSARNTSG----FREQVAAWLEKLSASAELRQQSFAV 355
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNL 255
D + + L NL L
Sbjct: 356 AADATESCEDRVALTWNNLRKTLL 379
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 47/208 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+LG G+F V+ G A+K + ++E +L+ ++H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 796 CNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH-H 845
+ LV++ + G F++ IL+R ++ V ++YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDR----------ILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 846 GHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMA 901
G IVH DLKP N+L +EN ++DFG+SK+ G T T GY+A
Sbjct: 126 G-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVA 175
Query: 902 PE------YGSEGIVSAKCDVYSYGVLL 923
PE Y D +S GV+
Sbjct: 176 PEVLAQKPYSKA------VDCWSIGVIT 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK-- 790
LLG+GSF VY+ + G VAIK+ + + + +E +I ++H ++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 791 -IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
F + LVLE NG F + R + M + + YLH
Sbjct: 78 NYFEDSNYV---YLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI--TMATIGYMAPEYGS 906
I+H DL +N+LL NM ++DFG++ L + T+ T Y++PE +
Sbjct: 133 ---ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPN---YISPEIAT 185
Query: 907 EGIVSAKCDVYSYGVLL 923
+ DV+S G +
Sbjct: 186 RSAHGLESDVWSLGCMF 202
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFN---LQLERAFRTFDS--------------ECEIL 780
L +G F + D A+K + L+ +R F ++ E +I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 781 RNVRHRNLVK---IFSSCCNIDFKALVLEFMPNG-------SFEKWLYSYNYFLDILQRL 830
++++ + I ++ + + ++ E+M N F +Y F+ I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEV-Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
I+ V Y+H+ + I H D+KP+NIL+D+N +SDFG S+ + D +
Sbjct: 155 CIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK 208
Query: 891 TITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR 944
+ T +M PE AK D++S G+ L F P F+ ++SL
Sbjct: 209 G-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 51/209 (24%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
+GRGS+G V A K F E EI++++ H N+++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 797 NIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH-HG 846
+ LV+E G FE+ ++ + IM DV + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFER----------VVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 847 HSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATI----GY 899
+ H DLKP N L + + DFG++ G M T Y
Sbjct: 127 -----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYY 174
Query: 900 MAPE-----YGSEGIVSAKCDVYSYGVLL 923
++P+ YG E CD +S GV++
Sbjct: 175 VSPQVLEGLYGPE------CDEWSAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 53/211 (25%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN--LQLERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG+GSFG V K A+KV N + T E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 795 CCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH- 844
+ +V E G F++ I++R I+ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDE----------IIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 845 HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATI---- 897
H IVH DLKP NILL +++ + DFG+S + M
Sbjct: 140 HN-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTA 187
Query: 898 GYMAPE-----YGSEGIVSAKCDVYSYGVLL 923
Y+APE Y + CDV+S GV+L
Sbjct: 188 YYIAPEVLRGTYDEK------CDVWSAGVIL 212
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 56/199 (28%), Positives = 83/199 (41%), Gaps = 25/199 (12%)
Query: 737 LLGRGSFGLVY----KGTLFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLV 789
LG+G FG VY K +A+KV L+ E E EI ++RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 790 KI---FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
++ F I L+LEF P G K L + F + M ++A L Y H
Sbjct: 78 RMYNYFHDRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHER 133
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
++H D+KP N+L+ ++DFG S +T T+ Y+ PE
Sbjct: 134 K----VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRT-MCGTLDYLPPEMIE 185
Query: 907 EGIVSAKCDVYSYGVLLME 925
K D++ GVL E
Sbjct: 186 GKTHDEKVDLWCAGVLCYE 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 56/261 (21%)
Query: 697 RRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNE----CNLLGRGSFGLVYKGT-L 751
+ N P + L + L A F + +++GRG +V +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 752 FDGTNVAIKVFNL--------QLERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKA 802
G A+K+ + QLE E ILR V H +++ + S + F
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 803 LVLEFMPNGS-FEKWLYSYNYFLDILQRL--------NIMIDVALVLEYLH-HGHSLAPI 852
LV + M G F+ + +++ +IM + + +LH + I
Sbjct: 177 LVFDLMRKGELFDY----------LTEKVALSEKETRSIMRSLLEAVSFLHANN-----I 221
Query: 853 VHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI----GYMAPE----- 903
VH DLKP NILLD+NM +SDFG S L G+ + + GY+APE
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCS 274
Query: 904 -YGSEGIVSAKCDVYSYGVLL 923
+ + D+++ GV+L
Sbjct: 275 MDETHPGYGKEVDLWACGVIL 295
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 64/273 (23%), Positives = 97/273 (35%), Gaps = 49/273 (17%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
GI S + L+ N+ D +L LE L L NS+ + L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130
Query: 179 GSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNN-LQ 232
N + + + L+ LWL +N +P + L L+L + L+
Sbjct: 131 FDN----WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 233 GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLP 292
A L L++LNLGM N+ ++ + L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK--------DMPNLT-------------------PLV 218
Query: 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
LE L + GN+ P S S L L + ++ S + F L L LNL N+L
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
++ + L L EL L+ NP
Sbjct: 279 SSL-----PHDLFTPLRY---LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 53/290 (18%), Positives = 91/290 (31%), Gaps = 42/290 (14%)
Query: 171 PKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNN 230
+ K+ ++P + ++ + L L +N + +L L L L +N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 231 LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGH 289
++ A L L L L N L+ +P F +S +R + L N + +P +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 290 SLPNLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLM 348
+P+L L L + I L L+L +P L L L +
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 349 FNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCE 408
N S SL +L + + + I F
Sbjct: 227 GNHFPEIRP--------GSFHGLSSLKKLWVMNSQVSLIER---NAFD------------ 263
Query: 409 LKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQ 458
L+ L+ L L N L+ + L L L+ N
Sbjct: 264 ----------GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 9/218 (4%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY-LCHLER 470
+PQ I S +L L +N + T L+ L L N ++ I L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSS-NS 528
L+ L L N L+ L+ LREL L +N + SIPS ++ + ++ ++L
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
L + + L L L+L + D+P ++ L L L ++GN F P SF L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
SL+ L V ++ +S + + L L +LN+++N L
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 11/210 (5%)
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYY-LCHLERLSQL 474
+L L L+L N + I VG F L L L+DN L IP +L +L +L
Sbjct: 97 HLHHLEVLQLGRNSIR-QIE--VGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLREL 152
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGS-NTLTYSIPSSLWSLEYILYVNLSSNSLSGPL 533
L N + + SL L LG L Y + L + Y+NL ++ +
Sbjct: 153 WLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211
Query: 534 PSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLES 593
P+ + L L L++S N P + GL L L + +Q + +F L SL
Sbjct: 212 PN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 594 LDVSSNNISGKIPKSLEALLYLKKLNVSYN 623
L+++ NN+S L YL +L++ +N
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 57/256 (22%), Positives = 83/256 (32%), Gaps = 33/256 (12%)
Query: 53 RVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL 112
LNL ++ I +L L L + N+ L L + N L
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSLSGSLPNDI--R 169
+ LS+L+ L NN IP + + L LDL E +
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPEN-IGNLSQLTDLNLAQ 228
L L+ L LG + +P+ L+ L+ L ++ N F + LS L L +
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMN 251
Query: 229 NNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
+ + A L L LNL NNLS +P +F
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLF------------------------ 286
Query: 289 HSLPNLEFLTLFGNNL 304
L L L L N
Sbjct: 287 TPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 60/265 (22%), Positives = 98/265 (36%), Gaps = 40/265 (15%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
N +L L NN+ ++ + L L L N F L L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
LT S A L EL L NP+ I F+
Sbjct: 135 LTVIPSGA--------FEYLSKLRELWLRNNPIESIPS---YAFN--------------- 168
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYYLCHL 468
+ LM L L + + I G F+ L+ L+L +++ +P L L
Sbjct: 169 -------RVPSLMRLDLGELKKLEYISE--GAFEGLFNLKYLNLGMCNIK-DMPN-LTPL 217
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
L +L ++GN+ P L+SL++L + ++ ++ ++ L ++ +NL+ N+
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQL 553
LS L+ L+ L L N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 7/206 (3%)
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
+P + + L+L +N++Q HL L L L N++ L SL
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 496 RELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSR-NQLS 554
L L N LT + L + + L +N + + + L+ LDL +L
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 555 GDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLY 614
GL +L L+L +P + L+ LE L++S N+ P S L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 615 LKKLNVSYNRLEGEIPIKGPFRNFSA 640
LKKL V +++ I + F ++
Sbjct: 244 LKKLWVMNSQVS-LIE-RNAFDGLAS 267
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/217 (24%), Positives = 79/217 (36%), Gaps = 11/217 (5%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
+ P GI + Q + H N + L L L N L+ + L
Sbjct: 25 AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 173 LEKLYLGSNDFFGQIPSS-LSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNN 230
LE+L L N + + L TL L L + L+ L L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 231 LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGH 289
LQ +L L HL L N +S VP F + ++ + L +N+++ H+
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSN 326
L L L LF NNL ++ L L L+ N
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 56/214 (26%), Positives = 82/214 (38%), Gaps = 18/214 (8%)
Query: 99 LRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158
+R+ L N +S + L IL H+N L+ LE LDL +N
Sbjct: 34 SQRIFL---HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 159 SLSGSLPNDI--RLPKLEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLP 212
+ S+ L +L L+L + P LQ L+L DN LP
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRC----GLQELGPGLFRGLAALQYLYLQDNALQ-ALP 145
Query: 213 ENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTIR 270
++ +L LT L L N + A L L+ L L N ++ V P F ++ +
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLM 204
Query: 271 LINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL 304
+ L N LS LP L L++L L N
Sbjct: 205 TLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 5/214 (2%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++P I + + L N ++ + + L L L+ N L L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 472 SQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSSNSL 529
QL L+ N ++ L L LHL L + L+ L + Y+ L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 530 SGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLI 589
+ + L L +L L N++S GL L L L N+ P +F L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 590 SLESLDVSSNNISGKIPKSLEALLYLKKLNVSYN 623
L +L + +NN+S ++L L L+ L ++ N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 48/204 (23%), Positives = 70/204 (34%), Gaps = 14/204 (6%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+P + Q ++L N+ S + LT L L N L A L +L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 246 EHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL 304
E L+L N V P F + + ++L L L L L L++L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL-QDNA 140
Query: 305 IGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWS 363
+ +P+ + L L L N S F L L L L N + A
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA---- 196
Query: 364 FLSSLTNCRSLTELALNVNPLRGI 387
+ L L L N L +
Sbjct: 197 ----FRDLGRLMTLYLFANNLSAL 216
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 5/193 (2%)
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
+P + Q + L+ N + L+ L L+ N L+ A L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 496 RELHLGSNTLTYSIPSSLWS-LEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
+L L N S+ + + L + ++L L P + L L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 555 GDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL 613
+P L +L L L GN+ + +F L SL+ L + N ++ P + L
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 614 YLKKLNVSYNRLE 626
L L + N L
Sbjct: 202 RLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 51/239 (21%), Positives = 80/239 (33%), Gaps = 36/239 (15%)
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
+ + L N ++ + +S CR+LT L L+ N L I F+
Sbjct: 34 SQRIFLHGNRISHVPA--------ASFRACRNLTILWLHSNVLARIDA---AAFT----- 77
Query: 402 FEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGS 460
L+ L L L DN ++ +L L L LQ
Sbjct: 78 -----------------GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-E 119
Query: 461 IP-YYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYI 519
+ L L L L N L L +L L L N ++ + L +
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 520 LYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
+ L N ++ P + + L L+ L L N LS ++ L+ L L L N +
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 53/188 (28%), Positives = 70/188 (37%), Gaps = 22/188 (11%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNE----LGKLRRLRLINFAYNEL 112
L L S L I L+ L LD+S+N + LG+L L L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL---DRCGL 117
Query: 113 S----GSFPSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSLSGSLPND 167
G F L+ LQ L +N+ +PD +L L L L N +S S+P
Sbjct: 118 QELGPGLFRG----LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPER 171
Query: 168 I--RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDL 224
L L++L L N P + + L TL+L N S LP L L L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL 230
Query: 225 NLAQNNLQ 232
L N
Sbjct: 231 RLNDNPWV 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/304 (19%), Positives = 103/304 (33%), Gaps = 62/304 (20%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSS 794
+L G F VY+ + G A+K E R E ++ + H N+V+ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 795 CCNI-------DFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALV 839
+ L+L + G + + R L I
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQ------LVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA---- 895
++++H PI+H DLK N+LL T + DFG + + D A
Sbjct: 149 VQHMHRQKP--PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 896 ------TIGYMAPE---YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946
T Y PE S + K D+++ G +L R+ P F LR
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-- 260
Query: 947 VKESLPHGLTEVVDANL-VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005
+V+ + L+ M L ++ PE+R+ + + +L
Sbjct: 261 -----------IVNGKYSIPPHDTQYTVFHSLIRAM-LQVN-----PEERLSIAEVVHQL 303
Query: 1006 KKIR 1009
++I
Sbjct: 304 QEIA 307
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 21/196 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK-- 790
LG+G F ++ + A K+ L E I R++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 791 -IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
F + +VLE S + + R + + L +YLH
Sbjct: 82 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 135
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI--TMATIGYMAPEYGSE 907
++H DLK N+ L+E++ + DFG++ + E D + + T Y+APE S+
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSK 189
Query: 908 GIVSAKCDVYSYGVLL 923
S + DV+S G ++
Sbjct: 190 KGHSFEVDVWSIGCIM 205
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/269 (22%), Positives = 91/269 (33%), Gaps = 41/269 (15%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
GI + ++L+ H N + +L LE L L N + ++ L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLEL 119
Query: 179 GSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNN-LQGDMP 236
N + + L+ LWL +N +P + L L+L + L
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
A L L +LNL M NL I + L L+
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR--------EIPNLT-------------------PLIKLDE 211
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
L L GN+L P S L L + + + F NL+ L +NL N+LT
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-- 269
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLR 385
+ L L + L+ NP
Sbjct: 270 ---LPHDLFTPLH---HLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 58/294 (19%), Positives = 103/294 (35%), Gaps = 46/294 (15%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
++P +S T+ + L L +N+ + +L L L L++N+++ A L L
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 246 EHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL 304
L L N L+ +P F +S ++ + L N + +P + +P+L L L
Sbjct: 115 NTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 305 IGTIP-NSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWS 363
+ I + S L L+L+ IP L L L+L N L+
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP------ 224
Query: 364 FLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGL 423
S L +L + + ++ I F NL L
Sbjct: 225 --GSFQGLMHLQKLWMIQSQIQVIER---NAFD----------------------NLQSL 257
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN 477
+ + L N L L+ + L+ N + C + LS + +
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN-----CDILWLSWWIKD 306
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 7/217 (3%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+P I + L L +N++ + + L+ L L N ++ L L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSS-NSL 529
+ L L N L+ L+ L+EL L +N + SIPS ++ + + ++L L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173
Query: 530 SGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLI 589
S + + L L L+L+ L +IP ++ L L L L+GN + P SF L+
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 590 SLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
L+ L + + I + + L L ++N+++N L
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 61/256 (23%), Positives = 85/256 (33%), Gaps = 33/256 (12%)
Query: 53 RVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL 112
LNL + I +L L L +S N+ L L + N L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSLSGSLPNDI--R 169
+ LS+L+ L NN IP + + L LDL E +
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQ 228
L L L L + +IP+ L+ L L L+ N S + L L L + Q
Sbjct: 184 LSNLRYLNLAMCNL-REIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQ 240
Query: 229 NNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
+ +Q A NLQ L +NL NNL+ LP L
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-------------------------LLPHDLF 275
Query: 289 HSLPNLEFLTLFGNNL 304
L +LE + L N
Sbjct: 276 TPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
+P + + L+L++N +Q HL L L L+ N++ L +L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 496 RELHLGSNTLTYSIPSS----LWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSR- 550
L L N LT +IP+ L L+ + L +N + + + L LDL
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKEL---WLRNNPIESIPSYAFNRIPSLRRLDLGEL 170
Query: 551 NQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLE 610
+LS GL +L L+LA IP + LI L+ LD+S N++S P S +
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 611 ALLYLKKLNVSYNRLEGEIPIKGPFRNFSA 640
L++L+KL + ++++ I + F N +
Sbjct: 229 GLMHLQKLWMIQSQIQ-VIE-RNAFDNLQS 256
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 65/279 (23%), Positives = 102/279 (36%), Gaps = 40/279 (14%)
Query: 302 NNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ 361
+ +P+ I+ ++L L+L N ++F +LR L L L N + T A
Sbjct: 52 RKNLREVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA-- 107
Query: 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLS 421
+L L L N L I G F LS
Sbjct: 108 ------FNGLANLNTLELFDNRLTTIPN---GAFV----------------------YLS 136
Query: 422 GLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYY-LCHLERLSQLLLNGN 479
L L L +N + +IP+ R L+ L L + I L L L L
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 480 NLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQH 539
NL IP L L L EL L N L+ P S L ++ + + + + ++ +
Sbjct: 196 NLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
Query: 540 LKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
L+ L+ ++L+ N L+ + L L + L N +N
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 62/268 (23%), Positives = 98/268 (36%), Gaps = 40/268 (14%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
N L L N + NS + L L LS N F L L L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
LTT + + L EL L NP+ I F+
Sbjct: 124 LTTIPN--------GAFVYLSKLKELWLRNNPIESIPS---YAFN--------------- 157
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYYLCHL 468
+ L L L + + I G F+ L+ L+L +L+ IP L L
Sbjct: 158 -------RIPSLRRLDLGELKRLSYISE--GAFEGLSNLRYLNLAMCNLR-EIPN-LTPL 206
Query: 469 ERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
+L +L L+GN+LS P L L++L + + + ++ +L+ ++ +NL+ N+
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGD 556
L+ L L + L N + +
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYY-LCHLERLSQL 474
+L L L+L N + TI G F L L L+DN L +IP +L +L +L
Sbjct: 86 HLRHLEILQLSRNHIR-TIEI--GAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKEL 141
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGS-NTLTYSIPSSLWSLEYILYVNLSSNSLSGPL 533
L N + + SLR L LG L+Y + L + Y+NL+ +L +
Sbjct: 142 WLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-I 200
Query: 534 PSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLES 593
P+ + L L LDLS N LS P + GL L L + +Q +F +L SL
Sbjct: 201 PN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259
Query: 594 LDVSSNNISGKIPKSLEALLYLKKLNVSYN 623
++++ NN++ L +L+++++ +N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 21/196 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVK-- 790
LG+G F ++ + A K+ L E I R++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 791 -IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
F + +VLE S + + R + + L +YLH
Sbjct: 108 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 161
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI--TMATIGYMAPEYGSE 907
++H DLK N+ L+E++ + DFG++ + E D + + T Y+APE S+
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSK 215
Query: 908 GIVSAKCDVYSYGVLL 923
S + DV+S G ++
Sbjct: 216 KGHSFEVDVWSIGCIM 231
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 54/212 (25%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG+G+F +V + G A K+ N + R F+ + E I R ++H N+V++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 795 CCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH- 844
F LV + + G FE I+ R + + + + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFED----------IVAREFYSEADASHCIQQILESIAYCHS 123
Query: 845 HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATI---- 897
+G IVH +LKP N+LL + ++DFG++ + + +
Sbjct: 124 NG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-------AWHGFAGTP 171
Query: 898 GYMAPE------YGSEGIVSAKCDVYSYGVLL 923
GY++PE Y D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 60/219 (27%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN--------LQLERAFRTFDSECEILRNVRHRNL 788
LG G+ G V VAIK+ + + ++E EIL+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 789 VKIFSSCCNIDFKA--LVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVA 837
+KI + D + +VLE M G F+K ++ +
Sbjct: 78 IKIKNF---FDAEDYYIVLELMEGGELFDK----------VVGNKRLKEATCKLYFYQML 124
Query: 838 LVLEYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTIT 893
L ++YLH +G I+H DLKP N+LL +E+ ++DFG SK+LGE S+ +T+
Sbjct: 125 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL- 176
Query: 894 MATIGYMAPE---------YGSEGIVSAKCDVYSYGVLL 923
T Y+APE Y D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 209
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 56/309 (18%), Positives = 102/309 (33%), Gaps = 31/309 (10%)
Query: 152 FLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRL 211
SL+ S+P+ + ++ L L +N S L C +LQ L L N + +
Sbjct: 35 ICKGSSGSLN-SIPSGL-TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TI 91
Query: 212 PENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTI 269
E+ +L L L+L+ N L + L L LNL N ++F +++ +
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL 151
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329
+++ + + L LE L + ++L P S+ + + L L
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 330 GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
+ + L L L T +SL + + + L ++
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271
Query: 390 PFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQG 449
+SGL+ L+ N+L R LQ
Sbjct: 272 LL--------------------------NQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305
Query: 450 LSLYDNDLQ 458
+ L+ N
Sbjct: 306 IWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 60/311 (19%), Positives = 109/311 (35%), Gaps = 52/311 (16%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
++ L L N + + + L L L+SN + +F +L L L+L +N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
L+ SS S SLT L L NP + + FS
Sbjct: 112 LSNLSS--------SWFKPLSSLTFLNLLGNPYKTLGET--SLFS--------------- 146
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLCHLER 470
+L+ L L++ + + I L+ L + +DLQ P L ++
Sbjct: 147 -------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS 530
+S L+L+ + + +S+ L L L + LS
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD----------------TFHFSELS 243
Query: 531 GPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPES-FGSLI 589
+S+ N+ ++ L + ++ + L L + NQ +P+ F L
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301
Query: 590 SLESLDVSSNN 600
SL+ + + +N
Sbjct: 302 SLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 8e-22
Identities = 54/263 (20%), Positives = 100/263 (38%), Gaps = 19/263 (7%)
Query: 78 LVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS----GSFPSWIGILSRLQILSFHN 133
+ SLD+S N ++L + L+ + N ++ SF S L L+ L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS----LGSLEHLDLSY 109
Query: 134 NSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPS-S 190
N ++ + LS L FL+L+ N + L KL+ L +G+ D F +I
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNL 250
+ T L+ L + + P+++ ++ ++ L L + + +E L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 251 GMNNLSGPVPPTIFNISTIRLINLIENQL------SGHLPLTLGHSLPNLEFLTLFGNNL 304
+L + T LI + S + L + + L L N L
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289
Query: 305 IGTIPNSI-TNASKLIGLDLSSN 326
++P+ I + L + L +N
Sbjct: 290 K-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 53/261 (20%), Positives = 95/261 (36%), Gaps = 17/261 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+LS+ + I L L +L ++ N + L L ++ +YN LS
Sbjct: 57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPD--FLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
SW LS L L+ N + + + +L+KL+ L + + L
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175
Query: 173 LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNL 231
LE+L + ++D P SL ++ L L + L E S + L L +L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDL 234
Query: 232 QGDMPTAI--------GNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHL 283
+ + ++ + +L V + IS + + NQL +
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-V 292
Query: 284 PLTLGHSLPNLEFLTLFGNNL 304
P + L +L+ + L N
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 55/295 (18%), Positives = 98/295 (33%), Gaps = 50/295 (16%)
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
++ L+L N +T S+ S L C +L L L N + I +FS
Sbjct: 54 VKSLDLSNNRITYISN--------SDLQRCVNLQALVLTSNGINTIEE---DSFS----- 97
Query: 402 FEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGS 460
+L L L L N L + ++ L L+L N + +
Sbjct: 98 -----------------SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-T 138
Query: 461 IP--YYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517
+ HL +L L + + I LT L EL + ++ L P SL S++
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 518 YILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITIS--------GLKDLAT 569
+ ++ L L + + L+L L +S
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 570 LSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKS-LEALLYLKKLNVSYN 623
+ + + + + L L+ S N + +P + L L+K+ + N
Sbjct: 259 VKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 43/225 (19%), Positives = 82/225 (36%), Gaps = 14/225 (6%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYL-CHLER 470
SIP + + L L +N + + + R LQ L L N + +I L
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSSNSL 529
L L L+ N LS + L+SL L+L N +SL+S L + + + +
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 530 SGPLPSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
+ L L L++ + L P ++ +++++ L L Q +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221
Query: 589 ISLESLDVSSNNISGKIPKSLEA--------LLYLKKLNVSYNRL 625
S+E L++ ++ L + + ++ L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 6/185 (3%)
Query: 447 LQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTL 505
++ L L +N + L L L+L N ++ I SL SL L L N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 506 TYSIPSSL-WSLEYILYVNLSSNSLSGPLPSSI-QHLKVLINLDLSRNQLSGDIPI-TIS 562
+ ++ SS L + ++NL N +S+ HL L L + I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 563 GLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSY 622
GL L L + + P+S S+ ++ L + + ++ ++ L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 623 NRLEG 627
L+
Sbjct: 232 TDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 29/184 (15%), Positives = 59/184 (32%), Gaps = 36/184 (19%)
Query: 59 LSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPS 118
+ + I L+FL L+I ++ L+ S S
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASD-----------LQSYE---------PKSLKS 196
Query: 119 WIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI---------R 169
+ + L H + F+ S +E L+L + L +++ +
Sbjct: 197 ----IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQ 228
+ + F Q+ L++ + L L + N+ +P+ I L+ L + L
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHT 310
Query: 229 NNLQ 232
N
Sbjct: 311 NPWD 314
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 49/234 (20%), Positives = 89/234 (38%), Gaps = 56/234 (23%)
Query: 723 LDIQRATDGFNE----CNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD--- 774
LD+ F + C ++G+G F +V + G A+K+ ++ +
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 775 --SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLN 831
E I ++H ++V++ + + +V EFM + I++R +
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE----------IVKRAD 122
Query: 832 ------------IMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDF 875
M + L Y H + I+H D+KP+ +LL + + + F
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLGGF 177
Query: 876 GISKLLGEGDDSVTQTITMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 923
G++ LGE + T +MAPE YG DV+ GV+L
Sbjct: 178 GVAIQLGESGLVAGGRV--GTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 54/216 (25%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN--------LQLERAFRTFDSECEILRNVRHRNL 788
LG G+ G V VAI++ + + ++E EIL+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALVL 840
+KI + D+ +VLE M G E L+ ++ + L +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGG--E--LFDK-----VVGNKRLKEATCKLYFYQMLLAV 252
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+YLH +G I+H DLKP N+LL +E+ ++DFG SK+LGE S+ +T+ T
Sbjct: 253 QYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL-CGT 304
Query: 897 IGYMAPE---------YGSEGIVSAKCDVYSYGVLL 923
Y+APE Y D +S GV+L
Sbjct: 305 PTYLAPEVLVSVGTAGYNRA------VDCWSLGVIL 334
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 56/214 (26%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN-LQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G+FG V+ G IK N + + ++E E+L+++ H N++KIF
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 796 CNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRL------------NIMIDVALVLEY 842
+ +V+E G E+ I+ +M + L Y
Sbjct: 90 EDYHNMYIVMETCEGGELLER----------IVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 843 LH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATI- 897
H +VH DLKP NIL + + DFG+++L +
Sbjct: 140 FHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-------HSTNAA 187
Query: 898 ---GYMAPE-----YGSEGIVSAKCDVYSYGVLL 923
YMAPE + CD++S GV++
Sbjct: 188 GTALYMAPEVFKRDVTFK------CDIWSAGVVM 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
+ +G GS G+V G VA+K+ +L+ ++ +E I+R+ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQ--RLN------IMIDVALVLEY 842
++ S + +++EF+ G+ DI+ RLN + V L Y
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---Y 899
LH ++H D+K ++ILL + +SDFG + V + ++ +G +
Sbjct: 157 LHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYW 207
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLME 925
MAPE S + + + D++S G++++E
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 56/228 (24%)
Query: 725 IQRATDGFNE----CNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSEC 777
+ A+ F++ LG+G+F +V + G A K+ N + R F+ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR-------- 829
I R ++H N+V++ S F LV + + G E L F DI+ R
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--L-----FEDIVAREFYSEADA 130
Query: 830 LNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGD 885
+ + + + Y H +G IVH +LKP N+LL + ++DFG++ + + +
Sbjct: 131 SHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 886 DSVTQTITMATI----GYMAPE------YGSEGIVSAKCDVYSYGVLL 923
GY++PE Y D+++ GV+L
Sbjct: 186 -------AWHGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 44/207 (21%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKIFS 793
LG+GSFG V G A+KV + ++ + + E ++L+ + H N++K++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 794 SCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH 844
+ + LV E G F++ I+ R I+ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDE----------IISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 845 HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
IVH DLKP N+LL ++ + DFG+S + T Y+A
Sbjct: 144 KNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIA 196
Query: 902 PE-----YGSEGIVSAKCDVYSYGVLL 923
PE Y KCDV+S GV+L
Sbjct: 197 PEVLHGTYDE------KCDVWSTGVIL 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 49/213 (23%)
Query: 735 CNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD-----SECEILRNVRHRNL 788
LG+G+F +V + + G A + N + D E I R ++H N+
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRLLKHPNI 72
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALVL 840
V++ S L+ + + G E L F DI+ R + + + +
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGG--E--L-----FEDIVAREYYSEADASHCIQQILEAV 123
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+ H G +VH +LKP N+LL + ++DFG++ + EG+ T
Sbjct: 124 LHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGT 176
Query: 897 IGYMAPE------YGSEGIVSAKCDVYSYGVLL 923
GY++PE YG D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
+ +G+G+ G VY + G VAI+ NLQ + +E ++R ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQ--RLN------IMIDVALVLEY 842
S D +V+E++ GS D++ ++ + + LE+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---Y 899
LH ++H D+K +NILL + + ++DFG + ++ TM +G +
Sbjct: 132 LHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTM--VGTPYW 182
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLME 925
MAPE + K D++S G++ +E
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 43/206 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG+GSFG V K A+KV N + T E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 795 CCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLHH 845
+ +V E G F++ I++R I+ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDE----------IIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 846 GHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
+ IVH DLKP NILL +++ + DFG+S + + + T Y+AP
Sbjct: 140 HN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAP 192
Query: 903 E-----YGSEGIVSAKCDVYSYGVLL 923
E Y KCDV+S GV+L
Sbjct: 193 EVLRGTYDE------KCDVWSAGVIL 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRT-FDSECEI-LRNVRHRNLVKIFSS 794
+GRG++G V K G +A+K ++ + + ++ +R+ +V+ + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 795 CCNIDFKALVLEFMPNGSFEKWLYSYNYFL-------DILQRLNIMIDVALVLEYLHHGH 847
+ +E M + SF+K Y Y Y + +IL + I + L +L
Sbjct: 90 LFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGK--ITLATVKALNHLKENL 145
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE---- 903
I+H D+KP+NILLD + + DFGIS G+ DS+ +T YMAPE
Sbjct: 146 K---IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 904 YGSEGIVSAKCDVYSYGVLLME 925
S + DV+S G+ L E
Sbjct: 200 SASRQGYDVRSDVWSLGITLYE 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 43/206 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQ--LERAFRTFDSECEILRNVRHRNLVKIFSS 794
LG G++G V AIK+ + E +L+ + H N++K++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 795 CCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLHH 845
+ LV+E G F++ I+ R I+ V + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDE----------IIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 846 GHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
+ IVH DLKP N+LL +++ + DFG+S + + + T Y+AP
Sbjct: 155 HN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAP 207
Query: 903 E-----YGSEGIVSAKCDVYSYGVLL 923
E Y KCDV+S GV+L
Sbjct: 208 EVLRKKYDE------KCDVWSIGVIL 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 52/218 (23%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKV-------------FNLQLERAFRTFDSECEILR 781
LG G++G V + AIKV N +E+ +E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIM 833
++ H N++K+F + + LV EF G F I+ R NIM
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGG---------ELFEQIINRHKFDECDAANIM 152
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQ 890
+ + YLH + IVH D+KP NILL + + + DFG+S + +
Sbjct: 153 KQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 891 TITMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 923
+ T Y+APE Y KCDV+S GV++
Sbjct: 209 ---LGTAYYIAPEVLKKKYNE------KCDVWSCGVIM 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
+ LG G+FG VYK G A KV + E + E EIL H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ + + +++EF P G+ + + + L Q + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPE---- 903
I+H DLK N+L+ ++DFG+S + ++ + + IG +MAPE
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSF--IGTPYWMAPEVVMC 191
Query: 904 -YGSEGIVSAKCDVYSYGVLLME 925
+ K D++S G+ L+E
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIE 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 22/238 (9%)
Query: 697 RRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNE----CNLLGRGSFGLVYKGT-L 751
+ G V D W++ ++ D + LG G+FG+V++ T
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 752 FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNG 811
G N A K E T E + + +RH LV + + + + ++ EFM G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 812 S-FEKWLYSYNYF--LDILQRLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDEN 867
FEK +N + + M V L ++H + VH DLKP NI+
Sbjct: 240 ELFEKVADEHNKMSEDEAV---EYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTK 291
Query: 868 MTAHV--SDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 923
+ + DFG++ L +T T + APE V D++S GVL
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 33/214 (15%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRT-FDSECEI-LRNVRHR 786
D LGRG++G+V K + G +A+K + + + +I +R V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 787 NLVK-----IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMID 835
V I +E M + S +K Y +D Q + I +
Sbjct: 67 FTVTFYGALFREGDVWI-----CMELM-DTSLDK---FYKQVIDKGQTIPEDILGKIAVS 117
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+ LE+LH S ++H D+KP+N+L++ + DFGIS G D V + I
Sbjct: 118 IVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAG 171
Query: 896 TIGYMAPE----YGSEGIVSAKCDVYSYGVLLME 925
YMAPE ++ S K D++S G+ ++E
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 47/207 (22%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSC 795
LG GSF + K A+K+ + ++E + E L+ H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEVF 75
Query: 796 CNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLN--------IMIDVALVLEYLH-H 845
+ LV+E + G FE+ I ++ + IM + + ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFER----------IKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 846 GHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
G +VH DLKP N+L ++N+ + DFG ++L + + T+ Y AP
Sbjct: 126 G-----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAAP 178
Query: 903 E------YGSEGIVSAKCDVYSYGVLL 923
E Y CD++S GV+L
Sbjct: 179 ELLNQNGYDES------CDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/212 (26%), Positives = 83/212 (39%), Gaps = 40/212 (18%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSS 794
+LG G+ V L A+K+ Q E E+L + HRN++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 795 CCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLN--------IMIDVALVLEYLH- 844
D LV E M GS I +R + ++ DVA L++LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSH----------IHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 845 HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDD-SVTQTITMATI--- 897
G I H DLKP NIL ++ + DF + + D S T + T
Sbjct: 130 KG-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 898 -GYMAPE-----YGSEGIVSAKCDVYSYGVLL 923
YMAPE I +CD++S GV+L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-23
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 57/238 (23%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD-----SECEILRNVRHRNLVKI 791
+G+GS+G+V AIK+ N R D +E +++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 792 FSSCCNIDFKALVLEFMPNGS-FEK----------------------------------- 815
+ + + LV+E G +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 816 ---WLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILL--DENMT 869
+ S ++ NIM + L YLH G I H D+KP N L +++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208
Query: 870 AHVSDFGISKLLGEGDDSVTQTITMA--TIGYMAPE--YGSEGIVSAKCDVYSYGVLL 923
+ DFG+SK + ++ +T T ++APE + KCD +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 18/224 (8%)
Query: 709 EDVLSLATWRRTSYLDIQRATDGFNE----CNLLGRGSFGLVYKGT-LFDGTNVAIKVFN 763
D W++ ++ + LG G+FG+V++ G K N
Sbjct: 26 YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 85
Query: 764 LQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNY 822
T +E I+ + H L+ + + + L+LEF+ G F++ + + +Y
Sbjct: 86 TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR-IAAEDY 144
Query: 823 FLDILQRLNIMIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISK 879
+ + +N M L+++H H IVH D+KP NI+ + + V DFG++
Sbjct: 145 KMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLAT 199
Query: 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 923
L + +T AT + APE V D+++ GVL
Sbjct: 200 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 49/208 (23%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNVRHRNLVKIFSSC 795
+G GS+ + + A+K+ + E EIL R +H N++ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 796 CNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRLN--------IMIDVALVLEYLH-H 845
+ + +V E M G +K IL++ ++ + +EYLH
Sbjct: 86 DDGKYVYVVTELMKGGELLDK----------ILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 846 GHSLAPIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
G +VH DLKP+NIL + + DFG +K L ++ + T T ++A
Sbjct: 136 G-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP-CYTANFVA 188
Query: 902 PE------YGSEGIVSAKCDVYSYGVLL 923
PE Y + CD++S GVLL
Sbjct: 189 PEVLERQGYDAA------CDIWSLGVLL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 58/281 (20%), Positives = 91/281 (32%), Gaps = 75/281 (26%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVR 784
R F +GRG FG+V++ D N AIK L E A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 785 HRNLVKIFSSCCNIDFKALVLE-------------------------------------- 806
H +V+ F++ + E
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 807 ---FMPNGSFEKWLY------------------SYNYFLDILQRLNIMIDVALVLEYLHH 845
+ S + +LY + L+I I +A +E+LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA---------- 895
++H DLKP+NI + V DFG+ + + ++ T M
Sbjct: 183 KG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
T YM+PE S K D++S G++L E E
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
F+ LG GS+G VYK G VAIK + E + E I++ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ S +V+E+ GS + N L + I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--- 145
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPEYGSE 907
+H D+K NILL+ A ++DFG++ L D++ + T+ IG +MAPE E
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQE 199
Query: 908 GIVSAKCDVYSYGVLLME 925
+ D++S G+ +E
Sbjct: 200 IGYNCVADIWSLGITAIE 217
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 53/277 (19%), Positives = 88/277 (31%), Gaps = 22/277 (7%)
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQ---EIGNLSGLM 424
RSL L V+ + S SL++ + I + +SGL
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 425 FLKLDDNELNGTIPTTVGRFQ--QLQGLSLYDNDLQGSIPY----YLCHLERLSQLLLNG 478
L L++ E+ GT P + L L+L + + L L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTLTYSI-------PSSLWSLEYILYVNLSSNSLSG 531
+ + +L L L N P +L+ + N + SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIP-ITISGLKDLATLSLAGNQFNGPIPESFGSLIS 590
+ L LDLS N L + L +L+L+ +P+ +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--K 275
Query: 591 LESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEG 627
L LD+S N + P E L + L++ N
Sbjct: 276 LSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 58/302 (19%), Positives = 85/302 (28%), Gaps = 30/302 (9%)
Query: 303 NLIGTIP--NSITNASKLIGLDLSSNLFS--------GHIPHTFGNLRFLRFLNLMFNSL 352
N P +S N ++L S ++ L+L ++
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFS-ASLRKFEAIKCELKG 411
P+ + L EL L + G PP + + L
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 412 SIPQEIGNLSGLMF-----LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSI----- 461
+ L + L + V F L L L DN G
Sbjct: 136 -RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 462 --PYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS-LEY 518
P L+ L+ SG A + L+ L L N+L + +
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 519 ILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
+ +NLS L L VL DLS N+L P L + LSL GN F
Sbjct: 255 LNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLDR-NPS-PDELPQVGNLSLKGNPFL 309
Query: 579 GP 580
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 52/270 (19%), Positives = 90/270 (33%), Gaps = 38/270 (14%)
Query: 50 RHHRVVALNLSSFSLGGIIPPH---LGNLSFLVSLDISENNFYGHLPNELGKLRRLRLIN 106
+ + L + + + I + +S L L + G P L + L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 107 FAYNELSGS-FPSWIG-----ILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSL 160
+S + +W+ + L++LS + + + L LDL +N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 161 SGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKF---SGRLPENIGN 217
G L S + P+ LQ L L + SG
Sbjct: 186 LGERG------------LISALCPLKFPT-------LQVLALRNAGMETPSGVCSALAAA 226
Query: 218 LSQLTDLNLAQNNLQGD-MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE 276
QL L+L+ N+L+ + L LNL L VP + + + +++L
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSY 283
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIG 306
N+L P LP + L+L GN +
Sbjct: 284 NRLD-RNPSPDE--LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 54/323 (16%), Positives = 91/323 (28%), Gaps = 67/323 (20%)
Query: 173 LEKLYLGSNDFFGQIP-SSLSECTHLQTLWLADNKFSGRLPEN---IGNLSQLTDLNLAQ 228
LE L + + + + L+ L + + R+ + +S L +L L
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 229 NNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
+ G P + +++ + L N+ L
Sbjct: 105 LEVTGTAPPPLLEATGP-------------------DLNILNLRNVSWATRDAWLAELQQ 145
Query: 289 HSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHI-------PHTFGNLRF 341
P L+ L++ + + + L LDLS N G P F L+
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
L N + + S + L L L+ N LR ++ + L
Sbjct: 206 LALRNAGMETPSGVCS--------ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN- 256
Query: 402 FEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSI 461
L L L +P G +L L L N L
Sbjct: 257 -----------------------SLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLD-RN 289
Query: 462 PYYLCHLERLSQLLLNGNNLSGA 484
P L ++ L L GN +
Sbjct: 290 P-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 41/222 (18%), Positives = 75/222 (33%), Gaps = 26/222 (11%)
Query: 418 GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLL-- 475
G S LK D E + T + + L+ L++ + I + + +S L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 476 -LNGNNLSGAIPACLGSLT--SLRELHLGSNTLT--YSIPSSL--WSLEYILYVNLSSNS 528
L ++G P L T L L+L + + + + L W + ++++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
++ L LDLS N G+ + + P F +L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISA-----------------LCPLKFPTL 203
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630
L + SG A + L+ L++S+N L
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 21/145 (14%), Positives = 46/145 (31%), Gaps = 6/145 (4%)
Query: 493 TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQ 552
L+ + ++ ++ SL+ + S + + L L L +
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 553 LSGDIPITISGL--KDLATLSLAGNQFNGPIPE----SFGSLISLESLDVSSNNISGKIP 606
++G P + DL L+L + L+ L ++ +
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 607 KSLEALLYLKKLNVSYNRLEGEIPI 631
+ + L L++S N GE +
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGL 191
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 46/207 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LGRG+ +VY+ A+KV +++ +E +L + H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQR--------LNIMIDVALVLEYLH-HG 846
+LVLE + G F I+++ + + + + YLH +G
Sbjct: 118 ETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 847 HSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAP 902
IVH DLKP N+L + ++DFG+SK++ T+ T GY AP
Sbjct: 169 -----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAP 219
Query: 903 E------YGSEGIVSAKCDVYSYGVLL 923
E YG E D++S G++
Sbjct: 220 EILRGCAYGPE------VDMWSVGIIT 240
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 47/213 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN--------LQLERAFRTFDSECEILRNVRHRN 787
LLG GS+G V + A+K+ + E ++LR +RH+N
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQLLRRLRHKN 67
Query: 788 LVKIFSSCCNIDFKA--LVLEFMPNGSFEKWLYSY------------NYFLDILQRLNIM 833
++++ N + + +V+E+ G E + YF ++
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID----- 120
Query: 834 IDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
LEYLH G IVH D+KP N+LL T +S G+++ L T
Sbjct: 121 -----GLEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 893 TMATIGYMAPE--YGSEGIVSAKCDVYSYGVLL 923
+ + + PE G + K D++S GV L
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 30/226 (13%)
Query: 718 RRTSYLDI-----QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-ERAF 770
++T YL I Q + +G G+ G V+K G +A+K +
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67
Query: 771 RTFDSECEIL-RNVRHRNLVKIF-----SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFL 824
+ + +++ ++ +V+ F ++ I +E M EK +
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI-----AMELM-GTCAEKLKKRMQGPI 121
Query: 825 DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884
+ + + L YL H ++H D+KP+NILLDE + DFGIS G
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS---GRL 175
Query: 885 DDSVTQTITMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLME 925
D + + YMAPE ++ + DV+S G+ L+E
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLV 789
F + +G+GSFG V+KG VAIK+ +L + E E +L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQ--RLN------IMIDVALVLE 841
K + S +++E++ GS LD+L+ L+ I+ ++ L+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG--- 898
YLH +H D+K N+LL E+ ++DFG++ L D+ + T +G
Sbjct: 134 YLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPF 184
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+MAPE + +K D++S G+ +E + P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 32/206 (15%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
++ +LG G FG V+K G +A K+ + + +E ++ + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 791 IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR---------LNIMIDVALVL 840
++ + + + LV+E++ G F++ I+ + M + +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDR----------IIDESYNLTELDTILFMKQICEGI 200
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATI 897
++H I+H DLKP NIL + DFG+++ + + T
Sbjct: 201 RHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTP 252
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLL 923
++APE + VS D++S GV+
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 44/236 (18%), Positives = 80/236 (33%), Gaps = 43/236 (18%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNV 783
R T F+E +G G FG V+K DG AIK L + E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 784 -RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL---QRLNIMIDVALV 839
+H ++V+ FS+ D + E+ GS + + + ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVS-------------------DFGISKL 880
L Y+H +VH D+KP+NI + + + D G
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 881 LGEGDDSVTQTITMATIG---YMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKP 932
+ G ++A E E K D+++ + ++ +
Sbjct: 184 ISS---------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 39/207 (18%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD------SECEILRNVRHRNLVK 790
LG G F +V K G A K + RA R E ILR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 791 IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLE 841
+ N L+LE + G F+ + Q+ + + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDF----------LAQKESLSEEEATSFIKQILDGVN 129
Query: 842 YLH-HGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
YLH I H DLKP NI+L + DFG++ + +G T
Sbjct: 130 YLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGT 181
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLL 923
++APE + + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 39/207 (18%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFD-----SECEILRNVRHRNLVK 790
LG G F +V K G A K +L + R E ILR +RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 791 IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLE 841
+ N L+LE + G F+ + ++ + + +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDF----------LAEKESLTEDEATQFLKQILDGVH 122
Query: 842 YLH-HGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
YLH I H DLKP NI+L N + DFGI+ + G+ T
Sbjct: 123 YLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGT 174
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLL 923
++APE + + + D++S GV+
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 70/234 (29%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDS----------------- 775
+G+GS+G+V D T A+KV + L + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 776 ------ECEILRNVRHRNLVKIF-----SSCCNIDFKALVLEFMPNGSFEKWLYSY---- 820
E IL+ + H N+VK+ + ++ +V E + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGP----VMEVPTLK 132
Query: 821 --------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV 872
YF D++ +EYLH+ I+H D+KP+N+L+ E+ +
Sbjct: 133 PLSEDQARFYFQDLI----------KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKI 178
Query: 873 SDFGISKLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVS-AKCDVYSYGVLL 923
+DFG+S +G D++ T+ T +MAPE + I S DV++ GV L
Sbjct: 179 ADFGVSNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 37/206 (17%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFD------SECEILRNVRHRNLVK 790
LG G F +V K G A K + RA R E ILR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 791 IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLE 841
+ N L+LE + G F+ + Q+ + + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDF----------LAQKESLSEEEATSFIKQILDGVN 129
Query: 842 YLHHGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
YLH I H DLKP NI+L + DFG++ + +G T
Sbjct: 130 YLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTP 182
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLL 923
++APE + + + D++S GV+
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 39/203 (19%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKIFS 793
LGRG FG+V++ K + E IL RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHE 68
Query: 794 SCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR---------LNIMIDVALVLEYL 843
S +++ ++ EF+ FE+ I ++ + V L++L
Sbjct: 69 SFESMEELVMIFEFISGLDIFER----------INTSAFELNEREIVSYVHQVCEALQFL 118
Query: 844 H-HGHSLAPIVHCDLKPNNILL--DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
H H I H D++P NI+ + T + +FG ++ L GD + Y
Sbjct: 119 HSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170
Query: 901 APEYGSEGIVSAKCDVYSYGVLL 923
APE +VS D++S G L+
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
F +LG GSF V T AIK+ ++ + E +++ +
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVT-RERDVMSRL 87
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
H VK++ + + + L + NG K++ F + R ++ LEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYL 146
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYMAP 902
H I+H DLKP NILL+E+M ++DFG +K+L + T Y++P
Sbjct: 147 HGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSP 201
Query: 903 EYGSEGIVSAK-----CDVYSYGVLLME 925
E +++ K D+++ G ++ +
Sbjct: 202 E-----LLTEKSACKSSDLWALGCIIYQ 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 65/218 (29%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNVRHRNLVKIFSS 794
+LG G G V + G A+K+ +A + E + + ++V I
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 795 CCNIDFKA----LVLEFMPNGS-FEKWLYSYNYFLDILQRLN----------IMIDVALV 839
N+ +++E M G F + I +R + IM D+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSR----------IQERGDQAFTEREAAEIMRDIGTA 140
Query: 840 LEYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+++LH H I H D+KP N+L +++ ++DFG +K + +
Sbjct: 141 IQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--------ALQ 187
Query: 896 TI----GYMAPE------YGSEGIVSAKCDVYSYGVLL 923
T Y+APE Y CD++S GV++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 52/213 (24%), Positives = 75/213 (35%), Gaps = 32/213 (15%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLE 174
+ P + IL N L+ ++L L+L L+ L D LP L
Sbjct: 24 ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLG 80
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQG 233
L L N +P L L ++ N+ + LP L +L +L L N L+
Sbjct: 81 TLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT 138
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
P + LE L+L NNL+ +P + N L N
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTE-LPAGLLN------------------------GLEN 173
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSN 326
L+ L L N+L TIP + L L N
Sbjct: 174 LDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 48/185 (25%), Positives = 71/185 (38%), Gaps = 18/185 (9%)
Query: 99 LRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158
L L + N L + + +RL L+ T ++ L L LDL N
Sbjct: 33 TTILHL---SENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHN 87
Query: 159 SLSGSLPNDIR-LPKLEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPE 213
L SLP + LP L L + N ++ +L LQ L+L N+ LP
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFN----RLTSLPLGALRGLGELQELYLKGNELK-TLPP 141
Query: 214 NI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLI 272
+ +L L+LA NNL + L+ L+ L L N+L +P F +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFA 200
Query: 273 NLIEN 277
L N
Sbjct: 201 FLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 7/158 (4%)
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS 530
+ L L+ N L A L T L +L+L LT + +L + ++LS N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 531 GPLPSSIQHLKVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLI 589
LP Q L L LD+S N+L+ +P+ GL +L L L GN+ P
Sbjct: 91 S-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 590 SLESLDVSSNNISGKIPKSL-EALLYLKKLNVSYNRLE 626
LE L +++NN++ ++P L L L L + N L
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 55/223 (24%), Positives = 77/223 (34%), Gaps = 49/223 (21%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
+P T L LS NL T L LNL LT L
Sbjct: 29 LPKDTTI------LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK----------LQV 72
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLK 427
L L L+ N L+ S+P L L L
Sbjct: 73 DGTLPVLGTLDLSHNQLQ--------------------------SLPLLGQTLPALTVLD 106
Query: 428 LDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGAI 485
+ N L ++P +LQ L L N+L+ ++P L +L +L L NNL+ +
Sbjct: 107 VSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-EL 163
Query: 486 PA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
PA L L +L L L N+L +IP + + + L N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 8/162 (4%)
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
+ NL+ A+P LHL N L ++L + +NL L+ L
Sbjct: 17 CDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV 72
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLD 595
L VL LDLS NQL +P+ L L L ++ N+ + L L+ L
Sbjct: 73 D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 596 VSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRN 637
+ N + P L L+KL+++ N L E+P G
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELP-AGLLNG 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 37/206 (17%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN------------LQLERAFRTFDSECEILRNVR 784
LG G+FG V+ V +K +L + E IL V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVAL 838
H N++K+ N F LV+E +G + L+++ +D RL+ I +
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL-D--LFAF---IDRHPRLDEPLASYIFRQLVS 141
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+ YL I+H D+K NI++ E+ T + DFG + L G T TI
Sbjct: 142 AVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIE 194
Query: 899 YMAPE-YGSEGIVSAKCDVYSYGVLL 923
Y APE + +++S GV L
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 39/207 (18%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN-LQLERAFRTFD-----SECEILRNVRHRNLVK 790
LG G F +V K G A K + + + R E IL+ ++H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 791 IFSSCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQR--------LNIMIDVALVLE 841
+ N L+LE + G F+ + ++ + + +
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDF----------LAEKESLTEEEATEFLKQILNGVY 128
Query: 842 YLH-HGHSLAPIVHCDLKPNNILL----DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
YLH I H DLKP NI+L + DFG++ + G+ T
Sbjct: 129 YLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGT 180
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLL 923
++APE + + + D++S GV+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 30/228 (13%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
P + + L N + +L+ LDL + ++ + L
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 173 LEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLA 227
L L L N I + S + LQ L + + L G+L L +LN+A
Sbjct: 78 LSTLILTGN----PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132
Query: 228 QNNLQG-DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLT 286
N +Q +P NL LEHL+L N + + T L + LS L L
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLR----VLHQMPLLNLSLDLSLN 187
Query: 287 LGHSLP-------NLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSN 326
+ + L+ L L N L ++P+ I + L + L +N
Sbjct: 188 PMNFIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 36/228 (15%)
Query: 407 CELKG--SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY 464
C IP + L L N L + F +LQ L L ++Q +I
Sbjct: 14 CMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 465 LC-HLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVN 523
L LS L+L GN + L+SL++L L S+ +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLEN------------ 117
Query: 524 LSSNSLSGPLPSSIQHLKVLINLDLSRNQL-SGDIPITISGLKDLATLSLAGNQFNGPIP 582
I HLK L L+++ N + S +P S L +L L L+ N+
Sbjct: 118 -----------FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 583 ESFGSLISLE----SLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
L + SLD+S N ++ I + LK+L + N+L+
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 49/233 (21%), Positives = 84/233 (36%), Gaps = 26/233 (11%)
Query: 163 SLPNDIRLPKLEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPENI-GN 217
+P+++ + L L N + S LQ L L+ + + + +
Sbjct: 21 KIPDNL-PFSTKNLDLSFN----PLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS 74
Query: 218 LSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNI-STIRLINLIE 276
LS L+ L L N +Q A L L+ L NL+ + T++ +N+
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHI---- 332
N + +L NLE L L N + + ++ L+LS +L +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 333 PHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
P F +R L+ L L N L + SL ++ L+ NP
Sbjct: 194 PGAFKEIR-LKELALDTNQLKSVPDGI--------FDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 18/192 (9%)
Query: 419 NLSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPY-YLCHLERLSQLLL 476
+ L L L E+ TI L L L N +Q S+ L L +L+
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIP-----SSLWSLEYILYVNLSSNSLSG 531
NL+ +G L +L+EL++ N + S S+L +LE++ +LSSN +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHL---DLSSNKIQS 163
Query: 532 PLPSSIQHLKVL----INLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGS 587
+ ++ L + ++LDLS N ++ P ++ L L+L NQ F
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDR 222
Query: 588 LISLESLDVSSN 599
L SL+ + + +N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 29/229 (12%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
+P S N LDLS N ++F + L+ L+L + T A S
Sbjct: 26 LPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-----YQS 74
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI-GNLSGLMFL 426
L++ L+ L L NP++ L + +SL+K A++ L S+ G+L L L
Sbjct: 75 LSH---LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL 129
Query: 427 KLDDNELNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPY----YLCHLERLS-QLLLNG 478
+ N + + F L+ L L N +Q SI L + L+ L L+
Sbjct: 130 NVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
N ++ I L+EL L +N L L + + L +N
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 47/216 (21%), Positives = 74/216 (34%), Gaps = 33/216 (15%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLP----NELGKLRRLRLINFAYNEL 112
L+LS L + + L LD+S + L L L L N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLIL---TGNPI 88
Query: 113 SGSFPSWIGI---LSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSLSGSLPND- 167
S G LS LQ L + + +F + +L L+ L++ N + S
Sbjct: 89 Q-SLAL--GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 168 --IRLPKLEKLYLGSNDFFGQI----PSSLSECTHLQ----TLWLADNKFSGRLPENIGN 217
L LE L L SN +I + L + +L L+ N + +
Sbjct: 144 YFSNLTNLEHLDLSSN----KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 218 LSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
+L +L L N L+ L L+ + L N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 46/205 (22%), Positives = 75/205 (36%), Gaps = 37/205 (18%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN--LQLERAFRTFDSECEILRNVRHR-NLVKIFS 793
LGRG F +V + G A K + + E +L + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 794 SCCNIDFKALVLEFMPNGS-FEKWLYSYNYFLDILQRL----------NIMIDVALVLEY 842
N L+LE+ G F L L ++ + + Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSL----------CLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 843 LH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
LH + IVH DLKP NILL + DFG+S+ +G M T
Sbjct: 147 LHQNN-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPE 198
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLL 923
Y+APE + ++ D+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIA 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 48/217 (22%), Positives = 79/217 (36%), Gaps = 64/217 (29%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSC 795
LG G G V + A+K+ +A R E E+ + ++V+I
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 796 CNIDFKA----LVLEFMPNGS-FEKWLYSYNYFLDILQRLN----------IMIDVALVL 840
N+ +V+E + G F + I R + IM + +
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSR----------IQDRGDQAFTEREASEIMKSIGEAI 174
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+YLH I H D+KP N+L N ++DFG +K + ++ T
Sbjct: 175 QYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTT 222
Query: 897 I----GYMAPE------YGSEGIVSAKCDVYSYGVLL 923
Y+APE Y CD++S GV++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 63/254 (24%), Positives = 101/254 (39%), Gaps = 50/254 (19%)
Query: 713 SLATWRRTSYLDIQRATD---GFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER 768
S + R +D+ D F L+G G++G VYKG + G AIKV ++ +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 769 AFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKA------LVLEFMPNGSFEKWLYSYN 821
E +L+ HRN+ + + + LV+EF GS
Sbjct: 64 -EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------- 114
Query: 822 YFLDILQRLN-----------IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTA 870
D+++ I ++ L +LH ++H D+K N+LL EN
Sbjct: 115 --TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEV 168
Query: 871 HVSDFGISKLLGEGDDSVTQTITMATIG---YMAPE-----YGSEGIVSAKCDVYSYGVL 922
+ DFG+S L D +V + T IG +MAPE + K D++S G+
Sbjct: 169 KLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 923 LMETFTRKKPTDEM 936
+E P +M
Sbjct: 224 AIEMAEGAPPLCDM 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-----LERAFRTFDSECEILRNVRHRNLVK 790
LG G++G V VA+K+ +++ E + E I + + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA------LV--LEY 842
+ + + L LE+ G E L+ I + + A L+ + Y
Sbjct: 70 FYGHRREGNIQYLFLEYCSGG--E--LFDR-----IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 843 LH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
LH G I H D+KP N+LLDE +SDFG++ + + T+ Y+A
Sbjct: 121 LHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 902 PE-YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
PE + DV+S G++L + P D+ W +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 4e-20
Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 17/210 (8%)
Query: 729 TDGFNECNLLGRG--SFGLVYKGT-LFDGTNVAIKVFNL--QLERAFRTFDSECEILRNV 783
+ ++G+G V G V ++ NL E + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWL-YSYNYFLDILQRLNIMIDVALVLEY 842
H N+V ++ + +V FM GS + + + ++ L I+ V L+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD--SVTQTITMATIG-- 898
+HH VH +K ++IL+ + ++S + + V ++
Sbjct: 144 IHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 899 -YMAPEYGSEGIV--SAKCDVYSYGVLLME 925
+++PE + + AK D+YS G+ E
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 5e-20
Identities = 54/310 (17%), Positives = 108/310 (34%), Gaps = 24/310 (7%)
Query: 56 ALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGS 115
S + I P + + ++ + + +L + I +++
Sbjct: 3 ETITVSTPIKQIFP--DDAFAETIKDNLKKKSV-TDAVT-QNELNSIDQIIANNSDIKSV 58
Query: 116 FPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEK 175
I L + L + N TD P L NL L +L L EN + L + L KL+
Sbjct: 59 QG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKS 113
Query: 176 LYLGSNDFFGQIP--SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233
L L N I + L L++L+L +NK + + L++L L+L N +
Sbjct: 114 LSLEHN----GISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS- 166
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
D+ + L L++L L N++S + + + ++ L + + L
Sbjct: 167 DIV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSN-LVV 222
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
+ +L P I++ ++ +L +F + +
Sbjct: 223 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280
Query: 354 TESSPADQWS 363
+ P +
Sbjct: 281 RVTQPLKEVY 290
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.6 bits (224), Expect = 8e-19
Identities = 55/258 (21%), Positives = 99/258 (38%), Gaps = 19/258 (7%)
Query: 374 LTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNEL 433
+ E P++ I P F A K K + ++ Q L+ + + +++++
Sbjct: 1 MGETITVSTPIKQIFP--DDAF-AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 55
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLT 493
+ + L L N L I L +L+ L L L+ N + L L
Sbjct: 56 --KSVQGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLK 109
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553
L+ L L N ++ I + L L + + L +N ++ + + L L L L NQ+
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165
Query: 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL 613
S DI ++GL L L L+ N + + L +L+ L++ S K L+
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 614 YLKKLNVSYNRLEGEIPI 631
+ + L I
Sbjct: 222 VPNTVKNTDGSLVTPEII 239
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 48/285 (16%), Positives = 88/285 (30%), Gaps = 51/285 (17%)
Query: 150 LEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSG 209
+ + + + D + K L + +E + + ++
Sbjct: 1 MGETITVSTPIK-QIFPDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK- 56
Query: 210 RLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTI 269
+ + I L +T L L N L D+ + NL+ L L L N + ++S++
Sbjct: 57 SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK--------DLSSL 105
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329
+ L L+ L+L N I I + + +L L L +N +
Sbjct: 106 K-------------------DLKKLKSLSLEHNG-ISDING-LVHLPQLESLYLGNNKIT 144
Query: 330 GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
L L L+L N ++ + L L L L+ N + +
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQISD----------IVPLAGLTKLQNLYLSKNHISDLRA 192
Query: 390 PFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELN 434
+ +L E E NL +K D L
Sbjct: 193 --LAGLK-NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 8e-18
Identities = 61/265 (23%), Positives = 108/265 (40%), Gaps = 25/265 (9%)
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLM 424
+ + L + + + S+ + A ++K S+ Q I L +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDN---DLQGSIPYYLCHLERLSQLLLNGNNL 481
L L+ N+L P + + L L L +N DL L L++L L L N +
Sbjct: 69 KLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS-----LKDLKKLKSLSLEHNGI 121
Query: 482 SGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLK 541
S I L L L L+LG+N +T + L L + ++L N +S + L
Sbjct: 122 S-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI--VPLAGLT 175
Query: 542 VLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNI 601
L NL LS+N +S D+ ++GLK+L L L + +L+ ++ + ++
Sbjct: 176 KLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 602 SGKIPKSLEALLYLKKLNVSYNRLE 626
P+ + +K NV ++ E
Sbjct: 234 --VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 64/377 (16%), Positives = 119/377 (31%), Gaps = 50/377 (13%)
Query: 298 TLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESS 357
T+ + I I ++ I +L + T L + + + + +
Sbjct: 4 TITVSTPIKQIFP-DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--- 57
Query: 358 PADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI 417
+ + ++T+L LN N L I P +
Sbjct: 58 -------VQGIQYLPNVTKLFLNGNKLTDIKP---------------------------L 83
Query: 418 GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN 477
NL L +L LD+N++ + ++L+ LSL N + I L HL +L L L
Sbjct: 84 TNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLG 139
Query: 478 GNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI 537
N ++ L LT L L L N ++ I L L + + LS N +S ++
Sbjct: 140 NNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL--RAL 193
Query: 538 QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVS 597
LK L L+L + S L T+ P S ++
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 253
Query: 598 SNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQV 657
+ ++ + + K ++ + + ++ + R+
Sbjct: 254 LPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITA 313
Query: 658 PPCKEDKGKGSKKAPFA 674
P +G K
Sbjct: 314 PKPPTKQGYVFKGWYTE 330
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERA---FRTFDSECEILRNVRHRN 787
F++ +G GSFG VY + + VAIK + +++ ++ E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
++ LV+E+ GS L + L ++ + L YLH +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPE- 903
++H D+K NILL E + DFG + ++ + +G +MAPE
Sbjct: 175 ----MIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF--VGTPYWMAPEV 221
Query: 904 --YGSEGIVSAKCDVYSYGVLLME 925
EG K DV+S G+ +E
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-----LERAFRTFDSECEILRNVRHRNLVK 790
LG G++G V VA+K+ +++ E + E I + + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA------LV--LEY 842
+ + + L LE+ G E L+ I + + A L+ + Y
Sbjct: 70 FYGHRREGNIQYLFLEYCSGG--E--LFDR-----IEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 843 LH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
LH G I H D+KP N+LLDE +SDFG++ + + T+ Y+A
Sbjct: 121 LHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 902 PE-YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK 948
PE + DV+S G++L + P D+ W +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G G+ +V VAIK NL + + + E + + H N+V ++S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 796 CNIDFKALVLEFMPNGS-------FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
D LV++ + GS + LD I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG---YMAPE-- 903
+H D+K NILL E+ + ++DFG+S L G D + +G +MAPE
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 904 -----YGSEGIVSAKCDVYSYGVLLME 925
Y K D++S+G+ +E
Sbjct: 199 EQVRGYDF------KADIWSFGITAIE 219
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 34/188 (18%), Positives = 70/188 (37%), Gaps = 16/188 (8%)
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDN---DLQGSIPYYLCHLERLSQLL 475
+ L + T T + L ++L + DL G + + + L
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLT 72
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
+N + + P + L++L L + +T +L L + +++S ++ + +
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLD 595
I L + ++DLS N DI + L +L +L++ + + L L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 596 VSSNNISG 603
S I G
Sbjct: 188 AFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 24/184 (13%), Positives = 66/184 (35%), Gaps = 14/184 (7%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
+S + ++ L ++ L +++ L ++ L + +
Sbjct: 22 FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNI- 76
Query: 183 FFGQIP--SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG 240
+ +S ++L+ L + + N+ L+ LT L+++ + + T I
Sbjct: 77 ---HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
L + ++L N + P + + ++ +N+ + + + + P L L F
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE---DFPKLNQLYAF 189
Query: 301 GNNL 304
+
Sbjct: 190 SQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 32/166 (19%), Positives = 67/166 (40%), Gaps = 8/166 (4%)
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN 527
+ LL ++ + A + SL + L + +T + + + I + +++
Sbjct: 22 FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 528 SLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGS 587
+ + I L L L + ++ D +SGL L L ++ + + I +
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 588 LISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKG 633
L + S+D+S N I L+ L LK LN+ ++ + I+
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIED 179
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 32/250 (12%), Positives = 67/250 (26%), Gaps = 72/250 (28%)
Query: 140 IPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIP--SSLSECTHL 197
IPD L ++S + + L + L + + + + ++
Sbjct: 17 IPD--STFKAYLNGLLGQSSTANITEAQ--MNSLTYITLANI----NVTDLTGIEYAHNI 68
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG 257
+ L + + + I LS L L + ++ D + L L L++ +
Sbjct: 69 KDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 258 PVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASK 317
+ I ++LP + + L N I I
Sbjct: 127 SILTKI-------------------------NTLPKVNSIDLSYNGAITDIMP------- 154
Query: 318 LIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTEL 377
L L+ LN+ F+ + + + L +L
Sbjct: 155 ------------------LKTLPELKSLNIQFDGVHD----------YRGIEDFPKLNQL 186
Query: 378 ALNVNPLRGI 387
+ G
Sbjct: 187 YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 23/155 (14%), Positives = 56/155 (36%), Gaps = 10/155 (6%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
+ L++ ++ + + + L I+ + N + L L + +++
Sbjct: 49 ITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDK 104
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
+ L+ L +L +++ D I + L K+ +DL N + LP+L+ L
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSL 164
Query: 177 YLGSNDFFGQIP--SSLSECTHLQTLWLADNKFSG 209
+ + + + + L L+ G
Sbjct: 165 NIQFD----GVHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 22/139 (15%), Positives = 47/139 (33%), Gaps = 5/139 (3%)
Query: 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476
I + L +++ P + L+ L + D+ L L L+ L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSS 536
+ + +I + +L + + L N I L +L + +N+ + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRG 176
Query: 537 IQHLKVLINLDLSRNQLSG 555
I+ L L + G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 26/176 (14%), Positives = 60/176 (34%), Gaps = 23/176 (13%)
Query: 217 NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST---IRLIN 273
+ L Q++ + L ++ L N++ + I I+ +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLT 72
Query: 274 LIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP 333
+ + + P++ L NLE L + G ++ +++ + L LD+S + I
Sbjct: 73 INNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 334 HTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
L + ++L +N T+ + L L L + + +
Sbjct: 130 TKINTLPKVNSIDLSYNGAITD---------IMPLKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 27/172 (15%), Positives = 60/172 (34%), Gaps = 16/172 (9%)
Query: 335 TFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGN 394
T + L ++ L ++T L+ + ++ +L +N P I
Sbjct: 39 TEAQMNSLTYITLANINVTD----------LTGIEYAHNIKDLTINNIHATNYNP--ISG 86
Query: 395 FSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYD 454
S +L + + ++ + L+ L L + + + +I T + ++ + L
Sbjct: 87 LS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 455 NDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLT 506
N I L L L L + + + + L +L+ S T+
Sbjct: 146 NGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIG 194
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 43/207 (20%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-------LERAFRTFDSECEILRNVRHRNL 788
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 789 VKIF---SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV------ 839
+K++ S+ + +V+E++ G E L+ Y I + + A
Sbjct: 74 IKLYQVISTPTDF---FMVMEYVSGG--E--LFDY-----ICKHGRVEEMEARRLFQQIL 121
Query: 840 --LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
++Y H +VH DLKP N+LLD +M A ++DFG+S ++ +G+ T + +
Sbjct: 122 SAVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSP 174
Query: 898 GYMAPE-YGSEGIVSAKCDVYSYGVLL 923
Y APE + D++S GV+L
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
F +G+GSFG V T A+K N ++ F E +I++ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGL 72
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
H LV ++ S + + +V++ + G L +F + +L I ++ + L+YL
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYL 131
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAP 902
+ I+H D+KP+NILLDE+ H++DF I+ +L TQ TMA T YMAP
Sbjct: 132 QNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAP 183
Query: 903 EYGSEGIVSAKC--------DVYSYGVLLMETFTRKKP 932
E + S++ D +S GV E ++P
Sbjct: 184 E-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 53/277 (19%), Positives = 105/277 (37%), Gaps = 26/277 (9%)
Query: 54 VVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
+ + ++ + +L + +L + + L L + N+++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQIT 76
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
P + L+++ L N + + L ++ LDL ++ + L L
Sbjct: 77 DLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNL 131
Query: 174 EKLYLGSNDFFGQIP--SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
+ LYL N QI S L+ T+LQ L + + + S + NLS+LT L N +
Sbjct: 132 QVLYLDLN----QITNISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKI 185
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSL 291
D+ + +L L ++L N +S P + N S + ++ L ++
Sbjct: 186 S-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF----YN 237
Query: 292 PNLEFLTLFGNNLIGTI-PNSITNASKLIGLDLSSNL 327
NL + I P +I++ +L+ NL
Sbjct: 238 NNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 66/347 (19%), Positives = 118/347 (34%), Gaps = 66/347 (19%)
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMF 349
+L N + +N+ T+ + + L + I L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
N +T L+ L N +TEL L+ NPL+ +
Sbjct: 73 NQITD----------LAPLKNLTKITELELSGNPLKNV---------------------- 100
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE 469
I L + L L ++ P + LQ L L N + P L L
Sbjct: 101 -----SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLT 151
Query: 470 RLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL 529
L L + +S P L +L+ L L N ++ I S L SL ++ V+L +N +
Sbjct: 152 NLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQI 207
Query: 530 SGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI-PESFGSL 588
S S + + L + L+ ++ + +L ++ PI P +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDN 262
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPF 635
+ S +++ N S ++ ++ ++N+ PF
Sbjct: 263 GTYASPNLTWNLTS-----------FINNVSYTFNQSVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 58/369 (15%), Positives = 121/369 (32%), Gaps = 83/369 (22%)
Query: 164 LPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTD 223
+ D L K+ G ++ + ++ + TL + E + L+ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 224 LNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHL 283
L L N + D+ + NL + L L N L + I+
Sbjct: 68 LELKDNQIT-DLA-PLKNLTKITELELSGNPLK-----NVSAIA---------------- 104
Query: 284 PLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLR 343
L +++ L L + I + + S L L L N + +I L L+
Sbjct: 105 ------GLQSIKTLDL-TSTQITDVTP-LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQ 154
Query: 344 FLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFE 403
+L++ ++ L+ L N LT L + N + I P
Sbjct: 155 YLSIGNAQVSD----------LTPLANLSKLTTLKADDNKISDISP-------------- 190
Query: 404 AIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPY 463
+ +L L+ + L +N+++ P + L ++L + + +
Sbjct: 191 -------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF 235
Query: 464 YLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVN 523
Y +L + + + T S LT+++ S + ++ Y +
Sbjct: 236 YNNNLVVPNVVKGPSGAP-------IAPATISDNGTYASPNLTWNLTSFINNVSYTFNQS 288
Query: 524 LSSNSLSGP 532
++ + + P
Sbjct: 289 VTFKNTTVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 55/280 (19%), Positives = 102/280 (36%), Gaps = 31/280 (11%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+ + I + L+ L+ L++ +N L L L ++ + + N L
Sbjct: 46 LSAFGTGVTTI--EGVQYLNNLIGLELKDNQI-TDLAP-LKNLTKITELELSGNPLKNVS 101
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
I L ++ L + TD L LS L+ L L N ++ ++ L L+ L
Sbjct: 102 A--IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYL 156
Query: 177 YLGSNDFFGQIP--SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
+G+ Q+ + L+ + L TL DNK S + +L L +++L N +
Sbjct: 157 SIGNA----QVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS-- 208
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ + N L + L ++ N NL+ +
Sbjct: 209 DVSPLANTSNLFIVTLTNQTIT--------NQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
Query: 295 EFLTLFGNNLIGTIPNSITNAS----KLIGLDLSSNLFSG 330
+ T NL + + I N S + + ++ FSG
Sbjct: 261 DNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 6/92 (6%)
Query: 535 SSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESL 594
L I + ++ ++ +T + L + TLS G E L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 595 DVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
++ N I+ + L+ L + +L +S N L+
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLK 98
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 46/207 (22%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFN------LQLERAFRTFDSECEILRNVRHRNLVK 790
+G+G+F V + G VAIK+ + L++ FR E I++ + H N+VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSY-------------NYFLDILQRLNIMIDVA 837
+F L++E+ G ++ Y + F I+
Sbjct: 79 LFEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEKEARSKFRQIVS--------- 125
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
++Y H IVH DLK N+LLD +M ++DFG S G
Sbjct: 126 -AVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAP 177
Query: 898 GYMAPE-YGSEGIVSAKCDVYSYGVLL 923
Y APE + + + DV+S GV+L
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 53/202 (26%), Positives = 75/202 (37%), Gaps = 35/202 (17%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRHRNLVKIF 792
+G G+FG+ VA+K E R E R++RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA------LV--LEYLH 844
A+++E+ G LY I D A L+ + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGE----LYER-----ICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
I H DLK N LLD + + DFG SK S ++ T+ T Y+AP
Sbjct: 134 SMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPAYIAP 186
Query: 903 E-YGSEGIVSAKCDVYSYGVLL 923
E + DV+S GV L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
+ ++GRG+FG V K T A+K+ + ++ + ++ E +I+
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFA 126
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA------ 837
+V++F + + + +V+E+MP G ++++ ++ A
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAE 176
Query: 838 --LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTIT 893
L L+ +H +H D+KP+N+LLD++ H+ +DFG + + T
Sbjct: 177 VVLALDAIHSMG----FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 894 MATIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
T Y++PE G +G +CD +S GV L EM G+
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY----------EMLVGD 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-------LERAFRTFDSECEILRNVRHRNL 788
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL-------- 840
+K++ +V+E++ G E L+ Y I + + + L
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGG--E--LFDY-----ICKNGRLDEKESRRLFQQILSGV 129
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG-- 898
+Y H +VH DLKP N+LLD +M A ++DFG+S ++ +G+ T + G
Sbjct: 130 DYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSP 179
Query: 899 -YMAPE-YGSEGIVSAKCDVYSYGVLL 923
Y APE + D++S GV+L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 64/255 (25%), Positives = 93/255 (36%), Gaps = 55/255 (21%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFNLQLERAFRTFDSEC-----EILRN 782
F + +LG+G FG V + T G A K L+ +R + +IL
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQILEK 240
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI-DVALVLE 841
V R +V + + D LVL M G + +Y R ++ LE
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 842 YLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMA-TI 897
LH IV+ DLKP NILLD++ H+ SD G++ + EG T+
Sbjct: 301 DLHRER-----IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRVGTV 349
Query: 898 GYMAPE------YGSEGIVSAKCDVYSYGVLLMETFT---------RKKPTDEMFTGEMS 942
GYMAPE Y D ++ G LL E +K +E+
Sbjct: 350 GYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 943 LRRWVKESLPHGLTE 957
V E +
Sbjct: 404 ----VPEEYSERFSP 414
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 72/242 (29%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQL-ERAFRTFDSECEILRN 782
F ++GRG+FG V K A+K+ N L+ E A F E ++L N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVN 130
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMID------- 835
+ + + + + + LV+++ G L + L + +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGD----LLTL------LSKFEDRLPEEMARFY 180
Query: 836 ---VALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVT 889
+ + ++ +H VH D+KP+NIL+D N H+ +DFG L E +
Sbjct: 181 LAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQS 233
Query: 890 QTITMATIGYMAPE-----------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFT 938
+ T Y++PE YG E CD +S GV + EM
Sbjct: 234 SVA-VGTPDYISPEILQAMEGGKGRYGPE------CDWWSLGVCMY----------EMLY 276
Query: 939 GE 940
GE
Sbjct: 277 GE 278
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 49/275 (17%), Positives = 87/275 (31%), Gaps = 48/275 (17%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
PS + L F LE +++ +N + + D+ LPK
Sbjct: 23 EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 173 LEKLYLGSNDFFGQIPSS-LSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNN 230
L ++ + + I +LQ L +++ LP+ + Q L++ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 231 -LQGDMPTAIGNLQM-LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLG 288
+ + L L L N + + + FN
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFN----------------------- 175
Query: 289 HSLPNLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNL 347
L+ L L NN + +PN + AS + LD+S + NL+ LR +
Sbjct: 176 --GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233
Query: 348 MFNSLTTESSPADQWSFLSSLTNCRSLTELALNVN 382
+L L +L +L E +L
Sbjct: 234 --YNLKK----------LPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 38/236 (16%), Positives = 74/236 (31%), Gaps = 18/236 (7%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP----YYLCH 467
IP ++ + L+ +L F L+ + + ND+ I L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 468 LERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS-SLWSLEYILYVNLSS 526
L + + NNL P +L +L+ L + + + +P + +++
Sbjct: 81 LHEI--RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQD 137
Query: 527 NSLSGPLPS-SIQHLKV-LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPES 584
N + S L + L L++N + +G + N +
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSA 640
F LD+S I LE L L+ + + ++P A
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP---TLEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 17/227 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNE----LGKLRRLRLINFAYNEL 112
L L I L ++IS+N+ + + L KL +R+ N L
Sbjct: 35 LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK--ANNL 92
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDFL-LNLSKLEFLDLMENSLSGSLPNDI--- 168
P L LQ L N +PD ++ + LD+ +N ++ +
Sbjct: 93 LYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 169 RLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLA 227
+ L+L N +I +S T L L L+DN LP ++ S L+++
Sbjct: 152 LSFESVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINL 274
+ + + NL+ L + NL PT+ + + +L
Sbjct: 211 RTRIHSLPSYGLENLKKLRARST--YNLK--KLPTLEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 48/287 (16%), Positives = 82/287 (28%), Gaps = 63/287 (21%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIP-HTFGNLRFLRFLNLM-F 349
N L L + + L +++S N I F NL L + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
N+L + A N +L L ++ ++ + + SL+
Sbjct: 90 NNLLYINPEA--------FQNLPNLQYLLISNTGIKHLPD---VHKIHSLQ--------- 129
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE 469
+ L + DN TI F L
Sbjct: 130 -------------KVLLDIQDNINIHTIERNS--FVGLSFE------------------- 155
Query: 470 RLSQLLLNGNNLSGAIPACLGSLTSLRELHL-GSNTLTYSIPSSLWSLEYILYVNLSSNS 528
L LN N + I + T L EL+L +N L + +++S
Sbjct: 156 -SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 213
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGN 575
+ +++LK L + +P T+ L L SL
Sbjct: 214 IHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 60/271 (22%), Positives = 99/271 (36%), Gaps = 70/271 (25%)
Query: 709 EDVLSLATWRRTSYLDIQRAT---DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKV 761
+ V W + ++ D F ++GRG+F V K T G A+K+
Sbjct: 37 KYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKI 93
Query: 762 FN----LQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWL 817
N L+ E ++L N R + ++ + + ++ LV+E+ G
Sbjct: 94 MNKWDMLKRGEVSCFR-EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL---- 148
Query: 818 YSYNYFLDILQRLNIMID----------VALVLEYLH-HGHSLAPIVHCDLKPNNILLDE 866
L L + I + + ++ +H G VH D+KP+NILLD
Sbjct: 149 ----LTL--LSKFGERIPAEMARFYLAEIVMAIDSVHRLG-----YVHRDIKPDNILLDR 197
Query: 867 NMTAHV--SDFGISKLLGEGDDSVTQTITMATIGYMAPE-------------YGSEGIVS 911
H+ +DFG L + + T Y++PE YG E
Sbjct: 198 C--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPE---- 250
Query: 912 AKCDVYSYGVLLMETFTRKKP-----TDEMF 937
CD ++ GV E F + P T E +
Sbjct: 251 --CDWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 69/266 (25%), Positives = 101/266 (37%), Gaps = 55/266 (20%)
Query: 706 PVKEDVLSLATWRRTSY--LDIQRAT-DGFNECNLLGRGSFGLVY----KGTLFDGTNVA 758
P +E + SL R + L+ Q D F + +LGRG FG V+ K T G A
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYA 214
Query: 759 IKVFNLQLERAFRTFDSEC-----EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSF 813
K L +R + + +IL V R +V + + LV+ M G
Sbjct: 215 CKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272
Query: 814 EKWLYSYNYFLDIL--QRLNIMI-DVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMT 869
+Y+ + R + LE+LH I++ DLKP N+LLD++
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDLKPENVLLDDD-- 325
Query: 870 AHV--SDFGISKLLGEGDDSVTQTITMA-TIGYMAPE------YGSEGIVSAKCDVYSYG 920
+V SD G++ L G T A T G+MAPE Y D ++ G
Sbjct: 326 GNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFS------VDYFALG 376
Query: 921 VLLMETFT---------RKKPTDEMF 937
V L E K E+
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELK 402
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH 785
++ + C ++G GSFG+V++ L + VAIK R E +I+R V+H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 786 RNLVK----IFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
N+V +S+ D LVLE++P + +Y +L + + L+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRA---SRHYAKLKQTMPMLLI 143
Query: 840 ----------LEYLH-HGHSLAPIVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDS 887
L Y+H G I H D+KP N+LLD + DFG +K+L G+ +
Sbjct: 144 KLYMYQLLRSLAYIHSIG-----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 888 VTQTITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
V+ + + Y APE Y + D++S G ++ E +
Sbjct: 199 VSY---ICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-17
Identities = 89/534 (16%), Positives = 165/534 (30%), Gaps = 132/534 (24%)
Query: 145 LNLSKLEFLDLMENSLSGS-----LPNDIRLPKLEKLYLGSNDFFGQ----IPSSLSECT 195
++L ++ LD+ LS + LP L + + + L I S+L
Sbjct: 1 MSLD-IQSLDIQCEELSDARWAELLPL---LQQCQVVRLDDCGLTEARCKDISSALRVNP 56
Query: 196 HLQTLWLADNKFSGRLPENIGNL-----SQLTDLNLAQNNLQ----GDMPTAIGNLQMLE 246
L L L N+ + ++ L+L L G + + + L L+
Sbjct: 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 247 HLNLGMNNLSGPVPPTIFNI-----STIRLINLIENQLSGHLPLTLGHSL---PNLEFLT 298
L+L N L + + + L LS L L P+ + LT
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 299 LFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSP 358
+ N++ +++ L + L L L +T+++
Sbjct: 177 VSNNDINEA-------GVRVLCQGLKDSPCQ------------LEALKLESCGVTSDN-- 215
Query: 359 ADQWSFLSS-LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI 417
L + + SL ELAL N +G+ + +
Sbjct: 216 ---CRDLCGIVASKASLRELALGSNK--------LGDVGMAE-LCPGLLHPSSR------ 257
Query: 418 GNLSGLMFLKLDDNELN----GTIPTTVGRFQQLQGLSLYDNDLQGS--------IPYYL 465
L L + + + G + + + L+ LSL N+L +
Sbjct: 258 -----LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 466 CHLERLSQLLLNGNNLSG----AIPACLGSLTSLRELHLGSNTLTYS--------IPSSL 513
C LE L + + + + L L EL + +N L + +
Sbjct: 313 CQLESLW---VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369
Query: 514 WSLEYILYVNLSSNSLS----GPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLAT 569
L + L+ +S L +++ L LDLS N + +G+ L
Sbjct: 370 SVLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNC------LGDAGILQLV- 419
Query: 570 LSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL----YLKKLN 619
S+ LE L + S ++ L+AL L+ ++
Sbjct: 420 ESVRQPGCL------------LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-16
Identities = 94/487 (19%), Positives = 147/487 (30%), Gaps = 100/487 (20%)
Query: 195 THLQTLWLADNKFS-GRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG----NLQMLEHLN 249
+Q+L + + S R E + L Q + L L I L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 250 LGMNNLSGPVPPTIFNI-----STIRLINLIENQLS----GHLPLTLGHSLPNLEFLTLF 300
L N L + I+ ++L L+ G L TL P L+ L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL-PTLQELHLS 121
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
N L L L L L L + SL+ S
Sbjct: 122 DNLL------GDAGLQLLCEGLLDPQCR-------------LEKLQLEYCSLSAASCEP- 161
Query: 361 QWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNL 420
S L EL ++ N I + + +K +
Sbjct: 162 ---LASVLRAKPDFKELTVSNND--------INEAGVRV-LCQGLKD-----------SP 198
Query: 421 SGLMFLKLDDNELN----GTIPTTVGRFQQLQGLSLYDNDLQGS-----IPYYLCHLERL 471
L LKL+ + + V L+ L+L N L P L RL
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 472 SQLLLNGNNLS----GAIPACLGSLTSLRELHLGSN--------TLTYSIPSSLWSLEYI 519
L + ++ G + L + SL+EL L N L ++ LE +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 520 LYVNLSSNSLSG----PLPSSIQHLKVLINLDLSRNQLSGDIPITIS-GLKD----LATL 570
+ S S + S + + L+ L +S N+L + GL L L
Sbjct: 319 ---WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375
Query: 571 SLAGNQFN----GPIPESFGSLISLESLDVSSNNISGKIPKSLEALL-----YLKKLNVS 621
LA + + + + SL LD+S+N + L + L++L +
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435
Query: 622 YNRLEGE 628
E
Sbjct: 436 DIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 71/388 (18%), Positives = 124/388 (31%), Gaps = 70/388 (18%)
Query: 57 LNLSSFSLG----GIIPPHLGNLSFLVSLDISENNF--------YGHLPNELGKLRRLRL 104
+ L L I L L L++ N L K+++L L
Sbjct: 33 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 92
Query: 105 INFAYNELS----GSFPSWIGILSRLQILSFHNNSFTDR----IPDFLL-NLSKLEFLDL 155
L+ G S + L LQ L +N D + + LL +LE L L
Sbjct: 93 ---QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 149
Query: 156 MENSLSGSLPNDI-----RLPKLEKLYLGSNDF----FGQIPSSLSECT-HLQTLWLADN 205
SLS + + P ++L + +ND + L + L+ L L
Sbjct: 150 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209
Query: 206 KFSGR----LPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM-----LEHLNLGMNNLS 256
+ L + + + L +L L N L + + L L + ++
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269
Query: 257 GPVPPTIFNI----STIRLINLIENQLSG----HLPLTLGHSLPNLEFLTLFGNNL---- 304
+ + +++ ++L N+L L TL LE L + +
Sbjct: 270 AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329
Query: 305 IGTIPNSITNASKLIGLDLSSN--------LFSGHIPHTFGNLRFLRFLNLMFNSLTTES 356
+ + L+ L +S+N + LR L L ++ S
Sbjct: 330 CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ---PGSVLRVLWLADCDVSDSS 386
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPL 384
+ ++L SL EL L+ N L
Sbjct: 387 CSS----LAATLLANHSLRELDLSNNCL 410
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 59/254 (23%), Positives = 97/254 (38%), Gaps = 53/254 (20%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEIL--- 780
F+ ++GRG FG VY T G A+K + + +E +L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLAL-NERIMLSLV 246
Query: 781 RNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
+V + + D + +L+ M G L + F + R ++ L L
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGL 305
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMA-TI 897
E++H+ +V+ DLKP NILLDE+ HV SD G++ + + T
Sbjct: 306 EHMHNRF----VVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-----KPHASVGTH 354
Query: 898 GYMAPEYGSEGIVSAK------CDVYSYGVLLMETFT--------RKKPTDEMFTGEMSL 943
GYMAPE ++ D +S G +L + + K E+ M+L
Sbjct: 355 GYMAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTL 407
Query: 944 RRWVKESLPHGLTE 957
+ LP +
Sbjct: 408 T--MAVELPDSFSP 419
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILR 781
+ F LLG+G+FG V K T G A+K+ + + T +E +L+
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL-TENRVLQ 203
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
N RH L + S D V+E+ G L F + R ++ L+
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALD 262
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YLH + +V+ DLK N++LD++ ++DFG+ K G D + +T T Y+A
Sbjct: 263 YLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLA 317
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
PE + D + GV++ E + P +++F
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/279 (20%), Positives = 103/279 (36%), Gaps = 23/279 (8%)
Query: 54 VVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
+ NL S+ + L+ + + + ++ + + L + + N+L+
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLT 81
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
P + L L L N D L +L KL+ L L N +S + + LP+L
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQL 136
Query: 174 EKLYLGSNDFFGQI--PSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
E LYLG+N +I + LS T L TL L DN+ S + L++L +L L++N++
Sbjct: 137 ESLYLGNN----KITDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHI 190
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSL 291
A+ L+ L+ L L N+ + + L ++
Sbjct: 191 --SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDY 248
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSG 330
+L + + + + F G
Sbjct: 249 EKPNVK----WHLPEFTNEVSFIFYQPVTIGKAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 59/262 (22%), Positives = 108/262 (41%), Gaps = 19/262 (7%)
Query: 365 LSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLM 424
+ S + L + + + S+ + A ++K S+ Q I L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGA 484
L L+ N+L P + + L L L +N ++ L L++L L L N +S
Sbjct: 72 KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDI 127
Query: 485 IPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLI 544
L L L L+LG+N +T + L L + ++L N +S + L L
Sbjct: 128 NG--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQ 181
Query: 545 NLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGK 604
NL LS+N +S D+ ++GLK+L L L + +L+ ++ + ++
Sbjct: 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT- 238
Query: 605 IPKSLEALLYLKKLNVSYNRLE 626
P+ + +K NV ++ E
Sbjct: 239 -PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 53/255 (20%), Positives = 94/255 (36%), Gaps = 54/255 (21%)
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPS-- 189
D ++ +L + S++ L ++++ ++ I S
Sbjct: 10 VPTPIKQIFSD--DAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNS----DIKSVQ 62
Query: 190 SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLN 249
+ ++ L+L NK + + + NL L L L +N ++ D+ +++ +L+ L+ L+
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118
Query: 250 LGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIP 309
L N I IN + + LP LE L L GNN I I
Sbjct: 119 LEHNG--------------ISDINGLVH-------------LPQLESLYL-GNNKITDIT 150
Query: 310 NSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLT 369
++ +KL L L N S I L L+ L L N ++ L +L
Sbjct: 151 V-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISD----------LRALA 197
Query: 370 NCRSLTELALNVNPL 384
++L L L
Sbjct: 198 GLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 32/248 (12%)
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
S L + L+ + + ++++ + I L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 249 NLGMNNLSGPVPPTIFNIST---IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
L N L+ I ++ + + L EN++ L L L+ L+L N I
Sbjct: 74 FLNGNKLT-----DIKPLANLKNLGWLFLDENKVKDLSSLK---DLKKLKSLSLEHNG-I 124
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
I + + +L L L +N + L L L+L N ++ +
Sbjct: 125 SDING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD----------I 171
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
L L L L+ N + + + +L E E NL
Sbjct: 172 VPLAGLTKLQNLYLSKNHISDLRA--LAGLK-NLDVLELFSQECLNKPINHQSNLVVPNT 228
Query: 426 LKLDDNEL 433
+K D L
Sbjct: 229 VKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 61/312 (19%), Positives = 105/312 (33%), Gaps = 56/312 (17%)
Query: 300 FGNNLIGTIPNSIT------NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLT 353
G+ I T+P I ++ I +L + T L + + + +
Sbjct: 3 LGSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 59
Query: 354 TESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSI 413
+ + + ++T+L LN N L I P
Sbjct: 60 S----------VQGIQYLPNVTKLFLNGNKLTDIKP------------------------ 85
Query: 414 PQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQ 473
+ NL L +L LD+N++ + ++L+ LSL N + I L HL +L
Sbjct: 86 ---LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLES 138
Query: 474 LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPL 533
L L N ++ L LT L L L N ++ I L L + + LS N +S
Sbjct: 139 LYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL- 193
Query: 534 PSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLES 593
++ LK L L+L + S L T+ P S +
Sbjct: 194 -RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
Query: 594 LDVSSNNISGKI 605
+ + ++
Sbjct: 253 VKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 45/272 (16%), Positives = 92/272 (33%), Gaps = 56/272 (20%)
Query: 213 ENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST---I 269
+ ++ NL + ++ + L ++ + +++ ++ I +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNV 70
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329
+ L N+L+ PL +L NL +L L N + + + + + KL L L N S
Sbjct: 71 TKLFLNGNKLTDIKPLA---NLKNLGWLFL-DENKVKDLSS-LKDLKKLKSLSLEHNGIS 125
Query: 330 GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
I +L L L L N +T ++ L+ L L+L N + I+P
Sbjct: 126 -DING-LVHLPQLESLYLGNNKITD----------ITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 390 PFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQG 449
+ L+ L L L N + + + + L
Sbjct: 174 ---------------------------LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDV 204
Query: 450 LSLYDNDLQGSIPYYLCHLERLSQLLLNGNNL 481
L L+ + + +L + + +L
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 38/210 (18%)
Query: 732 FNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILRNV 783
F LG GSFG V+ + G A+KV ++L++ T E +L V
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIV 63
Query: 784 RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
H +++++ + + ++++++ G L F + + + +V L LEYL
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYL 122
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITM-ATIGYM 900
H I++ DLKP NILLD+N H+ +DFG +K + + T T+ T Y+
Sbjct: 123 HSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTPDYI 170
Query: 901 APEYGSEGIVSAK-----CDVYSYGVLLME 925
APE +VS K D +S+G+L+ E
Sbjct: 171 APE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFD-GTNVAIK-VFNLQLERAFRTFDSECEILRNV 783
++ D F + G+G+FG V G G +VAIK V R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 784 RHRNLVK---IFSSCCNIDFK----ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
H N+V+ F + D + +V+E++P+ L+ R +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LHRC---CRNYYRRQVAPPP 128
Query: 837 ALV----------LEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGD 885
L+ + LH + H D+KP+N+L++ + T + DFG +K L +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS--VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 886 DSVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ + + Y APE +G++ + D++S G + E +
Sbjct: 187 PN---VAYICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 53/212 (25%), Positives = 76/212 (35%), Gaps = 47/212 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN----------LQLERAFRTFDSECEILRNVRH 785
LLG G FG VY G + D VAIK R E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 786 R--NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVA 837
++++ D L+LE P + L+ + + L V
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDF---ITERGALQEELARSFFWQVL 159
Query: 838 LVLEYLH-HGHSLAPIVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMA 895
+ + H G ++H D+K NIL+D N + DFG LL D+V
Sbjct: 160 EAVRHCHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDG 210
Query: 896 TIGYMAPEYGS----EGIVSAKCDVYSYGVLL 923
T Y PE+ G V+S G+LL
Sbjct: 211 TRVYSPPEWIRYHRYHG---RSAAVWSLGILL 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 44/207 (21%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-------LERAFRTFDSECEILRNVRHRNL 788
LG GSFG V T VA+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV--------L 840
+K++ +V+E+ G E L+ Y I+++ + D +
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GG--E--LFDY-----IVEKKRMTEDEGRRFFQQIICAI 121
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG-- 898
EY H IVH DLKP N+LLD+N+ ++DFG+S ++ +G+ T + G
Sbjct: 122 EYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SCGSP 171
Query: 899 -YMAPE-YGSEGIVSAKCDVYSYGVLL 923
Y APE + + DV+S G++L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 58/308 (18%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLER------AFRTFDSECEI 779
Q + + + +G G++G+VYK G VA+K L E A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 780 LRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
L+ + H N+V + + LV EFM +K L L Q + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
+ + H I+H DLKP N+L++ + ++DFG+++ G S T + T+ Y
Sbjct: 132 VAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV--VTLWY 185
Query: 900 MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------KPTDEMF 937
AP+ GS+ S D++S G + E T K P +
Sbjct: 186 RAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 938 TGEMSLRRWVKESLPH----GLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPE 993
L W + + + ++ F + LLS M L D P
Sbjct: 245 PQVQELPLWKQRTFQVFEKKPWSSII--------PGFCQEGIDLLSNM-LCFD-----PN 290
Query: 994 QRIHMTDA 1001
+RI DA
Sbjct: 291 KRISARDA 298
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 52/225 (23%)
Query: 732 FNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
+ + ++G GSFG+VY+ L D G VAIK R E +I+R + H N+V+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 791 ----IFSSCCNIDFKAL--VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV----- 839
+SS D L VL+++P +Y R + V V
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPET-----VYRV---ARHYSRAKQTLPVIYVKLYMY 163
Query: 840 -----LEYLH-HGHSLAPIVHCDLKPNNILLDENMTA-HVSDFGISKLLGEGDDSVTQTI 892
L Y+H G I H D+KP N+LLD + + DFG +K L G+ +V+
Sbjct: 164 QLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-- 216
Query: 893 TMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ + Y APE Y ++ DV+S G +L E +
Sbjct: 217 -ICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 53/218 (24%), Positives = 76/218 (34%), Gaps = 57/218 (26%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFN----------LQLERAFRTFDSECEILRNVR- 784
LLG+G FG V+ G L D VAIKV E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 785 ---HRNLVKIFSSCCNIDFKA------LVLEFMPNGSFEKWLYSYNYFLDILQRL----- 830
H ++++ D+ LVLE + L+ Y + L
Sbjct: 94 GGGHPGVIRLL------DWFETQEGFMLVLERPLPAQ-D--LFDY---ITEKGPLGEGPS 141
Query: 831 -NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEG--DD 886
V +++ H +VH D+K NIL+D A + DFG LL + D
Sbjct: 142 RCFFGQVVAAIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 887 SVTQTITMATIGYMAPEY-GSEGIVSAKCDVYSYGVLL 923
T Y PE+ + V+S G+LL
Sbjct: 198 FD------GTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILR 781
D F+ LG GSFG V K + G + A+K+ + ++L++ T +E IL+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTL-NEKRILQ 96
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
V LVK+ S + +V+E++ G L F + R + L E
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFE 155
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITM-ATIGYM 900
YLH +++ DLKP N+L+D+ V+DFG +K + +T T+ T +
Sbjct: 156 YLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEAL 205
Query: 901 APEYGSEGIVSAK-----CDVYSYGVLLME 925
APE I+ +K D ++ GVL+ E
Sbjct: 206 APE-----IILSKGYNKAVDWWALGVLIYE 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 38/155 (24%), Positives = 63/155 (40%), Gaps = 4/155 (2%)
Query: 774 DSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIM 833
D I +++ R S E Y FL + +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
VA +E+L + +H DL NILL E + DFG+++ + + D V +
Sbjct: 200 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 894 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 928
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 18/151 (11%)
Query: 738 LGRGSFGLVYKGTLFD------GTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLV 789
LGRG+FG V + F VA+K+ R SE +IL ++ H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 790 KIFSSCCNIDFKALV-LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ +C +V +EF G+ +L S N + G
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------NEFVPYKTKGARFRQGKD 140
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISK 879
+ DLK + + ++ S F K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEILRN 782
+ + +G G++G V+K VA+K L + A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
++H+N+V++ + LV EF +K+ S N LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
H + ++H DLKP N+L++ N +++FG+++ G + + T+ Y P
Sbjct: 117 CHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPP 170
Query: 903 E--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
+ +G++ + S D++S G + E +P +F G
Sbjct: 171 DVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/200 (28%), Positives = 79/200 (39%), Gaps = 17/200 (8%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
IPS++ + L L NK S LP L++L L L N LQ L+ L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 246 EHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL 304
E L + N L +P +F + + + L NQL LP + SL L +L+L N L
Sbjct: 88 ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 305 IGTIPNSI-TNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWS 363
++P + + L L L +N F L L+ L L N L P
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK--RVPEG--- 199
Query: 364 FLSSLTNCRSLTELALNVNP 383
+ + L L L NP
Sbjct: 200 ---AFDSLEKLKMLQLQENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/212 (25%), Positives = 79/212 (37%), Gaps = 43/212 (20%)
Query: 99 LRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158
++L L N+LS L++L++L ++N L LE L + +N
Sbjct: 39 TKKLDL---QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN 95
Query: 159 SLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSE-----CTHLQTLWLADNKFSGRL 211
L +LP + +L L +L L N Q+ SL T L L L N+ L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRN----QL-KSLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 212 PENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIR 270
P+ + L+ L +L L N L+ A L L+ L L N L VP F+
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFD----- 202
Query: 271 LINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
SL L+ L L N
Sbjct: 203 -------------------SLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 52/237 (21%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLE 174
+ PS I + + L +N + L+KL L L +N L +LP I
Sbjct: 30 AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI------ 80
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQG 233
L +L+TLW+ DNK LP + L L +L L +N L+
Sbjct: 81 -------------FKEL---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS 123
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
P +L L +L+LG N L +P +F+ L +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFD------------------------KLTS 158
Query: 294 LEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFN 350
L+ L L+ N L + ++L L L +N F +L L+ L L N
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 51/194 (26%), Positives = 75/194 (38%), Gaps = 20/194 (10%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACL-GSLTSL 495
IP + L L N L L +L L LN N L +PA + L +L
Sbjct: 35 IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 496 RELHLGSNTLTYSIPS----SLWSLEYILYVNLSSNSLSGPLPSSI-QHLKVLINLDLSR 550
L + N L ++P L +L + L N L LP + L L L L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAE---LRLDRNQLKS-LPPRVFDSLTKLTYLSLGY 142
Query: 551 NQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSL 609
N+L +P + L L L L NQ +F L L++L + +N + +
Sbjct: 143 NELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 610 EALLYLKKLNVSYN 623
++L LK L + N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 63/225 (28%), Positives = 84/225 (37%), Gaps = 53/225 (23%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
IP LDL SN S F L LR L L N L T + F
Sbjct: 35 IPADTKK------LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI----F-KE 83
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI-GNLSGLMFL 426
L N L L + N L+ ++P + L L L
Sbjct: 84 LKN---LETLWVTDNKLQ--------------------------ALPIGVFDQLVNLAEL 114
Query: 427 KLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGA 484
+LD N+L ++P V +L LSL N+LQ S+P + L L +L L N L
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-R 171
Query: 485 IPACL-GSLTSLRELHLGSNTLTYSIP----SSLWSLEYI-LYVN 523
+P LT L+ L L +N L +P SL L+ + L N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 36/237 (15%), Positives = 63/237 (26%), Gaps = 38/237 (16%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
+ Q L NL + + + + L + L K+ + +
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 179 GSNDFFGQIPSS-LSECTHLQTLWLADNKFSGRLPEN--IGNLSQLTDLNLAQNNLQGDM 235
+ I L E L+ L + + P+ + + L + N +
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 236 PT-AIGNLQ-MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPN 293
P A L L L N + V FN
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTS-VQGYAFN-------------------------GTK 180
Query: 294 LEFLTLFGNNLIGTIPNSI--TNASKLIGLDLSSNLFSGHIPH-TFGNLRFLRFLNL 347
L+ + L N + I S LD+S + +P +L+ L N
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/205 (19%), Positives = 75/205 (36%), Gaps = 15/205 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNE----LGKLRRLRLINFAYNEL 112
L L L I NL + + +S + L + L K+ + + N L
Sbjct: 36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN--TRNL 93
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPD--FLLNLSKLEFLDLMENSLSGSLPNDI-- 168
+ P + L L+ L N PD + + L++ +N S+P +
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
Query: 169 RLPK-LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI--GNLSQLTDLN 225
L L L +N F + T L ++L NK+ + ++ G S + L+
Sbjct: 153 GLCNETLTLKLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 226 LAQNNLQGDMPTAIGNLQMLEHLNL 250
++Q ++ + +L+ L N
Sbjct: 212 VSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 37/211 (17%), Positives = 71/211 (33%), Gaps = 21/211 (9%)
Query: 78 LVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL-----SGSFPSWIGILSRLQILSFH 132
+L + E + + L + I + + S SF + LS++ +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN----LSKVTHIEIR 88
Query: 133 NNSFTDRIP-DFLLNLSKLEFLDLMENSLSGSLPNDI---RLPKLEKLYLGSNDFFGQIP 188
N I D L L L+FL + L P+ L + N + IP
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 189 SSL--SECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAI--GNLQM 244
+ C TL L +N F+ + N ++L + L +N + G
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 245 LEHLNLGMNNLSGPVPPTIF-NISTIRLINL 274
L++ +++ +P ++ + N
Sbjct: 207 PSLLDVSQTSVTA-LPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 42/209 (20%), Positives = 80/209 (38%), Gaps = 12/209 (5%)
Query: 420 LSGLMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIP-YYLCHLERLSQLLLN 477
LKL + L TIP+ + + + + + + +L +++ + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 478 GNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIP--SSLWSLEYILYVNLSSNSLSGPLP 534
I L L L+ L + + L P + ++S + + ++ N +P
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 535 S-SIQHL-KVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPE-SFGSLIS- 590
+ Q L + L L N + +G K L + L N++ I + +FG + S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 591 LESLDVSSNNISGKIPKSLEALLYLKKLN 619
LDVS +++ K LE L L N
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 40/213 (18%), Positives = 70/213 (32%), Gaps = 21/213 (9%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
L L H F NL + + + + + S N +T + +
Sbjct: 36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES-------HSFYNLSKVTHIEIR 88
Query: 381 VNPLRGILPPFIGNFS--ASLRKFEAIKCELKGSIPQE--IGNLSGLMFLKLDDNELNGT 436
+ P L+ LK P + + L++ DN +
Sbjct: 89 NTRNLTYIDP--DALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 437 IPTTV--GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIP--ACLGSL 492
IP G + L LY+N S+ Y + +L + LN N I A G
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 493 TSLRELHLGSNTLTYSIPS-SLWSLEYILYVNL 524
+ L + ++T ++PS L L+ ++ N
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 19/154 (12%), Positives = 48/154 (31%), Gaps = 10/154 (6%)
Query: 493 TSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQ 552
+ + + IPS S + + L L + +L + + +S +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 553 LSGDIPITI-SGLKDLATLSLAGNQFNGPIP-ESFGSLISLESLDVSSNNISGKIP--KS 608
+ L + + + + I ++ L L+ L + + + P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 609 LEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQS 642
+ + L ++ N IP F+ ++
Sbjct: 126 VYSTDIFFILEITDNPYMTSIP-VNAFQGLCNET 158
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 56/338 (16%), Positives = 113/338 (33%), Gaps = 19/338 (5%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
PN + + L+G + + + P T G+ L +
Sbjct: 223 PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAP 282
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
L+ E D + S + C + P + G+ S K + +
Sbjct: 283 LSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQ---KECVLLKDRPE 339
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++ L +L + + + + ++LQ L + +I + L+ L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398
Query: 472 ---SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNS 528
+ L + L P L LR L + ++L+
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL------LENSVLKMEYADVRVLHLAHKD 452
Query: 529 LSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588
L+ + ++ L ++ +LDLS N+L +P ++ L+ L L + N + +L
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANL 507
Query: 589 ISLESLDVSSNNISG-KIPKSLEALLYLKKLNVSYNRL 625
L+ L + +N + + L + L LN+ N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 6e-14
Identities = 46/266 (17%), Positives = 83/266 (31%), Gaps = 27/266 (10%)
Query: 124 SRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDF 183
L S ++ + L+++ + +L + L S +
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL-SVEK 360
Query: 184 FGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQ 243
+ S L C LQ L + L I + L L + LQ L+
Sbjct: 361 STVLQSELESCKELQELEP---ENKWCLLTIILLMRALDPLLYEKETLQY-----FSTLK 412
Query: 244 MLEHLNLGM-----NNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLT 298
++ + + + +R+++L L+ L L + L
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV---LCHLEQLLLVTHLD 469
Query: 299 LFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSP 358
L +N + +P ++ L L S N ++ NL L+ L L N L
Sbjct: 470 L-SHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ---- 522
Query: 359 ADQWSFLSSLTNCRSLTELALNVNPL 384
+ + L +C L L L N L
Sbjct: 523 ---SAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 7e-14
Identities = 41/204 (20%), Positives = 68/204 (33%), Gaps = 15/204 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHL---PNELGKLRRLRLINFAYNELS 113
LS ++ L + L L+ + L L + ++ L
Sbjct: 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
P L L+ NS + + L L L+ L + +L +
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKM------EYADVRVLHLAHKDLT-VLCHLEQLLLV 465
Query: 174 EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQG 233
L L N +P +L+ L+ L +DN + + NL +L +L L N LQ
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ 522
Query: 234 -DMPTAIGNLQMLEHLNLGMNNLS 256
+ + L LNL N+L
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 2e-10
Identities = 44/206 (21%), Positives = 73/206 (35%), Gaps = 11/206 (5%)
Query: 425 FLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC----HLERLSQLLLNGNN 480
L LN +P R S + L P C E+L + L+
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 481 LSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHL 540
+ + + L S L+EL + +I + +L+ +LY + S
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 541 KVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNN 600
LD R++ + + D+ L LA + L+ + LD+S N
Sbjct: 420 ---AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474
Query: 601 ISGKIPKSLEALLYLKKLNVSYNRLE 626
+ +P +L AL L+ L S N LE
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 54/319 (16%), Positives = 98/319 (30%), Gaps = 18/319 (5%)
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
+L +++ V + R+ L+ L + ++
Sbjct: 241 PHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW 300
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
+L N + S+ + + R E S
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 361 QWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIK--CELKGSIPQEIG 418
S L +C+ L EL + + L + E ++ LK P
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNG 478
L L L +N + ++ L L DL ++ +L L ++ L L+
Sbjct: 421 YLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSH 472
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTLTYSIP--SSLWSLEYILYVNLSSNSLSG-PLPS 535
N L A+P L +L L L N L ++ ++L L+ + L +N L
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQEL---LLCNNRLQQSAAIQ 527
Query: 536 SIQHLKVLINLDLSRNQLS 554
+ L+ L+L N L
Sbjct: 528 PLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 38/160 (23%), Positives = 58/160 (36%), Gaps = 14/160 (8%)
Query: 23 IDSRSVLANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLD 82
+D + S + + RV L+L+ L + HL L + LD
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 83 ISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTD-RIP 141
+S N LP L LR L ++ + N L + + L RLQ L NN
Sbjct: 470 LSHNRL-RALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAI 526
Query: 142 DFLLNLSKLEFLDLMENSLSGSLPNDIR-----LPKLEKL 176
L++ +L L+L NSL LP + +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 730 DGFNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILR 781
+ F+ LLG+G+FG V K T G A+K+ + + T +E +L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
N RH L + + D V+E+ G L F + R ++ LE
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALE 119
Query: 842 YLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIG 898
YLH +V+ D+K N++LD++ H+ +DFG+ K G D + +T T
Sbjct: 120 YLHSRD-----VVYRDIKLENLMLDKD--GHIKITDFGLCK-EGISDGATMKTFC-GTPE 170
Query: 899 YMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
Y+APE YG D + GV++ E + P + +F
Sbjct: 171 YLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 46/208 (22%), Positives = 73/208 (35%), Gaps = 67/208 (32%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNVRHRNLVKIFSSC 795
LG G G V + A+K+ +A R E E+ R + ++V+I
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 796 CNIDFKA----LVLEFMPNGS-FEKWLYSYNYFLDILQRLN----------IMIDVALVL 840
N+ +V+E + G F + I R + IM + +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSR----------IQDRGDQAFTEREASEIMKSIGEAI 130
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISK-LLGEGDDSVTQTITMA 895
+YLH I H D+KP N+L N ++DFG +K GE
Sbjct: 131 QYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----------- 174
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLL 923
Y CD++S GV++
Sbjct: 175 --------YDKS------CDMWSLGVIM 188
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 48/234 (20%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNV-AIKVFN----LQLERAFRTFDSECEILR 781
F +LG+GSFG LV K + D + A+KV +R RT E +IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTK-MERDILV 81
Query: 782 NVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
V H +VK+ + F+ L+L+F+ G L F + + + ++
Sbjct: 82 EVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-EL 135
Query: 837 ALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTIT 893
AL L++LH G I++ DLKP NILLDE H+ +DFG+SK + +
Sbjct: 136 ALALDHLHSLG-----IIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEKKAYSFC 187
Query: 894 MATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKKP-----TDEMF 937
T+ YMAPE +V+ + D +S+GVL+ E T P E
Sbjct: 188 -GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 54/244 (22%)
Query: 738 LGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK---IFS 793
LG GSFG+V + + G A+K R E +I++ + H N++K F
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY----------- 842
+ + + K N K N+ ++ + + +++EY
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 843 -----------------------LHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGIS 878
+ HS I H D+KP N+L++ ++ T + DFG +
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSA 189
Query: 879 KLLGEGDDSVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEM 936
K L + S I + Y APE G+ + D++S G + E KP +
Sbjct: 190 KKLIPSEPS-VAYI--CSRFYRAPELMLGATE-YTPSIDLWSIGCVFGELILG-KP---L 241
Query: 937 FTGE 940
F+GE
Sbjct: 242 FSGE 245
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTN--VAIKVFNLQLER------AFRTFDSECEILR 781
+ ++ +G G++G+VYK + A+K L+ E R E IL+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIR----EISILK 55
Query: 782 NVRHRNLVK---IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL 838
++H N+VK + + + LV E + +K L L+ + + ++ +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRL---VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+ Y H ++H DLKP N+L++ ++DFG+++ G T I T+
Sbjct: 112 GIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI--VTLW 165
Query: 899 YMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y AP+ GS+ S D++S G + E
Sbjct: 166 YRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 57/255 (22%), Positives = 88/255 (34%), Gaps = 47/255 (18%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIK--VFNLQLERAFRTFDS---------ECEILRNVRHR 786
+ GS+G V G +G VAIK + R E +L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 787 NLVK---IFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
N++ IF LV E M + ++ + M + L L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
LH A +VH DL P NILL +N + DF +++ + T + Y A
Sbjct: 149 VLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRA 201
Query: 902 PEY-GSEGIVSAKCDVYSYGVLLMETFTRK--------------------KPTDE--MFT 938
PE + D++S G ++ E F RK P E +
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 939 GEMSLRRWVKESLPH 953
S R +++ SL +
Sbjct: 262 SSPSARDYLRNSLSN 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 54/238 (22%)
Query: 730 DGFNECNLLGRGSFG---LVYKGTLFDGTNV-AIKVFNLQLERAF---RTFDSEC----- 777
+ F +LG+G +G V K T + + A+KV L++A D+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV----LKKAMIVRNAKDTAHTKAER 72
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
IL V+H +V + + F+ L+LE++ G L F++ +
Sbjct: 73 NILEEVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 833 MIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVT 889
++++ L +LH G I++ DLKP NI+L+ HV +DFG+ K D +VT
Sbjct: 128 A-EISMALGHLHQKG-----IIYRDLKPENIMLNHQ--GHVKLTDFGLCK-ESIHDGTVT 178
Query: 890 QTITMATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKKP-----TDEMF 937
T TI YMAPE I+ D +S G L+ + T P +
Sbjct: 179 HTFC-GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 5e-15
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRT-FDS----E 776
LD++ + + + LG G F VYK VAIK L + + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 777 CEILRNVRHRNLVK---IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIM 833
++L+ + H N++ F NI +LV +FM E + + L M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNI---SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT 893
+ LEYLH I+H DLKPNN+LLDEN ++DFG++K G + + T +
Sbjct: 119 LMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV- 173
Query: 894 MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
T Y APE +G+ + D+++ G +L E R
Sbjct: 174 -VTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 46/261 (17%), Positives = 95/261 (36%), Gaps = 22/261 (8%)
Query: 72 LGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSF 131
L+ V ++ + + L + +L ++ N + + + + L+ L
Sbjct: 15 DPGLANAVKQNLGKQSV-TDLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIP--S 189
+N +D L +L+KLE L + N L +L I L +L+L +N ++
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLK-NLNG-IPSACLSRLFLDNN----ELRDTD 122
Query: 190 SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLN 249
SL +L+ L + +NK +G LS+L L+L N + + L+ + ++
Sbjct: 123 SLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWID 178
Query: 250 LGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIP 309
L + + + + ++ G S + L L
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVL----WELPVYTD 234
Query: 310 NSITNASKLIGLDLSSNLFSG 330
S+ I + + +F G
Sbjct: 235 EVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 38/225 (16%), Positives = 81/225 (36%), Gaps = 21/225 (9%)
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSL 191
P L+ +L + S++ L + L ++ +++ Q + +
Sbjct: 5 RPTPINQVFP--DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNI--QSLAGM 59
Query: 192 SECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM--LEHLN 249
T+L+ L L+ N+ S + +L++L +L++ +N L + + L L
Sbjct: 60 QFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLF 112
Query: 250 LGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIP 309
L N L + ++ + ++++ N+L + L L LE L L N I
Sbjct: 113 LDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVML---GFLSKLEVLDL-HGNEITNTG 166
Query: 310 NSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
+T K+ +DL+ L + +
Sbjct: 167 G-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/209 (21%), Positives = 74/209 (35%), Gaps = 15/209 (7%)
Query: 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476
L+ + L + T + +Q + ++++Q S+ + L +L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSS 536
+ N +S P L LT L EL + N L L + L +N L S
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDT--DS 123
Query: 537 IQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDV 596
+ HLK L L + N+L I + + L L L L GN+ L + +D+
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179
Query: 597 SSNNISGKIPKSLEALLYLKKLNVSYNRL 625
+ + K L + R
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 40/230 (17%), Positives = 83/230 (36%), Gaps = 22/230 (9%)
Query: 54 VVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS 113
V NL S+ ++ LS + + + +N L + L+ ++ ++N++S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHLSHNQIS 76
Query: 114 GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKL 173
P + L++L+ LS + N + + + L L L N L + I L L
Sbjct: 77 DLSP--LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELR-DTDSLIHLKNL 130
Query: 174 EKLYLGSNDFFGQIP--SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNL 231
E L + +N ++ L + L+ L L N+ + + L ++ ++L
Sbjct: 131 EILSIRNN----KLKSIVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184
Query: 232 QGDMPTAIGNLQMLEHLNLGMNNLSGPVPP-TIFNISTIRLINLIENQLS 280
+ L N + + P I N + ++
Sbjct: 185 VNEPVK---YQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 32/164 (19%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 465 LCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNL 524
L + L +++ + L+ ++ + ++ + S+ + + + ++L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 525 SSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKD--LATLSLAGNQFNGPIP 582
S N +S S ++ L L L ++RN+L ++G+ L+ L L N+
Sbjct: 71 SHNQISDL--SPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDT-- 121
Query: 583 ESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
+S L +LE L + +N + I L L L+ L++ N +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/199 (16%), Positives = 63/199 (31%), Gaps = 30/199 (15%)
Query: 189 SSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248
+ L + + LS + + N +N+Q + + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 249 NLGMNNLSGPVPPTIFNIST---IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
+L N +S + + + +++ N+L + L L L NN +
Sbjct: 69 HLSHNQIS-----DLSPLKDLTKLEELSVNRNRLKNLNGI----PSACLSRLFL-DNNEL 118
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
+ + + L L + +N I G L L L+L N +T
Sbjct: 119 RDTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN----------T 165
Query: 366 SSLTNCRSLTELALNVNPL 384
LT + + + L
Sbjct: 166 GGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/292 (17%), Positives = 94/292 (32%), Gaps = 55/292 (18%)
Query: 290 SLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMF 349
L N L G + + + S + + ++ + L+ L+L
Sbjct: 17 GLANAVKQNL-GKQSVTDLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 350 NSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
N ++ LS L + L EL++N N L+ +
Sbjct: 73 NQISD----------LSPLKDLTKLEELSVNRNRLKNL---------------------- 100
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLE 469
+ L L LD+NEL ++ + L+ LS+ +N L+ SI L L
Sbjct: 101 ------NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLS 150
Query: 470 RLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSL 529
+L L L+GN ++ L L + + L + + LY+ +
Sbjct: 151 KLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV----NEPVKYQPELYITNTVKDP 204
Query: 530 SGPL--PSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG 579
G P I + ++ + +L + + F+G
Sbjct: 205 DGRWISPYYISNGGSYVDGCVL-WELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 31/180 (17%), Positives = 65/180 (36%), Gaps = 28/180 (15%)
Query: 213 ENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIST---I 269
L+ NL + ++ + L +++ N +N+ ++ + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-----SLAGMQFFTNL 65
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329
+ ++L NQ+S PL L LE L++ N + + ++ L L L +N
Sbjct: 66 KELHLSHNQISDLSPLK---DLTKLEELSV-NRNRLKNLNGI--PSACLSRLFLDNNELR 119
Query: 330 GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
+ +L+ L L++ N L + + L L L L+ N +
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKS----------IVMLGFLSKLEVLDLHGNEITNTGG 167
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 29/257 (11%), Positives = 65/257 (25%), Gaps = 58/257 (22%)
Query: 737 LLGRGSFGLVYKGTLFD---GTNVAIKVFNLQLERA--FRT-FDSECEILRNVRHRNLVK 790
G ++ D VA+ + Q S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ +V E++ GS ++ + + + M +A + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR----A 148
Query: 851 PIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV 910
+ P+ + + + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD-------A 179
Query: 911 SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR-------------RWVKESLPHGLTE 957
+ + D+ G L + P E L + +P ++
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 958 VVDANLVGEEQAFSAKT 974
V ++ G+ SA T
Sbjct: 239 VAARSVQGDGGIRSAST 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 63/223 (28%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 732 FNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFN----LQLERAFRTFDSECEIL-RN 782
F +LG+GSFG V +K T AIK L + T E +L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLA 74
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
H L +F + + V+E++ G + S + F ++ L L++
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQF 133
Query: 843 LH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIGY 899
LH G IV+ DLK +NILLD++ H+ +DFG+ K D+ T T T Y
Sbjct: 134 LHSKG-----IVYRDLKLDNILLDKD--GHIKIADFGMCK-ENMLGDAKTNTFC-GTPDY 184
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
+APE + D +S+GVLL E + P +E+F
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 7e-15
Identities = 75/342 (21%), Positives = 134/342 (39%), Gaps = 46/342 (13%)
Query: 620 VSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCKEDKGKGSKKAPFALKFIL 679
+ + + + ++ + ++++ G LQ S++ +
Sbjct: 232 LKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPV 291
Query: 680 PLIISIVLIAIVIMFFIRRQNGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLG 739
P S + F + TK P ++ +++ + D + TD FN +LG
Sbjct: 292 PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLG 350
Query: 740 RGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRTFDSEC-----EIL-RNVRHRNLV 789
+GSFG V KGT A+K+ L+ + + D EC +L + L
Sbjct: 351 KGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHS 848
++ S +D V+E++ G + F + ++A+ L +L G
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKG-- 462
Query: 849 LAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIGYMAPE--- 903
I++ DLK +N++LD H+ +DFG+ K D T+T T Y+APE
Sbjct: 463 ---IIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIAPEIIA 515
Query: 904 ---YGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
YG D +++GVLL E + P DE+F
Sbjct: 516 YQPYGKS------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 65/309 (21%), Positives = 107/309 (34%), Gaps = 60/309 (19%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEI 779
++ + + L+G GS+G+V K G VAIK F + A R E ++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 780 LRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
L+ +RH NLV + C LV EF+ + + L + LD + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
+ + H + I+H D+KP NIL+ ++ + DFG ++ L + + AT Y
Sbjct: 137 IGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWY 190
Query: 900 MAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------KP 932
APE YG + DV++ G L+ E F +
Sbjct: 191 RAPELLVGDVKYGK-AV-----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244
Query: 933 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESP 992
+ LP S L L +D P
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRY---PKLSEVVIDLAKKC-LHID-----P 295
Query: 993 EQRIHMTDA 1001
++R +
Sbjct: 296 DKRPFCAEL 304
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 64/245 (26%)
Query: 732 FNECNLLGRGSFG---LVYKGTLFDGTNV-AIKVFN-----LQLERAFRTFDSECEILRN 782
F +LG G++G LV K + D + A+KV + + T +E ++L +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR-TERQVLEH 114
Query: 783 VRHRN-LVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNI---- 832
+R LV + + F+ L+L+++ G L+++ L +
Sbjct: 115 IRQSPFLVTLHYA-----FQTETKLHLILDYINGGE----LFTH------LSQRERFTEH 159
Query: 833 -----MIDVALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEG 884
+ ++ L LE+LH G I++ D+K NILLD N HV +DFG+SK
Sbjct: 160 EVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVAD 212
Query: 885 DDSVTQTITMATIGYMAPE---YGSEGIVSAKCDVYSYGVLLME---------TFTRKKP 932
+ TI YMAP+ G G A D +S GVL+ E K
Sbjct: 213 ETERAYDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNS 270
Query: 933 TDEMF 937
E+
Sbjct: 271 QAEIS 275
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 47/166 (28%), Positives = 67/166 (40%), Gaps = 16/166 (9%)
Query: 150 LEFLDLMENSLSGSLPNDI---RLPKLEKLYLGSNDFFGQIPS-SLSECTHLQTLWLADN 205
LDL N+LS L + RL L L L N I S + +L+ L L+ N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 206 KFSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF 264
L E + +L L L L N++ A ++ L+ L L N +S P +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELI 156
Query: 265 ----NISTIRLINLIENQLSGHLPLTLGHSLPNL--EFLTLFGNNL 304
+ + L++L N+L LPLT LP L L N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 36/142 (25%), Positives = 59/142 (41%), Gaps = 16/142 (11%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGS 180
L+ L L +N + + + L +LDL N L +L + L LE L L +
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 181 NDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPE----NIGNLSQLTDLNLAQNNLQ 232
N I ++ + LQ L+L+ N+ S R P + L +L L+L+ N L+
Sbjct: 122 N----HIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 233 GDMPTAIGNLQMLEHLNLGMNN 254
T + L L ++N
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/171 (22%), Positives = 66/171 (38%), Gaps = 11/171 (6%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENI--GNLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
+P SL ++ L L+ N S RL L+ L L L+ N+L A +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 245 LEHLNLGMNNLSGPVPPTIF-NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNN 303
L +L+L N+L + +F ++ + ++ L N + + + L+ L L N
Sbjct: 90 LRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 304 LIGTIPNSITNASKLIGL---DLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
+ I + +KL L DLSSN L L ++
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 14/173 (8%)
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIP--YYLCHLERLSQLLLNGNNLSGAIPAC-LGSL 492
+P ++ L L N+L + + L L LLL+ N+L+ I + +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 493 TSLRELHLGSNTLTYSIPS-SLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN 551
+LR L L SN L ++ L+ + + L +N + ++ + + L L LS+N
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 552 QLSGDIP----ITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNN 600
Q+S P + L L L L+ N+ L + + +N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 41/153 (26%), Positives = 59/153 (38%), Gaps = 6/153 (3%)
Query: 474 LLLNGNNLSGAIPA--CLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
L L+ NNLS + A LT+L L L N L + + + + Y++LSSN L
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFG---SL 588
L+ L L L N + + L L L+ NQ + E L
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKL 162
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVS 621
L LD+SSN + L+ L K +
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 38/143 (26%), Positives = 57/143 (39%), Gaps = 14/143 (9%)
Query: 493 TSLRELHLGSNTLTYSIPSS-----LWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLD 547
+ L L N L+ + + L +L + LS N L+ + + L LD
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSL---LLSHNHLNFISSEAFVPVPNLRYLD 94
Query: 548 LSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIP- 606
LS N L S L+ L L L N +F + L+ L +S N IS + P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 607 ---KSLEALLYLKKLNVSYNRLE 626
K L L L++S N+L+
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/224 (21%), Positives = 75/224 (33%), Gaps = 41/224 (18%)
Query: 259 VPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI-TNASK 317
VP ++ S L++L N LS L NL L L N+ + I +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPN 89
Query: 318 LIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTEL 377
L LDLSSN F +L+ L L L N + + + ++ L +L
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV--VVDRNAFEDMA------QLQKL 141
Query: 378 ALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTI 437
L+ N + I + + L LM L L N+L
Sbjct: 142 YLSQNQISRFPVELIKDGN----------------------KLPKLMLLDLSSNKLKKLP 179
Query: 438 PTTVGRFQQL--QGLSLYDNDLQGSIPYYLCHLERLSQLLLNGN 479
T + + GL L++N L+ C L +L
Sbjct: 180 LTDLQKLPAWVKNGLYLHNNPLECD-----CKLYQLFSHWQYRQ 218
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 40/141 (28%), Positives = 51/141 (36%), Gaps = 26/141 (18%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNE----LGKLRRLRLINFAYNEL 112
L LS L I + L LD+S N+ L L L L L N +
Sbjct: 69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLL---YNNHI 124
Query: 113 S----GSFPSWIGILSRLQILSFHNNSFTDRIP----DFLLNLSKLEFLDLMENSLSGSL 164
+F +++LQ L N + R P L KL LDL N L L
Sbjct: 125 VVVDRNAFED----MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KL 178
Query: 165 PNDI--RLPKLEK--LYLGSN 181
P +LP K LYL +N
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNN 199
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 60/299 (20%), Positives = 99/299 (33%), Gaps = 62/299 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEILRNVRHRNLVK 790
+G GS+G+V+K G VAIK F + A R E +L+ ++H NLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH-HGHSL 849
+ LV E+ + + L Y + +I + + H H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE------ 903
+H D+KP NIL+ ++ + DFG ++LL D + AT Y +PE
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELLVGDT 178
Query: 904 -YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------KPTDEMFTGEMS 942
YG + DV++ G + E + +
Sbjct: 179 QYGP-PV-----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 943 LRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ + +P S LL L +D P +R+
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKF---PNISYPALGLLKGC-LHMD-----PTERLTCEQL 282
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G G+ G+V NVAIK F Q RA+R E +++ V H+N++
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 791 ---IFSSCCNID-FKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVAL 838
+F+ +++ F+ +V+E M + L I L+ ++ +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM-----DANLCQV-----IQMELDHERMSYLLYQMLC 138
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
+++LH I+H DLKP+NI++ + T + DFG+++ G T + T
Sbjct: 139 GIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRY 191
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE D++S G ++ E
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 67/323 (20%), Positives = 121/323 (37%), Gaps = 75/323 (23%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEI 779
+ + +G+G+FG V+K G VA+K ++ E+ A R E +I
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 780 LRNVRHRNLVK---IFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLN 831
L+ ++H N+V I + + + LV +F + L + + +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 832 IMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQT 891
+M + L Y+H I+H D+K N+L+ + ++DFG+++ +S
Sbjct: 129 VMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 892 IT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK------------ 930
T + T+ Y PE YG D++ G ++ E +TR
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 931 --------KPTDEMFTGEMSLRRWVKESLPHG----LTEVVDANLVGEEQAFSAKTDCLL 978
T E++ + + K L G + + + V + A L+
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL-KAYVRDPYALD-----LI 292
Query: 979 SIMDLALDCCMESPEQRIHMTDA 1001
+ L LD P QRI DA
Sbjct: 293 DKL-LVLD-----PAQRIDSDDA 309
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 65/230 (28%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK---VFNLQLE--RAFRTFDSECEILRNVRHRNLVK- 790
LG G++G+V T G VAIK F+ L R R E +IL++ +H N++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 791 --IFSSCCNIDFKA--LVLEFMPNGSFEKWLYS-----------YNYFLDILQRLNIMID 835
I +F ++ E M + L+ YF I Q L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYF--IYQTLR---- 123
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG----ISKLLGEGDDSVTQT 891
++ LH + ++H DLKP+N+L++ N V DFG I + + + Q
Sbjct: 124 ---AVKVLH---G-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 892 ITM----ATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
M AT Y APE Y S + DV+S G +L E F R+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRR 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 52/218 (23%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G G+ G+V NVAIK F Q RA+R E +++ V H+N++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD------ILQRLN------IMIDV 836
+ N+ F P + E++ +Y +D I L+ ++ +
Sbjct: 126 LL----NV--------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
+++LH I+H DLKP+NI++ + T + DFG+++ G +T + T
Sbjct: 174 LCGIKHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYV--VT 226
Query: 897 IGYMAPEYGSEGIVSAKC----DVYSYGVLLMETFTRK 930
Y APE I+ D++S G ++ E K
Sbjct: 227 RYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 100 RRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENS 159
+L L L+ + L++L L+ N +L++L L L N
Sbjct: 38 EKLDL---QSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 160 LSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSE-----CTHLQTLWLADNKFSGRLP 212
L+ SLP + L +L+KLYLG N Q+ SL T L+ L L N+ +P
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGN----QL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
Query: 213 ENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
L+ L L+L+ N LQ A L L+ + L N
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 49/171 (28%), Positives = 71/171 (41%), Gaps = 22/171 (12%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
S PS GI + + L + L+KL +L+L N L +L + L +
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 173 LEKLYLGSNDFFGQIPSSLSE-----CTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNL 226
L L L +N Q+ +SL T L L+L N+ LP + L++L +L L
Sbjct: 85 LGTLGLANN----QL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRL 138
Query: 227 AQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN----ISTIRLIN 273
N LQ A L L+ L+L N L VP F+ + TI L
Sbjct: 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 17/153 (11%)
Query: 473 QLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS----SLWSLEYILYVNLSSNS 528
+L L L+ A LT L L+L N L ++ + L L + L++N
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELG---TLGLANNQ 94
Query: 529 LSGPLPSSI-QHLKVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPES-F 585
L+ LP + HL L L L NQL +P + L L L L NQ IP F
Sbjct: 95 LAS-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAF 151
Query: 586 GSLISLESLDVSSNNISGKIPKSLEALLYLKKL 618
L +L++L +S+N + +P A L KL
Sbjct: 152 DKLTNLQTLSLSTNQLQS-VPHG--AFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 7/156 (4%)
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG 257
+ L L + L++LT LNL N LQ +L L L L N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 258 PVPPTIFNIST-IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI-TNA 315
+P +F+ T + + L NQL LP + L L+ L L N + +IP
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL-NTNQLQSIPAGAFDKL 154
Query: 316 SKLIGLDLSSNLFSGHIPH-TFGNLRFLRFLNLMFN 350
+ L L LS+N +PH F L L+ + L N
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 49/167 (29%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSL 495
IP + L L L L +L+ L L+ N L + A LT L
Sbjct: 33 IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 496 RELHLGSNTLTYSIPSSLW-SLEYILYVNLSSNSLSGPLPSSI-QHLKVLINLDLSRNQL 553
L L +N L S+P ++ L + + L N L LPS + L L L L+ NQL
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQL 143
Query: 554 SGDIPITI-SGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSN 599
IP L +L TLSL+ NQ +F L L+++ + N
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 50/159 (31%), Positives = 66/159 (41%), Gaps = 12/159 (7%)
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPY-YLCHLERLSQLLLNGNNLSGA 484
L L L T +L L+L N LQ ++ L L L L N L+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 485 IPACLGSLTSLRELHLGSNTLTYSIPS----SLWSLEYILYVNLSSNSLSGPLPSSI-QH 539
LT L +L+LG N L S+PS L L+ L L++N L +P+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE-LR--LNTNQLQS-IPAGAFDK 153
Query: 540 LKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
L L L LS NQL L L T++L GNQF+
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 12/161 (7%)
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI-QHLKV 542
++P+ G +L L S L ++ L + ++NL N L L + + L
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84
Query: 543 LINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPES-FGSLISLESLDVSSNN 600
L L L+ NQL+ +P+ + L L L L GNQ +P F L L+ L +++N
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ 142
Query: 601 ISGKIPKSL-EALLYLKKLNVSYNRLEGEIPIKGPFRNFSA 640
+ IP + L L+ L++S N+L+ +P G F
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VP-HGAFDRLGK 180
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 54/185 (29%), Positives = 69/185 (37%), Gaps = 37/185 (20%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
LDL S + TF L L +LNL +N L T S+ LT L L L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD-----LTE---LGTLGLA 91
Query: 381 VNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTT 440
N L LP G F +L+ L L L N+L ++P+
Sbjct: 92 NNQLAS-LPL--GVFD----------------------HLTQLDKLYLGGNQLK-SLPSG 125
Query: 441 V-GRFQQLQGLSLYDNDLQGSIPY-YLCHLERLSQLLLNGNNLSGAIPACLGSLTSLREL 498
V R +L+ L L N LQ SIP L L L L+ N L L L+ +
Sbjct: 126 VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
Query: 499 HLGSN 503
L N
Sbjct: 185 TLFGN 189
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 49/148 (33%), Positives = 65/148 (43%), Gaps = 20/148 (13%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
S P+ GI + QIL H+N T P +L L+ L L N L +LP + L +
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 173 LEKLYLGSNDFFGQIPS-------SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLN 225
L L LG+N Q+ L HL+ L++ NK + LP I L+ LT L
Sbjct: 90 LTVLDLGTN----QLTVLPSAVFDRL---VHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 226 LAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
L QN L+ A L L H L N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 46/164 (28%), Positives = 59/164 (35%), Gaps = 33/164 (20%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLR 496
IPT Q L L+DN + P L L +L L N L SLT L
Sbjct: 38 IPTNA------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 497 ELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI-QHLKVLINLDLSRNQLSG 555
L LG+N LT LPS++ L L L + N+L+
Sbjct: 92 VLDLGTNQLTV-------------------------LPSAVFDRLVHLKELFMCCNKLTE 126
Query: 556 DIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSN 599
+P I L L L+L NQ +F L SL + N
Sbjct: 127 -LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 7/149 (4%)
Query: 407 CELKG--SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY 464
C K S+P I + L L DN++ P L+ L L N L ++P
Sbjct: 26 CRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG 82
Query: 465 LC-HLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVN 523
+ L +L+ L L N L+ A L L+EL + N LT +P + L ++ ++
Sbjct: 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 524 LSSNSLSGPLPSSIQHLKVLINLDLSRNQ 552
L N L + L L + L N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 43/156 (27%), Positives = 61/156 (39%), Gaps = 32/156 (20%)
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAI-GNLQMLEHLNLGMNNLS 256
Q L+L DN+ + P +L L +L L N L +P + +L L L+LG N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 257 GPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNAS 316
+P +F+ L +L+ L + N L +P I +
Sbjct: 102 V-LPSAVFD------------------------RLVHLKELFMCCNKL-TELPRGIERLT 135
Query: 317 KLIGLDLSSN-LFSGHIPH-TFGNLRFLRFLNLMFN 350
L L L N L S IPH F L L L N
Sbjct: 136 HLTHLALDQNQLKS--IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 44/163 (26%), Positives = 56/163 (34%), Gaps = 42/163 (25%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPA---DQWSFLSSLTNCRSLTEL 377
L L N + P F +L L+ L L N L + P D LT LT L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG--ALPVGVFDS------LTQ---LTVL 93
Query: 378 ALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTI 437
L N L LP F L L L + N+L +
Sbjct: 94 DLGTNQLTV-LPS--AVFD----------------------RLVHLKELFMCCNKLT-EL 127
Query: 438 PTTVGRFQQLQGLSLYDNDLQGSIPYY-LCHLERLSQLLLNGN 479
P + R L L+L N L+ SIP+ L L+ L GN
Sbjct: 128 PRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 63/303 (20%), Positives = 119/303 (39%), Gaps = 56/303 (18%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLE-----RAFRTFDSECEILRNV 783
+ + + + LG G++ VYKG VA+K L+ E A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 784 RHRNLVK---IFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
+H N+V I + ++ LV E++ +++L +++ + + L
Sbjct: 58 KHANIVTLHDIIHTEKSL---TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
Y H ++H DLKP N+L++E ++DFG+++ + + T+ Y
Sbjct: 114 AYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV--VTLWYR 167
Query: 901 APE--YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------KPTDEMFT 938
P+ GS S + D++ G + E T + PT+E +
Sbjct: 168 PPDILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 939 GEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHM 998
G +S + + P E L+ + LL+ + L + RI
Sbjct: 227 GILSNEEFKTYNYPKYRAE----ALLSHAPRLDSDGADLLTKL-LQFE-----GRNRISA 276
Query: 999 TDA 1001
DA
Sbjct: 277 EDA 279
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 51/235 (21%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEIL- 780
F+ ++G+GSFG V K A+KV L+ + SE +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIM-SERNVLL 93
Query: 781 RNVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMID 835
+NV+H LV + S F+ VL+++ G L FL+ R +
Sbjct: 94 KNVKHPFLVGLHFS-----FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-E 147
Query: 836 VALVLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTI 892
+A L YLH IV+ DLKP NILLD H+ +DFG+ K +S T T
Sbjct: 148 IASALGYLHSLN-----IVYRDLKPENILLDSQ--GHIVLTDFGLCK-ENIEHNSTTSTF 199
Query: 893 TMATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKKP-----TDEMF 937
T Y+APE ++ + D + G +L E P T EM+
Sbjct: 200 C-GTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 34/140 (24%), Positives = 50/140 (35%), Gaps = 13/140 (9%)
Query: 121 GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYL 178
+ + + N+ P KL +DL N +S L D L L L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87
Query: 179 GSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQG 233
N +I S LQ L L NK + L + +L L L+L N LQ
Sbjct: 88 YGN----KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 234 DMPTAIGNLQMLEHLNLGMN 253
L+ ++ ++L N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSL 495
+P T+ + L N ++ P ++L ++ L+ N +S + L SL
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 496 RELHLGSNTLTYSIPSSLW-SLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
L L N +T +P SL+ L + + L++N ++ + Q L L L L N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 555 GDIPITISGLKDLATLSLAGNQFN 578
T S L+ + T+ LA N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 28/127 (22%), Positives = 55/127 (43%), Gaps = 2/127 (1%)
Query: 474 LLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPL 533
+ L N + P LR + L +N ++ P + L + + L N ++ L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-L 95
Query: 534 PSSI-QHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLE 592
P S+ + L L L L+ N+++ L +L LSL N+ +F L +++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 593 SLDVSSN 599
++ ++ N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 31/131 (23%), Positives = 49/131 (37%), Gaps = 11/131 (8%)
Query: 81 LDISENNFYGHLPNELGKLRRLRLINFAYNELS----GSFPSWIGILSRLQILSFHNNSF 136
+ + +N P ++LR I+ + N++S +F L L L + N
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG----LRSLNSLVLYGNKI 92
Query: 137 TDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSEC 194
T+ L L+ L L N ++ L D L L L L N + S
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 195 THLQTLWLADN 205
+QT+ LA N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 13/135 (9%)
Query: 222 TDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIE----- 276
T++ L QN ++ P A + L ++L N +S + P F L +L
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQ----GLRSLNSLVLYG 89
Query: 277 NQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI-TNASKLIGLDLSSNLFSGHIPHT 335
N+++ LP +L L +L+ L L N + + + L L L N T
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 336 FGNLRFLRFLNLMFN 350
F LR ++ ++L N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 36/174 (20%), Positives = 56/174 (32%), Gaps = 43/174 (24%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSS 367
+P +IT + L N P F + LR ++L N ++ + A
Sbjct: 30 LPETITE------IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA-----FQG 78
Query: 368 LTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEI-GNLSGLMFL 426
L + L L L N + +P+ + L L L
Sbjct: 79 LRS---LNSLVLYGNKIT--------------------------ELPKSLFEGLFSLQLL 109
Query: 427 KLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGN 479
L+ N++N + L LSLYDN LQ L + + L N
Sbjct: 110 LLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 48/194 (24%), Positives = 66/194 (34%), Gaps = 39/194 (20%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
+ + L N + P + + KL +DLS+N S P F LR L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKG 411
+T P S L + L L LN N + + F
Sbjct: 92 IT--ELP---KSLFEGLFS---LQLLLLNANKINCLRV---DAFQ--------------- 125
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+L L L L DN+L T + +Q + L N CHL+ L
Sbjct: 126 -------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD-----CHLKWL 173
Query: 472 SQLLL-NGNNLSGA 484
+ L N SGA
Sbjct: 174 ADYLHTNPIETSGA 187
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 74/319 (23%), Positives = 121/319 (37%), Gaps = 77/319 (24%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER------AFRTFDSECEI 779
+ D + LG G++G VYK VAIK L+ E A R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 780 LRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLN------IM 833
L+ ++HRN++++ S + L+ E+ E L Y +D ++ +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKY---MDKNPDVSMRVIKSFL 138
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH-----VSDFGISKLLGEGDDSV 888
+ + + H +H DLKP N+LL + + + DFG+++ G
Sbjct: 139 YQLINGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 889 TQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK---------------- 930
T I T+ Y PE GS S D++S + E +
Sbjct: 195 THEI--ITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251
Query: 931 ----KPTDEMFTGEMSLRRWVKESLPH----GLTEVVDANLVGEEQAFSAKTDCLLSIMD 982
P D + G +L W K+S P L V+ A L +++ LL+ M
Sbjct: 252 EVLGLPDDTTWPGVTALPDW-KQSFPKFRGKTLKRVLGALL--DDEGLD-----LLTAM- 302
Query: 983 LALDCCMESPEQRIHMTDA 1001
L +D P +RI +A
Sbjct: 303 LEMD-----PVKRISAKNA 316
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 47/221 (21%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVR-HRNLVKIF-- 792
LGRG + V++ + + V +K+ + ++ R E +IL N+R N++ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 793 --SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL----VLEYLHHG 846
ALV E + N F++ + Q L D+ +L+ L +
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEILKALDYC 146
Query: 847 HSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQ-TITMATIGYMAPEY 904
HS I+H D+KP+N+++D E+ + D+G L E + + +A+ + PE
Sbjct: 147 HS-MGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 905 GSEGIVSAKC-----DVYSYGVLLMETFTRKKPTDEMFTGE 940
+V + D++S G +L RK+P F G
Sbjct: 202 ----LVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 43/229 (18%)
Query: 732 FNECNLLGRGSFGLV----YKGTLFDGTNVAIKVFNLQLERAFRTFDSEC-----EIL-R 781
FN +LG+GSFG V KGT A+K+ L+ + + D EC +L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
+ L ++ S +D V+E++ G + F + ++A+ L
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLF 135
Query: 842 YLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIG 898
+L G I++ DLK +N++LD H+ +DFG+ K D T+T T
Sbjct: 136 FLQSKG-----IIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTPD 186
Query: 899 YMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKKP-----TDEMF 937
Y+APE I++ + D +++GVLL E + P DE+F
Sbjct: 187 YIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 43/213 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G G++G V G VAIK F ++ RA+R E +L++++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 791 ---IFSSCCNID-FKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLN------IMIDVAL 838
+F+ ++ F LV+ FM + L + + + ++ +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKI-----MGLKFSEEKIQYLVYQMLK 137
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
L+Y+H A +VH DLKP N+ ++E+ + DFG+++ D +T + T
Sbjct: 138 GLKYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYV--VTRW 188
Query: 899 YMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE S + D++S G ++ E T K
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 67/231 (29%), Positives = 93/231 (40%), Gaps = 43/231 (18%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFN----LQLERAFRTFDSECEILR 781
D F +LG+GSFG V K T G A+KV LQ + T +E IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTM-TEKRILS 78
Query: 782 NV-RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
H L ++F D V+EF+ G + F + R ++ L
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISAL 137
Query: 841 EYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATI 897
+LH G I++ DLK +N+LLD H +DFG+ K G + T T T
Sbjct: 138 MFLHDKG-----IIYRDLKLDNVLLDHE--GHCKLADFGMCK-EGICNGVTTATFC-GTP 188
Query: 898 GYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMF 937
Y+APE YG D ++ GVLL E P D++F
Sbjct: 189 DYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 79/559 (14%), Positives = 161/559 (28%), Gaps = 68/559 (12%)
Query: 52 HRVVALNLSSFSLGGIIPPHLGNLSF----LVSLDISENNFYGHLPNELGKLRRLRLINF 107
+ + +G + + S+++ N
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGK-------------PHFADFNL 84
Query: 108 AYNELSGSFPSWIGILSR----LQILSFHNNSFTDR-IPDFLLNLSKLEFLDLME-NSLS 161
+ G WI +S L+ + TD + + + L L S
Sbjct: 85 VPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS 144
Query: 162 GSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSE----CTHLQTLWLAD--NKFSGRLPE 213
I L++L L +D LS T L +L ++ ++ S E
Sbjct: 145 TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204
Query: 214 NIG-NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGM------NNLSGPVPPTIFNI 266
+ L L L + + T + LE L G ++ + +
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264
Query: 267 STIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGT-IPNSITNASKLIGLDLSS 325
+R ++ + + +LP + L L L + + + KL L +
Sbjct: 265 KELRCLSGFWDAVPAYLP-AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD 323
Query: 326 NLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD--QWSFLSSLTNCRSLTELALNVNP 383
+ + + LR L + + + +S C L +
Sbjct: 324 YIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQ 383
Query: 384 L--RGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTV 441
+ ++ I ++ +F E K L L+ V
Sbjct: 384 MTNAALI--TIARNRPNMTRFRLCIIEPKAP-------------DYLTLEPLDIGFGAIV 428
Query: 442 GRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGA-IPACLGSLTSLRELHL 500
+ L+ LSL Y + +++ L + S + L SLR+L +
Sbjct: 429 EHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEI 488
Query: 501 -GSNTLTYSIPSSLWSLEYILYVNLSSNSLS----GPLPSSIQHLKVLINLDLSRNQLSG 555
++ ++ LE + + +SS S+S L + L V + +
Sbjct: 489 RDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEV---IDERGAPD 545
Query: 556 DIPITISGLKDLATLSLAG 574
P + + ++AG
Sbjct: 546 SRPESCPVERVFIYRTVAG 564
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 45/229 (19%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGTLFDGTN--VAIKVFNLQLER------AFRTFDSECE 778
RA + +G G++G V+K VA+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 779 I-----LRNVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSY-----NYF 823
+ L H N+V++F C LV E + ++ L +Y
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPG 116
Query: 824 LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883
+ ++M + L++LH +VH DLKP NIL+ + ++DFG++++
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS- 171
Query: 884 GDDSVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ T + T+ Y APE S + D++S G + E F RK
Sbjct: 172 --FQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G GS+G V + + VAIK VF ++ R R E IL + H ++VK
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 791 ---IFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
I F +VLE + F+K + Y ++ + ++ ++ + ++Y+
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYV-- 172
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
HS A I+H DLKP N L++++ + V DFG+++ + ++ +Q M
Sbjct: 173 -HS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 906 SE 907
Sbjct: 231 PH 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 55/226 (24%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK--VFNLQLE--RAFRTFDSECEILRNVRHRNLVKIF 792
LG G GLV+ VAIK V A R E +I+R + H N+VK+F
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 793 SSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIM-IDVALVLE---------- 841
I + S + M D+A VLE
Sbjct: 75 ----EI-LGP------SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123
Query: 842 ---Y-----LHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLG-EGDDSVTQT 891
Y L + HS A ++H DLKP N+ ++ E++ + DFG+++++ +
Sbjct: 124 LFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 892 ITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ T Y +P Y ++ I D+++ G + E T K
Sbjct: 183 EGLVTKWYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 52/220 (23%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK---VFNLQLE--RAFRTFDSECEILRNVRHRNLVK- 790
+G G++G+V + VAIK F Q R R E +IL RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 791 --IFSSCCNIDFKA--LVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMIDVALV 839
I + K +V + M K L + YFL Q +
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL--YQ----------I 137
Query: 840 LEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATI 897
L L + HS A ++H DLKP+N+LL+ + DFG++++ + D T +T +AT
Sbjct: 138 LRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVATR 195
Query: 898 GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE Y ++ I D++S G +L E + +
Sbjct: 196 WYRAPEIMLNSKGY-TKSI-----DIWSVGCILAEMLSNR 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 67/314 (21%), Positives = 120/314 (38%), Gaps = 65/314 (20%)
Query: 728 ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER-----AFRTFDSECEILR 781
++ F + LG G++ VYKG G VA+K L E A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-----LDILQRLNIMIDV 836
++H N+V+++ + LV EFM N +K++ S L++ +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
L + H I+H DLKP N+L+++ + DFG+++ G ++ + + T
Sbjct: 118 LQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV--VT 171
Query: 897 IGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK--------------------KPTD 934
+ Y AP+ GS S D++S G +L E T K P +
Sbjct: 172 LWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 935 EMFTG-------EMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDC 987
++ ++++ L L L + L + L L+
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL--DGNLMD-----FLHGL-LQLN- 281
Query: 988 CMESPEQRIHMTDA 1001
P+ R+ A
Sbjct: 282 ----PDMRLSAKQA 291
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 42/213 (19%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G G++G V G VAIK F +L RA+R E +L+++RH N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 791 IFSSCCNIDFKALVLEFMPNGSFEKW--LYSYNYFLD-----ILQRLNIMIDVALVLEY- 842
+ ++ F P+ + + + Y F+ +++ + D L Y
Sbjct: 89 LL----DV--------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 843 ----LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIG 898
L + H+ A I+H DLKP N+ ++E+ + DFG+++ D +T + T
Sbjct: 137 MLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYV--VTRW 190
Query: 899 YMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE + + D++S G ++ E T K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 40/215 (18%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFNLQLERAFRTFDSEC-----EIL 780
F+ ++GRGS+ V K T A++V ++ E D + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106
Query: 781 -RNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+ H LV + S V+E++ G + + R +++L
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 165
Query: 840 LEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMAT 896
L YLH G I++ DLK +N+LLD H+ +D+G+ K G T T T
Sbjct: 166 LNYLHERG-----IIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC-GT 216
Query: 897 IGYMAPE------YGSEGIVSAKCDVYSYGVLLME 925
Y+APE YG D ++ GVL+ E
Sbjct: 217 PNYIAPEILRGEDYGFS------VDWWALGVLMFE 245
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 16/147 (10%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLL-NLSKLEFLDLMENSLSGSLPNDI--RLP 171
P I L +NN FT + L +L ++ N ++ +
Sbjct: 25 KIPE--HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 172 KLEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNL 226
+ ++ L SN ++ L+TL L N+ + + + LS + L+L
Sbjct: 82 GVNEILLTSN----RLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 227 AQNNLQGDMPTAIGNLQMLEHLNLGMN 253
N + P A L L LNL N
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 17/132 (12%)
Query: 153 LDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQI----PSSLSECTHLQTLWLADNK 206
L L N + I +LP+L K+ +N +I + + + + L N+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNN----KITDIEEGAFEGASGVNEILLTSNR 92
Query: 207 FSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF- 264
+ + L L L L N + + L + L+L N ++ V P F
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 265 ---NISTIRLIN 273
++ST+ L+
Sbjct: 151 TLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 9/144 (6%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPY-YLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
IP L L +N+ L +L ++ + N ++ + +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 496 RELHLGSNTLTYSIPSSL-WSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
E+ L SN L ++ + LE + + L SN ++ S L + L L NQ++
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 555 GDIPITISGLKDLATLSLAGNQFN 578
P L L+TL+L N FN
Sbjct: 143 TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 5/129 (3%)
Query: 474 LLLNGNNLSGAIP-ACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGP 532
L LN N + L LR+++ +N +T + + + L+SN L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN- 95
Query: 533 LPSSI-QHLKVLINLDLSRNQLSGDIPI-TISGLKDLATLSLAGNQFNGPIPESFGSLIS 590
+ + + L+ L L L N+++ + + GL + LSL NQ P +F +L S
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 591 LESLDVSSN 599
L +L++ +N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 12/130 (9%)
Query: 259 VPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSI-TNASK 317
+P I + L N+ + + LP L + NN I I AS
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFEGASG 82
Query: 318 LIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTEL 377
+ + L+SN F L L+ L L N +T D SF L++ + L
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT--CVGND--SF-IGLSS---VRLL 134
Query: 378 ALNVNPLRGI 387
+L N + +
Sbjct: 135 SLYDNQITTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/176 (21%), Positives = 54/176 (30%), Gaps = 46/176 (26%)
Query: 308 IPNSITNASKLIGLDLSSNLFSGHIPHT--FGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
IP L L++N F+ + T F L LR +N N +T A
Sbjct: 30 IPQYTAE------LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGA-----F 77
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
+ + E+ L N L + F L L
Sbjct: 78 EGASG---VNEILLTSNRLEN-VQH--KMFK----------------------GLESLKT 109
Query: 426 LKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPY-YLCHLERLSQLLLNGN 479
L L N + + ++ LSLYDN + ++ L LS L L N
Sbjct: 110 LMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 47/231 (20%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLER---------AFRTFDSE 776
AT + +G G++G VYK G VA+K + R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 777 CEI-----LRNVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSY-----N 821
E+ L H N+V++ C LV E + ++ L +Y
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPP 114
Query: 822 YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881
L ++M L++LH IVH DLKP NIL+ T ++DFG++++
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 882 GEGDDSVTQTITMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ T + T+ Y APE S + D++S G + E F RK
Sbjct: 171 S---YQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 40/215 (18%)
Query: 730 DGFNECNLLGRGSFGLVY----KGTLFDGTNVAIKVFNLQLERAFRTFDSEC-----EIL 780
F+ ++GRGS+ V K T A+KV ++ E D + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63
Query: 781 -RNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALV 839
+ H LV + S V+E++ G + + R +++L
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 122
Query: 840 LEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMAT 896
L YLH G I++ DLK +N+LLD H+ +D+G+ K G T T T
Sbjct: 123 LNYLHERG-----IIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC-GT 173
Query: 897 IGYMAPE------YGSEGIVSAKCDVYSYGVLLME 925
Y+APE YG D ++ GVL+ E
Sbjct: 174 PNYIAPEILRGEDYGFS------VDWWALGVLMFE 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 40/183 (21%), Positives = 76/183 (41%), Gaps = 22/183 (12%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+GRGS+G VY NVAIK +F ++ R R E IL ++ +++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 791 ---IFSSCCNIDFKA--LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
+ + F +VLE + +K + + + + I+ ++ L ++
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFI-- 145
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
H + I+H DLKP N LL+++ + V DFG+++ + D+
Sbjct: 146 -HE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 906 SEG 908
+
Sbjct: 204 LKK 206
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 153 LDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLP 212
+L + S++ L ++++ ++D + + +++ L L NK
Sbjct: 24 ANLKKKSVT-DAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH---- 76
Query: 213 ENIG---NLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN-IST 268
+I L+ LT L L N LQ L L+ L L N L +P +F+ ++
Sbjct: 77 -DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTN 134
Query: 269 IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNA-SKLIGLDLSSN- 326
+ +NL NQL LP + L NL L L N L ++P + + ++L L L N
Sbjct: 135 LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQ 192
Query: 327 LFSGHIPH-TFGNLRFLRFLNLMFN 350
L S +P F L L+++ L N
Sbjct: 193 LKS--VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 24/188 (12%)
Query: 98 KLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLME 157
+L + I +++ S I L ++ L+ N I L+ L +L L
Sbjct: 39 ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-DISALK-ELTNLTYLILTG 94
Query: 158 NSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLS-----ECTHLQTLWLADNKFSGR 210
N L SLPN + +L L++L L N Q+ SL + T+L L LA N+
Sbjct: 95 NQLQ-SLPNGVFDKLTNLKELVLVEN----QL-QSLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 211 LPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF----N 265
LP+ + L+ LT+L+L+ N LQ L L+ L L N L VP +F +
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTS 206
Query: 266 ISTIRLIN 273
+ I L +
Sbjct: 207 LQYIWLHD 214
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 51/216 (23%), Positives = 78/216 (36%), Gaps = 27/216 (12%)
Query: 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNE 432
+ L + S + I L + +L L N+
Sbjct: 20 ETIKANLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNK 74
Query: 433 LNGTIPTTVGRFQ---QLQGLSLYDNDLQGSIPYYLCH-LERLSQLLLNGNNLSGAIPAC 488
L + + L L L N LQ S+P + L L +L+L N L
Sbjct: 75 L-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 489 LGSLTSLRELHLGSNTLTYSIPSSLW-SLEYILYVNLSSNSLSGPLPSSI-QHLKVLINL 546
LT+L L+L N L S+P ++ L + ++LS N L LP + L L +L
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDL 186
Query: 547 DLSRNQLSGDIPITISG----LKDLATLSLAGNQFN 578
L +NQL +P G L L + L N ++
Sbjct: 187 RLYQNQLKS-VP---DGVFDRLTSLQYIWLHDNPWD 218
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 52/214 (24%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
+L + T L + + + + + + L N + LAL
Sbjct: 24 ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQG-------IQYLPN---VRYLALG 71
Query: 381 VNPLRGILPPFIGNFSASLRKFEAIKCELKG--SIPQEI-GNLSGLMFLKLDDNELNGTI 437
N L + L + S+P + L+ L L L +N+L ++
Sbjct: 72 GNKLHD-ISAL-----KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SL 124
Query: 438 PTTV-GRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGAIPA-CLGSLTS 494
P V + L L+L N LQ S+P + L L++L L+ N L ++P LT
Sbjct: 125 PDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ 182
Query: 495 LRELHLGSNTLTYSIPS----SLWSLEYI-LYVN 523
L++L L N L S+P L SL+YI L+ N
Sbjct: 183 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 34/147 (23%), Positives = 60/147 (40%), Gaps = 18/147 (12%)
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVL 543
P + + +L ++T + L I + +++ + + IQ+L +
Sbjct: 12 IFPD--DAFAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKS-VQG-IQYLPNV 65
Query: 544 INLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISG 603
L L N+L DI + L +L L L GNQ F L +L+ L + N +
Sbjct: 66 RYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-- 121
Query: 604 KIPKSLEA-----LLYLKKLNVSYNRL 625
+SL L L LN+++N+L
Sbjct: 122 ---QSLPDGVFDKLTNLTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 62/243 (25%), Positives = 91/243 (37%), Gaps = 58/243 (23%)
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
NL +++ +++I I + + + LPN+ +L L G N +
Sbjct: 22 IKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSVQGI---QYLPNVRYLAL-GGNKL 75
Query: 306 GTIP--NSITNASKLIGLDLSSNLFSGHIPHT-FGNLRFLRFLNLMFNSLTTESSPADQW 362
I +TN L L L+ N +P+ F L L+ L L+ N L S P
Sbjct: 76 HDISALKELTN---LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ--SLPDG-- 127
Query: 363 SFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSG 422
LTN LT L L N L+ LP G F L+
Sbjct: 128 -VFDKLTN---LTYLNLAHNQLQS-LPK--GVFD----------------------KLTN 158
Query: 423 LMFLKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLCH-----LERLSQLLL 476
L L L N+L ++P V + QL+ L LY N L+ S+P L L + L
Sbjct: 159 LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP----DGVFDRLTSLQYIWL 212
Query: 477 NGN 479
+ N
Sbjct: 213 HDN 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 44/214 (20%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVRHRNLVK 790
+G G++G V G VA+K F + R +R E +L++++H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 791 ---IFSSCCNID-FKA--LVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMIDVA 837
+F+ +++ F LV M + + I Q L
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFL--IYQILR------ 143
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
L+Y+H A I+H DLKP+N+ ++E+ + DFG+++ D +T + AT
Sbjct: 144 -GLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYV--ATR 193
Query: 898 GYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 930
Y APE + + D++S G ++ E T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 7e-12
Identities = 36/200 (18%), Positives = 56/200 (28%), Gaps = 55/200 (27%)
Query: 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKV--------FNLQLERAFRTFDSECEI 779
T+ C +G G FG V++ D T VAIK+ N ++ F E I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 780 LRNV---------RHRNLVKIFSSCCNI------------------------------DF 800
+ + R + + S C D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 801 KALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKP 859
+VLEF G E+ + +I+ + L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHW 190
Query: 860 NNILLDENMTAHVSDFGISK 879
N+LL + + K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 51/237 (21%)
Query: 726 QRATDGFNECNL-LGRGSFGLVYKGTLFDGTN---VAIKVFNLQLERAFRTFDSECEI-- 779
+R D F +GRG++G VYK DG + A+K Q+E + + EI
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIAL 71
Query: 780 LRNVRHRNLVKIFSSCCNIDFKA--LVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMID 835
LR ++H N++ + + + L+ ++ E L+ + + + +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLP 126
Query: 836 VALV----------LEYLHHGHSLAPIVHCDLKPNNILLDENMTAH----VSDFGISKLL 881
+V + YLH ++H DLKP NIL+ ++D G ++L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 882 GEGDDSVTQ-TITMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ + T Y APE Y D+++ G + E T +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLTSE 233
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 45/149 (30%), Positives = 62/149 (41%), Gaps = 21/149 (14%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
S P+ GI ++ L NS L+ L L L N L SLPN + +L
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 173 LEKLYLGSNDFFGQIPS-------SLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDL 224
L L L +N Q+ S L T L+ L L N+ LP+ + L+QL DL
Sbjct: 78 LTYLNLSTN----QLQSLPNGVFDKL---TQLKELALNTNQLQ-SLPDGVFDKLTQLKDL 129
Query: 225 NLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
L QN L+ L L+++ L N
Sbjct: 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 31/107 (28%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 407 CELKG--SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY 464
C +G S+P I + +L L+ N L L L L N LQ
Sbjct: 14 CYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV 71
Query: 465 LCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS 511
L L+ L L+ N L LT L+EL L +N L S+P
Sbjct: 72 FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD 117
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 7/142 (4%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLE 246
+P+ + T L L N L+ LT L L N LQ L L
Sbjct: 22 VPTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 247 HLNLGMNNLSGPVPPTIFNIST-IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
+LNL N L +P +F+ T ++ + L NQL LP + L L+ L L+ N L
Sbjct: 80 YLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL- 136
Query: 306 GTIPNSI-TNASKLIGLDLSSN 326
++P+ + + L + L N
Sbjct: 137 KSVPDGVFDRLTSLQYIWLHDN 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHR------NLV 789
++G+GSFG V K +VA+K+ +R R E IL ++R + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 790 KIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYF----LDILQRLNIMIDVALVLEY 842
+ + F+ + E + +E L N F L ++++ + L+
Sbjct: 163 HMLEN---FTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRK--FAHSILQCLDA 215
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVTQTITMATIGYM 900
LH I+HCDLKP NILL + + V DFG S + + Q+ Y
Sbjct: 216 LHKNR----IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YR 266
Query: 901 APEYGSEGIVSAKCDVYSYGVLLMETFT 928
APE D++S G +L E T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 67/236 (28%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIK----VFNLQLE--RAFRTFDSECEILRNVR-HRNLV 789
LG+G++G+V+K G VA+K F + R FR E IL + H N+V
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 790 KIFSSCCNIDFKA--LVLEFMPNGSFEKWLYS-------YNYFLDILQRLNIMIDVALVL 840
+ + + + LV ++M + + Y + Q + V+
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK-------VI 122
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFG---------------ISKLLGEGD 885
+YLH G ++H D+KP+NILL+ V+DFG + +
Sbjct: 123 KYLHSGG----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 886 DSVTQTITM----ATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 930
+ + AT Y APE Y ++GI D++S G +L E K
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 45/235 (19%), Positives = 88/235 (37%), Gaps = 53/235 (22%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR----------- 784
LG G F V+ + + T+VA+K+ + + E ++L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 785 HRNLVKIFSS----CCNIDFKALVLEFMPNGSFEKWLYSYNYF---LDILQRLNIMIDVA 837
+++K+ N +V E + + + Y + L +++ I +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAH------VSDFGISKLLGEGDDSVTQT 891
L L+Y+H I+H D+KP N+L++ + ++D G + E + QT
Sbjct: 142 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 892 ITMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE 940
Y +PE +G D++S L+ E T +F +
Sbjct: 199 RE-----YRSPEVLLGAPWG------CGADIWSTACLIFELITGDF----LFEPD 238
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/304 (16%), Positives = 95/304 (31%), Gaps = 75/304 (24%)
Query: 54 VVALNLSSFSLGG----IIPPHLGNLSFLVSLDISENNFYGHLPNE-----------LGK 98
V + LS ++G + ++ + L + S + F G + +E L K
Sbjct: 34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS-DIFTGRVKDEIPEALRLLLQALLK 92
Query: 99 LRRLRLINFAYNELSGSFPSWIGIL----SRLQILSFHNNSFTD-------------RIP 141
+L + + N + + + L+ L HNN +
Sbjct: 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 152
Query: 142 DFLLNLSKLEFLDLMENS--------LSGSLPNDIRLPKLEKLYLGSNDFFGQ-----IP 188
N L + N + + + L + + N + +
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS---HRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 189 SSLSECTHLQTLWLADNKFSGR----LPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQM 244
L+ C L+ L L DN F+ L + + L +L L L +A G +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL-----SARGAAAV 264
Query: 245 LEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSG----HLPLTLGHSLPNLEFLTLF 300
++ + N ++ + L N++ L + +P+L FL L
Sbjct: 265 VDAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311
Query: 301 GNNL 304
GN
Sbjct: 312 GNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 51/301 (16%), Positives = 92/301 (30%), Gaps = 60/301 (19%)
Query: 126 LQILSFHNNSFTDR----IPDFLLNLSKLEFLDLMENS--------LSGSLPNDIRLPKL 173
++ S ++ T + LL ++ + L N+ LS ++ + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS---KKDL 62
Query: 174 EKLYLGSNDF----------FGQIPSSLSECTHLQTLWLADNKFSGR----LPENIGNLS 219
E + +L +C L T+ L+DN F L + + +
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 220 QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQL 279
L L L N L I + L+ L + + P +R I N+L
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIA--RALQELAVNKKAKNAP---------PLRSIICGRNRL 171
Query: 280 SG----HLPLTLGHSLPNLEFLTLFGNNL-----IGTIPNSITNASKLIGLDLSSNLFSG 330
T L + + N + + + +L LDL N F+
Sbjct: 172 ENGSMKEWAKTFQSH-RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 331 ----HIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNC--RSLTELALNVNPL 384
+ + LR L L L+ + A + + + L L L N +
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAA----VVDAFSKLENIGLQTLRLQYNEI 286
Query: 385 R 385
Sbjct: 287 E 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/321 (17%), Positives = 102/321 (31%), Gaps = 71/321 (22%)
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
+ +L +++T D+ S + L S+ E+ L+ N IG +A
Sbjct: 6 IEGKSLKLDAIT----TEDEKSVFAVLLEDDSVKEIVLSGNT--------IGTEAA---- 49
Query: 402 FEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNG--TIPTTVGRFQQLQGLSLYDNDLQG 459
+ + EI S + ++ D + + + +L + L DN
Sbjct: 50 -RWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108
Query: 460 ----SIPYYLCHLERLSQLLLNGNNLS-------------GAIPACLGSLTSLRELHLGS 502
+ +L L L L+ N L A+ + LR + G
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 503 NTLT----YSIPSSLWSLEYILYVNLSSNSL-----SGPLPSSIQHLKVLINLDLSRNQL 553
N L + S + V + N + L + + + L LDL N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT- 227
Query: 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGK----IPKSL 609
T G LA +L +L L ++ +S + + +
Sbjct: 228 -----FTHLGSSALAI-ALKSWP-------------NLRELGLNDCLLSARGAAAVVDAF 268
Query: 610 EAL--LYLKKLNVSYNRLEGE 628
L + L+ L + YN +E +
Sbjct: 269 SKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 59/390 (15%), Positives = 121/390 (31%), Gaps = 87/390 (22%)
Query: 245 LEHLNLGMNNLSG----PVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLT-- 298
+E +L ++ ++ V + +++ I L N + L ++ + + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 299 LFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSP 358
F + G + + I A +L+ L L + L N+ +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKC-------------PKLHTVRLSDNAFGPTAQE 112
Query: 359 ADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIG 418
+ L+ L L L+ N G+ P + +L++ K +
Sbjct: 113 P----LIDFLSKHTPLEHLYLHNN---GLGPQAGAKIARALQELAVNK---------KAK 156
Query: 419 NLSGLMFLKLDDNELNG----TIPTTVGRFQQLQGLSLYDNDL-----QGSIPYYLCHLE 469
N L + N L T + L + + N + + + L + +
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 470 RLSQLLLNGNNLSG----AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525
L L L N + A+ L S +LREL L L+ ++
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS---ARGAAAV--------- 264
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF 585
++ S +Q L L N+ I + ++ L T +
Sbjct: 265 VDAFSKLENIGLQT------LRLQYNE------IELDAVRTLKT-VIDEK---------- 301
Query: 586 GSLISLESLDVSSNNIS--GKIPKSLEALL 613
+ L L+++ N S + + +
Sbjct: 302 --MPDLLFLELNGNRFSEEDDVVDEIREVF 329
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 42/264 (15%), Positives = 71/264 (26%), Gaps = 60/264 (22%)
Query: 49 ARHHRVVALNLSSFSLGGIIPPH----------LGNLSFLVSLDISENNFYG----HLPN 94
A + S G + L L ++ +S+N F L +
Sbjct: 57 ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116
Query: 95 ELGKLRRLRLINFAYNELS-------------GSFPSWIGILSRLQILSFHNNSFTDR-- 139
L K L + N L + L+ + N +
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176
Query: 140 --IPDFLLNLSKLEFLDLMENS---------LSGSLPNDIRLPKLEKLYLGSNDFFGQ-- 186
+ L + +++N L L +L+ L L N F
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC---QELKVLDLQDNTFTHLGS 233
Query: 187 --IPSSLSECTHLQTLWLADNKFS-------GRLPENIGNLSQLTDLNLAQNNLQGDMPT 237
+ +L +L+ L L D S + N+ L L L N ++ D
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVR 292
Query: 238 AIG-----NLQMLEHLNLGMNNLS 256
+ + L L L N S
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 41/214 (19%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHR------NL 788
+L+G+GSFG V K + VAIK+ + + E +L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 789 VKIFSSCCNIDFKA---LVLEFMPNGSFE--KWLYSYNYF-LDILQRLNIMIDVALVLEY 842
V + F+ LV E + ++ + ++ L++ ++ + L +
Sbjct: 119 VHLKRH---FMFRNHLCLVFEMLSYNLYDLLR-NTNFRGVSLNLTRK--FAQQMCTALLF 172
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAH--VSDFGISKLLGEGDDSVTQTITMATIGYM 900
L I+HCDLKP NILL + + DFG S LG+ Q+ Y
Sbjct: 173 LATPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225
Query: 901 APE------YGSEGIVSAKCDVYSYGVLLMETFT 928
+PE Y D++S G +L+E T
Sbjct: 226 SPEVLLGMPYDL------AIDMWSLGCILVEMHT 253
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 23/133 (17%), Positives = 41/133 (30%), Gaps = 27/133 (20%)
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
+ +L L I + + + +DN+ +L + L +L L + N
Sbjct: 18 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74
Query: 230 NLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGH 289
+ L L L L N+L + + PL
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV--------ELGDL-------------DPL---A 110
Query: 290 SLPNLEFLTLFGN 302
SL +L +L + N
Sbjct: 111 SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 30/144 (20%), Positives = 46/144 (31%), Gaps = 35/144 (24%)
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
N L+L I +IEN LG +L + +
Sbjct: 17 NAVRDRELDLRGYK-----------------IPVIEN---------LGATLDQFDAIDF- 49
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPAD 360
+N I + +L L +++N L L L L NSL
Sbjct: 50 SDNEIRKLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-------V 101
Query: 361 QWSFLSSLTNCRSLTELALNVNPL 384
+ L L + +SLT L + NP+
Sbjct: 102 ELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 19/112 (16%), Positives = 39/112 (34%), Gaps = 16/112 (14%)
Query: 511 SSLWSLEYILYVNLSSNSLSGPLPSSIQHLKV----LINLDLSRNQLSGDIPITISGLKD 566
+ + ++L + I++L +D S N++ + L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRR 65
Query: 567 LATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKL 618
L TL + N+ +L L L +++N++ L L L L
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 30/116 (25%), Positives = 39/116 (33%), Gaps = 9/116 (7%)
Query: 70 PHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELS--GSFPSWIGILSRLQ 127
N LD+ + N L + I+F+ NE+ FP L RL+
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRLK 67
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLS--GSLPNDIRLPKLEKLYLGSN 181
L +NN L L L L NSL G L L L L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/107 (20%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 522 VNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI 581
V L++ + + + LDL ++ I + L + + N+ I
Sbjct: 2 VKLTAELIE--QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----I 54
Query: 582 P--ESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
+ F L L++L V++N I +AL L +L ++ N L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 3/89 (3%)
Query: 415 QEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQL 474
+ N L L ++ I Q + DN+++ + L RL L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 475 LLNGNNLSGAIPACLGSLTSLRELHLGSN 503
L+N N + +L L EL L +N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNN 98
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 24/97 (24%), Positives = 35/97 (36%), Gaps = 10/97 (10%)
Query: 290 SLPNLEFLTLFGNNLIGTIPN-SITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLM 348
NL L + + + + +L L + + P F L LNL
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 349 FNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLR 385
FN+L + W + L SL EL L+ NPL
Sbjct: 89 FNALESL-----SWKTVQGL----SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 2/93 (2%)
Query: 534 PSSIQHLKVLINLDLSRNQLSGDIP-ITISGLKDLATLSLAGNQFNGPIPESFGSLISLE 592
+ + L L + Q + + GL +L L++ + P++F L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 593 SLDVSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
L++S N + + L L++L +S N L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 20/101 (19%), Positives = 38/101 (37%), Gaps = 2/101 (1%)
Query: 180 SNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPEN-IGNLSQLTDLNLAQNNLQGDMPTA 238
+ D L +L L++ + + L + L +L +L + ++ L+ P A
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 239 IGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQL 279
L LNL N L + +++ + L N L
Sbjct: 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 2/95 (2%)
Query: 460 SIPYYLCHLERLSQLLLNGNNLSGAIPA-CLGSLTSLRELHLGSNTLTYSIPSSLWSLEY 518
++L E L++L + + L L LR L + + L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 519 ILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553
+ +NLS N+L ++Q L L L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 153 LDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPS-SLSECTHLQTLWLADNKFSGRL 211
L + SL + L +LY+ + + L L+ L + + +
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71
Query: 212 PENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL 255
+ +L+ LNL+ N L+ + L L+ L L N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 5/96 (5%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDF-LLNLSKLEFLDLMENSLSGSLPNDI--RLP 171
+ L L N + L L +L L ++++ L + D P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 172 KLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKF 207
+L +L L N + + LQ L L+ N
Sbjct: 81 RLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 25/114 (21%), Positives = 40/114 (35%), Gaps = 3/114 (2%)
Query: 466 CHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS-SLWSLEYILYVNL 524
C S L + L +L EL++ + + L L + + +
Sbjct: 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 525 SSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578
+ L P + L L+LS N L T+ GL L L L+GN +
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 22/117 (18%), Positives = 33/117 (28%), Gaps = 25/117 (21%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNE-LGKLRRLRLINFAYNELSGSFPSWIGILSRL 126
HL L L I HL L L LR + + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------- 69
Query: 127 QILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDF 183
++F +L L+L N+L ++ L++L L N
Sbjct: 70 ---FVAPDAFH--------FTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 5/95 (5%)
Query: 212 PENIGNLSQLTDLNLAQNN-LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIF-NISTI 269
++ LT+L + LQ + L L +L + + L V P F +
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL 304
+NL N L L L L+ L L GN L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 307 TIPNSITNASKLIGLDLSSNLFSGHIP-HTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
+ + A L L + + H+ L LR L ++ + L + A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA------ 75
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFS 396
L+ L L+ N L + + S
Sbjct: 76 --FHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 27/139 (19%), Positives = 57/139 (41%), Gaps = 20/139 (14%)
Query: 171 PKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNN 230
+ +L+ + ++LS + L L+ N ++ ++ + L L+L +N
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81
Query: 231 LQGDMPTAIGNL----QMLEHLNLGMNNLSGPVPPTIFNIST---IRLINLIENQLSGHL 283
+ I NL LE L + N ++ ++ I +R++ + N+++
Sbjct: 82 I-----KKIENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWG 131
Query: 284 PLTLGHSLPNLEFLTLFGN 302
+ +L LE L L GN
Sbjct: 132 EIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 33/179 (18%), Positives = 59/179 (32%), Gaps = 40/179 (22%)
Query: 464 YLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVN 523
E++ L + + A L +L + + L L +N +
Sbjct: 21 VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE----------------- 61
Query: 524 LSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLA----TLSLAGNQFNG 579
+S + ++ L L L RN + I L +A L ++ NQ
Sbjct: 62 ----KISS-----LSGMENLRILSLGRNLIK-----KIENLDAVADTLEELWISYNQIA- 106
Query: 580 PIPESFGSLISLESLDVSSNNISG-KIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRN 637
L++L L +S+N I+ L AL L+ L ++ N L +
Sbjct: 107 -SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 17/150 (11%)
Query: 432 ELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGS 491
E + T + L ++ + L L+ L L+ NN+ I + L
Sbjct: 16 ERKSVVATEA----EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68
Query: 492 LTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSN---SLSGPLPSSIQHLKVLINLDL 548
+ +LR L LG N + I + + + + +S N SLSG I+ L L L +
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYM 122
Query: 549 SRNQLSGDIPI-TISGLKDLATLSLAGNQF 577
S N+++ I ++ L L L LAGN
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 40/165 (24%), Positives = 58/165 (35%), Gaps = 38/165 (23%)
Query: 220 QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQL 279
+ +L+ ++ M + L+ +HL L NN I I +L
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN-----------IEKIS--SL----- 66
Query: 280 SGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNL 339
+ NL L+L G NLI I N A L L +S N + + L
Sbjct: 67 ---------SGMENLRILSL-GRNLIKKIENLDAVADTLEELWISYNQIA-SLSG-IEKL 114
Query: 340 RFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPL 384
LR L + N +T W + L L +L L NPL
Sbjct: 115 VNLRVLYMSNNKITN-------WGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 33/150 (22%), Positives = 56/150 (37%), Gaps = 23/150 (15%)
Query: 91 HLPNELGKLRRLRLINFAYNELS---GSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNL 147
+ L L+ + + + N + + + L+ILS N +I +
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 148 SKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSN--DFFGQIPSSLSECTHLQTLWLADN 205
LE L + N ++ SL +L L LY+ +N +G+I L+ L+ L LA N
Sbjct: 93 DTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
Query: 206 KFSGRLPEN----------IGNLSQLTDLN 225
EN + L L L+
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 30/155 (19%)
Query: 148 SKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKF 207
S ++ + L P +R +L SND G+I +E +L+ L L +
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVR--ELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGL 61
Query: 208 SGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNIS 267
+ N+ L +L L L++N + G + L L HLNL N L +IS
Sbjct: 62 I-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK--------DIS 111
Query: 268 TIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
T+ + L L+ L LF
Sbjct: 112 TLEPL----------------KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 6/111 (5%)
Query: 468 LERLSQLLLNGNNLS-GAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSS 526
+ +L+L+ + G I +L L L + L S+ S+L L + + LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 527 NSLSGPLPSSIQHLKVLINLDLSRNQLS--GDIPITISGLKDLATLSLAGN 575
N + G L + L L +L+LS N+L + + L+ L +L L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 32/163 (19%)
Query: 393 GNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELN-GTIPTTVGRFQQLQGLS 451
+ S+ + I EL+ P + L LD+ + N G I F L+ LS
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELV------LDNCKSNDGKIEGLTAEFVNLEFLS 55
Query: 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPS 511
L + L S+ L L +L +L L+ N + G + L +L L+L N L
Sbjct: 56 LINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----K 108
Query: 512 SLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
+ +LE ++ L+ L +LDL +++
Sbjct: 109 DISTLEP------------------LKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 4/107 (3%)
Query: 57 LNLSSFSLGGI-IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGS 115
L L + I L L + + N L KL +L+ + + N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSENRIFGG 86
Query: 116 FPSWIGILSRLQILSFHNNSFTD-RIPDFLLNLSKLEFLDLMENSLS 161
L L L+ N D + L L L+ LDL ++
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 7/100 (7%)
Query: 527 NSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFG 586
L P++++ L LD ++ G I + +L LSL +
Sbjct: 16 LELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNLP 68
Query: 587 SLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLE 626
L L+ L++S N I G + E L L LN+S N+L+
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 27/143 (18%), Positives = 42/143 (29%), Gaps = 31/143 (21%)
Query: 217 NLSQLTDLNLAQNNLQ-GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLI 275
+ + +L L G + LE L+L L + NL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-------------SVSNL- 67
Query: 276 ENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS--GHIP 333
LP L+ L L N + G + L L+LS N +
Sbjct: 68 -------------PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL- 113
Query: 334 HTFGNLRFLRFLNLMFNSLTTES 356
L L+ L+L +T +
Sbjct: 114 EPLKKLECLKSLDLFNCEVTNLN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-08
Identities = 77/498 (15%), Positives = 143/498 (28%), Gaps = 160/498 (32%)
Query: 455 NDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRE-----LH--LGS--NTL 505
ND Q Y ++ RL L L A L LR + LGS +
Sbjct: 121 NDNQVFAKY---NVSRLQPYL----KLRQA-------LLELRPAKNVLIDGVLGSGKTWV 166
Query: 506 TYSIPSSLWSLEY----ILYVNLSSNSLSGPLPSSIQHLKVLINLDL-SRNQLSGDIPIT 560
+ S I ++NL + + + +Q L I+ + SR+ S +I +
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 561 ISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEA-------LL 613
I ++ L + L+ L +V + K+ A LL
Sbjct: 227 IHSIQAELRRLLKSKPYEN-------CLLVLL--NVQN-------AKAWNAFNLSCKILL 270
Query: 614 YLKKLNVSYNRLEG----EIPIKGPFRNFS---AQSFSGNYALCGPPRLQVPP--CKEDK 664
+ V+ + L I + + +S Y C P L P
Sbjct: 271 TTRFKQVT-DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL--PREVLT--- 324
Query: 665 GKGSKKAPFALKFILPLIISIV---------------------LIAIVIMFF-------I 696
P +SI+ L I+
Sbjct: 325 -------------TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 697 RRQ-------NGNTKVPVKEDVLSLATWRRTSYLDIQRATDGFNECNLLGRGSFGLVYKG 749
R+ + +P +LSL W D+ + ++ +L+ +
Sbjct: 372 RKMFDRLSVFPPSAHIP--TILLSL-IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI-- 426
Query: 750 TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMP 809
++ + LE + E + HR++V ++ D L+ ++
Sbjct: 427 SIPS----------IYLE-----LKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 810 NGSFEKWLYSYNYF------LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPN--- 860
Y Y++ ++ +R+ + V L +L I H N
Sbjct: 471 Q-------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHDSTAWNASG 518
Query: 861 ---NILLD-ENMTAHVSD 874
N L + ++ D
Sbjct: 519 SILNTLQQLKFYKPYICD 536
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-07
Identities = 88/578 (15%), Positives = 165/578 (28%), Gaps = 185/578 (32%)
Query: 132 HNNSFTDRIPDFLLNLSK-LEF---LDLMENSLSGSLPNDI-RLP-KLEKLYL------- 178
H + D + F + D+ ++ LS + I +
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 179 -GSN---DFFGQI------------------PSSLSEC--THLQTLWLADNKFS----GR 210
F ++ PS ++ L+ + F+ R
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 211 LPENIGNLSQ-LTDLNLAQN----------------------NLQGDMPTAI-----GN- 241
+ L Q L +L A+N +Q M I N
Sbjct: 134 -LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 242 ------LQMLEHLNLGMNNLSGPVPPTIFNISTIRL-INLIENQLSGHLPLT-LGHSL-- 291
L+ML+ L + + S I+L I+ I+ +L L + L
Sbjct: 193 NSPETVLEMLQKLLY---QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 292 ----PNLEFLTLFGNN---LIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRF 344
N + F + L+ T +T+ + ++++ H T
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDF---LSAATTTHISLDHHSMTL-------- 298
Query: 345 LNLMFNSLTTESSPADQWSFLSSLTNCR--SLTELALNVNPLR-GILPPFIGNFSASLRK 401
+P + S L +CR L L NP R I+ I + A+
Sbjct: 299 ------------TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 402 FEAIKCE-LKGSIPQEIGNLSGL----MFLKL---DDNELNGTIPTTVGRFQQLQGLSLY 453
++ + C+ L I + L MF +L + IPT + LSL
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH---IPTIL--------LSLI 395
Query: 454 DNDLQGSIP-YYLCHLERLSQLLLNGNNLSGAIPAC----LGSLTSLRELHLGSNTL--T 506
D+ S + L + S + + +IP+ L + LH ++
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH---RSIVDH 452
Query: 507 YSIPSSL--WSL------EYI----------------------LYVNLS-------SNSL 529
Y+IP + L +Y ++++ +S
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 530 SGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDL 567
+ SI + L L + + + P + +
Sbjct: 513 AWNASGSILNT--LQQLKFYKPYICDNDPKYERLVNAI 548
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 8e-05
Identities = 55/380 (14%), Positives = 118/380 (31%), Gaps = 131/380 (34%)
Query: 28 VLANNWSISYPICNWVGISCGARHHRVVAL--NLS-SFSLGGIIPPH--LGNLSFLVSLD 82
VL N + N +SC +++ + L H L + S ++ D
Sbjct: 249 VLLNVQNAK--AWNAFNLSC-----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 83 ISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPD 142
++ +L L R E+ + P + I++ + D
Sbjct: 302 EVKSLLLKYLDCRPQDLPR---------EVLTTNPRRLSIIAES----IRD--GLATW-D 345
Query: 143 FLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFF-----GQIPSSLSECTHL 197
+++ + ++E+SL+ P + R K++ + IP+ L L
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYR-----KMF---DRLSVFPPSAHIPTIL-----L 392
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNN----------LQGDMPTAIGNL----- 242
+W K + +++L +L + + ++ + N
Sbjct: 393 SLIWFDVIK---SDVMVV--VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 243 QMLEHLNLGMN-NLSGPVPPT----IFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFL 297
+++H N+ + +PP ++ H+ GH L N+E
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYS----------------HI----GHHLKNIE-- 485
Query: 298 TLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESS 357
+ ++ LF F + RFL + +S+
Sbjct: 486 ----------------HPERM-------TLF----RMVFLDFRFLE------QKIRHDST 512
Query: 358 PADQWSFLSSLTNCRSLTEL 377
W+ S+ N +L +L
Sbjct: 513 A---WNASGSILN--TLQQL 527
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 1e-04
Identities = 32/141 (22%), Positives = 53/141 (37%), Gaps = 38/141 (26%)
Query: 49 ARHHRVVALN----LSSFSLGGIIPPHLGNLSFLVSLDISENNFYG-HLPN----ELGKL 99
HR + ++ +F +IPP+L + + G HL N E L
Sbjct: 443 YALHRSI-VDHYNIPKTFDSDDLIPPYLDQYFY---------SHIGHHLKNIEHPERMTL 492
Query: 100 RRLRLINFAY--NELSGSFPSWI---GILSRLQILSFHNNSFTDRIP----------DFL 144
R+ ++F + ++ +W IL+ LQ L F+ D P DFL
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 145 L----NLSKLEFLDLMENSLS 161
NL ++ DL+ +L
Sbjct: 553 PKIEENLICSKYTDLLRIALM 573
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 34/109 (31%), Positives = 48/109 (44%), Gaps = 14/109 (12%)
Query: 153 LDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSE-----CTHLQTLWLADN 205
L L +N L + + RLP L KL L N Q+ + + +H+Q L L +N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRN----QL-TGIEPNAFEGASHIQELQLGEN 88
Query: 206 KFSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
K + + L QL LNL N + MP + +L L LNL N
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 30/109 (27%), Positives = 42/109 (38%), Gaps = 13/109 (11%)
Query: 426 LKLDDNELNGTIPTTV-GRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSG 483
L L+DNEL + GR L L L N L I + +L L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 484 AIPA-CLGSLTSLRELHLGSNTLTYSIPS----SLWSLEYILYVNLSSN 527
I L L+ L+L N ++ + L SL + NL+SN
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSL---NLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 32/118 (27%), Positives = 50/118 (42%), Gaps = 6/118 (5%)
Query: 187 IPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
IP + T L L DN+ + + G L L L L +N L G P A +
Sbjct: 23 IPRDIPLHT--TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 246 EHLNLGMNNLSGPVPPTIFN-ISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
+ L LG N + + +F + ++ +NL +NQ+S + L +L L L N
Sbjct: 81 QELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSS--LWSLEYILYVNLSSNSLSGPLPSSI-QHL 540
IP EL L N L I S L +++ + L N L+G + + +
Sbjct: 22 EIPR--DIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGA 77
Query: 541 KVLINLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPE-SFGSLISLESLDVSS 598
+ L L N++ +I + GL L TL+L NQ + + SF L SL SL+++S
Sbjct: 78 SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLAS 135
Query: 599 N 599
N
Sbjct: 136 N 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/116 (26%), Positives = 41/116 (35%), Gaps = 21/116 (18%)
Query: 100 RRLRLINFAYNELSGSFPSWI-GILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158
L L NEL + G L L L N T P+ S ++ L L EN
Sbjct: 32 TELLL---NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 159 SLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPS-------SLSECTHLQTLWLADN 205
+ + N + L +L+ L L N QI L L +L LA N
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDN----QISCVMPGSFEHL---NSLTSLNLASN 136
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 27/135 (20%)
Query: 169 RLPKLEKLYL-GSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLA 227
+++L L S G++ E L+ L + + + N+ L++L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTL 287
N + G + L HLNL N + ++STI PL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK--------DLSTIE-------------PL-- 109
Query: 288 GHSLPNLEFLTLFGN 302
L NL+ L LF
Sbjct: 110 -KKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 123 LSRLQILSFHNNSFTD-RIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSN 181
S ++ L N+ + ++ +LEFL + L+ S+ N +L KL+KL L N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDN 74
Query: 182 DFFGQIPSSLSECTHLQTLWLADNKFSG-RLPENIGNLSQLTDLNLAQN 229
G + +C +L L L+ NK E + L L L+L
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 467 HLERLSQLLLNGN-NLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525
+ +L+L+ + + G + L L + LT SI ++L L + + LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSG-DIPITISGLKDLATLSLAGN 575
N +SG L + L +L+LS N++ + L++L +L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 403 EAIKCELKGSIPQEIGNLSGLMFLKLDDNELN-GTIPTTVGRFQQLQGLSLYDNDLQGSI 461
I EL+ P ++ L LD++ N G + F++L+ LS + L SI
Sbjct: 5 RRIHLELRNRTPSDVKELV------LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI 57
Query: 462 PYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLT-YSIPSSLWSLEYIL 520
L L +L +L L+ N +SG + +L L+L N + S L LE +
Sbjct: 58 AN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK 116
Query: 521 YVNLSSN 527
++L +
Sbjct: 117 SLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 20/88 (22%), Positives = 29/88 (32%), Gaps = 3/88 (3%)
Query: 72 LGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSF 131
L L + N L KL +L+ + + N +SG L L+
Sbjct: 38 TDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 132 HNNSFTD-RIPDFLLNLSKLEFLDLMEN 158
N D + L L L+ LDL
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 38/140 (27%), Positives = 53/140 (37%), Gaps = 28/140 (20%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLE 174
P GI + L N FT +P L N L +DL N +S +L N
Sbjct: 24 VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQS------ 73
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQG 233
F S++ T L TL L+ N+ +P L L L+L N++
Sbjct: 74 --------F-----SNM---TQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV 116
Query: 234 DMPTAIGNLQMLEHLNLGMN 253
A +L L HL +G N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 484 AIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVL 543
+P G + EL+L N T +P L + +++ ++LS+N +S S ++ L
Sbjct: 24 VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 544 INLDLSRNQLSGDIPITI-SGLKDLATLSLAGNQFNGPIPE-SFGSLISLESLDVSSN 599
+ L LS N+L IP GLK L LSL GN + +PE +F L +L L + +N
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 8/105 (7%)
Query: 174 EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNLQ 232
+LYL N F +P LS HL + L++N+ S L N++QL L L+ N L+
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 233 GDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFN----ISTIRLIN 273
P L+ L L+L N++S VP FN +S + +
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 13/104 (12%)
Query: 85 ENNFYGHLPNELGKLRRLRLINFAYNELS----GSFPSWIGILSRLQILSFHNNSFTDRI 140
+ N + +P EL + L LI+ + N +S SF + +++L L N I
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSN----MTQLLTLILSYNRLR-CI 93
Query: 141 PDFLLN-LSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSN 181
P + L L L L N +S +P L L L +G+N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 32/143 (22%), Positives = 48/143 (33%), Gaps = 33/143 (23%)
Query: 437 IPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLR 496
IP V L L N +P L + + L+ + L+ N +S ++T L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 497 ELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD 556
L L N L IP + LK L L L N +S
Sbjct: 82 TLILSYNRLR-CIPPRTFD-----------------------GLKSLRLLSLHGNDISV- 116
Query: 557 IPITI-SGLKDLATLSLAGNQFN 578
+P + L L+ L++ N
Sbjct: 117 VPEGAFNDLSALSHLAIGANPLY 139
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 29/174 (16%), Positives = 62/174 (35%), Gaps = 44/174 (25%)
Query: 737 LLGRGSFGLVYKGTLFDGTNVAIKVF---------NLQLERAFRTFDSECEILRNVRHRN 787
+G+G FG +Y + +V N L E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-------ELKFYQRAAKPE 94
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQR----------------- 829
++ + + + V ++ +G +K SY + +D
Sbjct: 95 QIQKWIRTRKLKYLG-VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 830 -LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISK 879
L + + + +LEY+H VH D+K +N+LL + + ++ D+G++
Sbjct: 154 VLQLSLRILDILEYIHEHE----YVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 44/226 (19%), Positives = 81/226 (35%), Gaps = 51/226 (22%)
Query: 737 LLGRGSFGLVYKG--TLFDGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHR------N 787
LG G+FG V + + VA+K+ N + + E +L+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 788 LVKIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYF---LDILQRLNIMIDVALVLE 841
V + +F + E + +FE +L N+ L ++ + + L
Sbjct: 84 CVLMSDW---FNFHGHMCIAFELLGKNTFE-FLKENNFQPYPLPHVRH--MAYQLCHALR 137
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI--------- 892
+LH + H DLKP NIL + + + S ++ +
Sbjct: 138 FLHENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 893 -TMATI----GYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 928
TI Y PE ++ + CDV+S G +L E +
Sbjct: 194 EHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.6 bits (130), Expect = 9e-08
Identities = 24/136 (17%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLL--NLSKLEFLDL---MENSLSGSLPNDI-------RL 170
L+ L + D + + +L +L LE L L +E+ N R
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 171 PKLEKLYLGSNDFFGQIPSSLSEC---THLQTLWLADNKFSGR----LPENIGNLSQLTD 223
P L+ L + + + E L+T+ ++ + L +++ + L
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 224 LNLAQNNLQGDMPTAI 239
+N+ N L +M +
Sbjct: 312 INMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 3e-07
Identities = 22/189 (11%), Positives = 53/189 (28%), Gaps = 27/189 (14%)
Query: 434 NGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGS-- 491
+ + L L + + ++ L L + L ++ +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 492 LTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN 551
L +L +L L Y + + S L L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLF---------------SKDRFPNLKWLGIVDA 262
Query: 552 QLSGDIPITISG---LKDLATLSLAGNQFNG----PIPESFGSLISLESLDVSSNNISGK 604
+ + L L T+ ++ + + + L+ +++ N +S +
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 605 IPKSLEALL 613
+ K L+ L
Sbjct: 323 MKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 31/203 (15%), Positives = 65/203 (32%), Gaps = 36/203 (17%)
Query: 185 GQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG--NL 242
+ L L L + K + L L L + L + I +L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 243 QMLEHLNL--GMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
LE L L G+ + + ++ PL PNL++L +
Sbjct: 219 PNLEKLVLYVGVEDYGF------------------DGDMNVFRPLFSKDRFPNLKWLGIV 260
Query: 301 GNNLIGTIPNSITNA---SKLIGLDLSSNLFSG----HIPHTFGNLRFLRFLNLMFNSLT 353
+ + +L +D+S+ + + + ++ L+F+N+ +N L+
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
Query: 354 TESSPADQWSFLSSLTNCRSLTE 376
+ SL +++
Sbjct: 321 ----DEMKKELQKSLPMKIDVSD 339
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 1e-05
Identities = 40/222 (18%), Positives = 71/222 (31%), Gaps = 35/222 (15%)
Query: 91 HLPNELGKLRRLRLINFAYNELSGSFPSWIG------ILSRLQILSFHNNSFTDRIPDFL 144
+ K + + + SWI +L + +L+ T+ +
Sbjct: 130 GIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK 189
Query: 145 LNLSKLEFLDLMENSLSGSLPNDI---RLPKLEKL--YLGSNDFFGQIPSSLSECTHLQT 199
L+ L+++ L S+ DI LP LEKL Y+G D+ + +
Sbjct: 190 KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD-----GDMNVFRP 244
Query: 200 LWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGN---LQMLEHLNLGMNNLS 256
L+ L L + Q + L LE +++ L+
Sbjct: 245 LFSK------------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 257 GPVPPTIF----NISTIRLINLIENQLSGHLPLTLGHSLPNL 294
+ I ++ IN+ N LS + L SLP
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 29/165 (17%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G G FGL+Y A V ++ + F SE + + V ++ +K +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQR-----------------LNIMIDVA 837
+D+ + F +G E SY + ++ L L + I +
Sbjct: 103 KQLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISK 879
VLEY+H VH D+K N+LL + + +++D+G+S
Sbjct: 162 DVLEYIHENE----YVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 68/446 (15%), Positives = 132/446 (29%), Gaps = 42/446 (9%)
Query: 100 RRLRLINFAYNELSGSFPSWIGILSR----LQILSFHNNSFTDRIPDFL--LNLSKLEFL 153
R + N G W+ +S L+ + F +D D L LE L
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143
Query: 154 DLME-NSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPSSLSE----CTHLQTLWLADNK 206
L + + + I K++ L + + F + L E T L+ L +
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203
Query: 207 FSGRLPENI----GNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPT 262
F+ P+++ N L + + + + LE G N +P
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAAANLEEFCGGSLNEDIGMPEK 262
Query: 263 IFNISTIRLINLIENQLSGHLPL-TLGHSLPNLEFLTLFGNNLIG-TIPNSITNASKLIG 320
N+ R + + G + L + L L L I L
Sbjct: 263 YMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322
Query: 321 LDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQW----SFLSSLTNCRSLTE 376
L+ + + + + L+ L + + + ++ C+ L
Sbjct: 323 LETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382
Query: 377 LALNVNPL--RGILPPFIGNFSASLRKFEAIKCELKGSIPQEIG---------NLSGLMF 425
+A+ V+ + + IG + +L F + + + I L
Sbjct: 383 MAVYVSDITNESLES--IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440
Query: 426 LKLDDNELNGT---IPTTVGRFQQLQGLSLYDNDLQ-GSIPYYLCHLERLSQLLLNGNNL 481
+ T + ++ + L + + L +L + G
Sbjct: 441 FAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500
Query: 482 S-GAIPACLGSLTSLRELHLGSNTLT 506
S AI A + L SLR L + +
Sbjct: 501 SERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 48/346 (13%), Positives = 100/346 (28%), Gaps = 53/346 (15%)
Query: 74 NLSFLVSLDISENNFYG-------HLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRL 126
+ + L L+ F + L +++ +F EL G F + L
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAAN-LEEF 248
Query: 127 QILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFG- 185
S + + L+ KL L L + ++ KL L
Sbjct: 249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE 308
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIG----- 240
+ + +C +L+ L + L QL L + + + M G
Sbjct: 309 DHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 241 -------NLQMLEHLNLGMNNLSGPVPPTIF----NISTIRLINL-----IENQLSGHLP 284
Q LE++ + +++++ +I N+ RL+ L I + +
Sbjct: 369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428
Query: 285 LTLGHSLPNLEFLTLFGNNLIGTIPNSITNAS---------KLIGLDLSSNLFSGH-IPH 334
+L L + +T+ + + L S +
Sbjct: 429 RSLLIGCKKLRRFAFYLR------QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482
Query: 335 TFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALN 380
L+ L + + + +++T SL L +
Sbjct: 483 FSRGCPNLQKLEMRGCCFSER-------AIAAAVTKLPSLRYLWVQ 521
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 31/150 (20%), Positives = 60/150 (40%), Gaps = 16/150 (10%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH-RNLVKIFSSC 795
+G GSFG++++GT L + VAIK + + E + + + ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 796 CNIDFKALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
LV++ + G S E L + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVY 129
Query: 855 CDLKPNNILLDENMTA-----HVSDFGISK 879
D+KP+N L+ + +V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 24/153 (15%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKV-----FNLQLERAFRTFDSECEILRNVRH-RNLVK 790
+G GSFG +Y GT + G VAIK+ + QL E +I + ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-------ESKIYKMMQGGVGIPT 69
Query: 791 IFSSCCNIDFKALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
I D+ +V+E + G S E + + L + + +EY+H +
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 850 APIVHCDLKPNNILLDENMTAH---VSDFGISK 879
+H D+KP+N L+ + + DFG++K
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 52/310 (16%), Positives = 94/310 (30%), Gaps = 55/310 (17%)
Query: 124 SRLQILSFHNNSFTDR----IPDFLL-NLSKLEFLDLMENSLSG----SLPNDIRLPK-- 172
+ + L+ NS + + L + + L+L N LS L +
Sbjct: 51 ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 173 LEKLYLGSNDFFGQ----IPSSLSEC-THLQTLWLADNKFSGRLPENIGNL-----SQLT 222
+ L LG NDF + + S + +L L N + + + + + +
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVN 170
Query: 223 DLNLAQNNLQGDMPTAIGNL-----QMLEHLNLGMNNLSGPVPPTI-----FNISTIRLI 272
LNL NNL + + L+L N L + + + +
Sbjct: 171 SLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSL 230
Query: 273 NLIENQLSGHLPLTLGHSL---PNLEFLTLFGNNL--IGT-----IPNSITNASKLIGLD 322
NL N L G L +L+ + L + + + + + N K+I +D
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 323 LSSN--------LFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSL 374
+ S I G +L+ L + + L L
Sbjct: 291 KNGKEIHPSHSIPISNLIRELSGKADVP---SLLNQCLIFAQK---HQTNIEDLNIPDEL 344
Query: 375 TELALNVNPL 384
E PL
Sbjct: 345 RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 45/301 (14%), Positives = 93/301 (30%), Gaps = 54/301 (17%)
Query: 132 HNNSFTDR----IPDFLLNLSKLEFLDLMENSLSGS----LPNDIRLPK--LEKLYLGSN 181
+ + +F + LDL N+L L + L L N
Sbjct: 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 182 DFFGQIPSSLSE-----CTHLQTLWLADNKFSGRLPENIGNL-----SQLTDLNLAQNNL 231
+ L + ++ +L L+ N S + + + +T L+L N+
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 232 QGDMPTAIGNL-----QMLEHLNLGMNNLSG----------PVPPTIFNISTIRLINLIE 276
+ + LNL N+L P + +NL
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA-----NVNSLNLRG 176
Query: 277 NQLS----GHLPLTLGHSLPNLEFLTLFGNNL----IGTIPNSI-TNASKLIGLDLSSNL 327
N L+ L L ++ L L N L + + + ++ L+L N
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236
Query: 328 FSG----HIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNP 383
G ++ +L+ L+ + L ++ + S + ++ N + + + N
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKE 295
Query: 384 L 384
+
Sbjct: 296 I 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 42/229 (18%), Positives = 76/229 (33%), Gaps = 64/229 (27%)
Query: 446 QLQGLSLYDNDLQGSIPYYLCHL-----ERLSQLLLNGNNLSGAIPACLGSL-----TSL 495
+ L+L N L L + ++ L L+GN LS L ++
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111
Query: 496 RELHLGSNTLTY-----------SIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHL---- 540
L LG N + ++P+S+ SL NL N L S L
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSL------NLRGNDLG---IKSSDELIQIL 162
Query: 541 ----KVLINLDLSRNQLSGDIPITISGLKDLA-----------TLSLAGNQFNGPIPESF 585
+ +L+L N + +LA +L L+ N
Sbjct: 163 AAIPANVNSLNLRGNN------LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL 216
Query: 586 GSLI-----SLESLDVSSNNISGKIPKSLEALL----YLKKLNVSYNRL 625
+ + SL++ N + G ++L+ L +L+ + + Y+ +
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 41/243 (16%)
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC-----HLERLSQLLLNG 478
M KL + + + + L L N+L L ++ L L+G
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 479 NNLSGAIPACLGSL-----TSLRELHLGSNTLTY----SIPSSLWSLEYIL-YVNLSSNS 528
N+L L + ++ L+L N L+Y + +L ++ + + ++L N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 529 LSGPLPSSIQHL--------KVLINLDLSRNQLSGDIPITIS-GLKD----LATLSLAGN 575
S S + +L+L N L + L + +L+L GN
Sbjct: 121 FS---SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN 177
Query: 576 QFNGPIPESFGSLI-----SLESLDVSSNNISGKIPKSL-EALL----YLKKLNVSYNRL 625
+ S+ SLD+S+N + K L ++ LN+ N L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 626 EGE 628
G
Sbjct: 238 HGP 240
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 43/220 (19%)
Query: 446 QLQGLSLYDNDLQGSIPYYLCHL-----ERLSQLLLNGNNLSG----AIPACLGSL-TSL 495
+ L L ND ++ L L GN+L + L ++ ++
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169
Query: 496 RELHLGSNTLTY-----------SIPSSLWSLEYILYVNLSSNSLS----GPLPSSIQHL 540
L+L N L SIP+S+ SL +LS+N L L +
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSL------DLSANLLGLKSYAELAYIFSSI 223
Query: 541 K-VLINLDLSRNQLSGDIPITISGLKD----LATLSLAGNQFNGP-------IPESFGSL 588
+++L+L N L G + LKD L T+ L + + +F ++
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 589 ISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGE 628
+ +D + I + L+ L +
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 33/150 (22%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH-RNLVKIFSSC 795
+G G+FG + G L+ VAIK+ ++ E + + + +++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 796 CNIDFKALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
+ A+VLE + G S E + + L I I + +EY+H + +++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN----LIY 128
Query: 855 CDLKPNNILL-----DENMTAHVSDFGISK 879
D+KP N L+ H+ DF ++K
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 44/234 (18%), Positives = 85/234 (36%), Gaps = 67/234 (28%)
Query: 737 LLGRGSFGLVYKG--TLFDGTNVAIKVFNLQLERAFRTF----DSECEILRNVRHR---- 786
LG G+FG V + G +VA+K+ + + SE ++L ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 787 --NLVKIFSSCCNIDFKA---LVLEFM-PNGSFEKWLY------SYNYF-LDILQRLNIM 833
V++ + +V E + + Y + F LD +++ +
Sbjct: 76 TFRCVQMLEW---FEHHGHICIVFELLGLS------TYDFIKENGFLPFRLDHIRK--MA 124
Query: 834 IDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI- 892
+ + +LH + H DLKP NIL ++ + I + + + +
Sbjct: 125 YQICKSVNFLHSNK----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 893 ---------TMATI----GYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 928
+T+ Y APE ++ S CDV+S G +L+E +
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 50/235 (21%), Positives = 88/235 (37%), Gaps = 65/235 (27%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVF-NLQLERAFRTFDSECEILRNVRHR-----NLV 789
+G G+FG V + + A+KV N++ + R+ E +IL+ +++ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 790 KIFSSCCNIDFKA---LVLEFMPNGSFEKWLYSYNYF---LDILQRLNIMIDVALVLEYL 843
K + L+ E + +E + NY ++ ++ I++ L YL
Sbjct: 100 KYHGK---FMYYDHMCLIFEPLGPSLYE-IITRNNYNGFHIEDIKL--YCIEILKALNYL 153
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVS-------------------------DFGIS 878
+ H DLKP NILLD+ DFG +
Sbjct: 154 RKMS----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 879 KLLGEGDDSVTQTITMATIGYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 928
+ S+ T Y APE ++ D++S+G +L E +T
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 36/142 (25%), Positives = 53/142 (37%), Gaps = 31/142 (21%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
S P+ GI S L +N L++L L L +N + SLP+ + +L K
Sbjct: 21 SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 173 LEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENI-GNLSQLTDLNLAQNNL 231
L LYL N ++ S LP + L+QL +L L N L
Sbjct: 78 LTILYLHEN----KLQS---------------------LPNGVFDKLTQLKELALDTNQL 112
Query: 232 QGDMPTAIGNLQMLEHLNLGMN 253
+ L L+ + L N
Sbjct: 113 KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 14/107 (13%)
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSGA 484
L+L+ N+L + QL LSL N +Q S+P + L +L+ L L+ N L +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 485 IPACLG---SLTSLRELHLGSNTLTYSIPS----SLWSLEYI-LYVN 523
+P G LT L+EL L +N L S+P L SL+ I L+ N
Sbjct: 91 LPN--GVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 56/316 (17%), Positives = 100/316 (31%), Gaps = 29/316 (9%)
Query: 84 SENNFYGHLPNE-----LGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTD 138
+ LP+E L L+ + + + S Q L +
Sbjct: 4 FPGVSWDSLPDELLLGIFSCLCLPELLKVS--GVCKRWYRLASDESLWQTLDLTGKNLHP 61
Query: 139 RIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYL-GSNDFFGQIPSSLSECTHL 197
+ LL+ + + + L +++ + L S + LS+C+ L
Sbjct: 62 DVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD--MPTAIGNLQMLEHLNL----- 250
Q L L + S + + S L LNL+ + + + T + + L+ LNL
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180
Query: 251 ----GMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIG 306
+ V I+ + L +N L TL PNL L L + ++
Sbjct: 181 FTEKHVQVAVAHVSE---TITQLNLSGYRKN-LQKSDLSTLVRRCPNLVHLDLSDSVMLK 236
Query: 307 TIP-NSITNASKLIGLDLSS-NLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSF 364
+ L L LS G + L+ L + + + +
Sbjct: 237 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF--GIVPDGTLQLLKEA 294
Query: 365 LSSLT-NCRSLTELAL 379
L L NC T +A
Sbjct: 295 LPHLQINCSHFTTIAR 310
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 32/190 (16%), Positives = 65/190 (34%), Gaps = 9/190 (4%)
Query: 445 QQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNT 504
Q + + + + + L N + L + L+ L L
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129
Query: 505 LTYSIPSSLWSLEYILYVNLSSNSL--SGPLPSSIQHLKVLINLDLSRNQLSGDIPITI- 561
L+ I ++L ++ +NLS S L + + L L+LS + + +
Sbjct: 130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189
Query: 562 --SGLKDLATLSLAGNQFN---GPIPESFGSLISLESLDVSS-NNISGKIPKSLEALLYL 615
+ + L+L+G + N + +L LD+S + + L YL
Sbjct: 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249
Query: 616 KKLNVSYNRL 625
+ L++S
Sbjct: 250 QHLSLSRCYD 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 738 LGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV-KIFSSC 795
+G GSFG +Y GT + VAIK+ N++ + E +I R ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 796 CNIDFKALVLEFMPNG-SFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVH 854
D+ LV++ + G S E + L + L + + +E++H +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----FLH 126
Query: 855 CDLKPNNILLDENMTAH---VSDFGISK 879
D+KP+N L+ A+ + DFG++K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/257 (20%), Positives = 82/257 (31%), Gaps = 79/257 (30%)
Query: 738 LGRGSFGLVYKG-TLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCC 796
LG G F V+ + VA+KV E T E +L++VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 797 NI---DFK---------ALVLEFMPNG-SFEKWLYSYNYF---LDILQRLNIMIDVALVL 840
DFK +V E + G KW+ NY L +++ I+ V L
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGL 159
Query: 841 EYLHHGHSLAPIVHCDLKPNNILL------------------------------------ 864
+YLH + I+H D+KP NILL
Sbjct: 160 DYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 865 -------------DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
E + ++D G + T+ I T Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ--TRQYRSLEVLIGSGYN 271
Query: 912 AKCDVYSYGVLLMETFT 928
D++S + E T
Sbjct: 272 TPADIWSTACMAFELAT 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 27/170 (15%), Positives = 58/170 (34%), Gaps = 38/170 (22%)
Query: 738 LGRGSFGLVYKGT---------LFDGTNVAIKV--FNLQLERAFRTFDSECEI------- 779
R + G++Y+ ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 780 -LRNVRHRNLVKIFSSCCNID-FKALVLEFMPNG-SFEKWLYSYNYFL----DILQRLNI 832
L + + + D ++ LVL + G S + L + +LQ
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISK 879
++D LE+LH VH ++ NI + D++ ++ +G +
Sbjct: 168 LLDA---LEFLHENE----YVHGNVTAENIFVDPEDQS-QVTLAGYGFAF 209
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 19/100 (19%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPK 172
S P+ GI + Q L +NN T P +L L+ L N L+ ++P + +L +
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 173 LEKLYLGSNDFFGQIPS-------SLSECTHLQTLWLADN 205
L +L L N + S +L L ++L +N
Sbjct: 83 LTQLDLNDN----HLKSIPRGAFDNL---KSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 48/272 (17%), Positives = 85/272 (31%), Gaps = 41/272 (15%)
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQI 187
+LS HN + ++ + NL LE ++ L + +L +F
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF-QNQ 64
Query: 188 PSSLSECTHLQTLWLADNKFSGRLPENIG-----NLSQLTDLNLAQNNLQGDMPTAIGN- 241
S + L+ L LA + + + L ++NLA L +
Sbjct: 65 RFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV 124
Query: 242 LQMLEHLNLGMNNLSGPVPPTI-----FNISTIRLINLIENQLSGHLPLTLGHSL---PN 293
L L +N+L + + I + L N L+ L L +
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 294 LEFLTLFGNNLIGTIPNSITNAS-KLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
+ L+L + + +L+ L N R L+ LN+ +N
Sbjct: 185 VTHLSLLHTG--------LGDEGLELLAAQLDRN-------------RQLQELNVAYNGA 223
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPL 384
++ A + SL L L N L
Sbjct: 224 GDTAALA----LARAAREHPSLELLHLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 29/162 (17%), Positives = 43/162 (26%), Gaps = 31/162 (19%)
Query: 123 LSRLQILSFHNNSFTDR----IPDFLL-NLSKLEFLDLMENS--------LSGSLPNDIR 169
R + L NS + D LL + ++ L L N L L +
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN-- 182
Query: 170 LPKLEKLYLGSNDF----FGQIPSSLSECTHLQTLWLADNKFSGR----LPENIGNLSQL 221
+ L L + + L LQ L +A N L L
Sbjct: 183 -TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241
Query: 222 TDLNLAQNNLQ-------GDMPTAIGNLQMLEHLNLGMNNLS 256
L+L N L D+ A + +S
Sbjct: 242 ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1022 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-64
Identities = 66/279 (23%), Positives = 121/279 (43%), Gaps = 26/279 (9%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
+G GSFG VYKG +VA+K+ N+ + + F +E +LR RH N++
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
A+V ++ S L+ ++++ ++I A ++YLH I+
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA----KSII 126
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY---GSEGIV 910
H DLK NNI L E++T + DFG++ + S +I +MAPE +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 911 SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAF 970
S + DVY++G++L E T + P + + + + L L++V
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---------- 236
Query: 971 SAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+C ++ L +C + ++R A ++ +
Sbjct: 237 ----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 4e-55
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 39/305 (12%)
Query: 721 SYLDIQRATDGFNEC---------NLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQL- 766
++ D A F + ++G G FG V G L VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 767 ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDI 826
E+ R F SE I+ H N++ + ++ EFM NGS + +L + +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 827 LQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886
+Q + ++ +A ++YL + VH DL NIL++ N+ VSDFG+S+ L +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 887 SVTQTIT---MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL 943
T T I + APE ++ DV+SYG+++ E + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-------- 235
Query: 944 RRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAA 1003
+T N + ++ DC ++ L LDC + R
Sbjct: 236 ----------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 1004 ELKKI 1008
L K+
Sbjct: 286 TLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 60/290 (20%), Positives = 115/290 (39%), Gaps = 22/290 (7%)
Query: 738 LGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN 797
+G+G FG V++G G VA+K+F+ + ER++ ++E +RH N++ ++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 798 IDFKA----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG----HSL 849
+ LV ++ +GS +L Y ++ + + + A L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGYMAPEYGSE 907
I H DLK NIL+ +N T ++D G++ D++ + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 908 GI------VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE--SLPHGLTEVV 959
I + D+Y+ G++ E R ++ V S+ V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ L + L + + +C + R+ L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-54
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 24/278 (8%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
+G G FGLV+ G + VAIK F E E++ + H LV++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+ C LV EFM +G +L + L + +DV + YL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---- 121
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
++H DL N L+ EN VSDFG+++ + + + + T + + +PE S S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYS 180
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971
+K DV+S+GVL+ E F+ K E + + + + L
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGF-----RLYKPRLASTH---- 230
Query: 972 AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ + C E PE R + +L +I
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-54
Identities = 60/280 (21%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV 789
+ LG G FG V+ G T VA+K + F +E +++ ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHGHS 848
++++ + ++ E+M NGS +L + + L I + L++ +A + ++ +
Sbjct: 72 RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
+H DL+ NIL+ + ++ ++DFG+++L+ E ++ + I + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 909 IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
+ K DV+S+G+LL E T + T + + ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPD----------- 233
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+C + L C E PE R + L+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-53
Identities = 66/284 (23%), Positives = 110/284 (38%), Gaps = 30/284 (10%)
Query: 738 LGRGSFGLVYKGTLF---DGTNVAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKIFS 793
LG G+FG V +G +VAIKV E+A E +I+ + + +V++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 794 SCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIV 853
C LV+E G K+L + + ++ V++ ++YL V
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131
Query: 854 HCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEYGSEGIVSA 912
H DL N+LL A +SDFG+SK LG D T + + APE + S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 913 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971
+ DV+SYGV + E + +KP +M E+ + + +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------------------MAFIEQGKRME 232
Query: 972 AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015
+C + L DC + E R ++ +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-53
Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV 789
+ LG+G FG V+ GT T VAIK + F E ++++ +RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDIL-QRLNIMIDVALVLEYLHHGHS 848
++++ + + +V E+M GS +L L Q +++ +A + Y+ +
Sbjct: 76 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEG 908
VH DL+ NIL+ EN+ V+DFG+++L+ + + + Q I + APE G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYG 189
Query: 909 IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968
+ K DV+S+G+LL E T+ + + V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYR---------------- 232
Query: 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+C S+ DL C + PE+R A L+
Sbjct: 233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-53
Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 11/292 (3%)
Query: 725 IQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFR-TFDSECEILRN 782
++ D F + + LG G+ G+V+K + G +A K+ +L+++ A R E ++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+V + + + ++ +E M GS ++ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
L H I+H D+KP+NIL++ + DFG+S L DS+ + + T YM+P
Sbjct: 120 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSF-VGTRSYMSP 172
Query: 903 EYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962
E S + D++S G+ L+E + P E+ L + T
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQ 1014
++ + ++I +L LD + P ++ + E + K L
Sbjct: 233 PGRPLSSYGMDSRPPMAIFEL-LDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-53
Identities = 58/277 (20%), Positives = 107/277 (38%), Gaps = 24/277 (8%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
LG G FG+V G +VAIK+ + F E +++ N+ H LV++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+ C ++ E+M NG +L + Q L + DV +EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES----KQ 120
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
+H DL N L+++ VSDFG+S+ + + D+ + + + + PE S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971
+K D++++GVL+ E ++ K E FT + + +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------------ 221
Query: 972 AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ + C E ++R + + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 4e-53
Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTN-----VAIKVFNLQL-ERAFRTFDSECEILRNVRH 785
++G G FG VYKG L + VAIK E+ F E I+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
N++++ ++ E+M NG+ +K+L + +LQ + ++ +A ++YL +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEY 904
VH DL NIL++ N+ VSDFG+S++L + ++ T I + APE
Sbjct: 129 ----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964
S ++ DV+S+G+++ E T + + + + + +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFR------------ 231
Query: 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
DC +I L + C + +R D + L K+
Sbjct: 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-53
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 32/280 (11%)
Query: 732 FNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKI 791
+G+G FG V G G VA+K ++ + + F +E ++ +RH NLV++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 792 FSSCCNIDFK-ALVLEFMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSL 849
+V E+M GS +L S L L +DV +EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---- 121
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGI 909
VH DL N+L+ E+ A VSDFG++K S TQ + + APE E
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKK 176
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969
S K DV+S+G+LL E ++ + + + R K
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------------- 219
Query: 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
A C ++ ++ +C R +L+ I+
Sbjct: 220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 1e-50
Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 30/292 (10%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNL 788
+ LG G +G VY+G VA+K F E +++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF-LDILQRLNIMIDVALVLEYLHHGH 847
V++ C ++ EFM G+ +L N + + L + ++ +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 133
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE 907
+H DL N L+ EN V+DFG+S+L+ GD I + APE +
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967
S K DV+++GVLL E T + +++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR--------------- 234
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQSSVA 1019
C + +L C +P R + + + Q+SS++
Sbjct: 235 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM----FQESSIS 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 2e-50
Identities = 63/318 (19%), Positives = 111/318 (34%), Gaps = 52/318 (16%)
Query: 721 SYLDIQRATDGFNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNLQLERAFR-TF 773
L ++ + +G G+FG V++ T VA+K+ + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 774 DSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------- 823
E ++ + N+VK+ C L+ E+M G ++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 824 -------------LDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTA 870
L ++L I VA + YL VH DL N L+ ENM
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVV 179
Query: 871 HVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 930
++DFG+S+ + D I +M PE + + DV++YGV+L E F+
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 931 KPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCME 990
E + ++ + +C L + +L C +
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNIL------------------ACPENCPLELYNLMRLCWSK 281
Query: 991 SPEQRIHMTDAAAELKKI 1008
P R L+++
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 61/284 (21%), Positives = 103/284 (36%), Gaps = 31/284 (10%)
Query: 727 RATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNV 783
RA D + +G GS+G K DG + K + E + SE +LR +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 784 RHRNLVKIFSSCCNIDFKAL--VLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVAL 838
+H N+V+ + + L V+E+ G + +LD L +M + L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 839 VLEYLH-HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
L+ H ++H DLKP N+ LD + DFG++++L D S + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVG-TP 178
Query: 898 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957
YM+PE + + K D++S G LL E P + L ++E +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPY 236
Query: 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
L ++ R + +
Sbjct: 237 RYSDELN-----------------EIITRMLNLKDYHRPSVEEI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 30/291 (10%)
Query: 736 NLLGRGSFGLVYKGTLFDGTN----VAIKVFNLQLERAF-RTFDSECEILRNVRHRNLVK 790
++GRG FG VY GTL D A+K N + F +E I+++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 791 IFSSCCNIDFKA-LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ C + +VL +M +G ++ + + + + + VA +++L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---- 148
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIGYMAPEYGSE 907
VH DL N +LDE T V+DFG+++ + + + T + +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967
+ K DV+S+GVLL E TR P +++ + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY--------------LLQG 250
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQSSV 1018
+ C + ++ L C E R ++ + + I F+ + V
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-50
Identities = 61/282 (21%), Positives = 108/282 (38%), Gaps = 32/282 (11%)
Query: 734 ECNLLGRGSFGLVYKGTLFD---GTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL 788
E LG G+FG V KG VA+K+ + +E +++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
V++ C + LV+E G K+L + + + ++ V++ ++YL +
Sbjct: 71 VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGYMAPEYGSE 907
VH DL N+LL A +SDFG+SK L ++ + + APE +
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP-HGLTEVVDANLVGE 966
S+K DV+S+GVL+ E F+ + P G+ ++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAMLEK 225
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ C + DL C E R L+
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-49
Identities = 58/307 (18%), Positives = 106/307 (34%), Gaps = 50/307 (16%)
Query: 736 NLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLERAFR-TFDSECEILRNV-RHRN 787
LG G+FG V + T + VA+K+ R SE ++L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY-----------------NYFLDILQRL 830
+V + +C ++ E+ G +L LD+ L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 831 NIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQ 890
+ VA + +L + +H DL NILL + DFG+++ + + V +
Sbjct: 149 SFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 891 TITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES 950
+ +MAPE + + + DV+SYG+ L E F+ + + +KE
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 951 LPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010
+ + D+ C P +R ++K
Sbjct: 265 FR-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ-- 305
Query: 1011 KFLQQSS 1017
+ +S+
Sbjct: 306 --ISEST 310
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 9e-49
Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 30/292 (10%)
Query: 723 LDIQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-----ERAFRTFDSE 776
L I + T+ F + +LG G+FG VYKG + +G V I V +L +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 777 CEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDV 836
++ +V + ++ ++ C + L+ + MP G ++ + + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 837 ALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMAT 896
A + YL +VH DL N+L+ ++DFG++KLLG +
Sbjct: 121 AKGMNYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 897 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956
I +MA E I + + DV+SYGV + E T G+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIP 218
Query: 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
++++ + + C + + + + C M + R + E K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 55/275 (20%), Positives = 101/275 (36%), Gaps = 25/275 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL-QLERAFRTFDSECEILRNVRHRN 787
+ ++ LG G++G V VA+K+ ++ + E I + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+VK + + + L LE+ G + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY-GS 906
I H D+KP N+LLDE +SDFG++ + + T+ Y+APE
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
+ DV+S G++L + P D+ W ++ + +D+ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
L +E+P RI + D
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 63/289 (21%), Positives = 103/289 (35%), Gaps = 32/289 (11%)
Query: 722 YLDIQR---ATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSEC 777
Y + R D + LG G+FG VYK A KV + + E + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 778 EILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVA 837
+IL + H N+VK+ + + +++EF G+ + + L Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 838 LVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATI 897
L YLH I+H DLK NIL + ++DFG+S I
Sbjct: 121 DALNYLHDNK----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--P 174
Query: 898 GYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952
+MAPE + K DV+S G+ L+E + P E+ + L + K P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP 233
Query: 953 HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ + + D C ++ + R +
Sbjct: 234 T----------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 66/288 (22%), Positives = 99/288 (34%), Gaps = 30/288 (10%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLF----DGTNVAIKVFNLQL---ERAFRTFDSECEILRN 782
LG GSFG+V +G +VA+K + A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+ HRNL++++ K +V E P GS L + + + VA + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS-VTQTITMATIGYMA 901
L +H DL N+LL + DFG+ + L + DD V Q + A
Sbjct: 127 LES----KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
PE S D + +GV L E FT + G L + KE
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--------- 233
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
DC I ++ + C PE R L + +
Sbjct: 234 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 4e-48
Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 36/280 (12%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL---QLERAFRTFDSECEILRNVR 784
F++ +G GSFG VY + + VAIK + Q ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
H N ++ LV+E+ + + + L ++ + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
++H D+K NILL E + DFG + ++ + + T +MAPE
Sbjct: 133 S----HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEV 182
Query: 905 ---GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
EG K DV+S G+ +E RK P M L + P +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSE 241
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ C + P+ R
Sbjct: 242 YFR-----------------NFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 57/277 (20%), Positives = 98/277 (35%), Gaps = 29/277 (10%)
Query: 737 LLGRGSFGLVYKGTLFDGTN----VAIKVFNLQLERAFR-TFDSECEILRNVRHRNLVKI 791
+G G FG V++G N VAIK + R F E +R H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 792 FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAP 851
+ +++E G +L Y LD+ + ++ L YL
Sbjct: 74 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---- 128
Query: 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVS 911
VH D+ N+L+ N + DFG+S+ + + + I +MAPE + +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 187
Query: 912 AKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFS 971
+ DV+ +GV + E + + R
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------------P 229
Query: 972 AKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+C ++ L C P +R T+ A+L I
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-47
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 51/300 (17%)
Query: 737 LLGRGSFGLVYKGTLFDGTN------VAIKVFNLQLERAFR-TFDSECEILRNV-RHRNL 788
+LG G+FG V T + + VA+K+ + + + R SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYN----------------------YFLDI 826
V + +C L+ E+ G +L S L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 827 LQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886
L VA +E+L VH DL N+L+ + DFG+++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF----KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRW 946
V + + +MAPE EGI + K DV+SYG+LL E F+ + + +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 947 VKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006
++ I + C +R + + L
Sbjct: 280 IQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 33/272 (12%)
Query: 738 LGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSS 794
+GRGSF VYKG VA + + + F E E+L+ ++H N+V+ + S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 795 CCNI----DFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLA 850
+ LV E M +G+ + +L + + I + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTP-- 133
Query: 851 PIVHCDLKPNNILL-DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGI 909
PI+H DLK +NI + + + D G++ L S + + + T +MAPE E
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK- 188
Query: 910 VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQA 969
DVY++G+ ++E T + P E RR P +V +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK----- 243
Query: 970 FSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
++ C ++ ++R + D
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-46
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 45/300 (15%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDG---TNVAIKVFNLQLER-AFRTFDSECEILRNV-R 784
+ +++G G+FG V K + + AIK + R F E E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------------LDILQR 829
H N++ + +C + + L +E+ P+G+ +L L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 830 LNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVT 889
L+ DVA ++YL +H DL NIL+ EN A ++DFG+S+ + V
Sbjct: 130 LHFAADVARGMDYLSQ----KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 182
Query: 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE 949
+T+ + +MA E + + + DV+SYGVLL E + M+ +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYE- 237
Query: 950 SLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009
+ + +C + DL C E P +R L ++
Sbjct: 238 -------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-46
Identities = 62/302 (20%), Positives = 120/302 (39%), Gaps = 38/302 (12%)
Query: 732 FNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNL-QLERAFRTFDSECEILRNVR 784
LG+GSFG+VY+G T VAIK N R F +E +++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------LDILQRLNIMID 835
++V++ +++E M G + +L S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 836 VALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA 895
+A + YL+ VH DL N ++ E+ T + DFG+++ + E D +
Sbjct: 142 IADGMAYLNA----NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
+ +M+PE +G+ + DV+S+GV+L E T + + + E LR ++ L
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--- 254
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015
+C + +L C +P+ R + + +K+ ++
Sbjct: 255 ---------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 1016 SS 1017
S
Sbjct: 300 VS 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFN---LQLERAFRTFDSECEILRNVRH 785
+ F LG+G FG VY +A+KV L+ E EI ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
N+++++ + L+LE+ P G+ + L + F D + + ++A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHS 124
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
++H D+KP N+LL ++DFG S S T+ T+ Y+ PE
Sbjct: 125 KR----VIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTL-CGTLDYLPPEMI 176
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR-RWVKESLPHGLTEVVDANLV 964
+ K D++S GVL E K P + E R V+ + P +TE
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE------- 229
Query: 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
DL +P QR + +
Sbjct: 230 --------------GARDLISRLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 54/274 (19%), Positives = 97/274 (35%), Gaps = 26/274 (9%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRN 787
+ +G+G+ G VY + G VAI+ NLQ + +E ++R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+V S D +V+E++ GS + Q + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE 907
++H D+K +NILL + + ++DFG + + + T +MAPE +
Sbjct: 137 ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTR 190
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967
K D++S G++ +E + P +L P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE-------------- 235
Query: 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
D C E+R +
Sbjct: 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (413), Expect = 8e-45
Identities = 61/275 (22%), Positives = 104/275 (37%), Gaps = 26/275 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNL 788
D ++ LG G+FG+V++ T G N A K E T E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
V + + + + ++ EFM G + + + + + + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 849 LAPIVHCDLKPNNILL--DENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
VH DLKP NI+ + + DFG++ L T T + APE
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAE 198
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
V D++S GVL + P + E+ L V + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMD 245
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ AFS ++ D + P R+ + A
Sbjct: 246 DSAFSGISE---DGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 9/211 (4%)
Query: 726 QRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILR 781
++ + F +LG GSF V L AIK+ + E E +++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 782 NVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
+ H VK++ + + + L + NG K++ F D ++ LE
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
YLH I+H DLKP NILL+E+M ++DFG +K+L + T Y++
Sbjct: 123 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
PE +E D+++ G ++ + P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-43
Identities = 65/313 (20%), Positives = 117/313 (37%), Gaps = 51/313 (16%)
Query: 730 DGFNECNLLGRGSFGLVYKGTL--------FDGTNVAIKVFNLQL-ERAFRTFDSECEIL 780
D LG G+FG V T VA+K+ E+ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 781 RNV-RHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYF---------------L 824
+ + +H+N++ + +C +++E+ G+ ++L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 825 DILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884
++ VA +EYL +H DL N+L+ E+ ++DFG+++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS----KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLR 944
D T + +MAPE + I + + DV+S+GVLL E FT L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 247
Query: 945 RWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004
+ +KE ++C + + DC P QR +
Sbjct: 248 KLLKEGHR-----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 1005 LKKIRVKFLQQSS 1017
L +I + +S
Sbjct: 291 LDRI----VALTS 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (399), Expect = 8e-43
Identities = 62/275 (22%), Positives = 107/275 (38%), Gaps = 26/275 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNL 788
D ++ LG G+FG+V++ G K N T +E I+ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
+ + + + L+LEF+ G + + +Y + + +N M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 849 LAPIVHCDLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
IVH D+KP NI+ + + V DFG++ L + +T AT + APE
Sbjct: 148 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 201
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966
V D+++ GVL + P + E L V + +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFD 248
Query: 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
E AFS D + + P +R+ + DA
Sbjct: 249 EDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 72/312 (23%), Positives = 112/312 (35%), Gaps = 49/312 (15%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNL-QLERAFRTFDSECEILRN 782
D LGRG+FG V + F VA+K+ R SE +IL +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 783 VRHRNLVKIFSSCCNIDFKAL--VLEFMPNGSFEKWLYS---------------YNYFLD 825
+ H V C L ++EF G+ +L S Y FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 826 ILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885
+ + VA +E+L +H DL NILL E + DFG+++ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRR 945
D V + + +MAPE + + + + DV+S+GVLL E F+ + R
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 946 WVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAEL 1005
+KE A + LDC P QR ++ L
Sbjct: 249 RLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 1006 KKIRVKFLQQSS 1017
+ LQ ++
Sbjct: 292 GNL----LQANA 299
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 7e-42
Identities = 59/291 (20%), Positives = 115/291 (39%), Gaps = 31/291 (10%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVR 784
+D + +LG G V+ L +VA+KV L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 785 HRNLVKIFSSCCNIDFKA----LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
H +V ++ + +V+E++ + +++ + + + ++ D L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMA-TIGY 899
+ H I+H D+KP NI++ V DFGI++ + + +SVTQT + T Y
Sbjct: 125 NFSHQ----NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959
++PE V A+ DVYS G +L E T + P ++ + ++ +P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH-- 238
Query: 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-MTDAAAELKKIR 1009
+ + L ++PE R + A+L ++
Sbjct: 239 --------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 2e-39
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 35/287 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNL------QLERAFRTFDSECEILRN 782
+ F+ ++GRG FG VY D G A+K + Q E ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
+V + + D + +L+ M G L + F + ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAP 902
+H+ +V+ DLKP NILLDE+ +SD G++ + ++ T GYMAP
Sbjct: 123 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAP 174
Query: 903 EYGSEGI-VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
E +G+ + D +S G +L + P + T + + ++ L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-HMTDAAAELKK 1007
L L +R+ + A E+K+
Sbjct: 235 ELR-----------------SLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 2e-39
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 39/285 (13%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRH 785
F LG GSFG V+ +G A+KV ++ + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
+++++ + + ++++++ G L + +V L LEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
I++ DLKP NILLD+N ++DFG +K + + ++ T Y+APE
Sbjct: 123 ----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVV 173
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKE--SLPHGLTEVVDANL 963
S + D +S+G+L+ E P + T + + + P E
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELRFPPFFNE------ 226
Query: 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-HMTDAAAELKK 1007
+ DL QR+ ++ + ++K
Sbjct: 227 ---------------DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 54/268 (20%), Positives = 111/268 (41%), Gaps = 27/268 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LGRG FG+V++ K ++ E IL RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+++ ++ EF+ + + + + L+ + ++ + V L++LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS----HNIGHF 126
Query: 856 DLKPNNILLDENMTAHV--SDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAK 913
D++P NI+ ++ + +FG ++ L GD+ Y APE +VS
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTA 183
Query: 914 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAK 973
D++S G L+ + P ++ E+ + +++A +E+AF
Sbjct: 184 TDMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFK-- 228
Query: 974 TDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ + MD ++ + R+ ++A
Sbjct: 229 -EISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 5e-38
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 34/290 (11%)
Query: 717 WRRTSYLDIQRATDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQ-LERAFRTFD 774
W++ DI+ D ++ ++LG G+F V VAIK + LE + +
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 775 SECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMI 834
+E +L ++H N+V + + L+++ + G + F ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 835 DVALVLEYLHHGHSLAPIVHCDLKPNNILL---DENMTAHVSDFGISKLLGEGDDSVTQT 891
V ++YLH IVH DLKP N+L DE+ +SDFG+SK+ G +
Sbjct: 115 QVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLS 167
Query: 892 ITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951
T GY+APE ++ S D +S GV+ P + + L + ++
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAE 225
Query: 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ D D S D + PE+R A
Sbjct: 226 YEFDSPYWD--------------DISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (350), Expect = 4e-37
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 19/284 (6%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRN 787
+ ++ +G G++G+VYK G A+K L+ E T E IL+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
+VK++ LV E + + +K L L+ + + ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-YGS 906
++H DLKP N+L++ ++DFG+++ G T I + Y AP+
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMG 174
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
S D++S G + E + + +TE+
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALD----CCMESPEQRIHMTDA 1001
+ L + + +D P QRI A
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 4e-37
Identities = 63/286 (22%), Positives = 109/286 (38%), Gaps = 35/286 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNL---------QLERAFRTFDSECEI 779
+ + +LGRG +V + A+K+ ++ +++ E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 780 LRNVR-HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVAL 838
LR V H N++++ + F LV + M G +L L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121
Query: 839 VLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT---MA 895
V+ LH + IVH DLKP NILLD++M ++DFG S L G+ T +A
Sbjct: 122 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 896 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL 955
+ + D++S GV++ P + LR + + G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGS 236
Query: 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
E D +S ++ DL + P++R +A
Sbjct: 237 PEWDD---------YSD------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 74/284 (26%), Positives = 108/284 (38%), Gaps = 28/284 (9%)
Query: 736 NLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL-----ERAFRTFDSECEILRNVRHRNLV 789
+ LG G F VYK VAIK L + RT E ++L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 790 KIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSL 849
+ + + +LV +FM E + + L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 850 APIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-YGSEG 908
I+H DLKPNN+LLDEN ++DFG++K G + T + T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR 176
Query: 909 IVSAKCDVYSYGVLLMETFTRKKPTDEM-----------FTGEMSLRRWVKESLPHGLTE 957
+ D+++ G +L E R G + +W
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ FSA D LL DL + +P RI T A
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLL---DLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 30/298 (10%)
Query: 725 IQRATDGFNECNLLGRGSFGLVYKGT--LFDGTNVAIKVFNLQL--ERAFRTFDSECEIL 780
+ RA + +G G++G V+K G VA+K +Q E + E +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 781 R---NVRHRNLVKIFSSCCNIDFKA-----LVLEFMPNGSFEKWLYSYNYFLDILQRLNI 832
R H N+V++F C LV E + + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 833 MIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTI 892
M + L++LH +VH DLKP NIL+ + ++DFG++++ + T
Sbjct: 122 MFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174
Query: 893 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP 952
+ T+ Y APE + + D++S G + E F RK ++ + + +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIG 232
Query: 953 HGLTEVVDANLVGEEQAFSAK---------TDCLLSIMDLALDCCMESPEQRIHMTDA 1001
E ++ QAF +K TD DL L C +P +RI A
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 19/285 (6%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHR 786
+ F + +G G++G+VYK G VA+K L E T E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHG 846
N+VK+ + LV EF+ + S + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 847 HSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-YG 905
++H DLKP N+L++ ++DFG+++ G + T + + Y APE
Sbjct: 122 R----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILL 175
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965
S D++S G + E TR+ + R + P + ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 966 EEQAFSAKTDCLLS---------IMDLALDCCMESPEQRIHMTDA 1001
+ +F S L P +RI A
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-36
Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFN---LQLERAFRTFDSECEIL-RNVR 784
+ F +LG+GSFG V+ AIK + ++ E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 785 HRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLH 844
H L +F + + V+E++ G + S + F D+ + ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
IV+ DLK +NILLD++ ++DFG+ K GD T Y+APE
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174
Query: 905 GSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLRRWVKESLPHGLTEVVDAN 962
+ D +S+GVLL E + P F G+ L ++ P ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPF-YPRWLEKE 229
Query: 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007
DL + + PE+R+ ++++
Sbjct: 230 AK-----------------DLLVKLFVREPEKRL---GVRGDIRQ 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-36
Identities = 54/290 (18%), Positives = 100/290 (34%), Gaps = 21/290 (7%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFN-LQLERAFRTFDSECEILRNVRHR 786
+ + +G G++G+V + VAIK + + + + E +IL RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 787 NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY--NYFLDILQRLNIMIDVALVLEYLH 844
N++ I + + ++ LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 845 HGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT-MATIGYMAPE 903
+ ++H DLKP+N+LL+ + DFG++++ D +AT Y APE
Sbjct: 127 SAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 904 YGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962
+ D++S G +L E + + + P N
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 963 LVGEEQAFSAKTDCLLSI-----------MDLALDCCMESPEQRIHMTDA 1001
L S + +DL +P +RI + A
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 57/284 (20%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL 788
+ + +G G++G V+K VA+K L E + E +L+ ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHS 848
V++ + LV EF + + S N LD + + + L + H +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 849 LAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPE-YGSE 907
++H DLKP N+L++ N +++FG+++ G + + T+ Y P+
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA 176
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKP------TDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
+ S D++S G + E +P D+ L E +T++ D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALD----CCMESPEQRIHMTDA 1001
A ++ + + + D +P QRI +A
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 5e-35
Identities = 43/283 (15%), Positives = 90/283 (31%), Gaps = 31/283 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G GSFG +Y GT + G VAIK+ ++ + E +I + ++ + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+++ + S E + + L + + +EY+H + +H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIHR 127
Query: 856 DLKPNNIL---LDENMTAHVSDFGISKLLGEGDDSVTQTITMA-----TIGYMAPEYGSE 907
D+KP+N L + ++ DFG++K + T Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 908 GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLRRWVKESLPHGLTEVVDANLVG 965
S + D+ S G +LM P + R ++ + + +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK----- 242
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
C + + + + +
Sbjct: 243 ---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 52/229 (22%), Positives = 81/229 (35%), Gaps = 22/229 (9%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRT------FDSECEILRNVR--HRN 787
LLG G FG VY G + D VAIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 788 LVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
++++ D L+LE + L + V + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 848 SLAPIVHCDLKPNNILLDEN-MTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY-G 905
++H D+K NIL+D N + DFG LL + T T Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIR 182
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLRRWVKESL 951
V+S G+LL + P +E+ G++ R+ V
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 35/283 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL------ERAFRTFDSECEILRN 782
D ++ LG G F +V K G A K + + + E IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 783 VRHRNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEY 842
++H N++ + N L+LE + G L+ + + L + +L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 843 LHHGHSLAPIVHCDLKPNNILLDENMTA----HVSDFGISKLLGEGDDSVTQTITMATIG 898
+++ HSL I H DLKP NI+L + + DFG++ + G++ T
Sbjct: 126 VYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 899 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958
++APE + + + D++S GV+ + P ++ ++ L V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANV 228
Query: 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
N E++ FS + D ++ P++R+ + D+
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-34
Identities = 56/280 (20%), Positives = 97/280 (34%), Gaps = 44/280 (15%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEIL-RNVRHRNLVKIFSS 794
+LG G G V + A+K+ +A R E E+ R + ++V+I
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 73
Query: 795 CCNIDFKA----LVLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSL 849
N+ +V+E + G + + + IM + ++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 850 APIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGS 906
I H D+KP N+L N ++DFG +K + T T Y+APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLG 186
Query: 907 EGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDA 961
CD++S GV++ P + G + R + P+ V
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
+ L + P QR+ +T+
Sbjct: 247 EVK-----------------MLIRNLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-34
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 732 FNECNLLGRGSFGLVYKGTLFD-GTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVK 790
+ + ++G GSFG+VY+ L D G VAIK + E +I+R + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 791 IFSSCCNID------FKALVLEFMPNGSFEKWLY--SYNYFLDILQRLNIMIDVALVLEY 842
+ + + LVL+++P + + L ++ M + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 843 LHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
+H I H D+KP N+LLD + + DFG +K L G+ +V+ + + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRA 190
Query: 902 P-EYGSEGIVSAKCDVYSYGVLLMETFTRKKP---------TDEMFTGEMSLRRWVKESL 951
P ++ DV+S G +L E + E+ + R +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA 1001
TE + + + L +P R+ +A
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (324), Expect = 1e-33
Identities = 38/283 (13%), Positives = 81/283 (28%), Gaps = 29/283 (10%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
+G GSFG++++GT L + VAIK + + E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 796 CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHC 855
+++ + S E L + + ++ +H +V+
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125
Query: 856 DLKPNNILLDENMTAH-----VSDFGISKLLGEGDDSVTQTITMA-----TIGYMAPEYG 905
D+KP+N L+ + + V DFG+ K + T YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965
S + D+ + G + M G + + + + +
Sbjct: 186 LGREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008
+ A + + K+
Sbjct: 236 PLRELCA--GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 6e-33
Identities = 58/285 (20%), Positives = 102/285 (35%), Gaps = 39/285 (13%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRH 785
D F+ LG GSFG V G + A+K+ + Q + +E IL+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
LVK+ S + +V+E++ G L F + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHS 159
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
+++ DLKP N+L+D+ V+DFG +K + ++ T +APE
Sbjct: 160 LD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEII 210
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLRRWVKESLPHGLTEVVDANL 963
+ D ++ GVL+ E P F + + + + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFPSHFSS--- 263
Query: 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-HMTDAAAELKK 1007
+ DL + +R ++ + ++K
Sbjct: 264 ---------------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 47/304 (15%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL 788
+ + +G+G+FG V+K G VA+K ++ E T E +IL+ ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 789 VKIFSSCCNIDFKA--------LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
V + C LV +F + F + + +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLNGL 130
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTIT--MATIG 898
Y+H I+H D+K N+L+ + ++DFG+++ +S T + T+
Sbjct: 131 YYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 899 YMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKKP--------------------TDEMF 937
Y PE E D++ G ++ E +TR T E++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 938 TGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH 997
+ + K L G V L + A DL + P QRI
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL--------DLIDKLLVLDPAQRID 298
Query: 998 MTDA 1001
DA
Sbjct: 299 SDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 36/285 (12%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRH 785
+ F+ LLG+G+FG V G A+K+ ++ + +E +L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 786 RNLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
L + + D V+E+ G L F + + ++ LEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHS 123
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
+V+ D+K N++LD++ ++DFG+ K T T Y+APE
Sbjct: 124 ----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVL 177
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL--PHGLTEVVDANL 963
+ D + GV++ E + P + + E + P L+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSP------ 230
Query: 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA-AAELKK 1007
L + P+QR+ + A E+ +
Sbjct: 231 ---------------EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 34/290 (11%)
Query: 730 DGFNECNLLGRGSFGLVYKGTLF----DGTNVAIKVFN----LQLERAFRTFDSECEILR 781
+ F +LG G++G V+ G A+KV +Q + +E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 782 NVRHR-NLVKIFSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
++R LV + + L+L+++ G L F + + I V ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYM 900
L H H L I++ D+K NILLD N ++DFG+SK + TI YM
Sbjct: 140 LALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYM 197
Query: 901 APE--YGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEV 958
AP+ G + D +S GVL+ E T P + + + E+
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-------------FTVDGEKNSQAEI 244
Query: 959 VDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDA-AAELKK 1007
L E + DL M+ P++R+ A E+K+
Sbjct: 245 SRRILKSEPPYPQ---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 4e-29
Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 730 DGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRN 787
D + LGRG + V++ + + V +K+ ++ + E +IL N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPN 91
Query: 788 LVKIFSSCCNIDFK--ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH 845
++ + + + ALV E + N F++ + L M ++ L+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 846 GHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEY 904
I+H D+KP+N+++D E+ + D+G+++ G + +A+ + PE
Sbjct: 148 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 905 GSE-GIVSAKCDVYSYGVLLMETFTRKKP 932
+ + D++S G +L RK+P
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-29
Identities = 50/287 (17%), Positives = 96/287 (33%), Gaps = 25/287 (8%)
Query: 732 FNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNL 788
+ + +G G++G V G VAIK E + E +L+++RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 789 VKIFSSCCNIDFKALVLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHH 845
+ + + +F F + L + ++ + L Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 846 GHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYG 905
I+H DLKP N+ ++E+ + DFG+++ DS +
Sbjct: 140 AG----IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVIL 191
Query: 906 SEGIVSAKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLRRWVKESLPHGLTEVVD 960
+ + D++S G ++ E T K + M + L
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 961 ANLVGEEQAFSAK------TDCLLSIMDLALDCCMESPEQRIHMTDA 1001
N + K T+ ++L + EQR+ +A
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-27
Identities = 58/296 (19%), Positives = 102/296 (34%), Gaps = 42/296 (14%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFS 793
+G G+ G+V NVAIK + + + E +++ V H+N++ + +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 794 SCC------NIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH 847
LV+E M LD + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 848 SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSE 907
I+H DLKP+NI++ + T + DFG+++ G T + T Y APE
Sbjct: 140 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG 192
Query: 908 GIVSAKCDVYSYGVLLMETFTRK--------------------KPTDEMFTGEMSLRRWV 947
D++S G ++ E K P E R
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 948 KESLPHGLTEVVDANLVGEEQAFSAKTDCLLS--IMDLALDCCMESPEQRIHMTDA 1001
E+ P ++ + L + DL + P +RI + DA
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 48/291 (16%), Positives = 103/291 (35%), Gaps = 27/291 (9%)
Query: 729 TDGFNECNLLGRGSFGLVYKGT-LFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRH 785
+ + + +G G++G V G VA+K + + E +L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 786 RNLVKIFSSC----CNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLE 841
N++ + +F + L G+ + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135
Query: 842 YLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMA 901
Y+H I+H DLKP+N+ ++E+ + DFG+++ D
Sbjct: 136 YIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAP 187
Query: 902 PEYGSEGIVSAKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLRRWVK--ESLPHGLT 956
+ + D++S G ++ E T + TD + ++ LR L ++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 957 EVVDANLVGEEQAFSAKT--DCLLSIMDLALD----CCMESPEQRIHMTDA 1001
N + + + LA+D + ++RI A
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 107 bits (268), Expect = 4e-26
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 11/307 (3%)
Query: 10 TDQSALLAFKADVIDSRSVLANNWSISYPICN--WVGISC--GARHHRVVALNLSSFSLG 65
D+ ALL K D+ + + L+ +W + CN W+G+ C + +RV L+LS +L
Sbjct: 6 QDKQALLQIKKDLGNP-TTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 66 GI--IPPHLGNLSFLVSLDISEN-NFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGI 122
IP L NL +L L I N G +P + KL +L + + +SG+ P ++
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
+ L L F N+ + +P + +L L + N +SG++P+ + +
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNL 242
+ + + T N +G
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
+ L L+L N + G +P + + + +N+ N L G +P G +L + N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP--QGGNLQRFDVSAYANN 301
Query: 303 NLIGTIP 309
+ P
Sbjct: 302 KCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 7e-17
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 32/298 (10%)
Query: 366 SSLTNCRSLTELALNVNPLRGI--LPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGL 423
+ T + L L+ L +P + N + L G IP I L+ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSG 483
+L + ++G IP + + + L L N L G++P + L L + +GN +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 484 AIPACLGSLTSLRE-LHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKV 542
AIP GS + L + + N LT IP + L S ++ S +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--NLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 543 LINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNIS 602
+ K+L L L N+ G +P+ L L SL+VS NN+
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 603 GKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPC 660
G+IP+ G + F +++ N LCG P +P C
Sbjct: 282 GEIPQG------------------------GNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 6e-09
Identities = 17/64 (26%), Positives = 25/64 (39%), Gaps = 2/64 (3%)
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSL 191
NN +P L L L L++ N+L G +P L + + +N P L
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP--L 309
Query: 192 SECT 195
CT
Sbjct: 310 PACT 313
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (265), Expect = 4e-25
Identities = 82/387 (21%), Positives = 138/387 (35%), Gaps = 27/387 (6%)
Query: 241 NLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF 300
L LG N++ V T ++ + + + + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFS 74
Query: 301 GNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLR----FLNLMFNSLTTES 356
N L P + N +KL+ + +++N + P + L +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 357 SPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQE 416
+ +++++ +L+ L G + + K S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 417 IGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476
+ L+ L L +N+++ P L LSL N L+ L L L+ L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSS 536
N +S P L LT L EL LG+N ++ P L L + + L+ N S
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISP 302
Query: 537 IQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDV 596
I +LK L L L N +S P+ S L L L A N+ + S +L ++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSDV--SSLANLTNINWLSA 358
Query: 597 SSNNISGKIPKSLEALLYLKKLNVSYN 623
N IS P L L + +L ++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.7 bits (234), Expect = 3e-21
Identities = 77/387 (19%), Positives = 146/387 (37%), Gaps = 23/387 (5%)
Query: 167 DIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNL 226
D L + K LG + + S ++ + TL + + L+ LT +N
Sbjct: 18 DTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 73
Query: 227 AQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLT 286
+ N L P + NL L + + N ++ P T + + L
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 287 LGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLS--SNLFSGHIPHTFGNLRFLRF 344
+ L T+ + + + + + DL +NL + N
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 345 LNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEA 404
+ +L + + +Q S ++ L +L EL+LN N L+ I + + + +L +
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDL 248
Query: 405 IKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYY 464
++ P + L+ L LKL N+++ P N+ Q
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDISP 302
Query: 465 LCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNL 524
+ +L+ L+ L L NN+S P + SLT L+ L +N ++ SSL +L I +++
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSA 358
Query: 525 SSNSLSGPLPSSIQHLKVLINLDLSRN 551
N +S P + +L + L L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.0 bits (227), Expect = 3e-20
Identities = 75/393 (19%), Positives = 132/393 (33%), Gaps = 42/393 (10%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
L+ + TD + +L ++ L + S+ L L ++ +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQ 77
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTA---- 238
P L T L + + +N+ + P L Q +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 239 --------IGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHS 290
I ++ L L G + ++ + + ++ + +++
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 291 LPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFN 350
L NLE L N + P I + L L L+ N T +L L L+L N
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 351 SLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELK 410
++ L+ L+ LTEL L N + I P G + + + + E
Sbjct: 252 QISN----------LAPLSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLE-- 298
Query: 411 GSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLER 470
I NL L +L L N ++ P V +LQ L +N + L +L
Sbjct: 299 --DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSN 503
++ L N +S P L +LT + +L L
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.4 bits (215), Expect = 1e-18
Identities = 72/381 (18%), Positives = 136/381 (35%), Gaps = 29/381 (7%)
Query: 200 LWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPV 259
L + + + +L Q+T L + ++ + L L +N N L+
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 260 PPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLI 319
P + N++ + I + NQ++ PL +L L ++ + N +L
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 320 GLDLSSNLFSGHIPHTFGNLRFLRFL-NLMFNSLTTESSPADQWSFLSSLTNCRSLT--- 375
+S + + +LTT + +S ++ LT
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 376 ELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNG 435
L N + I P I +L + +LK + +L+ L L L +N+++
Sbjct: 201 SLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 436 TIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSL 495
P + +L L L N + P +L N + + +L +L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISPISNLKNL 309
Query: 496 RELHLGSNTLTYSIP-SSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLS 554
L L N ++ P SSL L+ + ++N +S SS+ +L + L NQ+S
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRL---FFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 555 GDIPITISGLKDLATLSLAGN 575
P ++ L + L L
Sbjct: 365 DLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.8 bits (198), Expect = 1e-16
Identities = 52/207 (25%), Positives = 82/207 (39%), Gaps = 15/207 (7%)
Query: 71 HLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILS 130
L L+ L SL + N P + L ++ N+L + L+ L L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 131 FHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSS 190
NN ++ P L L+KL L L N +S + L L L L N P S
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPIS 304
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNL 250
+L L L N S P + +L++L L A N + +++ NL + L+
Sbjct: 305 --NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 251 GMNNLSGPVPPTIFNISTIRLINLIEN 277
G N +S P + N++ I + L +
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 8e-16
Identities = 74/368 (20%), Positives = 130/368 (35%), Gaps = 67/368 (18%)
Query: 53 RVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNEL 112
+V L + I + L+ L ++ S N P L L +L I N++
Sbjct: 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 113 SGSFPSWIGILSRLQILSFHNNSFTDRIPDF----------------------------- 143
+ P L + + D + +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 144 ---------LLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSEC 194
L + ++ + +L LE L +N P +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--L 218
Query: 195 THLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNN 254
T+L L L N+ + +L+ LTDL+LA N + P + L L L LG N
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 255 LSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITN 314
+S P + ++ + + L ENQ ++ +L NL +LTL+ NN+ P +++
Sbjct: 275 ISNISP--LAGLTALTNLELNENQ---LEDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 315 ASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSL 374
+KL L ++N S + NL + +L+ N ++ L+ L N +
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD----------LTPLANLTRI 375
Query: 375 TELALNVN 382
T+L LN
Sbjct: 376 TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 5e-08
Identities = 73/416 (17%), Positives = 133/416 (31%), Gaps = 69/416 (16%)
Query: 250 LGMNNLSGPVP-PTIF---NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
LG ++ P IF ++ L + ++ + T L + L I
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLG-I 56
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
+I + + L ++ S+N + P NL L + + N + + A+ +
Sbjct: 57 KSIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLT 113
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
+T++ N N + + + + S ++ +L L
Sbjct: 114 GLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN 173
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
L + + + S L L L L+ N +S
Sbjct: 174 LTTLERL--------------------DISSNKVSDISVLAKLTNLESLIATNNQISDIT 213
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545
P + T+L EL L N L ++ L L +
Sbjct: 214 PLGIL--TNLDELSLNGNQLKD--------------------------IGTLASLTNLTD 245
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKI 605
LDL+ NQ+S P+ SGL L L L NQ + P L +L +L+++ N +
Sbjct: 246 LDLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 301
Query: 606 PKSLEALLYLKKLNVSYNRLEGEIPIKGPFR----NFSAQSFSGNYALCGPPRLQV 657
P L L L + +N + P+ + F+ S +L +
Sbjct: 302 PI--SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLANLTNINW 355
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 19/106 (17%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 29 LANNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNF 88
L ++ IS + + L L ++ I P + +L+ L L + N
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 89 YGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNN 134
+ L L + ++ +N++S P + L+R+ L ++
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 4e-25
Identities = 42/213 (19%), Positives = 78/213 (36%), Gaps = 21/213 (9%)
Query: 737 LLGRGSFGLVYKGT-LFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSC 795
LG G F V+ + + T+VA+K+ + + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 796 CNIDFK---------------ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVL 840
N K +V E + + + ++ I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 841 EYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEGDDSVTQTITMATIGY 899
+Y+H I+H D+KP N+L++ + ++ I+ L T ++ T Y
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 900 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKP 932
+PE D++S L+ E T
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 8e-22
Identities = 56/316 (17%), Positives = 102/316 (32%), Gaps = 28/316 (8%)
Query: 40 CNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKL 99
C+ + C V +L LD+ N + L
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPD---------------TALLDLQNNKITEIKDGDFKNL 54
Query: 100 RRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENS 159
+ L + N++S P L +L+ L N + L +L +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 160 LSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLS 219
+ S+ N + + +L G + L + +AD + +P+ G
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPP 171
Query: 220 QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQL 279
LT+L+L N + ++ L L L L N++S ++ N +R ++L N+L
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 280 SGHLPLTLGHSLPNLEFLTLFGNNLIG------TIPNSITNASKLIGLDLSSNLFSGH-- 331
++ + L NN+ P T + G+ L SN
Sbjct: 232 VKVPGGL--ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
Query: 332 IPHTFGNLRFLRFLNL 347
P TF + + L
Sbjct: 290 QPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 1e-19
Identities = 47/261 (18%), Positives = 86/261 (32%), Gaps = 12/261 (4%)
Query: 372 RSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDN 431
L L N + I N +L I ++ P L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 432 ELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGS 491
+L Q+L+ ++ S+ L + + L N SG
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148
Query: 492 LTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN 551
+ L + + +T SL + +L N ++ +S++ L L L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 552 QLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISG------KI 605
+S +++ L L L N+ +P ++ + + +NNIS
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 606 PKSLEALLYLKKLNVSYNRLE 626
P +++ N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 65/290 (22%), Positives = 99/290 (34%), Gaps = 24/290 (8%)
Query: 292 PNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNS 351
P+ L L N + N L L L +N S P F L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 352 LTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPP-FIGNFSASLRKFEAIKCELK 410
L + EL ++ N + + F G + + +
Sbjct: 91 LKELPEKMPKTL-----------QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 411 GSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLER 470
G + L ++++ D + TIP G L L L N + L L
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLS 530
L++L L+ N++S L + LRELHL +N L +P L +YI V L +N++S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255
Query: 531 G------PLPSSIQHLKVLINLDLSRNQLSGD--IPITISGLKDLATLSL 572
P + L N + P T + A + L
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 3e-17
Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 6/248 (2%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
+P+++ L L +N++ + L L L +N + P L +L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
+L L+ N L +L LR + S+ + L ++ + + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSG 140
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
+ Q +K L + ++ ++ I L L L GN+ S L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 592 ESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCG 651
L +S N+IS SL +L++L+++ N+L + N
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 652 PPRLQVPP 659
PP
Sbjct: 258 GSNDFCPP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 33/203 (16%), Positives = 57/203 (28%), Gaps = 11/203 (5%)
Query: 32 NWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGH 91
+ + G VV L + GI + L + I++ N
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 165
Query: 92 LPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLE 151
L L L N+++ + + L+ L L NS + L N L
Sbjct: 166 PQGLPPSLTELHL---DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 152 FLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFG------QIPSSLSECTHLQTLWLADN 205
L L N L ++ +YL +N+ P ++ + L N
Sbjct: 223 ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
Query: 206 KFSGR--LPENIGNLSQLTDLNL 226
P + + L
Sbjct: 283 PVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 26/153 (16%), Positives = 50/153 (32%), Gaps = 3/153 (1%)
Query: 494 SLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQL 553
LR + L +P L ++L +N ++ ++LK L L L N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 554 SGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALL 613
S P + L L L L+ NQ + +L L + + + L ++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 614 YLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGN 646
++ E + S +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 1e-18
Identities = 25/160 (15%), Positives = 46/160 (28%), Gaps = 23/160 (14%)
Query: 736 NLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL----------ERAFRTFDSECEILRNVRH 785
L+G G V+ +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 786 RNLVKI--FSSCCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYL 843
R L K+ + ++ + E Y + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 844 HHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883
+H IVH DL N+L+ E + DF S +GE
Sbjct: 120 YHRG----IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE 154
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 5e-17
Identities = 59/262 (22%), Positives = 98/262 (37%), Gaps = 12/262 (4%)
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
+ + L N ++ + +S CR+LT L L+ N L I + +
Sbjct: 34 SQRIFLHGNRISHVPA--------ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85
Query: 402 FEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSI 461
+ +L+ P L L L LD L P LQ L L DN LQ
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 462 PYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILY 521
L L+ L L+GN +S L SL L L N + + P + L ++
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 522 VNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI 581
+ L +N+LS ++ L+ L L L+ N D L + ++ +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSL 264
Query: 582 PESFGSLISLESLDVSSNNISG 603
P+ L + +++N++ G
Sbjct: 265 PQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 6e-16
Identities = 63/266 (23%), Positives = 88/266 (33%), Gaps = 23/266 (8%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+P + Q ++L N+ S + LT L L N L A L +L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
E L+L N V P F+ ++ L L L L++L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPA------ 359
++ + L L L N S F L L L L N + A
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 360 ----------DQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCEL 409
+L R+L L LN NP A L+KF E+
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEV 260
Query: 410 KGSIPQEIGNLSGLMFLKLDDNELNG 435
S+PQ L+G +L N+L G
Sbjct: 261 PCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 6e-16
Identities = 51/265 (19%), Positives = 87/265 (32%), Gaps = 9/265 (3%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
+P + + + N R L ++ N L+ + L+ L+
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 128 ILSFHNNSFTDRI-PDFLLNLSKLEFLDLMENSLSGSLPN-DIRLPKLEKLYLGSNDFFG 185
L +N+ + P L +L L L L P L L+ LYL N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 186 QIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
+ + +L L+L N+ S L L L L QN + P A +L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 246 EHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
L L NNLS + + ++ + L +N L+ + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR--PLWAWLQKFRGSSSEVP 261
Query: 306 GTIPNSITNASKLIGLDLSSNLFSG 330
++P + L++N G
Sbjct: 262 CSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (178), Expect = 1e-14
Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 6/256 (2%)
Query: 405 IKCELKG--SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIP 462
C +G ++P I + + L N ++ + + L L L+ N L
Sbjct: 16 TSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 463 YYLCHLERLSQLLLNGNNLSGAI-PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILY 521
L L QL L+ N ++ PA L L LHL L P L + Y
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 522 VNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI 581
+ L N+L + + L L +L L N++S GL L L L N+
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 582 PESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQ 641
P +F L L +L + +NN+S ++L L L+ L ++ N + + +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253
Query: 642 SFSGNYALC-GPPRLQ 656
S + C P RL
Sbjct: 254 RGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 51/248 (20%), Positives = 82/248 (33%), Gaps = 4/248 (1%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGS- 115
+ L + + L L + N L L ++ + N S
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 116 FPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLP-KLE 174
P+ L RL L + P L+ L++L L +N+L + R L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
L+L N + L L L N+ + P +L +L L L NNL
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTL-GHSLPN 293
A+ L+ L++L L N + ++ +++ LP L G L
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGRDLKR 275
Query: 294 LEFLTLFG 301
L L G
Sbjct: 276 LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 32/176 (18%), Positives = 53/176 (30%), Gaps = 3/176 (1%)
Query: 34 SISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLP 93
+ +G + L L +L + +L L L + N
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 94 NELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFL 153
L L + N ++ P L RL L N+ + + L L L++L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 154 DLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSG 209
L +N L+K S++ +P L+ LA N G
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 48/327 (14%), Positives = 94/327 (28%), Gaps = 16/327 (4%)
Query: 219 SQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQ 278
Q +L L L +P +L+ L N+L+ +P ++ ++ + N
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 279 LSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGN 338
LS PL + N + L + + + L L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 339 LRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSAS 398
NL F + + + + L+ + + PF+ A
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 399 LRKFEAIKCELKGSIPQEIGNLSGLMFLKLD-DNELNGTIPTTVGRFQQLQGLSLYDNDL 457
+ + + + +L +L Y N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 458 QGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLE 517
I L +L ++ N L +PA L L N L +P +L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK 327
Query: 518 YILYVNLSSNSLSG--PLPSSIQHLKV 542
+ ++ N L +P S++ L++
Sbjct: 328 QL---HVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 25/92 (27%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
N S I + SL EL++ +N L +P+ LE + S N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPE 321
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDL 567
Q+LK L + N L P ++DL
Sbjct: 322 LPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 8e-07
Identities = 54/332 (16%), Positives = 96/332 (28%), Gaps = 28/332 (8%)
Query: 293 NLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
L L L ++P + L L S N + +P +L+ L N +L
Sbjct: 39 QAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 353 TTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGS 412
+ D L L + E + + + N S E +
Sbjct: 94 S------DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 413 IPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLS 472
++ L L L L S+ + L +L L+
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 473 QLLLNGNNLSGAIPACLGSLTSLRELHL--------GSNTLTYSIPSSLWSLEYILYVNL 524
+ + N L + S T + L +
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 525 SSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPES 584
N+ S + S L L++S N+L ++P L+ L + N +PE
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPEL 322
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLK 616
+L+ L V N + + P E++ L+
Sbjct: 323 PQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 8/91 (8%)
Query: 131 FHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSS 190
++ N+ ++ I LE L++ N L LP P+LE+L N ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--PRLERLIASFNH-LAEVPEL 322
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQL 221
+L+ L + N P+ ++ L
Sbjct: 323 PQ---NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 57/333 (17%), Positives = 93/333 (27%), Gaps = 17/333 (5%)
Query: 166 NDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLN 225
D + +L L + +P HL++L + N + LPE +L L N
Sbjct: 33 RDCLDRQAHELELNNLGL-SSLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDN 87
Query: 226 LAQNNLQGDMPTAIGNLQ--MLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHL 283
L P + N S + N S +L +L +
Sbjct: 88 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 284 PLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLR 343
LP L+ L L + + NL FL
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 344 FLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFE 403
+ N L T ++ + L + + I + + L
Sbjct: 208 TIYADNNLLKTLPDLPPSLEA-LNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266
Query: 404 AIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPY 463
I L L + +N+L +P R L+ L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 464 YLCHLERLSQLLLNGNNLSGAIPACLGSLTSLR 496
+L++L + N L P S+ LR
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 21/104 (20%), Positives = 34/104 (32%), Gaps = 10/104 (9%)
Query: 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
L +N S + ++ +N+ N+L L P LE L N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFN 314
Query: 303 NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLN 346
+L +P N L L + N P ++ LR +
Sbjct: 315 HL-AEVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 20/122 (16%), Positives = 34/122 (27%), Gaps = 9/122 (7%)
Query: 31 NNWSISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYG 90
V + + + + I L L++S N
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-I 297
Query: 91 HLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKL 150
LP +L RL ++N L+ P + L+ L N PD ++ L
Sbjct: 298 ELPALPPRLERLIA---SFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
Query: 151 EF 152
Sbjct: 350 RM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 9/97 (9%)
Query: 177 YLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
N +I S L+ L +++NK LP L L + N+L ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 237 TAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLIN 273
NL+ L++ N L P ++ +R+ +
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 50/325 (15%), Positives = 89/325 (27%), Gaps = 17/325 (5%)
Query: 269 IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNAS--KLIGLDLSSN 326
+ L LS +L P+LE L N+L +P + + +L +
Sbjct: 40 AHELELNNLGLS-----SLPELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 93
Query: 327 LFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRG 386
+ G + + + L L + E N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 387 ILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQ 446
LP + + + +P + ++ + + EL T
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 447 LQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLT 506
+L D + L L+ L N +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 507 YSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKD 566
I S + +N+S+N L LP+ L+ L S N L+ ++P LK
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQNLK- 327
Query: 567 LATLSLAGNQFNGPIPESFGSLISL 591
L + N P+ S+ L
Sbjct: 328 --QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 548 LSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPK 607
N S +I L L+++ N+ +P L E L S N+++ ++P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPE 321
Query: 608 SLEALLYLKKLNVSYNRLEGEIP 630
+ L K+L+V YN L E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 53/309 (17%), Positives = 94/309 (30%), Gaps = 24/309 (7%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRL-------INFAY 109
L L++ L + P +L SL S N+ LP L+ L + ++
Sbjct: 43 LELNNLGLSSL-PELPPHLE---SLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLP 97
Query: 110 NELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIR 169
L S + ++ + D + L L L + + L
Sbjct: 98 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPE 157
Query: 170 LPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQN 229
L L L D + + + +N+ L+ + N
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217
Query: 230 N----LQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPL 285
+ + + + L + V IF+ + NL S +
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 277
Query: 286 TLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFL 345
+L P+LE L + N LI +P L L S N + +P N L+ L
Sbjct: 278 SLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQN---LKQL 329
Query: 346 NLMFNSLTT 354
++ +N L
Sbjct: 330 HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 10/103 (9%)
Query: 194 CTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMN 253
+ L N S + L +LN++ N L ++P LE L N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 314
Query: 254 NLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEF 296
+L+ VP N+ + + N L P S+ +L
Sbjct: 315 HLAE-VPELPQNLKQLHVEY---NPLRE-FPDIPE-SVEDLRM 351
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 43/188 (22%), Positives = 62/188 (32%), Gaps = 5/188 (2%)
Query: 68 IPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQ 127
+PP L L +SEN Y L RL +N E + G L L
Sbjct: 25 LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLG 80
Query: 128 ILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQI 187
L +N + S L L +L++LYL N+
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140
Query: 188 PSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEH 247
P L+ L+ L LA+N + + L L L L +N+L +P +L
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199
Query: 248 LNLGMNNL 255
L N
Sbjct: 200 AFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 47/211 (22%), Positives = 76/211 (36%), Gaps = 7/211 (3%)
Query: 95 ELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLD 154
E+ K+ +N L+ + P + IL N L+ ++L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 155 LMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPEN 214
L + + L D LP L L L N L L ++ N+ +
Sbjct: 62 L-DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGA 119
Query: 215 IGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINL 274
+ L +L +L L N L+ P + LE L+L NNL+ + + + + L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 275 IENQLSGHLPLTLGHSLPNLEFLTLFGNNLI 305
EN L +P L F L GN +
Sbjct: 180 QENSLY-TIPKGFF-GSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 33/179 (18%), Positives = 57/179 (31%), Gaps = 5/179 (2%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+LS L L + L L++ G L L ++ ++N+L
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLD--RAELTKLQVDGTLPVLGTLDLSHNQLQSLP 93
Query: 117 PSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL 176
+ + + N T L L +L+ L L N L P + +
Sbjct: 94 LLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 177 YLGS-NDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
+ N+ L+ +L TL L +N +P+ L L N +
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 41/188 (21%), Positives = 67/188 (35%), Gaps = 6/188 (3%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++P ++ L L +N L T+ + +L L+L + + + L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVL 79
Query: 472 SQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
L L+ N L + N LT +L L + + L N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISL 591
P + L L L+ N L+ ++GL++L TL L N IP+ F L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 592 ESLDVSSN 599
+ N
Sbjct: 198 PFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 46/210 (21%), Positives = 76/210 (36%), Gaps = 7/210 (3%)
Query: 416 EIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLL 475
E+ ++ + + D L +P + + L L +N L L RL+QL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 476 LNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
L+ L+ +L L L L N L +++S N L+
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALT-VLDVSFNRLTSLPLG 118
Query: 536 SIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLD 595
+++ L L L L N+L P ++ L LSLA N L +L++L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 596 VSSNNISGKIPKSLEALLYLKKLNVSYNRL 625
+ N++ IPK L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 46/202 (22%), Positives = 59/202 (29%), Gaps = 15/202 (7%)
Query: 302 NNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ 361
+ +P + L LS NL T L LNL E +
Sbjct: 19 KRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----ELTKLQV 72
Query: 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLS 421
L L ++ L LP L + L
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--------SFNRLTSLPLGALRGLG 124
Query: 422 GLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNL 481
L L L NEL P + +L+ LSL +N+L L LE L LLL N+L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 482 SGAIPACLGSLTSLRELHLGSN 503
IP L L N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 9e-06
Identities = 34/226 (15%), Positives = 59/226 (26%), Gaps = 22/226 (9%)
Query: 262 TIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGL 321
+ +++ +N + L+ LP L + L L N L ++ ++L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 322 DLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQW------------SFLSSLT 369
+L + + L+ S
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 370 NCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLD 429
+ LPP + + L K L + L L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 430 DNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLL 475
+N L TIP L L+ N + C + + L
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN-----CEILYFRRWL 220
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 54/303 (17%), Positives = 94/303 (31%), Gaps = 45/303 (14%)
Query: 117 PSWIGILSRLQILSFH-NNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEK 175
P G L +++F SF D+ + +++ +DL + + S
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS------------ 61
Query: 176 LYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLA--QNNLQG 233
+ LS+C+ LQ L L + S + + S L LNL+ +
Sbjct: 62 ----------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 111
Query: 234 DMPTAIGNLQMLEHLNLGMNNLSG------PVPPTIFNISTIRLINLIENQLSGHLPLTL 287
+ T + + L+ LNL V I+ + L +N L +
Sbjct: 112 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171
Query: 288 GHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSS-NLFSGHIPHTFGNLRFLRFLN 346
+ L + L L LS G + L+ L
Sbjct: 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231
Query: 347 LMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIK 406
+ F + + + +L L +N + I P IGN ++ IK
Sbjct: 232 V-FGIVPDGTLQLLK----------EALPHLQINCSHFTTIARPTIGN--KKNQEIWGIK 278
Query: 407 CEL 409
C L
Sbjct: 279 CRL 281
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 546 LDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGK- 604
LDL+ L D+ + + + + P+ E F S ++ +D+S++ I
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 605 IPKSLEALLYLKKLNVSYNRLEGEIP 630
+ L L+ L++ RL I
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 44/292 (15%), Positives = 84/292 (28%), Gaps = 30/292 (10%)
Query: 247 HLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL-I 305
L+L NL V + + I + + L S ++ + L + + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAF-RCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEV 60
Query: 306 GTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFL 365
T+ ++ SKL L L S I +T L LNL S +E + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 366 SSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMF 425
S L ++ + NLSG
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVS--------------------ETITQLNLSGYRK 160
Query: 426 LKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAI 485
+ L + ND +L+ LS L ++
Sbjct: 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL-NYLQHLS--LSRCYDIIPET 217
Query: 486 PACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSI 537
LG + +L+ L + ++ +L ++ ++ + + +I
Sbjct: 218 LLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 38/254 (14%), Positives = 80/254 (31%), Gaps = 41/254 (16%)
Query: 414 PQEIGNL--SGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG-SIPYYLCHLER 470
P G L G++ + + ++ + ++Q + L ++ ++ ++ L +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 471 LSQLLLNGNNLSGAIPACLGSLTSLREL-------------------------------- 498
L L L G LS I L ++L L
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 499 HLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD-I 557
+ ++ ++ + N L + ++ L++LDLS + + +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 558 PITISGLKDLATLSLAG-NQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLK 616
L L LSL+ G + +L++L V G + EA L
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LP 249
Query: 617 KLNVSYNRLEGEIP 630
L ++ +
Sbjct: 250 HLQINCSHFTTIAR 263
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 27/122 (22%), Positives = 52/122 (42%), Gaps = 6/122 (4%)
Query: 198 QTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSG 257
+ L LA + ++ L +T L+L+ N L+ P A+ L+ LE L ++ +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55
Query: 258 PVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASK 317
+ N+ ++ + L N+L + S P L L L GN+L ++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 318 LI 319
++
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 28/124 (22%), Positives = 49/124 (39%), Gaps = 5/124 (4%)
Query: 127 QILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQ 186
++L + T + L L + LDL N L P L LE L ++D +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ--ASDNALE 56
Query: 187 IPSSLSECTHLQTLWLADNKF-SGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQML 245
++ LQ L L +N+ + + + +L LNL N+L + +ML
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 246 EHLN 249
++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 32/125 (25%), Positives = 48/125 (38%), Gaps = 10/125 (8%)
Query: 57 LNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF 116
L+L+ L + HL L + LD+S N P L LR L ++ + N L
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 117 PSWIGILSRLQILSFHNNSFTD-RIPDFLLNLSKLEFLDLMENSLSG--SLPNDIR--LP 171
RLQ L NN L++ +L L+L NSL + + LP
Sbjct: 60 GVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 172 KLEKL 176
+ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 523 NLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIP 582
+L+ L+ ++ L ++ +LDLS N+L P ++ L+ L L +
Sbjct: 4 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALENV 58
Query: 583 ESFGSLISLESLDVSSNNI-SGKIPKSLEALLYLKKLNVSYNRLEGEIPIKG 633
+ +L L+ L + +N + + L + L LN+ N L E I+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 28/125 (22%), Positives = 46/125 (36%), Gaps = 6/125 (4%)
Query: 496 RELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSG 555
R LHL LT + L L + +++LS N L P ++ L+ L L S N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 556 DIPITISGLKDLATLSLAGNQFNG-PIPESFGSLISLESLDVSSNNISGKIPKSLEALLY 614
+ L L L N+ + S L L++ N++ +
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 615 LKKLN 619
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 10/116 (8%)
Query: 412 SIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERL 471
++ + L + L L N L P + + L+ L DN L+ +
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQ- 68
Query: 472 SQLLLNGNNL-SGAIPACLGSLTSLRELHLGSNTLT------YSIPSSLWSLEYIL 520
+LLL N L A L S L L+L N+L + L S+ IL
Sbjct: 69 -ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 9/112 (8%)
Query: 248 LNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLF-GNNLIG 306
L+L +L+ V + + + ++L N+L P +L L L + ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNAL 55
Query: 307 TIPNSITNASKLIGLDLSSN-LFSGHIPHTFGNLRFLRFLNLMFNSLTTESS 357
+ + N +L L L +N L + L LNL NSL E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 33/225 (14%), Positives = 64/225 (28%), Gaps = 18/225 (8%)
Query: 123 LSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSND 182
L+ ++ ++ TD + +L + L ++ ++ L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQ 74
Query: 183 FFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNL 242
P L K + + + + + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 243 QMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGN 302
+ + ++ L+G +I + LT +L L L N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQ-----------VSDLTPLANLSKLTTLKADDN 183
Query: 303 NLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNL 347
+ P + + LI + L +N S P N L + L
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 36/221 (16%), Positives = 68/221 (30%), Gaps = 26/221 (11%)
Query: 74 NLSFLVSLDISENNFYGHLP-NELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFH 132
L+ + + ++N + +L + L + G + L+ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 133 NNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKL---------------Y 177
+N TD P L L ++ + L+
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 178 LGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPT 237
QI + +L+ + NLS+LT L N + +
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--IS 189
Query: 238 AIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQ 278
+ +L L ++L N +S P + N S + ++ L NQ
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 35/218 (16%), Positives = 70/218 (32%), Gaps = 14/218 (6%)
Query: 265 NISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLS 324
++ I ++ ++ + L + L+ FG + TI + + LIGL+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTG-VTTIEG-VQYLNNLIGLELK 71
Query: 325 SNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPL 384
N + P L+ + + L + + ++ L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 385 RGILPPFI-----GNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPT 439
+ + + + S + NLS L LK DDN+++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 440 TVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN 477
+ L + L +N + P L + L + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 37/225 (16%), Positives = 71/225 (31%), Gaps = 29/225 (12%)
Query: 314 NASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRS 373
+ I + + + + T +L + L+ +TT + + +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----------IEGVQYLNN 64
Query: 374 LTELALNVNPLRGI-------------LPPFIGNFSASLRKFEAIKCELKGSIPQEIGNL 420
L L L N + + L +++ ++IK S
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 421 SGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNN 480
+ I L + Q S L +L +L+ L + N
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 481 LSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525
+S P L SL +L E+HL +N ++ P L + + V L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 35/217 (16%), Positives = 71/217 (32%), Gaps = 22/217 (10%)
Query: 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNG 478
L+ + + + + T+ + LS + + +I + +L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 479 NNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQ 538
N ++ P + + EL +I L ++ S++Q
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 539 HLKVLINLDLSRNQL--------------SGDIPITISGLKDLATLSLAGNQFNGPIPES 584
L + +N + + L ++ L L TL N+ + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 585 FGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVS 621
SL +L + + +N IS P L L + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 25/204 (12%), Positives = 60/204 (29%), Gaps = 20/204 (9%)
Query: 444 FQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSN 503
++ +++ ++ L+ ++ L G ++ + L +L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 504 TLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISG 563
+T P + L ++ + + + + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 564 LKDLATLSLAGNQFNGPI--------------PESFGSLISLESLDVSSNNISGKIPKSL 609
L + G +L L +L N IS P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 610 EALLYLKKLNVSYNRLEGEIPIKG 633
+L L ++++ N++ P+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLAN 215
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 32/227 (14%), Positives = 60/227 (26%), Gaps = 25/227 (11%)
Query: 163 SLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLT 222
+ D L K+ G ++ + + ++ + TL + E + L+ L
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IEGVQYLNNLI 66
Query: 223 DLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGH 282
L L N + P L+ + + I +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 283 LPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFL 342
L +L +T T + S NL L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPLANLSKL 175
Query: 343 RFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILP 389
L N ++ +S L + +L E+ L N + + P
Sbjct: 176 TTLKADDNKISD----------ISPLASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 13/90 (14%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 543 LINLDLSRNQLS-GDIPITISGLKDLATLSLAGNQFNG----PIPESFGSLISLESLDVS 597
+ +LD+ +LS + L+ + L I + +L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 598 SNNISGKIPKSLEALLYLKKLNVSYNRLEG 627
SN + + L + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 19/92 (20%), Positives = 29/92 (31%), Gaps = 9/92 (9%)
Query: 534 PSSIQHLKVLINLDLSRNQLSGD----IPITISGLKDLATLSLAGNQFNGPIPESFGSLI 589
Q VL L L+ +S + T+ L L L+ N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 590 -----SLESLDVSSNNISGKIPKSLEALLYLK 616
LE L + S ++ L+AL K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 6/93 (6%)
Query: 150 LEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDF----FGQIPSSLSECTHLQTLWLA 203
++ LD+ LS + ++ L + + + L I S+L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 204 DNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMP 236
N+ + Q + + +LQ
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/91 (18%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 197 LQTLWLADNKFS-GRLPENIGNLSQLTDLNLAQNNLQGD----MPTAIGNLQMLEHLNLG 251
+Q+L + + S R E + L Q + L L + +A+ L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 252 MNNLSGPVPPTIFNISTIRLINLIENQLSGH 282
N L + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 12/90 (13%), Positives = 25/90 (27%), Gaps = 5/90 (5%)
Query: 173 LEKLYLGSNDF-FGQIPSSLSECTHLQTLWLADNKFSGR----LPENIGNLSQLTDLNLA 227
++ L + + + L Q + L D + + + L +LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 228 QNNLQGDMPTAIGNLQMLEHLNLGMNNLSG 257
N L + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 3e-05
Identities = 14/82 (17%), Positives = 25/82 (30%), Gaps = 9/82 (10%)
Query: 171 PKLEKLYLGSNDFFGQ----IPSSLSECTHLQTLWLADNKFSGRLPENIG-----NLSQL 221
L L+L D + ++L L+ L L++N + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 222 TDLNLAQNNLQGDMPTAIGNLQ 243
L L +M + L+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 10/100 (10%)
Query: 131 FHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-----RLPKLEKLYLGSNDFFG 185
+ + S L L L + +S S + + L +L L +N
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 186 QIPSSLSE-----CTHLQTLWLADNKFSGRLPENIGNLSQ 220
L E L+ L L D +S + + + L +
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 9/73 (12%)
Query: 567 LATLSLAGNQFNG----PIPESFGSLISLESLDVSSNNISGKIPKSLEALL-----YLKK 617
L L LA + + + + SL LD+S+N + L + L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 618 LNVSYNRLEGEIP 630
L + E+
Sbjct: 431 LVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 447 LQGLSLYDNDLQGSIPYYLC-HLERLSQLLLNGNNLSG----AIPACLGSLTSLRELHLG 501
+Q L + +L + L L++ + L+ L+ I + L +L EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 502 SNTLTYSIPSSLWSLEYILYVNLSSNSLSG 531
SN L + + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 11/94 (11%)
Query: 102 LRLINFAYNELSGS-FPSWIGILSRLQILSFHNNSFTDR----IPDFLLNLSKLEFLDLM 156
++ ++ ELS + + + +L + Q++ + T+ I L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 157 ENSLSGSLPNDI------RLPKLEKLYLGSNDFF 184
N L + + K++KL L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 18/87 (20%), Positives = 28/87 (32%), Gaps = 9/87 (10%)
Query: 186 QIPSSLSECTHLQTLWLADNKFSGR----LPENIGNLSQLTDLNLAQNNLQGDMPTAIG- 240
+ L+ LWLAD S L + L +L+L+ N L +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 241 ----NLQMLEHLNLGMNNLSGPVPPTI 263
+LE L L S + +
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 18/95 (18%), Positives = 35/95 (36%), Gaps = 10/95 (10%)
Query: 494 SLRELHLGSNTLTYSIPSSLWS-LEYILYVNLSSNSLSG----PLPSSIQHLKVLINLDL 548
++ L + L+ + + L L+ V L L+ + S+++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 549 SRNQLSGDIPITI-SGLKD----LATLSLAGNQFN 578
N+L + GL+ + LSL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 11/70 (15%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 566 DLATLSLAGNQFN-GPIPESFGSLISLESLDVSSNNISGK----IPKSLEALLYLKKLNV 620
D+ +L + + + E L + + + ++ I +L L +LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 621 SYNRLEGEIP 630
N L
Sbjct: 63 RSNELGDVGV 72
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 16/88 (18%), Positives = 28/88 (31%), Gaps = 4/88 (4%)
Query: 269 IRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNL----IGTIPNSITNASKLIGLDLS 324
I+ +++ +LS L L + + L L I +++ L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 325 SNLFSGHIPHTFGNLRFLRFLNLMFNSL 352
SN H + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 15/75 (20%), Positives = 23/75 (30%), Gaps = 5/75 (6%)
Query: 321 LDLSSNLFS-GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELAL 379
LD+ S L+ + + L LT S+L +L EL L
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPALAELNL 62
Query: 380 NVNPLRGILPPFIGN 394
N L + +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 23/117 (19%), Positives = 38/117 (32%), Gaps = 23/117 (19%)
Query: 453 YDNDLQGSIPYYLCHLERLSQLLLNGNNLSG----AIPACLGSLTSLRELHLGSNTLTYS 508
D ++ L L L ++S ++ A L + SLREL L +N L +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 509 IPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLK 565
L S+ Q +L L L S ++ + L+
Sbjct: 413 GILQL------------VESVR-------QPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 21/99 (21%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 116 FPSWIGILSRLQILSFHNNSFTDR----IPDFLLNLSKLEFLDLMENSLSGS----LPND 167
S L++L + +D + LL L LDL N L + L
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 168 IRLP--KLEKLYLGSNDFFGQIPSSLSE----CTHLQTL 200
+R P LE+L L + ++ L L+ +
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 16/77 (20%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 102 LRLINFAYNELSG----SFPSWIGILSRLQILSFHNNSFTDRIPDFLL-----NLSKLEF 152
LR++ A ++S S + + L+ L NN D L+ LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 153 LDLMENSLSGSLPNDIR 169
L L + S + + ++
Sbjct: 431 LVLYDIYWSEEMEDRLQ 447
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 4e-05
Identities = 30/234 (12%), Positives = 62/234 (26%), Gaps = 10/234 (4%)
Query: 302 NNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQ 361
+ + IP+ + I L F L + + N +
Sbjct: 17 ESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 362 WSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLS 421
+ L +NP P + S + + K Q++
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL--- 131
Query: 422 GLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNL 481
+ ++ + N + VG + L L N +Q + L + NNL
Sbjct: 132 --LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 482 SGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPS 535
+ L + + L +L+ + + + LP+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 25/216 (11%), Positives = 51/216 (23%), Gaps = 6/216 (2%)
Query: 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLE 174
PS + L F LE +++ +N + + D+ +
Sbjct: 22 EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 175 KLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGD 234
+ + + +L L +G + L +
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 235 MPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLS----GHLPLTLGHS 290
+ T N + + L+ I N + N LP + H
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 291 LPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSN 326
L + + + N KL +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 24/231 (10%), Positives = 56/231 (24%), Gaps = 16/231 (6%)
Query: 40 CNWVGISCGARH---------HRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYG 90
C+ C + L L I L ++IS+N+
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 91 HLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNN-----SFTDRIPDFLL 145
+ ++ + + + + + + D L
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 146 NLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADN 205
L+ D + + L+L N + + + +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 206 KFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLS 256
+ S L++++ + + NL+ L + NL
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 35/227 (15%), Positives = 65/227 (28%), Gaps = 9/227 (3%)
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI-RLPKLEKLYLGSNDFFGQIPSS 190
+ T IP L L + L LEK+ + ND I +
Sbjct: 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 191 LSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNN--LQGDMPTAIGNLQMLEHL 248
+ + + + L +N ++ + L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 249 NLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTI 308
++ N + F + + L N+ + L+ L L NN + +
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 309 P-NSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTT 354
P + AS + LD+S + NL+ LR + +L
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK 237
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 25/230 (10%), Positives = 58/230 (25%), Gaps = 9/230 (3%)
Query: 153 LDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLP 212
E+ ++ +P+D+ +L + S L+ + ++ N +
Sbjct: 13 FLCQESKVT-EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 213 ENIGNLSQLTDLNLA---QNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTI 269
++ + N L + + L P I ++ +
Sbjct: 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130
Query: 270 RLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFS 329
L + + L L N + + +N
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190
Query: 330 GHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLT--NCRSLTEL 377
F L++ + S P+ L L + +L +L
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIH--SLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 4e-05
Identities = 27/134 (20%), Positives = 44/134 (32%), Gaps = 4/134 (2%)
Query: 139 RIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQ 198
++ + L L S P+ + L S+ + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR-SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELL 68
Query: 199 TLWLADNKFSGR--LPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLS 256
+L L++N+ + + L LNL+ N L+ + LE L L N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 257 GPVPPTIFNISTIR 270
IS IR
Sbjct: 129 DTFRDQSTYISAIR 142
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 6e-05
Identities = 29/145 (20%), Positives = 51/145 (35%), Gaps = 12/145 (8%)
Query: 460 SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYI 519
+ + SQ L+ L L + L+ S+ + ++ ++ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPEL 67
Query: 520 LYVNLSSNSLSG--PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQF 577
L +NLS+N L + S +Q L L+LS N+L + + L L L GN
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 578 NGPIPESFG-------SLISLESLD 595
+ + L LD
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 16/114 (14%), Positives = 43/114 (37%), Gaps = 3/114 (2%)
Query: 532 PLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNG--PIPESFGSLI 589
+ + + L+ + + + I + +L +L+L+ N+ +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 590 SLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSF 643
+L+ L++S N + + L L++L + N L + + + + F
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 8e-05
Identities = 44/182 (24%), Positives = 67/182 (36%), Gaps = 10/182 (5%)
Query: 132 HNNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDI--RLPKLEKLYLGSNDFFGQIPS 189
+ IP + L L +N L + + RLP L KL L N G P+
Sbjct: 16 TGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 190 SLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLN 249
+ +H+Q L L +NK + L QL LNL N + MP + +L L LN
Sbjct: 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 250 LGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIP 309
L N + F +R +L P + +++ L + +
Sbjct: 133 LASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAP----SKVRDVQIKDLPHSEFKCSSE 187
Query: 310 NS 311
NS
Sbjct: 188 NS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 44/184 (23%), Positives = 63/184 (34%), Gaps = 15/184 (8%)
Query: 259 VPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNASKL 318
+P I + L +N+L L LP+L L L N L G PN+ AS +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 319 IGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELA 378
L L N F L L+ LNL N ++ S + SLT L
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP--------GSFEHLNSLTSLN 132
Query: 379 LNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIP 438
L NP F+ LRK + P + + + L +E +
Sbjct: 133 LASNPFNCNCHLAW--FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187
Query: 439 TTVG 442
+ G
Sbjct: 188 NSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 9e-04
Identities = 36/190 (18%), Positives = 64/190 (33%), Gaps = 17/190 (8%)
Query: 40 CNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNEL-GK 98
C + C R L IP H L +++N + L G+
Sbjct: 8 CEGTTVDCTGR-------GLKEIPRD--IPLHT------TELLLNDNELGRISSDGLFGR 52
Query: 99 LRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMEN 158
L L + N+L+G P+ S +Q L N + L L +L+ L+L +N
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112
Query: 159 SLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNL 218
+S +P +++ F L+ L P + ++
Sbjct: 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172
Query: 219 SQLTDLNLAQ 228
Q+ DL ++
Sbjct: 173 -QIKDLPHSE 181
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 22/216 (10%)
Query: 412 SIPQEIG------NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYL 465
++P I + + L + + + + ++D++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 466 CHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLS 525
+L +++L LNGN L+ L +L +L L L N + + +LS
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLS----SLKDLKKLKSLS 118
Query: 526 SNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESF 585
+ + HL L +L L N+++ ++ L L TLSL NQ + +P
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--L 174
Query: 586 GSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVS 621
L L++L +S N+IS ++L L L L +
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 31/198 (15%), Positives = 66/198 (33%), Gaps = 33/198 (16%)
Query: 74 NLSFLVSLDISENNFYGHLP-NELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFH 132
+ + ++ + + + NEL + ++ N + G I L + L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG-----IQYLPNVTKLFLN 76
Query: 133 NNSFTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLS 192
N TD L+ L+ L + + + L + L
Sbjct: 77 GNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 193 ECTHLQTLWLADNKFSGRL--------------------PENIGNLSQLTDLNLAQNNLQ 232
L++L+L +NK + + L++L +L L++N++
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191
Query: 233 GDMPTAIGNLQMLEHLNL 250
A+ L+ L+ L L
Sbjct: 192 D--LRALAGLKNLDVLEL 207
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 46/326 (14%), Positives = 100/326 (30%), Gaps = 34/326 (10%)
Query: 342 LRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRK 401
+ +L +++TTE D+ S + L S+ E+ L+ N + ++ AS +
Sbjct: 5 IEGKSLKLDAITTE----DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 402 FEAIK------CELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDN 455
E + +K IP+ + L + + + + Q+ L +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 456 DLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWS 515
+ + L + + A+ + LR + G N L
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 516 LEYILYVNLSSNSLSGP-------------LPSSIQHLKVLINLDLSRNQLSGDIPITIS 562
+ + + L + + + + + S + I +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 563 GLKDLATLSLAGNQFNGPIPE------SFGSLISLESLDVSSNNISGKIPKSLEALLY-- 614
+L L L + S I L++L + N I ++L+ ++
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 615 ---LKKLNVSYNRLEGEIPIKGPFRN 637
L L ++ NR E + R
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIRE 326
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 41/324 (12%), Positives = 89/324 (27%), Gaps = 26/324 (8%)
Query: 297 LTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSG----HIPHTFGNLRFLRFLNLMFNSL 352
L ++ + + + LS N + + + L
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 353 T--TESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELK 410
+ P L +L C L + L+ N + +F + E +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 411 GSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLER 470
G PQ ++ + + + P L L
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKN-APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190
Query: 471 LSQLLL------NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNL 524
+ + + L + C + + ++ + ++ +L S + + L
Sbjct: 191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250
Query: 525 SSNSLSGPLPSSI------QHLKVLINLDLSRNQLSGDIPITI-----SGLKDLATLSLA 573
+ LS +++ L L L N++ D T+ + DL L L
Sbjct: 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 310
Query: 574 GNQFN--GPIPESFGSLISLESLD 595
GN+F+ + + + S
Sbjct: 311 GNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 35/208 (16%), Positives = 62/208 (29%), Gaps = 22/208 (10%)
Query: 167 DIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNL 226
D L + K LG + + S ++ + TL + + L+ LT +N
Sbjct: 14 DTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 69
Query: 227 AQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLT 286
+ N L P + +N P+ N I +
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 287 LGHSLPNLEFLTLFGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLN 346
L + ++ T + +S + + P NL L L+
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQV---------TDLKP--LANLTTLERLD 178
Query: 347 LMFNSLTTESSPADQWSFLSSLTNCRSL 374
+ N ++ S L+ LTN SL
Sbjct: 179 ISSNKVSD-------ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.9 bits (89), Expect = 0.001
Identities = 33/210 (15%), Positives = 66/210 (31%), Gaps = 39/210 (18%)
Query: 140 IPDFLLNLSK---LEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTH 196
I D + + + + + L G +P +EK+ ++LS
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHG------MIPPIEKM-----------DATLSTLKA 49
Query: 197 LQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLS 256
+ L L+ N I +LS + +L + + L ++
Sbjct: 50 CKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQ 104
Query: 257 GPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTLFGNNLIGTIPNSITNAS 316
I + +R++ + N+++ + +L LE L L GN L
Sbjct: 105 IASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK------- 157
Query: 317 KLIGLDLSSNLFSGHIPHTFGNLRFLRFLN 346
+N S + L L+ L+
Sbjct: 158 -------ENNATSEYRIEVVKRLPNLKKLD 180
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 22/165 (13%), Positives = 42/165 (25%), Gaps = 30/165 (18%)
Query: 136 FTDRIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECT 195
++ + N + LDL + I + +
Sbjct: 7 LIEQAAQYT-NAVRDRELDLRGYKIP------------------------VIENLGATLD 41
Query: 196 HLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNL 255
+ +DN+ R + L +L L + N + L L L L N+L
Sbjct: 42 QFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99
Query: 256 SGPVPPTIFNISTIRLINLIENQLSGHLP---LTLGHSLPNLEFL 297
I + L + + +P + L
Sbjct: 100 VELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1022 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.9 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.84 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.82 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.74 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.68 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.66 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.63 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.29 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.19 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.71 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.41 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=217.6
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEE
Q ss_conf 8415987677220112229999997599789999901101--25677799999998304787610483167417715899
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 804 (1022)
...++|++.+.||+|+||+||+|+.. ..||||+++... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred CCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEE
T ss_conf 15451899889830788589999999--989999997346998999999999999984799878645679715-589999
Q ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 97158998888762048778999999999999999999982399999185179999677658995899611476003899
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~ 884 (1022)
|||+++|+|.+++...+..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~----~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA----KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC----CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 96589988899985235789999999999999999888750----99951614789979818997887500221333556
Q ss_pred CCCEEEECCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCC
Q ss_conf 97401102468864377555688---877852016758899999871999998324461039999986369982132023
Q 001710 885 DDSVTQTITMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
..........||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+................+...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~------ 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL------ 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG------
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC------
T ss_conf 77631256655743179999950568999953151635999999997889989989699999999658889860------
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 3446233312457979999999976203699999998999999998567420
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~ 1013 (1022)
...+..+++++.+++.+||+.||++||||+|++++|+.+.+..+
T Consensus 232 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 --------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp --------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --------HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf --------00365554999999999758897689299999999999997098
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.37 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=211.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 15987677220112229999997-59978999990110125677799999998304787610483167417715899971
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779889998999970
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 58998888762048778999999999999999999982399999185179999677658995899611476003899974
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 887 (1022)
++||+|.+++.... +++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH~----~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHS----NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 37980898864159--9999999999999999999998----7972267768886887899686425156413213666-
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHH
Q ss_conf 01102468864377555688877852016758899999871999998324461039999986369982132023344623
Q 001710 888 VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ..........+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~--------------- 234 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP--------------- 234 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC---------------
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCC---------------
T ss_conf -4444444777368266447998801203137299999804889989979999-99999857999---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3312457979999999976203699999998999999
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
....+..++.++.+++.+||++||++|||+.|+++|
T Consensus 235 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -888855379999999999866996689099999649
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.94 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=210.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf 15987677220112229999997-599789999901101-2567779999999830478761048316741771589997
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||+||+|+. .+++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 15899888876204877899999999999999999998239999918517999967765899589961147600389997
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 886 (1022)
|+++|+|.+++.... .+++..+..++.|++.|++|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~----~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG----IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 458980899975379-99999999999999999999997----5983575468997887899879832314224046886
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 401102468864377555688877-8520167588999998719999983244610399999863699821320233446
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------------- 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------- 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------------
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-------------
T ss_conf 5311132557474287286189999971016173799999982997888898599999998638887-------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233312457979999999976203699999998999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
......+++++.+++.+||+.||++|||++|++++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----88644699999999999767996689099999619
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.61 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=214.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEECC
Q ss_conf 15987677220112229999997599789999901101256777999999983047876104831674177158999715
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 808 (1022)
.++|+..+.||+|+||.||+|+..++..||||++..... ..+.+.+|++++++++||||++++|++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 699588889820888299999988999999999878867-6899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCE
Q ss_conf 89988887620487789999999999999999999823999991851799996776589958996114760038999740
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 888 (1022)
++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+|+........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~----~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH----TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC----CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 9991899752013478899999999999998776531----64310443153266668877686553210023688733-
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHHH
Q ss_conf 11024688643775556888778520167588999998719999983244610399999863699821320233446233
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ......+....+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~---------------- 220 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR---------------- 220 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCC----------------
T ss_pred EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCC----------------
T ss_conf 504300176667857860799984033210599999998789888778999-999999980688----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 3124579799999999762036999999989999999985674
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
...+..+++++.+++.+||+.||++||||+|++++|++|.+.
T Consensus 221 -~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 -LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -899543679999999997657976891999999999999857
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=372.57 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=214.7
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CC---CEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEE
Q ss_conf 159876772201122299999975-99---789999901101-2567779999999830478761048316741771589
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF-DG---TNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 803 (1022)
.++|++.+.||+|+||+||+|+.. ++ ..||||++.... ....+.+.+|++++++++||||++++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 00427856980278829999999579978899999997844598999999999999985799888618999962887799
Q ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 99715899888876204877899999999999999999998239999918517999967765899589961147600389
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~ 883 (1022)
||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~----~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD----MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 997227985300210456799999999999999998898852----7983576150448988999199888443157567
Q ss_pred CCCCEE---EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHC
Q ss_conf 997401---102468864377555688877852016758899999871-9999983244610399999863699821320
Q 001710 884 GDDSVT---QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 884 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... .....||+.|+|||...++.++.++|||||||++|||+| |+.||.+.... .....+....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~-------- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDY-------- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC--------
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCC--------
T ss_conf 777653650256668830038788836997861214453578999986799999999999--9999997378--------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 2334462333124579799999999762036999999989999999985674
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
+.+.+..++..+.+++.+||+.||++||||.|+++.|+++.+.
T Consensus 251 ---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 251 ---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ---------8999742269999999997587976892999999999998418
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.11 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=210.5
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEECC
Q ss_conf 5987677220112229999997-599789999901101256777999999983047876104831674177158999715
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 808 (1022)
+.|++.+.||+|+||.||+|+. .++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCE
Q ss_conf 89988887620487789999999999999999999823999991851799996776589958996114760038999740
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 888 (1022)
++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~----~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD----NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--C
T ss_conf 9981889998628999999999999999999999998----898871407003148789998997161230357786--4
Q ss_pred EEECCCCCCCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCC
Q ss_conf 11024688643775556-----8887785201675889999987199999832446103999998636998213202334
Q 001710 889 TQTITMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 963 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 963 (1022)
......||+.|+|||++ .+..|+.++||||+||++|||++|+.||.+....+. +........
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~------------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEP------------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCC------------
T ss_pred CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHCCCC------------
T ss_conf 1001025626479999832025788888066578789999998208899999899999-999970799------------
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 46233312457979999999976203699999998999999
Q 001710 964 VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 964 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.....+..+++++.+++.+||++||++|||+.|+++|
T Consensus 233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----8777656699999999999766996689199999629
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.87 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=214.3
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEECC-C-----CEEEEEEECCHH-HHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 841598767722011222999999759-9-----789999901101-25677799999998304-787610483167417
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFD-G-----TNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 798 (1022)
...++|++.+.||+|+||+||+|+... + ..||+|++.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 77899397019830788199999985788554204999999663358789999999999999715899686877888629
Q ss_pred CEEEEEEECCCCCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf 71589997158998888762048----------------------77899999999999999999998239999918517
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN----------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCD 856 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~D 856 (1022)
+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+ ++|+|||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~----~~IiHRD 189 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF----KSCVHRD 189 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH----TTEEETT
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECC
T ss_conf 958999972799959999986257775102210000122200125778999999999999999999973----9905052
Q ss_pred CCCCCEEECCCCCEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 999967765899589961147600389997401102468864377555688877852016758899999871-9999983
Q 001710 857 LKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDE 935 (1022)
Q Consensus 857 ik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~ 935 (1022)
|||+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf 70321443459828985142222045778615623435787657838872799996330300039999998389999999
Q ss_pred CCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 244610399999863699821320233446233312457979999999976203699999998999999998
Q 001710 936 MFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKK 1007 (1022)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 1007 (1022)
....+ .+...+.... +...+..+++++.+|+.+||+.||++|||++|++++|..
T Consensus 270 ~~~~~-~~~~~~~~~~-----------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDA-NFYKLIQNGF-----------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSH-HHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH-HHHHHHHCCC-----------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 89899-9999985699-----------------899887678999999999758896689399999999748
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.45 Aligned_cols=273 Identities=22% Similarity=0.291 Sum_probs=211.1
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEE
Q ss_conf 8415987677220112229999997-5997899999011012-5677799999998304787610483167417715899
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 804 (1022)
...++|++.+.||+|+||+||+|+. .+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 87568889789712778099999998999699999987540978999999999999867999999499999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 97158998888762048778999999999999999999982399999185179999677658995899611476003899
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~ 884 (1022)
|||+++|+|.+++...+. +++..+..++.|++.|+.|||+. .+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 mEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 976799868998742499-99999999999999999999985---99971445779946878998999548776256788
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH--CC----------
Q ss_conf 974011024688643775556888778520167588999998719999983244610399999863--69----------
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKES--LP---------- 952 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~---------- 952 (1022)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.......... ..
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf ----6211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred -------------CCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf -------------9821320233446233312457979999999976203699999998999999--9985
Q 001710 953 -------------HGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKI 1008 (1022)
Q Consensus 953 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i 1008 (1022)
....+..+.......+ .......+.++.+++.+||++||++|||+.|+++| +++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 22111122235413477887665026876-67644489999999999868994679089999609864769
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=366.92 Aligned_cols=253 Identities=23% Similarity=0.270 Sum_probs=211.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 15987677220112229999997-59978999990110125677799999998304787610483167417715899971
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEECCCCC
Q ss_conf 5899888876204877899999999999999999998239999918517999967765--89958996114760038999
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~--~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
++||+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~----~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE----NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH----CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC
T ss_conf 79988999997623789999999999999999999975----69760001546736416889869995452104425654
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+..........
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~------------ 244 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNM------------ 244 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCS------------
T ss_pred C---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCCCC------------
T ss_conf 3---20006862421889975899872676554659999998598998997999-9999998478898------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233312457979999999976203699999998999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.......+++++.+++.+||++||++|||++|+++|
T Consensus 245 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---942235899999999999756896679089998629
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=374.83 Aligned_cols=262 Identities=22% Similarity=0.346 Sum_probs=214.8
Q ss_pred HHHHHCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEE
Q ss_conf 9984159876772201122299999975-997899999011012567779999999830478761048316741771589
Q 001710 725 IQRATDGFNECNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 725 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 803 (1022)
.+...++|++.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEE
T ss_conf 17457993986598208880899999999996999999777610-39999999999986799988267752745785478
Q ss_pred EEECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECC
Q ss_conf 99715899888876204-87789999999999999999999823999991851799996776589958996114760038
Q 001710 804 VLEFMPNGSFEKWLYSY-NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~ 882 (1022)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~----~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK----KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 7631467606777530355415799999999999997888987----893057604576899899928983244546537
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCC
Q ss_conf 99974011024688643775556888778520167588999998719999983244610399999863699821320233
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
... ........|++.|+|||++.+..++.++||||+||++|||++|+.|+...... ......+....
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~----------- 233 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDY----------- 233 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC-----------
T ss_pred CCC-CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCC-----------
T ss_conf 887-22103556654666927872799981043021789999998679988774259-99999985588-----------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 446233312457979999999976203699999998999999998567
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~ 1010 (1022)
....+..++.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------888874330999999999757797689399999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=365.87 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=211.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 15987677220112229999997-59978999990110125677799999998304787610483167417715899971
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..........+.+|+.++++++||||+++++++.+....|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEECCCCC
Q ss_conf 5899888876204877899999999999999999998239999918517999967765--89958996114760038999
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD--ENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~--~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
++||+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|..+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~----~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE----HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf 89980888898638998999999999999999999997----79265131445531134678848995256303437887
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+........+.
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~------------ 247 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEF------------ 247 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCC------------
T ss_pred C---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC------------
T ss_conf 2---010047645348999747998976333898999999996889989979999-999998478898------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233312457979999999976203699999998999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.......+++++.+++.+||++||++|||+.|+++|
T Consensus 248 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---930024799999999999756996689189999609
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.83 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=210.3
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf 84159876772201122299999975997899999011012567779999999830478761048316741771589997
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 806 (1022)
...++|++.+.||+|+||.||+|+.+++..||||++..... ..+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 38899388679810798289999999999999999864768-88999999999986799988578731045-97699999
Q ss_pred CCCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 1589988887620487-789999999999999999999823999991851799996776589958996114760038999
Q 001710 807 FMPNGSFEKWLYSYNY-FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
|+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~----~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE----RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf 5789828888751478988788999999999999999974----895467564225156202440423410147735886
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
........|++.|+|||++.++.++.++|||||||++|||+||+.|+....... .....+....
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~-------------- 227 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY-------------- 227 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTC--------------
T ss_pred -CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHHCC--------------
T ss_conf -442035677444458289837999824564525799999996898888888999-9999997068--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 233312457979999999976203699999998999999998567
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRV 1010 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~ 1010 (1022)
....+..+++++.+++.+||+.||++||||+++++.|+.+-.
T Consensus 228 ---~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---888965571999999999758897689399999998611321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.16 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=215.2
Q ss_pred HCCCCCCCE-EECCCCEEEEEEEEC---CCCEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEE
Q ss_conf 159876772-201122299999975---99789999901101-2567779999999830478761048316741771589
Q 001710 729 TDGFNECNL-LGRGSFGLVYKGTLF---DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 803 (1022)
.++|.+.+. ||+|+||.||+|... ++..||||+++... ....+.+.+|++++++++||||++++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 99715899888876204877899999999999999999998239999918517999967765899589961147600389
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~ 883 (1022)
||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~----~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 998078996899752125699999999999999998789986----8810576764660454688542033134211554
Q ss_pred CCCCE-EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCC
Q ss_conf 99740-1102468864377555688877852016758899999871-999998324461039999986369982132023
Q 001710 884 GDDSV-TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 961 (1022)
Q Consensus 884 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1022)
..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .....+....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~---------- 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK---------- 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC----------
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCC----------
T ss_conf 3432113562113743358688727999954123220178999993899999997999--9999998189----------
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 3446233312457979999999976203699999998999999998567420346
Q 001710 962 NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQS 1016 (1022)
Q Consensus 962 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~~~~ 1016 (1022)
+...+..+++++.+++.+||+.+|++||+|.++.+.|+.+-.....+.
T Consensus 230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred -------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHCC
T ss_conf -------999997678999999999757797689099999999999999854111
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.88 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=214.0
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEECCC-----CEEEEEEECCHHH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEE
Q ss_conf 415987677220112229999997599-----7899999011012-5677799999998304787610483167417715
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDG-----TNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 801 (1022)
..++|+..++||+|+||.||+|..... ..||||++..... .....+.+|+.++++++||||++++|++.+....
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 88996861598117790999999968998787999999988445968999999999999856898783236778338803
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 89997158998888762048778999999999999999999982399999185179999677658995899611476003
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
++||||+.+|++.+++......+++..+..++.|++.|++|||+ .+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~----~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC----CCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 89997213574022210234542089999999999985412121----23425765644278889984998455103003
Q ss_pred CCCCC-CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCC
Q ss_conf 89997-40110246886437755568887785201675889999987199999832446103999998636998213202
Q 001710 882 GEGDD-SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
..... ........||+.|+|||++.++.++.++|||||||++|||++++.|+....... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~-------- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFR-------- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCC--------
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHHHHHHCCCC--------
T ss_conf 578765267426777734348888704999973556344898999996798865568999-99999863578--------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 334462333124579799999999762036999999989999999985674
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
...+..++..+.+++.+||+.||++||+|.|+++.|+.+.+.
T Consensus 232 ---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---------998504579999999997767976893999999999998669
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.48 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983047876104831674177158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 71589988887620487789999999999999999999823999991851799996776589958996114760038999
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
||+++|+|.+++..... +++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|.......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH~----~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS----KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHH----CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC
T ss_conf 50479858988750489-9999999999999999999998----894652202344146689987115556335448885
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ......+..
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~--------------- 220 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVE--------------- 220 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC---------------
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHCCC---------------
T ss_conf ----235578876349999758998931440467599999832999988899999-999997189---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233312457979999999976203699999998999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
...+..+++++.+++.+||++||++|||++|+++|
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----99986689999999999764797689099999719
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.80 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=211.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983047876104831674177158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 71589988887620487789999999999999999999823999991851799996776589958996114760038999
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
||+++|+|.+++...+. +++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH~----~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHG----KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHCC----CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 70489877776531599-9999999999999999976216----508847677412366888538860321024225677
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .........
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~--------------- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLE--------------- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTC---------------
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHCCC---------------
T ss_conf 6433355567755258440026898966623045699999803889989959999-999997189---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 23331245797999999997620369999999899999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELK 1006 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 1006 (1022)
...+..+++++.+++.+||+.||++|||++|+.++-.
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf ----9998547999999999985579768919789737789
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.33 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=216.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEECC
Q ss_conf 15987677220112229999997599789999901101256777999999983047876104831674177158999715
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFM 808 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 808 (1022)
.++|+..+.||+|+||+||+|+.+++..||||+++.... ..+.+.+|+.++++++||||++++|++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 699799689820788399999988998999999874757-7899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCE
Q ss_conf 89988887620487789999999999999999999823999991851799996776589958996114760038999740
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV 888 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 888 (1022)
++|++.+++......+++..+.+++.|+++|++|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~----~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES----KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH----TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-E
T ss_conf 8993888641024677689999999999999998754----6843466541358876998479886144202357872-2
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHH
Q ss_conf 1102468864377555688877852016758899999871-999998324461039999986369982132023344623
Q 001710 889 TQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEE 967 (1022)
Q Consensus 889 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 967 (1022)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||......+ ....+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~---------------- 218 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL---------------- 218 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTC----------------
T ss_pred EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHCC----------------
T ss_conf 52465788775780786379988521033643246739755999988999999--999998079----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 33124579799999999762036999999989999999985
Q 001710 968 QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 1008 (1022)
+...+..+++++.+++.+||+.||++||||.+++++|.+|
T Consensus 219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -7899654659999999997668976893999999874188
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.72 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=214.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCC----EEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEE
Q ss_conf 59876772201122299999975-997----89999901101-2567779999999830478761048316741771589
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT----NVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 803 (1022)
++|+..+.||+|+||+||+|+.. +|+ +||+|++.... .+..+.+.+|+.++++++||||++++|+|.+.. .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EEE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996198-369
Q ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 99715899888876204877899999999999999999998239999918517999967765899589961147600389
Q 001710 804 VLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~ 883 (1022)
++||+.+|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~----~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 998426874010111334579999999999999999999987----6950476212031167998758602552223354
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCC
Q ss_conf 997401102468864377555688877852016758899999871-9999983244610399999863699821320233
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
...........||+.|+|||++.++.++.++|||||||++|||+| |..||++....+ +...+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~----------- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE----------- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTC-----------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCC-----------
T ss_conf 4453223651058644670887469998356544079999999977999999999899--999997599-----------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 4462333124579799999999762036999999989999999985674
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
+...+..+++++.+++.+||+.||++|||+.|++++++.+...
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ------8999855689999999984789934691999999999998758
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.00 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=207.8
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 415987677220112229999997-5997899999011012-56777999999983047876104831674177158999
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
..+.|++.+.||+|+||+||+|+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCEECC
Q ss_conf 715899888876204877899999999999999999998239999918517999967765---89958996114760038
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLG 882 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~---~~~~~kl~Dfg~a~~~~ 882 (1022)
||++||+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||++. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~----~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHH----CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 5268984888653036-78878999999999999875241----305568704630011046888249983154358725
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCC
Q ss_conf 99974011024688643775556888778520167588999998719999983244610399999863699821320233
Q 001710 883 EGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 883 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
.... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ ..........+.
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~--------- 228 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYEF--------- 228 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCCC---------
T ss_pred CCCE---EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHCCCCCC---------
T ss_conf 8970---440032842259188737999807873451599999985979999989999-999986168777---------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 446233312457979999999976203699999998999999
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.......+++++.+++.+||++||++|||+.|+++|
T Consensus 229 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 ------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------876666789999999999760897579189998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.17 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=205.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--CCEEEE
Q ss_conf 15987677220112229999997-599789999901101--2567779999999830478761048316741--771589
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN--IDFKAL 803 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 803 (1022)
.++|++.+.||+|+||+||+|+. .+|+.||+|++.... +...+.+.+|++++++++||||+++++++.+ ....|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 99715899888876204---8778999999999999999999982399-9991851799996776589958996114760
Q 001710 804 VLEFMPNGSFEKWLYSY---NYFLDILQRLNIMIDVALVLEYLHHGHS-LAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~ 879 (1022)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+... ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred ECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHC
Q ss_conf 03899974011024688643775556888778520167588999998719999983244610399999863699821320
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
.+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+......
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~~~------ 232 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFR------ 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTCCC------
T ss_pred ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH--HHHHHHHCCCCC------
T ss_conf 2245777--556677882327999983999993898875278999980188998998999--999999718998------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233446233312457979999999976203699999998999999
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
..+..+++++.+++.+||++||++|||+.|++++
T Consensus 233 -----------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -----------8974359999999999767995579189999729
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.44 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=218.4
Q ss_pred HHHHHHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCHHH-HHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 8889984159876772201122299999975------997899999011012-567779999999830478761048316
Q 001710 722 YLDIQRATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQLE-RAFRTFDSECEILRNVRHRNLVKIFSS 794 (1022)
Q Consensus 722 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 794 (1022)
+.+++...++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 741771589997158998888762048-----------------------778999999999999999999982399999
Q 001710 795 CCNIDFKALVLEFMPNGSFEKWLYSYN-----------------------YFLDILQRLNIMIDVALVLEYLHHGHSLAP 851 (1022)
Q Consensus 795 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ 851 (1022)
+......++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~----~~ 160 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE----RK 160 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH----TT
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC----CC
T ss_conf 60598038999815899299999852755421000011100121034678898999999999999998554135----78
Q ss_pred EEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-
Q ss_conf 1851799996776589958996114760038999740110246886437755568887785201675889999987199-
Q 001710 852 IVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK- 930 (1022)
Q Consensus 852 ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~- 930 (1022)
|+||||||+|||++.++.+||+|||+|+...........+...|++.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 68548840116898999289833144211367764111577776767679899726889805630252362999980689
Q ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9998324461039999986369982132023344623331245797999999997620369999999899999999856
Q 001710 931 KPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIR 1009 (1022)
Q Consensus 931 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~ 1009 (1022)
+||.+.... .....+..... ...+..+++++.+++.+||+.+|++||||.|++++|++|.
T Consensus 241 ~p~~~~~~~--e~~~~v~~~~~-----------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHE--EVIYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHH--HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHH--HHHHHHHCCCC-----------------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 999998999--99999973997-----------------8887325299999999974889657939999999999842
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.32 Aligned_cols=246 Identities=23% Similarity=0.284 Sum_probs=201.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983047876104831674177158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
+.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 71589988887620487789999999999999999999823999991851799996776589958996114760038999
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
||+++|++..+..... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|......
T Consensus 95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~----~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHS----HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH----CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 8069994578997379-99999999999999999999986----89766678842179879997898443653346778-
Q ss_pred CCEEEECCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCC
Q ss_conf 7401102468864377555688---8778520167588999998719999983244610399999863699821320233
Q 001710 886 DSVTQTITMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 962 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1022)
....||+.|+|||++.+ +.|+.++||||+||++|||++|+.||.+....+ ..........+.
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~--------- 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA--------- 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred -----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC---------
T ss_conf -----73134766368899834678886721454558999999987889999979999-999998289998---------
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 446233312457979999999976203699999998999999
Q 001710 963 LVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 963 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.....+++++.+++.+||++||++|||+.|+++|
T Consensus 234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --------8878889999999999773796579189999719
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.99 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=206.8
Q ss_pred CEEECCCCEEEEEEEEC---CCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEECCCC
Q ss_conf 72201122299999975---99789999901101--25677799999998304787610483167417715899971589
Q 001710 736 NLLGRGSFGLVYKGTLF---DGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEFMPN 810 (1022)
Q Consensus 736 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 810 (1022)
+.||+|+||.||+|... .++.||||+++... +...+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCE-E
Q ss_conf 988887620487789999999999999999999823999991851799996776589958996114760038999740-1
Q 001710 811 GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDSV-T 889 (1022)
Q Consensus 811 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~ 889 (1022)
|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+|+.+....... .
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH~----~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 968999752257-8999999999999999766874----79556777611310235675123413453313432344322
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCHHH
Q ss_conf 102468864377555688877852016758899999871-9999983244610399999863699821320233446233
Q 001710 890 QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGEEQ 968 (1022)
Q Consensus 890 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 968 (1022)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.... .....+....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~----------------- 227 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE----------------- 227 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCC-----------------
T ss_conf 445677842039166537999843443034031328965899999998999--9999998289-----------------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 312457979999999976203699999998999999998567420
Q 001710 969 AFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFL 1013 (1022)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~ 1013 (1022)
+...+..++.++.+++.+||+.||++|||++++.+.|+..-.+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHCC
T ss_conf 999986567999999999758897689098999998528875047
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.28 Aligned_cols=249 Identities=21% Similarity=0.259 Sum_probs=208.5
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEE
Q ss_conf 15987677220112229999997-599789999901101---25677799999998304787610483167417715899
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 804 (1022)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 97158998888762048778999999999999999999982399999185179999677658995899611476003899
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~ 884 (1022)
|||++||+|.+++..... +++..+..++.|++.|++|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH~----~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHS----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 003579860555532567-7599999999999652113431----59622464777847658998888205652003567
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCC
Q ss_conf 97401102468864377555688877852016758899999871999998324461039999986369982132023344
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... .+.......
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~-------------- 220 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME-------------- 220 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC--------------
T ss_pred CC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH--HHHHHHHCC--------------
T ss_conf 86--205510088996666504898883331022306788998789999996999--999998528--------------
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 623331245797999999997620369999999-----8999999
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~eil~~ 1004 (1022)
....+..+++++.+++.+||++||++||+ +.|+++|
T Consensus 221 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf ----99898668999999998666389344225652349999729
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.36 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=196.4
Q ss_pred CCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE----CCEEEEEE
Q ss_conf 7677220112229999997-599789999901101--2567779999999830478761048316741----77158999
Q 001710 733 NECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN----IDFKALVL 805 (1022)
Q Consensus 733 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 805 (1022)
+..+.||+|+||+||+|+. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCEECCCC
Q ss_conf 715899888876204877899999999999999999998239999918517999967765-8995899611476003899
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD-ENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~-~~~~~kl~Dfg~a~~~~~~ 884 (1022)
||+++|+|.+++..... +++..+..++.|++.||+|||+.. .+|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH~~~--~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSS--SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred ECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHHCC--CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC
T ss_conf 57898948999751355-469999999999999999999789--979968767435116679998898005765423687
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCC
Q ss_conf 97401102468864377555688877852016758899999871999998324461039999986369982132023344
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
.....+||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+..... +.....
T Consensus 169 ----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~-i~~~~~------------ 230 (270)
T d1t4ha_ 169 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGVK------------ 230 (270)
T ss_dssp ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-HTTTCC------------
T ss_pred ----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHCCCC------------
T ss_conf ----6677553813008988478-9998671100799999998788999876559999999-973899------------
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 6233312457979999999976203699999998999999
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
....+..+++++.+++.+||++||++|||+.|+++|
T Consensus 231 ----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 ----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----865675578999999999763797589299999677
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.18 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=207.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH------HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEE
Q ss_conf 15987677220112229999997-5997899999011012------5677799999998304787610483167417715
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE------RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 801 (1022)
.++|++.+.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CEEEEECCC
Q ss_conf 8999715899888876204877899999999999999999998239999918517999967765899----589961147
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM----TAHVSDFGI 877 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~----~~kl~Dfg~ 877 (1022)
++||||+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~qi~~al~yLH~----~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEECCCCCCCCCHHCCCCC-CCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 999986778643100103564-2155789999999999876662----54221133301279825898666469643344
Q ss_pred CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCH
Q ss_conf 60038999740110246886437755568887785201675889999987199999832446103999998636998213
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
|........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .... +....
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~-i~~~~------ 232 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN-VSAVN------ 232 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHTTC------
T ss_pred HHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH-HHHH-HHHCC------
T ss_conf 210577763---122477774309999818999976652214099999970889988999999-9999-98168------
Q ss_pred HCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 20233446233312457979999999976203699999998999999
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.. ........++..+.+++.+||++||++|||++|+++|
T Consensus 233 -----~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 -----YE---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -----CC---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CC---CCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----88---8701047889999999999863896689199999619
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=352.75 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=201.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH---HHHHHH---HHHHHHHHHCCCCCCEEEEEEEEECCEE
Q ss_conf 15987677220112229999997-5997899999011012---567779---9999998304787610483167417715
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE---RAFRTF---DSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 801 (1022)
.++|++.+.||+|+||.||+|+. .+|+.||+|++....- .....+ ..++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 89997158998888762048778999999999999999999982399999185179999677658995899611476003
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
|+||||++||+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH~----~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHH----CCCCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 999991489838999873255-3278999999999999999997----79622044422167858896798220102333
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCC
Q ss_conf 89997401102468864377555688-87785201675889999987199999832446103999998636998213202
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
.... ....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||......+. ...........
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~------ 225 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA------ 225 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCC------
T ss_pred CCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHCCCCC------
T ss_conf 7886----43311345542168760389998441046778999999859998888998999--99998604688------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 3344623331245797999999997620369999999-----8999999
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIH-----MTDAAAE 1004 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~eil~~ 1004 (1022)
...+..+++++.+++.+||++||++||+ ++|+++|
T Consensus 226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---------CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ---------8788778999999999985669888088743579999749
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.17 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=212.7
Q ss_pred HHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCHH-HHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE
Q ss_conf 984159876772201122299999975------99789999901101-25677799999998304-78761048316741
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCN 797 (1022)
Q Consensus 726 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 797 (1022)
+...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|...+.++ +|++|+.+++++..
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 61679979844984167839999998677755578399999986001717899999999998861499849974115404
Q ss_pred C-CEEEEEEECCCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCC
Q ss_conf 7-71589997158998888762048---------------7789999999999999999999823999991851799996
Q 001710 798 I-DFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNN 861 (1022)
Q Consensus 798 ~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~N 861 (1022)
. ...++||||+++|+|.++++... ..+++..+..++.|++.||+|||+ ++|+||||||+|
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~----~~ivHrDlKp~N 164 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS----RKCIHRDLAARN 164 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGG
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCC
T ss_conf 7975799998458992999998536666653222023321468999999999999999998873----797178677310
Q ss_pred EEECCCCCEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCCC
Q ss_conf 776589958996114760038999740110246886437755568887785201675889999987199-9998324461
Q 001710 862 ILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-KPTDEMFTGE 940 (1022)
Q Consensus 862 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~-~p~~~~~~~~ 940 (1022)
||++.++.+||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||+++. .||......+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 65779982898457520011356652224751667210203686468899663221367899999868899998999899
Q ss_pred HHHHHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 03999998636998213202334462333124579799999999762036999999989999999985674
Q 001710 941 MSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
.+...+..... ...+..+++++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 245 -~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 -EFCRRLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHCCCC-----------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -99999963898-----------------888865789999999997677966791999999999799867
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.32 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=211.6
Q ss_pred CCEEECCCCEEEEEEEECC----CCEEEEEEECCH-HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCEEEEEEECC
Q ss_conf 7722011222999999759----978999990110-12567779999999830478761048316741-77158999715
Q 001710 735 CNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQ-LERAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDFKALVLEFM 808 (1022)
Q Consensus 735 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 808 (1022)
.++||+|+||+||+|+... ...||||+++.. .....+.+.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC-
Q ss_conf 8998888762048778999999999999999999982399999185179999677658995899611476003899974-
Q 001710 809 PNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS- 887 (1022)
Q Consensus 809 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 887 (1022)
++|+|.+++.......++..+.+++.|++.|+.|+|+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~----~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS----KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCC----CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 0674144210134540489999999998876520033----676257766875767799988991065232255665553
Q ss_pred -EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCH
Q ss_conf -0110246886437755568887785201675889999987199999832446103999998636998213202334462
Q 001710 888 -VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 888 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
.......||+.|+|||...+..++.++||||||+++|||++|+.||....... ....++....+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~-------------- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR-------------- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC--------------
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHCCCC--------------
T ss_conf 100256555645567688743799974574661999999997899998889999-99999980898--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 3331245797999999997620369999999899999999856742034
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~~~ 1015 (1022)
...+..++.++.+++.+||+.||++||+|.|++++|+++..++..+
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHH
T ss_conf ---8996447599999999976889768939999999999999752012
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.39 Aligned_cols=261 Identities=21% Similarity=0.338 Sum_probs=214.5
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEECC----CCEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEE
Q ss_conf 841598767722011222999999759----9789999901101-25677799999998304787610483167417715
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFD----GTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 801 (1022)
...++|++.+.||+|+||.||+|+... +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf 688996987799307882999999936996449999999365668799999999999998689999856988995-3747
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 89997158998888762048778999999999999999999982399999185179999677658995899611476003
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
++||||+++|++.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+|+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES----KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCC----CCEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 99998406980776542247899999999999999877523022----67441410265532067896787650342133
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCC
Q ss_conf 89997401102468864377555688877852016758899999871-99999832446103999998636998213202
Q 001710 882 GEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVD 960 (1022)
Q Consensus 882 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1022)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+ ....+....
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~--------- 226 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE--------- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC---------
T ss_pred CCCCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCC---------
T ss_conf 67762-330540058310326675169988745244424789999826999988899999--999998189---------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 3344623331245797999999997620369999999899999999856742
Q 001710 961 ANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
..+.+..+++++.+++.+||+.||++|||+.|++++|+.+.++.
T Consensus 227 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 227 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf --------99898777999999999976879768929999999999997786
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=354.02 Aligned_cols=245 Identities=23% Similarity=0.247 Sum_probs=206.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983047876104831674177158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 71589988887620487789999999999999999999823999991851799996776589958996114760038999
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
||+.+|+|.+++...+. +++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~----~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHS----LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHH----CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC
T ss_conf 23346622666751589-8999999999999998999985----998617679999360778978861010333225666
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..........
T Consensus 196 -----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~--------------- 254 (350)
T d1rdqe_ 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGK--------------- 254 (350)
T ss_dssp -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC---------------
T ss_pred -----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHCCC---------------
T ss_conf -----4336763567889971799885331145007899997588998995999-9999986179---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 2333124579799999999762036999999-----98999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~ 1004 (1022)
...+..+++++.+++.+||.+||++|+ +++++++|
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf ----8897668999999999983409986065534549999719
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=351.38 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=206.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983047876104831674177158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
++|++.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 71589988887620487789999999999999999999823999991851799996776589958996114760038999
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~ 885 (1022)
||++||++..++..... +++..+..++.|++.|++|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~----~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHS----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EECCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCC----CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC
T ss_conf 50378632234322221-1100799999999876554124----767705568105038689988983175216712456
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .........
T Consensus 159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~--------------- 217 (316)
T d1fota_ 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE--------------- 217 (316)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC---------------
T ss_pred -----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH-HHHHHHCCC---------------
T ss_conf -----43457634359999838999804304653336899975989999969999-999997089---------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 2333124579799999999762036999999-----98999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~ 1004 (1022)
...+...++++.+++.+|+.+||++|+ +++++++|
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ----8899778999999999995449976664310219999819
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.52 Aligned_cols=252 Identities=20% Similarity=0.314 Sum_probs=208.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 15987677220112229999997-59978999990110125677799999998304787610483167417715899971
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
-++|++.+.||+|+||+||+|.. .+++.||+|+++....+ ...+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 01058878983177839999999899969999997578665-99999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCEECCCCC
Q ss_conf 58998888762048778999999999999999999982399999185179999677658--9958996114760038999
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE--NMTAHVSDFGISKLLGEGD 885 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~--~~~~kl~Dfg~a~~~~~~~ 885 (1022)
++||+|.+++...+..+++..+..++.|++.|++|||+ .+|+||||||+|||++. ...+|++|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~----~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS----HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC
T ss_conf 89980889987538999999999999999999999987----69975135544434437885189976441110034677
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 74011024688643775556888778520167588999998719999983244610399999863699821320233446
Q 001710 886 DSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 886 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
......+++.|+|||...+..++.++||||+||++|+|++|+.||......+ ............
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~------------ 222 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTF------------ 222 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCC------------
T ss_pred ---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC------------
T ss_conf ---5321223322234021048777840113027999999982899999989999-999998389998------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233312457979999999976203699999998999999
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.......++.++.+++.+|+.+||++|||+.|+++|
T Consensus 223 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---802236789999999999866996689099999639
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.26 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=212.3
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 41598767722011222999999759978999990110125677799999998304787610483167417715899971
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
..++|++.+.||+|+||.||+|+..++..||||++..... ..+.+.+|+.++++++|+||+++++++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf 7799798469930798099999999999999999880448-88999999999986666788689999823-975999994
Q ss_pred CCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 58998888762048-77899999999999999999998239999918517999967765899589961147600389997
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 886 (1022)
+++|++..++.... ..+++..+..++.|++.|++|||+ .+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~----~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHH----HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 479943542000035530599999999999999998754----1143353123079998999299844255542568873
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCCH
Q ss_conf 40110246886437755568887785201675889999987199999832446103999998636998213202334462
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVGE 966 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 966 (1022)
.......||+.|+|||++..+.++.++||||||+++|||++|+.|+........ ....+.....
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~-------------- 232 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYR-------------- 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCC--------------
T ss_pred -EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH-HHHHHHHCCC--------------
T ss_conf -352454556654580898379989177413235899999868999998888999-9999982689--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 3331245797999999997620369999999899999999856742
Q 001710 967 EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 967 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
.+.+..+++++.+++.+||+.||++||+++++++.|+.+....
T Consensus 233 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf ---9998323799999999975669758919999999876662389
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.47 Aligned_cols=271 Identities=22% Similarity=0.305 Sum_probs=205.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----EEEEEE
Q ss_conf 5987677220112229999997599789999901101256777999999983047876104831674177----158999
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCNID----FKALVL 805 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 805 (1022)
.+|...+.||+|+||.||+|+. +|+.||||++...... ....+.|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-9989999998720046-7999999999962799868326889983798604899999
Q ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC----CCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 715899888876204877899999999999999999998239----9999185179999677658995899611476003
Q 001710 806 EFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH----SLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 806 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
||+++|+|.++++... +++..+.+++.+++.|++|+|+.. ..++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ECCCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf 6466989899986589--99899999999999999998876652046898661531731357868877688763866234
Q ss_pred CCCCCCE--EEECCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCH----------HH
Q ss_conf 8999740--110246886437755568887------78520167588999998719999983244610----------39
Q 001710 882 GEGDDSV--TQTITMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM----------SL 943 (1022)
Q Consensus 882 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~G~il~elltg~~p~~~~~~~~~----------~~ 943 (1022)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+........ ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf 67776200135525035476782210565454677767501220159999999628998876631124101225564309
Q ss_pred HHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 999986369982132023344623331245797999999997620369999999899999999856742
Q 001710 944 RRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
....... .+..+....+.......++..+.+++.+||+.||++||||.|++++|++|..+.
T Consensus 239 ~~~~~~~--------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 239 EEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHH--------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHH--------HCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 9999987--------502468887765577689999999999976069858959999999999888865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.63 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=216.6
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEE------CCCCEEEEEEECCHHH-HHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 8415987677220112229999997------5997899999011012-5677799999998304-787610483167417
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTL------FDGTNVAIKVFNLQLE-RAFRTFDSECEILRNV-RHRNLVKIFSSCCNI 798 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 798 (1022)
...++|+..+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCC
Q ss_conf 715899971589988887620487-----------------789999999999999999999823999991851799996
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYNY-----------------FLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNN 861 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~N 861 (1022)
...++||||+++|+|.++++.... .+++..+..++.||+.|++|||+ .+|+||||||+|
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~----~~ivHrDLKp~N 175 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS----KNCIHRDLAARN 175 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGG
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCCCC
T ss_conf 9789999737998799999853566544444533222334588999999999999999998875----792666241021
Q ss_pred EEECCCCCEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 77658995899611476003899974011024688643775556888778520167588999998719999983244610
Q 001710 862 ILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEM 941 (1022)
Q Consensus 862 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~ 941 (1022)
|+++.++.+|++|||.++...............||+.|+|||.+.++.++.++||||||+++|||+|++.|+........
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 00002575210234010233678861586201359687677886179999740010258999999858998877899899
Q ss_pred HHHHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 3999998636998213202334462333124579799999999762036999999989999999985674
Q 001710 942 SLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
.+...+....+. ..+..++.++.+|+.+||++||++||||.++++.|+++...
T Consensus 256 ~~~~~i~~~~~~-----------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKEGFRM-----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHTCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCC-----------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 999998668988-----------------98543659999999997577965792999999999876534
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.16 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=200.4
Q ss_pred HCCCCCCC-EEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE----CCEE
Q ss_conf 15987677-220112229999997-59978999990110125677799999998304-78761048316741----7715
Q 001710 729 TDGFNECN-LLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNV-RHRNLVKIFSSCCN----IDFK 801 (1022)
Q Consensus 729 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~ 801 (1022)
.++|.+.. .||+|+||+||+|+. .+++.||+|+++.. ..+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 89997158998888762048-778999999999999999999982399999185179999677658---99589961147
Q 001710 802 ALVLEFMPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE---NMTAHVSDFGI 877 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~---~~~~kl~Dfg~ 877 (1022)
|+|||||+||+|.+++...+ ..+++..+..++.|++.|++|||+ .+|+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~----~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999977899849999986278775799999999999999999997----6986444100220113555566311354551
Q ss_pred CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCH
Q ss_conf 60038999740110246886437755568887785201675889999987199999832446103999998636998213
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
|+....... .....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+...... ...........
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~--- 232 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMG--- 232 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC---
T ss_pred EEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH--HHHHHHHHHCC---
T ss_conf 233368886---4322677563792777489888888887645167788658899889887788--99999998538---
Q ss_pred HCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 20233446233312457979999999976203699999998999999
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
... ........+++++.+++.+|+++||++|||+.|+++|
T Consensus 233 ----~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ----QYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSS---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCC---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----888---8985434699999999999756996579099999709
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.52 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=216.7
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEECC--------CCEEEEEEECCHHH-HHHHHHHHHHHHHHHC-CCCCCEEEEEEEE
Q ss_conf 841598767722011222999999759--------97899999011012-5677799999998304-7876104831674
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTLFD--------GTNVAIKVFNLQLE-RAFRTFDSECEILRNV-RHRNLVKIFSSCC 796 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 796 (1022)
...++|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 25899697009851678289999985787555667549999998811286889999999999998139996973465220
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCC
Q ss_conf 1771589997158998888762048---------------7789999999999999999999823999991851799996
Q 001710 797 NIDFKALVLEFMPNGSFEKWLYSYN---------------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNN 861 (1022)
Q Consensus 797 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~N 861 (1022)
+....++||||+++|+|.+++.... ..+++..+++++.|++.|++|||+ .+|+||||||+|
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~----~~ivHrDiKp~N 165 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS----KKCIHRDLAARN 165 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGG
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEEEEECCCC
T ss_conf 1886899997369990999998606776432223345743467999999999999999987663----797863022102
Q ss_pred EEECCCCCEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf 7765899589961147600389997401102468864377555688877852016758899999871-999998324461
Q 001710 862 ILLDENMTAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGE 940 (1022)
Q Consensus 862 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~ 940 (1022)
||++.++.+||+|||.++...............+++.|+|||.+.++.|+.++||||||+++|||++ |..||.+....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH-
T ss_conf 2454789767622111011355555431466788846632667517988825554775888887401798989999999-
Q ss_pred HHHHHHHHHHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 03999998636998213202334462333124579799999999762036999999989999999985674
Q 001710 941 MSLRRWVKESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVK 1011 (1022)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~ 1011 (1022)
.....+...... ..+..+++++.+++.+||++||++|||+.|+++.|++|.+.
T Consensus 245 -~~~~~i~~~~~~-----------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 -ELFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHHHHHTTCCC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHCCCCC-----------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -999999728888-----------------98743529999999997667976793999999999888604
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.77 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=209.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCC--EEEEEEECCHH-HHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCEEEEE
Q ss_conf 59876772201122299999975-997--89999901101-25677799999998304-787610483167417715899
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLF-DGT--NVAIKVFNLQL-ERAFRTFDSECEILRNV-RHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 804 (1022)
++|++.+.||+|+||.||+|++. ++. .||||++.... .+..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 9715899888876204---------------8778999999999999999999982399999185179999677658995
Q 001710 805 LEFMPNGSFEKWLYSY---------------NYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
|||+++|+|.++++.. ...+++..+..++.||+.|+.|+|+ .+|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~----~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ----KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECGGGC
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC----CCCCCCCCCCCEEEECCCCC
T ss_conf 98028986999986403555551231012345789999999999999999876630----89545550520489868876
Q ss_pred EEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 8996114760038999740110246886437755568887785201675889999987199-999832446103999998
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 870 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~-~p~~~~~~~~~~~~~~~~ 948 (1022)
+||+|||+|+...... ......||..|+|||.+.++.++.++||||||+++|||++|. +||.+.... .+...+.
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLP 240 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGG
T ss_pred EEECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH
T ss_conf 3874344322444223---4553013775555387526999962215313889999983689999999999--9999998
Q ss_pred HHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 6369982132023344623331245797999999997620369999999899999999856742
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
.. .+...+..+++++.+++.+||+.||++||||.|++++|+++..+.
T Consensus 241 ~~-----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 QG-----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GT-----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HC-----------------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 26-----------------888887667899999999976789668949999999999998618
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.45 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=209.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCEEEEEEEC
Q ss_conf 159876772201122299999975997899999011012567779999999830478761048316741-7715899971
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN-IDFKALVLEF 807 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 807 (1022)
.++|++.+.||+|+||.||+|+. .|..||||+++.+. ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 89948857982079808999999-99099999988577--7999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 58998888762048-77899999999999999999998239999918517999967765899589961147600389997
Q 001710 808 MPNGSFEKWLYSYN-YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 886 (1022)
+++|+|.+++.... ..+++..+++++.|++.|++|||+ .+|+||||||+||+++.++.+|++|||.++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~----~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG----NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCC----CCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf 699989999874578888999999999999852321133----76553666567601468997763245600344787--
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCCC
Q ss_conf 401102468864377555688877852016758899999871-9999983244610399999863699821320233446
Q 001710 887 SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVG 965 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 965 (1022)
.....++..|+|||++.++.++.++||||||+++|||+| |+.||...... .....+....
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~-------------- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY-------------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC--------------
T ss_pred ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCC--------------
T ss_conf ---765566646778178727988858877757999999997899999999999--9999998089--------------
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 23331245797999999997620369999999899999999856742
Q 001710 966 EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 966 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
+...+..+++.+.+++.+||+.||++||||.+++++|+.++...
T Consensus 218 ---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 218 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ---99997657999999999975669768939999999999998677
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=346.06 Aligned_cols=260 Identities=21% Similarity=0.349 Sum_probs=211.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----E
Q ss_conf 15987677220112229999997-599789999901101---256777999999983047876104831674177----1
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID----F 800 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 800 (1022)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 58999715899888876204877899999999999999999998239999918517999967765899589961147600
Q 001710 801 KALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 801 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~ 880 (1022)
.|+||||++||+|.+++...+. +++..+..++.|++.|++|||+ .+|+||||||+||+++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH~----~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ----NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEEHHHHCCCCC-CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf 9999977889871011203589-9999999999999999999985----7952763467556657543201003444322
Q ss_pred CCCCCC-CEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHC
Q ss_conf 389997-4011024688643775556888778520167588999998719999983244610399999863699821320
Q 001710 881 LGEGDD-SVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 881 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ..........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~~------- 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPI------- 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCC-------
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCC-------
T ss_conf 12354433334642576243699998399999663202652899999769799899699999-9999846999-------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 2334462333124579799999999762036999999-9899999999856
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-HMTDAAAELKKIR 1009 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~eil~~L~~i~ 1009 (1022)
........+++++.+++.+|+++||++|| +++++.+.|.++.
T Consensus 233 --------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------CCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf --------9710034789999999999866797677739999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.97 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=209.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC--CC--CEEEEEEECCHH---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEE
Q ss_conf 159876772201122299999975--99--789999901101---25677799999998304787610483167417715
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTLF--DG--TNVAIKVFNLQL---ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFK 801 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 801 (1022)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++.... .+..+.+.+|+.++++++||||++++|++.+. ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CH
T ss_conf 48919978980388839999999889990799999999835557989999999999999868999987898777401-00
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 89997158998888762048778999999999999999999982399999185179999677658995899611476003
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
++||||+++|++.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+|++|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES----KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred HEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 11465423861254442126899999999999999999987521----78752056688815655654332561155530
Q ss_pred CCCCCCEE-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCHHC
Q ss_conf 89997401-102468864377555688877852016758899999871-9999983244610399999863699821320
Q 001710 882 GEGDDSVT-QTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
........ .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+....+ ....+... +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~---~----- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE---G----- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTS---C-----
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHHC---C-----
T ss_conf 3588752654763257310799998379999421566148999999968999999969999--99999847---9-----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 2334462333124579799999999762036999999989999999985
Q 001710 960 DANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKI 1008 (1022)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 1008 (1022)
.....+..++.++.+++.+||.+||++||||.|+.+.|++.
T Consensus 232 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf --------99998544539999999997688966792999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.54 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=203.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---HHHHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCEEEEE
Q ss_conf 5987677220112229999997-599789999901101---256777999999983-04787610483167417715899
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---ERAFRTFDSECEILR-NVRHRNLVKIFSSCCNIDFKALV 804 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 804 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|+++... ....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 97158998888762048778999999999999999999982399999185179999677658995899611476003899
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEG 884 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~ 884 (1022)
|||+++|+|.+++..... +++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+|++|||.|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH~----~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS----KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 750379808998640478-9999999999999999999986----89340347654044448996301555302323566
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHCCCCCC
Q ss_conf 97401102468864377555688877852016758899999871999998324461039999986369982132023344
Q 001710 885 DDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 964 (1022)
Q Consensus 885 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 964 (1022)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+..-+....
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~------------- 219 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN------------- 219 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-------------
T ss_pred C--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHCCC-------------
T ss_conf 5--3345457877768999982799883232011227898987388999998999--9999997189-------------
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH
Q ss_conf 62333124579799999999762036999999989-9999
Q 001710 965 GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMT-DAAA 1003 (1022)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~ 1003 (1022)
...+..+++++.+++.+||++||++||++. ++++
T Consensus 220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf -----98975679999999999654489878388999980
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.65 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=216.1
Q ss_pred HHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC
Q ss_conf 984159876772201122299999975------99789999901101-25677799999998304787610483167417
Q 001710 726 QRATDGFNECNLLGRGSFGLVYKGTLF------DGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI 798 (1022)
Q Consensus 726 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 798 (1022)
+...++|...+.||+|+||.||+|.+. +++.||||+++... ......+.+|+.++++++||||+++++++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 42689918835982078818999998786447789689999987012868999999999999976999884125478428
Q ss_pred CEEEEEEECCCCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 71589997158998888762048---------778999999999999999999982399999185179999677658995
Q 001710 799 DFKALVLEFMPNGSFEKWLYSYN---------YFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMT 869 (1022)
Q Consensus 799 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~ 869 (1022)
+..++||||+++|+|.+++.... ..+++..+.+++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~----~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA----NKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH----TTCBCSCCSGGGEEECTTCC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECEECCCCEEECCCCE
T ss_conf 81067776048998899987503321134446887999999999999999998764----79654328677540359964
Q ss_pred EEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 8996114760038999740110246886437755568887785201675889999987199-999832446103999998
Q 001710 870 AHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLRRWVK 948 (1022)
Q Consensus 870 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~-~p~~~~~~~~~~~~~~~~ 948 (1022)
+||+|||+|+...............|++.|+|||.+.++.++.++||||||+++|||+||. .||.+....+ ....+.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i~ 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVM 249 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHH
T ss_pred EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
T ss_conf 999424542023577630313402316323788887369988333444378999999968999999989999--999998
Q ss_pred HHCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 636998213202334462333124579799999999762036999999989999999985674203
Q 001710 949 ESLPHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQ 1014 (1022)
Q Consensus 949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~~ 1014 (1022)
... ....+..++..+.+++.+||+.+|++|||+.+++++|++..+..-+
T Consensus 250 ~~~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 EGG-----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp TTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HCC-----------------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCC
T ss_conf 088-----------------8888633539999999997577965893999999997876177875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=341.10 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=206.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH---------HHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 15987677220112229999997-599789999901101---------256777999999983047-8761048316741
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL---------ERAFRTFDSECEILRNVR-HRNLVKIFSSCCN 797 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 797 (1022)
.++|++.+.||+|+||+||+|+. .+++.||+|++.... +...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 77158999715899888876204877899999999999999999998239999918517999967765899589961147
Q 001710 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~ 877 (1022)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~----~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK----LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 760599997689866899998659-99999999999999999999987----5994323462548986899838712403
Q ss_pred CEECCCCCCCEEEECCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 60038999740110246886437755568------887785201675889999987199999832446103999998636
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL 951 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 951 (1022)
++.+..... .....||+.|+|||++. ...++.++||||+||++|||++|+.||.+....+ ..........
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY 232 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred EEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH-HHHHHHHCCC
T ss_conf 167268872---134524678889888605344567889923318565602310322888988999999-9999981898
Q ss_pred CCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 99821320233446233312457979999999976203699999998999999
Q 001710 952 PHGLTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.. .......+++++.+++.+||++||++||++.|+++|
T Consensus 233 ~~---------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 QF---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC---------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88---------------985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.44 Aligned_cols=272 Identities=23% Similarity=0.280 Sum_probs=207.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf 5987677220112229999997-5997899999011012--567779999999830478761048316741771589997
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE--RAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|+||+||+|+. .+++.||+|+++.... .....+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 15899888876204877899999999999999999998239999918517999967765899589961147600389997
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 886 (1022)
|+.++.+..........+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~----~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS----HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC----CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC
T ss_conf 237744555442025688889999999999999998652----8899213571140113467621035786134368864
Q ss_pred CEEEECCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCC--CCHHCC-C
Q ss_conf 40110246886437755568887-785201675889999987199999832446103999998636-998--213202-3
Q 001710 887 SVTQTITMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL-PHG--LTEVVD-A 961 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~-~ 961 (1022)
......||+.|+|||+..... ++.++||||+||++|+|++|+.||.+....+ .+........ +.. ...... .
T Consensus 158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf --10010365215411221366577742210333313427966879989889999-999999832898333144422242
Q ss_pred CCCC------HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 3446------233312457979999999976203699999998999999--9985
Q 001710 962 NLVG------EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKI 1008 (1022)
Q Consensus 962 ~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i 1008 (1022)
.... ...........+.++.+++.+|+++||++|||+.|+++| ++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 1243454322220444166789999999999763995579189999678701469
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.51 Aligned_cols=263 Identities=25% Similarity=0.280 Sum_probs=200.0
Q ss_pred CCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHH-----HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 677220112229999997-59978999990110125-----677799999998304787610483167417715899971
Q 001710 734 ECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLER-----AFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 734 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
..++||+|+||+||+|+. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 58998888762048778999999999999999999982399999185179999677658995899611476003899974
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 887 (1022)
++++++...... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~----~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ----HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred HCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHC----CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 345077655412-6677899999999999999988631----6355035776258853778411465761000578755-
Q ss_pred EEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC---CCHHCCC--
Q ss_conf 01102468864377555688-87785201675889999987199999832446103999998636998---2132023--
Q 001710 888 VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG---LTEVVDA-- 961 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 961 (1022)
.....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+....+ .+....+...... +......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf -43302047333639997267788805643630428999985969999999999-9999998518997254521000213
Q ss_pred --CCCC--HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --3446--233312457979999999976203699999998999999
Q 001710 962 --NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 962 --~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.... ...........++++.+++.+|+++||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44303478988678565689999999999763894569089999679
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.19 Aligned_cols=270 Identities=24% Similarity=0.281 Sum_probs=204.1
Q ss_pred HHHCCCCCCCEEECCCCEEEEEEEE-CC-CCEEEEEEECCHHH--HHHHHHHHHHHHHHHC---CCCCCEEEEEEEEE--
Q ss_conf 8415987677220112229999997-59-97899999011012--5677799999998304---78761048316741--
Q 001710 727 RATDGFNECNLLGRGSFGLVYKGTL-FD-GTNVAIKVFNLQLE--RAFRTFDSECEILRNV---RHRNLVKIFSSCCN-- 797 (1022)
Q Consensus 727 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-- 797 (1022)
+..++|++.+.||+|+||+||+|+. .+ ++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 87589798889921558699999998889989999998023245167999999999999874258988023663221466
Q ss_pred ---CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf ---77158999715899888876204877899999999999999999998239999918517999967765899589961
Q 001710 798 ---IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 798 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
....++++||++++.+..........+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~----~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS----HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCCCEEEECCCCCEEECC
T ss_conf 666746999997405871444443037899989999999999999999975----8898357986278985899754210
Q ss_pred CCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 14760038999740110246886437755568887785201675889999987199999832446103999998636998
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG 954 (1022)
Q Consensus 875 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 954 (1022)
||.+..... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+...........
T Consensus 160 fg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 160 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 235 (305)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred HHHHHHHCC---CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHCCCC
T ss_conf 001011002---34577765485114831001798881110003289999998787998998989-99999998407996
Q ss_pred CCHHC------CCCC--CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 21320------2334--46233312457979999999976203699999998999999
Q 001710 955 LTEVV------DANL--VGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 955 ~~~~~------~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
..... .... .............++.+.+|+.+|+++||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1105321111033302234564544044589999999999874896679189999669
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=334.60 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=207.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEEC
Q ss_conf 5987677220112229999997599789999901101--25677799999998304787610483167417715899971
Q 001710 730 DGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLEF 807 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 807 (1022)
++|++.+.||+|+||+||+|+..+++.||+|++.... +...+.+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 58998888762048778999999999999999999982399999185179999677658995899611476003899974
Q 001710 808 MPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDDS 887 (1022)
Q Consensus 808 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 887 (1022)
+.++.+..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~----~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD----RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHCC----CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC-
T ss_conf 0045678998604-775144568999999999998605----7488267877505686899787323664301146765-
Q ss_pred EEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC---CCCHHCC---
Q ss_conf 01102468864377555688-8778520167588999998719999983244610399999863699---8213202---
Q 001710 888 VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH---GLTEVVD--- 960 (1022)
Q Consensus 888 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 960 (1022)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. ........... .+.....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -410102431101378871788888410021117589999779799898898999-999998638997110421233322
Q ss_pred --CCCC--CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --3344--6233312457979999999976203699999998999999
Q 001710 961 --ANLV--GEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 961 --~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.... ............++++.+++.+|+++||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 143333356764666512589999999999866896689099998569
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.79 Aligned_cols=274 Identities=20% Similarity=0.218 Sum_probs=204.1
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----EE
Q ss_conf 415987677220112229999997-599789999901101-256777999999983047876104831674177----15
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL-ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID----FK 801 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 801 (1022)
..++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||+|+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 89997158998888762048778999999999999999999982399999185179999677658995899611476003
Q 001710 802 ALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLL 881 (1022)
Q Consensus 802 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~ 881 (1022)
+++++|+.+|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|...
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH~----~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHS----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99999625986566440589--9999999999999999999997----89867778764378879997787545705650
Q ss_pred CCCCCC-EEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCHHC
Q ss_conf 899974-01102468864377555688-8778520167588999998719999983244610399999863699821320
Q 001710 882 GEGDDS-VTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTEVV 959 (1022)
Q Consensus 882 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1022)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.... ..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDLN 238 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH-HHHHCCCCCHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998-76520699756642
Q ss_pred CC----------CCCC--HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 23----------3446--233312457979999999976203699999998999999--9985
Q 001710 960 DA----------NLVG--EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKI 1008 (1022)
Q Consensus 960 ~~----------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i 1008 (1022)
.. .... ...........+.++.+++.+|+++||++|||+.|++++ +++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 343322220244677557787778378999999999999764895679089998619865558
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.50 Aligned_cols=241 Identities=21% Similarity=0.235 Sum_probs=197.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHH------HHHHHHHHHHHHHHHCC--CCCCEEEEEEEEECC
Q ss_conf 15987677220112229999997-5997899999011012------56777999999983047--876104831674177
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLE------RAFRTFDSECEILRNVR--HRNLVKIFSSCCNID 799 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 799 (1022)
.++|++.+.||+|+||+||+|+. .+++.||+|++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCEEEEECCC
Q ss_conf 15899971589-98888762048778999999999999999999982399999185179999677658-99589961147
Q 001710 800 FKALVLEFMPN-GSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-NMTAHVSDFGI 877 (1022)
Q Consensus 800 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-~~~~kl~Dfg~ 877 (1022)
..++||||+.+ +++.+++..... +++..+..++.|++.|++|||+ .+|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~-l~e~~~~~~~~qi~~al~~lH~----~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN----CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEEECCCCCHHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 689999833686228999861589-9999999999999999999987----79755667611147744788489775465
Q ss_pred CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 600389997401102468864377555688877-8520167588999998719999983244610399999863699821
Q 001710 878 SKLLGEGDDSVTQTITMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT 956 (1022)
Q Consensus 878 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 956 (1022)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ...+...
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~----- 221 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----- 221 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC-----
T ss_pred CEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-------HHHHCCC-----
T ss_conf 3532444----55665658774799998489978865332554034536756889988736-------7761544-----
Q ss_pred HHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 320233446233312457979999999976203699999998999999
Q 001710 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
..+..++.++.+++.+||++||++|||++|++++
T Consensus 222 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------------7787799999999999760897589399998539
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.58 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=197.0
Q ss_pred CCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE------CCEEEE
Q ss_conf 987677220112229999997-5997899999011012567779999999830478761048316741------771589
Q 001710 731 GFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLVKIFSSCCN------IDFKAL 803 (1022)
Q Consensus 731 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~l 803 (1022)
+|...++||+|+||+||+|+. .+++.||+|++..... ...+|++++++++|+||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCEE
Q ss_conf 997158998888762--04877899999999999999999998239999918517999967765899-589961147600
Q 001710 804 VLEFMPNGSFEKWLY--SYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKL 880 (1022)
Q Consensus 804 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~Dfg~a~~ 880 (1022)
||||++++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~----~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 98416886078888631036899999999999999999999986----68764578860378735897116733660544
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC-----
Q ss_conf 389997401102468864377555688-87785201675889999987199999832446103999998636998-----
Q 001710 881 LGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHG----- 954 (1022)
Q Consensus 881 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 954 (1022)
...... ....+|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+......
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHHCCCHHHHHH
T ss_conf 047765---3200255555682776404688821000246527785502879989879999-999999974898177654
Q ss_pred -----CCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHHHHH
Q ss_conf -----21320233446233312457979999999976203699999998999999--998567
Q 001710 955 -----LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKIRV 1010 (1022)
Q Consensus 955 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i~~ 1010 (1022)
.....-+...............++++.+|+.+|+++||++|||+.|+++| ++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 306210110355445674444315689999999999976589557929999966984524667
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.83 Aligned_cols=269 Identities=22% Similarity=0.246 Sum_probs=205.4
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-----
Q ss_conf 415987677220112229999997-599789999901101--256777999999983047876104831674177-----
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNID----- 799 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 799 (1022)
..++|++.+.||+|+||+||+|.. .+|+.||+|+++... +...+.+.+|+++++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf -1589997158998888762048778999999999999999999982399999185179999677658995899611476
Q 001710 800 -FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGIS 878 (1022)
Q Consensus 800 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a 878 (1022)
+.++||||+ ++++..+.+... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~----~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 1599998405-521899987402--2699999999999999999873----78764566851111210012211343102
Q ss_pred EECCCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC--
Q ss_conf 00389997401102468864377555688-877852016758899999871999998324461039999986369982--
Q 001710 879 KLLGEGDDSVTQTITMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGL-- 955 (1022)
Q Consensus 879 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 955 (1022)
+..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ..+............
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCCCCCHHH
T ss_conf 206876-----310245533358899817878996501030038999999786998889768-99999985037884888
Q ss_pred CHH--------CCCCCCCH--HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--HHHHH
Q ss_conf 132--------02334462--33312457979999999976203699999998999999--99856
Q 001710 956 TEV--------VDANLVGE--EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE--LKKIR 1009 (1022)
Q Consensus 956 ~~~--------~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i~ 1009 (1022)
... ....+... ..........++++.+|+.+|+..||++|||+.|+++| ++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 865300034433115786665566775568999999999997729955792999996396237587
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.77 Aligned_cols=270 Identities=21% Similarity=0.237 Sum_probs=201.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--------
Q ss_conf 15987677220112229999997-599789999901101--2567779999999830478761048316741--------
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN-------- 797 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 797 (1022)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... +.....+.+|+.+++.++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 77158999715899888876204877899999999999999999998239999918517999967765899589961147
Q 001710 798 IDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGI 877 (1022)
Q Consensus 798 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~ 877 (1022)
....++||||++++.+..+... ...++...+..++.|++.|+.|||+ .+|+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~----~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR----NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHHCC----CCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 7638999853578741012220-3443308999999999999988522----9988567672220366899687631350
Q ss_pred CEECCCCCCC--EEEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC--C
Q ss_conf 6003899974--011024688643775556888-7785201675889999987199999832446103999998636--9
Q 001710 878 SKLLGEGDDS--VTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESL--P 952 (1022)
Q Consensus 878 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~ 952 (1022)
+..+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ........... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHH-HHHHHHHHHCCCCC
T ss_conf 02235544432113566024978742899707999891787006786466174487998998999-99999998418998
Q ss_pred CC-CCHHCCC----CCC---CH---HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 98-2132023----344---62---33312457979999999976203699999998999999
Q 001710 953 HG-LTEVVDA----NLV---GE---EQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ~~-~~~~~~~----~~~---~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.. ....... .+. .. ...........+.+.+|+.+||++||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 255344320344433201334455503340444599899999999873896589099999749
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=320.58 Aligned_cols=263 Identities=17% Similarity=0.193 Sum_probs=205.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCE-EEEEEEEECCEEEEEEE
Q ss_conf 15987677220112229999997-59978999990110125677799999998304787610-48316741771589997
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV-KIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||.||+|+. .+++.||||+...... ...+..|+++++.++|++++ .+.+++.+....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999951987789998
Q ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCEECCC
Q ss_conf 15899888876204877899999999999999999998239999918517999967765---899589961147600389
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLD---ENMTAHVSDFGISKLLGE 883 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~---~~~~~kl~Dfg~a~~~~~ 883 (1022)
|+ ++++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||+++ .+..++++|||+|+.+..
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS----KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 73-871333244306887689999999999999999997----9944266787660643357776156504675134255
Q ss_pred CCCC-----EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH--HHHHHHHCCCCCC
Q ss_conf 9974-----01102468864377555688877852016758899999871999998324461039--9999863699821
Q 001710 884 GDDS-----VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL--RRWVKESLPHGLT 956 (1022)
Q Consensus 884 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~ 956 (1022)
.... .......||+.|+|||...+..++.++||||+||++|||++|+.||.......... ..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 235 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--- 235 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS---
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC---
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789---
Q ss_pred HHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 32023344623331245797999999997620369999999899999999856742
Q 001710 957 EVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKF 1012 (1022)
Q Consensus 957 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~ 1012 (1022)
+.......+++++.+++..||+.+|++||++.++.+.|+.+..+.
T Consensus 236 -----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 236 -----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------CHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf -----------835753478899999999984399557919999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=319.75 Aligned_cols=267 Identities=15% Similarity=0.138 Sum_probs=214.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCEEEEEEE
Q ss_conf 15987677220112229999997-5997899999011012567779999999830478-761048316741771589997
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH-RNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 806 (1022)
.++|++.+.||+|+||+||+|+. .+++.||+|+...... ...+.+|++.++.++| ++++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCEEC
Q ss_conf 158998888762048778999999999999999999982399999185179999677658-----995899611476003
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDE-----NMTAHVSDFGISKLL 881 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~-----~~~~kl~Dfg~a~~~ 881 (1022)
|+ +++|.+++......++...+..++.|++.|++|||+ .+|+||||||+||+++. ++.+|++|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~----~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE----KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT----TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHH----CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 64-888799997520311068999999999999999997----7966266771315234754344795687236605771
Q ss_pred CCCCCC-----EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH-HHHHHHHCCCCC
Q ss_conf 899974-----01102468864377555688877852016758899999871999998324461039-999986369982
Q 001710 882 GEGDDS-----VTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL-RRWVKESLPHGL 955 (1022)
Q Consensus 882 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 955 (1022)
...... ......+||+.|+|||.+.+..+++++||||+|+++|||++|+.||.......... ...+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 233 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC---
T ss_conf 46766541110246762775102679896488888699989831999999869876788530219999999970567---
Q ss_pred CHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 132023344623331245797999999997620369999999899999999856742034
Q 001710 956 TEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAELKKIRVKFLQQ 1015 (1022)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i~~~~~~~ 1015 (1022)
. .........+++++.+++..|+..+|++||+++.+.+.++++..+....
T Consensus 234 --------~--~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 234 --------S--TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp --------H--SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --------C--CCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
T ss_conf --------9--9958965799899999999984399300859999999999999975999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.81 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=198.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE--CCEEEEE
Q ss_conf 15987677220112229999997-599789999901101256777999999983047-8761048316741--7715899
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSCCN--IDFKALV 804 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 804 (1022)
.++|++.+.||+|+||+||+|+. .+++.||+|+++... .+.+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 867189789831748199999988999799999988899---99999999999851579987679999981687712688
Q ss_pred EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCEECCC
Q ss_conf 9715899888876204877899999999999999999998239999918517999967765899-589961147600389
Q 001710 805 LEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM-TAHVSDFGISKLLGE 883 (1022)
Q Consensus 805 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~-~~kl~Dfg~a~~~~~ 883 (1022)
|||+++++|..+.+ .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+|++|||+|+....
T Consensus 111 ~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~----~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 86317985899746----89999999999999999988764----33443456441237748998366415654266468
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH------------HH
Q ss_conf 9974011024688643775556888-7785201675889999987199999832446103999998------------63
Q 001710 884 GDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVK------------ES 950 (1022)
Q Consensus 884 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~------------~~ 950 (1022)
... .....+|+.|+|||...+. .++.++||||+||++|||++|+.||............... ..
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 874---44322486424761026888888452323354555876048899988760189999999987884155555422
Q ss_pred -CCCC--CCHHCCCCCCC---HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -6998--21320233446---233312457979999999976203699999998999999
Q 001710 951 -LPHG--LTEVVDANLVG---EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 951 -~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.... ........... ..........+++++.+|+.+|+++||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 544474300000333433112115521124489999999999866995689089999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.24 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=201.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE------CC
Q ss_conf 15987677220112229999997-599789999901101--2567779999999830478761048316741------77
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCN------ID 799 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 799 (1022)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 15899971589988887620487789999999999999999999823999991851799996776589958996114760
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~ 879 (1022)
+.|+||||+.++.+..+ . ..+++..+..++.|++.|++|||+ .||+||||||+|||++.++.++++|||.++
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~---~~~~~~~i~~~~~qil~gl~~LH~----~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q---MELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T---SCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEEECCCHHHHHHH-H---CCCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 26999841446778765-0---389999999999999999988652----211245677632113654431320102321
Q ss_pred ECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCC-------
Q ss_conf 0389997401102468864377555688877852016758899999871999998324461039999986369-------
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLP------- 952 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 952 (1022)
..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ............
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred CCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHHH
T ss_conf 14666---5533221465555813314777787743335662578986598998889778-8999999720589879998
Q ss_pred ---------------CC---CCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---------------98---21320233446233312457979999999976203699999998999999
Q 001710 953 ---------------HG---LTEVVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 953 ---------------~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.. ......... ...........+.++.+|+.+|+..||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 76566777764175435666421264333--543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.78 Aligned_cols=268 Identities=20% Similarity=0.230 Sum_probs=207.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf 5987677220112229999997-599789999901101--2567779999999830478761048316741771589997
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNIDFKALVLE 806 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 806 (1022)
++|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 15899888876204877899999999999999999998239999918517999967765899589961147600389997
Q 001710 807 FMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKLLGEGDD 886 (1022)
Q Consensus 807 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~~~~~~~ 886 (1022)
++.++++..+....+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~----~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHS----RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ECCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHHHC----CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf 023322211212356-54036789999999999877433----9986001467612113378266520460110468875
Q ss_pred CEEEECCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC---CCCHH---C
Q ss_conf 40110246886437755568887-78520167588999998719999983244610399999863699---82132---0
Q 001710 887 SVTQTITMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPH---GLTEV---V 959 (1022)
Q Consensus 887 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---~ 959 (1022)
. .....+++.|+|||.+.... ++.++||||+||++|||++|+.||.................... .+... .
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred C--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf 1--00103443101466750698888044402654188998518999988999999999998611899735513443222
Q ss_pred CC----CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 23----3446233312457979999999976203699999998999999
Q 001710 960 DA----NLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 960 ~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
+. ...............++.+.+++.+|+++||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.57 Aligned_cols=254 Identities=23% Similarity=0.284 Sum_probs=204.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEE----CCCCEEEEEEECCHH----HHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECC
Q ss_conf 15987677220112229999997----599789999901101----2567779999999830478-76104831674177
Q 001710 729 TDGFNECNLLGRGSFGLVYKGTL----FDGTNVAIKVFNLQL----ERAFRTFDSECEILRNVRH-RNLVKIFSSCCNID 799 (1022)
Q Consensus 729 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 799 (1022)
.++|++.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 10259998983287839999998765887948999998367721016899999999999986467983999620002487
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 15899971589988887620487789999999999999999999823999991851799996776589958996114760
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~ 879 (1022)
..++++||+.+|+|.+++..... ..+.....++.|++.|++|+|+ .+|+||||||+||+++.++.+||+|||+|+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~----~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CEEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHC----CCEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 30012312341179999873045-4378888889999999988514----998965477320124699988874132022
Q ss_pred ECCCCCCCEEEECCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCH
Q ss_conf 03899974011024688643775556888--7785201675889999987199999832446103999998636998213
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLTE 957 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 957 (1022)
.+...... ......|++.|+|||...+. .++.++||||+||++|||++|+.||......+... .........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKS---- 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHC----
T ss_pred HHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHHCCCC----
T ss_conf 20344443-221222333331068760577688713251777799999976899988887777999-999833568----
Q ss_pred HCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 202334462333124579799999999762036999999-----98999999
Q 001710 958 VVDANLVGEEQAFSAKTDCLLSIMDLALDCCMESPEQRI-----HMTDAAAE 1004 (1022)
Q Consensus 958 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~ 1004 (1022)
....+..++.++.+++.+||++||++|| +++|+++|
T Consensus 252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -----------99886547999999999974458988199974509999749
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=317.88 Aligned_cols=274 Identities=27% Similarity=0.489 Sum_probs=201.5
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CEEEEECCCC--CCEEEEECCCCCCCC--CCCCCCCCCCCCCE
Q ss_conf 97558999999996235898743489999999855--0112882899--929999739997656--34888878887438
Q 001710 7 NLTTDQSALLAFKADVIDSRSVLANNWSISYPICN--WVGISCGARH--HRVVALNLSSFSLGG--IIPPHLGNLSFLVS 80 (1022)
Q Consensus 7 ~~~~d~~~ll~~k~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~~~~--~~~~~l~~l~~L~~ 80 (1022)
|+++|++||++||+++.+|. .+ ++|..+.|||. |.||+|+..+ .||+.|+|+++++.+ .+|+.+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l-~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-CC-CCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 89899999999999779998-67-78899999988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf 85558-85468888874312445501233332479888555545665435434466688840110174564523125753
Q 001710 81 LDISE-NNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENS 159 (1022)
Q Consensus 81 L~Ls~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 159 (1022)
|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|++++++.|.+.+.+|..+..++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCC-CCCCC-CCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHH
Q ss_conf 466667764-45534-4100212435555894554888777054433626678971102777664897313335687713
Q 001710 160 LSGSLPNDI-RLPKL-EKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNLSQLTDLNLAQNNLQGDMPT 237 (1022)
Q Consensus 160 l~~~~~~~~-~l~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 237 (1022)
+.+.+|..+ .+..+ +.+.++.|++++..+..+..+.. ..++++.+.+.+.++..+..+++++.+++++|.+.+.. .
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~ 238 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-G 238 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-G
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C
T ss_conf 356203121443112323102246435332433222222-23333334332222222222222111222222222222-2
Q ss_pred HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECC
Q ss_conf 32086998899924863557689654255655244023543332226
Q 001710 238 AIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLP 284 (1022)
Q Consensus 238 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 284 (1022)
.+..+++|+.|+|++|++++.+|..+.++++|++|++++|+++|.+|
T Consensus 239 ~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC
T ss_conf 22245544444476570666087688479999989795883516689
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.78 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=200.2
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-----C
Q ss_conf 415987677220112229999997-599789999901101--25677799999998304787610483167417-----7
Q 001710 728 ATDGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQL--ERAFRTFDSECEILRNVRHRNLVKIFSSCCNI-----D 799 (1022)
Q Consensus 728 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 799 (1022)
..++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++++.++|+|++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 15899971589988887620487789999999999999999999823999991851799996776589958996114760
Q 001710 800 FKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISK 879 (1022)
Q Consensus 800 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~ 879 (1022)
..+++++|+.+|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.+.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH~----~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEECCCCHHHHCCCCC--CCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 6499999625886232002245--3099999999999999999973----887651667763345543220013210001
Q ss_pred ECCCCCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC--
Q ss_conf 03899974011024688643775556888-778520167588999998719999983244610399999863699821--
Q 001710 880 LLGEGDDSVTQTITMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLRRWVKESLPHGLT-- 956 (1022)
Q Consensus 880 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 956 (1022)
.... ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+..... ...............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL 243 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred CCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHH
T ss_conf 2575-----44443454355583553377567855124320589999976889978898899-99999973079975773
Q ss_pred HH--------CCCCCCC-HH-HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 32--------0233446-23-3312457979999999976203699999998999999
Q 001710 957 EV--------VDANLVG-EE-QAFSAKTDCLLSIMDLALDCCMESPEQRIHMTDAAAE 1004 (1022)
Q Consensus 957 ~~--------~~~~~~~-~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 1004 (1022)
.. ....... .. .........++++.+|+.+|++.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2001024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=283.23 Aligned_cols=266 Identities=18% Similarity=0.198 Sum_probs=191.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-CCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 5987677220112229999997-599789999901101256777999999983047-----------8761048316741
Q 001710 730 DGFNECNLLGRGSFGLVYKGTL-FDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-----------HRNLVKIFSSCCN 797 (1022)
Q Consensus 730 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 797 (1022)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEECCCCCC-HHH-HHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-----
Q ss_conf 7--71589997158998-888-76204877899999999999999999998239999918517999967765899-----
Q 001710 798 I--DFKALVLEFMPNGS-FEK-WLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENM----- 868 (1022)
Q Consensus 798 ~--~~~~lv~e~~~~g~-L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~----- 868 (1022)
. ...+++++++..+. ... ........+++..+..++.|++.|++|||+. .+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~---~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR---CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCCCCC
T ss_conf 25652023432000354200000122346786899999999999998887640---586465677057056305765644
Q ss_pred -CEEEEECCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCC-----CHH
Q ss_conf -58996114760038999740110246886437755568887785201675889999987199999832446-----103
Q 001710 869 -TAHVSDFGISKLLGEGDDSVTQTITMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKKPTDEMFTG-----EMS 942 (1022)
Q Consensus 869 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~G~il~elltg~~p~~~~~~~-----~~~ 942 (1022)
.++++|||.+...... ....+||+.|+|||+..+..++.++||||+||++++|++|+.||...... ...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 30567531442123445-----4223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHHHHHCCCC---------CCHHCCC-----CCCC---------HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 999998636998---------2132023-----3446---------2333124579799999999762036999999989
Q 001710 943 LRRWVKESLPHG---------LTEVVDA-----NLVG---------EEQAFSAKTDCLLSIMDLALDCCMESPEQRIHMT 999 (1022)
Q Consensus 943 ~~~~~~~~~~~~---------~~~~~~~-----~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 999 (1022)
....+....... .....+. .+.. ...........+.++.+|+.+|+.+||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHHH
Q ss_conf 99999
Q 001710 1000 DAAAE 1004 (1022)
Q Consensus 1000 eil~~ 1004 (1022)
|+++|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHHCC
T ss_conf 99669
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.7e-40 Score=231.73 Aligned_cols=190 Identities=32% Similarity=0.421 Sum_probs=92.6
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 27775109990078788963311246545765892246788987733334333452313786114756544567532351
Q 001710 418 GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRE 497 (1022)
Q Consensus 418 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 497 (1022)
..++++..+++++|.+.+..+ +....+|+.|++++|.++.. ..+..+++|+.+++++|.+.+..+ +..+++|+.
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~ 267 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred CCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCE
T ss_conf 223532333035774478786--44457787888877777896--134325653410044674478775--355466877
Q ss_pred EECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 30458640112699520122135585358868888610011233335250357502586420011666555101357121
Q 001710 498 LHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQF 577 (1022)
Q Consensus 498 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 577 (1022)
+++++|++.+. ..+..+..++.+.+.+|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|++++|+|
T Consensus 268 L~l~~~~l~~~--~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 268 LKLGANQISNI--SPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred EECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCC
T ss_conf 54567445787--7323565222233232333332--21000024676777788778984--536689889898989989
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCHHHHCCCCCEEECCCC
Q ss_conf 3577822212133442321150403556820221135537984378
Q 001710 578 NGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYN 623 (1022)
Q Consensus 578 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N 623 (1022)
++ ++ .+.++++|++|++++|++++..| +..+++|+.|++++|
T Consensus 342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 SD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 99-74-67089999989897995899800--003999999639789
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-41 Score=237.29 Aligned_cols=261 Identities=33% Similarity=0.565 Sum_probs=216.3
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEEEEEC-CCCCCCCCCCCCCCCCCCEEE
Q ss_conf 7656763458886535852133210001100234313446771102777510999007-878896331124654576589
Q 001710 373 SLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDD-NELNGTIPTTVGRFQQLQGLS 451 (1022)
Q Consensus 373 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~~~~~~p~~l~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~ 451 (1022)
+++.|+|++|.+.+. ..+|..++++++|++|++++ |.+.+.+|..++++++|++|+
T Consensus 51 ~v~~L~L~~~~l~g~-----------------------~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~ 107 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKP-----------------------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107 (313)
T ss_dssp CEEEEEEECCCCSSC-----------------------EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEE
T ss_pred EEEEEECCCCCCCCC-----------------------CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 988998989988888-----------------------879847846753352020265433300243114542001102
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCC-CEEECCCCCCC
Q ss_conf 22467889877333343334523137861147565445675323513045864011269952012213-55853588688
Q 001710 452 LYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYI-LYVNLSSNSLS 530 (1022)
Q Consensus 452 L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~ 530 (1022)
|++|++.+..+..+..+..|+.++++.|.+...+|..+..++.++.+++++|.+.+.+|..+..+..+ +.+++++|+++
T Consensus 108 Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp EEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred HCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 03564344332222201110011112245555685122067400000023553356203121443112323102246435
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCHHH
Q ss_conf 88610011233335250357502586420011666555101357121357782221213344232115040355682022
Q 001710 531 GPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLE 610 (1022)
Q Consensus 531 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 610 (1022)
+..|..+..+. ...+++++|.+.+.+|..+..++.++.+++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+.
T Consensus 188 ~~~~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred CCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHH
T ss_conf 33243322222-2233333343322222222222221112222222222222-222455444444765706660876884
Q ss_pred HCCCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 113553798437815010699999887765666677235699876999986
Q 001710 611 ALLYLKKLNVSYNRLEGEIPIKGPFRNFSAQSFSGNYALCGPPRLQVPPCK 661 (1022)
Q Consensus 611 ~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~p~~~~~pc~ 661 (1022)
.+++|+.|++++|+++|.+|..+.++.+....+.+|..+||.| +|+|.
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c~ 313 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPACT 313 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC---CCCCC
T ss_conf 7999998979588351668986667998978868895001989---88989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.2e-38 Score=221.75 Aligned_cols=168 Identities=27% Similarity=0.399 Sum_probs=105.6
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 77751099900787889633112465457658922467889877333343334523137861147565445675323513
Q 001710 419 NLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLREL 498 (1022)
Q Consensus 419 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 498 (1022)
..++|+.|++++|.+.+. ..+..+++|+.+++++|.+.+.. .+..+++|+.+++++|.+.+..+ +..++.++.+
T Consensus 217 ~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l 290 (384)
T d2omza2 217 ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNL 290 (384)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred CCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf 457787888877777896--13432565341004467447877--53554668775456744578773--2356522223
Q ss_pred ECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 04586401126995201221355853588688886100112333352503575025864200116665551013571213
Q 001710 499 HLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFN 578 (1022)
Q Consensus 499 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 578 (1022)
.+.+|++.+ ...+..+++++.+++++|.+++.. .+..+++|+.|++++|++++ ++ .|+++++|+.|++++|+|+
T Consensus 291 ~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 291 ELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp ECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCC
T ss_conf 323233333--221000024676777788778984--53668988989898998999-74-6708999998989799589
Q ss_pred CCCCCCCCCCCCCCEEECCCCE
Q ss_conf 5778222121334423211504
Q 001710 579 GPIPESFGSLISLESLDVSSNN 600 (1022)
Q Consensus 579 ~~~~~~~~~l~~L~~L~L~~N~ 600 (1022)
+..| +.++++|+.|+|++|.
T Consensus 365 ~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 365 DLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp BCGG--GTTCTTCSEEECCCEE
T ss_pred CCHH--HCCCCCCCEEECCCCC
T ss_conf 9800--0039999996397895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.9e-35 Score=201.92 Aligned_cols=110 Identities=20% Similarity=0.308 Sum_probs=60.8
Q ss_pred CCCCCCCCEEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99998550112882899929999739997656348888788874388555885468888874312445501233332479
Q 001710 35 ISYPICNWVGISCGARHHRVVALNLSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSG 114 (1022)
Q Consensus 35 ~~~~~c~w~gv~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 114 (1022)
|..+-|.|.+|.|.. .+++ .+|..+. +.+++|+|++|+++...+..|.++++|++|++++|.+..
T Consensus 5 p~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CTTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEECCCEEEECC------------CCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 998895599998559------------9988-5198889--997989784991898696576046565231123443445
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCC
Q ss_conf 888555545665435434466688840110174564523125753466
Q 001710 115 SFPSWIGILSRLQILSFHNNSFTDRIPDFLLNLSKLEFLDLMENSLSG 162 (1022)
Q Consensus 115 ~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 162 (1022)
..|..|..+++|++|++++|+++. +|..+ ...++.|+++.|.+.+
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITK 114 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCB
T ss_pred CCHHHHHCCCCCCEECCCCCCCCC-CCCCH--HHHHHHHHCCCCCHHH
T ss_conf 235665279855783156875676-76400--1113232102461023
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-36 Score=206.50 Aligned_cols=206 Identities=25% Similarity=0.236 Sum_probs=70.4
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 099900787889633112465457658922467889877333343334523137-8611475654456753235130458
Q 001710 424 MFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLN-GNNLSGAIPACLGSLTSLRELHLGS 502 (1022)
Q Consensus 424 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~-~n~l~~~~~~~~~~l~~L~~L~L~~ 502 (1022)
++|+|++|+|+.+.+.+|.++++|+.|++++|.+..+.+..+.....+..+... .|.+....+..|.++++|++|++++
T Consensus 35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~ 114 (284)
T d1ozna_ 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114 (284)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCC
T ss_conf 88977488179879778641421300001344543321112122222222222210223544620101010277875688
Q ss_pred CEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC
Q ss_conf 64011269952012213558535886888861001123333525035750258642001166655510135712135778
Q 001710 503 NTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIP 582 (1022)
Q Consensus 503 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 582 (1022)
|.+....+..+....+|+.+++++|.++++.+..|..+++|+.|++++|+++...+..|.++++|+.+++++|++++..|
T Consensus 115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCH
T ss_conf 54432013533200012110200143144580574043405022314176566256665465634131421143466281
Q ss_pred CCCCCCCCCCEEECCCCEECCCCCCHHHHCCCCCEEECCCCCCEEEC
Q ss_conf 22212133442321150403556820221135537984378150106
Q 001710 583 ESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEI 629 (1022)
Q Consensus 583 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 629 (1022)
..|..+++|+.|++++|.+++..+..+..+++|+.+++++|+|.|.|
T Consensus 195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC
T ss_conf 67665320002333335221000002355465688981199887875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-34 Score=197.01 Aligned_cols=84 Identities=18% Similarity=0.132 Sum_probs=30.6
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf 4388555885468888874312445501233332479888555545665435434-466688840110174564523125
Q 001710 78 LVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFH-NNSFTDRIPDFLLNLSKLEFLDLM 156 (1022)
Q Consensus 78 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls-~n~l~~~~~~~~~~l~~L~~L~Ls 156 (1022)
+++|+|++|+++...+..|.+++.|++|++++|.+....+..+..+..+..++.. .+.++...+..|..+++|+.|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECC
T ss_conf 88897748817987977864142130000134454332111212222222222221022354462010101027787568
Q ss_pred CCCCC
Q ss_conf 75346
Q 001710 157 ENSLS 161 (1022)
Q Consensus 157 ~n~l~ 161 (1022)
+|.+.
T Consensus 114 ~n~~~ 118 (284)
T d1ozna_ 114 RCGLQ 118 (284)
T ss_dssp TSCCC
T ss_pred CCCCC
T ss_conf 85443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-33 Score=192.42 Aligned_cols=207 Identities=24% Similarity=0.237 Sum_probs=150.4
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 27775109990078788963311246545765892246788987733334333452313786114756544567532351
Q 001710 418 GNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRE 497 (1022)
Q Consensus 418 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 497 (1022)
.....+..++++++.++ .+|..+. ++++.|+|++|.|+++.+..|..+++|+.|++++|.|+. ++ .++.+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred CCCCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCC
T ss_conf 42689869980699988-6196757--688989884992898597786345655221356654444-31-1111223211
Q ss_pred EECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 30458640112699520122135585358868888610011233335250357502586420011666555101357121
Q 001710 498 LHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQF 577 (1022)
Q Consensus 498 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 577 (1022)
|++++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..++.|+.|++++|+|
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCC
T ss_conf 111222221-1111212222222222222311011001122221111221243421022123332211100000001565
Q ss_pred CCCCCCCCCCCCCCCEEECCCCEECCCCCCHHHHCCCCCEEECCCCCCEEECCC
Q ss_conf 357782221213344232115040355682022113553798437815010699
Q 001710 578 NGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSYNRLEGEIPI 631 (1022)
Q Consensus 578 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 631 (1022)
++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|.|.|..
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCCCH
T ss_conf 2237200134212423430139785-5686677788899998369998788643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=178.18 Aligned_cols=177 Identities=25% Similarity=0.220 Sum_probs=82.2
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 51099900787889633112465457658922467889877333343334523137861147565445675323513045
Q 001710 422 GLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLG 501 (1022)
Q Consensus 422 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 501 (1022)
++++|+|++|+|..+.+..|.++++|++|+|++|+|+.. + .+..+++|+.|++++|++. ..+..+.++++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 889898849928985977863456552213566544443-1-1111223211111222221-111121222222222222
Q ss_pred CCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC
Q ss_conf 86401126995201221355853588688886100112333352503575025864200116665551013571213577
Q 001710 502 SNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPI 581 (1022)
Q Consensus 502 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 581 (1022)
+|.+....+..+..+.++..+++++|.++...+..+..++.++.+++++|++++..+..|.++++|+.|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CC
T ss_conf 23110110011222211112212434210221233322111000000015652237200134212423430139785-56
Q ss_pred CCCCCCCCCCCEEECCCCEEC
Q ss_conf 822212133442321150403
Q 001710 582 PESFGSLISLESLDVSSNNIS 602 (1022)
Q Consensus 582 ~~~~~~l~~L~~L~L~~N~l~ 602 (1022)
|..+..+++|+.|+|++|.+.
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBC
T ss_pred CHHHCCCCCCCEEEECCCCCC
T ss_conf 866777888999983699987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=2.6e-26 Score=155.31 Aligned_cols=312 Identities=23% Similarity=0.218 Sum_probs=0.0
Q ss_pred CCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEEEEECCCCCCCCCCCCCEEEC
Q ss_conf 66489731333568771332086998899924863557689654255655244023543332226312589999528983
Q 001710 220 QLTDLNLAQNNLQGDMPTAIGNLQMLEHLNLGMNNLSGPVPPTIFNISTIRLINLIENQLSGHLPLTLGHSLPNLEFLTL 299 (1022)
Q Consensus 220 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L 299 (1022)
+++.|+|++|.++ .+| ...++|++|++++|+++ .+|.. +.+|+.|++++|++. .+....+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-----~l~~lp~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-----ALSDLPPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCC---SCCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-----CCCSCCTTCCEEEC
T ss_pred CCCEEEECCCCCC-CCC---CCCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-----HHHHHCCCCCCCCC
T ss_conf 9989993799988-788---98789888989999796-33620---332033266551432-----03210221111133
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEC
Q ss_conf 28414766883211234464222799956866995322212023002434545678999984211001346677656763
Q 001710 300 FGNNLIGTIPNSITNASKLIGLDLSSNLFSGHIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELAL 379 (1022)
Q Consensus 300 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~~~l~~~~~L~~L~L 379 (1022)
++|.+..... +..+..|+.|++++|.+. ..+.....+..+...+........ +..+..++.+++
T Consensus 106 ~~n~l~~lp~--~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~~~~~~~~~~~-------------l~~l~~l~~L~l 169 (353)
T d1jl5a_ 106 SNNQLEKLPE--LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEELPE-------------LQNLPFLTAIYA 169 (353)
T ss_dssp CSSCCSSCCC--CTTCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSSCCC-------------CTTCTTCCEEEC
T ss_pred CCCCCCCCCC--HHHHCCCEEECCCCCCCC-CCCCCCCCCCCHHHCCCCCCCCCC-------------CCCCCCCEECCC
T ss_conf 4554322210--011013123113565100-132233332100001222223332-------------000122200111
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf 45888653585213321000110023431344677110277751099900787889633112465457658922467889
Q 001710 380 NVNPLRGILPPFIGNFSASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQG 459 (1022)
Q Consensus 380 ~~N~l~~~~~~~~~~~~~~L~~l~~~~~~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 459 (1022)
+.|..... .......+.+....+.+. ....+..++.++.++++.|...
T Consensus 170 ~~n~~~~~-----------------------------~~~~~~~~~l~~~~~~~~--~~~~~~~l~~L~~l~l~~n~~~- 217 (353)
T d1jl5a_ 170 DNNSLKKL-----------------------------PDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK- 217 (353)
T ss_dssp CSSCCSSC-----------------------------CCCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-
T ss_pred CCCCCCCC-----------------------------CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 23344322-----------------------------221222222334443222--2122345553331222542223-
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 87733334333452313786114756544567532351304586401126995201221355853588688886100112
Q 001710 460 SIPYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQH 539 (1022)
Q Consensus 460 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 539 (1022)
........+..+.+..+.+. ..+.....+..........+.+. .+.......+......+.....
T Consensus 218 ---~~~~~~~~l~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~l~-----------~l~~~~~~~~~~~~~~~~~~~~ 282 (353)
T d1jl5a_ 218 ---TLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-----------ELPPNLYYLNASSNEIRSLCDL 282 (353)
T ss_dssp ---SCCSCCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSEES-----------CCCTTCCEEECCSSCCSEECCC
T ss_pred ---CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-----------CCCCHHCCCCCCCCCCCCCCCC
T ss_conf ---45532334333222333334-44333443222222223332223-----------4530001233335753234566
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCHHHHCCCCC
Q ss_conf 33335250357502586420011666555101357121357782221213344232115040355682022113553
Q 001710 540 LKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLK 616 (1022)
Q Consensus 540 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 616 (1022)
+++|+.|++++|+|+ .+| ..+++|+.|+|++|+|+ .+|.. +++|+.|++++|+++ .+|.....+..|+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp---~~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~L~ 350 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350 (353)
T ss_dssp CTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCEEE
T ss_pred CCCCCEEECCCCCCC-CCC---CCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCCCCCCEEE
T ss_conf 898898979799168-356---65487998989999687-54532---288898987699189-7776526567128
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.1e-33 Score=190.11 Aligned_cols=116 Identities=22% Similarity=0.177 Sum_probs=51.1
Q ss_pred CCCEEECCCCEECCCCCCCC----CCCCCCCEEECCCCCCCCC----CCCCC-CCCCCCCEEECCCCCCCCC----CCCC
Q ss_conf 23513045864011269952----0122135585358868888----61001-1233335250357502586----4200
Q 001710 494 SLRELHLGSNTLTYSIPSSL----WSLEYILYVNLSSNSLSGP----LPSSI-QHLKVLINLDLSRNQLSGD----IPIT 560 (1022)
Q Consensus 494 ~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~----~~~~~-~~l~~L~~L~L~~N~l~~~----~~~~ 560 (1022)
.|+.+++++|.+.......+ ....+|++|++++|.++.. ++..+ ...+.|+.|+|++|.|+.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHH
T ss_conf 43333233341023344321332211011113201210135766400111220456777889897997975999999999
Q ss_pred CCCCCCCCEECCCCCCCCCCCCCCCC-----CCCCCCEEECCCCEECCCCCCHH
Q ss_conf 11666555101357121357782221-----21334423211504035568202
Q 001710 561 ISGLKDLATLSLAGNQFNGPIPESFG-----SLISLESLDVSSNNISGKIPKSL 609 (1022)
Q Consensus 561 ~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~ 609 (1022)
+..+++|++|+|++|+|++.....+. +...|+.|++.+|.+.......+
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHH
T ss_conf 962998898989999698799999999997478866789898987898999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2.9e-28 Score=165.82 Aligned_cols=164 Identities=18% Similarity=0.198 Sum_probs=120.1
Q ss_pred CCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHH------------------HHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 76772201122299999975997899999011012------------------567779999999830478761048316
Q 001710 733 NECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLE------------------RAFRTFDSECEILRNVRHRNLVKIFSS 794 (1022)
Q Consensus 733 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 794 (1022)
.+.++||+|+||+||+|+..+|+.||+|+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 74177158999715899888876204877899999999999999999998239999918517999967765899589961
Q 001710 795 CCNIDFKALVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSD 874 (1022)
Q Consensus 795 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~D 874 (1022)
.. .+++|||++++...+ ++......++.|++.+++|||+ .+|+||||||+|||++++ .++++|
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~----~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH----RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH----TTEECSCCSTTSEEEETT-EEEECC
T ss_pred CC----CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHH----CCEEECCCCHHHEEEECC-CEEEEE
T ss_conf 28----889999504565420--------0157899999999999999826----888983689036114289-899987
Q ss_pred CCCCEECCCCCCCEEEECCCCCCCCCCC------CCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 1476003899974011024688643775------5568887785201675889999
Q 001710 875 FGISKLLGEGDDSVTQTITMATIGYMAP------EYGSEGIVSAKCDVYSYGVLLM 924 (1022)
Q Consensus 875 fg~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dvws~G~il~ 924 (1022)
||.|+........ .|... +. ....|+.++|+||+.--+.
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCH----------HHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 7884308998709----------9998779999999-7578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-32 Score=187.89 Aligned_cols=109 Identities=19% Similarity=0.116 Sum_probs=40.5
Q ss_pred CCCEEECCCCCCCCCCCC----CCCCCCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEECCCCCCCCCC----CCCC
Q ss_conf 135585358868888610----0112333352503575025864----20011-666555101357121357----7822
Q 001710 518 YILYVNLSSNSLSGPLPS----SIQHLKVLINLDLSRNQLSGDI----PITIS-GLKDLATLSLAGNQFNGP----IPES 584 (1022)
Q Consensus 518 ~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~----~~~~ 584 (1022)
.|+.+++++|.++..... .+...++|++|+|++|.++... +..+. ..+.|+.|+|++|.|++. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHH
T ss_conf 43333233341023344321332211011113201210135766400111220456777889897997975999999999
Q ss_pred CCCCCCCCEEECCCCEECCCCCCHHH-----HCCCCCEEECCCCCCE
Q ss_conf 21213344232115040355682022-----1135537984378150
Q 001710 585 FGSLISLESLDVSSNNISGKIPKSLE-----ALLYLKKLNVSYNRLE 626 (1022)
Q Consensus 585 ~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~l~l~~N~l~ 626 (1022)
+..+++|++|+|++|.|+......+. ....|+.+++.+|.+.
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 96299889898999969879999999999747886678989898789
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-24 Score=145.94 Aligned_cols=86 Identities=14% Similarity=0.203 Sum_probs=40.1
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCEE
Q ss_conf 87438855588546888887431244550123333247988-85555456654354344-66688840110174564523
Q 001710 76 SFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSF-PSWIGILSRLQILSFHN-NSFTDRIPDFLLNLSKLEFL 153 (1022)
Q Consensus 76 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L 153 (1022)
+.+++|+|++|.++...+..|.++++|++|++++|.+...+ +..|..+++++++++.. |.+....+..|..+++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred ECCCCCCC
Q ss_conf 12575346
Q 001710 154 DLMENSLS 161 (1022)
Q Consensus 154 ~Ls~n~l~ 161 (1022)
++++|.+.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred CCCHHHHC
T ss_conf 34211112
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=2.8e-24 Score=144.39 Aligned_cols=208 Identities=26% Similarity=0.350 Sum_probs=0.0
Q ss_pred CCCCHHCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 00011002343134467711027775109990078788963311246545765892246788987733334333452313
Q 001710 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476 (1022)
Q Consensus 397 ~~L~~l~~~~~~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 476 (1022)
+.+...++.+..+++.. .+..+.+|+.|++.+|.|.+. ..+..+++|+.|++++|.+.+..+ +..+++++.+++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCC
T ss_conf 99999984888767757--987848868997779999766--457448888376357853202543--112334320121
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 78611475654456753235130458640112699520122135585358868888610011233335250357502586
Q 001710 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD 556 (1022)
Q Consensus 477 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 556 (1022)
++|.++... .+.++++|+.+.++++... ....+...+.+..+.++.+.+....+ +...++|+.|++++|.+...
T Consensus 93 ~~n~~~~i~--~l~~l~~L~~l~l~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 93 SGNPLKNVS--AIAGLQSIKTLDLTSTQIT--DVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CSCCCSCCG--GGTTCTTCCEEECTTSCCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCC--CCCHHCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCCC
T ss_conf 112222222--2222222212212224433--11000002301222000000000000--01021110023333333310
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCHHHHCCCCCEEECCC
Q ss_conf 420011666555101357121357782221213344232115040355682022113553798437
Q 001710 557 IPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSSNNISGKIPKSLEALLYLKKLNVSY 622 (1022)
Q Consensus 557 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~ 622 (1022)
.+ |.++++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++
T Consensus 167 ~~--l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred HH--HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 01--0564633564458884177853--4479999989795996899802--03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.90 E-value=2.6e-24 Score=144.59 Aligned_cols=88 Identities=31% Similarity=0.337 Sum_probs=31.3
Q ss_pred CCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 75323513045864011269952012213558535886888861001123333525035750258642001166655510
Q 001710 491 SLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATL 570 (1022)
Q Consensus 491 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 570 (1022)
++++|+.|++++|.+....+..|..+++|++|++++|+++.+.+..|.++++|+.|+|++|+|+...+..|.++++|++|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
T ss_conf 87627213013632212121222112222101003553443497998079746552457745353597785687533420
Q ss_pred CCCCCCCC
Q ss_conf 13571213
Q 001710 571 SLAGNQFN 578 (1022)
Q Consensus 571 ~L~~N~l~ 578 (1022)
+|++|.+.
T Consensus 132 ~L~~N~~~ 139 (192)
T d1w8aa_ 132 NLASNPFN 139 (192)
T ss_dssp ECTTCCBC
T ss_pred CCCCCCCC
T ss_conf 00364434
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.90 E-value=1e-23 Score=141.39 Aligned_cols=88 Identities=30% Similarity=0.456 Sum_probs=30.8
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 34333452313786114756544567532351304586401126995201221355853588688886100112333352
Q 001710 466 CHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLIN 545 (1022)
Q Consensus 466 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 545 (1022)
..+++|+.|++++|.+....+..|..+++|++|++++|+|+...+..|.++++|+.|+|++|.|+.+.++.|..+++|++
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~ 130 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE
T ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf 78762721301363221212122211222210100355344349799807974655245774535359778568753342
Q ss_pred EECCCCCC
Q ss_conf 50357502
Q 001710 546 LDLSRNQL 553 (1022)
Q Consensus 546 L~L~~N~l 553 (1022)
|+|++|.+
T Consensus 131 l~L~~N~~ 138 (192)
T d1w8aa_ 131 LNLASNPF 138 (192)
T ss_dssp EECTTCCB
T ss_pred CCCCCCCC
T ss_conf 00036443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.8e-22 Score=134.69 Aligned_cols=186 Identities=24% Similarity=0.341 Sum_probs=0.0
Q ss_pred CCCCHHCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 00011002343134467711027775109990078788963311246545765892246788987733334333452313
Q 001710 397 ASLRKFEAIKCELKGSIPQEIGNLSGLMFLKLDDNELNGTIPTTVGRFQQLQGLSLYDNDLQGSIPYYLCHLERLSQLLL 476 (1022)
Q Consensus 397 ~~L~~l~~~~~~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 476 (1022)
.......+.+..+++.++. ..+.+|+.|++++|.+.+..+ +..+++|+.|++++|+|++..+ +..+++|+.|++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l 97 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCC
T ss_conf 9999998575765775188--795484589782798887444--7648998987698960258601--135862120143
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 78611475654456753235130458640112699520122135585358868888610011233335250357502586
Q 001710 477 NGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRNQLSGD 556 (1022)
Q Consensus 477 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 556 (1022)
++|+++ .++ .+.++++|+.|++++|.+. ....+..++.++.+++++|.++ .+..+..+++|+.+++++|++++.
T Consensus 98 ~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~--~~~~l~~l~~l~~l~~~~n~l~--~~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 98 DENKVK-DLS-SLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp CSSCCC-CGG-GGTTCTTCCEEECTTSCCC--CCGGGGGCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCCCC-CCC-CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 333321-222-1212221112234565322--1122011111222112223334--543100013321001346430256
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 420011666555101357121357782221213344232115
Q 001710 557 IPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVSS 598 (1022)
Q Consensus 557 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 598 (1022)
.+ +.++++|+.|+|++|+|+ .++ .+..+++|+.|+|++
T Consensus 172 ~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 VP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CC--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 45--367898999989799899-872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=1e-21 Score=130.59 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 39997656348888788874388555885468888874312445501233332479888555545665435434466688
Q 001710 59 LSSFSLGGIIPPHLGNLSFLVSLDISENNFYGHLPNELGKLRRLRLINFAYNELSGSFPSWIGILSRLQILSFHNNSFTD 138 (1022)
Q Consensus 59 l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 138 (1022)
+..+.+++.++. ..+..+++|++++|.++.. +.+..+++|++|++++|++++..| ++.+++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 677877885598--7946878998999999775--202137886757545655667640--1677522311112222222
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 84011017456452312575346666776445534410021243555589455488877705443362667897110277
Q 001710 139 RIPDFLLNLSKLEFLDLMENSLSGSLPNDIRLPKLEKLYLGSNDFFGQIPSSLSECTHLQTLWLADNKFSGRLPENIGNL 218 (1022)
Q Consensus 139 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l 218 (1022)
..+ +..++.|+.|++++|.+. ..+....+++|+.|++++|++... ..+..+++|++|++.+|++++..+ +.++
T Consensus 99 ~~~--l~~l~~L~~L~l~~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~~--l~~l 171 (199)
T d2omxa2 99 ITP--LANLTNLTGLTLFNNQIT-DIDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LANL 171 (199)
T ss_dssp CGG--GTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred CCC--CCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCC
T ss_conf 211--111223222111222222-321000122367764311110023--433321111112234555567701--1679
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCEE
Q ss_conf 766489731333568771332086998899
Q 001710 219 SQLTDLNLAQNNLQGDMPTAIGNLQMLEHL 248 (1022)
Q Consensus 219 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 248 (1022)
++|++|++++|++++. ..+..+++|+.|
T Consensus 172 ~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 172 TTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCEEECCCCCCCCC--CCCCCCCCCCCC
T ss_conf 9899997879979988--101278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2.4e-22 Score=133.93 Aligned_cols=12 Identities=25% Similarity=0.468 Sum_probs=4.0
Q ss_pred CCCEEECCCCCC
Q ss_conf 654354344666
Q 001710 125 RLQILSFHNNSF 136 (1022)
Q Consensus 125 ~L~~L~Ls~n~l 136 (1022)
+|++||+++|.+
T Consensus 47 ~L~~LdLs~~~i 58 (284)
T d2astb2 47 RVQHMDLSNSVI 58 (284)
T ss_dssp CCCEEECTTCEE
T ss_pred CCCEEECCCCCC
T ss_conf 788788989845
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.82 E-value=5.2e-23 Score=137.53 Aligned_cols=265 Identities=15% Similarity=0.120 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCC
Q ss_conf 69953222120230024345456789999842110013466776567634588865358521332100011002343134
Q 001710 331 HIPHTFGNLRFLRFLNLMFNSLTTESSPADQWSFLSSLTNCRSLTELALNVNPLRGILPPFIGNFSASLRKFEAIKCELK 410 (1022)
Q Consensus 331 ~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~~~~~~~~ 410 (1022)
.+...+....+|+.|++++|.+....... ....+..+++|+.++++++..............
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~----l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-------------- 83 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARW----LSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-------------- 83 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHH----HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH--------------
T ss_pred HHHHHHHHCCCCCEEECCCCCCCHHHHHH----HHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHH--------------
T ss_conf 99999963899788978498377899999----999998589988888877754334542106787--------------
Q ss_pred CCCCCCCCCCCCCEEEEEECCCCCCC----CCCCCCCCCCCCEEEEECCCCCCCCCCCC-------------CCCCCCCE
Q ss_conf 46771102777510999007878896----33112465457658922467889877333-------------34333452
Q 001710 411 GSIPQEIGNLSGLMFLKLDDNELNGT----IPTTVGRFQQLQGLSLYDNDLQGSIPYYL-------------CHLERLSQ 473 (1022)
Q Consensus 411 ~~~p~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-------------~~l~~L~~ 473 (1022)
.+...+...++|+.|++++|.+... +...+...++|+.|++++|.+.......+ ...+.|+.
T Consensus 84 -~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~ 162 (344)
T d2ca6a1 84 -LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 162 (344)
T ss_dssp -HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred -HHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf -9998875477756330000134554333101110023432100000246666543111121222211000146764211
Q ss_pred EECCCCCCC----CCCCCCCCCCCCCCEEECCCCEECCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCC
Q ss_conf 313786114----75654456753235130458640112-----699520122135585358868888----61001123
Q 001710 474 LLLNGNNLS----GAIPACLGSLTSLRELHLGSNTLTYS-----IPSSLWSLEYILYVNLSSNSLSGP----LPSSIQHL 540 (1022)
Q Consensus 474 L~l~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l 540 (1022)
+.+++|.+. ..+...+...+.|++|++++|++... ....+...++|+.|++++|.++.. +...+...
T Consensus 163 l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~ 242 (344)
T d2ca6a1 163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242 (344)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 10136501355433221111233321335433322222223200243321101211222333322222222344433232
Q ss_pred CCCCEEECCCCCCCCCCCCCC------CCCCCCCEECCCCCCCCCCCCCCCC-----CCCCCCEEECCCCEECCCCCCHH
Q ss_conf 333525035750258642001------1666555101357121357782221-----21334423211504035568202
Q 001710 541 KVLINLDLSRNQLSGDIPITI------SGLKDLATLSLAGNQFNGPIPESFG-----SLISLESLDVSSNNISGKIPKSL 609 (1022)
Q Consensus 541 ~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~ 609 (1022)
++|+.|+|++|.|+......+ .....|+.|++++|.|+......+. ++++|+.|++++|++. .....+
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~-~~~~~~ 321 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS-EEDDVV 321 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC-TTSHHH
T ss_pred CCCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC-CCCHHH
T ss_conf 2111103004756715667888776315688889898989869808999999999703899998978798089-862599
Q ss_pred HHCCCC
Q ss_conf 211355
Q 001710 610 EALLYL 615 (1022)
Q Consensus 610 ~~l~~L 615 (1022)
..+..+
T Consensus 322 ~~l~~~ 327 (344)
T d2ca6a1 322 DEIREV 327 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2.8e-18 Score=112.03 Aligned_cols=130 Identities=18% Similarity=0.123 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 73333433345231378611475654456753235130458640112699520122135585358868888610011233
Q 001710 462 PYYLCHLERLSQLLLNGNNLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLK 541 (1022)
Q Consensus 462 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 541 (1022)
...|.+..+++.|++++|+|+ .++..+..+++|+.|++++|+|+.. +.+..+++|+.|++++|.++...+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf 33525035750258642-0011666555101357121357782----221213344232
Q 001710 542 VLINLDLSRNQLSGDIP-ITISGLKDLATLSLAGNQFNGPIPE----SFGSLISLESLD 595 (1022)
Q Consensus 542 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ 595 (1022)
+|+.|++++|+|+.... ..+..+++|+.|++++|+++ ..+. .+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 34434203000166542110013653206640799634-56106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=1.2e-16 Score=103.28 Aligned_cols=10 Identities=30% Similarity=0.408 Sum_probs=3.1
Q ss_pred CCCEEECCCC
Q ss_conf 3442321150
Q 001710 590 SLESLDVSSN 599 (1022)
Q Consensus 590 ~L~~L~L~~N 599 (1022)
+|+.|++++|
T Consensus 91 ~L~~L~l~~N 100 (124)
T d1dcea3 91 RLVLLNLQGN 100 (124)
T ss_dssp TCCEEECTTS
T ss_pred CCCEEECCCC
T ss_conf 9999989799
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.66 E-value=2e-18 Score=112.79 Aligned_cols=147 Identities=23% Similarity=0.282 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCC--CCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 4333452313786--11475654456753235130458640112699520122135585358868888610011233335
Q 001710 467 HLERLSQLLLNGN--NLSGAIPACLGSLTSLRELHLGSNTLTYSIPSSLWSLEYILYVNLSSNSLSGPLPSSIQHLKVLI 544 (1022)
Q Consensus 467 ~l~~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 544 (1022)
....++.+++..+ .+. ..+..+..+++|++|+|++|+|+.. ..+..+++|+.|++++|.++ .++..+...++|+
T Consensus 21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 545331002555568520-0246776260461519944689986--44247825357341353432-1000033221233
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCC-CCCCCCCCCCEEECCCCEECCCCCCH----------HHHCC
Q ss_conf 25035750258642001166655510135712135778-22212133442321150403556820----------22113
Q 001710 545 NLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIP-ESFGSLISLESLDVSSNNISGKIPKS----------LEALL 613 (1022)
Q Consensus 545 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~ 613 (1022)
.|++++|+++ .++. +..+++|+.|++++|+|+.... ..+..+++|+.|++++|.+....+.. +..+|
T Consensus 97 ~L~l~~N~i~-~l~~-~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp 174 (198)
T d1m9la_ 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEECSEEECC-CHHH-HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred CCCCCCCCCC-CCCC-CCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 3333332222-2222-2222234111234102125542212367776302342798434676322220558999998788
Q ss_pred CCCEEE
Q ss_conf 553798
Q 001710 614 YLKKLN 619 (1022)
Q Consensus 614 ~L~~l~ 619 (1022)
+|+.||
T Consensus 175 ~L~~LD 180 (198)
T d1m9la_ 175 NLKKLD 180 (198)
T ss_dssp SCCEES
T ss_pred CCCEEC
T ss_conf 958769
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.7e-16 Score=100.06 Aligned_cols=110 Identities=18% Similarity=0.164 Sum_probs=63.9
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 355853588688886100112333352503575-0258642001166655510135712135778222121334423211
Q 001710 519 ILYVNLSSNSLSGPLPSSIQHLKVLINLDLSRN-QLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSLISLESLDVS 597 (1022)
Q Consensus 519 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 597 (1022)
...++.+++.+.. .|..+..+++|+.|++++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCEEEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECC
T ss_conf 9969852899765-860025765657431689866443692122566666721620212477420111245543333226
Q ss_pred CCEECCCCCCHHHHCCCCCEEECCCCCCEEECC
Q ss_conf 504035568202211355379843781501069
Q 001710 598 SNNISGKIPKSLEALLYLKKLNVSYNRLEGEIP 630 (1022)
Q Consensus 598 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 630 (1022)
+|+|+...+..+.. ..++.|++++|+|.|.+.
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGG
T ss_pred CCCCCCCCHHHHCC-CCCCCCCCCCCCCCCCCH
T ss_conf 78785157456335-321243357986338811
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=6.8e-16 Score=99.20 Aligned_cols=92 Identities=20% Similarity=0.143 Sum_probs=38.9
Q ss_pred CCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCC
Q ss_conf 995201221355853588-6888861001123333525035750258642001166655510135712135778222121
Q 001710 510 PSSLWSLEYILYVNLSSN-SLSGPLPSSIQHLKVLINLDLSRNQLSGDIPITISGLKDLATLSLAGNQFNGPIPESFGSL 588 (1022)
Q Consensus 510 ~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 588 (1022)
|..+..+++|+.|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+..|.++++|+.|+|++|+|+...+..|..
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~- 102 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG- 102 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCC-
T ss_conf 6002576565743168986644369212256666672162021247742011124554333322678785157456335-
Q ss_pred CCCCEEECCCCEEC
Q ss_conf 33442321150403
Q 001710 589 ISLESLDVSSNNIS 602 (1022)
Q Consensus 589 ~~L~~L~L~~N~l~ 602 (1022)
.+|+.|+|++|.+.
T Consensus 103 ~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 103 LSLQELVLSGNPLH 116 (156)
T ss_dssp CCCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 32124335798633
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.29 E-value=3.5e-11 Score=73.83 Aligned_cols=150 Identities=13% Similarity=0.094 Sum_probs=104.7
Q ss_pred HHHHHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCEEE
Q ss_conf 8998415987677220112229999997599789999901101256777999999983047-876104831674177158
Q 001710 724 DIQRATDGFNECNLLGRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKA 802 (1022)
Q Consensus 724 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 802 (1022)
++....+.|+..+..+.++.+.||+.. .++..+.+|+...........+.+|...++.+. +--+.+++.++...+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEE-ECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 999751352799767899877189999-0898699998488765325569999999998760699872899975089649
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q ss_conf 999715899888876204877899999999999999999998239-----------------------------------
Q 001710 803 LVLEFMPNGSFEKWLYSYNYFLDILQRLNIMIDVALVLEYLHHGH----------------------------------- 847 (1022)
Q Consensus 803 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 847 (1022)
+||++++|.++.+...... ....++.+++..++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEECCCCCCCCCCCCCC------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9998604334354334402------6999999899999998556842143576446565557789987765555430332
Q ss_pred --------------------CCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf --------------------999918517999967765899589961147600
Q 001710 848 --------------------SLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 848 --------------------~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~ 880 (1022)
....++|+|+.+.||++++++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=5.7e-12 Score=78.04 Aligned_cols=15 Identities=33% Similarity=0.629 Sum_probs=4.9
Q ss_pred CCCCCEECCCCCCCC
Q ss_conf 665551013571213
Q 001710 564 LKDLATLSLAGNQFN 578 (1022)
Q Consensus 564 l~~L~~L~L~~N~l~ 578 (1022)
+++|+.|+|++|.|+
T Consensus 90 l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 90 APNLKILNLSGNELK 104 (162)
T ss_dssp STTCCCCCCTTSCCC
T ss_pred CCCCCCCCCCCCCCC
T ss_conf 885610004357213
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.84 E-value=1.4e-08 Score=59.82 Aligned_cols=133 Identities=14% Similarity=0.053 Sum_probs=86.6
Q ss_pred CEEECCCC-EEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCEEEEEEECCCCCC
Q ss_conf 72201122-299999975997899999011012567779999999830478--761048316741771589997158998
Q 001710 736 NLLGRGSF-GLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH--RNLVKIFSSCCNIDFKALVLEFMPNGS 812 (1022)
Q Consensus 736 ~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~ 812 (1022)
+.+..|.. +.||+....++..+.+|...... ...+..|+..++.+.. -.+.++++++.+.+..++||++++|.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 87678654775899993898789999589667---768999999999998659998861322245661599987441355
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 888762048778999999999999999999982-----------------------------------------------
Q 001710 813 FEKWLYSYNYFLDILQRLNIMIDVALVLEYLHH----------------------------------------------- 845 (1022)
Q Consensus 813 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----------------------------------------------- 845 (1022)
+.+.. ... ...+.++...++.||.
T Consensus 93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCCCC------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 43221------268---999999999999873688544887554124688999999875411011340112137999999
Q ss_pred ----CC---CCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf ----39---999918517999967765899589961147600
Q 001710 846 ----GH---SLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 846 ----~~---~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~ 880 (1022)
.. ....++|+|+.+.||+++++..+.++||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.57 E-value=4.4e-07 Score=51.72 Aligned_cols=77 Identities=17% Similarity=0.206 Sum_probs=50.1
Q ss_pred CCEEECCCCEEEEEEEEC-CCCEEEEEEECCHHH-------HHHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCEEEE
Q ss_conf 772201122299999975-997899999011012-------56777999999983047-8--761048316741771589
Q 001710 735 CNLLGRGSFGLVYKGTLF-DGTNVAIKVFNLQLE-------RAFRTFDSECEILRNVR-H--RNLVKIFSSCCNIDFKAL 803 (1022)
Q Consensus 735 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~l 803 (1022)
.+.+|.|....||++... +++.+.+|....... ....+...|.+.++.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH
Q ss_conf 9971589988
Q 001710 804 VLEFMPNGSF 813 (1022)
Q Consensus 804 v~e~~~~g~L 813 (1022)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.29 E-value=4e-06 Score=46.55 Aligned_cols=158 Identities=9% Similarity=-0.033 Sum_probs=85.2
Q ss_pred CHHHHHHHHHCCCCCCCEE-----ECCCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCC-----CCCE
Q ss_conf 3188899841598767722-----01122299999975997899999011012567779999999830478-----7610
Q 001710 720 TSYLDIQRATDGFNECNLL-----GRGSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRH-----RNLV 789 (1022)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv 789 (1022)
.+..+++....+|...+.. ..|.--+.|+.+..+| .+++|++..... ...+..|...+..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-289998078999--8899999999875430255545564
Q ss_pred EEE-E--EEEECCEEEEEEECCCCCCHHHH--------------HHHC----C----C------------------CCCH
Q ss_conf 483-1--67417715899971589988887--------------6204----8----7------------------7899
Q 001710 790 KIF-S--SCCNIDFKALVLEFMPNGSFEKW--------------LYSY----N----Y------------------FLDI 826 (1022)
Q Consensus 790 ~~~-~--~~~~~~~~~lv~e~~~~g~L~~~--------------l~~~----~----~------------------~~~~ 826 (1022)
... | ..........++.+..+...... ++.. . . ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 999999999999999998239999918517999967765899589961147600
Q 001710 827 LQRLNIMIDVALVLEYLHHGHSLAPIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 827 ~~~~~i~~~i~~~l~~LH~~~~~~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~ 880 (1022)
......+......+..........|++|+|+.+.||+++.+...-+.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.29 E-value=7.1e-06 Score=45.20 Aligned_cols=137 Identities=11% Similarity=0.037 Sum_probs=76.6
Q ss_pred CCCEEEEEEEECCCCEEEEEEECCHHHHHHHHHHHHHHHHHHCCCCCCE--EEE-----EEEEECCEEEEEEECCCCCCH
Q ss_conf 1222999999759978999990110125677799999998304787610--483-----167417715899971589988
Q 001710 741 GSFGLVYKGTLFDGTNVAIKVFNLQLERAFRTFDSECEILRNVRHRNLV--KIF-----SSCCNIDFKALVLEFMPNGSF 813 (1022)
Q Consensus 741 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv--~~~-----~~~~~~~~~~lv~e~~~~g~L 813 (1022)
+.--.||+++..+|..|++|+.+... ...+.+..|...+..|....+. ... ......+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 61202699983899979999847877-88999999999999998559987875206898056653479999865277688
Q ss_pred H-----HHH---------HH----CC----CCCCH-------------------HHHHHHHHHHHHHHHHHHH---CCCC
Q ss_conf 8-----876---------20----48----77899-------------------9999999999999999982---3999
Q 001710 814 E-----KWL---------YS----YN----YFLDI-------------------LQRLNIMIDVALVLEYLHH---GHSL 849 (1022)
Q Consensus 814 ~-----~~l---------~~----~~----~~~~~-------------------~~~~~i~~~i~~~l~~LH~---~~~~ 849 (1022)
. .+. +. .. ...++ .....+...+...++.+.. ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 9918517999967765899589961147600
Q 001710 850 APIVHCDLKPNNILLDENMTAHVSDFGISKL 880 (1022)
Q Consensus 850 ~~ivH~Dik~~NIll~~~~~~kl~Dfg~a~~ 880 (1022)
.+++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.25 E-value=1.2e-07 Score=54.83 Aligned_cols=111 Identities=14% Similarity=0.104 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CEECCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCC----C
Q ss_conf 6753235130458-640112----6995201221355853588688----8861001123333525035750258----6
Q 001710 490 GSLTSLRELHLGS-NTLTYS----IPSSLWSLEYILYVNLSSNSLS----GPLPSSIQHLKVLINLDLSRNQLSG----D 556 (1022)
Q Consensus 490 ~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~----~ 556 (1022)
.+.++|++|+|++ +.++.. +...+...+.|+.|++++|.++ ..+...+...+.|+.|+|++|.|+. .
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCC-------CCCCCCCCCCCCEEECCCCE
Q ss_conf 420011666555101357121357-------78222121334423211504
Q 001710 557 IPITISGLKDLATLSLAGNQFNGP-------IPESFGSLISLESLDVSSNN 600 (1022)
Q Consensus 557 ~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~ 600 (1022)
+...+...+.|+.|++++|.+... +...+...++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.19 E-value=3.3e-06 Score=47.00 Aligned_cols=73 Identities=14% Similarity=0.202 Sum_probs=49.2
Q ss_pred CCEEECCCCEEEEEEEECC--------CCEEEEEEECCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCEEEEEE
Q ss_conf 7722011222999999759--------9789999901101256777999999983047-876104831674177158999
Q 001710 735 CNLLGRGSFGLVYKGTLFD--------GTNVAIKVFNLQLERAFRTFDSECEILRNVR-HRNLVKIFSSCCNIDFKALVL 805 (1022)
Q Consensus 735 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 805 (1022)
++.++.|-.-.+|++...+ ...|.+++... .. ......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CC-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 99917853343489996887754457898179996599-61-165899999999999757999808998189----5699
Q ss_pred ECCCCCCH
Q ss_conf 71589988
Q 001710 806 EFMPNGSF 813 (1022)
Q Consensus 806 e~~~~g~L 813 (1022)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEECCCCC
T ss_conf 97345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.71 E-value=7.2e-07 Score=50.54 Aligned_cols=121 Identities=11% Similarity=0.153 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCEEECCC-CEECCCCCCCCC----CCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCC
Q ss_conf 11475654456753235130458-640112699520----12213558535886888----8610011233335250357
Q 001710 480 NLSGAIPACLGSLTSLRELHLGS-NTLTYSIPSSLW----SLEYILYVNLSSNSLSG----PLPSSIQHLKVLINLDLSR 550 (1022)
Q Consensus 480 ~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~----~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~ 550 (1022)
.+...+.....+.++|++|++++ +.++......+. ..+.|+.|++++|.++. .+...+...+.++.+++++
T Consensus 4 ~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~ 83 (166)
T d1io0a_ 4 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES 83 (166)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred CHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCC
T ss_conf 39999999995599986887689999898999999988841982574301589611778999998775212210121025
Q ss_pred CCCCC----CCCCCCCCCCCCCE--ECCCCCCCCC----CCCCCCCCCCCCCEEECCCCE
Q ss_conf 50258----64200116665551--0135712135----778222121334423211504
Q 001710 551 NQLSG----DIPITISGLKDLAT--LSLAGNQFNG----PIPESFGSLISLESLDVSSNN 600 (1022)
Q Consensus 551 N~l~~----~~~~~~~~l~~L~~--L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~ 600 (1022)
|.+.. .+...+...++|+. |++++|.+.. .+...+...+.|+.|+++.+.
T Consensus 84 ~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 84 NFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp SCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred CCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 432201478899999848652477321677867679999999999849984788581898
|